CellID,Hoechst_1,CD4,FOXP3,PD-L1,Vimentin,Hoechst_2,IBA1,SOX2,PD-1,Hoechst_3,CD163,PAN-CK,gH2AX,Hoechst_4,TIM3,CD11c,CD8a,Hoechst_5,E-cadherin,CD66b,CD20,Hoechst_6,Ki67,p-S6,CD31,Hoechst_7,CD45RO,HLA-DBP1,NKG2A,CD45,Area,MajorAxisLength,MinorAxisLength,Eccentricity,Solidity,Extent,Orientation,X_centroid,Y_centroid,Sample,Condition,Replicate,phenotype,Delete,tim3,pd_l1,pd_1,p_s6,ki67,imageid,gh2ax,FinalPhenotype,GlobalCellType,Group,Batch,Tumor type,Same patient,Year,Tumor site,Tumor stage,Age at tumor,FA gene,Smoking,Gender,BMT,VPH status,Patient status,RCN,unique_cellid,Desmoplastic grade,Desmoplastic category,TDA,TDA_general
48,1989.10911424904,583.292682926829,920.234916559692,662.824133504493,3357.05263157895,1683.48010269576,405.286264441592,262.878048780488,1092.42105263158,2143.03722721438,553.487804878049,116.473684210526,1069.53915275995,1880.8973042362,556.057766367137,301.822849807445,1802.10783055199,2384.43132220796,332.410783055199,250.034659820282,1023.82926829268,2239.00770218228,235.925545571245,350.519897304236,1502.52888318357,732.480102695764,455.463414634146,218.069319640565,1001.25930680359,128.473684210526,779,32.5922047065124,30.5662232301654,0.34707205840437,0.972534332084894,0.811458333333333,-1.14568574508054,52062.5057766367,34662.2605905006,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_48,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
296,1205.77129337539,252.909305993691,116.468454258675,637.301261829653,1863.53391167192,1482.18533123028,2804.32886435331,260.590694006309,1087.42823343849,1892.07807570978,1450.27917981073,144.493690851735,1065.06309148265,601.169558359621,437.761041009464,270.743690851735,1405.36277602524,939.397476340694,296.514195583596,232.117507886435,990.197160883281,885.315457413249,210.587539432177,123.857255520505,581.932965299684,802.842271293375,461.3738170347,249.910883280757,1022.79810725552,131.274447949527,1268,41.8488367312049,38.5984094280113,0.386404725793492,0.973138910207214,0.737209302325581,0.259724853776104,50488.9463722397,34180.1096214511,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_296,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
321,2102.43930635838,456.920520231214,103.234104046243,631.953757225433,1405.70086705202,2643.16907514451,3297.14161849711,260.03323699422,1097.31213872832,4054.81647398844,1848.64884393064,113.89161849711,1075.28179190751,583.446531791908,431.68063583815,315.174855491329,1496.47398843931,865.255780346821,248.401734104046,225.900289017341,994.300578034682,806.741329479769,178.81936416185,163.018786127168,596.955202312139,1599.26156069364,543.790462427746,355.342485549133,1078.5274566474,131.514450867052,692,32.8587356493185,26.9991685119323,0.569957761528299,0.974647887323944,0.800925925925926,1.3747002038742,51268.9956647399,34349.3395953757,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
421,1672.20414847162,313.390829694323,102.243449781659,632.652838427948,1784.6135371179,1907.78711790393,2065.00109170306,251.920305676856,1090.95742358079,2499.08406113537,779.637554585153,111.343886462882,1067.53602620087,721.743449781659,662.794759825328,743.217248908297,2641.58187772926,987.684497816594,280.926855895197,228.436681222707,1017.76965065502,933.42903930131,193.564410480349,171.745633187773,647.11135371179,925.123362445415,478.094978165939,608.946506550218,1034.98471615721,131.890829694323,916,35.5903645074549,32.8351196784248,0.385795006093461,0.968287526427061,0.793073593073593,-0.387235739887731,51200.8558951965,34209.1812227074,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_421,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
3044,1714.43726708075,1246.79751552795,116.662111801242,633.047204968944,1526.25465838509,1979.37267080745,368.898136645963,257.87701863354,1085.78633540373,2421.38633540373,502.344099378882,108.704347826087,1070.55900621118,1119.24720496894,783.891925465839,287.160248447205,1794.4347826087,2017.3701863354,330.874534161491,236.862111801242,1098.78881987578,1980.53788819876,290.511801242236,156.530434782609,2570.86708074534,734.140372670807,388.780124223602,205.730434782609,1006.68198757764,130.086956521739,805,36.5839733328936,28.0731740559291,0.641213374331745,0.966386554621849,0.777027027027027,1.45331722415122,50120.2136645963,35116.1180124224,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_3044,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
3526,1344.99417475728,342.957281553398,100.895145631068,619.658252427184,953.271844660194,1763.10097087379,1915.38058252427,255.968932038835,1083.86019417476,2759.80582524272,738.009708737864,107.611650485437,1067.78446601942,1754.11650485437,873.440776699029,562.128155339806,1521.48737864078,1840.95533980582,352.446601941748,243.106796116505,995.803883495146,1557.87766990291,238.730097087379,185.699029126214,663.976699029126,857.654368932039,461.553398058252,216.316504854369,1011.69902912621,130.122330097087,515,26.4100359154051,24.8884468692574,0.334527600173049,0.964419475655431,0.733618233618234,-0.762580680208707,51318.0097087379,34653.1786407767,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_3526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
3754,1952.21970705726,277.411451398136,92.5805592543276,617.054593874834,865.87483355526,2291.58854860186,1168.09454061252,268.541944074567,1088.93741677763,2851.52197070573,885.342210386152,120.597869507324,1069.77496671105,696.035952063915,576.431424766977,276.637816245007,1516.76431424767,1119.18774966711,348.119840213049,245.043941411451,989.392809587217,1084.24900133156,232.229027962716,138.894806924101,586.260985352863,971.015978695073,509.981358189081,254.8655126498,1024.45672436751,130.884154460719,751,32.4934221670427,29.5066329990121,0.418796331405302,0.971539456662354,0.80752688172043,0.824018922592363,50980.7842876165,34305.5432756325,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_3754,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
4130,5454.86440677966,960.796610169492,1030.10169491525,617.694915254237,324.796610169492,4658.57062146893,1288.72316384181,274.0,1105.75706214689,8902.8418079096,788.672316384181,123.672316384181,1083.32203389831,643.531073446328,422.35593220339,274.638418079096,1428.46892655367,991.576271186441,280.293785310734,231.598870056497,981.497175141243,943.282485875706,223.949152542373,152.768361581921,583.949152542373,3089.68926553672,581.915254237288,317.54802259887,1045.66666666667,131.129943502825,177,17.13730897872,13.2600070391959,0.633490058099878,0.977900552486188,0.790178571428571,-0.474303750906756,51223.7514124294,35424.9830508475,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_4130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
4553,1439.09309309309,492.285285285285,944.966966966967,631.232732732733,1477.84084084084,1573.17567567568,344.767267267267,254.223723723724,1100.8993993994,2205.70870870871,715.081081081081,113.276276276276,1070.41591591592,932.983483483484,635.647147147147,304.442942942943,1490.31381381381,1552.0960960961,384.243243243243,248.779279279279,996.463963963964,977.753753753754,233.608108108108,143.836336336336,585.795795795796,727.648648648649,413.081081081081,211.660660660661,1011.24924924925,130.339339339339,666,31.6941752421877,26.7683077676663,0.535427329897878,0.963820549927641,0.770833333333333,-0.158604393048477,50641.0660660661,35133.6246246246,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_4553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
4629,1571.33333333333,368.032305433186,127.245227606461,650.279001468429,2329.39500734214,1513.43024963289,2287.29368575624,261.814977973568,1095.1483113069,2363.43024963289,2998.83700440529,137.599118942731,1076.40822320117,557.209985315712,424.770925110132,304.358296622614,1408.62848751836,923.588839941263,274.007342143906,233.75624082232,993.930983847283,928.806167400881,311.810572687225,141.743024963289,585.346549192364,613.888399412628,372.888399412628,215.004405286344,990.01174743025,129.419970631424,681,32.8308823352195,26.4402116707207,0.592805379022771,0.972857142857143,0.760044642857143,-0.42690356760647,50605.3142437592,35172.3142437592,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_4629,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
5000,2065.01823708207,124.699088145897,66.8449848024316,667.996960486322,1225.77507598784,2372.58662613982,446.759878419453,261.203647416413,1130.43161094225,4565.73252279635,497.094224924012,107.70820668693,1070.13373860182,2282.273556231,832.811550151976,371.127659574468,2265.22796352584,4677.93313069909,428.227963525836,245.753799392097,1072.65045592705,4393.31003039514,272.367781155015,299.440729483283,2624.29787234043,2276.12462006079,507.756838905775,295.516717325228,1038.8905775076,130.148936170213,329,26.7920002200262,15.6534180354055,0.811568584697694,0.950867052023121,0.761574074074074,1.55497889781693,51250.0364741641,35254.0212765957,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_5000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
5415,1933.72877846791,777.060041407868,102.590062111801,607.333333333333,436.913043478261,2413.26086956522,398.658385093168,264.215320910973,1086.31884057971,4270.0248447205,558.567287784679,115.509316770186,1070.80952380952,990.643892339544,557.329192546584,277.571428571429,1911.93995859213,1842.3933747412,326.792960662526,243.062111801242,1047.39751552795,1734.14906832298,211.308488612836,208.834368530021,1124.77225672878,1971.10351966874,561.527950310559,231.277432712215,1022.0,130.741200828157,483,27.9024764048379,22.1724642441323,0.60707904726876,0.956435643564356,0.75,1.30852767501516,51147.9233954451,34434.8633540373,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_5415,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
5550,2419.88482632541,789.457038391225,134.831809872029,657.828153564899,2076.25959780622,2500.54844606947,447.234003656307,266.319926873857,1133.01096892139,4222.03839122486,516.464351005484,111.047531992687,1080.20475319927,2707.46983546618,868.281535648994,389.828153564899,2212.49908592322,2665.45155393053,375.025594149909,245.937842778793,1026.37659963437,2113.91407678245,251.261425959781,282.084095063985,992.184643510055,1355.21755027422,452.63802559415,305.414990859232,1048.14990859232,129.842778793419,547,29.366061891762,23.7386723726626,0.588673382148139,0.975044563279857,0.75448275862069,-0.474184391355955,51174.2614259598,35489.6526508227,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_5550,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
5642,1862.47533632287,343.076233183857,93.5276532137519,613.303437967115,455.497757847534,2353.16143497758,1353.56651718984,256.364723467862,1086.24215246637,4206.97907324365,882.617339312407,109.748878923767,1065.0269058296,603.194319880419,424.766816143498,266.560538116592,1427.19730941704,963.119581464873,286.572496263079,233.437967115097,995.702541106129,911.59043348281,200.267563527653,128.569506726457,593.696562032885,1898.03437967115,519.357249626308,294.677130044843,1043.77130044843,130.396113602392,669,31.8325571698947,26.7903539269833,0.540097710621586,0.975218658892128,0.804086538461538,1.48202220997699,51241.8774289985,34625.2735426009,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_5642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
6337,4834.49042145594,1200.03831417625,461.145593869732,641.486590038314,1694.51724137931,5139.97701149425,631.130268199234,267.417624521073,1151.90804597701,9443.26436781609,945.704980842912,132.463601532567,1072.20689655172,1834.56704980843,536.911877394636,305.145593869732,1505.31034482759,1569.72413793103,339.375478927203,238.030651340996,1016.83908045977,1091.80842911877,218.578544061303,139.32183908046,626.429118773946,4223.57088122605,645.743295019157,360.23754789272,1103.74329501916,130.32183908046,261,20.2341176043822,16.4797984926617,0.58022532145374,0.96309963099631,0.767647058823529,1.27951870553615,51028.5095785441,33874.1992337165,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_6337,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
6439,3108.05743243243,565.297297297297,75.8445945945946,660.222972972973,2169.96959459459,2848.68581081081,1536.84459459459,262.807432432432,1118.73986486486,4668.32094594595,525.314189189189,136.023648648649,1077.24324324324,5117.69256756757,917.233108108108,380.195945945946,2070.17905405405,2005.63851351351,310.581081081081,231.195945945946,1015.60472972973,1685.81418918919,230.824324324324,250.493243243243,597.699324324324,1265.21621621622,454.949324324324,964.412162162162,1054.46959459459,130.807432432432,296,21.4784258568011,17.6318391430694,0.571058623215482,0.951768488745981,0.778947368421053,-0.984222724043198,50992.027027027,35867.0,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_6439,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
6651,2599.93595041322,273.006198347107,103.072314049587,654.853305785124,2415.14256198347,3143.88223140496,1286.37809917355,262.688016528926,1096.62396694215,4999.55165289256,3617.61363636364,120.464876033058,1074.52066115702,2304.19421487603,907.303719008264,1905.14256198347,1682.55785123967,1679.98347107438,303.318181818182,232.75,1003.42561983471,1293.22520661157,221.051652892562,207.985537190083,660.502066115703,1954.78925619835,542.667355371901,380.49173553719,1092.8347107438,130.886363636364,484,26.7717516233729,23.0455973321019,0.508913458542953,0.966067864271457,0.775641025641026,-0.535127859725383,51193.6363636364,34534.305785124,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_6651,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
7353,2392.40936863544,406.201629327902,186.812627291242,667.700610997963,2952.07942973523,2894.48676171079,340.720977596741,264.873727087576,1093.99592668024,4218.68228105906,630.845213849287,122.099796334012,1073.75967413442,721.949083503055,571.849287169043,277.12016293279,1445.7617107943,1145.82281059063,328.046843177189,239.716904276986,987.680244399185,1048.36456211813,231.097759674134,128.993890020367,583.900203665988,1984.30753564155,533.022403258656,224.344195519348,1058.64969450102,130.150712830957,491,28.7567036074399,21.8625924700868,0.649618059158348,0.972277227722772,0.769592476489028,1.53903466150686,50276.0610997963,34172.2362525458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_7353,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
7387,1356.56796116505,227.757281553398,148.356796116505,671.359223300971,4164.07038834951,1580.8932038835,780.444174757282,251.910194174757,1083.88106796116,2571.70873786408,1090.3640776699,108.604368932039,1089.95631067961,664.531553398058,500.934466019418,268.966019417476,1459.91990291262,1077.46116504854,319.788834951456,239.026699029126,977.847087378641,1001.33737864078,222.053398058252,133.944174757282,584.793689320388,1044.98300970874,481.354368932039,322.640776699029,1029.10194174757,131.087378640777,412,24.1988800240756,21.6996249065761,0.442597848357767,0.978622327790974,0.814229249011858,0.67894868741632,51398.6917475728,34635.8155339806,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_7387,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
8382,4071.26197183099,1256.57464788732,130.16338028169,642.380281690141,1756.02535211268,4201.45352112676,1126.98309859155,280.684507042254,1122.69577464789,6137.88732394366,685.521126760563,119.785915492958,1070.25915492958,3797.59718309859,1127.59154929577,504.8,2045.52957746479,3945.79154929577,395.152112676056,244.659154929577,1066.12394366197,3599.25915492958,255.957746478873,386.183098591549,684.045070422535,1815.87323943662,487.518309859155,573.997183098592,1061.72394366197,131.281690140845,355,26.8790694740976,16.85303371541,0.779023532487788,0.954301075268817,0.758547008547009,-1.35748243644815,50859.585915493,35558.8788732394,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_8382,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
8438,1936.3961352657,931.78421900161,115.225442834138,618.236714975845,1065.35104669887,2209.71497584541,394.12077294686,259.449275362319,1098.10305958132,2608.8421900161,584.595813204509,116.58615136876,1068.96779388084,598.49114331723,413.552334943639,278.115942028986,1463.35909822866,969.752012882448,298.119162640902,234.003220611916,984.524959742351,950.285024154589,211.911433172303,134.921095008052,584.175523349436,934.961352657005,512.888888888889,238.648953301127,1022.14653784219,130.447665056361,621,30.4525480378596,25.9666620763338,0.522413003245977,0.973354231974922,0.770471464019851,-1.31924905147802,51058.4653784219,34279.5330112721,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_8438,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
8648,2998.95454545455,482.196022727273,248.377840909091,707.640625,5507.06534090909,3800.76278409091,1770.18181818182,274.507102272727,1097.70454545455,5595.62073863636,1015.265625,127.748579545455,1076.609375,658.004261363636,517.143465909091,272.967329545455,1545.265625,1042.08380681818,322.555397727273,237.400568181818,990.642045454546,1026.02982954545,222.606534090909,137.363636363636,585.610795454545,1793.046875,536.916193181818,275.46875,1072.16903409091,131.278409090909,704,32.9733036601632,27.6485208872602,0.544882659616475,0.97913769123783,0.846153846153846,0.2293014561945,51012.7840909091,34306.4133522727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_8648,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
9853,2989.14730878187,610.359773371105,108.195467422096,644.651558073654,2638.31728045326,3364.66288951841,632.235127478753,253.169971671388,1167.49008498584,5980.50991501416,585.181303116147,113.130311614731,1069.65439093484,871.963172804533,566.558073654391,285.960339943343,1507.57223796034,1224.4730878187,343.915014164306,243.818696883853,988.008498583569,1077.69971671388,231.8611898017,137.025495750708,581.339943342776,1903.07365439093,456.623229461756,233.784702549575,1013.85269121813,127.130311614731,353,23.9269220112912,18.7814686705124,0.61955746135303,0.96978021978022,0.774122807017544,1.24506900450101,51767.6062322946,34524.0566572238,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_9853,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
9960,3411.03015075377,853.474874371859,1029.0175879397,631.942211055276,1615.19849246231,3398.57788944724,541.532663316583,272.891959798995,1108.43216080402,5959.85929648241,546.937185929648,113.997487437186,1076.13316582915,5025.64824120603,831.442211055276,479.537688442211,2007.91708542714,5536.93467336683,407.321608040201,245.678391959799,1038.26381909548,4623.21859296482,249.575376884422,541.185929648241,689.78391959799,1421.32663316583,460.505025125628,246.223618090452,1031.39698492462,130.904522613065,398,23.8923562393693,21.3796056386644,0.446406355277953,0.961352657004831,0.786561264822134,-0.774774257356107,50868.7864321608,35426.1231155779,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_9960,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
10740,1792.27692307692,176.402197802198,160.248351648352,772.164835164835,3718.16043956044,2335.9956043956,501.705494505495,256.158241758242,1244.76043956044,4152.07032967033,624.367032967033,116.340659340659,1082.16703296703,900.795604395604,463.832967032967,271.336263736264,1698.31208791209,1271.9010989011,262.602197802198,224.894505494505,1026.98021978022,1039.02197802198,181.149450549451,132.046153846154,972.650549450549,1933.16263736264,477.740659340659,247.813186813187,1058.96703296703,128.995604395604,455,27.9170094086195,20.8971930173961,0.663081761380393,0.968085106382979,0.765993265993266,-0.363960168285797,50310.4263736264,34686.8021978022,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_10740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
10927,3829.05444126075,1021.24068767908,129.753581661891,650.426934097421,2290.13467048711,4223.37535816619,610.040114613181,278.458452722063,1141.13753581662,7009.04011461318,631.530085959885,119.361031518625,1086.48710601719,1758.22063037249,629.481375358166,297.676217765043,1670.41547277937,1558.42979942693,306.56446991404,230.114613180516,1050.61318051576,1267.58166189112,223.352435530086,212.974212034384,6183.30372492837,3028.49856733524,539.902578796562,309.10888252149,1080.58166189112,130.730659025788,349,21.5968054054114,20.7161329386375,0.28265344746992,0.969444444444444,0.830952380952381,1.49765971801613,50798.100286533,35570.6504297994,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_10927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
11715,1765.55605381166,471.248878923767,213.735426008969,685.959641255605,4180.01793721973,2251.95739910314,343.540358744395,268.838565022422,1093.96860986547,3003.58968609865,527.390134529148,122.27130044843,1076.7869955157,713.096412556054,475.439461883408,267.822869955157,1379.23094170404,1098.51569506726,315.300448430493,235.57399103139,987.017937219731,1057.07174887892,219.29596412556,122.565022421525,585.013452914798,1259.88340807175,491.069506726457,219.013452914798,1055.30044843049,131.80269058296,446,29.528658723815,19.4431849458901,0.75262329955497,0.961206896551724,0.732348111658456,1.25222661065726,50632.735426009,34581.831838565,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_11715,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
11752,3738.45669291339,1048.87664041995,934.0656167979,649.703412073491,2574.05249343832,3746.76377952756,3929.53018372703,277.175853018373,1123.11811023622,5945.27296587927,928.309711286089,120.653543307087,1076.38582677165,903.301837270341,749.307086614173,448.661417322835,1641.05774278215,1705.20997375328,302.149606299213,235.698162729659,1008.92388451444,1901.4593175853,241.112860892388,535.632545931759,692.451443569554,1544.51968503937,536.94750656168,560.01312335958,1057.69291338583,129.808398950131,381,25.6104862405173,19.2979456945187,0.65742802267135,0.957286432160804,0.705555555555556,-1.44720471705448,51658.343832021,35110.7926509186,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_11752,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
11753,2339.8696461825,107.815642458101,86.9776536312849,700.841713221601,2408.75418994413,2843.23463687151,457.772811918063,268.379888268156,1190.74487895717,4719.93109869646,586.329608938547,118.776536312849,1079.40782122905,1856.33519553073,772.756052141527,337.858472998138,2835.89757914339,2024.54934823091,351.608938547486,242.491620111732,1008.20111731844,1852.37616387337,248.575418994413,183.603351955307,582.763500931099,2087.52513966481,553.281191806331,236.810055865922,1064.63687150838,130.716945996276,537,30.8533905841533,23.0710445471615,0.66396498039037,0.960644007155635,0.688461538461538,-0.542185811918814,51675.0782122905,35004.6797020484,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_11753,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
11964,1386.10344827586,250.272727272727,82.1347962382445,610.724137931035,543.884012539185,2043.32915360502,1067.55485893417,257.614420062696,1079.17084639498,3397.61912225705,980.545454545454,109.721003134796,1068.46394984326,692.347962382445,557.860501567398,531.101880877743,1509.80094043887,1296.21630094044,308.525078369906,236.438871473354,1004.1394984326,1346.54858934169,205.086206896552,235.880877742947,731.836990595611,2353.50940438871,533.98119122257,352.844827586207,1046.94200626959,131.009404388715,638,30.4088270782396,26.7741279602935,0.474097713867686,0.963746223564955,0.758620689655172,0.883926367816604,51202.1692789969,34653.197492163,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_11964,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
12390,1252.01767068273,321.538152610442,126.323694779116,656.971084337349,2627.89397590361,799.426506024096,658.338152610442,270.343775100402,1089.59678714859,1263.42891566265,694.498795180723,120.018473895582,1068.1686746988,625.421686746988,450.865863453815,298.187951807229,1414.77108433735,961.999196787148,277.253012048193,229.571887550201,998.596787148594,819.290763052209,202.124497991968,130.665863453815,584.336546184739,1049.40642570281,565.323694779117,236.489959839357,1045.90040160643,131.591164658635,1245,41.6928415190066,38.0394315374693,0.409359414977546,0.976470588235294,0.780075187969925,-1.42953888392655,49954.9004016064,35043.1421686747,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_12390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
14183,2066.88461538462,175.2,76.1076923076923,618.207692307692,953.323076923077,1764.69230769231,540.369230769231,261.276923076923,1117.83846153846,3104.52307692308,1098.11538461538,110.4,1077.34615384615,911.930769230769,486.923076923077,286.069230769231,1548.86153846154,1195.6,231.976923076923,218.053846153846,1492.08461538462,877.430769230769,180.861538461538,228.192307692308,844.738461538462,911.938461538462,433.184615384615,363.069230769231,1032.24615384615,129.853846153846,130,14.5228340214492,11.4020844003115,0.619350922131357,0.948905109489051,0.722222222222222,0.297451324752378,51534.6692307692,35648.4,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_14183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
14219,2142.00327332242,355.193126022913,244.090016366612,723.207855973813,7679.62520458265,2668.3387888707,701.685761047463,269.150572831424,1102.69558101473,3646.74468085106,1970.27168576105,125.52209492635,1098.32242225859,713.551554828151,783.929623567921,269.490998363339,1638.22258592471,971.148936170213,260.258592471358,227.682487725041,992.747954173486,863.762684124386,191.577741407529,222.155482815057,581.247135842881,1547.05073649754,548.846153846154,292.810147299509,1075.33551554828,131.816693944354,611,31.7649286800052,24.6047099795524,0.63246702072398,0.9776,0.788387096774193,-0.403624839434722,51613.8101472995,34466.2831423895,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_14219,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
14859,2369.07001795332,973.228007181328,852.405745062837,680.163375224417,4273.19389587074,2896.00179533214,1029.49910233393,263.24236983842,1106.42728904847,3721.29802513465,3158.17773788151,123.806104129264,1067.57271095153,1543.84201077199,727.759425493716,1054.47935368043,1703.26929982047,1504.68222621185,331.563734290844,237.533213644524,1025.28186714542,2359.69120287253,261.811490125673,337.822262118492,1345.14901256732,1430.01795332136,602.122082585278,400.951526032316,1072.33393177738,131.421903052065,557,30.0048880059955,23.676210088018,0.614292456796139,0.962003454231434,0.768275862068965,-0.451568037454424,50859.4326750449,33675.8491921005,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_14859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
15329,3854.74270557029,298.220159151194,250.716180371353,744.416445623342,7293.72944297082,4487.22015915119,443.183023872679,289.363395225464,1235.3050397878,7944.42705570292,687.281167108753,145.381962864721,1099.34217506631,944.387267904509,643.435013262599,280.427055702918,1419.72413793103,3460.83023872679,362.400530503979,242.474801061008,1078.27055702918,3980.46153846154,258.777188328912,360.835543766578,623.381962864721,2932.41379310345,590.732095490716,242.111405835544,1105.59946949602,134.307692307692,377,23.2146311832498,20.7537440181915,0.448078670253327,0.966666666666667,0.816017316017316,-0.525994029023216,49919.7665782493,34693.9204244032,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_15329,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
15646,2685.3829787234,326.872340425532,147.301418439716,657.244680851064,2747.72340425532,2932.69503546099,498.170212765957,259.478723404255,1089.67021276596,4980.03191489362,945.333333333333,119.542553191489,1091.91489361702,756.372340425532,455.77304964539,270.687943262411,1374.31560283688,1141.87234042553,299.003546099291,233.251773049645,990.716312056738,1046.69858156028,215.932624113475,136.620567375887,797.868794326241,1836.66666666667,497.507092198582,259.808510638298,1073.06028368794,130.159574468085,282,22.532518127658,15.9338810182816,0.707063079286228,0.969072164948454,0.789915966386555,-1.09971235801874,50097.9893617021,34273.9219858156,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_15646,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
15822,2541.26829268293,947.25,1655.91768292683,609.231707317073,736.399390243902,2769.88719512195,594.914634146341,267.121951219512,1093.28963414634,3494.7743902439,609.77743902439,115.612804878049,1072.1006097561,5824.41768292683,743.82012195122,346.469512195122,5587.16158536585,6425.6493902439,469.112804878049,263.5,1079.40548780488,5132.21646341463,284.746951219512,222.012195121951,771.207317073171,961.42987804878,485.332317073171,262.301829268293,1017.13414634146,129.823170731707,328,26.1902393001261,16.0043813758874,0.791567371078951,0.961876832844575,0.759259259259259,-1.43440746173456,51358.6859756098,35264.3414634146,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_15822,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
17178,2501.24293785311,106.053672316384,65.6412429378531,678.550847457627,1359.20621468927,2835.09039548023,368.423728813559,259.669491525424,1088.39830508475,5339.22316384181,558.926553672316,110.426553672316,1071.0395480226,2158.63276836158,750.313559322034,911.983050847458,1789.03672316384,1888.53389830508,297.926553672316,233.271186440678,1024.79378531073,1412.79096045198,215.872881355932,183.579096045198,632.443502824859,1976.44915254237,505.350282485876,237.822033898305,1040.99435028249,129.087570621469,354,22.2390449670792,20.3509130365727,0.403230747871037,0.959349593495935,0.766233766233766,-1.03210184100711,51672.1384180791,35192.2344632768,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_17178,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
17810,1860.47908745247,418.760456273764,170.712927756654,654.790874524715,2341.26996197719,1895.42775665399,703.239543726236,265.990494296578,1094.23764258555,2874.73384030418,765.838403041825,113.615969581749,1080.05703422053,806.619771863118,655.133079847909,573.222433460076,1622.40114068441,1211.50760456274,301.085551330798,581.749049429658,1010.76235741445,873.948669201521,208.779467680608,149.557034220532,593.739543726236,1083.69011406844,438.007604562738,271.56463878327,1046.81178707224,131.182509505703,526,36.6360577254983,18.3033823883934,0.866256095625732,0.952898550724638,0.710810810810811,-0.201286617958551,50005.3897338403,35136.391634981,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17810,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
18309,2191.40909090909,98.3311688311688,121.123376623377,714.313852813853,4801.06060606061,2326.11688311688,373.841991341991,263.619047619048,1100.74242424242,4113.42424242424,493.822510822511,120.987012987013,1094.66883116883,1515.19047619048,815.190476190476,489.002164502164,2006.48701298701,2307.47835497836,326.478354978355,235.047619047619,1015.32251082251,2045.84199134199,250.114718614719,246.038961038961,605.818181818182,1754.66233766234,457.041125541126,223.909090909091,1069.61688311688,129.238095238095,462,29.5405879106627,19.9326027338002,0.738043547813455,0.9625,0.77,-1.49891880966053,51405.2034632035,35783.4696969697,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_18309,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
18488,2985.73302107728,223.658079625293,137.126463700234,642.758782201405,2121.14754098361,3682.36299765808,470.447306791569,258.660421545667,1097.03278688525,4985.93676814988,549.229508196721,117.803278688525,1084.85714285714,807.475409836066,629.772833723653,406.976580796253,1648.98360655738,1214.02576112412,278.299765807963,414.311475409836,1003.27166276347,987.224824355972,215.332552693208,170.192037470726,591.59718969555,1336.19203747073,490.803278688525,237.021077283372,1041.17330210773,132.386416861827,427,25.528888465301,21.3108654896443,0.550591962292246,0.959550561797753,0.773550724637681,0.59457983082416,51907.756440281,34743.5737704918,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_18488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
18714,2442.28037383178,277.638629283489,177.101246105919,663.46261682243,4186.82710280374,802.769470404984,368.176012461059,241.507788161994,1094.23052959502,1637.69314641745,515.210280373832,107.034267912773,1066.68535825545,1132.6277258567,584.165109034268,307.954828660436,1758.82087227414,1229.27414330218,268.442367601246,491.704049844237,1064.83489096573,1038.97352024922,203.380062305296,223.22429906542,1796.05763239875,583.109034267913,363.605919003115,200.471962616822,987.688473520249,128.395638629283,642,29.3349022282365,27.8890467951346,0.31007496485378,0.959641255605381,0.764285714285714,-1.55953907779792,52106.5778816199,34728.5373831776,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_18714,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
19107,2593.87578947368,393.193684210526,106.050526315789,633.932631578947,1350.52210526316,2725.81894736842,2089.92210526316,272.04,1098.68631578947,4459.90947368421,2094.05052631579,118.993684210526,1070.47578947368,831.745263157895,488.983157894737,284.736842105263,1514.88842105263,1123.07789473684,298.686315789474,229.288421052632,1048.48842105263,1001.99157894737,215.461052631579,144.709473684211,1457.78736842105,1508.35789473684,537.581052631579,344.092631578947,1077.96631578947,131.098947368421,475,27.1752659281631,22.2817671102705,0.572466359508011,0.961538461538462,0.76,-0.844036704574138,50290.9915789474,35073.5557894737,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_19107,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
19424,3082.7578125,203.4328125,79.4703125,627.3375,909.278125,3724.89375,445.703125,280.8734375,1085.490625,5638.9859375,681.26875,122.003125,1078.315625,1857.0703125,674.696875,366.88125,1886.1125,2361.55625,376.425,237.3015625,1087.7578125,2010.059375,233.5359375,340.1046875,645.471875,2133.2703125,509.96875,242.0046875,1063.9296875,130.6484375,640,33.3903780742277,24.6873701679651,0.673314918881788,0.96969696969697,0.718294051627385,-1.18739027455034,50015.115625,35219.9875,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_19424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
19871,1797.64781021898,665.629562043796,228.740875912409,700.445255474453,4247.59854014599,2147.31204379562,2799.25,265.113138686131,1090.42700729927,2953.89416058394,5520.16605839416,126.576642335766,1080.29197080292,845.655109489051,839.366788321168,1144.36678832117,1619.18613138686,929.981751824818,229.60401459854,219.390510948905,1006.84306569343,786.102189781022,168.804744525547,217.733576642336,629.255474452555,1087.24087591241,488.439781021898,483.70802919708,1066.57846715328,130.310218978102,548,28.9768965223863,24.1563820563796,0.552303928996461,0.97335701598579,0.78735632183908,-0.252777059979245,50585.9105839416,34064.2609489051,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_19871,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
19987,1735.05,153.577777777778,78.5888888888889,607.605555555556,456.966666666667,1858.20555555556,326.072222222222,256.288888888889,1142.11666666667,3640.88333333333,492.511111111111,109.844444444444,1061.55555555556,896.288888888889,563.677777777778,280.594444444444,1652.57777777778,1404.22777777778,285.238888888889,225.85,1087.60555555556,1699.13888888889,212.522222222222,204.9,1406.66666666667,2362.15,494.061111111111,247.883333333333,1041.2,130.805555555556,180,16.2157583307542,14.1464054337788,0.488817083594667,0.952380952380952,0.75,0.654505620905687,50601.8777777778,35753.7444444444,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_19987,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
23409,1667.75510204082,221.589981447124,71.4823747680891,630.515769944341,1502.78849721707,2064.96846011132,397.604823747681,274.328385899814,1090.97031539889,3004.43042671614,605.836734693878,119.667903525046,1069.11688311688,723.875695732839,452.918367346939,282.519480519481,1483.59925788497,916.628942486085,217.397031539889,218.159554730983,1179.6159554731,666.539888682746,158.009276437848,125.320964749536,699.051948051948,1295.42115027829,497.102040816327,225.371057513915,1063.87384044527,130.641929499072,539,31.1902189886041,22.0536744299145,0.707143358826575,0.974683544303797,0.781159420289855,1.21089928456629,50137.8831168831,35054.1057513915,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_23409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
25296,1697.96829971182,167.904899135447,234.115273775216,727.386167146974,6522.60518731988,2004.98270893372,339.224783861671,266.648414985591,1092.56484149856,3786.62536023055,585.342939481268,116.172910662824,1069.38616714697,2543.13544668588,590.982708933718,297.504322766571,1818.29106628242,3565.71469740634,367.99711815562,243.106628242075,1043.3976945245,3438.73775216138,246.466858789625,940.273775216138,732.5734870317,1774.92219020173,505.14409221902,272.296829971182,1076.10951008646,130.07492795389,347,30.6834706705584,14.5520266174486,0.880383360443284,0.935309973045822,0.722916666666667,1.38067342744331,51256.7925072046,35236.553314121,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_25296,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
25439,1873.17010309278,326.033505154639,90.8041237113402,627.432989690722,1612.23195876289,2132.65206185567,357.966494845361,259.989690721649,1111.35309278351,4040.3118556701,487.175257731959,110.216494845361,1078.40206185567,989.778350515464,514.476804123711,280.878865979381,1881.63917525773,1502.51030927835,323.139175257732,244.682989690722,1071.68298969072,1247.43556701031,230.780927835052,153.556701030928,761.29381443299,2221.79381443299,529.729381443299,231.381443298969,1069.40979381443,130.569587628866,388,24.2004994355909,20.7664331088016,0.51348367660321,0.953316953316953,0.734848484848485,-1.29798174254599,51387.5360824742,35286.618556701,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_25439,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
25608,2579.4701986755,508.486754966887,164.003311258278,647.894039735099,1965.49337748344,2849.88079470199,1419.93708609272,269.751655629139,1116.15562913907,4568.61589403974,2145.94701986755,116.019867549669,1074.88410596026,698.347682119205,500.592715231788,294.58940397351,1697.2880794702,1091.41721854305,310.516556291391,236.559602649007,982.056291390728,1090.45695364238,227.423841059603,140.135761589404,593.658940397351,1678.46026490066,535.632450331126,447.854304635762,1051.09271523179,130.675496688742,302,20.8311163876834,18.6546860678975,0.445020812709264,0.974193548387097,0.794736842105263,-1.12223750123318,51417.4900662252,35015.7152317881,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_25608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
25992,2730.68468468468,400.594594594595,50.3018018018018,644.493243243243,1618.72972972973,3149.73873873874,1045.10135135135,269.265765765766,1212.35585585586,4990.27252252252,678.324324324324,112.279279279279,1080.75225225225,2306.83558558559,989.20045045045,928.912162162162,1836.53603603604,1316.32882882883,346.488738738739,238.322072072072,995.43018018018,1155.32432432432,250.47972972973,222.015765765766,601.565315315315,2082.28153153153,494.592342342342,449.281531531532,1087.77477477477,131.459459459459,444,29.8404032141948,18.9871136656628,0.77145096557916,0.967320261437908,0.755102040816326,-0.41415263331759,51165.8468468468,35656.1981981982,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_25992,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
26125,2533.73394495413,439.113149847095,125.238532110092,634.938837920489,1525.8501529052,2788.63914373089,2608.76146788991,263.003058103976,1099.58103975535,3635.45259938838,1067.42201834862,116.675840978593,1067.64525993884,627.434250764526,563.672782874618,304.281345565749,1487.9755351682,1021.41896024465,318.100917431193,239.064220183486,990.470948012232,1011.51681957187,220.018348623853,133.7125382263,588.813455657492,1076.15290519878,518.452599388379,363.009174311927,1039.41590214067,131.733944954128,327,22.2886814951949,18.8311224823849,0.534965703319775,0.973214285714286,0.825757575757576,-0.131603057697243,51099.0428134557,34267.2140672783,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_26125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
27004,4068.97133757962,924.582802547771,206.643312101911,635.229299363057,1375.78025477707,4471.03184713376,629.37898089172,266.245222929936,1134.02866242038,6539.96178343949,1017.3821656051,118.394904458599,1091.52547770701,3448.01592356688,589.675159235669,315.315286624204,3478.34713375796,1870.22929936306,292.404458598726,232.522292993631,998.700636942675,1354.36624203822,207.222929936306,175.557324840764,583.726114649682,1853.18789808917,503.213375796178,261.640127388535,1046.79936305732,131.907643312102,314,21.2661600328411,18.8324686121344,0.464524300413148,0.96319018404908,0.786967418546366,-1.46733743207435,51590.0095541401,34970.576433121,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_27004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
27090,2511.1914893617,403.417021276596,275.66170212766,710.214893617021,5493.20638297872,2934.56808510638,343.43829787234,266.63829787234,1093.52978723404,4804.66382978723,600.493617021277,131.840425531915,1098.10212765957,519.055319148936,353.834042553191,262.68085106383,1403.18936170213,816.282978723404,233.463829787234,222.440425531915,993.648936170213,788.536170212766,191.089361702128,128.148936170213,584.806382978723,2103.15531914894,543.706382978723,226.182978723404,1081.2914893617,129.348936170213,470,28.1188844329785,21.39320279742,0.648971587596149,0.963114754098361,0.791245791245791,-0.262971312739156,50321.4276595745,34035.0468085106,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_27090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
28156,2374.09947643979,298.952879581152,120.148342059337,651.450261780105,2372.66666666667,2880.4520069808,2099.28795811518,256.418848167539,1104.83071553229,4172.73298429319,720.73647469459,113.891797556719,1082.26178010471,715.858638743455,600.722513089005,310.284467713787,3292.56893542757,957.080279232112,251.724258289703,225.265270506108,1002.51657940663,832.102966841187,173.102966841187,130.788830715532,594.052356020942,1259.28970331588,479.507853403141,683.001745200698,1052.24432809773,132.364746945899,573,31.0398574274992,23.5790699348156,0.65034559163112,0.963025210084034,0.74609375,-0.0816415529717644,51068.6282722513,34439.7504363002,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_28156,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
28585,2585.923828125,240.68359375,100.47265625,628.361328125,1097.7109375,3371.509765625,728.0,265.1953125,1082.103515625,5625.412109375,586.19140625,119.46875,1080.404296875,652.69140625,538.169921875,268.482421875,1561.369140625,1136.853515625,307.564453125,233.41015625,1010.435546875,1129.798828125,208.998046875,393.669921875,588.857421875,2781.876953125,547.40234375,230.044921875,1063.087890625,131.453125,512,30.5604261072187,21.3952068274227,0.714049541418255,0.962406015037594,0.786482334869432,-1.53449054739435,50633.99609375,34688.130859375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_28585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
29642,4005.97756410256,266.820512820513,125.044871794872,655.25641025641,2107.0,3522.52564102564,859.621794871795,270.689102564103,1106.05128205128,6738.39102564103,1292.89743589744,113.871794871795,1083.99358974359,930.660256410256,581.596153846154,383.945512820513,1536.45192307692,1229.73397435897,314.307692307692,236.346153846154,1006.71153846154,1286.38782051282,243.173076923077,193.426282051282,585.480769230769,2386.07371794872,501.471153846154,304.375,1075.97756410256,129.762820512821,312,21.1746815194758,18.7922145240277,0.460836394327059,0.97196261682243,0.781954887218045,-1.27522231775032,51198.7147435897,35626.8493589744,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
29955,1245.195599022,249.621026894866,71.6479217603912,610.249388753056,505.809290953545,1449.23227383863,1793.54767726161,255.767726161369,1086.51100244499,2869.91687041565,803.168704156479,103.537897310513,1067.8533007335,1484.20537897311,619.992665036675,306.60391198044,1653.94865525672,2471.32762836186,385.141809290954,247.853300733496,1064.18092909535,2492.69437652812,350.315403422983,294.550122249389,1039.46454767726,1376.96577017115,439.00488997555,277.256723716381,1046.34963325183,129.911980440098,409,27.0667067170617,19.2930304727218,0.70137178371155,0.966903073286052,0.797270955165692,-1.43891715688653,50119.9902200489,35141.7799511002,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29955,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
30224,2717.15919282511,244.863228699552,258.298206278027,730.885650224215,7915.39910313901,2838.91031390135,306.681614349776,248.033632286996,1093.4932735426,4839.83183856502,706.603139013453,126.719730941704,1072.87668161435,1468.25560538117,748.343049327354,772.033632286995,1467.83632286996,1187.57623318386,271.282511210762,230.437219730942,986.948430493274,1441.2399103139,200.383408071749,194.513452914798,655.964125560538,1076.66367713004,487.208520179372,222.54932735426,1062.35874439462,131.215246636771,446,28.5553681069804,20.1856131184734,0.707319682600321,0.969565217391304,0.768965517241379,-0.154757652129989,51268.1412556054,33685.5695067265,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_30224,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
30333,3429.06323185012,971.83606557377,118.156908665105,645.606557377049,1634.32084309133,4436.54098360656,449.32318501171,259.725995316159,1128.59718969555,6349.66042154567,578.372365339578,122.152224824356,1078.86416861827,660.177985948478,457.449648711944,526.440281030445,1647.2131147541,1402.31850117096,314.697892271663,237.173302107728,1024.82903981265,1418.83840749415,228.817330210773,256.348946135831,722.96018735363,1712.92271662763,507.409836065574,267.833723653396,1034.56908665105,131.170960187354,427,26.5778820859983,20.5678600833782,0.633342889408733,0.959550561797753,0.782051282051282,1.24668954172558,51052.5690866511,34412.3466042155,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
30694,2227.18556701031,347.126288659794,182.76030927835,661.994845360825,3569.38144329897,2869.25257731959,424.610824742268,263.644329896907,1095.65979381443,2937.19072164948,521.556701030928,115.582474226804,1113.26546391753,1797.93298969072,480.886597938144,271.927835051546,1540.84536082474,1597.2706185567,269.484536082474,229.226804123711,996.332474226804,1536.03350515464,185.615979381443,218.386597938144,583.747422680412,856.585051546392,451.126288659794,215.984536082474,1021.63402061856,129.497422680412,388,25.4270938778068,19.4664357022714,0.643342522899718,0.965174129353234,0.739047619047619,1.23059755733269,51261.6520618557,34836.0902061856,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_30694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
31051,3068.65340909091,452.704545454545,135.5625,676.914772727273,2493.19886363636,2541.54545454545,3813.3125,272.142045454545,1104.41477272727,4626.57386363636,2162.63068181818,113.482954545455,1071.58522727273,2659.51704545455,1089.91477272727,1471.0625,2074.57386363636,4761.5625,418.090909090909,240.789772727273,1088.81818181818,4250.25,267.954545454545,544.642045454545,616.545454545455,1396.40340909091,455.585227272727,1040.6875,1059.39772727273,131.335227272727,176,16.1421646353317,13.9103068473822,0.507354578125327,0.972375690607735,0.785714285714286,-1.22547810326626,51327.6136363636,35626.25,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_31051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
31245,2659.96314496315,464.233415233415,689.289926289926,633.093366093366,1099.13022113022,2400.53071253071,1686.47665847666,258.017199017199,1083.60442260442,5185.54054054054,2120.08108108108,110.896805896806,1064.86732186732,971.208845208845,492.835380835381,286.5085995086,1582.64127764128,1060.50122850123,229.695331695332,216.113022113022,1324.43243243243,788.63144963145,182.437346437346,223.329238329238,621.717444717445,2187.17199017199,467.992628992629,641.174447174447,1051.49877149877,130.788697788698,407,25.5850426574595,20.3156283443088,0.60786137084286,0.953161592505855,0.745421245421245,-1.50868208294023,51526.3267813268,35675.5577395577,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_31245,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
32453,2701.60055096419,576.98347107438,76.66391184573,633.37741046832,1855.73829201102,3187.9476584022,381.730027548209,267.495867768595,1101.73278236915,4201.00275482094,506.592286501377,110.432506887052,1090.7217630854,843.292011019284,578.964187327824,283.719008264463,2024.0826446281,1096.43801652893,293.382920110193,228.531680440771,1002.40220385675,974.380165289256,221.209366391185,184.242424242424,610.997245179063,819.600550964187,413.33608815427,207.64738292011,1025.90909090909,131.460055096419,363,23.7309825437301,19.5164626871643,0.568903441505531,0.96031746031746,0.789130434782609,1.17527270914354,50759.9063360882,35286.1542699725,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_32453,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
32549,2624.4531835206,259.662921348315,132.404494382022,666.037453183521,2481.83895131086,2886.08988764045,2312.0,272.958801498127,1103.91011235955,4095.31086142322,576.52808988764,116.292134831461,1110.37078651685,844.179775280899,832.74531835206,612.441947565543,1879.76029962547,1347.40823970037,331.621722846442,235.591760299625,1029.41947565543,1297.92509363296,626.0,311.067415730337,671.176029962547,1519.5543071161,471.580524344569,1196.82771535581,1058.17602996255,130.397003745318,267,19.8672478144491,17.1183185146053,0.507528240380836,0.953571428571429,0.741666666666667,0.31913685705086,51075.1048689139,35763.127340824,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_32549,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
33160,3275.33630952381,263.607142857143,125.425595238095,655.127976190476,2366.61011904762,4237.09523809524,488.973214285714,278.666666666667,1106.5744047619,5399.17857142857,736.464285714286,124.803571428571,1114.25892857143,695.589285714286,518.044642857143,268.247023809524,1359.23214285714,1056.28869047619,289.369047619048,231.428571428571,1002.72023809524,987.77380952381,214.166666666667,147.883928571429,582.252976190476,1533.44642857143,526.282738095238,302.642857142857,1041.71130952381,131.107142857143,336,22.6425512881988,18.9321864282145,0.548526619052647,0.957264957264957,0.761904761904762,-0.867656524619292,50073.9880952381,34597.0416666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_33160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
33277,1516.45403899721,392.568245125348,80.1894150417827,597.949860724234,209.359331476323,1730.32311977716,336.972144846797,255.022284122563,1075.27576601671,3193.27576601671,510.183844011142,107.944289693593,1066.07799442897,1508.41782729805,515.362116991643,284.74930362117,1823.43454038997,2640.5348189415,352.874651810585,237.922005571031,1033.0417827298,2552.82451253482,250.281337047354,220.214484679666,1709.8495821727,1949.24791086351,439.637883008356,268.272980501393,1025.07242339833,128.161559888579,359,22.2640090042791,20.5550693372287,0.384218837659736,0.97027027027027,0.777056277056277,0.536798927995665,50777.3676880223,35768.4428969359,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_33277,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
33281,3028.12946428571,464.390625,109.779017857143,653.707589285714,2454.93303571429,3471.14732142857,5039.48214285714,259.703125,1108.953125,5202.92410714286,1286.03794642857,118.040178571429,1072.83035714286,1422.58258928571,577.928571428571,1778.63169642857,3368.37946428571,2578.07142857143,325.745535714286,288.569196428571,1062.91741071429,2226.64285714286,251.671875,384.825892857143,692.970982142857,1596.26339285714,530.888392857143,398.982142857143,1051.57142857143,130.941964285714,448,26.1444299184658,21.8903288665655,0.546767297945935,0.96969696969697,0.749163879598662,0.352336823720994,51937.5558035714,34326.1919642857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33281,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
33356,3565.23415977961,602.37741046832,105.644628099174,620.261707988981,980.283746556474,3962.00275482094,427.831955922865,261.504132231405,1119.21763085399,4284.85399449036,612.920110192837,122.107438016529,1073.47107438017,909.856749311295,934.28650137741,499.316804407714,1641.42699724518,1799.76584022039,368.727272727273,239.443526170799,1058.29201101928,1577.52341597796,236.98347107438,392.093663911846,649.278236914601,1195.22314049587,485.837465564738,224.28650137741,1029.83746556474,132.168044077135,363,23.5934331174072,19.6344324580839,0.554477008597442,0.965425531914894,0.785714285714286,-0.681890310728782,51506.7355371901,33916.303030303,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33356,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
34474,1535.74285714286,123.633766233766,56.1142857142857,604.877922077922,413.418181818182,1734.87012987013,311.233766233766,251.137662337662,1080.32467532468,3635.38181818182,483.558441558442,109.644155844156,1069.64935064935,846.831168831169,600.750649350649,278.480519480519,1708.01038961039,1333.25714285714,449.649350649351,242.158441558442,1014.54805194805,1314.02857142857,243.051948051948,144.184415584416,585.802597402597,2225.56623376623,490.153246753247,232.732467532468,1024.97662337662,131.27012987013,385,26.4058769913344,18.5865164214505,0.710320865885019,0.969773299748111,0.822649572649573,-0.141096994373912,50582.5246753247,34908.7012987013,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_34474,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
34503,2456.29639889197,275.357340720222,144.116343490305,658.916897506925,2589.81163434903,2281.92797783934,338.423822714681,265.434903047091,1087.37950138504,4733.58171745152,573.85595567867,127.930747922438,1104.34349030471,2691.58448753463,1884.85872576177,1910.73130193906,2001.3379501385,2918.3379501385,386.767313019391,246.850415512465,1026.60110803324,2284.27700831025,334.894736842105,392.418282548476,819.052631578947,1312.18005540166,501.836565096953,221.221606648199,1036.87257617729,130.432132963989,361,28.2472460070402,16.3325542018382,0.815895153071279,0.962666666666667,0.732251521298174,1.34194012072832,51906.9085872576,35085.8753462604,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_34503,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
35157,3673.0,1283.5421686747,137.081325301205,623.225903614458,1230.19879518072,4285.60240963855,432.894578313253,269.728915662651,1109.9578313253,5712.44277108434,561.987951807229,115.861445783133,1068.09939759036,1029.52710843373,576.44578313253,294.174698795181,1604.6656626506,1210.18373493976,237.512048192771,220.996987951807,1429.31024096386,713.403614457831,166.930722891566,121.894578313253,642.933734939759,1368.22891566265,493.762048192771,265.394578313253,1046.92469879518,133.225903614458,332,21.4306423149633,19.7769395436651,0.385196297716638,0.973607038123167,0.754545454545455,-1.30906306556884,50369.9518072289,35006.5361445783,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_35157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
35424,3407.71662125341,405.662125340599,114.049046321526,630.621253405995,1130.25613079019,3416.73841961853,1444.02179836512,272.99727520436,1097.32970027248,6684.69754768392,1044.09536784741,121.190735694823,1109.03542234332,939.392370572207,683.128065395095,288.980926430518,1689.86103542234,1255.07901907357,285.553133514986,227.452316076294,1378.76566757493,892.659400544959,187.99727520436,127.888283378747,2268.58583106267,2754.59128065395,591.318801089918,264.83378746594,1071.53678474114,132.043596730245,367,22.4188545671902,20.8961900015854,0.362249741091818,0.950777202072539,0.759834368530021,-1.24877596324329,50307.0081743869,35051.7247956403,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_35424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
35870,3393.15202702703,256.033783783784,103.040540540541,633.128378378378,1511.21959459459,3565.58445945946,794.118243243243,274.783783783784,1124.22972972973,6462.7804054054,1541.96621621622,117.956081081081,1082.95608108108,1320.00675675676,627.324324324324,287.385135135135,1849.12837837838,1446.83445945946,307.72972972973,233.581081081081,1082.60472972973,1155.99324324324,226.885135135135,194.976351351351,3644.57432432432,2808.68243243243,497.027027027027,329.449324324324,1063.47972972973,131.570945945946,296,19.8244876339725,19.0379246602202,0.278887889088645,0.954838709677419,0.778947368421053,-1.4385956235588,50805.6756756757,35518.7094594595,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_35870,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
36590,1311.38625592417,402.759478672986,114.398104265403,617.400473933649,804.951421800948,1649.58412322275,3036.61374407583,273.554502369668,1093.10900473934,2064.73578199052,771.954976303317,115.936018957346,1066.40639810427,1032.3317535545,1142.85308056872,516.181279620853,1613.03317535545,1589.8981042654,354.580568720379,246.484597156398,1005.12085308057,1610.14454976303,253.655213270142,222.309241706161,644.567535545024,1005.90995260664,531.71682464455,258.478672985782,1025.36966824645,131.591232227488,844,36.1936950323766,29.7527912468726,0.569424715493222,0.96127562642369,0.756272401433692,0.144377183223189,50480.0213270142,34764.6042654028,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_36590,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
36808,3447.22794117647,322.906862745098,124.629901960784,624.392156862745,901.602941176471,3124.22058823529,428.625,281.061274509804,1102.76470588235,5675.33578431373,571.18137254902,121.323529411765,1067.24754901961,1754.2181372549,826.075980392157,342.348039215686,1589.58088235294,1615.86519607843,314.575980392157,232.007352941176,1004.58578431373,1446.55392156863,232.210784313725,340.475490196078,621.796568627451,3093.13235294118,571.183823529412,360.906862745098,1027.37254901961,129.823529411765,408,27.4099612716099,19.0058966552935,0.720558856639541,0.957746478873239,0.728571428571429,0.160397126608121,51372.0710784314,35424.818627451,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_36808,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
37071,3345.9247311828,584.206989247312,134.975806451613,637.986559139785,1731.33333333333,4180.93817204301,3341.00537634409,269.228494623656,1098.38172043011,6232.70967741936,2206.92741935484,120.916666666667,1075.52688172043,1822.20698924731,1292.48924731183,2586.32795698925,1991.19086021505,2189.64247311828,345.905913978495,244.518817204301,1049.46505376344,1868.65591397849,237.897849462366,336.040322580645,736.387096774194,2049.97311827957,531.591397849462,344.75,1057.72580645161,131.559139784946,372,23.8831466033195,19.8713861547011,0.554737438651468,0.973821989528796,0.805194805194805,0.740325422555495,51909.8413978495,34400.0725806452,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_37071,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
38199,1731.8955954323,147.477977161501,111.610114192496,665.336052202284,2041.79934747145,2336.52528548124,294.469820554649,253.575856443719,1101.30831973899,4012.65742251223,465.437194127243,113.845024469821,1066.64763458401,2094.98205546493,815.406199021207,313.601957585644,1699.57096247961,2325.16965742251,375.923327895595,241.066884176183,996.778140293638,2191.72430668842,232.259380097879,250.603588907015,605.300163132137,2192.64600326264,506.494290375204,224.238172920065,1046.75367047308,129.756933115824,613,32.5091446264222,24.0678295767075,0.672232291889442,0.968404423380727,0.798177083333333,-0.242092592564082,51180.9363784666,34617.471451876,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_38199,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
39185,1934.76462196862,253.990014265335,138.323823109843,701.470756062767,5133.64907275321,2313.94436519258,370.475035663338,274.981455064194,1103.10128388017,3707.69757489301,1072.0727532097,219.794579172611,1069.78316690442,849.572039942939,622.199714693295,281.69757489301,1719.4179743224,1434.71326676177,266.935805991441,229.042796005706,1156.81883024251,1153.90442225392,195.83452211127,147.830242510699,4135.35092724679,1207.11697574893,434.726105563481,215.65335235378,1077.98002853067,130.199714693295,701,37.6846885635933,23.7193582148684,0.777068265217371,0.96423658872077,0.737894736842105,-0.116717128530168,50106.9814550642,35004.5848787447,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_39185,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
39531,2233.37853107345,203.129943502825,95.6214689265537,631.093220338983,1147.73728813559,2496.02542372881,2620.02542372881,258.0,1094.29096045198,4512.41242937853,1439.23728813559,111.398305084746,1072.75141242938,967.062146892655,702.963276836158,278.161016949152,1610.38700564972,1263.54237288136,334.104519774011,236.214689265537,1042.66101694915,1125.09322033898,239.994350282486,230.929378531073,587.875706214689,2014.00847457627,481.771186440678,304.33615819209,1080.60169491525,132.276836158192,354,22.4700884957285,20.0628549708887,0.450315657963183,0.975206611570248,0.804545454545455,1.24887667789334,49888.6327683616,34683.4915254237,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_39531,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
40177,1208.0106557377,205.054098360656,98.7139344262295,644.359836065574,2373.86803278689,627.127049180328,339.436065573771,248.572950819672,1076.45819672131,675.860655737705,474.095901639344,96.6229508196721,1061.2762295082,3946.34590163934,1302.86393442623,1325.76393442623,2673.73524590164,4331.7606557377,480.093442622951,256.016393442623,1074.49016393443,3749.37049180328,287.596721311475,684.582786885246,728.102459016393,572.927868852459,363.172950819672,197.6,983.355737704918,130.027868852459,1220,43.9770720169187,35.4268961866801,0.592491761002615,0.975219824140687,0.81063122923588,0.130616565366487,50560.5098360656,35121.787704918,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_40177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
40206,2400.64983164983,290.552188552189,125.117845117845,625.434343434343,1171.92592592593,2756.0,395.451178451178,257.491582491583,1087.6228956229,3269.78787878788,625.851851851852,114.286195286195,1075.3063973064,637.158249158249,869.023569023569,281.06734006734,2045.67003367003,1104.42087542088,318.868686868687,233.441077441077,999.565656565657,1015.05387205387,200.515151515152,150.979797979798,588.518518518518,917.063973063973,493.289562289562,229.646464646465,1019.52861952862,129.191919191919,297,21.6715431670235,17.6608660289976,0.579554508021812,0.964285714285714,0.75,-1.08143538763924,51121.2323232323,34240.7811447811,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_40206,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
40775,3614.61301369863,533.763698630137,135.705479452055,648.065068493151,1822.43835616438,3840.43493150685,1056.12671232877,282.003424657534,1167.34246575342,5393.96917808219,2437.27054794521,117.393835616438,1074.74315068493,759.051369863014,501.510273972603,342.482876712329,1734.57191780822,1020.09246575342,272.582191780822,226.832191780822,989.647260273973,908.729452054794,208.044520547945,141.109589041096,582.996575342466,1324.58219178082,555.232876712329,545.77397260274,1080.52739726027,135.044520547945,292,20.4281008535776,18.2345973190857,0.45080347539061,0.970099667774086,0.768421052631579,1.0955854113079,50853.8047945205,35291.0993150685,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_40775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
41684,1610.05555555556,314.6,77.3925925925926,632.725925925926,1234.16296296296,1773.41111111111,533.588888888889,262.262962962963,1119.25925925926,2962.11851851852,499.066666666667,112.581481481481,1074.9037037037,665.285185185185,673.318518518519,1674.95185185185,1603.7962962963,1011.53333333333,263.362962962963,221.214814814815,1025.27037037037,959.17037037037,216.337037037037,410.051851851852,621.47037037037,1326.56296296296,490.685185185185,297.87037037037,1043.94814814815,128.855555555556,270,19.7952270580893,17.5299630063112,0.464515214103464,0.96085409252669,0.75,1.14724386521019,51497.7111111111,35757.3666666667,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_41684,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
41870,2679.64304461942,183.711286089239,70.9527559055118,618.818897637795,1050.5406824147,3028.31233595801,438.0,254.209973753281,1084.15485564304,4913.74278215223,614.162729658793,115.393700787402,1072.89501312336,1993.63779527559,608.711286089239,292.018372703412,1715.46719160105,1385.98687664042,340.37532808399,238.916010498688,1045.56167979003,1195.39632545932,225.01312335958,208.280839895013,818.464566929134,1610.93175853018,514.666666666667,228.905511811024,1027.35695538058,129.246719160105,381,23.436545148304,20.9417968892428,0.448957580883339,0.959697732997481,0.75296442687747,1.24510984142633,51276.9212598425,34224.3727034121,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_41870,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
42015,3655.60416666667,908.096354166667,711.294270833333,686.369791666667,2770.80729166667,3531.9375,1007.43489583333,278.463541666667,1167.265625,5782.80729166667,652.796875,121.8125,1095.1015625,770.182291666667,477.190104166667,281.9296875,1471.625,1241.65625,333.239583333333,240.135416666667,987.919270833333,1284.06510416667,246.716145833333,220.296875,680.161458333333,1706.54166666667,560.369791666667,519.411458333333,1055.60677083333,130.953125,384,24.2233069573127,20.669784036134,0.521417835271955,0.952853598014888,0.695652173913043,-0.85381883167563,51913.1223958333,35234.0520833333,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_42015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
42104,3094.38181818182,296.881818181818,186.324242424242,683.20303030303,4358.0303030303,3305.70909090909,402.887878787879,252.415151515152,1090.41515151515,5077.68787878788,697.190909090909,123.924242424242,1079.25757575758,933.79696969697,490.212121212121,326.975757575758,1485.79090909091,1259.1303030303,298.721212121212,236.972727272727,1010.21515151515,2572.5,278.521212121212,201.30303030303,1911.27575757576,1763.04545454545,509.687878787879,229.966666666667,1075.48787878788,136.390909090909,330,21.1877845014765,20.0197999108372,0.327432352132592,0.956521739130435,0.785714285714286,0.757286712001451,50929.7181818182,33742.7909090909,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_42104,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
42124,3932.32853025937,996.521613832853,88.7406340057637,643.463976945245,2425.02305475504,4177.48703170029,600.265129682997,272.21613832853,1245.42074927954,6374.63112391931,566.71469740634,135.406340057637,1076.86167146974,875.613832853026,432.250720461095,281.982708933718,1629.36887608069,1491.10086455331,253.219020172911,221.841498559078,1123.46974063401,1649.15273775216,211.083573487032,240.648414985591,1701.77233429395,2119.53890489914,556.279538904899,250.190201729107,1100.65706051873,132.677233429395,347,22.6765133687629,19.6008376480181,0.502860908587341,0.953296703296703,0.788636363636364,1.34589602016558,51326.0057636888,35828.469740634,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_42124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
42883,2981.75559380379,156.476764199656,159.650602409639,727.571428571429,7418.06540447504,3872.01893287435,703.127366609294,271.734939759036,1144.82616179002,5098.53700516351,825.760757314974,125.452667814114,1075.08605851979,5246.61273666093,1223.05335628227,824.753872633391,2380.62822719449,6071.10843373494,511.719449225473,256.502581755594,1172.08089500861,5985.98106712565,289.698795180723,313.323580034423,608.115318416523,1856.32702237522,530.15834767642,256.235800344234,1070.66953528399,130.939759036145,581,34.4956977824036,21.4762504840384,0.782558029075212,0.957166392092257,0.733585858585859,-0.0163773359969987,51933.2736660929,34391.8760757315,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_42883,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
43023,2233.16605839416,87.4233576642336,108.886861313869,766.357664233577,3411.11678832117,2740.84306569343,337.153284671533,255.153284671533,1107.63868613139,4610.36313868613,1329.61313868613,146.36496350365,1075.48175182482,688.040145985401,445.846715328467,266.939781021898,1584.41605839416,1034.97627737226,266.355839416058,226.051094890511,1017.06569343066,955.416058394161,192.071167883212,149.894160583942,712.211678832117,1210.95802919708,482.200729927007,227.32299270073,1068.30656934307,131.939781021898,548,32.1482119374329,21.784710548139,0.735399633905504,0.96140350877193,0.707096774193548,1.12601016958842,51413.1879562044,33935.0839416058,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_43023,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
43238,3349.3313253012,675.882530120482,734.16265060241,611.123493975904,519.906626506024,4214.24698795181,827.719879518072,268.993975903614,1093.1234939759,7044.24096385542,1424.70481927711,123.153614457831,1075.3734939759,852.021084337349,817.307228915663,295.867469879518,1584.75,1196.56024096386,339.349397590361,242.096385542169,992.084337349398,1061.36144578313,221.728915662651,152.253012048193,607.861445783133,2798.18674698795,600.677710843373,357.012048192771,1094.68674698795,131.370481927711,332,22.0813531794424,19.1963404206288,0.494203590654938,0.96231884057971,0.79047619047619,-0.568484086426058,50970.3403614458,34339.7439759036,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_43238,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
43765,1782.40143884892,163.031654676259,68.7410071942446,608.634532374101,766.296402877698,2111.3309352518,1464.91223021583,250.271942446043,1078.47769784173,3913.29496402878,833.463309352518,109.460431654676,1065.15251798561,607.011510791367,401.644604316547,263.379856115108,1427.8618705036,965.303597122302,259.202877697842,225.024460431655,1021.31942446043,865.169784172662,190.18273381295,140.717985611511,632.241726618705,1944.71366906475,503.096402877698,326.120863309353,1051.70503597122,131.788489208633,695,35.4902627711714,24.9603171011564,0.710892751291576,0.974754558204768,0.794285714285714,-0.22604081870835,51576.0345323741,34122.1769784173,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_43765,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
44157,2388.15315315315,360.612612612613,133.457657657658,658.311711711712,2962.47747747748,2799.59099099099,2563.84504504505,259.572972972973,1096.51351351351,1484.58018018018,1212.05585585586,102.299099099099,1070.18018018018,456.675675675676,348.985585585586,248.843243243243,1477.00720720721,753.852252252252,204.297297297297,215.763963963964,999.025225225225,886.243243243243,191.12972972973,246.592792792793,584.574774774775,627.320720720721,407.371171171171,208.848648648649,987.345945945946,129.2,555,29.6718235881415,23.9613647671245,0.589804486105277,0.950342465753425,0.711538461538462,0.198439365814666,51595.7621621622,34756.5171171171,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_44157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
44974,2225.89902912621,211.695145631068,106.452427184466,652.209708737864,1463.77281553398,2725.65825242718,295.163106796116,253.464077669903,1107.42912621359,5204.2932038835,528.73786407767,115.939805825243,1062.98640776699,680.254368932039,521.801941747573,281.718446601942,1427.26213592233,1011.15339805825,339.304854368932,241.469902912621,978.438834951456,958.726213592233,237.44854368932,136.728155339806,584.271844660194,2663.00776699029,530.693203883495,225.798058252427,1046.56310679612,129.155339805825,515,32.1238853274469,20.5498089823839,0.768620553998402,0.968045112781955,0.746376811594203,-1.17683282015514,51428.4737864078,34426.3087378641,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_44974,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
45750,3312.44776119403,956.893034825871,130.019900497512,667.467661691542,3252.43034825871,3632.5,1107.09452736318,269.161691542289,1097.06965174129,5041.26368159204,654.654228855721,119.171641791045,1077.45771144279,542.708955223881,771.547263681592,1364.99502487562,1491.36069651741,962.360696517413,249.728855721393,220.129353233831,1006.21641791045,908.758706467662,185.86815920398,436.425373134328,721.358208955224,1135.12935323383,462.805970149254,234.365671641791,1053.32835820896,132.139303482587,402,24.4433957282829,20.9948945395355,0.512111633775504,0.957142857142857,0.761363636363636,0.266744855078162,50476.3756218905,35064.3109452736,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_45750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
46000,3549.45325779037,511.949008498584,79.5240793201133,632.407932011331,1354.67422096317,4338.37110481586,2335.62889518414,273.376770538244,1099.96600566572,6735.90084985836,1276.79886685552,117.943342776204,1074.26062322946,733.257790368272,539.934844192635,274.067988668555,1405.45892351275,1057.58073654391,318.229461756374,235.43342776204,989.220963172804,988.090651558074,217.552407932011,130.084985835694,588.764872521247,2914.29745042493,591.419263456091,428.694050991501,1091.07082152974,132.28895184136,353,23.3926661151193,19.333135576904,0.562993388096128,0.972451790633609,0.844497607655502,-1.4134770841621,51114.1501416431,34889.492917847,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
46324,2294.52614379085,716.56862745098,234.486928104575,619.823529411765,1246.3660130719,2192.66993464052,578.843137254902,270.56862745098,1092.16013071895,4394.02941176471,519.359477124183,113.81045751634,1067.48039215686,1118.1568627451,986.084967320261,1698.8137254902,1866.76797385621,1830.89869281046,340.277777777778,242.06862745098,1030.88235294118,1420.47058823529,276.09477124183,463.450980392157,883.794117647059,2180.37254901961,508.228758169935,276.676470588235,1031.61437908497,129.150326797386,306,21.5404700045071,18.1256841497548,0.540302042557854,0.959247648902821,0.766917293233083,1.05300100918888,51817.7875816993,35423.7712418301,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46324,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
46647,2922.42537313433,650.624378109453,1363.00497512438,630.577114427861,1518.28855721393,3390.31592039801,1278.07213930348,277.517412935323,1113.86815920398,4103.34825870647,833.293532338308,114.567164179104,1071.14427860697,571.452736318408,424.753731343284,271.517412935323,1488.41293532338,934.415422885572,270.524875621891,230.962686567164,989.181592039801,907.728855721393,208.402985074627,155.738805970149,590.803482587065,1145.53233830846,506.621890547264,254.828358208955,1048.55472636816,131.253731343284,402,23.564943548471,21.7605476692183,0.383769776612196,0.975728155339806,0.797619047619048,-0.0208522333742178,50651.7462686567,35247.1094527363,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46647,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
46938,3154.17010309278,251.208762886598,109.064432989691,676.631443298969,1642.31443298969,3741.40979381443,2037.76030927835,267.94587628866,1115.97164948454,6340.20360824742,1768.77577319588,115.193298969072,1081.1881443299,1807.34020618557,694.126288659794,360.780927835052,1850.26288659794,2925.32474226804,406.162371134021,255.626288659794,1016.49742268041,2488.62886597938,268.89175257732,521.242268041237,605.969072164948,2440.61082474227,516.396907216495,321.755154639175,1065.16494845361,130.690721649485,388,26.2546289551075,18.9654472090074,0.691511089679761,0.967581047381546,0.776,-1.10930654529012,51289.0231958763,35080.8788659794,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
47117,2423.48661800487,222.175182481752,120.978102189781,638.596107055961,1582.33333333333,2804.15571776156,328.627737226277,259.705596107056,1094.43552311436,4321.78102189781,606.946472019465,122.111922141119,1067.76885644769,638.104622871046,430.070559610706,260.827250608272,1364.80291970803,1151.06326034063,277.540145985401,234.632603406326,1008.08759124088,1154.19464720195,206.895377128954,162.622871046229,584.530413625304,1302.66909975669,465.530413625304,214.992700729927,1019.57907542579,129.408759124088,411,28.4999730069919,18.4327254509571,0.762691116656583,0.967058823529412,0.724867724867725,-1.11125956822326,50190.4355231144,34579.1824817518,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_47117,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
47460,2592.54577464789,778.56338028169,86.0915492957746,624.147887323944,919.25,2656.39436619718,446.258802816901,252.371478873239,1092.84683098592,4258.10915492958,574.767605633803,112.445422535211,1077.1073943662,982.760563380282,528.325704225352,286.322183098592,1679.85387323944,892.227112676056,271.144366197183,232.18485915493,995.892605633803,866.43661971831,218.017605633803,152.698943661972,587.18485915493,733.586267605634,405.352112676056,208.478873239437,1009.08274647887,128.225352112676,568,31.5531264239287,23.0785960907824,0.681926972583877,0.957841483979764,0.771739130434783,-0.103037497045342,52052.0845070423,34757.3028169014,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_47460,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
47522,2858.80815347722,1122.89448441247,1010.78417266187,613.083932853717,962.645083932854,3023.03357314149,445.031175059952,267.930455635492,1093.84652278177,3802.54676258993,543.561151079137,116.942446043165,1067.95683453237,2129.53956834532,745.263788968825,856.448441247002,1835.69544364508,1886.11990407674,338.002398081535,889.62829736211,1026.1654676259,1335.64508393285,260.851318944844,279.263788968825,729.884892086331,1038.96163069544,522.309352517986,250.671462829736,1013.15347721823,131.52278177458,417,23.702637726338,22.4413963177816,0.321854963671311,0.967517401392111,0.7882797731569,0.657464489995612,51989.0095923261,34784.071942446,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_47522,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
47845,3141.18092909535,551.79706601467,1279.87530562347,619.205378973105,1124.48655256724,3152.32029339853,859.268948655257,271.535452322738,1131.67481662592,5460.27628361858,1248.27872860636,116.361858190709,1072.9511002445,1677.96821515892,993.858190709046,839.234718826406,2775.58679706601,2582.48166259169,289.623471882641,230.317848410758,1017.9315403423,2298.20537897311,214.80684596577,1012.77261613692,635.466992665037,1974.03178484108,560.81662591687,402.293398533007,1049.96577017115,130.371638141809,409,28.6446144270737,18.3268077471117,0.768541931133027,0.955607476635514,0.730357142857143,1.24829190830294,51808.9853300734,35149.511002445,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_47845,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
47940,3826.35598705502,209.220064724919,90.9935275080906,628.032362459547,826.977346278317,4540.07443365696,354.15857605178,278.326860841424,1129.48867313916,7150.22330097087,789.974110032362,121.974110032362,1103.13915857605,3472.26537216829,1311.18446601942,2078.77022653722,2103.69579288026,4840.19741100324,413.637540453075,243.705501618123,1116.77346278317,4342.41747572816,255.245954692557,580.268608414239,673.974110032362,2032.12944983819,535.411003236246,285.935275080906,1087.05177993528,134.822006472492,309,22.8551698216069,17.2458148950312,0.65622009634182,0.968652037617555,0.774436090225564,0.953114137674865,51351.9902912621,35174.0097087379,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_47940,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
49359,3785.1181556196,386.051873198847,132.340057636888,695.994236311239,4641.17867435158,4079.24495677233,599.904899135447,279.622478386167,1256.66282420749,5681.12968299712,659.095100864553,132.651296829971,1106.86455331412,1940.78962536023,795.512968299712,1193.734870317,1848.34870317003,1369.36023054755,306.386167146974,230.844380403458,1030.84438040346,1163.12103746398,263.870317002882,390.106628242075,656.648414985591,1505.8818443804,503.760806916426,327.432276657061,1054.08069164265,131.743515850144,347,22.6834412017438,19.5138050809349,0.509844594231868,0.966573816155989,0.754347826086956,-1.23895550720815,51015.2507204611,35789.7867435158,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_49359,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
50261,4877.38951310861,1425.07865168539,87.1985018726592,660.385767790262,2466.79026217228,4743.85393258427,825.711610486891,276.767790262172,1240.2734082397,8117.73033707865,726.992509363296,138.689138576779,1086.37078651685,2692.6404494382,614.475655430712,382.232209737828,1582.734082397,1375.02996254682,304.711610486891,233.0,1024.04868913858,1487.8127340824,249.865168539326,210.228464419476,611.962546816479,3185.97378277154,579.61797752809,379.955056179775,1080.78277153558,131.966292134831,267,18.8683507274406,18.4079706916482,0.219553732517766,0.95017793594306,0.780701754385965,-0.760984545125603,51036.9737827715,35821.7116104869,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_50261,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
50773,2745.18997912317,687.605427974948,137.0751565762,649.081419624217,2289.38204592902,3362.46555323591,5398.09185803758,265.267223382046,1098.28392484342,4787.08559498956,1041.42171189979,126.757828810021,1075.58037578288,1514.70563674322,1160.82045929019,1223.37369519833,1917.94572025052,2868.33194154489,463.832985386221,349.407098121086,1050.0,1496.14822546973,279.653444676409,267.620041753653,710.169102296451,1617.91231732777,500.870563674321,245.722338204593,1047.38413361169,134.108559498956,479,31.6868921289859,19.4690857330854,0.788978501486898,0.961847389558233,0.798333333333333,-0.245813551561751,51598.9749478079,33850.0459290188,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_50773,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
51012,3491.86376021798,109.108991825613,105.896457765668,656.035422343324,2935.91825613079,3516.02179836512,594.389645776567,264.91280653951,1186.32697547684,5716.41144414169,588.452316076294,118.258855585831,1074.76294277929,8869.65667574932,1886.73569482289,2356.11716621253,6966.76839237057,7741.20163487738,555.613079019074,278.814713896458,1069.6757493188,6469.13623978202,331.41416893733,342.397820163488,939.313351498638,1452.22070844687,532.41689373297,403.539509536785,1043.26158038147,130.474114441417,367,22.944754935292,20.4935293670194,0.449722428528276,0.95822454308094,0.725296442687747,-1.00088681331441,51679.9209809264,34928.2588555858,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_51012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
51048,1256.64532520325,251.158536585366,93.3231707317073,614.621951219512,853.605691056911,1707.11585365854,3066.18089430894,277.917682926829,1086.22052845528,1876.96443089431,851.391260162602,110.447154471545,1062.90447154472,635.358739837398,613.814024390244,282.232723577236,1629.90853658537,1048.05894308943,337.950203252033,241.373983739837,993.980691056911,981.048780487805,238.790650406504,189.639227642276,586.204268292683,842.193089430894,431.640243902439,271.055894308943,1009.05081300813,128.611788617886,984,38.5702197264016,32.5537915963088,0.536321706935955,0.972332015810277,0.782193958664547,-0.488312779122012,50253.7195121951,35525.8617886179,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_51048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
52829,3230.73400673401,752.080808080808,947.956228956229,638.397306397306,1828.00336700337,3669.92255892256,1162.64646464646,277.882154882155,1132.73737373737,6043.37037037037,1721.29292929293,127.10101010101,1076.24915824916,9513.17508417508,1464.92255892256,1142.23232323232,3739.45454545455,9937.85521885522,602.030303030303,286.710437710438,1065.98316498316,9262.06734006734,3027.14478114478,389.787878787879,712.144781144781,2433.86531986532,700.882154882155,316.851851851852,1100.94276094276,132.498316498317,297,19.9122371324244,19.0238930807036,0.295356774497433,0.96742671009772,0.822714681440443,0.752782796598023,51729.7609427609,34835.202020202,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52829,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
52974,3544.53333333333,769.256140350877,1499.6701754386,620.733333333333,1551.20701754386,3892.60350877193,515.161403508772,270.908771929825,1091.89122807018,6892.82105263158,545.698245614035,118.870175438596,1077.30526315789,1683.98245614035,716.901754385965,1100.6701754386,1737.8350877193,1714.98947368421,312.350877192982,234.329824561404,1052.54736842105,1211.8701754386,249.978947368421,395.898245614035,771.852631578947,3102.11929824561,537.578947368421,279.414035087719,1050.05263157895,130.140350877193,285,26.5234481090377,13.7757821142846,0.854542625213379,0.94059405940594,0.703703703703704,-1.37188252973132,51798.1368421053,35407.0912280702,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52974,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
52991,1095.13880126183,187.996845425868,71.3722397476341,613.01261829653,1153.34384858044,1148.56151419558,2831.08832807571,244.618296529968,1080.96845425868,1859.38485804416,753.858044164038,109.028391167192,1065.55520504732,695.287066246057,423.482649842271,264.444794952681,1451.98422712934,1053.96529968454,299.564668769716,261.593059936909,1002.29022082019,1011.07570977918,207.971608832808,144.971608832808,880.01261829653,856.419558359621,450.671924290221,283.659305993691,1035.92113564669,132.280757097792,317,22.047699089269,18.364239199632,0.553375006570752,0.960606060606061,0.758373205741627,1.23311213762356,51531.1356466877,34447.9558359621,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52991,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
53027,2822.37078651685,1138.90561797753,93.2404494382022,654.157303370787,1908.00674157303,3480.80449438202,1105.97303370787,262.505617977528,1237.91235955056,5958.66741573034,982.314606741573,114.125842696629,1082.87191011236,1422.68988764045,503.191011235955,275.101123595506,1679.72584269663,1184.07415730337,284.577528089888,227.737078651685,1083.39550561798,998.880898876404,209.737078651685,137.269662921348,1211.97078651685,2550.89213483146,520.696629213483,597.656179775281,1097.98426966292,132.815730337079,445,24.6326046782662,23.0500767980033,0.352651457501503,0.961123110151188,0.773913043478261,0.487970069046342,50246.4179775281,35091.9617977528,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_53027,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
53340,3398.18181818182,401.123966942149,97.2920110192838,635.479338842975,1642.91460055096,3468.20936639118,3849.87878787879,260.768595041322,1095.74380165289,6070.76584022039,729.184573002755,119.371900826446,1073.69421487603,1921.3085399449,685.589531680441,563.71349862259,4159.0826446281,1337.31680440771,298.501377410468,229.936639118457,1003.8044077135,1208.40771349862,219.245179063361,167.840220385675,619.242424242424,1122.09366391185,467.275482093664,224.928374655647,1030.84848484848,131.300275482094,363,23.7037309930793,19.588773195171,0.563082897560145,0.955263157894737,0.75625,-1.25049158119591,51913.7465564738,34230.5344352617,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_53340,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
53791,2369.96801705757,525.087420042644,305.398720682303,633.81236673774,1668.05970149254,2358.72068230277,1814.48614072495,263.545842217484,1110.19829424307,4685.24307036247,2845.27931769723,117.304904051173,1075.3368869936,1115.95735607676,617.194029850746,315.149253731343,1632.04904051173,2488.3091684435,398.194029850746,248.852878464819,1034.35181236674,2318.93176972281,459.415778251599,317.415778251599,586.422174840085,1987.17270788913,525.400852878465,493.889125799574,1060.78464818763,130.454157782516,469,31.3558914486031,19.1728169892483,0.791276732824742,0.953252032520325,0.796264855687606,-0.0420009193222978,51437.9978678038,35781.0,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_53791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
55125,2662.63868613139,473.901459854015,183.941605839416,651.64598540146,2018.98540145985,3033.2299270073,399.777372262774,267.032846715328,1089.75912408759,4358.85766423358,642.970802919708,124.79197080292,1077.24452554745,592.251824817518,476.554744525547,372.642335766423,1469.5401459854,913.978102189781,287.178832116788,229.350364963504,981.5,860.569343065693,201.788321167883,138.317518248175,610.755474452555,1735.25547445255,517.160583941606,224.905109489051,1088.1496350365,131.226277372263,274,22.8890169768599,15.3300167352029,0.742582806767559,0.954703832752613,0.794202898550725,0.0541438726934329,50640.1204379562,33961.7773722628,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_55125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
55814,3594.40384615385,875.357142857143,2031.19230769231,638.802197802198,1709.0467032967,3678.39560439561,1551.16208791209,270.403846153846,1167.04945054945,5800.73351648352,1851.71703296703,116.173076923077,1090.64285714286,2805.83241758242,1195.68406593407,735.159340659341,3004.64835164835,4026.75549450549,431.601648351648,256.315934065934,1110.29395604396,3538.76923076923,547.758241758242,300.906593406593,712.142857142857,1597.49175824176,493.96978021978,508.802197802198,1054.5521978022,131.335164835165,364,22.6526727303464,20.5129016187328,0.424260863217604,0.968085106382979,0.825396825396825,-0.793483549807119,50963.7994505494,35697.4587912088,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_55814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
55853,3408.03812316716,527.152492668622,157.721407624633,624.592375366569,882.390029325513,4076.36656891496,1679.06744868035,286.466275659824,1095.8651026393,5510.10263929619,2912.54252199413,135.381231671554,1069.51906158358,690.472140762463,509.894428152493,280.134897360704,1405.84750733138,1226.08797653959,362.211143695015,245.263929618768,1022.86803519062,1213.0,260.557184750733,136.398826979472,586.243401759531,1910.39882697947,565.410557184751,807.99706744868,1085.68914956012,130.630498533724,341,23.3124005116896,18.8748159969683,0.586917094369526,0.96056338028169,0.741304347826087,-1.03662633945605,50145.8005865103,34174.8914956012,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_55853,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
56868,2048.83911671924,463.340694006309,130.06309148265,634.504731861199,1967.70031545741,2296.0094637224,3148.30914826498,261.182965299684,1086.86119873817,4394.6403785489,1069.95583596215,115.287066246057,1069.53943217666,1098.78548895899,651.955835962145,290.722397476341,1579.69716088328,1303.70977917981,251.955835962145,224.324921135647,1560.55205047319,813.552050473186,180.293375394322,123.214511041009,594.637223974763,2013.0189274448,500.324921135647,553.842271293375,1058.13880126183,131.93690851735,317,24.1859987464044,16.7198011287384,0.722567059535659,0.963525835866261,0.754761904761905,-0.880787871068369,50378.9747634069,34975.5520504732,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_56868,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57423,2958.82808716707,351.099273607748,98.1259079903148,629.053268765133,1782.17191283293,3085.85472154964,1503.76997578692,275.89588377724,1194.66343825666,5536.97578692494,1842.22276029056,121.35593220339,2744.33171912833,1122.8813559322,592.280871670702,543.755447941889,1593.14527845036,1718.82324455206,344.910411622276,239.491525423729,1017.82566585956,1944.799031477,253.903147699758,561.765133171913,637.675544794189,2974.0387409201,555.883777239709,522.297820823245,1085.43583535109,131.004842615012,413,26.1567508154698,20.2362889128471,0.633607653898078,0.949425287356322,0.722027972027972,1.18039863866868,50924.794188862,35694.1186440678,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57423,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57688,2573.64028776978,806.985611510791,92.0455635491607,612.726618705036,507.115107913669,2946.06474820144,591.942446043165,266.872901678657,1104.42206235012,5230.93045563549,526.007194244604,111.047961630695,1079.81774580336,3090.15827338129,634.73860911271,315.00479616307,1792.52038369305,3346.2206235012,383.393285371703,242.973621103117,1048.60431654676,3154.1103117506,250.812949640288,254.83932853717,2600.50839328537,1832.39808153477,499.26139088729,234.386091127098,1037.18705035971,130.786570743405,417,29.2125672576029,18.2329180583016,0.781307428801335,0.974299065420561,0.783834586466165,-1.30325520588345,51648.4916067146,35270.2853717026,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57688,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57714,4457.12671232877,929.702054794521,2088.48630136986,641.606164383562,1881.49657534247,5065.94863013699,491.078767123288,283.907534246575,1147.88356164384,6802.49657534247,629.979452054794,128.945205479452,1078.23287671233,618.982876712329,428.311643835617,273.739726027397,1482.39726027397,924.174657534246,273.246575342466,225.171232876712,986.941780821918,888.623287671233,209.184931506849,181.010273972603,586.369863013699,2605.61643835616,544.133561643836,276.510273972603,1094.8595890411,132.171232876712,292,20.0918097705137,18.59531350045,0.378705820820119,0.954248366013072,0.768421052631579,-0.984800808861553,50564.0821917808,35756.2431506849,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57714,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57716,1980.10344827586,1412.42857142857,719.857142857143,643.51724137931,1410.85221674877,1941.4039408867,1950.43842364532,266.128078817734,1119.41871921182,3479.87684729064,2301.86206896552,109.068965517241,1068.53201970443,2510.18226600985,698.369458128079,358.837438423645,2054.08374384236,5106.0,399.512315270936,246.566502463054,1066.49261083744,5411.78325123153,267.694581280788,218.674876847291,2796.73891625616,1307.6157635468,513.748768472906,526.009852216749,1049.58128078818,132.014778325123,203,19.1686353607521,13.5714794498206,0.706207954915604,0.948598130841122,0.763157894736842,-1.39497897640762,51220.2019704433,35256.0098522167,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_57716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57730,2396.19896193772,327.951557093426,231.783737024221,720.690311418685,6199.28200692042,3010.58131487889,2396.55709342561,266.167820069204,1104.95155709343,4452.38235294118,2104.58650519031,120.759515570934,1073.66089965398,905.237024221453,644.939446366782,304.735294117647,1706.63494809689,1333.12110726644,332.202422145329,243.584775086505,996.266435986159,1155.01903114187,229.628027681661,170.778546712803,582.915224913495,1484.74221453287,585.453287197232,377.873702422145,1103.01730103806,132.648788927336,578,30.135630456124,24.5189872177539,0.581395369031709,0.960132890365448,0.797241379310345,0.207877126465412,51796.0588235294,34634.6937716263,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57735,2869.27792207792,1034.76363636364,95.2181818181818,614.038961038961,602.88051948052,3185.58701298701,772.924675324675,254.205194805195,1224.03116883117,5260.61298701299,587.441558441558,115.171428571429,1084.83636363636,844.974025974026,627.825974025974,321.916883116883,1580.48311688312,1200.96883116883,341.111688311688,237.646753246753,993.244155844156,1129.52727272727,227.184415584416,156.477922077922,589.309090909091,959.262337662338,453.880519480519,220.698701298701,1023.98961038961,131.763636363636,385,23.7648910280506,20.6526352030602,0.494742251058131,0.967336683417086,0.797101449275362,-1.09385814060349,51095.9766233766,34475.6,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
57914,3307.39205955335,711.665012406948,149.220843672457,661.233250620347,3342.45161290323,4014.62034739454,478.436724565757,273.315136476427,1209.158808933,5809.62779156328,584.280397022333,119.975186104218,1084.2382133995,1021.52357320099,514.975186104218,278.493796526055,1913.20843672457,1529.99255583127,323.208436724566,241.250620347394,1043.26550868486,1267.94044665012,231.692307692308,152.915632754342,685.620347394541,2055.21091811414,560.848635235732,303.069478908189,1055.83126550868,129.856079404466,403,24.8539849594878,20.7092219595669,0.552918297270008,0.95952380952381,0.767619047619048,-1.53782427609958,51369.6501240695,35305.4416873449,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57914,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
58278,3230.68,330.777777777778,118.886666666667,663.728888888889,2729.51111111111,3260.59111111111,648.497777777778,266.862222222222,1126.17777777778,5178.92666666667,825.931111111111,114.815555555556,1096.60444444444,4640.87333333333,1004.92888888889,1032.25111111111,1988.35555555556,4001.6,402.18,240.971111111111,1046.25111111111,3403.81111111111,256.88,524.126666666667,611.962222222222,1472.92666666667,461.671111111111,280.766666666667,1330.31333333333,131.944444444444,450,25.2029024671454,22.8113092716824,0.425185061400383,0.961538461538462,0.782608695652174,0.14735153171109,51187.9711111111,35653.0022222222,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_58278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
58929,2899.5656779661,653.476694915254,943.896186440678,646.067796610169,2646.58050847458,2745.83474576271,975.947033898305,257.069915254237,1094.22669491525,3720.75211864407,2614.74152542373,113.889830508475,1066.50423728814,919.247881355932,528.362288135593,328.879237288136,1843.24788135593,1455.98093220339,320.512711864407,235.290254237288,1183.3093220339,1481.45762711864,197.627118644068,178.120762711864,585.25,863.911016949153,407.78813559322,241.385593220339,1012.80720338983,129.406779661017,472,27.0921958036958,22.2564026033317,0.570199806511858,0.959349593495935,0.760064412238325,-1.37042644360079,51768.4766949152,34658.125,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_58929,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
61563,2055.91954022989,193.44540229885,86.0431034482759,623.689655172414,1072.90804597701,2090.19252873563,427.031609195402,267.120689655172,1103.78735632184,4297.95689655172,600.063218390805,115.833333333333,1081.25287356322,601.798850574713,427.60632183908,267.037356321839,1485.13793103448,951.741379310345,282.603448275862,227.39367816092,994.695402298851,907.715517241379,218.129310344828,174.192528735632,585.42816091954,2657.18103448276,513.640804597701,243.597701149425,1055.33620689655,130.07183908046,348,22.1388851955887,20.014049863628,0.427484922002466,0.966666666666667,0.790909090909091,0.49688739005171,50557.5775862069,35734.1724137931,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_61563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
61814,2422.54826254826,479.550193050193,117.698841698842,638.212355212355,1461.54247104247,2984.64864864865,3731.67567567568,270.80694980695,1100.01351351351,4222.35135135135,1081.861003861,118.540540540541,1072.87451737452,1044.28571428571,762.34555984556,290.507722007722,1624.04054054054,1547.26640926641,339.03667953668,239.826254826255,1009.00193050193,1483.25868725869,227.812741312741,228.839768339768,689.706563706564,1859.17374517374,528.054054054054,432.797297297297,1061.66216216216,133.005791505792,518,33.1849204614677,20.2742346779986,0.791671334972304,0.95045871559633,0.668387096774194,-0.961162418083783,50606.6776061776,34968.6988416988,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_61814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
62135,2472.96848739496,192.34243697479,90.3970588235294,620.13025210084,934.313025210084,2826.94537815126,309.800420168067,253.817226890756,1093.72058823529,4871.96638655462,637.023109243697,114.399159663866,1079.30672268908,673.422268907563,505.355042016807,291.670168067227,1450.81512605042,1049.14075630252,344.388655462185,241.464285714286,985.523109243698,1085.3256302521,255.153361344538,157.947478991597,604.483193277311,1803.85294117647,505.808823529412,223.913865546218,1052.42857142857,130.53781512605,476,29.9359527258609,20.4149789681817,0.731393936063278,0.967479674796748,0.793333333333333,1.50386246162199,51429.4978991597,34393.7521008403,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_62135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
63237,3554.95609756098,148.99512195122,97.2926829268293,642.546341463415,2759.51707317073,4120.00487804878,370.312195121951,285.580487804878,1086.8,7398.61951219512,582.648780487805,120.370731707317,1080.38048780488,817.185365853658,568.19512195122,368.692682926829,1445.45853658537,987.951219512195,268.551219512195,332.478048780488,997.551219512195,913.882926829268,207.287804878049,139.307317073171,599.463414634146,3871.72682926829,548.453658536585,328.70243902439,1048.24390243902,130.89756097561,205,19.472519845563,13.4710558914601,0.722090803689744,0.957943925233645,0.770676691729323,1.35024387930801,50922.0048780488,35255.2487804878,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_63237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
63576,3540.01520912548,198.201520912548,153.034220532319,673.885931558935,4347.02661596958,3712.66539923954,370.045627376426,259.653992395437,1089.07984790875,7559.62737642586,547.471482889734,120.425855513308,1070.29657794677,1115.0,611.106463878327,286.300380228137,1726.8783269962,2269.77186311787,330.562737642586,237.901140684411,1049.71482889734,3045.02661596958,243.243346007605,1097.16349809886,874.182509505703,3832.7072243346,560.433460076046,343.144486692015,1040.02661596958,130.58174904943,263,21.6959269144127,15.5099319646441,0.699249619268434,0.963369963369963,0.782738095238095,1.27990450874567,52027.4220532319,34391.2661596958,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_63576,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
63841,3694.20882352941,422.291176470588,120.561764705882,619.391176470588,492.679411764706,4476.88823529412,1790.68823529412,278.964705882353,1104.78235294118,5196.56764705882,993.805882352941,118.438235294118,1083.66176470588,838.85,497.482352941176,276.405882352941,1422.82352941176,1184.44705882353,326.379411764706,240.091176470588,993.438235294118,1073.98823529412,220.926470588235,133.758823529412,582.444117647059,1272.57647058824,507.885294117647,279.879411764706,1033.97058823529,130.429411764706,340,21.3853555298891,20.3494215250334,0.307467076705941,0.965909090909091,0.772727272727273,-0.116425580331068,51156.0,34919.6441176471,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_63841,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
64264,1708.87619047619,157.72380952381,140.804761904762,680.5,3579.02380952381,1604.16666666667,361.895238095238,263.3,1082.54761904762,3185.37142857143,576.909523809524,116.8,1076.24761904762,1413.14761904762,976.333333333333,1533.41428571429,1703.58095238095,3029.97619047619,352.2,238.961904761905,1032.01428571429,2806.11904761905,237.438095238095,267.280952380952,648.0,1082.38571428571,439.042857142857,268.861904761905,1038.84761904762,129.357142857143,210,23.6477500372762,11.3458222419902,0.877386404022892,0.954545454545455,0.8300395256917,-1.5544162804038,51705.5380952381,35444.0666666667,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64264,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
64581,3804.15635179153,664.674267100977,892.42996742671,640.42671009772,1786.87947882736,4089.45602605863,465.57654723127,261.99348534202,1098.28664495114,6936.79153094463,524.560260586319,113.332247557003,1078.85667752443,1685.61237785016,1241.45276872964,1892.49185667752,1820.11400651466,1453.81433224756,291.589576547231,232.465798045603,1012.06188925081,1176.35830618893,207.967426710098,147.934853420195,701.671009771987,2269.55048859935,522.986970684039,245.511400651466,1039.85993485342,134.377850162866,307,24.6419110434972,15.9212503196928,0.763248935841555,0.95046439628483,0.697727272727273,-0.65887322667536,51502.8469055375,34911.9022801303,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64581,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
64783,1379.86301369863,122.579908675799,106.591324200913,658.353881278539,3039.54566210046,1534.53196347032,479.826484018265,246.066210045662,1086.14611872146,2564.61872146119,447.74200913242,105.075342465753,1072.21232876712,2139.47260273973,927.431506849315,1368.96803652968,1628.64383561644,1289.73059360731,299.452054794521,230.46803652968,1015.83333333333,1166.43607305936,214.356164383562,145.892694063927,657.954337899543,787.326484018265,415.399543378995,214.680365296804,1019.01826484018,130.189497716895,438,28.5898116958547,19.5988765961833,0.728054161960805,0.966887417218543,0.732441471571906,-0.6001112844042,50430.9474885845,35034.6210045662,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64783,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
64936,1641.42361111111,372.557291666667,179.248263888889,663.451388888889,3247.953125,2116.57291666667,325.119791666667,257.284722222222,1087.609375,2898.62673611111,619.277777777778,120.501736111111,1077.23090277778,647.116319444444,582.555555555556,269.395833333333,1456.65104166667,1051.80729166667,308.157986111111,237.657986111111,986.0,976.546875,214.203125,146.128472222222,598.942708333333,1401.25,519.178819444444,226.548611111111,1052.00868055556,131.053819444444,576,29.9818887320351,24.6667414614355,0.568444806974547,0.964824120603015,0.743225806451613,1.4440442132334,50868.9253472222,33873.796875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65285,3456.66486486486,292.724324324324,127.124324324324,641.902702702703,1447.42162162162,3623.09189189189,444.654054054054,275.854054054054,1091.37837837838,6318.34054054054,608.875675675676,125.0,1082.15675675676,1678.14594594595,1332.47027027027,2488.98378378378,3027.61621621622,3754.93513513514,393.545945945946,241.848648648649,1060.58378378378,4378.26486486486,320.172972972973,347.886486486486,630.935135135135,2322.6,494.34054054054,246.091891891892,1060.92432432432,130.913513513514,185,18.6538285466456,12.7130802255456,0.731793346732394,0.948717948717949,0.680147058823529,-0.874519792085835,50264.1459459459,35161.8972972973,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65285,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65481,3498.41390728477,788.337748344371,305.218543046358,640.973509933775,1719.29470198675,3877.35430463576,2811.11258278146,274.708609271523,1133.32450331126,6034.80794701987,648.556291390728,136.009933774834,1095.45364238411,2103.93708609272,569.039735099338,465.53642384106,1966.90397350993,1682.63907284768,326.980132450331,232.940397350993,1023.82450331126,1623.84437086093,244.350993377483,301.119205298013,605.08940397351,2366.95695364238,528.198675496689,1109.21523178808,1071.21523178808,132.672185430464,302,21.3477188380441,18.0692448636378,0.532507807499375,0.971061093247588,0.798941798941799,-0.100580728666145,51172.7715231788,35854.8741721854,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65481,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65552,2519.57092819615,699.024518388792,394.276707530648,804.739054290718,12707.2399299475,3396.83362521891,427.768826619965,277.574430823117,1142.27145359019,4400.26970227671,733.14711033275,146.660245183888,1068.17513134851,732.155866900175,509.786339754816,315.639229422067,1438.39229422067,1119.99299474606,364.523642732049,245.690017513135,982.884413309982,1059.57267950963,243.506129597198,153.173380035026,597.626970227671,1921.58493870403,574.85288966725,237.451838879159,1079.73905429072,131.621716287215,571,31.9881078169601,22.7521184604791,0.702920897514176,0.974402730375427,0.783264746227709,-0.768734447959186,50948.8598949212,33976.7320490368,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_65552,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65567,2456.45739130435,315.853913043478,105.786086956522,630.427826086957,1276.10434782609,3003.05391304348,2727.86260869565,265.973913043478,1092.52173913043,4389.06956521739,2002.46086956522,111.12,1070.16173913043,790.20347826087,447.690434782609,299.982608695652,1436.59826086957,1017.54260869565,277.227826086956,228.770434782609,987.84347826087,943.749565217391,214.953043478261,132.126956521739,595.686956521739,1366.54782608696,433.56,337.140869565217,1049.96695652174,132.24347826087,575,31.3195523600312,23.4412739070837,0.663185639209324,0.972927241962775,0.762599469496021,0.558141614757472,50049.8991304348,35062.3286956522,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65597,2772.24867724868,371.587301587302,57.2222222222222,614.62962962963,634.634920634921,2548.98941798942,623.851851851852,258.804232804233,1106.06349206349,5343.7671957672,619.439153439153,113.550264550265,1068.28042328042,611.68253968254,350.486772486773,265.687830687831,1476.78835978836,820.560846560847,195.322751322751,210.529100529101,1082.7619047619,667.232804232804,166.201058201058,176.851851851852,598.714285714286,2822.84656084656,477.989417989418,267.539682539683,1040.54497354497,129.809523809524,189,18.6360155567874,12.9364746866365,0.719815659866074,0.954545454545455,0.75,-0.431565599120229,50684.5502645503,35576.380952381,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65609,2856.32456140351,353.460526315789,106.833333333333,605.561403508772,362.991228070175,3237.10526315789,1141.66228070175,280.824561403509,1090.41666666667,4495.92105263158,654.907894736842,115.381578947368,1060.46052631579,754.188596491228,779.140350877193,1067.33333333333,1523.36842105263,1721.85526315789,361.578947368421,241.662280701754,1049.68859649123,1835.90789473684,284.460526315789,1511.70614035088,879.092105263158,1395.16666666667,480.934210526316,225.662280701754,1040.45614035088,130.872807017544,228,21.6537300411869,13.5086215958911,0.781546232262952,0.957983193277311,0.7125,-1.05528197092086,50257.7587719298,35269.2456140351,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65609,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65627,1339.42005420054,292.883468834688,122.311653116531,641.861788617886,1922.027100271,1543.90785907859,2307.65040650406,251.387533875339,1085.44986449864,2832.85636856369,1371.30894308943,113.059620596206,1066.53116531165,666.59891598916,474.856368563686,288.265582655827,1431.48780487805,1000.88888888889,327.273712737127,240.311653116531,978.647696476965,926.411924119241,219.924119241192,128.327913279133,589.880758807588,1311.9756097561,493.078590785908,287.447154471545,1050.37127371274,131.273712737127,369,24.5789307294446,19.147266147835,0.627009814737407,0.955958549222798,0.738,1.49122743317276,50637.0,34103.4173441734,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65627,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
65993,3502.38811188811,236.34965034965,87.5769230769231,627.398601398601,1102.53146853147,3692.17132867133,344.374125874126,273.307692307692,1091.1958041958,6749.44755244755,558.409090909091,114.839160839161,1076.05944055944,1941.4965034965,603.534965034965,285.300699300699,1723.84615384615,2786.32517482517,342.108391608392,241.482517482517,1032.38811188811,2841.34615384615,243.01048951049,284.479020979021,2885.93706293706,2749.91608391608,523.888111888112,227.370629370629,1049.3006993007,128.601398601399,286,21.4620504276208,17.0293743403889,0.608616582306622,0.959731543624161,0.716791979949875,1.10762014115848,51161.5979020979,35338.7832167832,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_65993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
66129,3101.96120689655,733.443965517241,787.443965517241,636.590517241379,1713.12931034483,2953.87931034483,1926.07327586207,267.25,1100.40086206897,6214.35775862069,955.237068965517,116.504310344828,1072.30172413793,858.650862068965,464.887931034483,279.081896551724,1512.59482758621,1171.80172413793,242.504310344828,221.625,1300.40948275862,1014.72413793103,202.452586206897,212.068965517241,1346.875,2825.74137931034,520.439655172414,350.887931034483,1046.97413793103,131.775862068966,232,22.5494683636285,13.2183960807716,0.810169659667067,0.962655601659751,0.811188811188811,-1.46511093753038,51794.1120689655,35556.4482758621,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_66129,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
66420,2118.02840909091,148.25,100.596590909091,640.951704545455,1864.875,2107.19318181818,337.326704545455,259.644886363636,1087.62215909091,4286.94886363636,488.355113636364,114.576704545455,1068.54261363636,733.400568181818,605.826704545455,310.110795454545,1658.45738636364,1386.99431818182,296.369318181818,231.184659090909,1014.98295454545,1183.26136363636,211.883522727273,208.673295454545,596.767045454545,1929.63920454545,475.181818181818,222.644886363636,1043.92329545455,129.159090909091,352,26.258592082728,17.0745291095313,0.759724226350572,0.961748633879781,0.741052631578947,1.18969819857567,52049.9261363636,35143.8409090909,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_66420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
66706,2105.99,448.693333333333,95.0666666666667,618.51,1022.60333333333,1974.64666666667,709.033333333333,263.916666666667,1143.94666666667,4639.89333333333,1802.29333333333,108.323333333333,1063.93333333333,919.93,513.583333333333,276.253333333333,1939.69666666667,1400.65666666667,305.423333333333,238.196666666667,1021.63,1174.59666666667,228.956666666667,153.083333333333,587.256666666667,2638.41333333333,494.123333333333,390.76,1051.22,128.526666666667,300,20.8138989676338,18.3604529352452,0.471016068023901,0.974025974025974,0.789473684210526,-1.13225290959304,51095.44,35466.2333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_66706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
66794,4006.39867109635,833.252491694352,1712.60797342193,627.355481727575,1241.76411960133,4608.50830564784,419.847176079734,268.142857142857,1115.75415282392,7965.91694352159,646.830564784053,115.222591362126,1075.51495016611,727.046511627907,445.627906976744,275.405315614618,1416.49833887043,1004.75083056478,279.152823920266,228.787375415282,986.431893687708,959.993355481728,250.757475083056,136.883720930233,580.794019933555,2681.47176079734,562.279069767442,314.787375415282,1069.14285714286,129.764119601329,301,23.0268041974832,16.6722627036607,0.689760930572632,0.955555555555556,0.769820971867008,1.36755358166063,51162.9667774086,35102.7209302326,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_66794,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
67491,5378.58333333333,810.710526315789,1581.23684210526,638.504385964912,1583.26754385965,4210.11842105263,529.214912280702,279.122807017544,1093.59649122807,8590.25438596491,611.245614035088,123.460526315789,1079.99561403509,4164.3552631579,1100.14912280702,393.570175438596,2086.25,6084.30263157895,425.381578947368,250.90350877193,1024.76754385965,5308.75,446.837719298246,206.736842105263,594.671052631579,3147.68859649123,592.583333333333,282.035087719298,1056.19736842105,132.447368421053,228,19.4976537991963,14.9467817771112,0.64213226574764,0.946058091286307,0.666666666666667,-0.663006457946666,51419.2587719298,35498.9078947368,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_67491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
67647,2107.73933649289,1151.25592417062,206.916271721959,648.183254344392,1997.15007898894,2480.98736176935,379.390205371248,264.210110584518,1110.07109004739,4218.49921011058,511.211690363349,114.611374407583,1073.45813586098,2845.19589257504,723.238546603475,397.150078988942,1642.97630331754,3857.63665086888,335.236966824645,238.703001579779,1011.99684044234,3443.5560821485,237.260663507109,284.230647709321,822.091627172196,1156.27962085308,488.139020537125,222.905213270142,1028.54344391785,130.758293838863,633,31.9552473311728,25.3237357694016,0.609904351354219,0.966412213740458,0.732638888888889,-1.24563676250639,51683.570300158,35284.1500789889,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_67647,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
68166,2323.82505910165,156.836879432624,165.108747044917,686.806146572104,4640.73286052009,2245.21985815603,335.921985815603,259.513002364066,1093.15130023641,4583.63593380615,520.593380614657,118.404255319149,1076.74468085106,1169.70921985816,519.366430260047,300.179669030733,1616.67375886525,2224.5390070922,327.158392434988,242.912529550827,1032.60283687943,2548.14893617021,236.378250591016,272.737588652482,591.706855791962,1509.44444444444,481.4231678487,221.990543735224,1053.94326241135,130.10401891253,423,29.5040968198876,18.2764147760029,0.785033384251806,0.959183673469388,0.742105263157895,1.37353319232538,51978.6075650118,35110.1489361702,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_68166,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
68829,2147.5593220339,130.029055690073,71.7772397094431,632.426150121065,1406.34140435835,2613.82082324455,326.992736077482,255.849878934625,1095.98305084746,4554.70944309927,679.365617433414,114.995157384988,1073.41888619855,474.842615012106,568.389830508475,310.394673123487,1516.91041162228,799.566585956416,216.629539951574,220.598062953995,1010.33171912833,738.208232445521,158.409200968523,192.099273607748,625.924939467312,1639.29539951574,503.360774818402,227.832929782082,1064.42857142857,130.242130750605,413,29.3253163287891,18.0401898226368,0.788390898063906,0.958236658932715,0.724561403508772,1.48485242010615,51193.5447941889,34343.2445520581,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_68829,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
69494,3420.328125,267.925,144.275,722.68125,4412.9375,4203.5375,364.940625,283.709375,1090.3875,5915.840625,603.740625,156.434375,1072.64375,665.96875,479.315625,273.13125,1406.28125,986.3625,289.584375,231.621875,985.028125,921.046875,203.453125,129.2125,582.075,2406.984375,526.134375,343.0,1062.59375,130.49375,320,25.7437040862168,16.0344496295103,0.782341788480802,0.952380952380952,0.701754385964912,-0.441752693260772,50293.66875,34379.6375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_69494,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
69903,4045.93150684932,439.791095890411,111.345890410959,627.037671232877,1269.19520547945,4289.22945205479,693.873287671233,271.883561643836,1099.20890410959,7075.3595890411,666.77397260274,120.013698630137,1094.01712328767,6491.04794520548,939.191780821918,337.760273972603,7889.20205479452,3788.20205479452,317.688356164384,238.739726027397,994.058219178082,2761.69178082192,225.595890410959,165.530821917808,588.517123287671,2943.73630136986,563.996575342466,273.078767123288,1060.19520547945,131.212328767123,292,20.2041980941942,18.7436456070041,0.373300589389473,0.966887417218543,0.808864265927978,-0.936702845373953,51494.1712328767,35116.3698630137,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_69903,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
70413,951.954545454546,307.026737967914,74.5294117647059,605.280748663102,471.299465240642,1351.64438502674,293.927807486631,255.168449197861,1118.2192513369,2535.6871657754,465.01871657754,104.216577540107,1066.91176470588,740.42513368984,560.307486631016,278.818181818182,1516.47326203209,1043.93048128342,302.29679144385,234.069518716578,987.48128342246,963.22192513369,208.080213903743,145.893048128342,580.596256684492,1807.98128342246,511.954545454545,226.868983957219,1020.44652406417,129.320855614973,374,23.0899457970072,20.664133745506,0.446184970507513,0.954081632653061,0.742063492063492,-1.19155027469329,51192.7700534759,34976.0668449198,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_70413,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
70943,3993.16030534351,794.68320610687,126.900763358779,631.099236641221,1638.52671755725,4352.77099236641,404.270992366412,267.614503816794,1106.67938931298,7875.87786259542,550.767175572519,117.473282442748,1083.87404580153,851.63358778626,692.645038167939,403.492366412214,2310.67175572519,1497.64122137405,294.034351145038,233.145038167939,1013.2786259542,1605.07633587786,722.851145038168,184.496183206107,602.339694656489,3770.0534351145,569.053435114504,253.889312977099,1061.77480916031,131.190839694656,262,22.7701936686914,14.764430773425,0.76129096345503,0.973977695167286,0.793939393939394,1.2980332921664,51550.5419847328,35000.7213740458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_70943,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
70984,1425.314415437,266.805902383655,138.861520998865,650.905788876277,2725.28036322361,1762.69466515324,356.649262202043,264.797956867196,1088.44608399546,2288.39387060159,602.238365493757,118.761634506243,1076.11918274688,1117.8649262202,1008.60499432463,295.407491486947,1648.32236095346,1549.85357548241,332.104426787741,240.704880817253,1020.05788876277,877.586833144154,186.660612939841,148.66515323496,585.373439273553,1295.15777525539,568.098751418842,231.003405221339,1063.43473325766,131.023836549376,881,40.9614724231513,27.8095314290086,0.734212963267187,0.964950711938664,0.700317965023847,0.65882993635136,50934.5641316686,34205.1293984109,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_70984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
71055,2489.03045685279,208.253807106599,115.756345177665,639.743654822335,1826.92639593909,3019.57360406091,346.119289340102,263.370558375635,1101.24873096447,4842.84517766498,665.395939086294,118.857868020305,1076.43654822335,1010.70050761421,721.096446700508,748.200507614213,2214.79949238579,1082.73350253807,338.459390862944,242.177664974619,1013.43147208122,970.771573604061,219.261421319797,157.142131979695,602.370558375635,1515.16751269036,519.598984771574,238.92385786802,1065.21065989848,131.581218274112,394,25.5966211002032,19.6412615657488,0.641242779596846,0.963325183374083,0.788,1.3488996490664,51115.6218274112,34339.9010152284,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_71055,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
71112,3796.42592592593,510.595238095238,210.828042328042,683.65873015873,4110.74603174603,4527.2962962963,3382.60582010582,292.050264550265,1113.58201058201,6820.65873015873,1977.74867724868,129.65873015873,1077.03439153439,763.216931216931,697.042328042328,606.727513227513,2117.11111111111,1191.58994708995,293.785714285714,229.068783068783,1022.22222222222,1858.54232804233,227.02380952381,226.60582010582,607.330687830688,2405.83597883598,560.783068783069,680.693121693122,1113.66402116402,131.891534391534,378,26.5882015753699,18.3291065229327,0.724409488244903,0.961832061068702,0.765182186234818,-0.258022447883945,50639.6984126984,35312.7513227513,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71112,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
71887,2874.95475113122,759.943438914027,83.0678733031674,609.27149321267,702.156108597285,3191.95701357466,439.610859728507,268.018099547511,1087.81674208145,5635.91176470588,543.549773755656,112.39592760181,1077.71040723982,1428.08597285068,661.601809954751,519.420814479638,1702.26923076923,1766.15837104072,326.823529411765,232.090497737556,1042.10180995475,1427.62895927602,215.823529411765,183.02036199095,653.628959276018,2222.94343891403,539.640271493213,240.739819004525,1050.32352941176,130.033936651584,442,24.9045877638678,22.7157703093254,0.409941364720381,0.956709956709957,0.736666666666667,-0.965507245401722,50748.5384615385,35335.8416289593,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
71938,2177.90559440559,583.888111888112,117.283216783217,638.667832167832,1679.1958041958,2471.08391608392,544.465034965035,271.937062937063,1094.15384615385,4792.18531468531,526.702797202797,111.63986013986,1072.47902097902,4895.79020979021,1189.58741258741,577.636363636364,2686.95804195804,4164.37062937063,378.13986013986,247.506993006993,1038.7972027972,3274.83566433566,246.160839160839,419.755244755245,684.122377622378,2390.52797202797,524.70979020979,415.475524475524,1045.27622377622,130.230769230769,286,20.4025710096036,17.880120609237,0.481645660888495,0.959731543624161,0.794444444444444,1.12141401264219,50964.9965034965,35391.3951048951,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
71973,1110.40914158305,244.871794871795,146.74358974359,656.966555183947,3302.52173913043,1260.70903010033,375.451505016722,265.405797101449,1094.90523968785,1632.50501672241,577.265328874024,113.518394648829,1071.38127090301,757.882943143813,1053.0602006689,354.471571906355,1687.30100334448,978.086956521739,275.447045707915,230.33110367893,993.246376811594,875.307692307692,194.715719063545,166.415830546265,630.278706800446,999.352285395764,552.390189520624,230.659977703456,1027.04570791527,130.006688963211,897,33.9392871115047,33.6696665963402,0.125798614734078,0.967637540453074,0.753781512605042,0.816095239608498,51393.0791527313,34672.6477146042,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_71973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
72944,4638.23300970874,376.495145631068,119.296116504854,608.135922330097,254.917475728155,5454.6067961165,563.73786407767,284.368932038835,1083.0145631068,8870.00970873786,629.791262135922,122.150485436893,1068.54368932039,659.97572815534,444.131067961165,265.179611650485,1441.06796116505,911.155339805825,257.135922330097,228.78640776699,990.470873786408,860.388349514563,195.679611650485,133.509708737864,581.553398058252,3724.27669902913,601.082524271845,240.02427184466,1047.1213592233,130.834951456311,206,17.3969963537068,15.1367411988006,0.492914326681657,0.962616822429906,0.8046875,-0.714889058091403,50922.7281553398,35056.7378640777,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_72944,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
72980,3526.88323353293,356.853293413174,246.452095808383,696.302395209581,5538.15568862275,4671.07185628743,368.350299401198,274.140718562874,1083.4371257485,5239.46706586826,601.476047904192,135.778443113772,1078.37125748503,690.431137724551,573.110778443114,277.670658682635,1547.88622754491,1465.16167664671,337.48502994012,240.709580838323,992.002994011976,1399.29041916168,220.269461077844,207.173652694611,591.784431137725,1791.89820359281,555.428143712575,231.937125748503,1054.17664670659,130.392215568862,334,25.2107878371973,16.8731196736197,0.743008726194287,0.965317919075144,0.785882352941176,-1.41307141136345,50981.1437125748,34076.754491018,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_72980,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
73289,5141.30331753554,701.099526066351,2490.78199052133,644.63981042654,1405.36966824645,3944.68246445498,831.630331753555,262.924170616114,1129.99526066351,7863.24644549763,566.635071090047,118.293838862559,1083.43127962085,2695.3317535545,1014.17061611374,527.706161137441,2378.43601895735,2286.84834123223,346.734597156398,232.962085308057,1036.54502369668,2276.81990521327,263.96682464455,620.791469194313,688.454976303317,2648.02369668247,561.037914691943,320.0,1060.31279620853,129.791469194313,211,18.7570285856428,14.3545272577468,0.64368813134283,0.967889908256881,0.732638888888889,-1.05552166202419,51265.6350710901,35648.5545023697,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_73289,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
73636,3985.16759776536,870.572625698324,115.469273743017,651.977653631285,2573.6843575419,3787.27932960894,1072.75418994413,276.276536312849,1115.6061452514,6261.56703910614,2074.38826815642,119.837988826816,1092.94972067039,1100.13407821229,580.173184357542,374.54748603352,1800.16201117318,2592.93575418994,305.435754189944,235.561452513966,1026.68715083799,2888.04189944134,219.790502793296,203.203910614525,592.650837988827,1499.09217877095,491.692737430168,321.986033519553,1054.53351955307,132.466480446927,358,22.5063713440904,20.2731756970112,0.434286167700372,0.970189701897019,0.778260869565217,1.28672614931561,50854.1508379888,35454.7206703911,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_73636,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
74399,1160.55963302752,815.756880733945,84.8669724770642,629.917431192661,1671.00458715596,1333.96330275229,970.334862385321,252.004587155963,1191.46330275229,2814.16055045872,749.743119266055,104.600917431193,1065.86697247706,766.784403669725,437.880733944954,407.752293577982,1390.04587155963,1586.01834862385,283.963302752294,229.142201834862,993.747706422018,1695.52293577982,210.220183486239,157.183486238532,630.247706422018,1369.99541284404,450.94495412844,328.876146788991,1044.44036697248,132.834862385321,218,17.2331737323611,16.115873156135,0.354210522236866,0.943722943722944,0.754325259515571,0.869183130113488,50540.3394495413,34902.5366972477,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_74399,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
74782,2887.46710526316,405.976973684211,637.013157894737,618.993421052632,926.644736842105,3015.28618421053,374.904605263158,260.924342105263,1093.07894736842,5909.18092105263,628.930921052632,109.5,1070.13815789474,685.463815789474,468.273026315789,298.434210526316,1415.12828947368,1099.45065789474,306.881578947368,234.828947368421,997.733552631579,1042.50328947368,228.230263157895,138.417763157895,582.723684210526,2332.94736842105,498.138157894737,285.424342105263,1041.46052631579,129.743421052632,304,20.990250423442,18.4515331484092,0.47672488428657,0.971246006389776,0.8,-0.661113167869206,50884.0131578947,35241.5032894737,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_74782,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75049,4927.44390243902,952.419512195122,165.585365853659,657.365853658537,2925.46829268293,5344.47804878049,1491.82926829268,288.517073170732,1115.69756097561,9248.85365853658,2605.61463414634,132.692682926829,1078.29268292683,1426.93170731707,832.239024390244,641.756097560976,1667.64390243902,1726.49268292683,395.385365853659,250.390243902439,1020.54146341463,1594.3512195122,273.970731707317,380.00487804878,751.419512195122,3745.39024390244,576.6,482.765853658537,1090.41951219512,132.69756097561,205,18.1274016638965,14.4513394311665,0.60370256182782,0.949074074074074,0.759259259259259,-1.26406006082107,50701.8195121951,35335.2243902439,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75049,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75386,2748.73401534527,397.381074168798,109.808184143223,625.539641943734,1141.06393861893,3119.10741687979,3072.69820971867,261.754475703325,1088.57033248082,5148.68286445013,1090.11253196931,131.644501278772,1064.93094629156,678.613810741688,503.112531969309,273.127877237852,1429.50383631714,1085.73913043478,329.312020460358,244.25831202046,977.312020460358,1037.77237851662,233.388746803069,129.828644501279,584.268542199488,1695.98721227621,493.058823529412,430.790281329923,1054.27877237852,133.058823529412,391,24.4408683879404,20.551825296023,0.541222374960641,0.960687960687961,0.739130434782609,-0.640129221069685,51445.3222506394,34878.2890025575,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75409,1102.59183673469,66.2006802721088,74.4659863945578,627.986394557823,1732.17346938776,1191.88775510204,335.676870748299,253.272108843537,1088.94557823129,1942.97278911565,585.700680272109,109.204081632653,1062.4387755102,621.258503401361,512.741496598639,327.843537414966,1641.79591836735,973.680272108844,271.343537414966,227.425170068027,998.204081632653,930.017006802721,208.87074829932,197.261904761905,587.431972789116,890.551020408163,432.112244897959,212.091836734694,1042.08503401361,129.65306122449,294,24.2140507333517,15.558062062524,0.766267176812054,0.939297124600639,0.765625,1.56012994756457,51993.3503401361,35128.306122449,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_75409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75475,3056.25995316159,1255.037470726,125.824355971897,628.548009367682,1338.22950819672,3465.1943793911,554.098360655738,279.583138173302,1118.51522248244,4582.77049180328,579.96018735363,114.709601873536,1070.85011709602,911.259953161592,517.981264637002,280.081967213115,1920.16159250585,1390.99297423888,308.252927400468,245.391100702576,1025.8149882904,1170.64402810304,224.906323185012,155.337236533958,589.19906323185,1091.40046838407,464.768149882904,251.892271662763,1033.49414519906,131.428571428571,427,27.5442120441892,19.8418007589974,0.693598400778498,0.963882618510158,0.790740740740741,1.32480992486281,51066.0234192038,35492.3442622951,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75475,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75618,2162.16487455197,156.645161290323,88.4982078853047,594.89605734767,193.086021505376,2166.86379928315,302.996415770609,258.720430107527,1082.55555555556,4483.86021505376,438.247311827957,104.874551971326,1067.82795698925,779.878136200717,521.326164874552,296.272401433692,1580.76344086022,1300.71326164875,329.26523297491,236.283154121864,1004.52688172043,1130.68817204301,237.426523297491,200.838709677419,582.544802867384,3209.83512544803,465.652329749104,236.587813620072,1003.98924731183,127.989247311828,279,20.2954770021961,17.5943110540885,0.498468200714548,0.948979591836735,0.775,-1.34203256844536,50849.6021505376,35756.6200716846,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75618,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
75720,2357.83823529412,350.625,70.0147058823529,620.080882352941,802.716911764706,2560.14338235294,931.727941176471,253.007352941176,1094.45220588235,4920.5,544.022058823529,106.492647058824,1094.89705882353,1461.17279411765,1171.05147058824,692.386029411765,1770.80514705882,1709.36764705882,298.716911764706,238.588235294118,1007.09191176471,1513.68014705882,222.808823529412,164.672794117647,624.0625,1934.98529411765,501.198529411765,238.426470588235,1038.67279411765,130.305147058824,272,19.6760703589731,17.6580102549239,0.44114505150395,0.954385964912281,0.755555555555556,-1.34032231606455,51616.4301470588,35062.3235294118,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75720,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
76202,2644.69130434783,320.532608695652,129.223913043478,632.880434782609,1240.03695652174,3499.71956521739,377.34347826087,272.897826086957,1089.1847826087,5177.76739130435,588.7,128.686956521739,1085.58260869565,649.441304347826,467.369565217391,335.210869565217,1405.67826086957,1051.22173913043,337.617391304348,251.965217391304,993.410869565217,1016.21739130435,230.0,131.873913043478,588.873913043478,2171.85869565217,557.189130434783,226.576086956522,1049.7652173913,129.408695652174,460,30.0866174767731,19.5263765392712,0.760783819303909,0.960334029227557,0.755336617405583,-0.335803098405201,50774.8717391304,34545.9934782609,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_76202,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
76319,4601.33757961783,1109.33757961783,420.480891719745,703.095541401274,5058.07006369427,4619.46178343949,377.019108280255,272.716560509554,1161.42675159236,7393.16560509554,563.073248407643,125.073248407643,1086.75477707006,723.331210191083,626.226114649682,349.277070063694,1624.84394904459,1129.54140127389,305.764331210191,236.914012738854,990.885350318471,1170.35668789809,228.426751592357,214.468152866242,625.197452229299,2284.70382165605,564.990445859873,255.68152866242,1084.56687898089,130.31847133758,314,23.1429270629488,17.3898847433676,0.65983274459402,0.969135802469136,0.747619047619048,0.923699476156416,51803.2834394904,34949.8407643312,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_76319,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
76537,5020.03802281369,1067.00760456274,1833.00380228137,653.893536121673,2011.93155893536,4967.63498098859,407.513307984791,275.794676806084,1179.26615969582,8159.44866920152,538.140684410646,138.589353612167,1083.99239543726,798.543726235741,396.140684410646,273.825095057034,1544.74144486692,932.045627376426,215.961977186312,213.619771863118,1196.59695817491,830.395437262357,187.969581749049,224.121673003802,596.969581749049,2752.14448669202,564.783269961977,236.0,1070.71863117871,132.068441064639,263,23.8854830570034,14.0415105438037,0.80895688673757,0.970479704797048,0.782738095238095,1.4085932648629,51338.9087452472,35846.752851711,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_76537,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
77512,1124.5905707196,466.225806451613,265.930521091811,612.488833746898,582.037220843672,1337.87096774194,611.126550868486,254.14888337469,1087.78163771712,2459.38461538462,470.183622828784,106.426799007444,1064.86104218362,3398.45905707196,711.578163771712,408.657568238213,2225.57816377171,3503.60794044665,346.600496277916,236.037220843672,1044.62282878412,2936.95285359801,237.627791563275,226.511166253102,606.818858560794,1120.97022332506,480.352357320099,288.563275434243,1012.26054590571,130.679900744417,403,24.0981212720349,21.3249296540523,0.465741464403595,0.978155339805825,0.834368530020704,-0.32717770212127,51749.1513647643,35249.8287841191,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_77512,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
78026,2012.47949526814,624.649842271293,96.4700315457413,609.429022082019,509.328075709779,2021.85804416404,463.927444794953,268.006309148265,1104.29968454259,2722.97791798107,535.01261829653,112.034700315457,1070.32176656151,1360.88958990536,713.066246056782,434.526813880126,3531.68769716088,2627.71924290221,315.167192429022,239.826498422713,1042.80126182965,2601.70347003155,232.662460567823,178.965299684543,649.955835962145,942.268138801262,500.675078864353,228.214511041009,1012.4952681388,129.312302839117,317,21.7037041846741,18.6538551273305,0.5111728256072,0.954819277108434,0.758373205741627,-1.46452343811412,51612.7634069401,35019.3438485804,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_78026,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
78217,975.350806451613,263.302419354839,96.5927419354839,636.108870967742,1224.42741935484,1106.62096774194,2211.8185483871,255.120967741935,1086.90322580645,2386.89919354839,499.625,101.33064516129,1077.36290322581,943.592741935484,501.95564516129,276.79435483871,1835.55241935484,1445.22580645161,311.056451612903,233.850806451613,1023.99193548387,1189.6814516129,223.048387096774,148.600806451613,1341.81048387097,1217.36290322581,451.258064516129,1097.95564516129,1045.60887096774,128.858870967742,248,21.3734429360493,14.8240837987565,0.720384509656148,0.961240310077519,0.787301587301587,-1.32245798833906,51244.1451612903,35277.8467741935,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_78217,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
78371,1528.75416666667,142.7125,65.2458333333333,622.220833333333,1173.52916666667,1485.275,326.3625,256.5375,1085.16666666667,2983.8375,545.116666666667,125.929166666667,1068.47916666667,1409.16666666667,697.316666666667,287.825,1992.28333333333,1521.81666666667,320.166666666667,239.108333333333,1018.17083333333,1390.05,247.395833333333,417.091666666667,912.845833333333,1457.23333333333,457.566666666667,290.104166666667,1070.65416666667,129.841666666667,240,22.8067189538239,13.6511177200159,0.801080335826075,0.948616600790514,0.714285714285714,-1.08714148657924,51307.1208333333,35805.6291666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_78371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
78487,3784.47157894737,388.277894736842,119.332631578947,629.896842105263,1331.14105263158,4364.34526315789,2409.82105263158,262.130526315789,1104.97473684211,5592.38315789474,1280.17894736842,122.8,1078.04,656.341052631579,571.452631578947,337.149473684211,1663.39789473684,962.957894736842,286.258947368421,231.458947368421,995.983157894737,925.743157894737,201.532631578947,134.364210526316,606.231578947368,1029.37263157895,484.650526315789,287.147368421053,1035.93473684211,133.856842105263,475,27.7353634001984,21.8656448778261,0.615205245240099,0.977366255144033,0.83041958041958,1.14955193612408,51174.2294736842,34166.4378947368,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_78487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
78860,4570.16260162602,299.983739837398,124.959349593496,640.081300813008,1727.75609756098,4894.4593495935,1974.53658536585,278.642276422764,1101.77642276423,8716.01219512195,2912.20731707317,122.914634146341,1086.5081300813,1183.82926829268,720.243902439024,311.991869918699,1580.39024390244,1555.00406504065,323.89837398374,238.569105691057,1013.51219512195,1458.84146341463,223.776422764228,252.849593495935,689.813008130081,2189.5487804878,526.191056910569,516.556910569106,1066.16260162602,133.565040650407,246,21.4872064947272,14.5987287089092,0.733754294540634,0.946153846153846,0.780952380952381,1.45935029763757,51266.756097561,35077.8902439024,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_78860,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
79142,2506.66666666667,180.687134502924,87.1959064327485,634.03216374269,1911.4269005848,2593.26900584795,606.722222222222,259.745614035088,1093.93274853801,5155.14035087719,621.152046783626,113.073099415205,1089.95906432749,923.695906432748,812.611111111111,328.014619883041,1722.29532163743,2681.61695906433,336.614035087719,239.891812865497,1020.80994152047,3034.95614035088,269.614035087719,182.078947368421,622.321637426901,2255.44736842105,517.014619883041,259.698830409357,1051.92397660819,130.476608187135,342,22.1271314752615,19.8112425116597,0.445389058928817,0.957983193277311,0.777272727272727,-1.27883373417685,52098.8976608187,34950.4210526316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79142,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
79218,2014.78507462687,552.641791044776,66.4119402985075,618.692537313433,986.14328358209,2188.65671641791,675.555223880597,267.011940298507,1086.68358208955,4378.83582089552,727.370149253731,108.767164179104,1073.8447761194,960.94328358209,495.89552238806,295.89552238806,1667.77910447761,2083.7223880597,335.95223880597,374.597014925373,1015.30746268657,2422.86567164179,407.901492537314,189.074626865672,911.301492537313,2441.78507462687,496.411940298507,315.808955223881,1052.08955223881,130.334328358209,335,21.7313067876531,19.6543447639155,0.426631907973436,0.954415954415954,0.759637188208617,-0.767326668559926,51003.7343283582,35453.8059701493,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79218,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
79333,2966.39719626168,363.161214953271,106.911214953271,647.341121495327,2103.52336448598,3035.1191588785,939.859813084112,264.030373831776,1161.14719626168,5103.80140186916,1074.59345794393,114.593457943925,1083.8808411215,1009.71728971963,517.880841121495,289.663551401869,1565.44392523364,1045.85981308411,223.035046728972,214.439252336449,1427.39018691589,762.109813084112,180.857476635514,227.336448598131,597.299065420561,1424.76635514019,457.334112149533,606.794392523365,1045.63317757009,130.03738317757,428,25.6092954106428,21.3060408280332,0.554827919000205,0.966139954853273,0.77536231884058,-0.943774579843587,51578.3761682243,35671.1051401869,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
79527,4751.33647798742,1091.92452830189,131.418238993711,628.367924528302,1101.26100628931,5227.70125786163,1398.02830188679,276.85534591195,1089.41509433962,8130.42452830189,749.135220125786,122.383647798742,1089.16352201258,2574.27987421384,894.588050314465,440.503144654088,2126.61635220126,2210.4213836478,334.179245283019,243.424528301887,1019.16666666667,1680.89937106918,273.955974842767,297.352201257862,629.5,2757.84905660377,545.411949685535,291.632075471698,1051.69811320755,131.896226415094,318,24.008222910609,17.0534958106577,0.703879948631615,0.969512195121951,0.760765550239234,1.02017872531877,51430.0534591195,35102.427672956,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79527,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
80656,3794.99652777778,162.111111111111,339.145833333333,634.493055555556,1346.67013888889,3992.90625,593.527777777778,270.392361111111,1148.53125,7743.89583333333,698.753472222222,120.815972222222,1077.70833333333,802.666666666667,451.177083333333,279.489583333333,1534.76388888889,2250.27430555556,393.9375,244.430555555556,1180.93402777778,2370.19097222222,242.791666666667,378.222222222222,587.447916666667,4110.41666666667,543.135416666667,344.520833333333,1342.38541666667,131.034722222222,288,22.3160860177155,16.6154717679681,0.667565203388256,0.956810631229236,0.761904761904762,-1.19626929676098,50437.0416666667,35501.1770833333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_80656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
81294,2987.42857142857,464.256559766764,119.355685131195,626.142857142857,1238.44023323615,3692.02332361516,2162.19241982507,268.65306122449,1095.77259475219,6079.26239067055,744.725947521866,119.227405247813,1074.44897959184,4965.84839650146,686.495626822157,412.562682215743,1618.5860058309,6016.02332361516,409.297376093294,252.209912536443,1004.25364431487,6429.37609329446,308.839650145773,277.857142857143,667.370262390671,2336.11078717201,563.422740524781,240.930029154519,1057.60641399417,131.279883381924,343,25.3730303359382,17.2363369373803,0.733844729820366,0.966197183098592,0.745652173913044,-0.970908416051178,51121.6647230321,34998.5102040816,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_81294,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
82280,4170.93670886076,455.194092827004,148.413502109705,650.691983122363,2576.76793248945,4283.69620253165,1724.24894514768,257.856540084388,1082.77215189873,7668.8776371308,2659.51054852321,129.164556962025,1080.46835443038,1231.82278481013,720.080168776371,726.286919831224,1631.8776371308,2673.01687763713,396.004219409283,250.37552742616,1079.44725738397,3285.99578059072,261.637130801688,276.68776371308,786.751054852321,2780.38396624473,559.210970464135,375.966244725738,1082.69198312236,131.050632911392,237,19.5746307886898,15.5266300522992,0.608959023902493,0.936758893280632,0.692982456140351,-0.810281353481268,50954.582278481,33777.1308016878,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_82280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
82310,2258.98095238095,633.736507936508,467.936507936508,647.292063492063,1775.26666666667,2416.52063492064,668.853968253968,258.796825396825,1120.42222222222,4117.43492063492,464.498412698413,126.631746031746,1074.14285714286,1415.14920634921,739.425396825397,903.650793650794,2895.49206349206,2821.57777777778,397.352380952381,243.580952380952,1050.67619047619,2602.22222222222,290.714285714286,270.838095238095,618.765079365079,1863.07301587302,457.952380952381,329.053968253968,1056.29523809524,130.657142857143,315,21.1662966178597,18.9588232212808,0.444642562733705,0.963302752293578,0.789473684210526,0.172313465093765,51032.746031746,35884.0571428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_82310,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
82883,2249.16692667707,294.455538221529,107.8127925117,671.411856474259,1366.62090483619,3101.6224648986,386.552262090484,273.441497659906,1219.29641185647,4691.40561622465,659.976599063963,134.173166926677,1071.01560062402,925.365054602184,711.614664586583,296.386895475819,1453.70670826833,1486.34477379095,395.157566302652,253.550702028081,981.711388455538,1590.14820592824,262.892355694228,169.519500780031,781.778471138846,1765.83151326053,553.001560062403,246.745709828393,1081.12168486739,131.363494539782,641,33.1057888893958,24.8876540498758,0.659435216265692,0.969742813918306,0.776969696969697,0.0928242227905147,50605.2776911076,34248.5101404056,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_82883,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
83324,1727.18587360595,344.366790582404,99.6183395291202,615.94175960347,819.539033457249,2216.61214374226,2236.57496902107,275.783147459727,1084.14374225527,2820.30978934325,1127.05204460967,123.54770755886,1067.08798017348,1291.34324659232,506.548946716233,282.365551425031,1472.77571251549,2371.21437422553,352.169764560099,243.468401486989,995.443618339529,2421.53903345725,239.84634448575,147.12019826518,580.250309789343,1248.5551425031,554.285006195787,268.10780669145,1028.40396530359,130.428748451053,807,34.0523548794685,30.2155905813487,0.461139811355978,0.972289156626506,0.788856304985337,-0.997943286554961,50699.7732342007,34573.6282527881,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_83324,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
83787,3503.04843304843,893.222222222222,112.464387464387,642.136752136752,1885.28774928775,3059.37606837607,731.207977207977,268.934472934473,1101.12820512821,5691.00854700855,612.809116809117,116.877492877493,1082.150997151,2916.15384615385,1167.62962962963,765.746438746439,1928.65811965812,2619.4415954416,405.031339031339,244.62962962963,1032.93162393162,2366.2735042735,267.458689458689,295.814814814815,705.618233618234,1426.5641025641,452.883190883191,302.837606837607,1020.10826210826,129.706552706553,351,23.7863101267894,18.875038628239,0.608537274953554,0.969613259668508,0.769736842105263,0.156911530620749,51492.6296296296,35625.7264957265,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_83787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
84295,3934.30593607306,460.616438356164,77.2694063926941,612.082191780822,877.931506849315,3931.14611872146,424.876712328767,264.662100456621,1104.75799086758,8028.04109589041,581.429223744292,115.013698630137,1068.08675799087,2296.22374429224,768.799086757991,321.598173515982,2382.90410958904,2548.38812785388,385.406392694064,247.232876712329,1057.6803652968,2192.48401826484,281.091324200913,358.401826484018,593.196347031963,3674.34703196347,543.123287671233,270.269406392694,1060.57534246575,130.077625570776,219,17.9263515243462,15.5918529390834,0.493452407354528,0.969026548672566,0.760416666666667,1.25372536268336,51939.8721461187,34959.6529680365,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_84295,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
85274,3478.26829268293,421.003484320558,133.393728222997,654.456445993031,2204.39024390244,3146.57142857143,4997.42160278746,279.885017421603,1101.9512195122,5674.44947735192,1463.98954703833,120.414634146341,1085.66202090592,5907.86411149826,945.341463414634,350.947735191638,4467.86759581882,6180.22648083624,461.268292682927,251.031358885017,1085.73867595819,4808.25783972125,259.97212543554,257.146341463415,599.630662020906,1833.08362369338,475.439024390244,604.222996515679,1072.05226480836,131.811846689895,287,21.7762169807602,16.8222713362328,0.635006734823506,0.950331125827814,0.767379679144385,1.54242942300889,50887.0975609756,35531.2055749129,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85274,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
85345,2367.3152173913,436.454347826087,108.739130434783,625.841304347826,1104.35434782609,2506.37826086957,3218.8,249.119565217391,1093.07173913043,3455.50217391304,978.282608695652,110.091304347826,1076.46086956522,805.176086956522,941.515217391304,551.286956521739,2677.66956521739,1016.2347826087,293.10652173913,230.85652173913,995.878260869565,933.458695652174,189.210869565217,139.754347826087,604.708695652174,858.591304347826,461.502173913043,267.895652173913,1029.24565217391,130.189130434783,460,24.8913464047638,23.6272903963562,0.314621983716523,0.964360587002096,0.736,-0.56412563796661,51145.3434782609,34172.2195652174,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85345,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
85616,2380.84057971014,611.811594202899,237.717948717949,699.317725752508,5130.09364548495,2344.26978818283,1848.28985507246,270.523968784838,1094.02341137124,2643.99331103679,2832.14715719064,125.919732441472,1080.23411371237,715.616499442586,545.480490523969,281.173913043478,1429.10367892977,1049.55406911929,359.307692307692,244.246376811594,988.560758082497,985.771460423634,233.21850613155,131.820512820513,584.226309921962,730.916387959866,454.270903010034,216.327759197324,1003.12931995541,128.911928651059,897,40.9174592984861,28.0025757225385,0.729137329656667,0.968682505399568,0.754415475189235,0.179450516750593,50912.9241917503,34130.4960981048,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_85616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
86963,3158.56280193237,310.763285024155,105.5,634.809178743961,1257.99275362319,3674.6690821256,541.128019323672,268.028985507246,1087.961352657,5973.85024154589,705.942028985507,128.565217391304,1083.01207729469,669.429951690821,494.671497584541,278.857487922705,1387.03140096618,1045.23429951691,339.632850241546,241.432367149758,985.68115942029,1027.09661835749,235.676328502415,127.971014492754,578.898550724638,2659.99758454106,519.427536231884,312.756038647343,1054.79951690821,131.685990338164,414,30.4907476031975,18.1588399630822,0.803316412607213,0.960556844547564,0.657142857142857,-0.334002861144044,50539.4492753623,34783.3429951691,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_86963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
87385,4262.31793478261,1031.27989130435,782.282608695652,641.85597826087,2139.89945652174,4297.71739130435,374.54347826087,276.366847826087,1176.36956521739,6400.38043478261,589.486413043478,130.260869565217,1077.91304347826,1452.94836956522,719.369565217391,781.013586956522,4374.51630434783,3169.00543478261,378.532608695652,251.171195652174,1141.89130434783,3168.85597826087,333.489130434783,1258.22554347826,724.20652173913,2052.90760869565,519.782608695652,247.475543478261,1040.5027173913,130.404891304348,368,23.3269390497884,20.1771793085905,0.501817895939106,0.955844155844156,0.8,0.0583214556111139,50989.9347826087,35788.6413043478,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_87385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
87864,4059.24691358025,936.707818930041,94.5020576131687,654.111111111111,2222.74074074074,4423.01646090535,1261.17695473251,283.555555555556,1116.04938271605,8571.86008230453,2972.54732510288,133.024691358025,1083.05349794239,983.349794238683,724.452674897119,334.493827160494,1599.59259259259,1328.39094650206,326.942386831276,244.320987654321,998.995884773662,1036.43209876543,217.831275720165,145.810699588477,593.625514403292,3089.32510288066,568.781893004115,281.679012345679,1044.35802469136,130.448559670782,243,18.9658234181529,16.4310972713313,0.499432225035606,0.941860465116279,0.75,0.683274039213127,51655.695473251,34856.6913580247,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_87864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
88923,1829.92084432718,849.836411609499,99.5435356200528,623.572559366755,1252.05277044855,1748.8654353562,463.018469656992,272.018469656992,1094.48548812665,2463.64907651715,531.005277044855,114.928759894459,1068.7598944591,1679.59366754617,886.889182058047,342.926121372032,1813.4327176781,4240.13984168865,403.116094986807,246.379947229551,1031.81794195251,5071.81530343008,815.029023746702,274.622691292876,589.569920844327,980.712401055409,467.622691292876,220.517150395778,1011.99472295515,129.569920844327,379,24.6148801739766,19.6970695909239,0.599720096977455,0.954659949622166,0.751984126984127,-0.443406445005434,51436.0448548813,35608.6121372032,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_88923,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
89386,2236.02325581395,225.552325581395,67.4622093023256,626.656976744186,1298.83139534884,2594.48546511628,1430.95639534884,259.56976744186,1089.65697674419,4656.54941860465,1735.56976744186,110.886627906977,1075.38662790698,1064.55523255814,1134.50581395349,284.392441860465,2239.84011627907,1535.3226744186,382.816860465116,242.421511627907,1027.03197674419,1211.87209302326,225.354651162791,155.761627906977,584.767441860465,1742.04360465116,507.622093023256,300.848837209302,1081.44186046512,130.593023255814,344,24.9682493036828,17.5918087452599,0.709637304067711,0.966292134831461,0.744588744588745,0.646126852207564,50552.113372093,34230.261627907,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_89386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
89473,3230.4,173.464285714286,82.9142857142857,628.971428571429,1509.03571428571,3454.52142857143,518.621428571429,260.335714285714,1079.68571428571,6065.05714285714,533.257142857143,116.042857142857,1069.05714285714,1892.4,1337.99285714286,929.178571428571,1801.81428571429,1960.61428571429,314.65,235.428571428571,1025.43571428571,1533.8,232.078571428571,763.192857142857,661.935714285714,2535.4,506.607142857143,236.157142857143,1027.93571428571,129.457142857143,140,15.9237209550553,11.2203172463526,0.709575805853171,0.939597315436242,0.729166666666667,1.23896612156321,50506.2785714286,34270.3571428571,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89473,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
89593,2687.1010989011,344.432967032967,140.32967032967,700.487912087912,2268.75384615385,3426.07912087912,1233.76923076923,264.265934065934,1129.65054945055,5993.79120879121,3774.58021978022,127.413186813187,1077.81758241758,690.47032967033,509.316483516484,276.481318681319,1368.83736263736,1030.31648351648,314.797802197802,235.221978021978,983.213186813187,968.351648351648,216.881318681319,124.931868131868,582.059340659341,2699.27032967033,568.698901098901,638.23956043956,1105.30769230769,130.536263736264,455,34.6214700646843,16.7745064838129,0.874784794048428,0.953878406708595,0.743464052287582,0.16783143968756,50349.8923076923,34283.4505494506,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_89593,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
89952,2674.83265306122,1087.8693877551,92.0775510204082,622.94693877551,1220.76326530612,2724.72653061224,321.216326530612,246.832653061224,1223.35102040816,5354.20408163265,505.057142857143,111.697959183673,1067.14285714286,2458.52244897959,604.416326530612,301.436734693878,1713.42040816327,2935.91836734694,362.477551020408,245.90612244898,1035.25306122449,2618.31020408163,251.836734693878,599.457142857143,880.677551020408,1858.91428571429,468.016326530612,248.363265306122,1021.47346938776,130.25306122449,245,18.4338359440025,16.9093161015904,0.39820202303907,0.98,0.800653594771242,1.29363356511968,51915.3469387755,34192.8571428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
90657,3986.5907821229,749.768156424581,323.037709497207,698.653631284916,2936.99720670391,4609.5125698324,917.22905027933,270.326815642458,1157.53212290503,7531.71927374302,2631.78072625698,128.494413407821,1080.08100558659,612.916201117318,483.600558659218,330.740223463687,1438.37569832402,909.652234636872,275.949720670391,228.504189944134,979.06843575419,866.810055865922,209.66061452514,141.210893854749,590.06843575419,3283.9594972067,613.712290502793,428.335195530726,1117.47625698324,133.328212290503,716,32.3998097201735,28.2438392706583,0.489989110588535,0.967567567567568,0.771551724137931,-0.203361286296375,51615.3198324022,34167.562849162,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_90657,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
91247,5120.63888888889,1314.29166666667,871.302083333333,628.496527777778,1364.18402777778,5166.13541666667,446.708333333333,278.75,1139.22569444444,8386.95138888889,613.989583333333,124.388888888889,1080.77430555556,2064.65625,924.288194444444,424.954861111111,2122.49652777778,2576.5625,341.756944444444,234.451388888889,1050.91319444444,2462.34722222222,230.420138888889,201.934027777778,596.631944444444,2055.30902777778,502.09375,236.361111111111,1063.62152777778,133.128472222222,288,20.1992910608785,18.2235936616947,0.431339341314018,0.96,0.8,0.130696501749934,50906.0034722222,35445.4409722222,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_91247,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
91528,2417.83239171375,461.423728813559,117.612052730697,638.354048964218,1211.67608286252,2770.31073446328,3547.97175141243,268.369114877589,1096.03389830508,4657.84557438795,1802.75141242938,115.431261770245,1087.38229755179,3095.33333333333,790.785310734463,551.04143126177,1911.0395480226,2620.91902071563,344.25988700565,240.926553672316,1039.72316384181,1223.35028248588,221.094161958569,354.612052730697,585.322033898305,2140.72693032015,480.587570621469,448.715630885122,1064.20903954802,131.858757062147,531,29.7113936217603,23.0862853509927,0.629478472929719,0.965454545454546,0.7375,-0.339142978765456,49966.2128060264,35205.2033898305,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_91528,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
91661,4745.86725663717,323.271386430678,123.286135693215,653.563421828909,2498.80235988201,5612.10619469027,752.339233038348,266.619469026549,1106.41002949853,8110.6401179941,953.076696165192,125.017699115044,1088.05309734513,1285.60471976401,758.622418879056,298.362831858407,2011.83185840708,1316.44837758112,266.427728613569,223.578171091445,1254.44247787611,875.454277286136,166.82005899705,132.0,1653.2005899705,1633.6784660767,512.433628318584,249.781710914454,1082.60471976401,134.283185840708,339,22.241070624967,19.599832759274,0.472659721390282,0.960339943342776,0.770454545454546,0.167620678656036,51263.5309734513,34064.1268436578,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_91661,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
91743,1893.8533145275,123.280677009873,85.5613540197461,639.627644569817,1695.68406205924,2183.62341325811,399.313117066291,268.449929478138,1090.42736248237,4294.90550070522,612.779971791255,116.314527503526,1070.3215796897,1576.07052186178,764.125528913963,962.42736248237,1549.97743300423,1526.55712270804,289.043723554302,229.983074753173,1003.74894217207,1307.38928067701,207.679830747532,437.368124118477,622.291960507757,2349.4682651622,493.504936530324,223.787023977433,1076.62341325811,131.047954866008,709,43.9229331507731,20.6952490967898,0.882041438973894,0.950402144772118,0.716161616161616,-1.51766713933881,50042.6191819464,35202.2482369535,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_91743,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
92610,1733.50325732899,107.407166123778,95.4413680781759,668.193811074919,2238.88436482085,2188.27035830619,284.936482084691,245.969055374593,1117.43811074919,4183.05048859935,520.28338762215,120.801302931596,1081.0325732899,971.737785016287,546.436482084691,280.358306188925,1444.87296416938,1061.44625407166,282.861563517915,229.837133550489,985.913680781759,1041.95439739414,208.315960912052,134.14657980456,591.64006514658,2406.27850162866,515.298045602606,225.047231270358,1051.91530944625,130.596091205212,614,36.1516046311403,21.7357782076486,0.799068758116805,0.962382445141066,0.685267857142857,-0.935662955476292,51560.4478827362,34317.993485342,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_92610,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
93760,4259.48698884758,358.115241635688,229.64312267658,708.970260223048,6341.46468401487,5202.93680297398,382.074349442379,284.256505576208,1129.843866171,8580.23791821561,598.28624535316,131.936802973978,1084.38661710037,1126.83643122677,641.899628252788,302.914498141264,1786.30855018587,1560.72118959108,306.847583643123,235.728624535316,1003.90334572491,1781.69144981413,226.078066914498,173.104089219331,590.698884758364,2987.23791821561,547.182156133829,234.260223048327,1078.89591078067,132.364312267658,269,20.6810904832081,16.5840132548682,0.597468217353884,0.967625899280576,0.800595238095238,-1.51779455729035,51238.9628252788,34983.5204460967,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_93760,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
94404,2740.83923705722,217.403269754768,73.0790190735695,630.422343324251,1509.6348773842,3203.39782016349,687.016348773842,265.027247956403,1088.26975476839,5426.81471389646,502.318801089918,113.092643051771,1085.57493188011,2204.49863760218,1064.19346049046,1239.13623978202,1784.78201634877,5260.10354223433,410.711171662125,250.190735694823,1056.43324250681,5422.52861035422,286.825613079019,909.760217983651,626.719346049046,2347.60762942779,526.686648501362,234.566757493188,1039.88555858311,132.395095367847,367,22.5733372612569,20.9414157570386,0.37331214902912,0.96578947368421,0.758264462809917,-1.3626531583069,51266.2370572207,35142.1416893733,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_94404,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
94884,2825.40656565657,619.911616161616,752.260101010101,662.775252525253,3174.43181818182,3611.69444444444,352.717171717172,259.674242424242,1104.98232323232,5712.57575757576,532.361111111111,118.861111111111,1074.28535353535,1159.0101010101,770.765151515152,509.643939393939,1772.57323232323,1982.22474747475,334.876262626263,409.868686868687,991.94696969697,1525.60606060606,244.982323232323,164.176767676768,597.530303030303,2123.43686868687,545.121212121212,293.613636363636,1061.88383838384,130.717171717172,396,25.3407082256481,20.0425835136955,0.611913925210057,0.963503649635036,0.792,-1.52503385730101,51897.4772727273,34724.3383838384,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_94884,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
94911,2437.00427350427,651.136752136752,72.2777777777778,608.794871794872,702.115384615385,2255.15384615385,345.867521367521,261.555555555556,1091.80341880342,5572.47008547009,477.448717948718,130.166666666667,1072.33333333333,1236.98290598291,567.32905982906,279.897435897436,1588.46153846154,1423.65811965812,332.568376068376,232.918803418803,1004.97008547009,1266.60256410256,232.662393162393,187.901709401709,1994.33333333333,3694.5641025641,539.957264957265,259.025641025641,1030.65384615385,130.970085470085,234,19.6681316807882,15.2462010831953,0.631749238534678,0.966942148760331,0.821052631578947,-1.46875455086778,51569.6025641026,35426.3461538462,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_94911,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
95639,2374.08353808354,580.366093366093,119.334152334152,635.373464373464,1102.81818181818,2817.22604422604,2768.84520884521,266.891891891892,1100.16953316953,3422.03194103194,1759.65847665848,117.437346437346,1075.41769041769,1042.74692874693,622.452088452088,296.746928746929,1725.49877149877,1229.67076167076,363.022113022113,243.599508599509,1011.58968058968,1094.1769041769,232.845208845209,159.899262899263,585.995085995086,1185.88452088452,538.412776412776,275.936117936118,1042.98771498771,131.130221130221,407,26.5341758113124,19.8385604492092,0.664080927553622,0.953161592505855,0.782692307692308,-0.209165607987472,50994.2481572482,34337.6461916462,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_95639,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
95982,2562.17557251908,583.587786259542,419.022900763359,852.847328244275,11746.2061068702,2853.69465648855,376.106870229008,273.526717557252,1108.58778625954,4931.26717557252,901.770992366412,142.687022900763,1066.27480916031,847.06106870229,487.18320610687,270.893129770992,1553.75572519084,1039.82442748092,300.198473282443,235.419847328244,1001.19083969466,1045.3358778626,215.984732824427,143.740458015267,607.175572519084,1492.90839694656,518.190839694656,225.572519083969,1024.98473282443,130.610687022901,131,14.4125352760739,11.6228861958215,0.591312024593629,0.942446043165468,0.775147928994083,0.653128932782694,51054.2671755725,34008.2290076336,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_95982,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
96456,3532.1124260355,265.05325443787,102.881656804734,619.698224852071,590.98224852071,3695.73964497041,873.976331360947,268.775147928994,1095.23668639053,4914.72781065089,1253.38461538462,128.094674556213,1069.19526627219,755.591715976331,489.295857988166,265.704142011834,1526.55621301775,1192.42603550296,285.869822485207,230.183431952663,1101.10059171598,1083.79881656805,202.899408284024,191.147928994083,899.739644970414,772.047337278107,430.183431952663,223.360946745562,1027.2426035503,134.994082840237,169,17.3234780033112,12.5020517275062,0.692224169921911,0.965714285714286,0.764705882352941,-0.191722434250277,51339.8934911243,33817.1597633136,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_96456,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
97995,3268.5787965616,392.469914040115,155.902578796562,652.719197707736,2477.05730659026,4101.64183381089,1166.47277936963,268.974212034384,1097.39255014327,5765.33810888252,2856.65616045845,136.338108882521,1068.76790830946,874.942693409742,711.825214899714,283.641833810888,1501.09742120344,1065.02865329513,301.085959885387,233.30659025788,999.229226361032,989.300859598854,206.896848137536,145.14899713467,601.656160458453,1814.40114613181,534.756446991404,361.856733524355,1047.08309455587,128.882521489971,349,22.4684484659675,19.8535937918557,0.468202796193862,0.961432506887052,0.793181818181818,-0.564689102045469,50838.4756446991,34589.3810888252,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_97995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
98435,3070.70447761194,138.253731343284,85.8716417910448,629.337313432836,1449.45373134328,3643.45373134328,348.137313432836,261.967164179104,1100.88358208955,5611.11940298507,655.489552238806,132.964179104478,1077.29850746269,638.644776119403,440.540298507463,336.328358208955,1514.11641791045,800.635820895522,228.09552238806,223.2,995.101492537313,697.182089552239,161.570149253731,135.394029850746,587.534328358209,1625.51940298507,527.420895522388,233.182089552239,1063.13432835821,130.958208955224,335,22.3582219733715,19.1019911327358,0.519680108790459,0.954415954415954,0.761363636363636,-1.45923613258638,51119.7582089552,34311.447761194,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_98435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
98574,4268.47634069401,1291.44794952681,144.274447949527,664.955835962145,3135.77287066246,4556.45110410095,748.041009463722,266.198738170347,1089.57413249211,7027.77287066246,1142.67192429022,126.340694006309,1078.67192429022,1521.90220820189,792.757097791798,316.662460567823,2263.66561514196,1876.45741324921,343.006309148265,240.485804416404,1243.05362776025,1091.6309148265,191.258675078864,179.17665615142,3206.05047318612,1817.70977917981,540.583596214511,338.760252365931,1086.7665615142,132.350157728707,317,22.6080217188635,17.9438489082068,0.608317346938168,0.951951951951952,0.754761904761905,-0.564811066276068,51287.7129337539,34068.3596214511,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_98574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
98607,3122.05993690852,410.492113564669,97.8517350157729,637.725552050473,1710.03785488959,3608.82649842271,4301.6119873817,260.552050473186,1091.14195583596,5669.57728706625,1031.13880126183,110.381703470032,1073.94321766562,741.148264984227,495.804416403786,274.283911671924,1586.70662460568,2028.62460567823,360.009463722397,242.078864353312,1001.69085173502,2153.2523659306,235.876971608833,434.735015772871,582.851735015773,1221.89589905363,497.741324921136,255.059936908517,1016.17665615142,129.728706624606,317,21.3670888040419,19.1368587211913,0.444813700887971,0.954819277108434,0.754761904761905,1.5674350180824,51379.1545741325,34617.2649842271,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_98607,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
98901,1939.76388888889,212.058333333333,79.8444444444444,615.441666666667,790.077777777778,2183.04722222222,2374.60277777778,252.352777777778,1097.11666666667,3849.20833333333,1841.65,104.063888888889,1064.54166666667,696.002777777778,483.852777777778,269.877777777778,1384.10833333333,948.888888888889,280.472222222222,226.113888888889,1030.975,879.65,210.180555555556,133.466666666667,584.722222222222,1650.63611111111,463.483333333333,253.6,1037.74722222222,130.180555555556,360,25.9824631359946,17.7775105397697,0.729283259213442,0.949868073878628,0.72,-0.436797519617812,49901.7194444444,34661.5277777778,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_98901,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
99062,3529.36858974359,1111.00961538462,1909.67628205128,660.612179487179,2477.83653846154,3758.19871794872,636.275641025641,267.038461538462,1107.48076923077,5816.59294871795,545.628205128205,121.214743589744,1084.47756410256,3856.98717948718,1403.33012820513,771.182692307692,1866.11858974359,4576.65384615385,429.439102564103,255.439102564103,1024.99038461538,3673.79487179487,287.525641025641,293.26282051282,707.471153846154,1457.14102564103,486.224358974359,261.371794871795,1057.70833333333,129.541666666667,312,21.6671494503985,18.5179813704581,0.519193007474052,0.96,0.781954887218045,0.289412288371605,51993.7275641026,35083.3173076923,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_99062,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
99284,3859.51769911504,373.004424778761,109.995575221239,624.743362831858,992.91592920354,3646.30530973451,958.526548672566,282.314159292035,1116.47787610619,5988.28761061947,2975.25221238938,127.154867256637,2254.96017699115,3927.92477876106,739.889380530973,439.41592920354,2874.21238938053,4830.91150442478,463.650442477876,239.836283185841,1096.08849557522,4586.56194690266,255.690265486726,284.743362831858,616.150442477876,1457.23451327434,556.880530973451,411.83185840708,1053.71681415929,130.12389380531,226,17.7754692615376,16.2432210863097,0.406164794339913,0.969957081545064,0.830882352941177,-1.40946209090634,50920.1991150442,35406.3274336283,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_99284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
100364,2167.54117647059,152.094117647059,83.0588235294118,632.6,2032.92941176471,2210.67058823529,332.411764705882,251.039215686275,1100.80392156863,4056.29411764706,488.419607843137,112.094117647059,1074.70980392157,615.466666666667,419.109803921569,352.466666666667,1584.33333333333,921.56862745098,241.972549019608,220.313725490196,978.533333333333,835.478431372549,196.192156862745,153.956862745098,599.721568627451,1173.90196078431,469.576470588235,223.470588235294,1048.51764705882,130.113725490196,255,18.5370642409413,17.5550624441045,0.321159980421018,0.965909090909091,0.745614035087719,-1.39151499886061,52029.0431372549,34346.1921568627,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_100364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
100498,2026.41772151899,577.144303797468,67.6835443037975,632.810126582278,1361.2253164557,2072.98987341772,810.850632911392,254.048101265823,1097.11139240506,3090.86582278481,503.336708860759,106.549367088608,1076.19746835443,966.855696202532,567.060759493671,288.60253164557,1577.96455696203,1266.16962025316,249.650632911392,225.407594936709,997.789873417722,1319.47848101266,201.713924050633,206.886075949367,632.660759493671,912.946835443038,466.93417721519,544.154430379747,1020.55189873418,130.121518987342,395,23.7244240393694,21.2658460844704,0.443308046349724,0.972906403940887,0.817805383022774,-1.30521848825726,51627.2,34930.3113924051,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_100498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
100615,3906.65799256506,241.434944237918,151.14126394052,659.53531598513,3079.32342007435,3740.28624535316,599.973977695167,274.899628252788,1145.53531598513,6764.48698884758,627.888475836431,119.698884758364,1100.89591078067,3898.57992565056,1005.55762081784,426.063197026022,2995.21933085502,3129.59851301115,340.241635687732,239.081784386617,1038.40520446097,2373.7063197026,247.754646840149,246.197026022305,615.646840148699,3189.71003717472,498.074349442379,284.096654275093,1065.15241635688,130.918215613383,269,22.3872197714028,15.3667453050664,0.72721755513614,0.96415770609319,0.753501400560224,1.09796548583602,50915.6394052045,35669.2342007435,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_100615,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
100719,3197.8578553616,1203.26184538653,2247.52119700748,629.127182044888,1302.88528678304,3676.64588528678,1797.26932668329,273.192019950125,1102.69825436409,5470.28428927681,1039.71072319202,115.531172069825,1083.97755610973,895.209476309227,932.910224438903,1992.15710723192,3534.09975062344,1317.60598503741,288.029925187032,233.630922693267,1004.89027431421,1390.30673316708,228.009975062344,363.84289276808,608.187032418953,1773.90024937656,503.845386533666,390.68578553616,1072.00498753117,131.296758104738,401,25.3731711602407,20.3095692092317,0.59941982724527,0.961630695443645,0.795634920634921,-0.357875139556387,50951.3865336658,35612.0199501247,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_100719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
101248,2779.11641791045,322.337313432836,79.3880597014925,639.325373134328,1536.98208955224,3153.70746268657,3226.13731343284,253.307462686567,1110.37014925373,5094.09552238806,1323.52835820896,117.90447761194,1075.7223880597,606.29552238806,451.89552238806,308.55223880597,1362.17014925373,897.319402985075,278.34328358209,231.677611940299,987.298507462686,866.208955223881,210.985074626866,145.119402985075,593.110447761194,1131.8447761194,479.149253731343,358.75223880597,1067.42686567164,130.731343283582,335,23.0924100545302,18.5391860030348,0.596213465601187,0.97667638483965,0.809178743961353,-0.0918312874466368,51458.7194029851,33867.4955223881,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_101248,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
102407,1807.86808510638,821.625531914894,111.885106382979,625.251063829787,1331.15744680851,1659.04680851064,1149.57872340426,270.353191489362,1092.82127659574,2584.0170212766,1010.1914893617,114.617021276596,1072.49361702128,840.293617021277,459.034042553192,281.029787234043,1499.56170212766,1049.56170212766,277.259574468085,225.927659574468,991.034042553192,998.48085106383,211.548936170213,172.940425531915,845.872340425532,955.812765957447,498.685106382979,311.063829787234,1025.29361702128,129.71914893617,235,18.4409199794763,16.2978849357767,0.467885396129726,0.959183673469388,0.773026315789474,0.172934509252585,51866.3531914894,35214.1404255319,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_102407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
102568,3381.83276450512,415.365187713311,117.003412969283,635.880546075085,1640.49146757679,3442.25255972696,3407.84641638225,279.460750853242,1099.9385665529,5617.88054607509,1867.795221843,117.341296928328,1076.88054607509,1513.19453924915,684.307167235495,539.450511945392,2332.41979522184,3274.61774744027,337.587030716724,233.860068259386,1036.27645051195,3738.65529010239,277.713310580205,254.334470989761,602.726962457338,1894.23890784983,490.675767918089,1138.04436860068,1070.33788395904,130.150170648464,293,22.0967193028583,17.0390062639663,0.636701669523935,0.957516339869281,0.775132275132275,-1.16736243290323,50943.5426621161,35593.8600682594,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_102568,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
102645,2832.81030444965,201.571428571429,161.615925058548,687.976580796253,4142.81264637002,3459.31147540984,477.334894613583,256.983606557377,1101.08899297424,5828.54566744731,508.948477751756,116.775175644028,1087.65573770492,693.936768149883,438.646370023419,292.416861826698,1610.1943793911,952.878220140515,212.770491803279,214.749414519906,997.430913348946,897.824355971897,175.154566744731,165.754098360656,611.665105386417,2287.11475409836,508.128805620609,253.585480093677,1050.62763466042,132.627634660422,427,28.0281002298786,19.5882583566812,0.715239651832968,0.970454545454546,0.832358674463938,-1.4067909201482,52000.8196721311,34478.355971897,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_102645,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
103070,1777.6359832636,812.330543933054,137.033472803347,663.665271966527,2646.21338912134,1838.37656903766,1354.51046025105,267.305439330544,1142.73221757322,4108.24686192469,2016.12970711297,112.046025104603,1077.54811715481,704.410041841004,575.083682008368,317.171548117155,1562.1589958159,1514.21338912134,310.108786610879,232.627615062761,1013.75313807531,1586.17991631799,229.36820083682,175.213389121339,580.092050209205,2085.50209205021,544.008368200837,356.548117154812,1071.02928870293,131.309623430962,239,20.4439481267768,14.8989180572223,0.684759499213459,0.967611336032389,0.739938080495356,0.986797959933554,51302.820083682,35423.9665271967,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_103070,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
103264,4739.51546391753,954.109965635739,1384.07560137457,668.907216494845,3569.15807560137,5000.19243986254,2000.66666666667,278.384879725086,1107.72508591065,7340.60824742268,617.931271477663,143.044673539519,1078.6735395189,1565.80756013746,791.604810996564,411.089347079038,2967.37113402062,3626.84879725086,450.058419243986,261.357388316151,1074.54295532646,3482.6323024055,309.979381443299,296.137457044674,613.72852233677,2182.79037800687,522.697594501718,437.704467353952,1078.74570446735,131.817869415808,291,20.1594196947073,18.4359822572696,0.404564264969197,0.96039603960396,0.76984126984127,-1.2387582675439,50923.2817869416,35821.7903780069,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_103264,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
103343,4259.5017921147,1118.32616487455,127.046594982079,665.673835125448,3135.44444444444,4752.28673835125,447.641577060932,282.691756272401,1120.36200716846,7538.95340501792,624.516129032258,122.437275985663,1109.55913978495,684.333333333333,473.763440860215,289.94623655914,1435.64874551971,1106.05376344086,326.906810035842,237.878136200717,996.21146953405,1043.93189964158,244.448028673835,140.745519713262,608.326164874552,2258.27598566308,524.598566308244,229.329749103943,1072.15053763441,133.028673835125,279,20.6655703872978,17.2085549946939,0.553700054477484,0.962068965517241,0.775,-0.988034938396692,50768.0430107527,35261.6738351254,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_103343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
103678,4871.92542372881,1202.06779661017,1984.09830508475,645.28813559322,1994.1593220339,4338.47796610169,698.786440677966,275.769491525424,1278.25084745763,8066.98644067797,944.084745762712,119.830508474576,1087.91525423729,4529.90169491525,1085.83050847458,544.593220338983,2188.78305084746,4325.46440677966,398.966101694915,239.023728813559,1050.87796610169,3429.79661016949,295.593220338983,884.64406779661,650.945762711864,2954.43389830508,568.393220338983,421.433898305085,1059.8813559322,132.884745762712,295,21.2091671938239,17.8498429120037,0.54008605644456,0.970394736842105,0.78042328042328,-0.299653589078092,51369.1389830508,35676.9830508475,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_103678,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
104567,1697.12151394422,295.898406374502,142.750996015936,673.882470119522,3411.29282868526,1882.85258964143,2397.11354581673,254.390438247012,1098.40836653386,3046.97211155378,4858.64741035857,111.812749003984,1068.75896414343,736.802788844622,575.607569721116,273.553784860558,1502.42430278884,1097.3984063745,314.870517928287,236.081673306773,991.332669322709,1022.04581673307,219.527888446215,149.229083665339,583.778884462151,1078.63147410359,473.737051792829,569.762948207171,1069.47410358566,133.782868525896,502,31.8041783772515,20.1720026638637,0.773122797289008,0.958015267175572,0.74702380952381,1.54635455993875,51405.9741035857,34601.9581673307,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
104799,3626.2358490566,345.72641509434,135.566037735849,619.031446540881,947.864779874214,4152.93710691824,642.845911949686,269.735849056604,1105.01886792453,7192.19811320755,575.09748427673,116.160377358491,1083.72955974843,2179.9213836478,833.64465408805,826.660377358491,1739.75786163522,1506.0251572327,317.820754716981,239.185534591195,1021.80503144654,1224.84905660377,229.415094339623,205.72641509434,591.569182389937,2157.20440251572,530.981132075472,266.864779874214,1042.61949685535,129.971698113208,318,21.2942825649545,19.1383139290442,0.438453985890819,0.954954954954955,0.757142857142857,0.594969878031174,51247.4308176101,35118.3270440252,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
104891,4646.564,1042.068,2269.852,648.972,2108.992,4719.06,1295.928,275.112,1119.572,7055.464,1659.94,125.044,1073.828,2554.576,920.372,938.164,3660.396,3949.268,398.592,247.916,1042.908,3260.188,278.22,282.548,682.648,1602.968,573.988,546.912,1068.804,131.92,250,19.5318338942772,16.3134087402469,0.549913582910657,0.972762645914397,0.773993808049536,1.24233142287728,51929.916,34836.448,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_104891,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
105269,2825.94236311239,367.982708933718,194.795389048991,683.904899135447,3980.56195965418,3267.29971181556,338.394812680115,264.64265129683,1092.43227665706,4843.0,581.400576368876,127.832853025937,1087.07204610951,661.210374639769,484.121037463977,272.472622478386,1450.12680115274,1036.2939481268,336.919308357349,241.293948126801,984.126801152738,1038.4265129683,227.625360230548,169.291066282421,595.948126801153,1694.25360230548,539.129682997118,226.149855907781,1056.49567723343,129.478386167147,347,29.8277726249637,14.8210922513443,0.867814102807331,0.971988795518207,0.797701149425287,1.40819759688992,50981.795389049,34116.2161383285,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_105269,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
105487,1908.73200992556,333.153846153846,136.560794044665,607.133995037221,428.18858560794,2078.3746898263,587.384615384615,265.870967741935,1089.37965260546,4201.10669975186,496.523573200992,107.196029776675,1069.25558312655,1917.58808933002,517.898263027295,712.27047146402,1629.24813895782,2592.36724565757,348.153846153846,846.692307692308,1017.56327543424,2031.46898263027,307.548387096774,266.548387096774,605.560794044665,2611.59801488834,489.779156327543,511.079404466501,1027.10918114144,127.632754342432,403,27.410631351577,18.7588347969447,0.729141029167748,0.954976303317536,0.746296296296296,-0.123541033985795,50996.3374689826,35427.8114143921,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_105487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
105558,1491.34674922601,203.904024767802,92.0743034055728,612.835913312693,879.984520123839,1879.41795665635,333.393188854489,263.783281733746,1082.1919504644,3559.0866873065,541.681114551084,115.02786377709,1070.89473684211,804.30959752322,635.28173374613,282.334365325077,1399.97213622291,1301.89473684211,347.659442724458,247.609907120743,981.941176470588,1209.63157894737,233.235294117647,194.09907120743,633.978328173375,2343.35913312693,534.585139318885,222.349845201238,1041.51083591331,131.758513931889,323,21.7494580833444,19.0177293389619,0.48520550639056,0.958456973293769,0.80952380952381,-0.0404566125424115,50421.0092879257,34483.2848297214,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_105558,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
106878,2167.85428571429,456.611428571429,91.5028571428571,647.005714285714,2074.63142857143,2616.87142857143,531.885714285714,269.545714285714,1095.74571428571,4548.32,576.797142857143,112.92,1096.69428571429,1288.21142857143,521.96,373.322857142857,1579.36857142857,3071.34571428571,296.774285714286,231.802857142857,996.631428571429,3434.25714285714,223.022857142857,185.934285714286,596.328571428571,1731.82857142857,487.32,234.782857142857,1054.50857142857,128.285714285714,350,23.6972092504643,18.9252403609386,0.601825799397931,0.956284153005464,0.757575757575758,-0.849629865613488,50887.62,35346.1257142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106878,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
107113,3529.26732673267,421.977722772277,99.9034653465347,643.69801980198,805.940594059406,4614.89108910891,1122.41831683168,272.445544554455,1133.30198019802,5451.25247524752,1034.94554455446,121.80198019802,1078.18564356436,754.445544554455,551.230198019802,288.532178217822,1356.39108910891,1151.7400990099,376.445544554455,248.871287128713,978.559405940594,1117.55693069307,254.683168316832,123.769801980198,597.858910891089,1374.63613861386,477.544554455446,321.871287128713,1076.30940594059,133.618811881188,404,25.2505084169786,20.4454415254097,0.586838295398932,0.973493975903614,0.841666666666667,0.253287356611072,50364.2277227723,34744.3589108911,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_107113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
107638,2427.52604166667,379.164930555556,143.258680555556,639.581597222222,1300.34548611111,3162.61805555556,2099.85590277778,272.248263888889,1097.65277777778,4846.88541666667,1641.57291666667,133.557291666667,1069.65625,586.194444444444,466.541666666667,269.154513888889,1398.11284722222,892.657986111111,279.107638888889,231.387152777778,997.446180555556,831.637152777778,200.244791666667,130.828125,581.383680555556,2492.92881944444,591.423611111111,335.149305555556,1116.36631944444,133.131944444444,576,29.4302684521735,25.0831337860829,0.523068982148047,0.96,0.791208791208791,0.465592075298723,50212.2621527778,34112.0503472222,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_107638,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108429,2430.08291457286,385.78391959799,187.103015075377,667.464824120603,3188.43718592965,2859.75628140704,442.731155778895,278.369346733668,1091.70854271357,4656.41457286432,582.824120603015,125.459798994975,1087.90452261307,852.281407035176,864.319095477387,272.349246231156,1546.25125628141,1116.25376884422,290.143216080402,228.356783919598,996.442211055276,1046.77135678392,224.711055276382,175.020100502513,625.967336683417,1818.20100502513,499.369346733668,226.399497487437,1075.54522613065,130.776381909548,398,28.6661059271134,17.9873944347586,0.778633064997823,0.952153110047847,0.695804195804196,-0.883306853752748,50478.6155778894,35446.1507537688,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108429,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108668,2393.79649122807,261.512280701754,133.659649122807,670.061403508772,3678.15964912281,2859.21578947368,352.347368421053,265.071929824561,1095.90877192982,4635.28070175439,871.750877192982,134.687719298246,1068.10175438597,4205.58771929825,852.117543859649,387.108771929825,2818.73157894737,4566.52280701754,411.09649122807,246.919298245614,1023.40526315789,1541.02456140351,216.335087719298,195.731578947368,596.545614035088,1452.54385964912,506.20350877193,226.878947368421,1063.68421052632,131.331578947368,570,29.9526083227642,24.3242285322777,0.583531513485765,0.967741935483871,0.814285714285714,1.1384316489663,51505.4157894737,33995.3350877193,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108668,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108699,2817.69565217391,633.775362318841,284.80193236715,624.951690821256,1250.8115942029,3576.56038647343,695.243961352657,260.932367149758,1117.88405797101,6009.461352657,1584.29710144928,117.200483091787,1073.09661835749,717.850241545894,492.869565217391,275.43961352657,1452.74396135266,1121.86714975845,341.176328502415,244.446859903382,978.272946859903,1060.29710144928,233.951690821256,134.118357487923,585.384057971014,2787.54589371981,593.541062801932,339.777777777778,1066.25362318841,131.386473429952,414,27.2295996886509,19.5627229579443,0.695593131705459,0.960556844547564,0.766666666666667,-1.56568152351789,51619.6884057971,34406.2753623188,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108831,4491.90034364261,171.931271477663,72.2096219931271,641.762886597938,2355.06529209622,4423.51890034364,518.061855670103,268.13058419244,1098.57388316151,7261.2439862543,616.694158075601,117.182130584192,1090.60481099656,666.931271477663,508.185567010309,303.134020618557,1678.27835051546,1006.264604811,253.690721649484,227.113402061856,994.378006872852,933.649484536082,200.666666666667,147.182130584192,588.06529209622,1927.9381443299,530.360824742268,252.621993127148,1057.87628865979,131.388316151203,291,20.421398320636,18.172923876822,0.456163162218586,0.973244147157191,0.808333333333333,-1.40137116058805,51958.4467353952,34868.3024054983,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_108831,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108837,4909.46370967742,901.495967741936,1402.5564516129,632.899193548387,1537.27822580645,5166.71774193548,1356.40322580645,277.826612903226,1114.86693548387,8097.79032258064,587.161290322581,120.112903225806,1076.35887096774,3380.57661290323,1001.67741935484,877.108870967742,1666.02419354839,5754.01612903226,367.657258064516,245.66935483871,1004.52419354839,6117.35080645161,324.673387096774,504.596774193548,712.282258064516,2289.27822580645,546.233870967742,549.479838709677,1044.84677419355,129.959677419355,248,19.1247713395513,16.5702596909488,0.499300009476908,0.96875,0.767801857585139,-1.52014611876053,51639.8830645161,35101.2943548387,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_108837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
108882,3075.27135678392,597.547738693467,595.108040201005,622.241206030151,758.055276381909,3471.03266331658,632.738693467337,283.258793969849,1094.05778894472,4734.36432160804,1227.20100502513,127.266331658291,1071.19849246231,704.78391959799,458.040201005025,276.412060301508,1518.09045226131,1065.97738693467,303.600502512563,239.291457286432,982.721105527638,1025.34924623116,226.439698492462,138.221105527638,583.879396984925,2337.05527638191,655.188442211055,278.356783919598,1041.66834170854,129.912060301508,398,28.5755295392003,17.7824053624011,0.782782918912886,0.956730769230769,0.692173913043478,-0.655407344944151,51904.932160804,34540.7060301508,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108882,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
109065,3429.71924290221,630.927444794953,951.902208201893,647.621451104101,2583.88643533123,3696.87066246057,1225.70662460568,258.596214511041,1095.11987381703,6438.32176656151,898.223974763407,116.586750788644,1077.68138801262,610.8738170347,633.760252365931,272.041009463722,1569.03785488959,1030.93059936909,307.07570977918,231.870662460568,994.738170347003,920.015772870662,208.599369085173,160.470031545741,582.593059936909,2175.95899053628,529.640378548896,323.429022082019,1051.65299684543,131.593059936909,317,22.1101068130828,18.276121187128,0.562796056778747,0.975384615384615,0.794486215538847,-0.582506968509826,51482.1766561514,34892.523659306,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_109065,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
109865,2287.8476702509,255.202508960573,102.08064516129,622.879928315412,1315.94982078853,2982.83154121864,3151.20250896057,257.944444444444,1091.73476702509,3999.79390681004,701.139784946237,119.025089605735,1071.16666666667,702.890681003584,552.462365591398,281.127240143369,1515.46594982079,1032.59856630824,355.091397849462,243.81541218638,987.448028673835,969.829749103943,237.462365591398,159.903225806452,584.566308243728,1475.99641577061,513.564516129032,275.281362007168,1056.33691756272,131.4229390681,558,29.8167047690837,24.0952965290379,0.58902611534725,0.96875,0.765432098765432,0.720938980712565,50744.7759856631,34153.8960573477,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_109865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
109932,2178.12322274882,163.061611374408,165.412322274882,676.625592417062,3767.69668246446,2298.43601895735,324.668246445498,257.350710900474,1090.42654028436,4387.34123222749,505.208530805687,117.232227488152,1072.77725118483,838.682464454976,515.218009478673,273.914691943128,1515.02369668246,1021.56398104265,268.090047393365,226.18009478673,990.0,977.625592417062,212.758293838863,158.303317535545,582.81990521327,1736.51658767773,480.303317535545,220.554502369668,1039.90995260663,129.563981042654,211,18.5398140020151,14.6027505802983,0.616132174367732,0.946188340807175,0.732638888888889,0.609755410870336,51959.9478672986,35139.5308056872,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_109932,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
109990,3430.66355140187,465.242990654206,151.971962616822,640.233644859813,1767.18691588785,3526.34112149533,2929.02803738318,274.322429906542,1097.61682242991,6199.27570093458,5521.55140186916,116.275700934579,1073.11214953271,2697.69158878505,1208.05140186916,616.191588785047,1767.46261682243,2889.14018691589,332.107476635514,231.827102803738,1021.90654205607,2892.78504672897,274.299065420561,242.289719626168,644.457943925234,2215.28504672897,477.747663551402,618.285046728972,1078.19158878505,131.630841121495,214,17.3713877724213,15.6897023120061,0.429236311482623,0.968325791855204,0.786764705882353,1.43062710167682,50219.8738317757,35292.9953271028,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_109990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
110232,4179.80368098159,1129.99693251534,489.248466257669,644.506134969325,2348.89263803681,5363.26073619632,484.401840490798,276.515337423313,1122.91717791411,7814.08895705521,673.156441717791,118.634969325153,1081.23619631902,934.521472392638,834.650306748466,278.536809815951,1648.6226993865,1576.60429447853,359.444785276074,242.846625766871,1003.90797546012,1402.44478527607,240.165644171779,174.60736196319,585.325153374233,2842.5490797546,582.447852760736,282.687116564417,1058.49386503067,131.168711656442,326,21.2729390967277,19.550517208185,0.394182334171002,0.967359050445104,0.817042606516291,1.54388693155582,51247.5153374233,34963.1932515337,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_110232,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
110863,1609.50649350649,480.506493506493,122.45974025974,639.441558441558,1866.32987012987,1980.54285714286,1379.74545454545,256.85974025974,1093.28311688312,3694.87272727273,860.306493506494,117.34025974026,1070.43116883117,4424.18701298701,633.568831168831,333.631168831169,1624.9012987013,5072.90649350649,418.041558441558,251.953246753247,1061.61298701299,4627.17922077922,265.044155844156,2408.62857142857,703.381818181818,1844.93766233766,569.784415584416,648.901298701299,1078.14025974026,133.532467532468,385,23.47859443077,20.9628598538018,0.450354437795329,0.974683544303797,0.797101449275362,1.4160265474385,51117.6233766234,34383.6051948052,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_110863,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
111021,2636.5684754522,1092.78552971576,1655.52713178295,684.09819121447,3626.48062015504,2707.69250645995,3379.70542635659,259.664082687339,1111.90439276486,3878.53746770026,2573.45736434109,124.894056847545,1070.07235142119,1102.01033591731,844.532299741602,327.136950904393,3980.87338501292,2357.57105943152,418.217054263566,248.630490956072,1049.83204134367,2150.64599483204,2512.49612403101,1093.15245478036,1105.0180878553,1259.834625323,563.821705426357,460.010335917313,1068.51679586563,131.77519379845,387,22.9693031349753,21.5165083672034,0.349997605252259,0.9675,0.801242236024845,-0.323127172680494,51470.7932816537,33803.8914728682,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67+,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_111021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
111762,2168.86647727273,251.460227272727,118.775568181818,653.448863636364,2036.24147727273,2825.45170454545,342.602272727273,261.673295454545,1095.5625,3263.11363636364,543.590909090909,117.548295454545,1137.42045454545,1027.66761363636,531.835227272727,278.40625,1463.94318181818,2867.31534090909,358.403409090909,241.306818181818,1018.45170454545,3314.73011363636,251.545454545455,714.380681818182,584.571022727273,1259.59090909091,473.619318181818,215.133522727273,1040.26420454545,129.988636363636,352,26.8209093255158,16.8795029381811,0.777129119957409,0.948787061994609,0.712550607287449,-0.362938764229903,50085.2926136364,34483.5454545455,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_111762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
112212,1661.16352201258,1000.88679245283,122.220125786164,677.459119496855,2352.60691823899,2033.67295597484,4175.03773584906,268.103773584906,1122.81761006289,2776.06603773585,562.081761006289,111.62893081761,1072.31446540881,1691.09119496855,535.930817610063,292.46855345912,1636.05031446541,4081.04088050314,383.182389937107,245.525157232704,1025.23899371069,3769.43710691824,259.339622641509,185.286163522013,834.981132075472,1131.00314465409,441.487421383648,1338.08805031447,1053.61635220126,132.301886792453,318,21.6939493985489,18.6902194184138,0.507688581990309,0.963636363636364,0.72108843537415,-0.942660985778121,51146.0503144654,35447.144654088,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_112212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
112906,2767.83841463415,423.396341463415,160.128048780488,650.210365853659,2296.28963414634,4086.28353658537,480.716463414634,278.533536585366,1116.51524390244,5103.56402439024,528.149390243902,116.481707317073,1099.7743902439,1725.68292682927,594.506097560976,314.783536585366,1778.44207317073,2834.67987804878,343.774390243902,236.40243902439,1090.72865853659,2687.5487804878,236.125,265.97256097561,2393.34756097561,2218.01524390244,478.17987804878,259.786585365854,1054.64329268293,129.213414634146,328,25.5361422890159,17.2420228662883,0.737634004027491,0.923943661971831,0.663967611336032,-1.3955668248792,50792.9024390244,35586.7621951219,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_112906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
114436,3619.755,836.33,605.48,622.65,1306.175,2903.085,380.555,266.98,1152.995,6128.84,551.57,112.105,1074.385,5115.36,869.69,1333.78,1949.39,2722.265,336.22,245.84,1028.885,2684.56,249.14,374.515,673.235,2881.27,499.215,249.07,1047.935,128.58,200,19.8548819909249,12.8285019049944,0.763241571151909,0.966183574879227,0.740740740740741,-0.515345389749358,50994.115,35588.26,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114436,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
114735,3702.07514450867,1837.36705202312,3031.60115606936,627.473988439306,1580.87283236994,3688.19942196532,800.031791907515,280.06936416185,1109.5549132948,4330.00289017341,659.985549132948,119.416184971098,1084.87283236994,6010.8063583815,1488.40173410405,353.260115606936,2043.96820809249,7551.93641618497,429.78323699422,254.413294797688,1027.13583815029,7170.0,285.884393063584,204.413294797688,593.367052023121,1157.20809248555,522.315028901734,302.184971098266,1027.09537572254,131.580924855491,346,25.2509117454891,17.4636531201899,0.722276073618392,0.969187675070028,0.752173913043478,-0.924895835008264,51531.8497109827,34893.6445086705,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
114984,1943.81297709924,249.360687022901,93.4484732824428,636.477099236641,2014.67175572519,2308.24618320611,1426.63167938931,266.538167938931,1091.14122137405,3507.46564885496,2870.49045801527,124.74427480916,1075.90839694656,966.267175572519,498.55534351145,283.269083969466,2007.60496183206,1647.16603053435,343.543893129771,245.88358778626,1031.01145038168,1494.97328244275,250.551526717557,206.612595419847,1186.21374045802,1569.39885496183,463.986641221374,756.230916030534,1066.59732824427,129.05534351145,524,29.5932785858326,22.5858719241616,0.646151088865251,0.973977695167286,0.752873563218391,-0.391498868223181,50740.9561068702,35804.7595419847,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_114984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115072,3149.25766871166,1042.27607361963,1707.78527607362,637.80981595092,2140.46012269939,3241.83435582822,545.319018404908,258.067484662577,1110.58895705521,3991.15337423313,613.018404907975,113.184049079755,1081.81595092025,679.447852760736,492.914110429448,269.78527607362,1575.07975460123,1107.53374233129,279.558282208589,231.877300613497,983.098159509202,1037.05521472393,224.60736196319,139.349693251534,583.411042944785,1251.14110429448,650.153374233129,262.509202453988,1029.57055214724,129.472392638037,163,16.2726407336309,12.8234180692735,0.61562984000153,0.947674418604651,0.679166666666667,-1.07072331180173,51832.2760736196,34656.8711656442,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_115072,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115122,2271.90064102564,150.407051282051,70.6121794871795,642.769230769231,1672.49679487179,2155.38461538462,304.009615384615,243.669871794872,1093.63461538462,4440.33974358974,597.233974358974,114.509615384615,1082.6858974359,701.650641025641,684.451923076923,314.355769230769,1481.19230769231,1116.50320512821,312.528846153846,238.650641025641,983.599358974359,1079.44871794872,224.205128205128,190.035256410256,643.759615384615,1568.15705128205,494.445512820513,222.737179487179,1066.04807692308,131.179487179487,312,25.4997818901168,15.6081078352514,0.790789736950451,0.954128440366972,0.71395881006865,-1.06582032873047,51294.0833333333,33706.0480769231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_115122,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115412,3632.83392226148,1190.71024734982,155.250883392226,671.600706713781,2657.60777385159,4026.98233215548,1110.66431095406,279.696113074205,1188.17314487633,4918.75971731449,1131.54416961131,131.183745583039,1078.97879858657,2300.9964664311,1318.95053003534,724.332155477032,1908.89752650177,3981.93286219081,374.526501766784,242.067137809187,1025.81625441696,4352.80212014134,255.572438162544,406.427561837456,808.795053003534,1047.0,473.43109540636,434.876325088339,1059.35335689046,133.572438162544,283,23.2439658864282,15.5649049139804,0.742693002051467,0.949664429530201,0.723785166240409,1.26372621469458,50566.6890459364,35061.2473498233,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_115412,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115562,3337.55555555556,593.09604519774,177.322033898305,655.210922787194,2236.52165725047,4276.66666666667,3912.85310734463,293.105461393597,1128.12429378531,5819.85687382298,988.790960451977,128.90395480226,1072.47080979284,723.35593220339,568.941619585687,273.645951035782,1473.72316384181,1094.12241054614,301.092278719397,230.623352165725,994.077212806026,1067.89265536723,224.23352165725,240.016949152542,587.91713747646,2260.18079096045,524.623352165725,379.35593220339,1128.75894538606,132.124293785311,531,38.6615538429366,17.5747905091367,0.890705631073004,0.955035971223022,0.7375,0.0079526902625213,50453.779661017,35486.0338983051,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_115562,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115885,3028.58241758242,246.345054945055,83.0659340659341,630.958241758242,1393.22857142857,2663.6989010989,397.536263736264,268.463736263736,1105.88131868132,4042.36043956044,643.336263736264,115.072527472527,1072.26373626374,747.701098901099,552.443956043956,437.975824175824,1508.47692307692,1082.78021978022,294.410989010989,232.58021978022,993.303296703297,1017.51428571429,225.476923076923,187.538461538462,591.345054945055,617.206593406593,361.767032967033,204.074725274725,998.797802197802,128.874725274725,455,26.8554452247094,21.85658731282,0.581060247922017,0.959915611814346,0.791304347826087,0.979059670615682,51920.8065934066,35287.7824175824,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_115885,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
115964,2422.46843177189,137.67617107943,110.696537678208,660.071283095723,2598.3116089613,3079.39511201629,420.682281059063,263.91649694501,1097.48268839104,4582.95112016293,599.519348268839,138.828920570265,1069.57026476578,1847.68431771894,654.028513238289,352.668024439918,1794.43380855397,2425.97148676171,317.238289205703,237.488798370672,1041.76578411405,2212.03258655804,208.93482688391,176.549898167006,603.091649694501,1358.18737270876,477.926680244399,227.258655804481,1070.48268839104,130.580448065173,491,31.4292982707744,20.2541610991854,0.764658524180729,0.972277227722772,0.754224270353303,1.28516104457837,50269.9918533605,34795.1853360489,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_115964,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116199,3509.88674033149,955.03591160221,102.961325966851,625.795580110497,976.604972375691,4048.41160220994,371.270718232044,265.069060773481,1113.38397790055,6585.89226519337,517.850828729282,113.950276243094,1087.95303867403,772.831491712707,473.850828729282,280.864640883978,1473.38674033149,930.458563535912,209.850828729282,214.864640883978,1251.2044198895,677.046961325967,158.933701657459,129.71270718232,595.704419889503,1975.92817679558,480.837016574586,227.941988950276,1060.7955801105,131.138121546961,362,23.3685661128737,19.7427500131775,0.535015620705838,0.967914438502674,0.793859649122807,0.0301530525518904,50241.9834254144,35064.2624309392,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_116199,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116233,2293.67,480.325,62.875,617.4,646.545,2524.57,1866.02,258.09,1158.54,3173.62,631.28,122.905,1087.16,784.595,650.265,1084.115,3759.93,1267.13,299.92,228.48,1050.67,1169.755,223.455,254.355,658.83,1018.71,468.895,1172.535,1031.76,130.975,200,18.1614015984354,14.090432639928,0.630923556812151,0.956937799043062,0.740740740740741,1.14032129986579,51102.315,35877.835,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116646,2045.26751592357,344.608280254777,151.374203821656,646.031847133758,2244.14808917197,2614.77388535032,341.488853503185,263.235668789809,1089.44267515924,3783.25159235669,548.18949044586,120.59076433121,1086.70859872611,1081.53662420382,857.117834394904,278.971337579618,1961.10031847134,1604.93152866242,358.945859872611,239.764331210191,1062.81687898089,1426.78025477707,218.334394904459,242.264331210191,618.156050955414,1422.85668789809,501.523885350318,220.020700636943,1046.84394904459,129.533439490446,628,39.3117118356203,20.605112242802,0.851627863491287,0.96319018404908,0.747619047619048,-1.53327703336889,50497.5493630573,34123.5334394904,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_116646,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116814,2035.68145800317,348.987321711569,142.139461172742,636.551505546751,1839.08874801902,2290.43740095087,3032.48494453249,259.857369255151,1106.69572107765,2945.19175911252,1695.22820919176,117.101426307448,1069.18700475436,1066.77337559429,594.350237717908,408.559429477021,1439.8351822504,1239.52773375594,337.152139461173,239.803486529318,1042.34548335975,1175.58161648177,237.315372424723,147.120443740095,587.632329635499,1009.90015847861,480.820919175911,254.125198098257,1057.1236133122,131.678288431062,631,34.0277571570929,23.6996791958345,0.717575437697707,0.963358778625954,0.742352941176471,-1.40313386708838,50198.5229793978,34199.0903328051,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116913,2888.3024691358,332.907407407407,652.833333333333,646.515432098765,2217.19444444444,3060.72530864198,888.027777777778,264.935185185185,1150.3950617284,5133.73456790123,762.932098765432,125.070987654321,1074.03395061728,2337.91358024691,608.87962962963,311.956790123457,1587.17901234568,2195.75925925926,340.567901234568,237.774691358025,1011.4475308642,1903.32098765432,260.293209876543,239.626543209877,612.907407407407,2081.90432098765,532.049382716049,301.274691358025,1061.25,130.648148148148,324,23.7335394947911,17.4639395277686,0.677162227539294,0.964285714285714,0.74141876430206,-1.27314925834582,51419.5864197531,35803.9814814815,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116913,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116957,2513.74215246637,254.540358744395,103.170403587444,629.013452914798,1263.13004484305,3407.61210762332,745.094170403587,272.706278026906,1086.81614349776,5662.97757847534,1395.55829596413,125.748878923767,1071.55829596413,679.020179372197,543.062780269058,266.97533632287,1471.99551569507,1051.76905829596,297.230941704036,233.881165919282,997.890134529148,982.233183856502,208.45067264574,157.701793721973,582.32735426009,3377.68385650224,595.280269058296,630.735426008969,1093.21076233184,132.952914798206,446,26.4938268273259,21.5999440751633,0.579063914664611,0.971677559912854,0.816849816849817,0.0153284985847315,50597.8923766816,34687.0739910314,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116957,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
116996,3861.83090379009,854.623906705539,180.396501457726,617.725947521866,1115.23032069971,3881.02915451895,351.6472303207,275.740524781341,1120.3556851312,6451.54518950437,542.434402332362,114.271137026239,1074.62682215743,1646.67055393586,737.66472303207,487.985422740525,4435.56851311953,3081.10787172012,348.34110787172,235.241982507289,1101.48396501458,2591.42274052478,223.711370262391,328.405247813411,663.871720116618,1590.68513119534,471.037900874636,220.338192419825,1042.39358600583,129.443148688047,343,22.9822085462459,19.0208386187985,0.561269364447064,0.977207977207977,0.820574162679426,1.1717737215225,50813.4023323615,35372.0437317784,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116996,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
117311,2485.62222222222,204.3,117.364814814815,645.533333333333,1988.88703703704,3246.69074074074,323.412962962963,261.92037037037,1085.82222222222,4940.59074074074,563.944444444444,121.059259259259,1066.88333333333,604.642592592593,467.290740740741,269.014814814815,1422.84259259259,1019.17592592593,336.666666666667,245.166666666667,979.118518518518,940.081481481481,227.953703703704,137.161111111111,587.190740740741,2439.44259259259,551.92037037037,227.959259259259,1048.86851851852,130.677777777778,540,35.0515338161653,19.6488589717075,0.828106644260006,0.966010733452594,0.73469387755102,-0.23264600859343,50759.0666666667,34356.312962963,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_117311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
117676,3515.5775862069,366.704022988506,128.344827586207,641.916666666667,2135.28448275862,3884.82471264368,677.649425287356,275.336206896552,1096.26149425287,6487.80172413793,1087.99425287356,115.41091954023,1095.44827586207,2078.03735632184,746.060344827586,334.235632183908,4091.12931034483,3773.74137931034,376.152298850575,241.758620689655,1117.97701149425,3519.96551724138,239.764367816092,296.933908045977,670.64367816092,2054.75862068966,502.083333333333,302.525862068966,1067.48850574713,129.994252873563,348,22.7029823601559,19.6436717260983,0.501347007612628,0.969359331476323,0.796338672768879,-1.54500922537551,50815.6120689655,35311.3879310345,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
117836,4365.23558897243,452.315789473684,179.007518796992,679.701754385965,4005.78696741855,5095.56140350877,2430.4962406015,301.285714285714,1108.54636591479,7027.78446115288,3276.4335839599,136.917293233083,1088.1954887218,666.328320802005,478.082706766917,291.822055137845,1452.2656641604,965.197994987469,280.483709273183,229.070175438596,993.548872180451,884.170426065163,203.974937343358,139.726817042607,583.12030075188,2465.21804511278,560.822055137845,813.165413533835,1101.59147869674,132.611528822055,399,29.3756543768619,17.3236500353485,0.807601832683292,0.959134615384615,0.671717171717172,-0.524221273406851,50669.8220551378,35265.0726817043,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117836,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
117972,3592.12615384615,904.953846153846,121.009230769231,633.156923076923,1368.37538461538,3753.51384615385,588.418461538462,270.227692307692,1107.64307692308,5418.41538461538,501.836923076923,111.904615384615,1080.40615384615,1381.77846153846,630.596923076923,303.295384615385,1914.38461538462,1449.27692307692,300.196923076923,233.110769230769,1037.41846153846,1109.23384615385,212.356923076923,160.609230769231,1386.28923076923,1382.97538461538,507.563076923077,290.513846153846,1030.91076923077,131.055384615385,325,25.1716291323509,16.6628971093812,0.749529147381908,0.961538461538462,0.703463203463203,0.879469978886373,51285.4861538462,35315.5353846154,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
118704,3072.81707317073,570.978048780488,74.8170731707317,633.663414634146,1084.16097560976,3312.90975609756,805.478048780488,267.143902439024,1091.71951219512,4611.43658536585,804.209756097561,113.153658536585,1074.99024390244,1069.90243902439,861.673170731707,910.69756097561,1657.14634146341,1248.4512195122,304.434146341463,226.6,1008.16829268293,1108.02926829268,207.036585365854,301.89756097561,658.929268292683,790.239024390244,408.860975609756,360.063414634146,1008.01951219512,130.29756097561,410,27.1911082618554,19.2399103179079,0.706632290421302,0.953488372093023,0.732142857142857,0.259697132769126,51733.4512195122,35228.3414634146,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_118704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
119488,2571.74149659864,267.377551020408,129.697278911565,655.598639455782,2379.87074829932,3279.60204081633,353.904761904762,267.159863945578,1097.09523809524,4189.80952380952,536.544217687075,119.214285714286,1085.09183673469,774.374149659864,439.401360544218,268.040816326531,1676.59863945578,1097.56802721088,260.578231292517,230.901360544218,1010.13945578231,937.414965986395,185.802721088435,127.734693877551,593.615646258503,1321.44897959184,503.959183673469,232.826530612245,1053.27210884354,130.37074829932,294,22.6292453739784,16.6273532413799,0.678313335186655,0.957654723127036,0.703349282296651,1.10047936565825,50295.2891156463,34711.3537414966,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_119488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
119490,4346.77391304348,1197.33913043478,128.408695652174,640.539130434783,1638.00869565217,5288.76811594203,577.252173913044,277.365217391304,1123.14492753623,5570.8,522.214492753623,111.866666666667,1078.09565217391,908.510144927536,553.707246376812,280.547826086957,1874.3768115942,1374.36811594203,302.428985507246,235.660869565217,1042.66666666667,1139.00579710145,218.47536231884,163.878260869565,980.684057971014,1038.89855072464,437.852173913043,356.310144927536,1020.0,131.098550724638,345,25.4556891420659,17.2667392016286,0.734779809784265,0.963687150837989,0.811764705882353,1.41524031714263,51301.2202898551,35271.9391304348,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_119490,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
119876,3127.86379928315,298.111111111111,100.035842293907,629.387096774194,1380.78136200717,3450.07168458781,485.853046594982,281.143369175627,1092.41577060932,4411.35125448029,637.534050179211,119.186379928315,1073.91756272401,672.921146953405,441.924731182796,285.326164874552,1427.10752688172,964.039426523298,261.569892473118,227.827956989247,990.111111111111,886.146953405018,217.523297491039,143.724014336918,603.89605734767,968.960573476702,442.093189964158,261.021505376344,1029.22580645161,132.448028673835,279,21.9872642075882,16.2980122752026,0.671231426540493,0.958762886597938,0.734210526315789,-0.602085981898255,50610.6415770609,35395.7813620072,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_119876,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
120031,3379.22707423581,193.026200873362,136.406113537118,640.235807860262,1828.10480349345,3145.41048034935,392.187772925764,284.873362445415,1097.23580786026,5883.93886462882,547.423580786026,116.008733624454,1079.60698689956,1081.94323144105,479.733624454148,315.454148471616,1488.7423580786,1220.95633187773,290.35807860262,235.353711790393,985.847161572052,1147.14410480349,230.834061135371,155.414847161572,595.331877729258,2565.94759825327,508.46288209607,279.515283842795,1049.6768558952,129.851528384279,229,21.7633910029219,13.6502755389847,0.778848002674469,0.94238683127572,0.743506493506494,-1.5374348260413,51289.0480349345,35457.9170305677,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_120031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
120083,3913.35628742515,1259.91017964072,108.946107784431,665.865269461078,2482.68562874251,4850.32335329341,933.706586826347,269.09880239521,1155.59580838323,6664.52095808383,1302.7874251497,137.679640718563,1076.88023952096,790.461077844311,1468.08682634731,278.847305389222,1713.05389221557,1044.94610778443,275.880239520958,230.110778443114,1003.08383233533,917.775449101796,193.398203592814,154.200598802395,641.526946107784,1879.49700598802,524.209580838323,405.116766467066,1074.97904191617,133.550898203593,334,22.0036954903134,19.3482911583865,0.476231253211974,0.965317919075144,0.759090909090909,-1.3231230968502,50868.5329341317,34474.1167664671,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_120083,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
120416,3673.19653179191,1428.1676300578,121.910404624277,667.326589595376,2865.73988439306,3372.78034682081,1875.98265895954,272.14450867052,1272.92196531792,5285.57803468208,1470.33526011561,116.893063583815,1083.20520231214,5513.26878612717,741.277456647399,403.341040462428,1800.54624277457,3879.0838150289,345.64161849711,243.849710982659,1017.25722543353,2957.89595375723,241.381502890173,185.861271676301,786.335260115607,1489.29479768786,484.85549132948,695.78612716763,1068.75722543353,132.28323699422,346,22.1981064422973,19.9241501510123,0.44089070345322,0.958448753462604,0.748917748917749,1.49227178599652,51069.563583815,35563.0462427746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_120416,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
120447,3855.30901287554,239.326180257511,110.643776824034,637.197424892704,2537.30042918455,3846.26180257511,512.248927038627,273.085836909871,1119.39055793991,6130.30472103004,939.163090128755,120.708154506438,1076.90128755365,906.386266094421,495.50643776824,282.75965665236,1607.4678111588,910.669527896996,216.510729613734,230.047210300429,1144.83261802575,695.476394849785,161.240343347639,158.845493562232,599.236051502146,1898.39484978541,644.201716738197,528.356223175966,1084.69527896996,130.725321888412,233,21.2379950493671,13.9862746456719,0.752537262364321,0.951020408163265,0.792517006802721,1.55699414513811,51844.1502145923,34830.30472103,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_120447,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
121365,3317.41907514451,688.757225433526,67.1791907514451,627.005780346821,1210.59826589595,2935.85260115607,1035.88728323699,265.164739884393,1112.08959537572,5958.45375722543,1688.54046242775,111.158959537572,1099.91040462428,4600.26300578035,1115.18786127168,515.838150289017,5849.17919075145,3133.8901734104,345.0,232.361271676301,1017.04624277457,2298.43641618497,237.343930635838,208.343930635838,608.491329479769,1912.69075144509,453.64161849711,361.630057803468,1039.96242774566,129.907514450867,346,24.6085094538437,17.9368678810376,0.684632062231728,0.961111111111111,0.752173913043478,-0.991772158809157,51203.6184971098,35713.338150289,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_121365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
121479,3409.03821656051,592.799363057325,97.015923566879,627.993630573248,1722.57643312102,3203.36305732484,837.531847133758,267.076433121019,1134.06369426752,6904.13694267516,972.535031847134,116.487261146497,1076.16878980892,841.732484076433,543.509554140127,281.143312101911,1624.92675159236,1381.99044585987,303.257961783439,231.175159235669,1009.8949044586,1200.22292993631,220.226114649682,239.496815286624,1932.96815286624,3420.03184713376,544.43949044586,322.025477707006,1052.71656050955,130.993630573248,314,21.0554778028128,19.1642971873005,0.414210611807554,0.960244648318043,0.785,0.800937713915297,51595.601910828,35351.6560509554,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_121479,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
122119,2053.84716157205,142.454148471616,85.2096069868996,638.532751091703,1718.42358078603,2093.19213973799,415.46288209607,255.270742358079,1133.21397379913,3993.7423580786,455.484716157205,105.61135371179,1080.33624454148,1629.44541484716,825.606986899563,340.943231441048,4725.30131004367,2528.04366812227,354.703056768559,239.737991266376,1061.85152838428,2116.28820960699,236.558951965065,208.755458515284,639.742358078603,1306.75545851528,407.56768558952,222.008733624454,1035.01746724891,129.908296943231,229,18.8495707465434,15.5318256565507,0.566606821425166,0.966244725738397,0.748366013071895,0.66994120051819,50887.7729257642,35415.9737991266,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_122119,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
122323,1298.9674267101,188.087947882736,97.4332247557003,636.258957654723,2289.58469055375,1547.51954397394,343.311074918567,249.115635179153,1096.59771986971,2360.97394136808,461.703583061889,107.273615635179,1090.332247557,1727.37459283388,689.855048859935,294.232899022801,1695.3664495114,1811.12540716612,385.978827361564,250.731270358306,1004.00488599349,1252.76058631922,258.918566775244,185.255700325733,583.846905537459,936.899022801303,409.488599348534,212.236156351792,1001.28338762215,128.822475570033,614,30.607778796272,25.8046302133606,0.537797178918351,0.96998420221169,0.787179487179487,0.337796402215281,51772.5244299674,34551.6172638436,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_122323,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
123197,2356.5119047619,73.3869047619048,47.6636904761905,650.97619047619,2382.38095238095,2960.6994047619,368.854166666667,264.080357142857,1115.36607142857,4445.75,951.434523809524,156.654761904762,1068.3125,1292.49702380952,731.133928571429,291.360119047619,1723.48214285714,1546.375,274.050595238095,233.720238095238,1427.08333333333,1324.3005952381,208.967261904762,190.199404761905,634.014880952381,1243.38988095238,525.041666666667,225.627976190476,1076.30952380952,130.684523809524,336,20.8953254217306,20.5869829645694,0.171158701554253,0.96,0.761904761904762,-0.0140403804242745,51036.2708333333,33719.6458333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_123197,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
123306,5512.36279069767,1221.11162790698,1227.9023255814,647.037209302326,2029.83720930233,5905.71627906977,719.6,287.06511627907,1135.1023255814,10087.5395348837,1268.86976744186,128.8,1080.48837209302,636.883720930233,453.888372093023,281.483720930232,1452.7023255814,1057.06511627907,335.874418604651,241.325581395349,981.660465116279,1034.6,251.953488372093,138.237209302326,580.46976744186,3627.14418604651,574.944186046512,355.223255813953,1044.7023255814,130.53023255814,215,19.1911911737407,14.275103177652,0.668361931736484,0.951327433628319,0.754385964912281,-0.306497765267869,50528.0465116279,35409.5953488372,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_123306,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
123604,3234.39534883721,1269.8488372093,1184.52325581395,622.727906976744,967.137209302326,3267.25348837209,472.076744186047,273.797674418605,1154.41860465116,4353.41860465116,590.883720930233,118.513953488372,1073.63720930233,1424.51627906977,614.106976744186,311.644186046512,1656.33488372093,3919.0488372093,381.804651162791,249.897674418605,1008.29069767442,5512.59302325581,317.218604651163,371.779069767442,585.886046511628,1143.25813953488,501.541860465116,241.167441860465,1020.51395348837,130.213953488372,430,25.7904211867639,21.3211099467881,0.562633354363845,0.959821428571429,0.723905723905724,-1.45080209631384,51998.2697674419,34615.8837209302,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_123604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
123840,2399.10909090909,784.360606060606,189.024242424242,632.733333333333,1721.02727272727,2589.88484848485,1156.55151515152,276.160606060606,1112.5,3880.79090909091,1903.41818181818,113.493939393939,1103.18181818182,691.463636363636,432.233333333333,282.127272727273,1452.90303030303,1037.98787878788,276.084848484848,229.881818181818,989.354545454546,998.981818181818,218.933333333333,158.212121212121,591.639393939394,1284.4303030303,534.978787878788,651.539393939394,1050.31818181818,131.172727272727,330,23.850850040136,17.8283248063981,0.664270564968376,0.970588235294118,0.755148741418764,-1.06537844328515,51168.7878787879,35402.4393939394,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_123840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
123982,3300.72307692308,214.194871794872,88.8871794871795,637.325641025641,927.987179487179,3773.41538461538,617.389743589744,275.458974358974,1145.41794871795,6659.69487179487,724.274358974359,113.730769230769,1074.60512820513,2900.39230769231,943.882051282051,329.530769230769,5459.68974358974,4420.24871794872,418.741025641026,245.807692307692,1069.25897435897,4165.42564102564,261.510256410256,344.020512820513,594.302564102564,3034.78461538462,533.65641025641,338.961538461538,1065.73846153846,129.297435897436,390,27.686997860578,17.9695128135678,0.760768342076416,0.970149253731343,0.742857142857143,1.05484420937442,50784.258974359,35362.4666666667,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_123982,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
124023,4113.18789808917,492.286624203822,140.127388535032,634.799363057325,1764.15605095541,5102.78343949045,1084.67834394904,264.535031847134,1112.47133757962,5840.87579617834,874.140127388535,123.987261146497,1075.53503184713,1113.92675159236,624.90127388535,288.566878980892,1896.24522292994,1101.29936305732,241.815286624204,223.633757961783,1162.08917197452,801.971337579618,160.019108280255,129.426751592357,883.066878980892,980.216560509554,465.127388535032,238.710191082803,1046.95541401274,131.535031847134,314,20.7366996815311,19.3125870887285,0.364191594757393,0.975155279503106,0.786967418546366,-1.15038219792852,51146.5796178344,34101.7420382166,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_124023,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
124481,3070.45973154362,406.154362416107,99.1275167785235,632.338926174497,1089.54697986577,3306.4966442953,1728.61744966443,275.473154362416,1088.1610738255,5307.80872483222,1538.07718120805,119.352348993289,1076.28523489933,3105.71140939597,1099.96644295302,927.479865771812,1952.52348993289,2139.21140939597,309.469798657718,231.06711409396,1016.36912751678,2179.06040268456,402.640939597315,399.238255033557,723.744966442953,1901.86577181208,487.124161073826,457.687919463087,1099.06040268456,134.479865771812,298,22.3973465370193,17.1354639978719,0.64395104236146,0.949044585987261,0.745,-0.830885214908419,50241.1308724832,35170.7986577181,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_124481,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
124646,1197.96385542169,514.927710843373,511.301204819277,617.192771084337,1801.6686746988,1043.25903614458,277.71686746988,246.975903614458,1090.09036144578,1295.48795180723,424.210843373494,97.644578313253,1061.46385542169,2290.48795180723,730.795180722892,333.957831325301,2054.65662650602,3256.07831325301,383.373493975904,239.530120481928,1090.20481927711,2828.05421686747,247.295180722892,315.722891566265,584.753012048193,796.21686746988,488.487951807229,224.0,1014.33734939759,126.487951807229,166,16.6780942654148,12.84671757173,0.637711974070581,0.948571428571429,0.798076923076923,1.32171613796852,51811.1807228916,34556.1204819277,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_124646,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
125424,2701.60208333333,510.602083333333,135.51875,637.429166666667,1381.58125,3192.34375,3179.36666666667,270.041666666667,1099.12708333333,4814.05416666667,1649.28333333333,113.55625,1072.87916666667,829.025,538.039583333333,286.485416666667,1494.96041666667,1290.95,319.9875,237.991666666667,1010.00625,1225.7,220.683333333333,163.179166666667,581.485416666667,1354.08541666667,511.341666666667,357.775,1061.99791666667,130.141666666667,480,31.2021428514175,19.9300816977687,0.769421984322818,0.975609756097561,0.842105263157895,1.52085710379854,51206.9375,35037.16875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
125511,5663.47,357.44,155.205,676.3275,3923.52,5406.0925,1597.62,287.7325,1131.8875,9537.0525,679.8725,130.8975,1077.8275,878.8875,640.6625,295.6875,1646.5225,1213.0775,308.7925,240.095,1022.41,1022.515,229.6875,254.195,807.46,3731.145,599.665,381.205,1094.2075,131.3025,400,23.8460574078929,21.4163826567297,0.439770877876261,0.963855421686747,0.756143667296786,-1.09901581812322,51795.0,35360.6975,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125511,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
125762,1413.82727272727,334.204545454545,178.068181818182,669.831818181818,2786.87272727273,1657.91363636364,354.140909090909,269.309090909091,1086.52727272727,3263.75,540.481818181818,112.781818181818,1075.78636363636,611.086363636364,574.631818181818,792.445454545455,1415.69545454545,986.622727272727,287.577272727273,229.695454545455,994.977272727273,1034.2,222.636363636364,381.05,681.445454545455,2168.69545454545,478.095454545455,218.445454545455,1048.79545454545,130.504545454545,220,18.2244096786311,15.4804643393839,0.527692124130012,0.956521739130435,0.718954248366013,0.867521200503911,50338.3636363636,35216.3090909091,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_125762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
125877,4707.02542372881,444.779661016949,190.478813559322,653.194915254237,3029.19491525424,5552.10169491526,407.834745762712,297.46186440678,1100.03389830508,8536.6186440678,609.610169491525,126.199152542373,1095.37711864407,933.35593220339,1597.8686440678,2771.43220338983,2021.77118644068,1422.04237288136,316.834745762712,232.775423728814,1034.36016949153,1138.6186440678,211.584745762712,249.745762711864,717.114406779661,3497.97033898305,552.618644067797,298.601694915254,1045.77542372881,129.093220338983,236,18.5301473827455,16.290425541303,0.476580342786211,0.983333333333333,0.819444444444444,0.241615344505373,50436.2669491526,35145.313559322,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125877,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
126563,4030.89911504425,446.318584070796,83.8070796460177,621.21592920354,952.127433628319,4646.34159292035,553.669026548673,276.385840707965,1099.61061946903,7225.71150442478,679.640707964602,118.047787610619,1080.48849557522,849.088495575221,536.89203539823,313.734513274336,1610.73451327434,1063.21238938053,282.67610619469,227.297345132743,1005.27079646018,956.164601769912,216.994690265487,164.736283185841,586.853097345133,2146.56991150442,475.272566371681,278.76814159292,1060.15752212389,131.171681415929,565,29.5014589053789,24.6268286236461,0.550604164048215,0.975820379965458,0.779310344827586,-1.17624549921782,50604.8371681416,35464.9415929204,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_126563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
126844,2546.44080604534,153.057934508816,113.065491183879,684.612090680101,4023.46095717884,2805.68010075567,686.403022670025,267.23677581864,1122.05793450882,4244.23425692695,1036.75314861461,115.35516372796,1091.86649874055,1462.2443324937,593.357682619647,353.702770780856,1710.56675062972,2096.84130982368,367.405541561713,239.901763224181,1012.19647355164,1936.41309823678,237.425692695214,242.551637279597,583.352644836272,1033.52141057935,443.614609571788,330.392947103275,1045.4483627204,129.662468513854,397,24.1757763277691,20.9302380854797,0.500472436379334,0.961259079903148,0.784584980237154,-1.04230275891153,50798.0780856423,35277.3123425693,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_126844,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
126873,4166.09574468085,527.81914893617,220.989361702128,683.975177304965,4163.57446808511,5370.03546099291,1254.70567375887,279.351063829787,1099.75177304965,7240.35460992908,3876.12056737589,136.510638297872,1089.55319148936,805.223404255319,661.024822695035,284.833333333333,1503.36170212766,1297.90425531915,407.716312056738,254.904255319149,988.492907801418,1252.8865248227,268.265957446808,149.904255319149,585.602836879433,2897.54255319149,607.528368794326,439.36524822695,1123.21631205674,133.08865248227,282,19.5165514244472,18.5434385188389,0.311826392551832,0.969072164948454,0.824561403508772,1.31724047911057,50829.4680851064,33992.5567375887,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_126873,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
127260,3647.38675958188,305.885017421603,117.149825783972,622.334494773519,1022.37630662021,3996.67595818815,367.714285714286,256.209059233449,1088.8362369338,6084.57491289199,545.641114982578,120.362369337979,1074.13240418118,1165.52264808362,665.372822299652,285.250871080139,1870.0,1325.41463414634,296.599303135888,231.466898954704,1133.21602787456,1142.06271777003,197.714285714286,145.84668989547,4426.76655052265,1542.36933797909,492.749128919861,229.017421602787,1041.43205574913,130.679442508711,287,22.828300026594,16.0759623358218,0.70998978078905,0.947194719471947,0.779891304347826,-1.52656209001461,51292.0383275261,34262.7421602787,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_127260,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
128275,2511.86842105263,160.694736842105,101.836842105263,621.468421052632,1741.33157894737,2949.03157894737,329.884210526316,272.926315789474,1078.93684210526,5118.4,525.08947368421,116.710526315789,1067.26315789474,5398.18421052632,1017.35789473684,1447.96315789474,1843.53157894737,2937.31052631579,359.842105263158,235.410526315789,1014.28947368421,2161.14210526316,342.852631578947,684.378947368421,632.1,3395.83157894737,490.626315789474,296.963157894737,1023.03157894737,126.073684210526,190,17.0016534379058,14.2357967041247,0.546715603565064,0.954773869346734,0.745098039215686,0.54483548232148,50720.7842105263,35652.3842105263,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
128309,2416.42124542125,474.747252747253,170.39010989011,675.457875457876,3514.2619047619,3007.69047619048,1392.32051282051,267.263736263736,1103.60989010989,4478.30586080586,2918.84615384615,119.384615384615,1075.57509157509,570.677655677656,397.648351648352,265.578754578755,1355.35531135531,891.842490842491,257.954212454212,222.611721611722,1029.95238095238,814.71978021978,197.338827838828,119.197802197802,582.613553113553,1735.02564102564,509.027472527473,402.880952380952,1091.40476190476,132.42673992674,546,34.7644408430332,20.1730131217433,0.814419024088682,0.969804618117229,0.78,-0.0343363797466547,49944.7307692308,34642.4725274725,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128309,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
128507,3243.07417582418,315.354395604396,201.013736263736,703.384615384615,5257.48901098901,3418.97527472527,359.25,264.557692307692,1107.01648351648,5648.08791208791,533.10989010989,122.747252747253,1109.73901098901,2217.55494505495,924.464285714286,701.431318681319,2538.75,1183.30494505495,251.879120879121,224.799450549451,1003.72527472527,858.57967032967,188.07967032967,145.315934065934,611.711538461538,2238.77472527473,515.741758241758,271.868131868132,1066.93681318681,131.458791208791,364,27.3033625936868,17.0151485831982,0.78207146333582,0.950391644908616,0.764705882352941,-1.48418264721555,51594.5549450549,34885.1730769231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128507,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
129078,3126.75257731959,986.835051546392,93.4742268041237,620.367697594502,958.460481099656,3278.07560137457,490.711340206186,277.73883161512,1103.11340206186,4455.07216494845,752.993127147766,113.412371134021,1072.12714776632,939.518900343643,861.292096219931,704.477663230241,1675.14089347079,1554.27835051546,320.955326460481,234.611683848797,1034.48797250859,1336.46048109966,234.848797250859,666.79381443299,726.481099656357,1026.47079037801,503.697594501718,271.546391752577,1018.4295532646,129.718213058419,291,20.3344070175643,18.3064626453349,0.435331359210182,0.973244147157191,0.808333333333333,1.39926375793927,50699.1202749141,35317.2371134021,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_129078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
129484,1361.64942528736,902.336206896552,156.758620689655,667.23275862069,3263.31609195402,1476.01436781609,356.310344827586,242.755747126437,1146.04885057471,2915.1724137931,591.942528735632,117.310344827586,1072.30459770115,964.488505747126,612.060344827586,309.793103448276,3697.02011494253,1042.66954022989,264.695402298851,228.17816091954,994.591954022988,927.48275862069,205.913793103448,172.014367816092,611.474137931035,1342.66091954023,564.359195402299,259.155172413793,1072.87643678161,130.669540229885,348,24.786133080896,17.9036252957671,0.691554524189723,0.953424657534246,0.71900826446281,0.8054692719874,51427.1293103448,33790.7413793103,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_129484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
129539,1290.9028340081,385.813765182186,73.4372469635628,624.133603238866,1358.67611336032,1165.91497975709,383.894736842105,262.834008097166,1085.12955465587,1728.08906882591,519.943319838057,106.206477732794,1067.45748987854,2141.53846153846,1033.15789473684,1362.99190283401,1645.80971659919,2699.10931174089,337.178137651822,238.518218623482,1027.76923076923,2402.86639676113,276.372469635628,444.919028340081,808.874493927126,817.165991902834,448.570850202429,227.380566801619,1011.74493927126,128.68016194332,247,19.0696644282687,16.5057808939418,0.500819543974413,0.96484375,0.762345679012346,0.627714332218891,51754.6315789474,35224.4210526316,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_129539,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
129777,701.613430127042,243.352087114338,111.669691470054,621.40834845735,1764.40653357532,826.500907441016,348.450090744102,267.53720508167,1087.68058076225,1239.30671506352,613.756805807623,115.252268602541,1062.3611615245,770.689655172414,466.321234119782,275.323049001815,1381.91288566243,982.533575317604,261.324863883848,222.40834845735,985.473684210526,895.094373865699,196.611615245009,126.597096188748,589.468239564428,944.80943738657,505.960072595281,223.105263157895,1012.84754990926,130.001814882033,551,27.9761824071212,25.1351313987941,0.439080941659387,0.963286713286713,0.784900284900285,0.63855139182917,49966.4264972777,34818.4301270417,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_129777,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
131467,2675.00568181818,280.653409090909,239.957386363636,724.201704545455,6112.62784090909,2661.76704545455,342.247159090909,264.84375,1095.38352272727,5211.25,524.607954545455,123.434659090909,1080.44318181818,1140.35795454545,548.463068181818,322.127840909091,2364.34090909091,2326.82670454545,319.073863636364,237.502840909091,995.053977272727,2594.69318181818,248.161931818182,157.105113636364,595.585227272727,1955.44034090909,509.84375,225.306818181818,1063.13636363636,129.261363636364,352,27.2831380645049,16.7949956967049,0.788073212256296,0.946236559139785,0.666666666666667,0.669766101161445,51838.4119318182,35085.8352272727,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_131467,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
131533,4733.84615384615,1111.51538461538,278.353846153846,642.296153846154,1511.93461538462,4598.38461538462,462.346153846154,284.076923076923,1137.45384615385,7093.08076923077,586.776923076923,118.426923076923,1075.78846153846,4686.61153846154,742.119230769231,340.3,3157.91923076923,7551.81538461538,433.126923076923,249.5,1038.21923076923,6934.70384615385,274.296153846154,207.615384615385,594.061538461538,1722.61538461538,523.684615384615,244.35,1049.59615384615,134.684615384615,260,19.6285051120359,16.9184227890879,0.507025094353553,0.962962962962963,0.760233918128655,0.859779802305918,50890.0807692308,35476.5307692308,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_131533,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
131836,1732.96253602305,278.634005763689,149.680115273775,663.907780979827,3132.77809798271,1978.47262247839,340.832853025937,264.118155619597,1094.24495677233,3759.8530259366,700.801152737752,117.161383285303,1074.3083573487,4291.63112391931,1173.98847262248,2242.31412103746,1833.89048991354,5210.19020172911,397.49855907781,248.659942363112,1033.43227665706,4084.98270893372,290.224783861671,336.21325648415,679.593659942363,1373.13832853026,486.017291066282,246.07492795389,1061.80691642651,130.317002881844,347,22.7686540558729,19.5423867645217,0.513144488251302,0.948087431693989,0.754347826086956,1.48761866829556,51592.8876080692,35153.0028818444,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_131836,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
131887,3903.19343065693,217.094890510949,107.514598540146,647.945255474453,2138.77737226277,4123.24817518248,476.518248175182,275.996350364964,1168.6496350365,6096.9197080292,773.478102189781,125.85401459854,1072.33211678832,615.711678832117,394.620437956204,268.98905109489,1474.52919708029,975.934306569343,283.273722627737,228.602189781022,986.908759124088,929.069343065693,217.467153284672,179.13503649635,586.186131386861,2110.43795620438,504.85401459854,353.372262773723,1068.72627737226,131.401459854015,274,19.6150041379404,17.8126023267352,0.418729376727572,0.989169675090253,0.848297213622291,0.154528318002757,50544.1715328467,35757.8576642336,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_131887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
131941,1539.58091286307,388.066390041494,237.672199170124,712.01244813278,6302.08506224066,1675.67219917012,353.091286307054,256.908713692946,1106.72406639004,3160.32780082988,604.591286307054,128.879668049793,1071.17219917012,698.572614107884,388.948132780083,265.730290456432,1479.05186721992,1015.51659751037,212.470954356846,219.365145228216,1267.69087136929,638.601659751037,142.560165975104,124.769709543568,589.103734439834,1023.5601659751,476.726141078838,226.960580912863,1029.70539419087,130.317427385892,482,27.6524905171594,22.2165073946913,0.595415475817871,0.967871485943775,0.776167471819646,-1.19687256202381,51388.020746888,34217.2863070539,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_131941,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
132189,1959.37714285714,313.005714285714,196.295238095238,686.020952380952,4880.44761904762,2047.19238095238,464.348571428571,277.939047619048,1106.97714285714,3254.92,684.900952380952,129.142857142857,1077.87619047619,762.617142857143,927.180952380952,642.207619047619,1717.41714285714,1278.49142857143,312.702857142857,235.017142857143,1019.52761904762,1091.9619047619,236.895238095238,171.508571428571,607.958095238095,1151.13142857143,501.935238095238,247.15619047619,1044.53523809524,130.131428571429,525,30.3943225315075,22.0773706190662,0.687309214887678,0.968634686346863,0.795454545454545,-0.180277060602823,51807.3638095238,35283.0361904762,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_132189,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
133480,2362.65418502203,112.356828193833,97.4977973568282,631.013215859031,1584.61453744493,2655.27973568282,353.453744493392,268.513215859031,1092.26431718062,4572.83259911894,673.726872246696,115.301762114537,1072.79735682819,1766.93171806167,613.381057268722,305.539647577093,2363.82599118943,2752.23568281938,387.361233480176,250.685022026432,1069.63215859031,2754.83259911894,269.229074889868,518.660792951542,1921.0550660793,1285.22466960352,496.647577092511,256.733480176211,1065.33700440529,131.105726872247,454,39.8575252459785,14.5508632092931,0.930979320018934,0.945833333333333,0.756666666666667,-1.54961480013694,51364.7731277533,35245.90969163,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_133480,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134320,3744.49689440994,909.807453416149,916.413043478261,618.683229813665,605.555900621118,3299.22049689441,403.925465838509,271.130434782609,1098.64906832298,6972.29192546584,580.015527950311,116.95652173913,1079.92857142857,906.049689440994,512.704968944099,277.285714285714,1942.98447204969,1415.50310559006,312.0,244.965838509317,1033.12422360248,1178.03726708075,228.459627329193,152.344720496894,592.093167701863,2244.95652173913,521.785714285714,290.900621118012,1045.82298136646,130.854037267081,322,21.685624360468,18.963475618345,0.485075636787981,0.949852507374631,0.770334928229665,-1.52623050857689,51068.3167701863,35473.3540372671,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134450,530.601965601966,857.398034398034,249.579852579853,702.599508599509,121.383292383292,400.44226044226,311.280098280098,244.474201474201,1111.69778869779,1023.76167076167,653.7542997543,109.4914004914,1059.55282555283,1974.82800982801,503.280098280098,291.542997542998,1580.63882063882,1671.62162162162,337.570024570025,238.528255528256,1018.54791154791,1418.52334152334,236.385749385749,410.759213759214,865.230958230958,575.206388206388,379.385749385749,200.977886977887,985.248157248157,128.515970515971,407,25.6281172587641,20.2247702421414,0.614183397440253,0.969047619047619,0.782692307692308,1.49317538429973,51480.4250614251,34046.6633906634,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134450,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134455,3840.19272727273,884.563636363636,174.716363636364,686.127272727273,3148.15636363636,3422.41454545455,992.865454545455,267.0,1128.45090909091,5640.09090909091,572.832727272727,113.763636363636,1099.62909090909,691.32,471.44,372.229090909091,1498.24363636364,1106.45818181818,281.098181818182,224.658181818182,988.658181818182,1135.72727272727,220.181818181818,220.069090909091,597.581818181818,1380.44363636364,438.421818181818,574.883636363636,1063.25454545455,130.810909090909,275,23.4617685741825,15.0554378468357,0.766954994667315,0.964912280701754,0.735294117647059,-1.08678090677007,51314.2836363636,35676.6690909091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134509,3861.72619047619,1318.7380952381,1773.55654761905,618.651785714286,1157.28571428571,4629.9880952381,404.598214285714,269.910714285714,1100.63095238095,5652.0505952381,675.223214285714,123.994047619048,1073.01488095238,1027.85416666667,493.431547619048,283.27380952381,1668.84226190476,1166.47321428571,252.696428571429,225.625,1208.00297619048,909.217261904762,168.943452380952,139.110119047619,925.321428571429,1464.93154761905,570.520833333333,263.52380952381,1032.90178571429,130.217261904762,336,22.3128779302158,19.2435272567968,0.506158636189455,0.968299711815562,0.8,-0.673347771434968,51321.630952381,34282.4613095238,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134509,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134634,2022.27682403433,258.276824034335,123.542918454936,655.81330472103,2491.20815450644,2695.24678111588,432.834763948498,272.343347639485,1110.34549356223,3428.35836909871,667.875536480687,116.944206008584,1082.22746781116,694.160944206009,480.843347639485,275.002145922747,1434.91201716738,1207.19098712446,323.577253218884,236.952789699571,993.31974248927,1205.70600858369,242.978540772532,164.540772532189,1984.9356223176,1343.84549356223,515.87339055794,265.105150214592,1073.71459227468,130.094420600858,466,39.3260460262373,15.3554795584975,0.920617395453942,0.94908350305499,0.681286549707602,-0.211637963412736,49986.8605150215,34864.2725321888,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_134634,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
134881,3744.8141025641,979.169871794872,87.2435897435897,642.413461538462,2445.72115384615,4856.15064102564,369.865384615385,262.778846153846,1139.47435897436,7137.58012820513,528.054487179487,118.073717948718,1098.98717948718,5183.4391025641,694.855769230769,329.916666666667,1845.13141025641,7291.20833333333,417.163461538462,257.746794871795,1016.48717948718,8492.875,282.836538461538,184.032051282051,594.022435897436,2332.86858974359,543.647435897436,236.458333333333,1066.42628205128,132.051282051282,312,22.0046552603554,18.1460203035217,0.565651192063926,0.957055214723926,0.742857142857143,0.859972974000452,51877.233974359,34715.0032051282,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_134881,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
135246,2880.38248847926,356.601382488479,158.108294930876,652.205069124424,2088.92396313364,3233.92165898618,345.790322580645,259.873271889401,1096.99078341014,4913.63133640553,561.937788018433,119.81797235023,1140.19815668203,637.096774193548,495.783410138249,275.476958525346,1444.93778801843,1055.35944700461,327.640552995392,239.970046082949,990.205069124424,1010.16359447005,225.046082949309,146.387096774194,647.559907834101,1432.28341013825,488.184331797235,230.891705069124,1049.83410138249,130.119815668203,434,35.4850470293255,15.6919809894032,0.896909620792982,0.941431670281996,0.729411764705882,-0.0922230814359378,50649.1152073733,34242.6520737327,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_135246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
135849,4113.53191489362,1222.0079787234,99.3058510638298,646.074468085106,2346.33776595745,5054.11968085106,1105.63563829787,266.281914893617,1150.96542553191,7458.23936170213,666.704787234043,121.773936170213,1090.88031914894,2977.35106382979,817.220744680851,369.664893617021,1954.27925531915,1728.79521276596,312.151595744681,238.061170212766,999.731382978723,1845.6170212766,231.702127659574,195.473404255319,600.226063829787,2556.54255319149,569.002659574468,275.81914893617,1087.31914893617,133.534574468085,376,22.9230341790668,20.9298199956049,0.407853144384112,0.954314720812183,0.743083003952569,-0.231337412065526,51878.7287234043,34694.7606382979,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_135849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
136566,2778.33540372671,306.552795031056,130.686335403727,643.807453416149,2181.43788819876,3254.15838509317,343.83850931677,257.888198757764,1090.86645962733,4236.92857142857,516.754658385093,118.512422360248,1082.2701863354,909.928571428571,481.083850931677,267.863354037267,1932.63664596273,1368.49689440994,298.099378881988,241.186335403727,1035.17391304348,1198.01552795031,203.931677018634,236.475155279503,1071.25776397516,982.645962732919,469.636645962733,240.077639751553,1015.57763975155,130.263975155279,322,23.4765267010464,17.558757589305,0.663779578756854,0.949852507374631,0.731818181818182,1.14345801608196,51179.9099378882,34408.1832298137,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_136566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
136867,1741.72,168.712,101.044,638.432,2074.988,2098.756,391.492,257.5,1093.068,3208.004,469.22,109.84,1065.448,4359.432,701.956,347.86,4328.244,3947.52,394.16,254.28,998.648,2678.712,262.88,164.032,584.984,1148.124,469.516,219.588,1015.28,130.16,250,20.0032458381286,15.9822124857415,0.60135632674681,0.954198473282443,0.78125,1.45276296391897,51759.036,35011.512,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_136867,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
137231,3265.5931372549,492.794117647059,118.191176470588,624.406862745098,1023.20098039216,2784.96078431373,1128.46568627451,280.328431372549,1103.77450980392,4861.07843137255,1761.33823529412,123.132352941176,1258.95588235294,1169.12254901961,470.176470588235,279.789215686275,1551.0931372549,1614.08333333333,258.68137254902,223.43137254902,993.426470588235,1429.6862745098,205.642156862745,172.906862745098,595.450980392157,1443.64705882353,555.75,805.470588235294,1039.28921568627,130.887254901961,204,19.8534713596259,13.3445597864911,0.740412762471306,0.935779816513762,0.728571428571429,1.52997573754974,51150.4852941177,35400.2794117647,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137231,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
137554,1018.86033519553,335.053072625698,108.525139664804,626.36312849162,1271.37709497207,1028.57262569832,1217.65363128492,274.553072625698,1083.68156424581,1777.12849162011,2109.47206703911,116.628491620112,1063.56983240223,2851.63966480447,653.139664804469,341.821229050279,1543.56145251397,1408.85754189944,264.776536312849,225.374301675978,1007.97765363128,1143.84357541899,207.050279329609,136.162011173184,599.122905027933,1100.67877094972,521.896648044693,654.768156424581,1037.5,130.139664804469,358,22.9350660100982,19.9057806898601,0.496705671051358,0.972826086956522,0.811791383219955,0.724823799900837,50433.7653631285,35221.2290502793,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137554,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
138212,2067.31766612642,225.034035656402,217.94489465154,791.040518638574,8792.12803889789,2388.56564019449,1055.42139384117,260.18152350081,1152.53160453809,4316.90761750405,645.317666126418,117.520259319287,1082.85251215559,667.350081037277,748.061588330632,516.726094003242,1701.86061588331,1077.29497568882,288.259319286872,229.502431118314,1014.81847649919,967.557536466775,209.293354943274,168.492706645057,643.254457050243,1764.60777957861,475.008103727715,362.606158833063,1070.13938411669,130.888168557536,617,33.7690752480241,23.33039526391,0.722968981450877,0.9640625,0.779040404040404,-0.233044509126505,50456.4359805511,35084.4262560778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_138212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
139035,4770.62,527.9,667.892,633.948,1618.412,4375.672,867.456,271.48,1093.34,7179.952,590.972,133.672,1105.108,724.928,618.488,896.116,1604.544,1029.896,301.472,230.424,1003.74,1008.756,251.584,210.332,588.548,2199.276,571.468,290.064,1071.56,130.74,250,19.2230701051476,16.6265130358888,0.501901208503463,0.957854406130268,0.771604938271605,-0.799332278214499,51085.092,35815.476,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_139035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
139182,3625.0316091954,752.945402298851,2161.21264367816,615.859195402299,675.991379310345,3276.15229885057,1170.13793103448,267.146551724138,1105.44827586207,4891.07183908046,532.755747126437,111.818965517241,1071.62356321839,1939.16954022988,716.387931034483,362.905172413793,2843.91091954023,1472.69252873563,307.462643678161,236.784482758621,1010.42528735632,1175.94540229885,224.908045977011,182.69540229885,612.264367816092,961.560344827586,466.008620689655,290.149425287356,1009.72701149425,128.896551724138,348,22.9663708810868,19.6196466769667,0.519817747263117,0.948228882833788,0.71900826446281,0.849195945096811,51642.0862068966,35126.4885057471,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_139182,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
139388,2132.26086956522,297.301242236025,95.6024844720497,626.760869565217,327.431677018634,2527.6801242236,561.965838509317,265.878881987578,1088.65217391304,4700.16459627329,697.962732919255,120.590062111801,1066.04347826087,721.791925465839,604.260869565217,284.425465838509,1431.97826086957,1252.11180124224,354.692546583851,247.745341614907,989.788819875776,1491.4099378882,242.770186335404,170.350931677019,618.894409937888,1876.93788819876,555.223602484472,229.316770186335,1057.32608695652,131.425465838509,322,21.2572637336296,19.3339272253168,0.415658028938901,0.969879518072289,0.807017543859649,-0.237372138717827,50618.1024844721,34795.1242236025,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_139388,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
139792,1340.61721611722,323.285714285714,100.558608058608,616.175824175824,938.650183150183,1578.12087912088,2910.1336996337,261.989010989011,1085.71611721612,1871.32051282051,985.785714285714,116.203296703297,1064.85897435897,732.868131868132,474.177655677656,271.956043956044,1512.68131868132,1085.30402930403,314.483516483516,234.326007326007,991.241758241758,1021.32417582418,214.221611721612,137.915750915751,583.60989010989,1016.29487179487,516.558608058608,254.468864468864,1101.26007326007,130.712454212454,546,30.8612530324127,22.5804083290898,0.681653611573247,0.966371681415929,0.76577840112202,0.117343772436039,51043.6355311355,34238.521978022,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_139792,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
140737,2673.58805031447,444.380503144654,176.418238993711,674.116352201258,3628.86477987421,3174.88679245283,879.01572327044,259.122641509434,1088.14150943396,4585.64150943396,644.842767295597,119.889937106918,1068.20440251572,1349.79245283019,710.694968553459,748.559748427673,1852.36477987421,1351.35220125786,298.295597484277,228.116352201258,1144.42452830189,940.14465408805,195.694968553459,194.11320754717,1385.03773584906,1441.08805031447,495.062893081761,264.132075471698,1054.60062893082,131.056603773585,318,22.0270106576268,18.5024390414375,0.542603962922974,0.952095808383234,0.727688787185355,-1.51789770819348,51192.2735849057,34086.9874213836,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_140737,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
140903,2493.41241685144,272.062084257206,118.454545454545,663.458980044346,2974.19955654102,3202.56541019956,1917.50776053215,270.20399113082,1099.11529933481,4896.022172949,1620.24168514412,120.133037694013,1086.0266075388,959.39689578714,804.855875831486,867.330376940133,1545.24168514412,993.139689578714,252.062084257206,221.10199556541,1002.72949002217,918.986696230599,203.667405764967,243.647450110865,660.953436807095,1741.83813747228,467.906873614191,527.611973392461,1096.37694013304,139.328159645233,451,31.119598681726,18.6707341908375,0.800024702461195,0.945492662473795,0.791228070175439,-0.0856754133330917,50223.4589800443,35169.3747228381,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_140903,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
140905,5109.97186700767,641.639386189258,771.838874680307,673.329923273657,3383.2378516624,5112.22250639386,530.424552429668,276.86189258312,1186.75191815857,7728.95907928389,791.693094629156,127.143222506394,1101.45012787724,995.946291560102,589.764705882353,346.979539641944,2316.81585677749,1367.37084398977,302.488491048593,237.150895140665,993.634271099744,1234.55242966752,221.772378516624,157.554987212276,647.754475703325,2281.61381074169,583.690537084399,349.181585677749,1218.14833759591,134.529411764706,391,27.9796675452162,18.0865763894136,0.762982991917197,0.967821782178218,0.708333333333333,0.846383079423749,51782.4040920716,34942.3913043478,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_140905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
140926,3113.27777777778,335.91975308642,129.057613168724,659.364197530864,2250.18724279835,3303.85596707819,1666.51028806584,268.246913580247,1092.91769547325,5760.25102880658,3747.4012345679,116.582304526749,1078.68930041152,618.617283950617,559.170781893004,666.600823045267,1493.92798353909,877.189300411523,208.378600823045,272.086419753086,1002.51646090535,724.111111111111,169.637860082305,194.450617283951,620.545267489712,2290.15226337449,492.954732510288,960.67695473251,1081.40946502058,131.744855967078,486,30.9200282075692,20.2611132932316,0.755390641674747,0.966202783300199,0.72863568215892,-1.10142405424145,50028.0699588477,35157.6687242798,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_140926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
141671,2360.41463414634,577.835365853659,565.170731707317,608.457317073171,613.478658536585,2518.66768292683,941.27743902439,267.085365853659,1097.39634146341,4884.49085365854,1747.92073170732,115.390243902439,1066.70731707317,1918.7987804878,555.673780487805,283.548780487805,1671.25304878049,2474.94817073171,345.399390243902,235.640243902439,1021.50914634146,2065.5762195122,233.692073170732,189.493902439024,1536.15853658537,3019.04268292683,527.518292682927,512.259146341463,1063.76524390244,129.920731707317,328,23.1322345054495,18.1863485145732,0.61798391862337,0.95906432748538,0.743764172335601,-0.864704351142952,50595.6768292683,35734.1097560976,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_141671,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
142444,2369.25045045045,435.398198198198,207.609009009009,724.284684684685,4191.73873873874,2765.54774774775,1900.28468468468,263.927927927928,1096.25585585586,4327.80540540541,3743.41981981982,119.25045045045,1091.84684684685,2039.0018018018,794.574774774775,1119.34954954955,1517.35675675676,1838.8018018018,305.536936936937,234.254054054054,1010.3027027027,1673.43423423423,227.989189189189,354.347747747748,656.854054054054,1491.96216216216,480.790990990991,786.428828828829,1078.79459459459,131.189189189189,555,36.6589207999196,19.3017487173253,0.85016115939543,0.963541666666667,0.663082437275986,0.65948293920995,49896.9513513514,34754.0720720721,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_142444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
142596,3308.7697368421,110.516447368421,78.2993421052632,630.947368421053,1423.70723684211,2817.23355263158,1122.13486842105,264.019736842105,1140.85855263158,4944.77302631579,1305.99671052632,115.141447368421,1088.35197368421,1091.81907894737,654.381578947368,338.148026315789,3686.65789473684,1260.56907894737,295.467105263158,230.233552631579,1158.03289473684,1223.29276315789,225.473684210526,197.1875,596.302631578947,1280.89473684211,422.151315789474,336.378289473684,1033.30592105263,128.842105263158,304,19.7909162510722,19.6177997962588,0.131977353904404,0.955974842767296,0.8,-0.151605932315055,50933.9243421053,35756.1151315789,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_142596,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
143309,1335.05054151625,151.330324909747,84.9097472924188,640.891696750902,2452.53790613718,1634.48736462094,504.960288808664,260.738267148014,1095.26353790614,3041.28339350181,500.835740072202,109.947653429603,1078.60108303249,3228.01805054152,721.770758122744,317.07761732852,1777.04512635379,3995.70577617328,481.075812274368,253.895306859206,1011.27797833935,3713.69314079422,276.142599277978,166.93321299639,588.483754512635,1496.70397111913,491.34476534296,230.79963898917,1040.31227436823,129.402527075812,554,32.1327840806655,21.9593526417549,0.730049729012995,0.977072310405644,0.776998597475456,-0.299438011000632,51778.380866426,35078.9837545126,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_143309,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
143558,1088.48484848485,300.32196969697,86.75,626.80303030303,1090.94696969697,1205.19696969697,3428.69696969697,243.810606060606,1092.66666666667,2171.38257575758,2060.86363636364,103.587121212121,1065.86363636364,4529.75378787879,1374.32575757576,537.109848484848,1686.74621212121,4793.08333333333,409.306818181818,248.079545454545,1004.34090909091,4373.85984848485,322.507575757576,566.969696969697,768.140151515152,790.05303030303,418.55303030303,329.386363636364,1019.53787878788,133.227272727273,264,20.8905325119145,16.1014496190599,0.637133540050729,0.967032967032967,0.776470588235294,1.18451563714761,50636.5151515152,34391.8446969697,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_143558,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
144287,1888.39428571429,487.9,137.994285714286,635.651428571429,1783.54285714286,2049.58285714286,3400.52571428571,264.5,1097.56857142857,2683.9,1510.35142857143,118.985714285714,1065.44285714286,843.388571428571,447.734285714286,279.628571428571,1526.12857142857,1012.82,218.12,221.511428571428,1251.86857142857,638.32,145.04,123.577142857143,586.777142857143,1034.08571428571,496.145714285714,295.822857142857,1038.68285714286,129.785714285714,350,22.7063600858417,19.68104162404,0.49871958771437,0.961538461538462,0.72463768115942,-1.21671817243225,51415.3114285714,34259.7457142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
144540,1439.33333333333,301.925170068027,70.530612244898,615.414965986395,1140.69727891156,1522.67006802721,509.047619047619,255.80612244898,1112.6156462585,3234.71768707483,603.017006802721,106.302721088435,1071.02721088435,2185.02721088435,850.268707482993,354.656462585034,1704.09863945578,3711.76530612245,357.078231292517,245.068027210884,1034.94557823129,3209.43537414966,251.636054421769,724.568027210884,686.43537414966,1956.8843537415,507.02380952381,257.054421768707,1025.15986394558,129.608843537415,294,20.8894573724755,17.9495812840439,0.511530566379578,0.963934426229508,0.773684210526316,-0.988958430289011,51924.7789115646,34942.2414965986,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144540,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
144633,1166.23357664234,530.733576642336,56.8576642335766,631.251824817518,1118.05839416058,1326.44525547445,1570.31751824818,246.507299270073,1087.2700729927,2616.46715328467,434.912408759124,100.302919708029,1076.72262773723,1317.93430656934,707.554744525547,296.021897810219,3051.73357664234,3299.49635036496,335.116788321168,242.193430656934,1029.59854014599,3512.17153284672,248.48905109489,160.514598540146,590.693430656934,1232.60948905109,448.441605839416,777.120437956204,1026.54379562044,130.306569343066,274,19.9164745395322,17.5358801667944,0.474099830270903,0.951388888888889,0.761111111111111,0.0573785734957783,51801.7372262774,35053.5474452555,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_144633,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
144743,3239.11009174312,954.08256880734,788.550458715596,683.859327217125,3824.48929663609,3782.88379204893,458.388379204893,267.302752293578,1154.51070336391,6606.77675840979,601.892966360856,120.483180428135,1078.52293577982,678.021406727829,479.871559633028,329.140672782875,1477.76146788991,982.155963302752,263.168195718654,229.11620795107,988.788990825688,920.076452599388,198.996941896024,140.211009174312,588.507645259939,3081.44036697248,639.247706422018,300.816513761468,1101.8623853211,135.709480122324,327,21.8803567613876,19.0816738906082,0.489342780141689,0.970326409495549,0.778571428571429,0.646375986996958,51538.5840978593,34797.4006116208,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144743,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
145185,3498.33876221498,1593.30944625407,972.351791530945,674.234527687296,2806.19218241042,3505.42671009772,342.749185667752,253.550488599349,1147.04885993485,5957.84690553746,535.899022801303,122.745928338762,1072.10423452769,547.671009771987,404.410423452769,265.648208469055,1391.1009771987,832.097719869707,245.439739413681,223.13680781759,980.973941368078,776.550488599349,186.045602605863,146.439739413681,595.827361563518,1874.9348534202,571.671009771987,251.892508143322,1062.66449511401,130.234527687296,307,22.4537338168673,17.4576505057141,0.628889960443333,0.965408805031446,0.769423558897243,-1.08688472493391,51430.2931596091,33838.5960912052,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145185,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
145543,4555.77777777778,1074.04814814815,1646.22222222222,648.044444444444,1980.75555555556,3667.17407407407,541.607407407407,272.625925925926,1099.06296296296,7388.75555555556,542.907407407407,124.092592592593,1079.45555555556,1063.62222222222,542.77037037037,656.640740740741,1517.32962962963,1528.24444444444,319.288888888889,233.840740740741,987.996296296296,1854.14074074074,234.274074074074,199.185185185185,765.862962962963,2003.32962962963,523.548148148148,270.544444444444,1044.73703703704,129.607407407407,270,20.1361624305634,17.1413484524263,0.524724899150845,0.957446808510638,0.74792243767313,0.961192546506515,51961.8888888889,35247.3111111111,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_145543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
145630,2192.00778210117,102.215953307393,70.9630350194552,636.854085603113,1835.06809338521,2529.82684824903,828.474708171206,261.036964980545,1090.50583657588,4522.57976653696,652.515564202335,112.990272373541,1071.18871595331,1929.47859922179,1005.71206225681,393.988326848249,1983.10894941634,2748.95914396887,342.894941634241,243.371595330739,1021.9766536965,3295.21789883269,254.540856031128,267.443579766537,706.822957198444,2186.11089494163,547.982490272374,291.970817120623,1053.9766536965,130.603112840467,514,31.6213742239222,20.9608832864293,0.748733865079598,0.958955223880597,0.690860215053763,-1.22145293516238,51692.5116731517,34974.5680933852,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145630,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
146118,1579.465625,724.665625,136.690625,668.259375,2375.103125,1851.971875,2708.74375,248.8375,1146.90625,3359.23125,2187.20625,111.75625,1082.225,692.040625,515.509375,409.053125,1689.821875,1048.996875,269.940625,231.5375,1011.0125,1005.54375,197.640625,182.878125,623.2375,999.3125,452.3,466.409375,1038.703125,133.075,320,20.3879282214975,20.1929684936382,0.137962221464062,0.960960960960961,0.761904761904762,1.38102356350574,51092.584375,34438.0625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146118,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
146121,1690.29658792651,122.682414698163,81.010498687664,640.212598425197,2325.90813648294,1866.99475065617,459.370078740158,253.792650918635,1090.13910761155,2711.10498687664,644.183727034121,118.175853018373,1069.55905511811,1125.28871391076,596.511811023622,289.110236220472,1556.33333333333,1207.80839895013,230.643044619423,222.795275590551,1482.12335958005,697.958005249344,141.821522309711,123.307086614173,586.404199475066,906.128608923884,466.653543307087,230.955380577428,1038.85564304462,131.304461942257,381,33.0258195251343,15.125322493832,0.888960036624964,0.938423645320197,0.646859083191851,-1.17183947488681,51197.8320209974,34011.0183727034,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
146535,1992.14658634538,223.423694779116,88.5100401606426,621.680722891566,1024.84136546185,2525.20481927711,336.050200803213,262.212851405622,1094.34738955823,3360.19076305221,565.676706827309,122.765060240964,1072.19678714859,621.612449799197,515.377510040161,284.520080321285,1523.19879518072,1010.21084337349,311.680722891566,235.771084337349,993.058232931727,929.939759036145,213.632530120482,151.192771084337,595.616465863454,1247.22489959839,525.218875502008,225.010040160642,1023.43574297189,134.397590361446,498,31.4143427436357,20.7676625885729,0.750307881235225,0.954022988505747,0.698457223001403,1.25139513237804,51289.1606425703,34477.8995983936,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_146535,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
146684,2061.02166064982,729.140794223827,92.2093862815884,625.126353790614,1752.30685920578,2442.80866425993,714.689530685921,265.007220216606,1089.6642599278,3455.52707581227,589.574007220217,111.231046931408,1063.84837545126,4157.24548736462,567.73285198556,891.007220216606,1923.11913357401,3028.87003610108,365.895306859206,992.472924187726,1041.83032490975,1820.35379061372,263.537906137184,260.28880866426,779.472924187726,1534.02527075812,499.447653429603,303.064981949458,1022.8880866426,130.108303249097,277,23.7382148289562,15.0306452061432,0.774001740931565,0.961805555555556,0.752717391304348,1.25888445637346,51420.5018050542,35265.036101083,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146684,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
147013,3187.48318042813,311.152905198777,88.6666666666667,633.666666666667,1400.73394495413,3030.52905198777,489.082568807339,268.214067278287,1111.54434250765,5301.08868501529,605.764525993884,114.446483180428,1088.74923547401,1605.90825688073,771.681957186544,350.006116207951,2146.09174311927,1907.13455657492,366.131498470948,241.299694189602,1082.37308868502,1566.62385321101,238.626911314985,658.192660550459,702.645259938838,1588.71865443425,457.376146788991,277.382262996942,1041.73088685015,131.428134556575,327,21.8721707236164,19.0892380430087,0.488142819894432,0.958944281524927,0.782296650717703,0.227909434115192,50827.4342507645,35576.4311926606,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
147612,989.748780487805,128.358536585366,95.8682926829268,678.434146341463,3815.51463414634,1194.94390243902,322.163414634146,252.453658536585,1087.36097560976,2395.93414634146,602.158536585366,140.117073170732,1070.02195121951,2029.15609756098,850.50243902439,337.641463414634,1641.56097560976,3937.22926829268,360.09512195122,240.690243902439,1048.95853658537,3731.86585365854,243.139024390244,252.414634146341,591.765853658537,1150.97073170732,493.829268292683,225.551219512195,1056.70975609756,130.363414634146,410,25.0450207331585,20.9670464683498,0.546936261195947,0.964705882352941,0.745454545454545,0.301480117868381,51441.6341463415,33941.6487804878,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147612,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
147995,3436.97340425532,801.289893617021,296.970744680851,615.872340425532,617.204787234043,3430.51861702128,1465.82446808511,266.904255319149,1150.56117021277,5086.31117021277,595.082446808511,111.667553191489,1080.77393617021,3136.82180851064,993.436170212766,2216.71542553192,4224.94414893617,3997.18617021277,415.468085106383,243.872340425532,1100.73404255319,3210.72606382979,271.050531914894,489.332446808511,599.148936170213,1398.77393617021,445.356382978723,318.803191489362,1026.39361702128,130.813829787234,376,26.4302518754824,18.4897614582181,0.714565919852068,0.954314720812183,0.710775047258979,-0.793616833775523,51109.2367021277,35708.3989361702,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
148122,2416.5291005291,155.911816578483,155.514991181658,803.098765432099,4479.2962962963,2973.02292768959,333.008818342152,259.15873015873,1113.05114638448,5399.12169312169,686.821869488536,142.89594356261,1084.3897707231,4526.70194003527,813.132275132275,321.188712522046,1943.30864197531,5861.24338624339,410.559082892416,247.192239858907,1026.81481481481,1483.11287477954,257.049382716049,151.102292768959,593.008818342152,1972.67724867725,525.162257495591,227.723104056437,1071.52557319224,130.776014109347,567,34.1268549295455,21.1920507334731,0.783827422198064,0.962648556876061,0.703473945409429,0.985014565101386,51537.8659611993,34009.7160493827,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148122,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
148807,2289.52811735941,178.652811735941,128.899755501223,665.474327628362,2805.15403422983,2650.64792176039,330.303178484108,261.41075794621,1098.54767726161,4142.43031784841,574.987775061125,117.012224938875,1070.9902200489,665.765281173594,453.557457212714,264.525672371638,1462.25672371638,1087.77995110024,289.919315403423,231.339853300733,992.99511002445,1016.10513447433,202.98533007335,130.107579462103,1126.95354523227,1205.097799511,460.244498777506,213.79706601467,1040.32273838631,131.924205378973,409,24.6213796318558,21.7292822317688,0.470242679117769,0.960093896713615,0.740942028985507,-0.96861209242826,50288.8875305623,34650.3349633252,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_148807,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
149082,2553.46346153846,730.905769230769,777.417307692308,638.428846153846,1582.16538461538,2829.29230769231,674.609615384615,260.480769230769,1109.97307692308,4105.08269230769,463.917307692308,107.569230769231,1072.19230769231,806.557692307692,471.475,274.365384615385,1829.02884615385,1302.99038461538,291.440384615385,234.001923076923,1034.99038461538,1076.68269230769,209.175,149.028846153846,752.111538461538,893.880769230769,443.476923076923,562.436538461538,1021.63076923077,129.717307692308,520,29.9975152454192,22.1512317324911,0.674324058123872,0.97196261682243,0.779610194902549,1.17113627491826,51287.4346153846,35289.4442307692,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_149082,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
149297,1770.39166666667,117.358333333333,61.3166666666667,614.691666666667,554.525,1313.59166666667,635.883333333333,252.158333333333,1083.25833333333,3185.39166666667,535.308333333333,103.325,1068.225,3802.81666666667,931.108333333333,887.191666666667,1983.90833333333,2702.74166666667,389.341666666667,235.975,1032.89166666667,1808.00833333333,238.758333333333,679.875,621.933333333333,1269.05,424.008333333333,214.266666666667,1023.29166666667,130.175,120,13.7911275816823,11.1332994023029,0.590168826824078,0.94488188976378,0.714285714285714,-1.18349965135675,51354.6916666667,35706.25,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_149297,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
150321,3654.60664819945,893.858725761773,97.8393351800554,634.180055401662,1448.04432132964,3704.64819944598,1145.05540166205,271.299168975069,1226.59279778393,6032.78947368421,552.216066481994,135.371191135734,1092.27146814404,2076.01385041551,823.17728531856,1632.06925207756,3818.65927977839,4955.04709141274,397.459833795014,245.290858725762,1033.15789473684,5909.08310249307,413.667590027701,414.002770083103,605.814404432133,2400.65096952909,518.052631578947,296.08864265928,1071.03601108033,129.85595567867,361,27.4424694542551,17.0335668183579,0.784047404549035,0.96524064171123,0.730769230769231,-0.405022420460614,51060.1274238227,35868.6703601108,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
150625,1526.4875,666.520833333333,151.383333333333,667.158333333333,2981.37083333333,1597.2375,366.033333333333,255.658333333333,1101.41666666667,3063.32083333333,527.954166666667,126.6625,1077.5625,1400.2125,591.5875,287.65,1998.91666666667,4218.8125,441.533333333333,251.833333333333,1035.9875,4702.1375,282.925,232.891666666667,798.9625,1817.3125,458.266666666667,223.058333333333,1048.47083333333,131.020833333333,240,18.3116580161058,16.7102634007789,0.408970043385273,0.975609756097561,0.784313725490196,-0.824022097436694,50698.0416666667,35861.8375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150625,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
150969,1261.13211845103,218.077448747153,149.656036446469,664.813211845103,3460.91571753986,1675.55125284738,353.296127562642,267.888382687927,1087.9589977221,2601.26651480638,643.674259681093,125.512528473804,1069.96583143508,1447.05466970387,974.512528473804,323.02277904328,1793.51480637813,1463.00911161731,405.990888382688,250.96583143508,1003.05922551253,1251.92255125285,254.277904328018,178.268792710706,592.086560364465,1486.00683371298,564.567198177677,232.113895216401,1050.83143507973,130.542141230068,439,25.6827883885562,21.7880873129831,0.529429959294295,0.969094922737307,0.804029304029304,0.130597769160215,50790.1047835991,34244.4350797267,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_150969,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
151010,3801.85207100592,958.905325443787,115.778106508876,638.168639053254,1756.82544378698,3823.68934911243,1078.15088757396,274.180473372781,1102.10355029586,6029.68343195266,1682.95562130178,118.352071005917,1082.76627218935,4242.33136094675,755.763313609467,350.917159763314,8645.76923076923,2416.21597633136,290.165680473373,227.526627218935,1035.0650887574,1617.12721893491,199.289940828402,145.766272189349,596.467455621302,1072.25147928994,462.139053254438,346.177514792899,1032.79289940828,131.615384615385,338,23.0788940298269,18.7089754306762,0.585526823461853,0.960227272727273,0.731601731601732,-0.806217090256332,50779.3550295858,35322.7011834319,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
151183,945.203349282297,397.540669856459,129.143540669856,626.535885167464,1209.33732057416,1081.69138755981,2017.21291866029,261.27990430622,1087.2009569378,1550.46650717703,869.710526315789,115.696172248804,1072.34210526316,779.074162679426,516.019138755981,290.543062200957,1389.96650717703,1054.21052631579,326.478468899522,236.717703349282,1008.37081339713,989.8995215311,227.265550239234,135.724880382775,583.153110047847,924.598086124402,496.602870813397,258.787081339713,1030.24401913876,130.739234449761,418,26.2322253322402,20.3189247120743,0.632477459013306,0.958715596330275,0.774074074074074,0.0922840257878906,50202.4401913876,34170.3157894737,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
151249,3283.91168091168,643.663817663818,98.8660968660969,644.22792022792,2379.90883190883,3617.83760683761,456.336182336182,274.011396011396,1207.72364672365,6107.22792022792,695.373219373219,114.222222222222,1093.39601139601,3143.87749287749,742.581196581197,409.492877492877,4062.2962962963,3782.02279202279,383.549857549858,245.094017094017,1037.97435897436,3733.64957264957,267.185185185185,209.797720797721,653.866096866097,2334.16239316239,509.920227920228,263.94301994302,1059.44444444444,130.435897435897,351,22.5822614533377,19.85096026246,0.476727680166512,0.959016393442623,0.76304347826087,-0.0431497853164336,51286.8034188034,35569.6438746439,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151249,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
152952,2239.53174603175,512.978835978836,237.645502645503,698.740740740741,5550.37566137566,2536.17724867725,530.436507936508,272.243386243386,1102.75661375661,4799.77248677249,724.867724867725,127.346560846561,1104.2380952381,650.320105820106,551.470899470899,270.960317460317,1474.11375661376,1060.93915343915,284.039682539683,231.978835978836,992.804232804233,1006.1746031746,215.634920634921,140.338624338624,584.582010582011,2484.53174603175,562.187830687831,239.367724867725,1101.69841269841,131.029100529101,378,24.8548247056477,19.9527257441002,0.596287813828585,0.959390862944162,0.74703557312253,-0.844081987746532,51808.3888888889,34256.5291005291,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_152952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
153007,3642.34817813765,732.983805668016,106.246963562753,624.902834008097,1459.46558704453,3389.42914979757,454.902834008097,267.182186234818,1087.55870445344,5007.65587044534,560.963562753036,115.008097165992,1070.23481781377,5435.14574898785,926.502024291498,326.165991902834,4605.47773279352,7757.74898785425,438.757085020243,257.951417004049,1024.74089068826,10747.0769230769,301.842105263158,187.465587044534,595.206477732793,1236.57085020243,540.182186234818,273.805668016194,1048.34412955466,130.987854251012,247,19.1417778913042,16.5469361286356,0.502734415384279,0.946360153256705,0.764705882352941,0.0061398037568353,51745.9068825911,34913.4251012146,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_153007,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
153959,3153.83989501312,757.939632545932,135.742782152231,661.761154855643,1847.28346456693,3408.78215223097,2662.49868766404,262.062992125984,1095.28346456693,5412.98162729659,1563.11023622047,123.10498687664,1080.46194225722,847.359580052493,496.086614173228,276.404199475066,1585.65091863517,1284.17585301837,331.748031496063,240.291338582677,1063.22834645669,1963.93175853018,311.868766404199,685.763779527559,1192.71653543307,1746.11023622047,521.92125984252,370.695538057743,1090.83202099738,133.755905511811,381,27.3551980183984,17.7664885530705,0.760383841377618,0.964556962025316,0.721590909090909,-0.95953943697006,50903.2414698163,33677.6745406824,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_153959,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
155950,2028.20955882353,134.915441176471,77.7573529411765,630.525735294118,1654.68382352941,2416.5,829.441176470588,267.132352941176,1094.42279411765,4489.12867647059,922.511029411765,113.746323529412,1077.73529411765,4441.46691176471,1007.54779411765,328.305147058824,2108.40073529412,3177.49264705882,366.889705882353,243.257352941176,1014.61397058824,2452.19485294118,243.069852941176,169.238970588235,591.654411764706,2397.49264705882,552.430147058824,249.599264705882,1052.19485294118,130.448529411765,272,20.0453932396204,17.3441686352366,0.501349927081994,0.96113074204947,0.755555555555556,-1.00949666643804,51707.3125,34986.6433823529,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_155950,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
156386,4536.9298245614,977.985964912281,108.00350877193,655.385964912281,2567.29824561404,4633.66666666667,1114.39298245614,280.810526315789,1169.50175438596,7534.73684210526,672.042105263158,116.761403508772,1089.31929824561,700.319298245614,587.259649122807,410.736842105263,1544.75087719298,1108.81754385965,280.59298245614,252.722807017544,1012.70175438596,1044.68070175439,214.901754385965,185.414035087719,663.028070175439,2260.77192982456,562.621052631579,470.922807017544,1052.23859649123,131.245614035088,285,20.8254072107123,17.4460097972122,0.546088967519446,0.962837837837838,0.753968253968254,1.29491575318254,50918.9228070175,35282.4456140351,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_156386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
156679,3915.33734939759,298.156626506024,109.213855421687,633.496987951807,1414.63554216867,4485.58734939759,1808.60843373494,281.045180722892,1115.36445783133,6930.11445783133,1724.48795180723,123.939759036145,1081.44578313253,1637.9578313253,999.861445783133,1214.81325301205,2123.28915662651,2230.15662650602,370.075301204819,243.39156626506,1053.04518072289,1663.89759036145,256.006024096386,352.954819277108,643.186746987952,2044.53614457831,483.743975903614,714.813253012048,1111.24397590361,133.536144578313,332,27.5006421360219,15.4444318574726,0.827407112980317,0.937853107344633,0.741071428571429,0.0098001316601467,50628.3403614458,35468.1656626506,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_156679,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
156795,2207.64810126582,375.926582278481,119.817721518987,654.455696202532,2674.26075949367,2575.74683544304,3208.04050632911,249.141772151899,1090.30886075949,4451.38227848101,3193.80759493671,122.620253164557,1073.22025316456,3593.61518987342,815.217721518987,706.422784810127,1793.54683544304,2676.94936708861,349.070886075949,244.169620253165,1024.41265822785,5145.75949367089,341.708860759494,236.539240506329,691.184810126582,1636.98987341772,496.650632911392,457.698734177215,1043.80506329114,134.670886075949,395,29.116710310591,17.458247969279,0.800303228340343,0.949519230769231,0.705357142857143,0.367203328537986,51571.9164556962,33865.4151898734,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_156795,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
157028,1889.67272727273,69.5127272727273,74.4181818181818,647.952727272727,2395.0,1944.79636363636,310.767272727273,251.247272727273,1096.2,3654.01090909091,468.803636363636,119.574545454545,1075.65454545455,2776.69818181818,777.425454545454,339.090909090909,5310.17090909091,4327.11636363636,366.694545454546,233.858181818182,1040.70909090909,4146.76,238.021818181818,189.883636363636,601.607272727273,1109.59272727273,463.28,221.283636363636,1041.42545454545,130.752727272727,275,23.1564427175544,15.154260465473,0.756122979194147,0.951557093425606,0.735294117647059,-1.23400656900562,52016.6690909091,34314.1272727273,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_157028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
157464,3525.98016997167,405.929178470255,127.359773371105,624.764872521247,876.776203966006,3391.04815864023,371.898016997167,268.164305949009,1096.02266288952,4879.34560906516,613.14730878187,114.300283286119,1085.25212464589,523.198300283286,378.090651558074,264.399433427762,1471.0283286119,830.436260623229,239.974504249292,224.011331444759,999.668555240793,811.419263456091,187.968838526912,130.535410764873,582.903682719547,1108.29745042493,505.543909348442,232.898016997167,1015.86968838527,129.824362606232,353,25.0455170495133,18.0175898163858,0.694602442315934,0.956639566395664,0.729338842975207,0.824806995099436,51578.7847025496,34814.1076487252,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157464,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
157476,1391.80913978495,228.215053763441,86.8844086021505,612.728494623656,629.126344086022,1683.08064516129,290.631720430108,249.989247311828,1078.77688172043,3143.2311827957,490.793010752688,107.709677419355,1072.42204301075,608.120967741935,536.045698924731,268.166666666667,1425.68010752688,1056.88440860215,316.959677419355,237.935483870968,982.58064516129,1034.75,227.408602150538,148.983870967742,632.182795698925,1549.66129032258,489.551075268817,218.784946236559,1040.0752688172,131.048387096774,372,29.3192150493893,16.2159842801138,0.833125595016608,0.944162436548223,0.664285714285714,-0.387959864730565,50718.626344086,34454.7849462366,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_157476,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
157527,3367.48328267477,347.534954407295,149.31914893617,678.595744680851,3864.68389057751,3520.89361702128,1149.34042553191,267.057750759878,1140.56534954407,6262.39817629179,1198.91489361702,127.702127659574,1116.96656534954,5748.78419452888,992.240121580547,614.954407294833,2092.74772036474,5724.53191489362,409.29179331307,244.173252279635,1045.25227963526,4587.18541033435,267.22188449848,276.960486322188,617.206686930091,2481.95136778116,458.009118541033,275.410334346505,1056.34346504559,128.908814589666,329,22.0103804027696,19.0611977969233,0.500027602630756,0.959183673469388,0.787081339712919,0.301306646563212,51218.188449848,35808.8571428571,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157527,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
158118,3204.07917888563,316.671554252199,154.551319648094,616.736070381232,1859.58651026393,3954.99413489736,516.117302052786,269.181818181818,1110.6862170088,6495.26099706745,999.950146627566,122.809384164223,1075.56598240469,676.111436950147,514.935483870968,281.74780058651,1670.79472140762,1166.79472140762,489.126099706745,318.612903225806,1000.64516129032,1127.57771260997,247.202346041056,140.894428152493,584.527859237537,2640.26686217009,737.33431085044,416.032258064516,1115.41055718475,133.451612903226,341,22.8811832084012,19.02584414853,0.555515573323062,0.955182072829132,0.773242630385488,0.972274399129377,51844.6891495601,34693.1964809384,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158118,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
158161,1429.68055555556,322.513888888889,124.967592592593,674.791666666667,2128.59722222222,1244.50925925926,2017.70833333333,265.240740740741,1105.58796296296,2646.56481481481,598.939814814815,109.643518518519,1074.33796296296,1060.69907407407,546.523148148148,285.75462962963,1810.33333333333,1387.48148148148,326.300925925926,237.939814814815,1010.78703703704,1186.11111111111,234.435185185185,172.606481481481,646.74537037037,1145.375,469.467592592593,1312.35185185185,1050.81481481481,130.148148148148,216,20.9142242440055,13.2437276348142,0.773955324002145,0.931034482758621,0.73469387755102,1.35956845429887,51135.2407407407,35419.5555555556,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158161,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
158167,3159.59589041096,490.472602739726,183.043378995434,651.75799086758,2154.69178082192,3668.09132420091,2669.27397260274,264.086757990868,1093.37442922374,4790.81506849315,724.422374429224,126.470319634703,1067.54566210046,1506.15525114155,705.557077625571,318.853881278539,1917.80593607306,1308.80136986301,328.406392694064,233.593607305936,995.111872146119,963.751141552511,206.91095890411,152.805936073059,589.72602739726,1435.45890410959,499.342465753425,244.86301369863,1067.19406392694,132.72602739726,438,27.3165143112698,20.4312953190402,0.663758850395398,0.958424507658643,0.772486772486772,-1.40550710602406,50614.9223744292,33922.3059360731,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158167,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
158811,3640.54341736695,1277.70028011204,140.935574229692,662.0,2870.59943977591,3869.84593837535,447.218487394958,268.84593837535,1318.92717086835,6515.82072829132,664.585434173669,114.63025210084,1074.98319327731,2658.84033613445,580.879551820728,293.394957983193,1880.35854341737,2417.79271708683,346.053221288515,242.47619047619,1044.09803921569,2042.9299719888,234.207282913165,155.806722689076,817.081232492997,2596.92156862745,610.778711484594,324.285714285714,1073.31652661064,133.428571428571,357,23.508298914686,19.391046704122,0.565337592632647,0.959677419354839,0.705533596837945,-0.589409152647878,51378.6022408964,35326.8095238095,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158811,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
158985,4604.75965665236,393.858369098713,227.725321888412,706.93991416309,4943.84978540772,4267.32188841202,451.716738197425,277.901287553648,1170.12446351931,7854.56223175966,1472.79399141631,129.300429184549,1078.61373390558,2258.02145922747,1036.92703862661,318.690987124464,1662.28755364807,1326.45493562232,315.931330472103,234.635193133047,1009.72532188841,1235.11158798283,236.459227467811,179.669527896996,596.309012875536,2979.02145922747,518.291845493562,361.44635193133,1087.62660944206,131.124463519313,233,17.8556172766489,16.657593113682,0.360122784607362,0.970833333333333,0.761437908496732,0.0947822722645308,50429.313304721,35628.4420600858,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_158985,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
159061,3745.93835616438,153.092465753425,124.61301369863,631.760273972603,1462.06164383562,4101.63356164384,469.619863013699,275.952054794521,1096.39726027397,7312.67123287671,640.140410958904,120.236301369863,1100.56164383562,4383.33219178082,571.698630136986,333.801369863014,1607.15068493151,7543.67123287671,384.821917808219,247.479452054795,995.191780821918,7960.95547945205,274.441780821918,147.503424657534,589.876712328767,2941.82534246575,528.626712328767,235.434931506849,1055.66780821918,130.784246575342,292,22.7044243090557,16.4372835460393,0.689833237612041,0.948051948051948,0.746803069053708,1.49167294602498,50932.3219178082,35352.0239726027,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_159061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
159195,3400.61386138614,483.026402640264,92.0660066006601,619.60396039604,785.412541254125,3023.83498349835,478.904290429043,273.316831683168,1100.28712871287,5077.79537953795,596.323432343234,115.841584158416,1076.25412541254,1262.3597359736,823.135313531353,300.96699669967,1894.7095709571,1392.22112211221,283.798679867987,227.445544554455,1229.73597359736,1006.57095709571,197.49504950495,174.798679867987,1656.38943894389,1289.88448844884,458.722772277228,238.277227722772,1049.77227722772,132.359735973597,303,20.8099537529474,18.8162027428843,0.427125323106121,0.958860759493671,0.759398496240602,0.0075620444329424,50792.8580858086,35551.402640264,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_159195,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
160095,3914.48459383754,301.207282913165,148.372549019608,634.428571428571,1723.03361344538,4466.81512605042,901.593837535014,272.504201680672,1113.87675070028,6029.64145658263,703.949579831933,120.985994397759,1082.73389355742,729.549019607843,706.210084033613,857.694677871148,2475.01680672269,1115.90196078431,301.296918767507,235.12324929972,1009.18487394958,1142.80112044818,248.176470588235,199.210084033613,930.705882352941,1643.71988795518,538.960784313726,306.551820728291,1054.3893557423,132.963585434174,357,25.5565879659476,17.8481345037107,0.715730044410078,0.959677419354839,0.782894736842105,1.28207385603497,51951.3781512605,34827.6694677871,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_160095,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
160145,3966.21126760563,1134.46830985915,608.725352112676,624.264084507042,839.024647887324,4453.05985915493,373.352112676056,256.93661971831,1102.02464788732,7778.8661971831,662.964788732394,125.806338028169,1082.97535211268,674.017605633803,579.239436619718,370.93661971831,1375.3838028169,1096.31690140845,283.260563380282,229.785211267606,1028.89788732394,2497.77816901408,296.507042253521,940.169014084507,717.521126760563,1962.90845070423,534.700704225352,224.144366197183,1056.69366197183,132.260563380282,284,21.1225578533698,17.1627164280681,0.58291907949719,0.975945017182131,0.788888888888889,-1.09827976275234,51529.0845070423,33917.6056338028,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_160145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
161030,1940.48927038627,178.390557939914,60.8154506437768,634.25321888412,1855.81545064378,2278.84120171674,1177.0,259.81974248927,1157.88841201717,3887.03004291845,545.030042918455,123.665236051502,1081.42918454936,3032.71673819743,1135.5364806867,3582.27038626609,1849.93991416309,3263.70386266094,397.892703862661,251.523605150215,1036.77253218884,2435.98283261803,285.44635193133,426.935622317596,658.429184549356,1723.7339055794,432.987124463519,266.300429184549,1051.32188841202,130.047210300429,233,18.3888059932667,16.2253110398507,0.470599044669241,0.962809917355372,0.761437908496732,-0.824932001596466,50889.5965665236,35827.5364806867,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_161030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
161150,1979.20747663551,323.803738317757,154.654205607477,662.179439252336,2640.49158878505,2676.99439252336,1227.93644859813,261.78691588785,1095.49345794393,4260.03364485981,2098.04859813084,117.732710280374,1071.94579439252,673.6,641.366355140187,292.865420560748,1494.09906542056,1197.13644859813,330.418691588785,238.934579439252,1002.91214953271,1115.94392523364,222.85046728972,144.766355140187,633.398130841122,2016.86355140187,526.005607476636,513.884112149533,1067.25420560748,131.082242990654,535,27.2021158498895,25.0906785269889,0.38628454809547,0.96745027124774,0.762108262108262,0.937621023891811,51286.3495327103,34727.1065420561,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_161150,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
162139,1941.52647058824,476.955882352941,163.164705882353,648.182352941176,3118.25,2363.20882352941,559.45,254.211764705882,1111.08529411765,3985.49117647059,472.6,110.976470588235,1080.72058823529,1044.01764705882,519.576470588235,339.291176470588,1548.49411764706,1170.58529411765,258.635294117647,228.835294117647,1003.06176470588,1121.64117647059,203.902941176471,173.905882352941,603.270588235294,1549.38823529412,479.238235294118,244.514705882353,1033.34117647059,129.179411764706,340,22.5106595114621,19.3271784732326,0.512681364569308,0.96045197740113,0.772727272727273,-1.12119861331286,51671.0411764706,35148.1294117647,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_162139,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
162453,4081.5974025974,765.561688311688,122.386363636364,647.12012987013,2487.22402597403,3526.27272727273,669.159090909091,269.788961038961,1117.49025974026,6663.30844155844,577.681818181818,115.779220779221,1085.48701298701,5567.16883116883,1495.50324675325,1060.95779220779,2092.99675324675,6093.13636363636,401.324675324675,238.912337662338,1060.79220779221,5569.94805194805,248.737012987013,277.25,673.798701298701,1852.00324675325,516.454545454545,239.720779220779,1048.5,132.25974025974,308,21.0392076846074,18.7078517851505,0.457538253527097,0.96551724137931,0.77,-0.998330424460036,51374.3246753247,35580.4123376623,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_162453,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
163713,4892.21176470588,821.133333333333,1377.11764705882,634.435294117647,1478.58039215686,5419.59607843137,857.780392156863,284.180392156863,1142.8,8431.74509803922,906.0,121.058823529412,1082.62352941176,714.254901960784,474.380392156863,299.505882352941,1398.63921568627,1105.67450980392,313.988235294118,236.78431372549,985.63137254902,1045.7137254902,239.717647058824,133.803921568627,581.427450980392,2798.49803921569,571.133333333333,402.392156862745,1072.97254901961,130.933333333333,255,19.7612283761786,16.5291255740209,0.548055130485226,0.96958174904943,0.787037037037037,0.791775636145691,50871.0901960784,35224.3647058824,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_163713,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
163734,3241.81985294118,187.985294117647,82.1654411764706,626.375,1000.64338235294,2629.88235294118,349.389705882353,269.966911764706,1106.26838235294,4579.05882352941,717.794117647059,115.794117647059,1074.61397058824,3196.19852941176,557.786764705882,299.279411764706,1541.67279411765,3922.67647058824,367.768382352941,239.466911764706,1096.23161764706,3969.15808823529,256.014705882353,793.955882352941,851.202205882353,1151.25,423.375,221.268382352941,1052.03676470588,131.488970588235,272,27.578878748109,12.6307588780118,0.888959059150541,0.928327645051195,0.71957671957672,0.066718294197239,50155.8235294118,35301.8897058823,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_163734,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
163778,2294.64729458918,254.138276553106,167.354709418838,724.765531062124,7179.83166332665,3024.10420841683,452.140280561122,267.735470941884,1109.36873747495,4460.48296593186,1006.91783567134,130.629258517034,1109.97595190381,684.97995991984,570.615230460922,271.74749498998,1423.36873747495,1041.44889779559,323.813627254509,238.925851703407,991.949899799599,1033.52104208417,220.673346693387,138.386773547094,584.971943887776,1788.95591182365,547.605210420842,248.200400801603,1073.85370741483,131.434869739479,499,37.5178700535288,17.4506527557834,0.88524286478875,0.959615384615385,0.72953216374269,0.0638007912473161,50919.6052104208,34342.7254509018,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_163778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
164600,3443.01453488372,251.398255813953,120.93023255814,632.875,1342.91860465116,3960.58139534884,1534.57848837209,281.258720930233,1105.98546511628,6094.76453488372,857.255813953488,119.94476744186,1076.39825581395,711.244186046512,553.026162790698,273.552325581395,1431.70639534884,1146.13372093023,327.781976744186,238.485465116279,989.287790697674,1070.29941860465,240.755813953488,137.113372093023,581.747093023256,1992.18895348837,527.165697674419,552.973837209302,1098.39534883721,130.436046511628,344,22.8943223230431,19.182190027165,0.545888313950487,0.960893854748603,0.747826086956522,-1.17553649857549,50886.8081395349,35211.5552325581,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_164600,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
164670,3846.98055555556,518.394444444444,123.302777777778,658.797222222222,2571.65555555556,3799.48333333333,3883.29444444444,282.180555555556,1132.45277777778,6814.21944444444,1380.38055555556,124.886111111111,1075.50277777778,742.030555555556,615.772222222222,282.941666666667,1587.90277777778,1219.71111111111,312.819444444444,239.577777777778,1000.26388888889,1118.34722222222,239.388888888889,178.355555555556,605.027777777778,1875.36666666667,556.102777777778,536.505555555556,1090.80833333333,132.605555555556,360,24.4550576329524,18.8865072517122,0.635264636384383,0.939947780678851,0.745341614906832,0.916735664248062,51793.8416666667,35335.9833333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_164670,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
164894,4190.04458598726,1169.73248407643,1331.62738853503,620.321656050955,698.283439490446,4526.00955414013,1510.72611464968,274.764331210191,1106.36305732484,6454.9076433121,585.821656050955,117.251592356688,1078.86624203822,4579.08917197452,1313.02547770701,1307.12738853503,2130.76433121019,4693.33757961783,373.665605095541,242.385350318471,1040.68152866242,4904.12101910828,374.84076433121,300.257961783439,826.735668789809,1616.6178343949,529.464968152866,808.544585987261,1062.04140127389,132.031847133758,314,20.6160488249011,19.5752057808469,0.313727775156732,0.972136222910217,0.747619047619048,0.60371362336108,51575.423566879,35056.0700636943,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_164894,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
164899,4012.01204819277,1103.45180722892,201.578313253012,688.307228915663,4410.63855421687,4128.59337349398,518.939759036145,276.753012048193,1274.02108433735,7335.06024096385,739.442771084337,119.039156626506,1084.03313253012,895.460843373494,594.674698795181,292.722891566265,1707.15060240964,2047.6656626506,333.728915662651,240.545180722892,1026.21385542169,2011.48795180723,243.222891566265,288.081325301205,1098.34939759036,3248.44578313253,577.614457831325,279.55421686747,1051.36746987952,134.960843373494,332,22.502510553142,18.8207712045656,0.548141832938634,0.959537572254335,0.794258373205742,0.282442950482235,51389.6054216867,35347.7861445783,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_164899,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
165177,2695.48093841642,222.495601173021,107.263929618768,633.0,1392.46627565982,3190.95894428152,321.741935483871,258.287390029326,1086.15249266862,5412.79178885631,620.096774193548,120.290322580645,1080.10557184751,549.407624633431,390.991202346041,279.290322580645,1480.40175953079,859.41642228739,256.730205278592,226.228739002933,991.24926686217,772.123167155425,183.049853372434,133.683284457478,585.633431085044,1859.28445747801,510.932551319648,223.730205278592,1042.90615835777,130.680351906158,341,28.0481177027867,15.7027674053132,0.828593284669741,0.939393939393939,0.676587301587302,-1.27112539229153,51353.8826979472,34422.9560117302,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_165177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
165204,4084.8091286307,687.302904564315,106.639004149378,610.253112033195,926.867219917012,3958.32365145228,326.705394190871,266.564315352697,1122.11203319502,8200.44398340249,525.871369294606,119.460580912863,1070.19917012448,2493.04149377593,774.780082987552,356.48132780083,2080.0622406639,1306.28215767635,282.804979253112,225.697095435685,1020.93360995851,937.522821576764,219.103734439834,158.846473029046,592.414937759336,4776.72199170124,553.340248962656,232.394190871369,1041.13692946058,128.526970954357,241,18.6331794300512,16.487996265767,0.465832459013481,0.971774193548387,0.787581699346405,-0.293911046870576,50570.7593360996,35568.6265560166,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_165204,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
165438,3998.73413897281,442.939577039275,109.803625377643,669.957703927493,3074.07854984894,4291.2416918429,559.036253776435,276.208459214501,1135.7250755287,7589.36858006042,952.347432024169,120.380664652568,1108.3081570997,601.365558912387,445.969788519638,281.202416918429,1492.81873111782,977.353474320242,279.948640483384,230.716012084592,994.867069486405,929.287009063444,212.229607250755,142.791540785498,583.655589123867,2652.65256797583,528.280966767372,294.350453172205,1077.76435045317,132.824773413897,331,23.8342454200205,17.7565331205914,0.667063514236801,0.967836257309942,0.79951690821256,-0.114163113958445,50842.1601208459,35252.5438066465,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_165438,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
165880,1856.69262295082,358.678278688525,116.190573770492,634.545081967213,1794.27663934426,2219.79303278689,2104.71516393443,261.159836065574,1085.83606557377,2533.32991803279,2348.01229508197,116.704918032787,1070.71721311475,2079.06762295082,708.645491803279,308.129098360656,1911.33401639344,2064.96516393443,474.008196721311,259.930327868852,1013.21926229508,1764.58196721311,310.622950819672,167.59631147541,616.547131147541,1150.42418032787,550.983606557377,284.446721311475,1028.71106557377,129.678278688525,488,29.4880805960912,21.1149243028734,0.698049543527729,0.966336633663366,0.753086419753086,-0.680948007616737,50934.5696721311,34281.1045081967,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_165880,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166161,2456.75,367.926470588235,101.948529411765,621.779411764706,720.955882352941,3177.97058823529,1404.68382352941,278.205882352941,1092.48529411765,3380.80147058824,671.463235294118,116.522058823529,1073.40441176471,686.617647058824,483.448529411765,281.625,1382.74264705882,1096.70588235294,362.977941176471,239.985294117647,981.742647058824,1087.00735294118,252.286764705882,134.058823529412,586.757352941176,734.051470588235,416.544117647059,207.397058823529,1009.77941176471,131.735294117647,136,13.6465975934763,12.8184539498716,0.343055844859459,0.964539007092198,0.804733727810651,0.698703404298178,50674.9558823529,34991.625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166161,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166505,1778.76221498371,579.57654723127,171.237785016287,621.130293159609,762.71661237785,1817.65472312704,379.302931596091,273.612377850163,1103.25732899023,3771.96416938111,720.153094462541,115.127035830619,1072.14332247557,1116.94788273616,604.00325732899,299.172638436482,1531.4657980456,2524.12703583062,315.244299674267,235.983713355049,1000.2996742671,2248.80781758958,228.413680781759,214.117263843648,595.156351791531,1462.25732899023,459.384364820847,269.915309446254,1091.94788273616,131.811074918567,307,27.1739687748523,14.4660609384996,0.84652438237483,0.95046439628483,0.710648148148148,1.31869495190228,51652.8697068404,35516.1889250814,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_166505,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166600,3783.66666666667,229.42962962963,117.788888888889,688.5,3518.3,4496.61111111111,317.222222222222,264.662962962963,1122.84074074074,7802.0,575.611111111111,136.22962962963,1063.43333333333,576.07037037037,421.62962962963,268.2,1332.52592592593,886.9,283.474074074074,230.048148148148,980.762962962963,846.307407407407,202.648148148148,124.514814814815,584.103703703704,4536.71111111111,570.881481481482,263.088888888889,1059.45925925926,127.907407407407,270,23.7941638366947,14.5245288188138,0.792074827510412,0.931034482758621,0.703125,-1.30891084227997,50282.0814814815,34366.7703703704,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166600,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166602,2886.92339544513,614.091097308489,147.142857142857,646.594202898551,2030.38923395445,3512.69151138716,1067.08695652174,258.219461697723,1098.03519668737,4488.52587991718,3089.71842650104,122.56314699793,1076.02277432712,678.418219461698,554.223602484472,288.285714285714,1354.13871635611,1066.31262939959,352.403726708075,250.300207039337,983.505175983437,977.75983436853,234.494824016563,140.024844720497,586.389233954451,1365.93581780538,509.546583850932,408.844720496894,1036.05797101449,129.801242236025,483,32.4347578145499,19.084614717863,0.808569924731098,0.956435643564356,0.686079545454545,-0.377506510495527,51636.817805383,33994.7577639752,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166602,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166865,3859.93103448276,723.287356321839,973.448275862069,665.287356321839,3022.94540229885,4439.33620689655,1058.65804597701,271.402298850575,1154.79022988506,6506.17816091954,941.244252873563,138.204022988506,1079.54597701149,1569.02011494253,775.132183908046,1553.2816091954,2245.16954022989,2413.16954022989,361.373563218391,238.284482758621,1039.43965517241,2087.12931034483,255.899425287356,404.85632183908,614.359195402299,2410.3132183908,536.10632183908,349.531609195402,1083.90229885057,130.781609195402,348,22.2811621638131,20.1729329330174,0.42460086053172,0.956043956043956,0.753246753246753,-0.174048524776961,51088.1005747126,35855.0862068966,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
166907,2847.9218328841,250.029649595687,99.4150943396226,625.768194070081,1115.46361185984,2921.39892183288,401.040431266846,264.789757412399,1087.88948787062,5683.88140161725,819.345013477089,113.862533692722,1071.01886792453,795.827493261456,444.55795148248,266.741239892183,1822.09973045822,1214.93530997305,270.935309973046,228.803234501348,1045.84905660377,995.88679245283,210.210242587601,139.067385444744,613.21832884097,2531.36388140162,477.016172506739,323.824797843666,1066.25876010782,129.706199460916,371,22.5097343560301,21.2242546481134,0.333097818637438,0.953727506426735,0.766528925619835,-0.747415183478249,50123.0808625337,35453.0970350404,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_166907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
167828,2480.53623188406,418.04347826087,554.388888888889,614.688405797101,605.282608695652,2795.40338164251,530.364734299517,264.3961352657,1089.64734299517,5440.55314009662,637.615942028986,113.95652173913,1070.87922705314,1699.70531400966,925.219806763285,416.809178743961,2635.59661835749,1748.07729468599,361.729468599034,248.420289855072,1005.83333333333,1481.35748792271,254.311594202899,151.514492753623,625.021739130435,3276.11835748792,578.574879227053,322.217391304348,1042.66425120773,128.690821256039,414,30.8710847770542,17.2240480950076,0.829884882718765,0.962790697674419,0.785578747628083,-1.56262890462995,51638.7560386473,34962.1811594203,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_167828,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
167996,1787.25632911392,555.582278481013,89.4841772151899,620.01582278481,912.791139240506,1961.84493670886,781.892405063291,267.29746835443,1108.98101265823,3722.99683544304,671.471518987342,121.71835443038,1078.26898734177,2300.57911392405,719.927215189873,343.379746835443,1587.49050632911,1965.68987341772,378.009493670886,245.060126582278,1001.08227848101,1465.57594936709,265.892405063291,316.193037974684,729.768987341772,2324.51265822785,528.306962025316,245.79746835443,1071.20253164557,129.689873417722,316,23.776836933776,16.9602337079273,0.700849594867838,0.957575757575758,0.763285024154589,-1.23467268521605,50588.7879746835,35780.3481012658,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_167996,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
168010,3582.42618384401,650.805013927577,225.239554317549,680.621169916434,2952.23955431755,5150.24512534819,426.220055710306,291.83286908078,1165.4930362117,6948.60167130919,746.518105849582,140.16991643454,1082.20334261838,1322.56824512535,773.534818941504,289.818941504178,1820.54596100279,1570.14484679666,274.66295264624,225.389972144847,1079.8077994429,1458.34818941504,188.596100278552,156.047353760446,2804.28133704735,2464.39554317549,627.707520891365,237.980501392758,1072.77158774373,132.440111420613,359,22.9502813613808,19.9819330596915,0.491882147249101,0.957333333333333,0.777056277056277,-0.672599814006201,50613.6908077994,34449.7075208914,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_168010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
168710,2810.33095238095,148.864285714286,77.3071428571429,632.033333333333,1789.64047619048,2852.17857142857,377.483333333333,268.252380952381,1091.71904761905,5334.61666666667,534.207142857143,119.454761904762,1079.08333333333,1782.64285714286,582.704761904762,283.140476190476,1635.78095238095,2296.64285714286,332.619047619048,239.621428571429,1027.10238095238,2008.71428571429,240.828571428571,625.514285714286,734.240476190476,1764.27142857143,507.321428571429,228.102380952381,1041.55952380952,128.914285714286,420,26.0567818872662,20.6551853063029,0.609613216253841,0.963302752293578,0.729166666666667,-0.788604720145415,51750.0452380952,35101.6642857143,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_168710,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
168797,2766.39240506329,1152.86708860759,1195.79430379747,655.607594936709,2143.67721518987,3010.39240506329,758.835443037975,264.882911392405,1195.8164556962,4357.10759493671,1457.51265822785,111.224683544304,1078.17405063291,1207.35126582278,955.0,919.183544303798,1842.74050632911,1332.16455696203,309.642405063291,232.310126582278,1003.75316455696,1266.68037974684,237.405063291139,217.382911392405,640.322784810127,1520.56329113924,525.908227848101,511.060126582278,1064.83544303797,132.212025316456,316,21.0873132662462,19.2132038678525,0.412127437711573,0.972307692307692,0.79,0.718192014031374,51017.5379746835,35711.1993670886,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168797,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
168917,3496.1718061674,255.198237885463,140.348017621145,685.555066079295,3958.48017621145,4341.32599118943,464.718061674009,267.863436123348,1164.49779735683,6768.50660792952,658.176211453744,132.810572687225,1081.01321585903,607.665198237885,467.105726872247,270.555066079295,1464.57268722467,1103.27753303965,338.528634361233,243.4140969163,980.933920704846,1151.57709251101,247.563876651982,143.594713656388,583.061674008811,2398.73127753304,541.651982378855,266.735682819383,1076.25991189427,130.105726872247,227,17.1758254867741,16.903621700655,0.177327353526061,0.97008547008547,0.785467128027682,0.504757351004803,50873.731277533,34454.5198237885,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168917,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
169902,2510.46555323591,182.741127348643,76.5636743215031,626.480167014614,1216.02922755741,3008.74321503132,3155.92901878914,261.48643006263,1096.35281837161,5389.12734864301,1108.63465553236,110.400835073069,1071.33611691023,3110.24425887265,557.757828810021,335.131524008351,2021.21711899791,1924.60960334029,279.137787056367,230.578288100209,1007.24634655532,1392.73277661795,200.363256784969,183.574112734864,585.141962421712,1640.44676409186,488.501043841336,423.851774530271,1048.36325678497,131.651356993737,479,26.3662714513915,23.2018187959266,0.475008822066935,0.967676767676768,0.767628205128205,-1.04181993466602,51258.5594989562,35096.9958246347,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_169902,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
170072,2991.28057553957,161.532374100719,101.482014388489,617.086330935252,1035.82014388489,3429.56115107914,329.827338129496,261.460431654676,1084.78417266187,5334.94244604317,556.63309352518,115.330935251799,1068.08633093525,563.482014388489,415.820143884892,261.510791366906,1368.82014388489,892.805755395683,269.568345323741,229.453237410072,992.63309352518,856.884892086331,197.482014388489,125.007194244604,583.820143884892,2220.60431654676,518.697841726619,241.41726618705,1019.25899280576,129.741007194245,139,16.9869226338915,10.5320261781849,0.784595569512227,0.958620689655172,0.723958333333333,-0.429498259211184,50351.6043165468,34241.3956834532,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_170072,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
170213,4490.55639097744,1230.25939849624,2995.94736842105,667.007518796992,3643.06015037594,4844.75563909774,420.928571428571,269.071428571429,1137.67293233083,7808.39097744361,605.300751879699,118.477443609023,1069.96616541353,596.496240601504,411.875939849624,264.31954887218,1456.08646616541,919.597744360902,271.642857142857,253.097744360902,993.43984962406,885.842105263158,204.597744360902,137.15037593985,633.413533834586,2258.14661654135,562.924812030075,265.15037593985,1062.62030075188,131.96992481203,266,19.9614464647657,17.0211360078879,0.522400041884863,0.956834532374101,0.738888888888889,-0.940353854819724,51517.5939849624,34807.9736842105,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_170213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
170288,1348.91256830601,447.147540983607,147.819672131148,647.318761384335,2086.32240437158,1547.03825136612,1769.57741347905,265.693989071038,1087.8378870674,1982.24408014572,3262.69216757741,113.486338797814,1064.92167577413,689.032786885246,435.378870673953,281.582877959927,1448.90892531876,1099.12750455373,302.267759562842,233.788706739526,996.914389799636,1051.06375227687,212.746812386157,132.173041894353,911.342440801457,939.51548269581,479.857923497268,339.120218579235,1023.68670309654,130.84335154827,549,28.4123174285812,24.6504507256334,0.497267406797789,0.964850615114236,0.782051282051282,-1.01499211335015,51272.7923497268,34609.1675774135,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_170288,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
170585,3015.47522522523,347.826576576577,125.927927927928,636.186936936937,1872.41441441441,3441.52252252252,4228.44369369369,278.587837837838,1097.08333333333,4897.64414414414,1390.94369369369,121.414414414414,1069.88963963964,2881.38963963964,903.972972972973,749.842342342342,1800.72072072072,1948.59009009009,389.918918918919,251.477477477477,1009.9009009009,1433.2027027027,256.286036036036,312.378378378378,610.533783783784,1748.91441441441,527.957207207207,507.713963963964,1054.8018018018,130.524774774775,444,29.504964024018,19.2313306746459,0.758391043883413,0.963123644251627,0.714975845410628,-0.560813412758835,50710.9774774775,35203.490990991,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_170585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
171087,3620.90756302521,511.025210084034,180.193277310924,668.159663865546,3062.18067226891,4030.90756302521,2159.58403361345,283.155462184874,1103.52941176471,6462.82773109244,2964.26890756303,128.147058823529,1070.05462184874,734.403361344538,657.004201680672,278.542016806723,1436.81092436975,1208.53781512605,339.827731092437,236.596638655462,993.995798319328,1161.35294117647,251.180672268908,129.714285714286,609.5,2382.33193277311,549.273109243697,957.81512605042,1123.48739495798,131.567226890756,238,18.7139386486452,16.2132942269332,0.499393470187111,0.971428571428571,0.826388888888889,1.25590836938589,50800.3319327731,35068.7647058823,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171087,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
171130,3962.26737967914,426.513368983957,115.245989304813,636.564171122995,1519.35828877005,4379.78342245989,2519.95454545455,277.318181818182,1146.58556149733,6367.22459893048,670.508021390374,118.451871657754,1085.95989304813,738.727272727273,547.446524064171,322.114973262032,2859.50802139037,1101.48395721925,273.125668449198,228.839572192513,990.799465240642,968.705882352941,192.29679144385,161.692513368984,607.331550802139,1429.11764705882,519.954545454545,798.898395721925,1054.73796791444,131.363636363636,374,26.260073318284,18.4892787601082,0.71011740143765,0.93734335839599,0.708333333333333,1.00640021749644,51302.4919786096,35126.0347593583,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
172500,5401.18090452261,693.110552763819,97.7738693467337,632.904522613065,1539.69346733668,6103.65829145729,1091.8743718593,285.170854271357,1167.07035175879,9621.54271356784,1090.608040201,131.51256281407,1071.55778894472,4736.38190954774,1854.07035175879,1727.84422110553,3105.4824120603,7844.1608040201,606.336683417085,284.72864321608,1054.79396984925,4136.10050251256,302.08040201005,749.758793969849,770.663316582915,5750.14070351759,804.48743718593,605.507537688442,1165.79899497487,132.256281407035,199,16.8650753002577,15.0429141937011,0.452121148200968,0.970731707317073,0.780392156862745,0.459632384596939,51748.8944723618,34792.5477386935,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_172500,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
172764,4329.56568364611,1137.72117962466,85.4879356568365,642.345844504021,1769.64343163539,5303.28954423592,499.463806970509,288.672922252011,1184.1072386059,7123.51742627346,619.871313672922,125.865951742627,1093.27077747989,2807.47721179625,876.099195710456,372.005361930295,3794.90348525469,3271.08310991957,431.935656836461,244.88471849866,1044.3726541555,2294.00268096515,257.198391420912,284.962466487936,643.332439678284,1774.69973190349,531.718498659517,268.378016085791,1073.76943699732,134.72654155496,373,25.1264289245814,19.0732412487874,0.650984749704281,0.958868894601542,0.740079365079365,1.06004690707377,50615.2278820375,35488.4959785523,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_172764,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
173976,2574.40509259259,961.81712962963,1314.98611111111,737.615740740741,8281.66203703704,3187.67824074074,1037.00694444444,270.185185185185,1109.36342592593,3950.50462962963,1833.88425925926,130.462962962963,1064.90509259259,3475.88888888889,759.5,316.548611111111,1842.21064814815,5434.01157407407,402.310185185185,249.222222222222,1012.12037037037,4820.68055555556,264.631944444444,384.717592592593,598.597222222222,1352.17361111111,451.777777777778,218.456018518519,1031.02083333333,129.337962962963,432,26.5685185785119,20.9057908759321,0.617127398375384,0.966442953020134,0.755244755244755,-0.361147353901245,51776.9444444444,34619.1111111111,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
174145,1148.76211453744,330.103524229075,159.162995594714,659.017621145375,2273.32599118943,1335.41629955947,344.348017621145,255.167400881057,1088.93612334802,1809.13876651982,588.310572687225,116.909691629956,1069.96255506608,716.746696035242,528.905286343612,275.95154185022,1468.04625550661,1160.22246696035,364.777533039648,249.328193832599,977.625550660793,1104.09471365639,248.290748898678,145.687224669604,593.284140969163,888.116740088106,479.081497797357,216.898678414097,1035.0154185022,136.522026431718,454,26.1927891436956,22.2612909490318,0.526941580713396,0.957805907172996,0.759197324414716,-1.31813725064951,50609.4030837004,33832.6629955947,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_174145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
174243,4328.87755102041,1138.56326530612,70.6489795918367,626.281632653061,1243.42448979592,3573.27346938776,503.587755102041,281.669387755102,1119.82040816327,7060.79183673469,603.816326530612,121.628571428571,1110.79183673469,1918.22448979592,574.571428571429,297.102040816327,1615.30204081633,1359.43265306122,347.257142857143,243.518367346939,1019.04897959184,1171.12244897959,246.718367346939,205.567346938776,975.791836734694,1970.70612244898,508.444897959184,245.628571428571,1028.74285714286,131.616326530612,245,19.7451871253978,15.9234090982864,0.59130899351373,0.95703125,0.758513931888545,-1.10520582421519,51847.2285714286,35339.7387755102,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_174243,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
174272,2500.57097791798,210.0,157.867507886435,655.741324921136,3106.13880126183,2867.28075709779,712.93690851735,263.135646687697,1121.53943217666,5262.21135646688,674.498422712934,116.697160883281,1072.58675078864,1604.73501577287,598.230283911672,335.410094637224,3755.95268138801,1173.02208201893,285.066246056782,233.536277602524,994.706624605678,1509.71924290221,241.372239747634,143.981072555205,584.561514195584,2876.13249211356,531.829652996845,329.81072555205,1043.08201892744,130.1261829653,317,22.8430797736818,17.7896365802716,0.627302424195848,0.954819277108434,0.733796296296296,1.42983098899239,51575.7823343849,34895.4479495268,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_174272,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
174727,2846.12333333333,420.876666666667,140.776666666667,645.46,2379.41,2541.38333333333,2495.04,269.42,1089.35,5191.90666666667,4148.15,112.866666666667,1073.02333333333,565.786666666667,649.703333333333,402.5,1459.13666666667,811.613333333333,203.293333333333,213.536666666667,1009.05333333333,786.59,182.486666666667,423.776666666667,690.37,2568.89,490.553333333333,760.64,1077.23333333333,130.886666666667,300,21.9899538254264,17.3718385670619,0.613120023435117,0.970873786407767,0.802139037433155,-0.20885775658328,49988.9166666667,35251.6266666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_174727,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
174930,634.047337278107,857.644970414201,242.742603550296,659.955621301775,82.9201183431953,672.636094674556,424.360946745562,283.609467455621,1120.06804733728,1339.7573964497,856.298816568047,116.289940828402,1065.73372781065,1484.04733727811,703.01775147929,293.372781065089,1926.09467455621,1231.53846153846,297.494082840237,234.633136094675,1090.80473372781,1147.12721893491,220.417159763314,139.491124260355,896.636094674556,570.650887573964,361.35798816568,194.556213017751,981.491124260355,130.076923076923,338,21.6209437953242,19.9556475057286,0.384853596624637,0.957507082152974,0.766439909297052,0.949775263652272,50210.8461538462,34905.6183431953,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_174930,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
175010,4333.82527881041,866.397769516729,125.133828996283,653.739776951673,1690.76208178439,3559.59479553903,1077.35687732342,267.371747211896,1095.72118959108,6216.41635687732,1463.13011152416,114.884758364312,1108.12639405204,1261.94423791822,703.966542750929,567.959107806691,1803.20446096654,3951.79553903346,332.635687732342,232.602230483271,1049.35687732342,4517.92936802974,253.174721189591,321.884758364312,596.583643122677,1392.53159851301,473.156133828996,422.654275092937,1040.20817843866,131.267657992565,269,19.8514787379488,17.2825025735409,0.492008869283136,0.96415770609319,0.791176470588235,1.37565960083238,51293.2713754647,35677.9851301115,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_175010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
175820,5301.47804878049,437.639024390244,119.609756097561,630.239024390244,720.731707317073,7156.63902439024,766.2,282.009756097561,1108.01463414634,9580.00975609756,869.985365853659,128.795121951219,1073.79512195122,1051.64390243902,550.658536585366,272.936585365854,1390.25365853659,1153.41463414634,338.19512195122,241.624390243902,984.912195121951,1128.94146341463,247.146341463415,134.190243902439,581.521951219512,4366.85365853659,576.126829268293,391.273170731707,1045.86341463415,128.834146341463,205,20.846970588571,12.5672164663593,0.797868310225569,0.949074074074074,0.669934640522876,-0.755785499080807,50226.3951219512,34426.5463414634,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_175820,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
176644,3229.31472081218,123.53807106599,222.492385786802,738.032994923858,7634.730964467,4010.97461928934,342.855329949239,260.578680203046,1096.38324873096,6010.98223350254,805.515228426396,144.51269035533,1075.27157360406,594.045685279188,472.832487309645,276.479695431472,1477.04822335025,928.055837563452,251.078680203046,224.776649746193,1001.36040609137,872.657360406091,185.152284263959,138.631979695431,610.253807106599,1452.04822335025,501.472081218274,237.845177664975,1081.27664974619,133.791878172589,394,27.94018944089,17.9856875595424,0.765260239367762,0.951690821256039,0.688811188811189,0.5924839363726,51345.5152284264,33786.7335025381,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_176644,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
176826,2105.45238095238,194.030612244898,105.527210884354,639.146258503401,2286.42857142857,2673.01700680272,330.081632653061,253.323129251701,1094.73129251701,5038.30952380952,537.394557823129,114.37074829932,1078.08163265306,3268.04421768707,1523.87755102041,3485.29931972789,2129.89795918367,2624.55782312925,359.289115646258,236.221088435374,1077.31292517007,1956.97619047619,235.574829931973,307.302721088435,830.795918367347,2374.98299319728,534.197278911565,231.258503401361,1058.68367346939,130.119047619048,294,22.5638755704161,16.6791715677673,0.673488177372333,0.973509933774834,0.777777777777778,1.09540890081253,51173.2585034014,34288.1870748299,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_176826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
176857,1794.93991416309,337.356223175966,166.521459227468,658.461373390558,3250.44206008584,2407.91201716738,372.130901287554,269.124463519313,1086.12446351931,3928.81330472103,584.175965665236,117.549356223176,1080.80901287554,1230.85622317597,527.888412017167,369.802575107296,1430.40343347639,1902.0364806867,338.751072961373,237.244635193133,993.44635193133,2364.78111587983,220.255364806867,148.1330472103,587.484978540773,2097.81115879828,548.036480686695,235.012875536481,1062.50429184549,129.982832618026,466,29.0289501962372,20.5002066490198,0.708013706003808,0.976939203354298,0.803448275862069,1.53545230207521,51199.025751073,34725.2103004292,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_176857,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
176863,3752.13666666667,530.743333333333,101.496666666667,627.78,1423.82,3830.35,542.953333333333,271.45,1109.8,6911.18333333333,628.413333333333,117.386666666667,1074.22333333333,2937.01666666667,1021.11666666667,382.75,5569.58333333333,2356.65333333333,348.213333333333,233.016666666667,1035.29333333333,2471.05333333333,243.38,417.11,672.963333333333,3478.43666666667,494.993333333333,226.66,1038.81,129.71,300,22.0681945194262,17.3991504130866,0.615128912748306,0.955414012738854,0.714285714285714,0.636279101138107,50820.4466666667,35600.3633333333,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_176863,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
177253,2132.71916508539,380.557874762808,126.335863377609,633.136622390892,1446.23529411765,2523.45540796964,2672.055028463,262.267552182163,1095.46489563567,3045.3339658444,844.254269449715,116.406072106262,1064.88425047438,474.514231499051,360.595825426945,248.180265654649,1449.31688804554,746.451612903226,215.011385199241,221.366223908918,994.332068311196,675.734345351044,158.85009487666,125.631878557875,580.039848197343,920.984819734345,478.001897533207,256.324478178368,1042.17647058824,131.711574952562,527,28.8319649432028,23.2959014381771,0.589198001556299,0.970534069981584,0.78422619047619,1.12534293959364,50712.4990512334,34146.6508538899,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
177807,1546.867003367,185.188552188552,114.488215488215,648.464646464646,2613.59764309764,1830.97643097643,396.271043771044,251.355218855219,1096.17676767677,3258.40404040404,575.47138047138,106.511784511785,1088.22222222222,631.124579124579,440.659932659933,272.20202020202,1406.41245791246,979.920875420875,276.86531986532,226.082491582492,996.215488215488,939.491582491582,201.272727272727,124.173400673401,585.851851851852,1422.85016835017,463.154882154882,245.626262626263,1042.67676767677,130.240740740741,594,34.5705173631535,21.9407799562595,0.77278542081534,0.961165048543689,0.727941176470588,0.250563294003512,50560.7306397306,34923.3047138047,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177807,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
177862,2919.6570155902,278.04008908686,138.973273942094,721.276169265033,6435.05345211581,3805.01113585746,2569.35412026726,263.922048997773,1097.3986636971,4922.61024498886,6290.87973273942,125.779510022272,1076.56124721604,990.552338530067,779.942093541203,289.256124721604,1499.99554565702,1162.0579064588,326.358574610245,237.407572383074,992.913140311804,982.532293986637,209.873051224944,134.15144766147,603.102449888641,1721.67260579065,528.801781737194,393.43429844098,1101.63919821826,132.6570155902,449,29.8611296112252,19.1767598857241,0.766538737043428,0.961456102783726,0.668154761904762,0.640884841084685,50944.4832962138,34352.4120267261,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177862,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
177995,1663.02682926829,304.893902439024,124.328048780488,639.998780487805,1922.58170731707,2077.06097560976,375.296341463415,262.565853658537,1088.90975609756,2811.76951219512,649.05,124.774390243902,1070.45487804878,665.535365853659,507.607317073171,276.863414634146,1506.60975609756,1059.89146341463,320.006097560976,238.264634146341,997.289024390244,980.546341463415,218.014634146341,314.440243902439,586.519512195122,1186.54024390244,534.95243902439,229.05487804878,1035.85853658537,131.651219512195,820,34.937325011725,29.925441781532,0.516069932807716,0.975029726516052,0.803921568627451,1.2720716709287,50928.7353658537,33951.5487804878,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
178314,3753.52442159383,1058.35732647815,833.07969151671,632.81233933162,1461.69665809769,4301.43187660668,692.403598971722,270.159383033419,1121.87917737789,6368.97429305913,530.676092544987,114.778920308483,1079.75321336761,2430.0822622108,1033.50385604113,1281.68894601542,3898.32133676093,3636.03856041131,369.316195372751,241.066838046272,1079.32133676093,3408.25192802057,254.501285347044,433.778920308483,642.149100257069,1449.80719794344,461.586118251928,271.591259640103,1042.3881748072,131.231362467866,389,24.2144190421715,20.6112984071878,0.524842471898339,0.960493827160494,0.736742424242424,0.496761255747186,51217.7197943445,35726.8277634961,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_178314,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
179826,3980.81125827815,266.453642384106,105.476821192053,609.251655629139,573.082781456954,4650.12913907285,431.827814569536,275.009933774834,1085.75165562914,6676.23509933775,646.327814569536,124.205298013245,1078.87417218543,1573.14900662252,817.993377483444,358.248344370861,2970.39735099338,2635.02317880795,413.132450331126,252.82119205298,1044.06953642384,1837.41721854305,251.086092715232,258.072847682119,2083.17549668874,3272.11589403973,771.662251655629,432.572847682119,1117.81456953642,133.920529801325,302,23.5785892283113,16.5414224811144,0.71262594507912,0.961783439490446,0.722488038277512,1.00544029972526,51764.8874172186,34860.6357615894,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_179826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
180278,4747.35744680851,457.187234042553,989.234042553191,619.110638297872,1092.71489361702,4628.4,381.651063829787,270.340425531915,1082.5829787234,7783.36170212766,532.340425531915,121.059574468085,1078.08085106383,927.072340425532,526.285106382979,281.463829787234,1588.75319148936,958.659574468085,213.310638297872,221.634042553191,1220.34893617021,677.148936170213,155.085106382979,145.187234042553,583.387234042553,3315.16170212766,675.353191489362,317.702127659574,1060.92340425532,130.948936170213,235,23.6197599084184,12.7142127653147,0.842761511934973,0.951417004048583,0.785953177257525,1.55376313435131,51830.4595744681,34863.9063829787,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_180278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
180305,5087.14285714286,250.265010351967,125.217391304348,633.171842650103,1701.69772256729,5962.14492753623,352.689440993789,290.47619047619,1083.68944099379,10487.3768115942,559.83850931677,131.621118012422,1066.46997929607,1354.12008281574,636.88198757764,329.625258799172,1733.98757763975,1681.20082815735,390.32298136646,247.089026915114,997.703933747412,1479.41614906832,353.962732919255,411.946169772257,586.732919254658,6056.10559006211,542.445134575569,301.708074534161,1039.84265010352,128.801242236025,483,34.068743037813,18.1046327241926,0.847111774497842,0.966,0.71875,-0.435272556959881,50375.2608695652,35470.3354037267,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_180305,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
180849,3046.66141732283,166.871391076115,64.3779527559055,617.832020997375,831.811023622047,3322.98162729659,891.230971128609,267.089238845144,1095.61154855643,5488.91338582677,676.409448818898,116.456692913386,1074.41469816273,3774.61679790026,1234.81102362205,1590.85826771654,4649.62204724409,5047.30183727034,403.380577427822,246.677165354331,1039.57480314961,4442.08661417323,274.181102362205,832.711286089239,867.089238845144,1332.4750656168,514.608923884514,228.721784776903,1068.50131233596,132.942257217848,381,25.6222300508096,19.1240065801074,0.665516232114063,0.969465648854962,0.762,-0.324007693657243,52069.2677165354,34611.6929133858,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_180849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
181104,2939.86411149826,204.588850174216,121.717770034843,654.95818815331,3836.57142857143,2941.3275261324,433.756097560976,277.432055749129,1097.22648083624,5435.45644599303,547.059233449477,116.257839721254,1073.01045296167,4728.60975609756,1822.64459930314,5184.12543554007,2167.2787456446,5626.82926829268,437.665505226481,257.794425087108,1050.71428571429,4685.95470383275,385.693379790941,345.05574912892,769.81881533101,2126.8850174216,495.592334494774,229.522648083624,1041.97212543554,129.613240418118,287,22.3233320934392,16.3691707455754,0.679930763095041,0.969594594594595,0.815340909090909,-1.44861966926776,51793.2473867596,35435.4912891986,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_181104,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
182561,1850.47101449275,281.550724637681,159.710144927536,656.86231884058,3110.53623188406,2217.76811594203,322.644927536232,262.427536231884,1087.50724637681,3144.76086956522,505.195652173913,114.992753623188,1082.91304347826,662.514492753623,443.746376811594,272.666666666667,1400.23188405797,997.108695652174,301.072463768116,235.434782608696,987.579710144928,908.079710144928,213.340579710145,127.094202898551,581.101449275362,1460.81884057971,494.811594202899,221.210144927536,1051.03623188406,128.731884057971,138,17.9859190444278,9.79689215411919,0.8386323441023,0.945205479452055,0.696969696969697,0.257886576893773,50874.5869565217,34879.5072463768,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_182561,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
183010,1719.33449477352,185.076655052265,71.9059233449477,642.202090592334,1585.37630662021,1909.24390243902,1404.59233449477,256.101045296167,1087.12891986063,3794.5331010453,1712.0,105.682926829268,1072.73867595819,2385.17770034843,841.383275261324,853.81881533101,1446.99651567944,1979.8606271777,318.710801393728,231.358885017422,987.331010452962,1896.29616724739,238.219512195122,774.825783972125,644.926829268293,1935.79790940766,449.662020905923,523.811846689895,1076.54006968641,131.379790940767,287,22.7222141828859,16.1840378381447,0.701919590329352,0.963087248322148,0.755263157894737,0.979776974835223,50221.2543554007,35196.243902439,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_183010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
183698,3791.05384615385,311.407692307692,98.5307692307692,625.35,862.284615384615,4639.89615384615,706.876923076923,271.596153846154,1084.06538461538,7238.30769230769,621.215384615385,122.092307692308,1078.22692307692,569.896153846154,438.823076923077,315.515384615385,1447.07692307692,893.5,251.423076923077,228.680769230769,998.773076923077,845.730769230769,191.076923076923,137.011538461538,600.711538461538,3260.87307692308,537.076923076923,241.738461538462,1051.82692307692,130.776923076923,260,22.0643252991369,15.0235826053897,0.73237709399159,0.966542750929368,0.773809523809524,-1.20714365470916,50236.2615384615,34783.7,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_183698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
183874,4190.47524752475,1348.01650165017,146.907590759076,660.551155115512,2562.79867986799,4649.0396039604,688.943894389439,263.488448844884,1097.81188118812,6898.26732673267,643.821782178218,128.316831683168,1076.23432343234,4428.42574257426,1311.70297029703,802.201320132013,2067.37623762376,5847.38613861386,439.716171617162,254.171617161716,1052.38943894389,4929.50825082508,291.788778877888,569.102310231023,689.240924092409,1501.59075907591,524.445544554455,237.409240924092,1043.51485148515,131.831683168317,303,20.6836826355401,18.8782402327802,0.408604033617657,0.946875,0.759398496240602,-1.07324802423222,51492.2178217822,33904.3531353135,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_183874,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
183898,1174.40794979079,232.859832635983,84.1464435146443,612.081589958159,731.880753138075,1397.34728033473,2117.53765690377,259.127615062761,1086.49581589958,1734.03974895397,685.05230125523,114.679916317992,1069.10041841004,813.497907949791,735.142259414226,273.504184100418,1627.97071129707,1368.14225941423,284.571129707113,233.541841004184,1014.41422594142,1222.70711297071,200.930962343096,287.836820083682,662.096234309623,972.989539748954,534.355648535565,229.223849372385,1018.82008368201,132.355648535565,478,26.8793753747339,22.7031442548899,0.535349481704085,0.973523421588595,0.796666666666667,0.890431786693977,50911.6987447699,33894.9728033473,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_183898,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
184028,2403.21374045802,817.274809160305,420.229007633588,640.083969465649,1611.82442748092,2496.40458015267,823.977099236641,264.614503816794,1105.9465648855,4417.67175572519,537.057251908397,133.026717557252,1072.74045801527,2063.19847328244,538.576335877863,417.393129770992,1707.34351145038,2860.40076335878,315.416030534351,228.885496183206,992.309160305344,2615.65267175573,238.038167938931,235.19465648855,581.86641221374,2625.40839694657,549.557251908397,496.13358778626,1077.70992366412,130.847328244275,262,20.6624960886496,16.3870714639369,0.609113765551354,0.949275362318841,0.689473684210526,0.688114289902021,51167.9541984733,35836.4541984733,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
184120,1264.20912547529,410.098859315589,116.657794676806,618.19391634981,785.699619771863,1524.98098859316,1004.5247148289,278.155893536122,1085.63498098859,2126.58935361217,1135.7680608365,110.840304182509,1063.1825095057,2198.55893536122,865.45247148289,604.273764258555,1711.65019011407,3000.15589353612,404.479087452472,242.874524714829,1106.57414448669,2385.84790874525,345.399239543726,527.133079847909,868.083650190114,1081.463878327,481.844106463878,279.098859315589,1044.16349809886,130.015209125475,263,23.0063986457187,14.8997066942173,0.761952287133991,0.946043165467626,0.703208556149733,-1.15659925976556,50147.9429657795,35530.4030418251,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
184218,2364.97315436242,564.581655480984,107.10514541387,639.879194630872,1803.57941834452,2562.72483221476,520.677852348993,269.693512304251,1092.87472035794,3523.55928411633,1267.20357941834,114.639821029083,1083.61744966443,1915.07829977629,818.261744966443,547.454138702461,1771.78970917226,1987.83445190157,326.315436241611,235.82774049217,1029.1677852349,1734.14093959732,279.156599552573,677.787472035794,821.859060402685,1100.62192393736,518.581655480984,307.178970917226,1031.83445190157,130.391498881432,447,28.3699054482246,20.1276881765834,0.704732395839669,0.965442764578834,0.788359788359788,-0.215324032906689,51778.6756152125,35203.158836689,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184218,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
184534,3799.09708737864,1233.68608414239,131.838187702265,632.255663430421,1435.61812297735,4625.31715210356,469.559870550162,269.822006472492,1105.18770226537,7545.4142394822,579.831715210356,117.63430420712,1086.15857605178,1892.32686084142,1021.54368932039,1771.48867313916,1611.25242718447,1166.46925566343,296.663430420712,232.831715210356,1012.47572815534,1054.39158576052,224.73139158576,172.0,637.640776699029,2255.47896440129,521.95145631068,233.673139158576,1047.59546925566,130.744336569579,309,20.8144495228239,18.9611422863461,0.412493496920486,0.965625,0.858333333333333,1.40762718763415,51211.3624595469,35116.5339805825,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
184749,1531.23387096774,292.600806451613,64.3467741935484,601.177419354839,221.310483870968,1696.11693548387,294.165322580645,250.596774193548,1065.95161290323,3446.40725806452,485.314516129032,106.036290322581,1061.19758064516,808.963709677419,682.185483870968,275.870967741935,2020.55241935484,1203.16129032258,294.616935483871,238.302419354839,1034.6814516129,1033.72177419355,209.778225806452,149.342741935484,2540.33870967742,1497.83064516129,496.979838709677,221.092741935484,1022.48790322581,131.350806451613,248,20.2778292136242,15.598018975918,0.638989540627389,0.957528957528958,0.729411764705882,-0.346652947471071,51544.4556451613,34160.3588709677,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184749,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
185646,4357.72448979592,195.122448979592,115.942176870748,640.486394557823,1960.48979591837,4225.63945578231,828.431972789116,273.574829931973,1092.07482993197,7107.24829931973,1103.63605442177,116.931972789116,1106.60544217687,2753.68707482993,724.333333333333,382.244897959184,1755.60544217687,1303.93197278912,287.78231292517,228.489795918367,1011.62585034014,1183.88775510204,221.707482993197,287.826530612245,593.442176870748,2865.2380952381,504.989795918367,344.391156462585,1089.01020408163,131.486394557823,294,20.3930739584518,18.4676824215567,0.424162685152538,0.954545454545455,0.7,-1.01417936422015,50899.2857142857,35680.0680272109,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_185646,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
186079,1039.19889502762,345.232044198895,201.397790055249,684.265193370166,3310.42541436464,962.900552486188,1395.41436464088,261.906077348066,1099.88397790055,1489.44751381215,1668.71270718232,119.530386740331,1064.43093922652,753.28729281768,527.585635359116,293.53591160221,1829.67403314917,1307.45856353591,378.32044198895,250.198895027624,990.685082872928,1253.19889502762,265.033149171271,150.707182320442,583.281767955801,1093.28729281768,506.895027624309,314.878453038674,1045.07182320442,130.28729281768,181,17.9018068457814,12.8734933781182,0.694889027708626,0.962765957446808,0.819004524886878,0.26282411131806,51922.0165745856,34444.9337016575,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_186079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
186098,3360.82437275986,1050.12544802867,115.860215053763,641.057347670251,1614.00716845878,4311.50537634409,1524.42652329749,269.78853046595,1100.37275985663,5162.18637992832,625.207885304659,115.641577060932,1078.05734767025,1924.97849462366,777.222222222222,558.035842293907,1811.37992831541,1680.27598566308,304.609318996416,235.63082437276,1006.59139784946,1550.1146953405,219.451612903226,188.26164874552,618.731182795699,1218.49462365591,472.953405017921,688.663082437276,1055.68817204301,131.308243727599,279,20.1923457806802,17.5941846109215,0.490698553114668,0.96875,0.772853185595568,-0.938544708521249,51325.0860215054,35123.5053763441,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_186098,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
187553,2261.90342679128,161.398753894081,93.9781931464174,631.956386292835,1037.56697819315,2532.64797507788,318.155763239875,259.202492211838,1096.88161993769,4013.04672897196,684.336448598131,122.274143302181,1068.45482866044,2940.70404984424,676.221183800623,298.109034267913,1658.07788161994,4487.64485981308,419.669781931464,252.034267912772,1064.0,4537.24299065421,280.585669781931,273.679127725857,605.504672897196,1368.26791277259,476.526479750779,213.934579439252,1075.66043613707,131.489096573209,321,26.8590076928748,15.4672837697539,0.817541619820107,0.935860058309038,0.636904761904762,-0.587314799526063,50084.261682243,34696.3707165109,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_187553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
188705,1177.7064516129,104.535483870968,63.6451612903226,622.077419354839,989.690322580645,1250.87741935484,314.861290322581,254.264516129032,1089.39677419355,2502.25483870968,513.387096774194,106.438709677419,1065.76129032258,864.325806451613,528.68064516129,296.541935483871,1573.6935483871,1228.3,289.041935483871,225.603225806452,1005.27419354839,1348.13225806452,588.925806451613,323.696774193548,627.925806451613,1356.84193548387,426.725806451613,214.093548387097,1048.86774193548,130.651612903226,310,24.015217721271,16.6194166500351,0.721862133029712,0.962732919254658,0.748792270531401,-0.374161722110818,50754.5258064516,35761.2387096774,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_188705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
188814,3457.84745762712,209.296610169492,74.6440677966102,620.322033898305,1058.49576271186,4358.74152542373,1662.08050847458,274.296610169492,1103.1313559322,5027.16949152542,668.830508474576,126.881355932203,1065.95762711864,806.686440677966,744.995762711864,370.228813559322,1509.05508474576,1049.06779661017,279.707627118644,230.974576271186,993.237288135593,985.800847457627,205.122881355932,134.436440677966,605.148305084746,949.28813559322,437.300847457627,213.21186440678,1057.69491525424,130.296610169492,236,20.3758594683793,14.7420369885994,0.690319099622435,0.975206611570248,0.776315789473684,1.07108714340359,50279.813559322,34817.5762711864,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_188814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
189108,2334.99176276771,688.171334431631,688.845140032949,652.354200988468,1776.90609555189,2447.54200988468,1023.59637561779,257.115321252059,1104.28336079077,4362.51729818781,571.996705107084,110.596375617792,1078.99505766063,2827.63426688633,1200.80724876442,1329.99176276771,2038.77594728171,3375.92915980231,487.891268533773,236.37726523888,1047.64085667216,2829.53377265239,330.181219110379,662.998352553542,655.654036243822,1129.07248764415,464.283360790774,308.644151565074,1030.53047775947,130.120263591433,607,34.8427339474275,22.2757211735442,0.768939250123069,0.96964856230032,0.788311688311688,1.46106987665338,51700.1713344316,35246.2487644152,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189108,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
189963,2838.96688741722,1047.43046357616,195.76821192053,637.307947019868,1369.72185430464,3086.71854304636,488.67880794702,269.12582781457,1105.79139072848,4419.27483443709,586.579470198675,113.87417218543,1077.96688741722,778.738410596026,462.930463576159,277.35761589404,1489.55629139073,1149.45695364238,318.907284768212,231.62582781457,992.652317880795,1116.92052980132,239.824503311258,181.238410596026,584.529801324503,1229.2417218543,445.516556291391,313.798013245033,1050.34768211921,131.135761589404,302,21.6001444481111,17.8256928242462,0.564755850775584,0.977346278317152,0.836565096952909,-0.728080890872879,50807.8907284768,35717.9337748344,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190066,2719.25301204819,474.18875502008,114.522088353414,635.815261044177,1804.44176706827,2975.47791164659,5889.66265060241,260.349397590361,1091.13253012048,5169.63453815261,913.550200803213,117.991967871486,1067.02008032129,1528.79518072289,1558.55421686747,2659.4297188755,1926.38152610442,2885.84337349398,382.489959839357,244.70281124498,1042.20883534137,2715.32530120482,246.81124497992,515.550200803213,1036.26907630522,1680.75502008032,534.164658634538,491.586345381526,1051.82730923695,131.240963855422,249,19.2168243139159,16.5229170424758,0.510605400865965,0.957692307692308,0.768518518518518,-0.882359702299844,51231.5903614458,34222.3614457831,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190070,2165.51824817518,190.613138686131,145.379562043796,678.423357664234,4236.68613138686,2335.13138686131,766.416058394161,267.408759124088,1098.89051094891,3690.86861313869,936.751824817518,118.240875912409,1072.66423357664,2032.23357664234,990.489051094891,708.686131386861,2510.99270072993,4743.61313868613,421.051094890511,250.627737226277,1016.01459854015,7514.46715328467,340.839416058394,268.306569343066,731.335766423358,1378.61313868613,458.029197080292,316.430656934307,1051.24087591241,129.014598540146,137,15.9457201936814,10.9818326934894,0.725045513986261,0.938356164383562,0.713541666666667,-1.11424727005813,50445.3941605839,35603.1459854015,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_190070,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190091,2581.59076923077,223.270769230769,104.707692307692,634.655384615385,1692.52923076923,3158.95384615385,1970.61846153846,268.833846153846,1096.43076923077,5204.70461538461,1333.40307692308,114.473846153846,1074.23692307692,1329.89846153846,451.218461538462,285.523076923077,1463.52923076923,1117.38769230769,299.193846153846,232.587692307692,988.747692307692,1036.08307692308,210.849230769231,152.184615384615,583.483076923077,1872.29538461538,515.667692307692,399.904615384615,1068.50153846154,130.575384615385,325,25.7936389941433,16.1139539069942,0.780844139759437,0.950292397660819,0.78125,1.51805736067483,51082.4984615385,35078.5076923077,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190091,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190167,2326.76512455516,565.886120996441,522.302491103203,616.455516014235,605.298932384342,2365.81850533808,765.163701067616,257.149466192171,1087.128113879,4487.02135231317,2256.56227758007,126.174377224199,1075.00711743772,758.800711743772,470.156583629893,295.188612099644,1530.52669039146,1303.40925266904,331.032028469751,234.220640569395,991.085409252669,1324.43416370107,243.0,207.562277580071,589.288256227758,1990.27046263345,456.679715302491,350.313167259786,1047.48754448399,130.003558718861,281,24.8366214537097,14.4648496001201,0.812902319255468,0.965635738831615,0.718670076726343,-0.460896532781865,50827.359430605,35832.5516014235,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190167,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190176,3121.91899441341,914.282122905028,159.893854748603,682.902234636872,3315.44134078212,2646.20670391061,1527.52234636872,268.854748603352,1218.35474860335,4057.03072625698,579.807262569832,108.793296089385,1072.56983240223,2321.51675977654,966.68156424581,561.502793296089,1855.49162011173,4268.96089385475,367.891061452514,241.597765363129,1031.78491620112,4321.24022346369,260.748603351955,302.148044692737,670.938547486033,1078.58659217877,445.315642458101,659.90782122905,1018.15642458101,130.662011173184,358,23.9182361929957,19.1291865984707,0.600301038839804,0.978142076502732,0.813636363636364,1.02236076969318,51313.1536312849,35517.251396648,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190176,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
190608,3421.81663113006,280.767590618337,124.769722814499,641.076759061834,2000.28784648188,3894.18763326226,1019.53518123667,269.974413646055,1136.31982942431,5544.67164179104,901.914712153518,138.498933901919,1086.82515991471,741.876332622601,424.579957356077,271.328358208955,1492.06396588486,1166.28144989339,318.302771855011,230.076759061834,989.147121535181,1114.8144989339,234.046908315565,185.170575692964,585.390191897655,1763.17057569296,541.575692963753,405.607675906183,1061.02345415778,132.215351812367,469,26.9578113659581,22.2606474564183,0.564023543706876,0.96701030927835,0.721538461538462,-0.884104273565304,50645.7484008529,35846.631130064,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
191447,3757.65060240964,223.319277108434,73.2680722891566,625.210843373494,1098.21084337349,4087.01204819277,477.05421686747,274.918674698795,1102.81927710843,6524.70180722892,903.897590361446,120.036144578313,1107.88554216867,698.518072289157,408.027108433735,284.713855421687,1514.18674698795,823.990963855422,203.638554216867,212.105421686747,1041.01506024096,715.430722891566,168.942771084337,169.44578313253,1058.93674698795,1968.99096385542,474.897590361446,346.984939759036,1055.59337349398,132.765060240964,332,24.2451470816797,17.5707462649075,0.689052017245366,0.956772334293948,0.794258373205742,-0.417305037286773,50668.2981927711,35554.906626506,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191447,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
191510,2365.4598540146,492.956204379562,136.79197080292,649.846715328467,1393.55839416058,555.321167883212,288.507299270073,247.054744525547,1082.41605839416,1171.16058394161,635.762773722628,113.302919708029,1064.69708029197,613.967153284672,605.262773722628,271.07299270073,1497.22262773723,948.412408759124,305.642335766423,234.448905109489,978.715328467153,987.547445255474,240.777372262774,154.131386861314,589.102189781022,871.452554744526,529.824817518248,227.273722627737,1025.04744525547,130.496350364963,274,23.4351983803665,14.997130152281,0.768424549616072,0.964788732394366,0.721052631578947,-0.845924221131362,50813.6788321168,33776.3357664234,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191510,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
191543,2558.02985074627,694.037313432836,760.690298507463,619.779850746269,1422.38059701493,1923.77985074627,545.414179104478,262.80223880597,1101.5447761194,3784.03358208955,509.992537313433,112.205223880597,1067.13432835821,920.182835820896,504.884328358209,290.589552238806,1515.88432835821,953.585820895522,213.623134328358,213.973880597015,1239.64925373134,731.477611940299,177.60447761194,221.436567164179,587.936567164179,957.335820895522,420.488805970149,221.324626865672,1033.0447761194,129.835820895522,268,19.7740353051836,17.3513738423936,0.479608293694317,0.95373665480427,0.744444444444444,-0.959749279360566,51744.276119403,35592.026119403,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_191543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
192030,2395.30864197531,242.485596707819,168.674897119342,683.934156378601,5508.329218107,3230.48148148148,449.078189300412,279.329218106996,1112.11934156379,4753.1646090535,765.864197530864,127.913580246914,1074.81069958848,1033.52263374486,548.086419753086,298.736625514403,1588.22222222222,1476.23456790123,374.448559670782,243.366255144033,1031.41563786008,1367.07818930041,255.283950617284,151.008230452675,859.876543209877,1075.91769547325,482.864197530864,228.592592592592,1041.44855967078,130.61316872428,243,19.0076952029938,16.2836674939926,0.515834654403686,0.956692913385827,0.799342105263158,-1.26481936661588,51305.658436214,34118.646090535,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_192030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
192036,2239.73517786561,206.391304347826,61.4940711462451,631.260869565217,1824.81422924901,2472.84584980237,2902.7628458498,265.415019762846,1107.93675889328,3926.99604743083,818.928853754941,133.03162055336,1072.46245059289,5081.66403162055,821.146245059289,875.96442687747,1918.20158102767,4742.71541501976,356.415019762846,239.197628458498,1044.35177865613,4531.89723320158,260.754940711462,785.95256916996,731.01976284585,1552.93280632411,448.260869565217,306.97233201581,1073.67588932806,131.150197628458,253,23.0707893905978,14.075793615314,0.792314242035335,0.926739926739927,0.733333333333333,1.44932560386775,51044.2450592885,35852.395256917,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_192036,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
192504,2948.26741573034,294.78202247191,108.65393258427,640.320224719101,1553.43146067416,3190.76966292135,386.670786516854,267.532584269663,1115.68539325843,3546.93595505618,729.496629213483,152.04606741573,1082.4808988764,807.537078651685,418.974157303371,271.167415730337,1565.04943820225,1275.30561797753,250.555056179775,226.389887640449,1040.95280898876,1078.58539325843,179.641573033708,159.531460674157,750.121348314607,784.485393258427,430.211235955056,211.51797752809,1038.14269662921,132.342696629213,890,38.442043658095,29.5288824266453,0.640281578960989,0.980176211453744,0.829450139794967,0.198210913554673,51424.6685393258,33979.1696629213,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_192504,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
192843,2238.95275590551,175.57217847769,196.564304461942,699.238845144357,5801.97637795276,2278.56955380577,403.89501312336,271.698162729659,1102.71653543307,4336.37532808399,511.293963254593,116.939632545932,1072.70078740157,2237.43307086614,695.212598425197,990.472440944882,1617.70866141732,2150.23097112861,368.409448818898,243.910761154856,1012.24409448819,1891.86351706037,254.926509186352,295.640419947507,633.068241469816,1388.24409448819,440.204724409449,248.488188976378,1051.1469816273,130.640419947507,381,34.9089779215338,13.9421545068353,0.916782897602672,0.943069306930693,0.725714285714286,1.46113298916394,51562.5826771654,35538.530183727,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_192843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
192886,1434.4437751004,367.911646586345,130.126506024096,645.269076305221,2108.98393574297,1628.48393574297,374.056224899598,259.600401606426,1102.9718875502,2251.62248995984,747.072289156627,140.755020080321,1067.99598393574,1045.14658634538,603.224899598394,288.044176706827,1561.43975903614,1131.83935742972,234.251004016064,222.795180722892,1326.02610441767,690.793172690763,141.907630522088,123.670682730924,584.833333333333,785.142570281124,436.70281124498,214.206827309237,1033.72289156627,131.100401606426,498,29.0464001847611,21.873653802235,0.657952965568454,0.963249516441006,0.801932367149758,1.13324543330946,51269.3614457831,33969.9939759036,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_192886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
193539,2418.58306188925,239.703583061889,211.413680781759,697.557003257329,5499.18892508143,2594.85016286645,333.342019543974,255.684039087948,1097.92833876221,3816.22475570033,582.048859934853,129.123778501629,1075.65146579805,727.736156351792,429.944625407166,272.436482084691,1462.51140065147,825.042345276873,200.022801302932,214.237785016287,1110.38436482085,639.579804560261,149.589576547231,125.293159609121,592.57003257329,945.667752442997,463.228013029316,221.762214983713,1043.8013029316,131.824104234528,307,26.7131665499671,14.8057195113496,0.832351571655171,0.968454258675079,0.664502164502164,-0.735898340845329,51502.5895765472,34174.4462540717,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193539,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
193586,845.338983050847,156.751412429379,69.5649717514124,606.056497175141,151.536723163842,884.468926553672,509.146892655367,260.028248587571,1088.41242937853,1755.18644067797,713.802259887006,110.033898305085,1065.22598870057,579.310734463277,685.971751412429,270.994350282486,1499.17514124294,1024.48587570621,245.146892655367,218.847457627119,1023.29943502825,910.819209039548,186.960451977401,136.474576271186,582.231638418079,1187.45197740113,606.016949152542,256.71186440678,1051.08474576271,142.514124293785,177,17.3367686039504,13.0102343093529,0.660936636216655,0.956756756756757,0.800904977375566,-1.56989780274345,49979.2711864407,34990.8813559322,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_193586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
194278,3715.25569620253,162.374683544304,163.929113924051,685.010126582279,3557.72911392405,3763.87341772152,512.86835443038,267.248101265823,1131.81772151899,5727.14936708861,537.779746835443,136.911392405063,1089.67594936709,1252.09620253165,594.060759493671,992.977215189873,1606.95189873418,1198.15443037975,315.19746835443,231.427848101266,998.918987341772,1171.20759493671,248.33670886076,228.154430379747,604.845569620253,1816.47088607595,503.681012658228,329.169620253165,1076.05569620253,131.893670886076,395,23.9504250165158,21.1474143989271,0.469436673469414,0.95873786407767,0.748106060606061,-1.10255999816837,51079.8734177215,35837.4632911392,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
194785,2857.13519313305,399.967811158798,135.055793991416,645.343347639485,1879.58369098712,3437.9635193133,4443.23605150215,263.549356223176,1098.48497854077,4755.68240343348,1343.65450643777,118.836909871245,1070.59871244635,620.517167381974,471.027896995708,269.56008583691,1457.55793991416,964.394849785408,321.040772532189,239.242489270386,985.791845493562,893.959227467811,218.008583690987,137.457081545064,581.99356223176,1416.20386266094,501.628755364807,378.815450643777,1059.50214592275,132.094420600858,466,29.3864673455095,20.2721181355764,0.723956752667721,0.9648033126294,0.792517006802721,-1.34428672942855,50698.6137339056,34166.4678111588,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194785,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
195355,3751.25905292479,894.072423398329,580.476323119777,618.403899721449,988.824512534819,3767.63509749304,991.66295264624,271.008356545961,1125.96935933148,6238.54317548747,966.732590529248,113.359331476323,1077.89693593315,1967.05849582173,827.284122562674,1637.14763231198,1729.29805013928,2230.91364902507,301.231197771588,228.649025069638,1038.8635097493,1681.19777158774,235.091922005571,317.481894150418,618.33704735376,2341.26462395543,504.456824512535,353.640668523677,1047.44289693593,130.442896935933,359,24.7287439616669,18.5572509589283,0.660947196158404,0.952254641909814,0.755789473684211,-0.06314126705275,51043.295264624,35741.2590529248,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_195355,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
195618,3771.54008438819,830.126582278481,1768.52320675105,631.367088607595,1617.99156118143,3602.55696202532,909.725738396624,273.518987341772,1179.70886075949,5166.74683544304,586.751054852321,117.552742616034,1072.04641350211,1602.52320675105,742.299578059072,376.240506329114,1896.69620253165,2830.51054852321,363.902953586498,242.729957805907,1003.7552742616,2990.9746835443,275.324894514768,199.945147679325,601.050632911392,1063.65400843882,476.113924050633,389.426160337553,1030.10970464135,130.704641350211,237,17.5939040471653,17.1938919915562,0.212025345040659,0.979338842975207,0.820069204152249,0.668663123318236,51177.5654008439,35719.8860759494,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_195618,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
195968,2645.83185840708,498.41592920354,176.203539823009,671.946902654867,3621.04424778761,2020.96460176991,2911.11504424779,263.035398230089,1103.69026548673,2544.69911504425,5160.12389380531,111.433628318584,1067.46017699115,781.495575221239,946.327433628318,281.911504424779,3412.83185840708,983.601769911504,269.070796460177,228.044247787611,992.070796460177,869.469026548673,196.433628318584,254.672566371681,586.433628318584,828.902654867257,398.398230088496,229.380530973451,988.893805309734,129.16814159292,113,15.364058461503,9.48130351353506,0.786877436267905,0.933884297520661,0.672619047619048,-0.636002466709939,51778.6017699115,34675.2831858407,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_195968,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
196341,2353.46634615385,288.980769230769,107.822115384615,618.307692307692,1103.86057692308,2623.11057692308,1194.42788461538,264.009615384615,1089.85096153846,5045.49038461538,638.403846153846,112.134615384615,1071.04807692308,807.586538461538,583.485576923077,299.134615384615,1500.39423076923,1356.38942307692,323.197115384615,234.230769230769,1002.0,1260.11538461538,219.663461538462,160.9375,588.889423076923,2298.8125,534.192307692308,252.576923076923,1048.64903846154,129.543269230769,208,18.5286935448546,14.2793226023647,0.637246572964888,0.962962962962963,0.764705882352941,0.664813226688093,51367.4134615385,35025.9423076923,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196341,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
196360,5143.25,791.036458333333,1318.421875,625.140625,945.661458333333,5940.89583333333,603.125,270.588541666667,1098.23958333333,9224.63020833333,582.473958333333,121.96875,1077.79166666667,1707.80729166667,869.375,300.739583333333,8873.14583333333,2358.89583333333,346.958333333333,240.322916666667,1029.0,1635.94791666667,219.109375,169.171875,613.572916666667,3249.61458333333,594.421875,378.479166666667,1057.421875,129.166666666667,192,19.6027005024752,12.4942945738905,0.770552783082644,0.945812807881773,0.777327935222672,0.155149477888192,52026.1666666667,34561.03125,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
196455,1383.885,150.2275,63.07,599.385,192.3425,1610.9325,291.2525,248.3725,1081.2025,3437.3675,518.985,111.3075,1065.145,1922.2475,584.7425,365.1425,1791.945,3155.5475,417.2,238.885,1058.7525,2522.205,231.8525,171.3175,607.48,2439.535,528.76,228.3575,1024.23,131.145,400,28.2977499228539,18.0768180082564,0.769366516609369,0.966183574879227,0.793650793650794,-1.5664265707251,51492.77,33939.285,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
196624,2706.37987012987,217.548701298701,109.672077922078,650.522727272727,2414.84415584416,3125.93506493506,926.698051948052,264.100649350649,1108.11363636364,5124.43831168831,809.246753246753,117.012987012987,1102.20454545455,801.12012987013,740.792207792208,715.457792207792,1594.62012987013,1387.91883116883,343.220779220779,245.402597402597,1013.65909090909,1316.17857142857,246.061688311688,288.74025974026,707.064935064935,1707.55519480519,479.084415584416,295.555194805195,1048.00649350649,129.581168831169,308,21.784205429431,18.0378648554286,0.560691305135115,0.968553459119497,0.777777777777778,-0.0599242565694111,51546.5681818182,34945.3181818182,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196624,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
197520,2589.06231454006,690.249258160237,188.228486646884,707.943620178042,6131.0237388724,2791.22255192878,1393.38278931751,269.640949554896,1103.43323442136,3609.51632047478,1221.96439169139,122.961424332344,1072.54302670623,591.952522255193,453.341246290801,406.922848664689,2563.44510385757,1709.6528189911,267.047477744807,228.890207715134,1018.48961424332,1786.11869436202,215.916913946588,231.480712166172,661.06824925816,1212.65578635015,552.13353115727,337.563798219585,1053.61721068249,130.032640949555,337,23.7427553262416,18.1947011009591,0.642451392315151,0.957386363636364,0.732608695652174,1.07574428944384,51933.881305638,34854.5667655786,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_197520,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
197747,3134.2752293578,1316.2752293578,884.816513761468,627.995412844037,1212.63990825688,3238.88073394495,700.575688073395,271.266055045872,1123.71330275229,4887.36009174312,616.158256880734,120.298165137615,1068.90825688073,2310.26605504587,673.373853211009,368.885321100918,1724.71559633028,2457.60321100917,333.690366972477,238.405963302752,1035.21559633028,2063.44266055046,234.564220183486,611.112385321101,894.302752293578,1394.85779816514,563.81880733945,293.534403669725,1042.3876146789,132.614678899083,436,27.030092836803,21.186327857888,0.621006745029656,0.958241758241758,0.6976,0.688700592842445,51788.7362385321,35162.0389908257,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
198691,2455.28834355828,198.196319018405,70.3926380368098,615.503067484663,1172.71165644172,2265.1717791411,324.331288343558,251.601226993865,1078.22085889571,4663.55214723926,464.006134969325,110.165644171779,1064.58282208589,3418.65644171779,630.184049079755,315.269938650307,1727.49079754601,2070.81595092025,298.374233128834,233.736196319018,994.552147239264,1474.63190184049,223.730061349693,145.865030674847,585.361963190184,1549.00613496933,474.509202453988,218.80981595092,1026.93865030675,128.736196319018,163,16.2569075315057,12.8492645993032,0.612606572313763,0.915730337078652,0.684873949579832,-1.54344819547455,51750.7607361963,34999.4969325153,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_198691,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
198698,1862.27180527383,124.740365111562,75.5963488843813,629.933062880325,1725.02231237323,2219.6430020284,1228.3569979716,255.7261663286,1107.64503042596,3849.29614604462,611.910750507099,107.80121703854,1096.9168356998,839.683569979716,639.529411764706,450.450304259635,1738.40770791075,1457.60243407708,447.066937119675,279.286004056795,1007.99188640974,1381.19878296146,239.255578093306,187.336713995943,588.111561866126,1902.97160243408,485.391480730223,283.371196754564,1036.33062880325,127.967545638945,493,29.3025173448246,21.5034007568536,0.679320822116132,0.968565815324165,0.800324675324675,-0.223499658283154,51804.9269776876,35105.0060851927,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_198698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
198819,2404.11538461538,413.388461538462,136.246153846154,648.071153846154,2565.43461538462,2367.83846153846,2297.88846153846,263.561538461538,1095.88653846154,4491.26538461538,1855.26153846154,126.5,1075.58653846154,1404.68461538462,1198.87884615385,1518.47884615385,1700.675,1907.05769230769,315.786538461538,230.480769230769,1041.45,2015.49615384615,225.955769230769,285.853846153846,636.980769230769,1409.31346153846,445.457692307692,476.140384615385,1061.44807692308,131.261538461538,520,27.5061532868335,24.4656816520304,0.457008885899573,0.955882352941176,0.8,-0.918865566539052,51345.9326923077,35579.0038461538,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_198819,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
199090,2941.88036117381,239.23927765237,176.428893905192,690.6230248307,4158.27539503386,2831.18058690745,662.600451467269,270.697516930023,1091.05643340858,5122.03611738149,508.686230248307,116.864559819413,1083.93679458239,2319.01354401806,536.230248306998,299.893905191874,1860.79909706546,1710.04740406321,301.909706546275,239.86230248307,1027.69300225734,1397.55304740406,223.68848758465,156.577878103837,644.286681715576,1672.15349887133,485.507900677201,367.194130925508,1038.20090293454,131.702031602709,443,26.694829250232,21.2141919897183,0.60701165717773,0.960954446854664,0.774475524475524,0.351073765867477,51124.4266365688,35438.2979683973,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
199216,2902.7513368984,215.291443850267,99.4064171122995,627.855614973262,1230.10160427807,3379.22994652406,466.147058823529,270.708556149733,1088.35561497326,6072.53475935829,700.74064171123,121.251336898396,1078.0320855615,685.957219251337,496.280748663102,318.120320855615,1548.91443850267,1098.43048128342,284.903743315508,231.144385026738,998.799465240642,1039.42245989305,218.31550802139,154.050802139037,596.427807486631,2578.50267379679,589.799465240642,264.810160427807,1060.0320855615,129.975935828877,374,24.3730984432395,19.5913249284407,0.594886959958149,0.958974358974359,0.772727272727273,0.879479340391338,51946.5534759358,34570.2914438503,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199216,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
199283,4264.87410071942,760.776978417266,66.5287769784173,635.478417266187,1502.38489208633,4763.1618705036,842.273381294964,274.165467625899,1164.19784172662,7181.98561151079,733.197841726619,137.55035971223,1085.87050359712,5528.39568345324,952.258992805755,601.028776978417,1795.71582733813,7303.51079136691,414.823741007194,247.18345323741,1029.46402877698,6244.5035971223,290.478417266187,244.482014388489,594.823741007194,2690.22302158273,540.780575539568,272.334532374101,1069.5035971223,131.507194244604,278,20.1841710045424,18.5047745866626,0.399355013760916,0.86875,0.661904761904762,-0.410594555361021,51047.8597122302,35834.226618705,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199283,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
199510,1632.29447852761,267.267893660532,136.905930470348,649.139059304703,2929.53578732106,2165.90388548057,401.40899795501,261.629856850716,1092.58077709611,2897.77096114519,514.815950920245,111.59509202454,1074.28425357873,749.01226993865,555.952965235174,273.249488752556,1542.04294478528,1111.54601226994,308.130879345603,237.251533742331,991.425357873211,987.498977505112,213.703476482618,146.059304703476,588.366053169734,1378.1063394683,500.224948875256,221.78118609407,1043.03680981595,130.321063394683,489,27.8787316019718,22.9042266840842,0.570112967969648,0.97410358565737,0.783653846153846,0.505816732271616,51220.3844580777,34938.4233128834,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199510,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
199586,2310.23155216285,203.234096692112,63.9745547073791,624.880407124682,1347.82188295165,2944.26972010178,1489.63613231552,265.277353689567,1095.43002544529,4958.64885496183,1436.2213740458,111.025445292621,1066.09923664122,1714.58269720102,930.666666666667,485.618320610687,3063.02290076336,2388.73027989822,340.702290076336,238.315521628499,1064.01017811705,2294.69974554707,232.641221374046,166.24427480916,610.809160305344,2381.15776081425,537.791348600509,430.977099236641,1062.01272264631,130.580152671756,393,23.9658146954387,21.3172111870585,0.456966115274046,0.965601965601966,0.779761904761905,0.193451753459873,51632.6717557252,35004.4402035623,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
200282,1813.4776119403,162.582089552239,154.422885572139,690.427860696517,3536.37810945274,2319.43283582089,366.52736318408,274.333333333333,1106.3184079602,2650.2736318408,712.626865671642,136.726368159204,1064.4776119403,615.89552238806,456.154228855721,270.149253731343,1356.71641791045,987.597014925373,293.746268656716,234.089552238806,987.47263681592,943.865671641791,207.975124378109,145.328358208955,582.44776119403,1250.86069651741,543.522388059701,226.482587064677,1050.86567164179,131.154228855721,201,17.6433456848449,14.5202359121205,0.568060881392047,0.95260663507109,0.738970588235294,0.82445720508717,50324.7164179105,34594.5970149254,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_200282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
200535,1977.62987012987,480.896103896104,56.8116883116883,619.922077922078,1123.01298701299,1923.27922077922,939.272727272727,256.077922077922,1089.83116883117,3726.22727272727,475.805194805195,126.701298701299,1060.85714285714,1291.53896103896,550.175324675325,317.175324675325,1730.71428571429,1196.37662337662,308.11038961039,233.227272727273,990.551948051948,1220.55844155844,232.305194805195,197.876623376623,587.525974025974,1757.31818181818,446.655844155844,363.233766233766,1045.5974025974,132.883116883117,154,14.295444092149,13.7932545980364,0.262725344269339,0.950617283950617,0.733333333333333,0.866195500622858,50964.0,35853.3766233766,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_200535,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
200656,3941.95307917889,240.759530791789,86.6744868035191,625.859237536657,1017.13782991202,4275.07038123167,833.372434017595,277.709677419355,1094.89736070381,6399.45747800586,899.079178885631,115.648093841642,1109.27565982405,4772.59237536657,941.521994134897,1362.33724340176,1906.99120234604,4278.29618768328,388.360703812317,242.985337243402,1044.17008797654,3724.82697947214,245.74780058651,482.815249266862,655.387096774194,1451.9853372434,483.064516129032,318.782991202346,1046.46920821114,132.190615835777,341,22.490322982873,19.3476804625196,0.509843955015589,0.982708933717579,0.811904761904762,0.931700222372961,50884.3284457478,35290.5307917889,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_200656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
202409,2343.73850574713,189.882183908046,166.979885057471,697.873563218391,4480.17528735632,2711.75574712644,363.206896551724,272.537356321839,1099.85344827586,4757.08045977012,729.275862068965,116.272988505747,1068.64655172414,1019.58045977011,519.58908045977,306.67816091954,1577.53448275862,1321.52873563218,306.775862068966,232.44540229885,1054.19252873563,1257.49425287356,251.583333333333,281.301724137931,652.557471264368,1907.31034482759,512.221264367816,248.146551724138,1091.17528735632,130.804597701149,348,32.8569814639192,13.5887917060199,0.91047052969427,0.945652173913044,0.748387096774194,1.3550481095974,51218.2155172414,35227.341954023,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_202409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
203256,2159.68531468531,528.895104895105,125.167832167832,648.688811188811,2399.04195804196,2379.04895104895,4342.73076923077,257.482517482517,1112.19230769231,3721.21328671329,3437.66433566434,119.111888111888,1080.37062937063,4419.1958041958,1207.10839160839,416.171328671329,9063.75174825175,4935.73076923077,496.769230769231,259.804195804196,1022.36363636364,4382.6013986014,1293.24475524476,601.475524475524,642.237762237762,1739.47902097902,681.41958041958,529.863636363636,1095.83216783217,132.146853146853,286,20.1832481773818,18.1732411797147,0.435037955923901,0.969491525423729,0.83625730994152,1.17369995205951,51448.5,33807.1993006993,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_203256,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
205225,4596.98235294118,1397.69411764706,1432.27058823529,627.8,1240.65294117647,5420.49411764706,404.682352941176,280.741176470588,1103.95294117647,8755.45294117647,548.788235294118,118.629411764706,1072.91176470588,983.476470588235,519.976470588235,277.3,1848.94705882353,1454.93529411765,322.094117647059,242.570588235294,1056.91176470588,1178.85294117647,224.829411764706,140.823529411765,610.894117647059,3400.28235294118,611.023529411765,250.205882352941,1064.62941176471,132.094117647059,170,17.5946662267564,12.3286050458257,0.713454780771678,0.949720670391062,0.714285714285714,-1.01832026463292,51156.6941176471,35266.7705882353,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_205225,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
205781,3621.70063694268,414.210191082803,311.264331210191,777.267515923567,8772.70700636943,4409.06369426752,392.898089171975,270.923566878981,1174.67515923567,6890.67834394904,598.474522292994,137.070063694268,1082.01910828025,513.710191082803,383.012738853503,345.62101910828,1597.61464968153,944.754777070064,234.506369426752,223.96178343949,1024.56050955414,910.257961783439,176.611464968153,169.277070063694,670.837579617834,1884.98407643312,535.012738853503,233.146496815287,1069.24840764331,132.146496815287,314,21.6204326289385,18.5411669908608,0.514357052489398,0.975155279503106,0.785,-0.791381972611914,51044.6114649682,34445.6687898089,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_205781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
205926,4399.15277777778,1086.54861111111,993.989583333333,640.315972222222,1981.12847222222,4873.77777777778,463.048611111111,275.413194444444,1092.92708333333,8480.19444444445,564.635416666667,120.774305555556,1082.46875,958.986111111111,523.631944444444,276.920138888889,1745.35763888889,1383.09375,303.989583333333,235.947916666667,1137.63888888889,1100.69444444444,211.902777777778,151.680555555556,856.763888888889,3230.58680555556,603.131944444444,267.607638888889,1080.88541666667,131.375,288,21.7371692090357,16.8819632481263,0.629944225915211,0.96969696969697,0.80672268907563,-1.41505241563611,51172.8541666667,35257.1145833333,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_205926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
206466,477.643076923077,911.649230769231,259.276923076923,658.329230769231,111.369230769231,585.766153846154,378.52,280.301538461538,1112.36923076923,1426.30461538462,1107.37538461538,114.418461538462,1064.42153846154,2828.68923076923,691.283076923077,308.153846153846,1795.0,4157.16,398.04,251.255384615385,1098.42153846154,3768.80307692308,260.036923076923,187.363076923077,1068.03692307692,814.876923076923,420.304615384615,206.966153846154,1043.15692307692,131.978461538462,325,20.6086639448393,20.0915527598584,0.222607857151124,0.961538461538462,0.773809523809524,-0.948107902189062,51091.1015384615,35205.4707692308,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_206466,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
206685,3475.17358490566,339.596226415094,161.388679245283,661.018867924528,3464.92075471698,4730.60754716981,433.260377358491,274.230188679245,1084.51320754717,6283.27547169811,713.260377358491,144.060377358491,1073.98867924528,890.196226415094,556.724528301887,283.181132075472,1433.64528301887,1271.50943396226,377.283018867925,247.188679245283,979.845283018868,1127.97358490566,237.543396226415,120.883018867925,584.090566037736,2875.19622641509,581.135849056604,266.977358490566,1043.61132075472,132.275471698113,265,22.8517508448366,15.1196958095934,0.749819205009337,0.94306049822064,0.6625,-0.778161470249523,50848.3283018868,34435.4264150943,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206685,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
206965,2737.41052631579,129.426315789474,58.6263157894737,615.915789473684,557.610526315789,3106.51578947368,626.363157894737,273.421052631579,1093.70526315789,4232.58947368421,757.494736842105,114.010526315789,1067.63684210526,2471.81052631579,674.273684210526,327.015789473684,1569.65789473684,2157.70526315789,319.1,238.121052631579,997.726315789474,1532.41578947368,221.078947368421,156.052631578947,591.505263157895,1172.21052631579,499.621052631579,371.863157894737,1053.18421052632,132.626315789474,190,18.0475930111482,13.5409201854211,0.661109379934911,0.95959595959596,0.753968253968254,-0.30782835716002,50731.8157894737,35203.3105263158,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206965,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
206973,1471.31766055046,280.067660550459,134.993119266055,651.854357798165,2891.0126146789,2014.51720183486,468.40252293578,256.373853211009,1089.11697247706,3353.16972477064,991.985091743119,112.942660550459,1105.52637614679,659.29128440367,430.100917431193,271.254587155963,1421.65940366972,1022.93463302752,286.68119266055,229.732798165138,995.926605504587,999.829128440367,198.364678899082,137.844036697248,588.746559633028,1696.8497706422,508.034403669725,263.946100917431,1067.83142201835,130.574541284404,872,47.5307474073258,23.4655515127721,0.869636804934389,0.975391498881432,0.806660499537465,0.0519123497776828,51267.3417431193,34750.8417431193,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_206973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
207046,2915.71428571429,906.797909407666,140.644599303136,672.679442508711,3412.60278745645,3621.25087108014,481.400696864112,272.620209059233,1140.0,4485.80836236934,531.815331010453,128.080139372822,1075.93728222997,2460.51219512195,939.606271777004,752.864111498258,2290.90940766551,3614.71080139373,455.205574912892,244.655052264808,1188.73170731707,3016.67944250871,268.031358885017,272.602787456446,598.08362369338,1327.08710801394,505.909407665505,267.665505226481,1067.89198606272,130.393728222997,287,21.6287294449661,17.0183883308893,0.617154751579444,0.950331125827814,0.719298245614035,1.0409385678798,51181.2717770035,35794.668989547,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
207878,3252.95544554455,1084.06683168317,117.638613861386,618.430693069307,984.433168316832,3947.92574257426,483.173267326733,272.061881188119,1237.37871287129,6358.14108910891,584.022277227723,117.542079207921,1086.37376237624,832.084158415842,995.690594059406,908.378712871287,1559.44306930693,1266.81930693069,325.772277227723,417.430693069307,1003.54207920792,1141.71534653465,224.623762376238,240.259900990099,736.34900990099,2275.76485148515,580.071782178218,399.95297029703,1077.57425742574,130.054455445545,404,25.4723651528295,20.4893473115255,0.594121200570155,0.957345971563981,0.765151515151515,0.970086810942913,51144.4430693069,35030.0198019802,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207878,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
207999,1584.81690140845,285.219718309859,130.459154929577,632.919718309859,1394.1985915493,2077.86478873239,358.819718309859,272.312676056338,1085.74788732394,3494.80281690141,600.498591549296,120.216901408451,1088.44788732394,545.956338028169,409.283098591549,264.047887323944,1396.2338028169,879.830985915493,253.629577464789,225.359154929577,987.821126760563,861.712676056338,186.601408450704,127.516901408451,585.4,2283.8985915493,582.381690140845,233.392957746479,1067.49577464789,131.119718309859,710,45.3272559934059,20.3071324915093,0.894027787674083,0.964673913043478,0.751322751322751,0.128535791221384,50554.0943661972,34616.4507042254,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207999,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
208264,1525.77650429799,365.41547277937,103.163323782235,629.449856733524,1708.59025787966,1391.72206303725,3087.6446991404,251.541547277937,1090.10028653295,1997.61318051576,1300.77936962751,111.925501432665,1070.6217765043,624.925501432665,476.272206303725,266.361031518625,1442.21776504298,944.948424068768,267.747851002865,224.962750716332,983.43553008596,895.349570200573,198.790830945559,136.785100286533,587.335243553009,833.56446991404,453.489971346705,252.74212034384,1013.60458452722,129.85100286533,349,22.2900184102112,20.2945639589007,0.413558240087796,0.958791208791209,0.791383219954649,1.08349663760986,51843.5243553009,34234.8968481375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208264,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
208302,3837.28731343284,758.220149253731,460.555970149254,626.298507462687,1436.91791044776,4658.9776119403,607.720149253731,271.548507462687,1118.34701492537,7681.11194029851,878.25,117.339552238806,1084.6828358209,2287.59328358209,558.600746268657,290.264925373134,1595.75,4056.35447761194,381.847014925373,244.194029850746,1019.17537313433,3695.25,241.253731343284,373.388059701493,591.410447761194,3057.85074626866,583.152985074627,378.167910447761,1080.92537313433,129.84328358209,268,21.8947311694395,15.5997322018049,0.701684342291977,0.940350877192982,0.716577540106952,-1.39803595955675,51345.8358208955,35024.9888059701,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208302,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
209036,1964.52651515152,216.257575757576,86.3181818181818,623.25,1443.44696969697,2266.63636363636,320.75,248.549242424242,1085.82954545455,3812.62878787879,507.57196969697,110.049242424242,1077.1553030303,783.988636363636,443.212121212121,283.969696969697,1495.31060606061,810.731060606061,198.515151515152,212.227272727273,1016.43181818182,666.852272727273,153.784090909091,124.651515151515,598.916666666667,1449.63636363636,491.647727272727,222.212121212121,1044.68560606061,130.049242424242,264,22.5703673132835,15.0127588089918,0.746706650415774,0.956521739130435,0.75,-1.3149513477942,51512.6590909091,34193.2954545455,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_209036,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
210081,3755.80285714286,116.725714285714,52.7742857142857,618.542857142857,487.654285714286,4507.11428571429,1145.16285714286,274.217142857143,1097.67142857143,6415.61428571429,837.782857142857,122.574285714286,1070.56,1010.26571428571,555.868571428571,289.134285714286,1443.51714285714,1335.85428571429,327.26,236.985714285714,1019.97142857143,1189.48285714286,238.717142857143,140.922857142857,644.088571428571,3002.22,500.765714285714,272.474285714286,1039.77142857143,132.414285714286,350,24.5827657457662,18.1600050493062,0.674002432253282,0.972222222222222,0.757575757575758,0.718216690616948,50069.8742857143,35053.7857142857,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_210081,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
210658,2021.8093306288,143.066937119675,150.261663286004,687.896551724138,3445.50304259635,2339.34685598377,341.490872210953,272.111561866126,1107.25963488844,3973.3752535497,618.215010141988,127.979716024341,1074.48681541582,615.590263691684,659.95537525355,722.939148073022,1683.50912778905,1158.51724137931,260.888438133874,221.722109533469,1009.56389452333,1268.91480730223,203.951318458418,599.924949290061,658.371196754564,1530.33874239351,474.711967545639,222.281947261663,1089.8275862069,131.275862068966,493,32.4476358477503,19.415288104082,0.801229202183168,0.962890625,0.7703125,0.231615339000719,50083.9614604462,35211.9452332657,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_210658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
210724,2957.3203125,382.48828125,139.97265625,655.8828125,2103.42578125,2739.44921875,2366.125,267.64453125,1109.125,4867.16015625,2921.22265625,120.75390625,1085.078125,693.640625,413.69140625,291.72265625,1605.5234375,1027.94140625,277.4375,227.45703125,1027.52734375,1104.328125,283.73828125,232.97265625,610.15625,1753.2109375,466.06640625,761.0390625,1068.9921875,131.2890625,256,22.1644622857377,14.756016723793,0.746173825702347,0.941176470588235,0.761904761904762,-1.28489022160983,50754.94140625,35647.58984375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_210724,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
210779,499.175862068966,581.989655172414,177.11724137931,624.58275862069,96.2379310344828,608.651724137931,392.168965517241,273.68275862069,1107.2275862069,1207.87586206897,906.506896551724,104.813793103448,1059.26551724138,964.78275862069,672.986206896552,286.7,1745.08620689655,1146.11379310345,267.275862068966,231.165517241379,1237.34482758621,965.089655172414,197.255172413793,144.851724137931,2583.8724137931,571.175862068966,360.558620689655,196.451724137931,982.6,131.055172413793,290,20.1423122585463,18.3523417018062,0.412110641753941,0.966666666666667,0.767195767195767,-1.50921797881563,50185.3172413793,34920.5620689655,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_210779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
211317,1871.88744588745,291.52380952381,188.900432900433,672.147186147186,3721.35930735931,2350.27272727273,340.597402597403,256.753246753247,1099.95238095238,3381.00432900433,682.636363636364,136.575757575758,1068.16883116883,3426.5367965368,650.341991341991,690.281385281385,2338.04329004329,4357.28138528139,416.047619047619,1439.30735930736,1077.69264069264,3492.38961038961,717.281385281385,502.917748917749,2218.70995670996,1074.51082251082,494.480519480519,226.138528138528,1058.16883116883,131.21645021645,231,18.0195715676928,16.3732871155619,0.417582331654642,0.9625,0.754901960784314,-0.909283633510272,51087.2034632035,34033.5584415584,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211317,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
211663,4138.06333333333,318.77,78.6666666666667,637.06,1704.82,4645.12333333333,453.866666666667,276.76,1143.34333333333,7648.26,638.32,122.57,1094.20666666667,827.016666666667,605.36,274.38,1755.38,1324.97,304.163333333333,229.966666666667,1053.84666666667,1208.77333333333,222.093333333333,378.1,3868.28333333333,2961.73666666667,508.23,247.63,1076.93333333333,131.34,300,20.3111464042568,18.8617024850286,0.370987135699176,0.964630225080386,0.75187969924812,-0.423142556177135,50652.08,35572.2333333333,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212152,3321.75892857143,883.191964285714,550.107142857143,622.714285714286,1007.21875,3139.88392857143,564.816964285714,264.642857142857,1096.71428571429,4977.28571428571,848.558035714286,112.589285714286,1072.33035714286,1072.77678571429,459.495535714286,301.566964285714,1615.16517857143,1799.60714285714,338.174107142857,237.549107142857,1005.89285714286,2357.71875,256.4375,301.526785714286,1384.55357142857,1662.70982142857,477.084821428571,260.696428571429,1039.55803571429,130.589285714286,224,18.4484206088137,15.9307285214447,0.504300824048681,0.957264957264957,0.775086505190311,-1.03864845100225,50748.1785714286,35628.9955357143,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212152,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212214,1464.84574468085,164.537234042553,136.946808510638,688.617021276596,5203.24468085106,1553.87765957447,434.234042553192,284.265957446808,1080.1170212766,2594.15425531915,493.781914893617,117.38829787234,1072.75,2113.82978723404,1291.11170212766,376.920212765957,2141.5,2450.81382978723,345.590425531915,241.670212765957,1021.62765957447,3125.30319148936,268.441489361702,287.882978723404,696.627659574468,1284.97340425532,504.941489361702,328.494680851064,1019.67553191489,130.952127659574,188,16.5924734449591,14.4674252568104,0.489635928063669,0.94949494949495,0.737254901960784,1.34840183569193,51652.7287234043,34920.8989361702,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212214,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212348,4354.98576512455,666.473309608541,156.427046263345,670.896797153025,3589.29181494662,4455.64768683274,775.967971530249,283.298932384342,1198.55871886121,8198.59786476868,902.612099644128,126.284697508897,1073.67259786477,4388.37010676157,804.555160142349,350.505338078292,6389.81850533808,5348.64412811388,398.039145907473,243.85409252669,1027.23487544484,4921.02491103203,273.569395017794,201.619217081851,635.565836298932,3811.84697508897,539.302491103203,434.807829181495,1053.97864768683,131.612099644128,281,19.6322713989192,18.261876185621,0.367061164811676,0.98943661971831,0.821637426900585,-1.05440805342195,50603.9679715302,35567.6014234875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212348,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212359,1124.42196531792,152.982658959538,84.8757225433526,637.184971098266,1306.27167630058,1135.06358381503,870.517341040462,260.635838150289,1091.57803468208,2266.41907514451,676.708092485549,104.352601156069,1088.14161849711,827.158959537572,497.173410404624,285.170520231214,1775.45664739884,1319.89595375723,300.315028901734,236.453757225434,1023.36416184971,1128.29190751445,224.124277456647,160.332369942197,952.537572254335,1117.65895953757,431.719653179191,542.985549132948,1038.58959537572,129.803468208092,346,21.537478181135,20.4579542467454,0.312624000399626,0.982954545454545,0.823809523809524,-0.134624512805235,51060.3901734104,35537.8843930636,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212359,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212472,2082.2614379085,294.385620915033,55.8823529411765,622.59477124183,986.339869281046,1640.69934640523,508.705882352941,256.065359477124,1178.81045751634,4064.57516339869,487.745098039216,105.830065359477,1076.75816993464,4268.42483660131,684.529411764706,465.267973856209,1926.03921568627,4708.37908496732,382.56862745098,244.869281045752,1033.33986928105,4632.22222222222,281.339869281046,242.366013071895,610.202614379085,1870.26797385621,468.954248366013,265.901960784314,1026.39869281046,128.222222222222,153,16.5809503716723,11.7751377722628,0.704039709802055,0.962264150943396,0.796875,-0.2720986889119,51168.3333333333,35738.5947712418,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212482,1899.05985915493,410.757042253521,107.387323943662,627.140845070423,1985.42253521127,1472.97535211268,2767.43661971831,266.785211267606,1087.77112676056,1689.72183098592,930.507042253521,112.549295774648,1067.15845070423,3128.38732394366,770.570422535211,350.176056338028,2109.66549295775,4623.05633802817,422.369718309859,261.450704225352,1007.24295774648,5785.79225352113,273.950704225352,273.070422535211,602.397887323944,1006.15492957746,551.165492957746,279.102112676056,1022.53169014085,128.827464788732,284,23.5400669144354,15.5045073695111,0.752455315974831,0.972602739726027,0.747368421052632,0.757789094940017,51904.4330985916,34680.1443661972,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212482,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
212727,5085.29268292683,687.151219512195,158.19512195122,643.385365853659,2061.21951219512,5953.64878048781,546.551219512195,276.8,1155.08292682927,9757.65853658537,894.707317073171,123.565853658537,1062.96097560976,790.921951219512,488.136585365854,276.448780487805,1416.19512195122,1158.59512195122,324.736585365854,236.756097560976,983.141463414634,1073.4487804878,222.956097560976,136.785365853659,579.141463414634,3927.65853658537,608.721951219512,306.429268292683,1069.68292682927,129.980487804878,205,18.042438669718,14.5077885073144,0.594504289528197,0.976190476190476,0.803921568627451,-1.09270705768126,51375.4536585366,34974.0341463415,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212727,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
213560,4460.88349514563,260.922330097087,106.511326860841,643.326860841424,2156.66990291262,5175.49190938511,803.699029126214,286.31715210356,1103.54368932039,6937.57928802589,1147.48220064725,123.504854368932,1086.58899676375,919.220064724919,828.220064724919,288.203883495146,1466.32686084142,2404.20388349515,343.961165048544,239.919093851133,997.36569579288,2851.42394822006,258.73786407767,171.663430420712,689.427184466019,1826.80582524272,504.427184466019,249.608414239482,1056.34627831715,130.394822006472,309,22.0054055931817,17.9028059824464,0.581475368453882,0.965625,0.78030303030303,1.44984578568937,50831.7508090615,35219.1003236246,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_213560,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
213636,3808.78353658537,1060.25304878049,742.740853658537,611.588414634146,827.896341463415,4155.08536585366,413.173780487805,273.213414634146,1098.78963414634,6241.48475609756,529.432926829268,114.393292682927,1072.53658536585,2767.16463414634,774.332317073171,293.631097560976,1635.81707317073,5911.46646341463,376.463414634146,246.067073170732,1008.58841463415,6121.04268292683,259.121951219512,167.676829268293,583.701219512195,2495.30487804878,583.060975609756,245.582317073171,1041.88414634146,131.942073170732,328,21.3814469266308,19.7144433751341,0.387106414489829,0.947976878612717,0.743764172335601,-1.07231165540556,51567.5579268293,35096.9329268293,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_213636,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
213705,4286.8829113924,937.041139240506,1995.83544303797,645.237341772152,1796.94936708861,4009.93987341772,618.139240506329,272.053797468354,1124.82278481013,7037.96835443038,564.351265822785,120.727848101266,1075.94303797468,824.693037974684,549.20253164557,1048.2246835443,2354.20886075949,1753.15189873418,321.607594936709,232.841772151899,1028.34810126582,2220.69936708861,230.98417721519,241.189873417722,589.063291139241,2202.41455696203,579.626582278481,332.462025316456,1056.28481012658,130.341772151899,316,20.5545304834484,19.6224044442972,0.297726958002612,0.966360856269113,0.831578947368421,-0.953861972645196,51484.6424050633,35737.8227848101,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_213705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
214092,1837.52051282051,295.669230769231,105.341025641026,639.117948717949,922.64358974359,2321.38974358974,732.95641025641,260.138461538462,1106.26153846154,4171.05128205128,771.953846153846,123.776923076923,1083.94358974359,599.415384615385,407.279487179487,267.861538461538,1439.65128205128,901.928205128205,281.648717948718,230.528205128205,989.697435897436,868.474358974359,198.371794871795,125.146153846154,582.184615384615,1812.05641025641,531.323076923077,234.692307692308,1241.16153846154,131.828205128205,390,22.891810840493,21.7480601293199,0.312138260131828,0.951219512195122,0.706521739130435,-0.60018764119894,51023.3794871795,34251.7435897436,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_214092,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
214153,3108.7275862069,798.751724137931,221.78275862069,640.062068965517,1910.48620689655,3452.23448275862,1556.99310344828,262.606896551724,1188.31034482759,6900.74827586207,1063.56206896552,121.179310344828,1074.05862068966,1476.37931034483,590.862068965517,289.910344827586,2001.34137931034,1739.8,293.403448275862,223.637931034483,1201.58275862069,1183.67586206897,177.158620689655,132.237931034483,1668.9,3889.89655172414,623.489655172414,284.386206896552,1074.23448275862,130.444827586207,290,19.9877459729348,18.5276019043081,0.375189732954972,0.963455149501661,0.803324099722992,-1.0377940977206,51447.8137931035,34285.5724137931,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_214153,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
214416,2265.32394366197,219.150234741784,146.380281690141,687.462441314554,4173.38732394366,2415.04460093897,363.025821596244,272.887323943662,1093.70422535211,4223.27464788732,657.424882629108,122.511737089202,1074.99765258216,2920.25117370892,917.49765258216,570.347417840376,1648.23708920188,2900.49530516432,361.849765258216,247.143192488263,1015.12676056338,2616.74647887324,256.884976525822,322.199530516432,638.849765258216,1525.95070422535,514.598591549296,296.983568075117,1082.69483568075,131.976525821596,426,27.9060943644664,20.0654413232639,0.694974501040148,0.957303370786517,0.740869565217391,-0.714400889425286,51834.8755868545,35257.2488262911,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_214416,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
215353,1746.23880597015,180.497512437811,146.601990049751,673.373134328358,3632.5223880597,2157.19402985075,699.10447761194,261.835820895522,1095.40298507463,3920.71641791045,657.1592039801,124.164179104478,1069.97512437811,1222.24378109453,735.293532338308,811.437810945274,2189.24378109453,2968.64179104478,377.044776119403,252.606965174129,1014.65671641791,3202.57213930348,238.094527363184,207.900497512438,621.796019900498,1503.53233830846,484.870646766169,224.532338308458,1074.12935323383,131.398009950249,201,19.3140630133528,13.4111973787929,0.719613596286285,0.943661971830986,0.705263157894737,1.245744625604,50297.5870646766,34809.0049751244,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_215353,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
215356,2455.87338501292,237.307493540052,149.385012919897,661.708010335917,3598.03100775194,2914.95348837209,603.617571059431,275.764857881137,1107.90439276486,3541.54780361757,565.364341085271,117.271317829457,1080.10852713178,620.273901808786,401.8165374677,269.945736434109,1412.27648578811,952.3669250646,266.049095607235,225.033591731266,986.726098191214,937.62015503876,224.93023255814,144.361757105943,594.891472868217,981.97157622739,438.702842377261,222.806201550388,1039.00516795866,131.209302325581,387,25.2885664036007,19.5331604050077,0.635123327919103,0.972361809045226,0.814736842105263,-0.0002981714281543,50598.8139534884,35416.0852713178,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_215356,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
215859,3082.42857142857,209.380952380952,99.0793650793651,683.862433862434,1544.97883597884,3125.30687830688,317.534391534392,267.867724867725,1096.80952380952,5893.47619047619,545.333333333333,124.010582010582,1081.7037037037,2916.04761904762,856.396825396825,323.111111111111,2344.49735449735,3301.04761904762,345.645502645503,231.68253968254,1061.34391534392,2604.62962962963,329.73544973545,222.116402116402,601.412698412698,3171.02116402116,498.354497354497,420.486772486773,1053.79365079365,129.513227513228,189,18.3582080589038,13.2325627697785,0.693145005322913,0.921951219512195,0.694852941176471,-0.866227566430351,50656.8888888889,35786.2433862434,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_215859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
216458,4221.2766798419,1002.50592885375,105.671936758893,617.051383399209,1039.18972332016,3645.55335968379,383.221343873518,271.940711462451,1111.77075098814,7624.71146245059,533.798418972332,116.766798418972,1082.1581027668,996.379446640316,791.371541501976,364.97233201581,1613.4347826087,1247.00395256917,315.00395256917,229.695652173913,1000.16996047431,1101.01976284585,217.399209486166,169.98814229249,1141.16205533597,3782.05138339921,557.0,248.936758893281,1061.23320158103,130.592885375494,253,26.8714576312266,12.2811446113485,0.88944970546217,0.940520446096654,0.695054945054945,-1.36031449900197,51590.1936758893,35425.5019762846,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_216458,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
216625,2345.50859106529,189.302405498282,140.817869415808,662.481099656357,3733.2439862543,2430.01374570447,316.893470790378,268.53264604811,1091.2852233677,4270.25773195876,482.615120274914,116.395189003436,1073.15120274914,923.79381443299,530.570446735395,284.594501718213,1595.98625429553,1191.37800687285,262.432989690722,221.85910652921,1255.40206185567,884.529209621993,187.144329896907,161.529209621993,701.33676975945,1754.25429553265,468.886597938144,272.759450171821,1048.32989690722,130.264604810997,291,24.0106945289552,15.520565350125,0.762996866496386,0.973244147157191,0.729323308270677,0.928958728628216,50761.5635738832,35535.3161512028,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_216625,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
216790,1049.4450867052,171.774566473988,92.4450867052023,645.433526011561,1228.45086705202,1263.58959537572,370.664739884393,273.965317919075,1101.22543352601,2012.30057803468,655.658959537572,119.393063583815,1064.69942196532,748.820809248555,591.774566473988,376.028901734104,1735.63005780347,1497.1098265896,282.549132947977,227.693641618497,1002.06358381503,1612.08670520231,213.745664739884,427.046242774567,611.560693641619,1315.93063583815,512.728323699422,226.416184971098,1070.94219653179,131.086705202312,173,16.421506073703,13.4209874830172,0.57623910876528,0.961111111111111,0.768888888888889,-0.859491834339467,50052.3121387283,35219.4219653179,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_216790,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
216905,2301.73252279635,158.130699088146,146.860182370821,701.957446808511,5315.00303951368,2020.79635258359,396.756838905775,263.48632218845,1096.63829787234,4482.22492401216,584.696048632219,119.775075987842,1084.99696048632,2337.71124620061,537.300911854103,301.550151975684,1574.65653495441,1574.2462006079,310.130699088146,236.896656534954,997.978723404255,1318.17325227964,226.306990881459,164.677811550152,588.115501519757,1458.24012158055,470.942249240122,225.83282674772,1060.73860182371,129.306990881459,329,32.4587713200121,13.1619389938902,0.91409631224497,0.950867052023121,0.758064516129032,1.42964547062269,51881.1671732523,35261.2310030395,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_216905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
216997,4951.08520179372,482.237668161435,135.755605381166,712.92600896861,2605.79372197309,5580.86995515695,2437.79372197309,287.071748878924,1223.91031390135,8656.58295964126,1631.90582959641,130.2466367713,1071.68161434978,1763.36771300448,708.242152466368,303.618834080717,1754.40582959641,2339.5201793722,325.650224215247,253.724215246637,1018.54035874439,2179.9798206278,220.912556053812,281.625560538117,653.105381165919,2767.62331838565,610.85201793722,358.486547085202,1124.76905829596,132.834080717489,446,25.7845069252399,22.0588898768394,0.517787162078212,0.971677559912854,0.775652173913044,-1.01476369701365,51522.4461883408,34838.3139013453,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_216997,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
217076,4203.76380368098,428.079754601227,109.159509202454,630.576687116564,1203.11963190184,4777.26687116564,529.803680981595,275.113496932515,1117.49079754601,7039.1472392638,596.144171779141,118.79754601227,1074.46625766871,886.076687116564,530.049079754601,281.656441717791,1543.02760736196,1001.70858895706,216.230061349693,215.033742331288,1335.05521472393,697.558282208589,157.677914110429,119.812883435583,698.493865030675,1604.9509202454,495.950920245399,316.671779141104,1073.81901840491,132.558282208589,326,21.1417396936594,19.6808651148342,0.365271763176777,0.950437317784257,0.776190476190476,0.139093307074662,50262.7607361963,35060.8312883436,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_217076,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
217806,4528.04048582996,381.238866396761,70.7165991902834,618.813765182186,1485.00809716599,4430.45748987854,514.400809716599,276.093117408907,1096.67611336032,8552.20647773279,663.765182186235,120.348178137652,1074.04048582996,728.82995951417,399.983805668016,284.287449392713,1522.55870445344,879.842105263158,202.591093117409,212.773279352227,1218.14574898785,755.161943319838,174.87044534413,231.210526315789,696.623481781377,3301.57489878542,509.599190283401,262.615384615385,1065.43319838057,129.327935222672,247,20.8932766819397,15.0803024593597,0.692124890469932,0.957364341085271,0.726470588235294,1.00572376463286,51622.8016194332,35665.7327935223,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_217806,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
218061,3981.45593869732,549.049808429119,616.628352490421,641.494252873563,1672.69348659004,4568.6245210728,655.245210727969,280.95785440613,1240.19540229885,7436.30651340996,576.83908045977,134.942528735632,1097.02681992337,3838.68199233716,943.283524904215,2233.52873563218,1811.60153256705,2394.25670498084,387.0,247.620689655172,1020.38314176245,1677.11494252874,274.896551724138,321.551724137931,648.980842911877,2882.22222222222,526.068965517241,301.195402298851,1074.27203065134,131.16091954023,261,20.3728777216521,16.3661301074998,0.595535049908379,0.945652173913044,0.767647058823529,-1.30072230226288,50893.8007662835,35810.2030651341,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_218061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
218083,1084.14791666667,148.916666666667,78.8708333333333,620.441666666667,1282.48125,1325.25,311.839583333333,245.5125,1085.26458333333,2412.52916666667,559.44375,107.085416666667,1073.07083333333,673.75625,611.804166666667,293.064583333333,1435.46875,1223.02916666667,286.3125,232.458333333333,981.372916666667,2605.21458333333,254.008333333333,470.020833333333,719.90625,1262.10625,482.120833333333,227.90625,1034.9625,135.402083333333,480,28.4534081225461,21.5476576992242,0.653071568358684,0.96,0.740740740740741,0.496081778297856,51624.4895833333,34114.4541666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_218083,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
218085,3675.36507936508,648.526984126984,120.698412698413,640.222222222222,1574.91746031746,3239.90476190476,1500.56825396825,280.590476190476,1137.63174603175,5407.99365079365,2390.57142857143,120.533333333333,1077.56825396825,902.777777777778,536.84126984127,462.301587301587,1600.37777777778,2319.26666666667,310.171428571429,238.088888888889,1034.20317460317,2927.00634920635,256.936507936508,335.75873015873,683.098412698413,1479.67301587302,511.495238095238,570.844444444444,1059.76825396825,130.320634920635,315,22.611681606992,17.7747145328165,0.618117805991723,0.957446808510638,0.795454545454545,1.3682057371884,51147.7142857143,35590.5555555556,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_218085,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
218630,1356.23134328358,86.0037313432836,89.3544776119403,647.123134328358,2776.26865671642,1556.33955223881,345.623134328358,245.190298507463,1082.30597014925,1900.36940298507,468.003731343284,135.940298507463,1079.5447761194,745.652985074627,608.585820895522,319.973880597015,1445.25,1191.41044776119,407.582089552239,254.503731343284,981.388059701493,1169.75746268657,366.037313432836,137.171641791045,585.940298507463,770.421641791045,438.832089552239,218.190298507463,1011.52611940299,129.917910447761,268,20.3802307416109,16.8333580882976,0.563721343947821,0.957142857142857,0.788235294117647,-1.14631035129898,50986.6343283582,34548.1455223881,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_218630,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
218846,3986.31775700935,914.747663551402,145.760124610592,642.847352024922,1948.96573208723,4576.753894081,401.872274143302,273.202492211838,1113.5046728972,7122.41433021807,623.003115264798,118.778816199377,1075.52024922118,761.06230529595,489.13707165109,390.16199376947,1470.30841121495,1095.45794392523,299.981308411215,267.816199376947,985.897196261682,1091.44236760125,226.956386292835,162.984423676012,592.909657320872,2177.76323987539,542.548286604361,243.794392523364,1047.51401869159,130.591900311526,321,22.2386212033295,18.6783117619972,0.542734653185862,0.966867469879518,0.764285714285714,-0.732615624157259,51389.8847352025,35099.8598130841,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_218846,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
219051,1560.48773841962,331.618528610354,80.841961852861,616.539509536785,897.822888283379,1750.02452316076,3574.76566757493,246.741144414169,1101.94277929155,3292.81198910082,865.858310626703,105.08719346049,1068.53950953678,680.888283378747,452.566757493188,341.057220708447,1491.88283378747,996.700272479564,301.318801089918,234.940054495913,992.806539509537,965.49591280654,207.354223433243,146.068119891008,599.945504087194,1150.86920980926,473.449591280654,307.716621253406,1037.39782016349,130.577656675749,367,26.8878355021416,17.5631382167237,0.75718528935123,0.95822454308094,0.784188034188034,1.45424474965683,51069.7738419619,34477.9891008174,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_219051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
219288,3219.59722222222,295.101851851852,172.560185185185,681.990740740741,3876.18518518519,2582.21296296296,1439.06944444444,269.199074074074,1087.12962962963,5597.56481481481,3056.25925925926,122.62962962963,1076.74074074074,695.981481481482,485.986111111111,389.967592592593,1547.06481481481,1050.27777777778,276.819444444444,223.189814814815,986.148148148148,999.412037037037,213.99537037037,186.097222222222,586.550925925926,2492.13425925926,518.416666666667,603.75,1068.2037037037,129.74537037037,216,24.8035605715553,11.1620951386389,0.893018541434825,0.923076923076923,0.571428571428571,-0.690920536166318,50899.3287037037,35598.8981481481,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_219288,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
219298,2455.10924369748,445.710084033613,72.4159663865546,613.735294117647,673.852941176471,2836.61764705882,362.478991596639,261.138655462185,1086.07142857143,4841.74789915966,485.384453781513,106.153361344538,1077.34663865546,1118.44117647059,500.470588235294,282.745798319328,1559.73109243697,1207.83823529412,313.453781512605,228.90756302521,999.247899159664,1108.51890756303,238.346638655462,203.840336134454,599.340336134454,2288.15336134454,464.424369747899,296.691176470588,1041.9243697479,128.760504201681,476,25.1587422943421,24.1090001097929,0.285847059773461,0.967479674796748,0.7616,-0.292349054315548,50793.0819327731,35738.1953781513,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_219298,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
219642,1879.87449392713,815.0,116.943319838057,631.307692307692,1593.10526315789,1853.62753036437,672.631578947368,267.473684210526,1111.15384615385,2608.02024291498,1186.53846153846,114.388663967611,1071.91093117409,4886.7044534413,802.574898785425,349.287449392713,5840.85425101215,3256.79352226721,387.821862348178,235.744939271255,1041.10526315789,2340.55465587045,240.748987854251,208.076923076923,600.582995951417,1020.22267206478,436.757085020243,305.210526315789,1015.60728744939,130.963562753036,247,20.64051613502,15.3878328386725,0.666487848215214,0.98015873015873,0.762345679012346,-0.77336548800014,50831.0647773279,35662.8947368421,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_219642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
220013,3136.90778097983,655.435158501441,115.296829971182,634.0,1935.39481268012,3165.31700288184,590.100864553314,269.253602305476,1126.36311239193,6210.0288184438,530.296829971182,114.657060518732,1083.09510086455,1777.4265129683,703.121037463977,808.85590778098,1706.09510086455,2924.49279538905,361.674351585014,307.685878962536,1050.43804034582,2524.09798270893,263.755043227666,1095.98847262248,1361.1181556196,2737.74351585014,537.723342939481,271.239193083573,1061.40922190202,130.616714697406,347,25.6017602774056,17.3866525542121,0.73402780281661,0.94550408719346,0.722916666666667,-1.1238327168721,51893.1844380403,35440.878962536,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
220505,3384.98947368421,306.343859649123,79.1333333333333,641.066666666667,1904.50877192982,3491.21754385965,5298.73333333333,279.242105263158,1097.30175438596,5996.15438596491,935.4,116.378947368421,1079.6701754386,1778.23157894737,939.256140350877,556.19649122807,1719.24912280702,1710.01754385965,326.035087719298,378.501754385965,1025.46666666667,1368.57894736842,229.670175438596,335.884210526316,764.080701754386,1818.13684210526,491.831578947368,460.540350877193,1075.22807017544,129.564912280702,285,20.5966175713355,17.6953311131591,0.511744441722773,0.979381443298969,0.838235294117647,0.116566697598718,50898.2561403509,35274.6631578947,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220505,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
220847,1212.78600823045,266.843621399177,84.9012345679012,613.827160493827,641.80658436214,1451.94238683128,2302.64197530864,250.131687242798,1079.98353909465,3023.96296296296,1096.12757201646,110.543209876543,1069.83950617284,765.925925925926,875.172839506173,642.086419753086,1581.18106995885,1172.19341563786,321.641975308642,235.148148148148,999.271604938272,1118.57201646091,226.506172839506,1407.64197530864,654.218106995885,1445.74485596708,498.004115226337,263.082304526749,1034.88065843621,131.263374485597,243,20.2013499474792,15.3233930022275,0.651634488027338,0.952941176470588,0.752321981424149,0.719533128709401,51149.0864197531,34483.2139917695,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_220847,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
221604,3713.61261261261,552.896396396396,269.189189189189,618.603603603604,946.72972972973,3962.8018018018,1017.82432432432,291.756756756757,1097.59009009009,6158.34234234234,739.522522522523,123.774774774775,1069.51801801802,618.504504504505,440.648648648649,272.013513513513,1448.19369369369,1037.59009009009,303.869369369369,233.166666666667,983.076576576577,1023.75225225225,277.220720720721,136.932432432432,581.545045045045,1829.73423423423,533.990990990991,235.085585585586,1061.0045045045,133.689189189189,222,19.5151149589411,14.5862113342683,0.664338902006883,0.952789699570816,0.725490196078431,-0.750080481868806,50979.7297297297,35342.2972972973,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_221604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
222129,2800.26542324247,453.641319942611,197.878048780488,684.87230989957,4580.81492109039,2473.95695839311,776.955523672884,273.992826398852,1106.88809182209,3216.59110473458,683.292682926829,122.242467718795,1078.20946915352,630.540889526542,456.104734576758,270.595408895265,1523.26398852224,897.205164992826,256.12912482066,224.621233859397,992.416068866571,850.087517934003,192.391678622669,136.720229555237,580.665710186514,578.172166427547,376.715925394548,203.241032998565,986.365853658537,129.692969870875,697,34.7137848233304,25.6190322575572,0.674792549622163,0.973463687150838,0.788461538461538,1.31805075404526,51719.106169297,34647.5753228121,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_222129,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
222233,1876.19130434783,182.291304347826,177.94347826087,716.3,5372.56956521739,2323.05652173913,434.930434782609,270.178260869565,1102.83043478261,3321.75217391304,724.95652173913,117.278260869565,1069.93043478261,2246.97826086957,1319.12173913043,1084.67391304348,2803.0,6016.03043478261,452.804347826087,256.604347826087,1058.51739130435,7221.66086956522,351.34347826087,810.113043478261,984.195652173913,1331.90869565217,454.791304347826,316.626086956522,1038.95652173913,128.552173913043,230,20.7454261556267,14.1816915389838,0.729851525243413,0.950413223140496,0.766666666666667,1.1908952453099,50457.4826086957,35594.1086956522,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_222233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
222778,4709.86206896552,1120.70881226054,167.651340996169,644.463601532567,2190.10344827586,5936.03831417624,478.0,278.578544061303,1099.53256704981,6988.72796934866,651.908045977012,126.639846743295,1064.70498084291,1725.45593869732,585.865900383142,282.743295019157,1899.04214559387,2456.8275862069,368.938697318008,245.379310344828,1062.66283524904,1943.27586206897,221.655172413793,256.072796934866,1224.19157088123,2018.00766283525,572.869731800766,235.697318007663,1048.41762452107,130.287356321839,261,20.1414584450257,16.5297788194816,0.571381896833208,0.952554744525547,0.767647058823529,1.33440984676888,51339.4789272031,34555.0727969349,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_222778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
223001,1714.6223628692,156.934599156118,90.2151898734177,632.959915611814,1769.17932489451,1803.89873417722,380.635021097046,260.39029535865,1087.82489451477,3192.34599156118,865.438818565401,106.907172995781,1071.15611814346,1750.64978902954,613.367088607595,292.438818565401,1805.9388185654,1936.03164556962,345.814345991561,238.706751054852,1030.37974683544,1572.24894514768,233.845991561181,345.242616033755,845.006329113924,1277.0864978903,426.689873417722,237.759493670886,1030.5864978903,129.143459915612,474,26.040538982164,23.5620994702239,0.425786200536801,0.971311475409836,0.759615384615385,-1.10825697592183,50805.7088607595,35488.6856540084,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_223001,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
223623,4725.53359683794,612.664031620553,110.624505928854,691.766798418972,4252.06324110672,5167.0,964.094861660079,285.869565217391,1277.69169960474,7708.42292490119,630.458498023715,122.715415019763,1093.47035573123,653.185770750988,518.596837944664,396.612648221344,1538.36363636364,890.604743083004,249.545454545455,221.446640316206,992.770750988142,821.715415019763,205.521739130435,187.466403162055,578.786561264822,2831.61660079051,596.355731225296,525.723320158103,1147.4347826087,128.782608695652,253,18.6926152543094,17.3094877104158,0.377506977156283,0.961977186311787,0.739766081871345,0.0960977848514546,51152.4664031621,35641.023715415,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_223623,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
223986,1248.40069686411,187.108013937282,202.547038327526,726.965156794425,5240.07665505226,1256.63763066202,454.878048780488,246.12543554007,1086.06968641115,2313.33797909408,678.411149825784,141.034843205575,1073.87456445993,2976.38675958188,564.912891986063,396.177700348432,1634.12543554007,3628.98606271777,427.219512195122,239.090592334495,1118.12195121951,2274.69337979094,211.81881533101,196.735191637631,695.8606271777,1112.32055749129,477.665505226481,254.505226480836,1055.35191637631,131.724738675958,287,21.3156091764626,17.1760764860598,0.592190416357777,0.953488372093023,0.755263157894737,-0.646619918189196,50525.4634146341,33763.6794425087,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_223986,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
224012,2267.66666666667,160.75,102.133333333333,661.283333333333,2701.70833333333,1927.85833333333,371.333333333333,264.691666666667,1091.075,3959.45,573.65,113.8,1074.33333333333,1344.04166666667,1210.06666666667,1621.10833333333,1760.225,1173.925,279.775,221.6,1021.29166666667,1008.81666666667,205.266666666667,318.466666666667,769.216666666667,1665.35,476.691666666667,217.066666666667,1088.275,131.433333333333,120,14.849311685597,10.3138605886337,0.719426807508137,0.930232558139535,0.714285714285714,-0.497267285387263,50189.0583333333,35317.4083333333,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_224012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
224186,3487.2037037037,435.601851851852,81.4953703703704,627.638888888889,1308.64351851852,2824.84259259259,674.060185185185,269.981481481481,1097.21296296296,6217.40740740741,512.736111111111,111.101851851852,1087.81018518519,1515.86111111111,1095.78240740741,1590.15740740741,1768.97222222222,4203.73148148148,377.680555555556,248.953703703704,1028.85648148148,4381.16203703704,351.148148148148,358.194444444444,840.305555555556,2620.96296296296,496.75462962963,246.550925925926,1058.28240740741,129.930555555556,216,20.0688451007968,13.7318915129433,0.729257601434402,0.96,0.705882352941177,-0.824210638150025,50984.6064814815,35563.3240740741,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_224186,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
224938,3538.825,1271.94285714286,281.2,676.346428571429,3362.72857142857,4008.11428571429,2098.325,283.646428571429,1173.36071428571,6978.70357142857,1868.02857142857,125.228571428571,1091.11785714286,1208.11071428571,684.907142857143,700.317857142857,1579.93214285714,3095.78928571429,382.078571428571,238.589285714286,1026.03928571429,3190.85714285714,248.032142857143,1572.83928571429,602.35,3226.34285714286,577.946428571429,597.157142857143,1081.41071428571,132.5,280,20.0982332795167,17.7637500252761,0.467777338496617,0.962199312714777,0.736842105263158,0.969273853653987,51881.5928571429,34993.7428571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_224938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
225836,4848.18727915194,718.791519434629,92.8197879858657,635.091872791519,1900.6890459364,5166.88339222615,825.501766784452,284.636042402827,1167.074204947,7569.75265017668,2777.36749116608,128.69964664311,1082.23674911661,2152.34275618375,781.413427561837,340.109540636042,1730.62897526502,2031.70318021201,346.614840989399,244.971731448763,998.780918727915,1221.71024734982,255.321554770318,134.713780918728,589.978798586572,2762.10600706714,648.385159010601,604.102473498233,1094.70671378092,133.717314487633,283,20.0598954411131,18.013581859107,0.440016234375281,0.969178082191781,0.78393351800554,0.663753386755948,51669.6713780919,34868.9540636042,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_225836,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
226202,2493.74579831933,404.808823529412,173.831932773109,697.03781512605,4327.43067226891,2900.52731092437,4018.60504201681,280.502100840336,1114.21218487395,4096.44117647059,1393.10924369748,120.525210084034,1074.88865546218,709.71218487395,725.117647058824,303.605042016807,1663.50210084034,1131.85714285714,318.275210084034,234.144957983193,996.661764705882,1124.82142857143,223.350840336134,281.65756302521,600.873949579832,1122.43277310924,448.09243697479,388.928571428571,1047.66806722689,130.495798319328,476,27.6471565144977,22.1081984522155,0.600459170282279,0.963562753036437,0.705185185185185,-0.624309983626575,50626.3508403361,35363.3025210084,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_226202,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
227117,758.748387096774,268.662903225806,163.135483870968,668.143548387097,4527.00806451613,947.856451612903,325.788709677419,259.403225806452,1099.02096774194,1350.50161290323,498.516129032258,114.212903225806,1066.76935483871,696.204838709677,805.625806451613,308.296774193548,1500.84516129032,1042.53548387097,290.803225806452,233.175806451613,1000.9064516129,927.91935483871,201.487096774194,181.1,697.646774193548,964.662903225806,506.11935483871,232.190322580645,1023.4564516129,129.477419354839,620,32.6643446835673,24.2658799078921,0.669418100832252,0.970266040688576,0.775,0.376846341405601,51237.0967741935,34901.5919354839,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_227117,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
227627,2875.67615658363,231.85409252669,145.106761565836,660.70462633452,3357.66548042705,2693.128113879,377.007117437722,275.516014234875,1109.56939501779,5621.27402135231,595.480427046263,124.256227758007,1087.87900355872,2388.67615658363,1377.6512455516,2225.95017793594,2191.37722419929,3592.78291814947,389.672597864769,248.348754448398,1057.98576512456,3237.38078291815,283.416370106762,365.384341637011,717.302491103203,1739.59786476868,459.975088967972,262.928825622776,1064.91103202847,130.448398576512,281,24.5742567016517,14.6030321371561,0.804286996635591,0.962328767123288,0.836309523809524,-1.48848813252542,51820.3451957295,35451.743772242,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_227627,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
228136,2649.55021834061,341.489082969432,116.318777292576,624.947598253275,1383.02183406114,2600.3056768559,422.711790393013,280.650655021834,1120.21397379913,5353.78602620087,648.135371179039,121.912663755459,1072.05240174672,1425.07423580786,824.03056768559,346.576419213974,1778.06550218341,3237.89956331878,349.729257641921,238.628820960699,1029.93886462882,4898.36244541485,263.502183406114,266.724890829694,900.92576419214,1624.8384279476,470.410480349345,248.414847161572,1065.70305676856,128.951965065502,229,23.5578322964181,12.4645233943059,0.848557512081647,0.96218487394958,0.765886287625418,-1.38188126511569,51535.8733624454,35617.7947598253,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_228136,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
230190,1936.138424821,122.634844868735,84.3842482100239,652.971360381862,2814.48687350835,1951.70405727924,320.797136038186,264.214797136038,1099.77326968974,3899.3937947494,571.510739856802,117.894988066826,1077.52983293556,784.341288782816,442.639618138425,267.124105011933,1835.40572792363,1198.91646778043,270.947494033413,230.751789976134,1044.21718377088,985.985680190931,212.136038186158,139.868735083532,598.91169451074,1530.50119331742,442.964200477327,223.754176610979,1061.00715990453,130.758949880668,419,28.6321430814137,18.7563127619153,0.755560478229192,0.961009174311927,0.70066889632107,0.629797261636941,50102.4653937948,35401.0023866348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_230190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
230570,5251.76129032258,1811.38064516129,150.229032258065,654.983870967742,2218.34516129032,4883.07741935484,570.235483870968,279.345161290323,1282.68064516129,8041.56774193548,655.409677419355,120.361290322581,1097.67096774194,1374.30322580645,1137.54838709677,1683.3064516129,1715.42903225806,1613.46451612903,292.206451612903,224.754838709677,1002.26451612903,1461.51612903226,227.245161290323,371.722580645161,661.648387096774,2159.04516129032,573.387096774194,313.88064516129,1082.40967741935,132.445161290323,310,22.4017441389212,17.6836093180815,0.613897973002153,0.959752321981424,0.776942355889724,-1.07960895172644,51334.0193548387,35684.0064516129,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_230570,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
231207,2606.43369175627,133.089605734767,76.5340501792115,627.376344086022,1590.05376344086,2782.12186379928,457.867383512545,259.351254480287,1130.41577060932,3228.82795698925,447.491039426523,118.26523297491,1074.78494623656,1026.93906810036,736.215053763441,512.899641577061,2075.74551971326,1619.27240143369,341.168458781362,243.437275985663,1162.05017921147,1941.53046594982,271.749103942652,246.516129032258,623.075268817204,765.695340501792,368.967741935484,213.670250896057,1000.49462365591,128.881720430108,279,20.3593731621449,17.5019636014634,0.510881076081223,0.96875,0.815789473684211,-0.44123964842943,50948.5304659498,35798.2329749104,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_231207,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
231365,1361.21673003802,135.600760456274,65.9543726235741,623.121673003802,648.657794676806,836.041825095057,459.731939163498,250.448669201521,1099.10836501901,1621.96958174905,807.614068441065,110.899239543726,1064.71863117871,1060.24524714829,465.178707224335,317.61216730038,1887.09885931559,1384.82509505703,265.745247148289,240.973384030418,1011.99809885932,1352.71292775665,213.108365019011,391.406844106464,1067.33650190114,646.840304182509,382.114068441065,206.716730038023,992.448669201521,128.309885931559,526,28.3951390047997,23.5916504361061,0.55652013321921,0.968692449355433,0.782738095238095,1.28472711472609,52101.4657794677,34763.3574144487,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_231365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
231407,2231.67518248175,360.350364963504,108.124087591241,640.912408759124,1108.68613138686,2457.23722627737,2285.51824817518,265.868613138686,1099.03284671533,3526.2299270073,1339.80656934307,110.343065693431,1076.69343065693,1327.87591240876,1076.39781021898,593.025547445255,1634.59489051095,1362.60948905109,344.032846715328,632.054744525547,1007.31751824818,1032.66423357664,261.222627737226,238.810218978102,582.580291970803,1086.44525547445,453.638686131387,249.773722627737,1040.21897810219,130.518248175182,274,20.9644486454536,16.7199820436557,0.603266340661323,0.951388888888889,0.76750700280112,-1.54577145145419,49971.7810218978,35137.2080291971,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_231407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232368,4629.1052631579,1183.72807017544,399.004385964912,633.368421052632,1334.90789473684,4722.06140350877,474.017543859649,279.320175438596,1137.74122807018,7830.52631578947,607.372807017544,125.671052631579,1091.14912280702,1159.37280701754,642.885964912281,446.855263157895,5905.44736842105,1956.74561403509,344.973684210526,238.355263157895,1032.84210526316,1571.02631578947,243.504385964912,220.605263157895,590.934210526316,2252.73684210526,543.868421052632,250.320175438596,1064.60964912281,132.964912280702,228,18.0590928455438,16.1503012713281,0.447461851234422,0.966101694915254,0.788927335640138,-0.803509154059198,50604.9868421053,35524.6842105263,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232368,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232485,1925.25,187.302631578947,86.7894736842105,634.473684210526,1283.60526315789,2197.56578947368,2187.90131578947,261.434210526316,1091.08552631579,4067.94736842105,1118.07236842105,112.743421052632,1093.53947368421,956.16447368421,539.828947368421,290.078947368421,1833.17105263158,1473.19078947368,341.368421052632,242.730263157895,1018.68421052632,1274.77631578947,244.526315789474,213.085526315789,685.532894736842,1535.11184210526,433.723684210526,250.361842105263,1029.57236842105,131.111842105263,152,16.0720080216528,12.1153609477518,0.657083840052471,0.95,0.723809523809524,1.03474246867462,51032.3289473684,35528.8552631579,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232485,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232625,1289.70088300221,143.967991169978,90.9889624724062,630.835540838852,1993.47571743929,666.509933774834,528.496688741722,258.530905077263,1085.23951434879,796.083885209713,638.777041942605,98.8896247240618,1063.3940397351,2629.36644591611,965.075055187638,952.412803532009,1867.83885209713,2568.85209713024,327.111479028698,233.409492273731,1035.41059602649,2282.09823399558,228.988962472406,345.366445916115,685.804635761589,592.930463576159,384.692052980132,201.965783664459,988.76710816777,128.916114790287,906,37.3986170796926,30.9196570849481,0.562555725765549,0.977346278317152,0.807486631016043,-0.796157147689971,50490.9602649007,35172.9139072848,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232625,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232774,4789.45428571429,271.771428571429,137.291428571429,637.365714285714,1756.39714285714,5199.88285714286,401.391428571429,311.008571428571,1091.37142857143,7682.49714285714,608.368571428571,125.005714285714,1084.94857142857,1893.36,736.794285714286,728.825714285714,1638.63428571429,5129.39428571429,356.617142857143,239.511428571428,1009.08571428571,5665.63714285714,269.357142857143,387.814285714286,1118.07428571429,2934.57142857143,507.44,398.748571428571,1047.50857142857,128.294285714286,350,23.5036008087105,18.9900360029182,0.58923344531547,0.966850828729282,0.80091533180778,1.40975350905502,50722.8171428571,35635.1257142857,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_232774,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232847,3347.80191693291,756.805111821086,125.916932907348,647.97124600639,2305.70607028754,4018.9552715655,1136.81150159744,272.14696485623,1128.77635782748,5865.28115015974,1564.67731629393,118.341853035144,1078.02555910543,2381.77955271565,1167.87220447284,1398.75399361022,2308.32268370607,3242.52396166134,401.808306709265,245.993610223642,1061.02236421725,2722.303514377,296.894568690096,1128.85623003195,770.702875399361,1617.42811501597,483.638977635783,438.134185303514,1057.66773162939,130.977635782748,313,22.779912606058,17.6295648330674,0.63329759866592,0.948484848484848,0.756038647342995,-0.233583395539828,50680.5143769968,35330.8434504792,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232847,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232976,2603.53271028037,265.698598130841,138.560747663551,659.932242990654,3343.45327102804,2699.71962616822,347.778037383178,265.773364485981,1087.18224299065,4628.6285046729,512.778037383178,114.376168224299,1073.54205607477,615.679906542056,450.203271028037,265.301401869159,1625.80140186916,1095.17289719626,280.481308411215,227.371495327103,1007.31308411215,884.235981308411,206.345794392523,138.18691588785,582.042056074766,1778.71495327103,507.147196261682,232.007009345794,1027.06542056075,128.81308411215,428,29.8109151501125,18.5084476697531,0.783920323697886,0.959641255605381,0.6848,0.745859043645097,52017.5046728972,34905.4322429907,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
232996,1633.85869565217,166.699275362319,67.8007246376812,613.278985507246,1416.90217391304,1941.8152173913,620.684782608696,260.217391304348,1084.33695652174,3758.36594202899,753.036231884058,106.858695652174,1063.51811594203,1021.03623188406,509.695652173913,466.54347826087,1860.86956521739,1480.73913043478,314.057971014493,674.471014492754,1027.1847826087,1233.27173913043,223.586956521739,168.815217391304,631.126811594203,2450.5652173913,488.224637681159,366.692028985507,1041.99275362319,127.565217391304,276,28.0424918055112,12.726002770373,0.891097751860333,0.932432432432432,0.681481481481481,1.32727308157928,51443.8079710145,35271.0869565217,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232996,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
233015,1875.50759878419,451.048632218845,465.823708206687,623.316109422492,764.066869300912,1653.55319148936,356.255319148936,266.106382978723,1096.82370820669,2349.98480243161,609.19452887538,107.376899696049,1084.39513677812,1177.97568389058,521.158054711246,357.77811550152,1573.89361702128,1279.05775075988,294.197568389058,231.428571428571,996.747720364742,1326.70516717325,237.240121580547,154.425531914894,590.26443768997,1081.65349544073,481.711246200608,236.410334346505,1089.80243161094,133.386018237082,329,25.8723112491415,16.7233687373422,0.763014866692006,0.948126801152738,0.652777777777778,0.868369284906092,51872.3343465046,35091.1398176292,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
233400,3532.39252336449,515.274143302181,164.585669781931,654.411214953271,2633.39875389408,3609.4953271028,1920.55451713396,279.785046728972,1097.56386292835,5901.77881619938,1148.10591900312,122.065420560748,1080.9968847352,737.95015576324,421.750778816199,276.965732087227,1527.97196261682,968.177570093458,213.732087227414,215.448598130841,1259.69158878505,697.984423676013,165.785046728972,169.018691588785,593.408099688473,2063.71339563863,509.183800623053,541.426791277259,1096.96261682243,131.190031152648,321,23.671800136459,17.347022703835,0.680429187528109,0.949704142011834,0.694805194805195,0.623972678583845,50724.8878504673,35566.3333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_233400,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
233434,2095.0330672748,882.091220068415,297.11858608894,767.737742303307,7747.47776510832,2293.32497149373,3298.46294184721,281.498289623717,1114.26681870011,2940.6488027366,4617.96579247434,136.798175598632,1074.70011402509,812.099201824401,621.645381984036,355.517673888255,1553.20296465222,1151.04561003421,359.246294184721,244.076396807298,998.599771949829,1040.11288483466,228.847206385405,155.830102622577,623.941847206385,982.743443557583,485.366020524515,353.083238312429,1067.43671607754,133.047890535918,877,38.9990914419187,28.8265674802175,0.673529903130411,0.966923925027563,0.769298245614035,-1.3748539259104,50678.1288483466,33883.2212086659,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233434,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
233901,2253.83861236802,151.088989441931,89.604826546003,748.532428355958,1963.44645550528,2176.57466063348,1034.76621417798,264.30467571644,1154.17797888386,3891.79034690799,2558.91553544495,108.912518853695,1096.11764705882,3437.18099547511,686.731523378582,357.995475113122,1780.73906485671,2763.41176470588,333.476621417798,234.067873303167,996.120663650076,2337.60030165913,238.41628959276,170.306184012066,588.340874811463,1353.76470588235,459.437405731523,428.481146304676,1053.16138763198,130.600301659125,663,41.0357314639334,21.1761795296787,0.856563007951868,0.947142857142857,0.753409090909091,-1.44244016580694,51270.532428356,35537.4600301659,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233901,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
233962,2753.54826254826,1251.2972972973,121.11583011583,637.401544401544,2007.85328185328,2565.25096525096,410.799227799228,260.467181467181,1170.78764478764,4350.85328185328,600.548262548263,114.96138996139,1076.22393822394,1257.42084942085,660.169884169884,300.42471042471,1828.96138996139,2062.02316602317,349.227799227799,239.65250965251,1003.13513513514,1124.45945945946,235.092664092664,144.745173745174,589.791505791506,1397.37451737452,554.455598455598,291.030888030888,1053.17760617761,131.247104247104,259,18.9750289506957,17.4781270747823,0.389297653816335,0.952205882352941,0.757309941520468,0.896461258406476,51697.277992278,34892.6138996139,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233962,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
234922,1599.54441260745,264.54441260745,74.5988538681948,638.587392550143,1053.40974212034,2045.5787965616,701.730659025788,256.246418338109,1088.85386819484,3966.88252148997,1785.24928366762,113.10888252149,1068.31232091691,699.661891117478,703.78223495702,560.272206303725,1576.54441260745,884.467048710602,221.661891117478,220.727793696275,1017.71919770774,746.925501432665,162.36676217765,166.759312320917,619.873925501433,2178.96561604585,507.641833810888,477.32664756447,1063.0659025788,132.787965616046,349,24.4931629669266,18.1725308618688,0.670462960706636,0.961432506887052,0.734736842105263,0.112639527160374,50648.3180515759,34459.6848137536,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_234922,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
235778,1206.97494305239,87.1640091116173,61.8564920273349,621.01138952164,1275.93621867882,1431.57403189066,304.917995444191,262.097949886105,1081.37813211845,2748.64464692483,460.175398633257,107.715261958998,1066.10706150342,3453.68564920273,794.815489749431,370.439635535308,9555.6993166287,5914.20273348519,454.312072892938,243.038724373576,1103.99316628702,5143.78587699317,252.785876993166,319.564920273348,665.132118451025,1567.67653758542,449.284738041002,230.177676537585,1046.73348519362,129.453302961276,439,28.0140960462331,20.2068033139702,0.692614008986647,0.964835164835165,0.731666666666667,-0.711831620906096,50823.6264236902,35405.1343963554,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_235778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
235903,4361.13194444444,493.652777777778,129.006944444444,644.46875,1814.24652777778,4400.52777777778,736.8125,289.847222222222,1120.30208333333,6368.09375,730.420138888889,122.916666666667,1090.84027777778,1099.92013888889,515.506944444444,283.298611111111,1464.23958333333,1225.25694444444,315.708333333333,236.534722222222,984.28125,1160.46875,245.489583333333,150.270833333333,615.708333333333,1822.34375,558.472222222222,406.184027777778,1049.43402777778,130.753472222222,288,21.6070355067056,17.0148588732367,0.616354956148429,0.95049504950495,0.761904761904762,0.243931846444396,51180.5486111111,35418.1631944444,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_235903,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
235934,2829.81002638522,294.931398416887,142.197889182058,660.414248021108,2723.30870712401,2786.92612137203,511.311345646438,266.862796833773,1107.01583113456,4755.75461741425,978.548812664908,127.675461741425,1085.52242744063,618.171503957784,410.852242744063,265.324538258575,1423.37203166227,993.121372031662,282.551451187335,225.78364116095,991.981530343008,926.277044854881,199.4327176781,122.02110817942,581.865435356201,1469.38258575198,533.467018469657,295.765171503958,1090.36411609499,132.248021108179,379,26.9731564399613,17.9947257850272,0.744937200553485,0.959493670886076,0.721904761904762,0.489462237016895,50409.0686015831,33983.9841688654,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_235934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236425,1661.95708154506,270.828326180258,94.1888412017167,613.987124463519,553.549356223176,1844.97854077253,1435.63090128755,262.115879828326,1087.39055793991,3347.21030042918,903.068669527897,107.25321888412,1069.03433476395,581.304721030043,495.064377682403,445.115879828326,1522.5321888412,909.768240343348,213.527896995708,216.811158798283,1013.21888412017,732.785407725322,163.364806866953,155.412017167382,611.068669527897,1582.29184549356,492.751072961373,235.214592274678,1020.14592274678,130.287553648069,233,22.1283034377188,13.4715156364477,0.793330521930094,0.94331983805668,0.756493506493506,-0.209912751831021,50409.8111587983,35095.7811158798,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_236425,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236520,2451.85365853659,195.271341463415,95.75,630.710365853659,1411.5762195122,2507.2256097561,1464.1493902439,260.045731707317,1235.91158536585,4883.95426829268,507.420731707317,111.719512195122,1069.99695121951,1051.44817073171,546.332317073171,326.371951219512,1659.84146341463,1609.61585365854,344.77743902439,236.795731707317,999.954268292683,1242.25609756098,220.189024390244,146.618902439024,579.109756097561,1932.25,488.496951219512,464.161585365854,1032.59756097561,130.301829268293,328,22.6940627416868,18.518059851578,0.578070271719464,0.961876832844575,0.784688995215311,-0.359139257655757,51807.1859756098,35080.3262195122,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_236520,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236533,2319.05787781351,521.530546623794,87.3987138263666,617.807073954984,1246.28938906752,2252.61093247588,442.003215434084,270.43729903537,1109.18971061093,3333.57234726688,508.08038585209,112.263665594855,1081.69774919614,845.443729903537,548.057877813505,606.266881028939,1555.10932475884,2055.15112540193,326.411575562701,233.215434083601,1020.3922829582,2801.15434083601,476.913183279743,398.038585209003,611.408360128617,931.472668810289,446.456591639871,265.819935691318,1013.87459807074,129.707395498392,311,21.4973715555172,18.7670541652781,0.487732796228328,0.959876543209877,0.744019138755981,-0.101005811332177,51415.4180064309,35636.8874598071,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_236533,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236586,1975.59595959596,263.838383838384,130.454545454545,651.065656565657,2016.14141414141,2112.70707070707,308.540404040404,254.217171717172,1095.25757575758,3443.0101010101,618.242424242424,122.590909090909,1066.01515151515,727.555555555556,464.863636363636,270.848484848485,1420.05555555556,1126.43939393939,301.944444444444,231.515151515152,982.186868686869,1006.27272727273,240.540404040404,134.878787878788,585.515151515152,961.919191919192,432.626262626263,208.20202020202,1038.0,128.489898989899,198,19.4034980240281,13.0077060962057,0.742018469722421,0.951923076923077,0.733333333333333,1.13532288084406,50036.6565656566,34722.7373737374,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_236586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236632,1453.93223140496,295.342148760331,203.55867768595,701.988429752066,5586.62809917355,1661.16363636364,542.528925619835,259.262809917355,1096.33223140496,2225.88429752066,651.81652892562,115.56694214876,1075.42148760331,542.353719008264,537.760330578512,275.985123966942,1457.00826446281,878.280991735537,259.738842975207,230.730578512397,994.479338842975,840.274380165289,214.115702479339,134.090909090909,594.127272727273,997.629752066116,481.623140495868,243.006611570248,1037.94049586777,131.19173553719,605,40.2429055131295,19.6592467717524,0.872555722259384,0.940902021772939,0.663377192982456,0.373502660404405,51479.505785124,34766.320661157,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_236632,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
236995,2846.13225806452,1063.0064516129,153.361290322581,676.612903225806,3108.74516129032,3249.08709677419,3491.97419354839,270.51935483871,1202.18387096774,6022.63870967742,2605.88387096774,121.854838709677,1069.43225806452,732.248387096774,594.064516129032,294.790322580645,1927.41290322581,976.08064516129,254.341935483871,218.645161290323,1000.92258064516,878.525806451613,243.270967741935,169.68064516129,594.509677419355,2535.46451612903,486.174193548387,376.922580645161,1065.91612903226,132.806451612903,310,22.8115579561024,17.3247353587031,0.650540206215653,0.971786833855799,0.776942355889724,-0.636282989401426,50189.1516129032,35192.1322580645,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_236995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237035,4561.52961672474,1528.29965156794,132.306620209059,649.745644599303,1699.35888501742,4515.39024390244,537.344947735192,280.501742160279,1232.5818815331,8153.87804878049,654.466898954704,126.80487804878,1079.32404181185,755.05574912892,591.693379790941,283.627177700348,1783.96167247387,1389.8606271777,324.05574912892,236.156794425087,1044.49477351916,1200.87456445993,239.602787456446,230.933797909408,2938.42160278746,3399.98257839721,550.94425087108,271.923344947735,1071.54006968641,132.09756097561,287,21.3965553000547,17.1542764239894,0.597685366493662,0.953488372093023,0.759259259259259,1.29379940146059,50818.8397212544,35546.1881533101,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237203,2321.69064748201,856.838129496403,826.913669064748,663.402877697842,1734.80575539568,2518.0071942446,1658.03237410072,259.197841726619,1199.68705035971,3351.36690647482,471.197841726619,107.13309352518,1072.03597122302,1018.52158273381,559.985611510791,282.841726618705,1932.1654676259,1474.42805755396,317.025179856115,238.791366906475,1031.03956834532,1189.78417266187,221.805755395683,159.967625899281,1529.98201438849,927.636690647482,458.212230215827,960.705035971223,1025.9964028777,129.55035971223,278,21.1626120341582,16.7374117918811,0.611951403233476,0.961937716262976,0.735449735449735,-1.09202987964164,51267.2158273381,35277.2086330935,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237235,2786.06198347107,258.768595041322,106.342975206612,637.359504132231,1323.3305785124,2691.09504132231,391.132231404959,278.297520661157,1105.18595041322,4449.03305785124,556.946280991736,121.219008264463,1070.9132231405,530.252066115703,326.644628099174,263.004132231405,1446.03305785124,778.487603305785,201.5,213.657024793388,1032.07438016529,726.384297520661,181.595041322314,201.752066115702,1499.65702479339,1031.40495867769,428.797520661157,258.049586776859,1075.42148760331,129.136363636364,242,31.2022663019445,10.0146958301774,0.947092572151699,0.9453125,0.780645161290323,1.56216006646983,51673.4834710744,35560.0165289256,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_237235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237252,2685.33333333333,229.36231884058,126.760869565217,658.205314009662,2792.83333333333,2973.17149758454,1199.52898550725,250.471014492754,1099.70531400966,4793.73188405797,717.096618357488,120.652173913043,1090.69323671498,589.475845410628,513.164251207729,341.973429951691,1449.04106280193,947.852657004831,265.31884057971,226.454106280193,994.915458937198,904.594202898551,203.673913043478,193.154589371981,608.393719806763,1517.49516908213,533.333333333333,266.113526570048,1069.40338164251,131.93961352657,414,24.9219441738031,21.5248920836123,0.504019399918532,0.953917050691244,0.75,0.761171485246449,51472.2463768116,33847.6086956522,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237283,1457.58865248227,548.867021276596,222.732269503546,701.281914893617,4715.81205673759,1582.99468085106,2623.94858156028,266.725177304965,1098.9609929078,2193.64007092199,4414.84219858156,130.835106382979,1063.15602836879,2576.08333333333,2036.82269503546,1639.72163120567,2193.5780141844,3184.87234042553,448.413120567376,252.576241134752,1070.8085106383,2155.14893617021,236.950354609929,349.166666666667,787.400709219858,1276.50531914894,560.714539007092,421.629432624114,1112.80673758865,133.668439716312,564,28.3694695091417,25.6375252570136,0.428163564565577,0.964102564102564,0.720306513409962,0.275790729884711,50687.0744680851,33967.030141844,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237283,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237303,4222.49,591.29,826.23,672.513333333333,3934.40666666667,4409.96333333333,764.976666666667,277.343333333333,1138.99333333333,7071.59,696.406666666667,146.57,1084.36,3341.44,898.143333333333,450.223333333333,10485.3233333333,3504.97,384.76,241.59,1056.14333333333,3523.84,255.996666666667,231.133333333333,603.053333333333,2214.8,505.436666666667,263.57,1066.45,131.873333333333,300,21.8699053064332,17.5787054794171,0.594919663497176,0.958466453674121,0.75187969924812,-0.675514136988399,50938.4966666667,35836.1533333333,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237303,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237365,3582.91906005222,720.443864229765,652.370757180157,655.924281984334,2587.03916449086,3366.20104438642,1006.1592689295,275.169712793734,1156.95561357702,5791.89817232376,586.895561357702,120.007832898172,1073.80417754569,590.373368146214,354.483028720627,266.955613577023,1717.66318537859,855.451697127937,202.201044386423,214.164490861619,1166.18015665796,751.759791122715,175.997389033943,204.31592689295,593.772845953003,1909.22193211488,551.793733681462,373.22454308094,1059.70234986945,131.279373368146,383,33.647487501672,14.5492764883533,0.901680428681849,0.950372208436724,0.650254668930391,1.16561990365728,51914.4673629243,35411.2062663185,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237570,2863.02395209581,216.236526946108,69.6826347305389,620.850299401198,1398.10479041916,3072.14670658683,333.952095808383,267.053892215569,1083.2005988024,5600.34431137725,504.206586826347,114.90119760479,1082.82934131737,790.77245508982,452.571856287425,280.338323353293,1533.0,1006.40718562874,221.535928143713,217.925149700599,1293.61377245509,729.017964071856,168.314371257485,157.787425149701,589.320359281437,2591.4371257485,466.152694610778,230.667664670659,1048.31137724551,129.122754491018,334,26.0109878967953,16.3940128916605,0.776373913458832,0.968115942028986,0.785882352941176,-1.37523270498774,50714.7155688623,35534.9820359281,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_237570,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
237617,3616.28761061947,1488.41592920354,165.654867256637,646.075221238938,2279.00884955752,4341.97345132743,483.637168141593,264.097345132743,1109.77433628319,5126.16814159292,693.951327433628,121.194690265487,1072.96017699115,879.70796460177,548.615044247788,277.553097345133,1631.36725663717,991.87610619469,239.79203539823,223.057522123894,1249.89380530973,708.889380530973,145.650442477876,125.371681415929,784.862831858407,1214.8185840708,515.061946902655,232.424778761062,1062.16371681416,133.628318584071,226,19.2732584662717,14.9771499982959,0.629383496704198,0.94560669456067,0.743421052631579,-1.28600022496129,51221.0309734513,34069.6327433628,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
238185,2570.866359447,208.235023041475,116.884792626728,635.760368663594,3062.76036866359,3090.89861751152,415.096774193548,271.658986175115,1094.93087557604,4843.01843317972,559.778801843318,115.10599078341,1082.76036866359,3212.47926267281,1261.79723502304,2449.44700460829,2806.65898617512,4505.70967741936,394.456221198157,247.709677419355,1027.22119815668,4133.72811059908,248.188940092166,769.138248847926,800.129032258065,2174.76958525346,524.73732718894,235.267281105991,1053.866359447,129.557603686636,217,19.6250688485918,14.0908260388792,0.696041703651024,0.96875,0.753472222222222,-0.980056481115993,51341.66359447,35144.5391705069,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_238185,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
240466,1810.044397463,167.697674418605,200.194503171247,718.253699788584,5308.09302325581,2051.49260042283,315.655391120507,260.205073995772,1092.911205074,3407.8266384778,575.059196617336,125.883720930233,1070.76532769556,637.213530655391,374.985200845666,278.488372093023,1430.54968287526,928.164904862579,200.353065539112,212.951374207188,1222.33615221987,646.972515856237,153.541226215645,119.771670190275,593.194503171247,1055.06131078224,430.556025369979,219.818181818182,1047.03594080338,130.6088794926,473,28.198053633523,21.4146305517657,0.65058145926238,0.953629032258064,0.767857142857143,1.35126551867436,50149.5095137421,35028.8604651163,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_240466,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
240636,4200.09293680297,903.312267657993,250.617100371747,653.951672862454,1970.69888475836,4946.76951672862,645.639405204461,274.7843866171,1209.47955390335,7245.48698884758,1055.61338289963,120.174721189591,1078.49814126394,1338.50185873606,1425.17100371747,581.275092936803,3190.61338289963,1137.42750929368,295.182156133829,231.687732342007,994.204460966543,989.657992565056,208.936802973978,139.148698884758,613.64312267658,2430.94423791822,603.814126394052,315.226765799256,1062.84758364312,128.918215613383,269,27.8394736154114,12.3633079358441,0.895980827970991,0.937282229965157,0.68974358974359,-1.25870019380221,51420.219330855,35030.1486988848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_240636,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
240791,4803.73841059603,516.26821192053,174.473509933775,667.387417218543,2820.11589403973,5576.29470198676,2622.84768211921,273.788079470199,1161.28476821192,8030.05298013245,1194.45033112583,131.155629139073,1095.49337748344,823.420529801325,445.390728476821,278.099337748344,1477.72847682119,2290.16225165563,354.476821192053,239.430463576159,1041.93377483444,2498.38079470199,226.701986754967,455.688741721854,774.291390728477,2203.61258278146,572.311258278146,274.980132450331,1082.41390728477,133.433774834437,302,20.9981927242974,18.3440572434099,0.4866415908318,0.974193548387097,0.798941798941799,-0.178596923938645,51182.8344370861,34143.1887417219,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_240791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
241025,4281.1935483871,743.83064516129,87.9596774193548,659.766129032258,2791.90725806452,3931.11290322581,554.072580645161,271.907258064516,1236.43548387097,7238.71774193548,1531.02016129032,128.616935483871,1095.14516129032,906.407258064516,633.149193548387,1049.14516129032,1654.66129032258,2048.23387096774,328.766129032258,234.66935483871,1041.03629032258,2128.25,288.520161290323,860.693548387097,617.411290322581,2927.54435483871,532.991935483871,321.947580645161,1081.16532258065,130.866935483871,248,19.0934061308956,16.7976684519493,0.475412888515055,0.928838951310862,0.688888888888889,-0.545275879413814,51001.6411290323,35773.2096774194,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_241025,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
241702,1555.89347079038,255.917525773196,152.60824742268,655.388316151203,3449.05498281787,1941.87972508591,316.518900343643,255.058419243986,1091.01718213058,3180.45017182131,504.010309278351,110.656357388316,1091.40549828179,701.945017182131,1113.27835051546,338.587628865979,1557.82474226804,1056.12027491409,275.852233676976,229.45704467354,988.092783505155,931.951890034364,188.807560137457,172.048109965636,706.762886597938,1492.83505154639,476.841924398626,227.731958762887,1035.90034364261,129.773195876289,291,22.7087940665167,16.4738813011162,0.688284773154986,0.950980392156863,0.734848484848485,-0.384329191136472,51520.8625429553,34741.8900343643,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_241702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
241729,2801.37404580153,961.870229007634,1210.95419847328,628.24427480916,1276.42748091603,3228.77099236641,475.87786259542,262.740458015267,1205.48854961832,3669.28244274809,500.992366412214,110.839694656489,1075.06106870229,3636.12977099237,1120.54198473282,369.587786259542,1996.45801526718,2792.78625954198,335.007633587786,237.786259541985,1030.48091603053,1866.22900763359,229.091603053435,260.442748091603,708.427480916031,852.12213740458,434.496183206107,253.763358778626,1014.59541984733,131.381679389313,131,14.6338240806528,11.4197664997895,0.625320675969705,0.929078014184397,0.727777777777778,1.47880016028761,51494.4045801527,34976.1374045801,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_241729,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
242370,1254.61980830671,281.156549520767,97.667731629393,631.025559105431,1046.94888178914,1405.05750798722,1694.44728434505,256.268370607029,1086.99361022364,2755.82428115016,2399.17252396166,117.85303514377,1065.90095846645,609.945686900958,627.41214057508,280.274760383387,1831.94568690096,901.32268370607,244.115015974441,219.600638977636,1007.08626198083,835.702875399361,170.683706070288,124.498402555911,596.252396166134,1702.36102236422,515.693290734824,309.329073482428,1068.08945686901,130.974440894569,313,25.8342406535286,15.6566220057175,0.79543302546049,0.951367781155015,0.752403846153846,1.51867881861346,50417.4600638978,33860.3003194888,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
242699,1455.50867052023,520.398843930636,289.225433526012,611.606936416185,760.057803468208,1356.80346820809,409.416184971098,251.982658959538,1090.45086705202,2725.28323699422,494.277456647399,123.653179190751,1079.05202312139,1017.36416184971,547.075144508671,277.138728323699,1904.01156069364,1430.26589595376,318.28901734104,236.653179190751,1027.45664739884,1288.18497109827,236.011560693642,187.479768786127,595.086705202312,1509.60693641618,476.450867052023,269.682080924855,1029.20809248555,130.260115606936,173,15.4688585525483,14.2742568890737,0.385342151318367,0.955801104972376,0.720833333333333,1.15730253013552,50757.5028901734,35831.2832369942,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
242752,2291.54564755839,526.636942675159,848.997876857749,642.607218683652,2654.90658174098,2257.7898089172,3045.47983014862,261.532908704883,1090.61995753715,4391.8195329087,1473.25265392781,111.006369426752,1069.30785562633,1453.91082802548,603.891719745223,283.235668789809,1631.58598726115,1452.63906581741,276.195329087049,231.12101910828,1077.64118895966,1194.88110403397,218.747346072187,522.216560509554,1681.94479830149,1597.87261146497,514.938428874735,303.968152866242,1058.016985138,131.231422505308,471,36.2381319887234,16.6123100414308,0.888735312979729,0.959266802443992,0.726851851851852,-1.38916878349527,51759.5987261147,35124.0445859873,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_242752,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
242866,1255.48632218845,788.650455927052,414.0273556231,795.045592705167,12099.6443768997,1433.64741641337,486.255319148936,288.164133738602,1167.25227963526,2048.89969604863,746.079027355623,133.881458966565,1068.86626139818,1033.71732522796,818.033434650456,287.206686930091,1580.3829787234,1357.06686930091,364.869300911854,245.987841945289,989.589665653495,1215.0273556231,241.693009118541,147.544072948328,599.765957446809,1122.52279635258,543.966565349544,260.790273556231,1047.77203647416,132.030395136778,329,22.4107937118448,18.745158284845,0.548067087449522,0.976261127596439,0.787081339712919,-1.14732693507602,51290.2492401216,34973.4407294833,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242866,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
243066,4108.32394366197,963.426056338028,233.056338028169,654.602112676056,2446.69014084507,4205.87323943662,550.475352112676,270.852112676056,1095.98943661972,6919.02816901408,555.651408450704,123.5,1098.3661971831,657.672535211268,432.105633802817,268.68661971831,1615.53873239437,895.538732394366,226.341549295775,217.218309859155,1002.11971830986,780.345070422535,179.869718309859,189.355633802817,980.165492957746,1456.30633802817,474.246478873239,241.235915492958,1050.43309859155,131.5,284,22.3849450600173,16.2120302859048,0.689549969988941,0.953020134228188,0.759358288770054,-1.25244075111421,51737.014084507,35166.7992957746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_243066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
243447,2681.32714617169,404.280742459397,132.524361948956,655.150812064965,2341.81902552204,2771.25290023202,3622.92575406032,246.863109048724,1085.19721577726,5066.80278422274,2969.81438515081,120.116009280742,1077.88167053364,4329.22041763341,701.206496519722,469.255220417633,1534.16937354988,3964.29234338747,377.440835266821,249.494199535963,1056.75870069606,3798.96983758701,409.596287703016,967.470997679814,1806.55220417633,1583.01392111369,475.389791183295,514.403712296984,1042.87703016241,130.475638051044,431,30.1941779366626,18.3855816117783,0.79323817862772,0.972911963882618,0.798148148148148,1.42067199432856,51530.6055684455,33806.7656612529,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_243447,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
243553,2421.53070175439,251.324561403509,91.2719298245614,610.697368421053,608.223684210526,2716.38596491228,470.565789473684,269.399122807018,1076.14035087719,5629.44736842105,562.956140350877,122.030701754386,1072.4649122807,651.232456140351,419.995614035088,273.315789473684,1483.94736842105,1003.74561403509,279.245614035088,232.017543859649,987.837719298246,980.34649122807,229.171052631579,148.289473684211,582.09649122807,3850.37719298246,604.543859649123,252.236842105263,1041.08771929825,130.026315789474,228,22.5569781317203,12.9292974534774,0.819426737649065,0.938271604938272,0.633333333333333,0.915794762150989,51847.1315789474,35033.201754386,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_243553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
244569,1612.07865168539,147.250936329588,145.288389513109,675.52808988764,4221.7191011236,1894.07865168539,1655.97378277154,268.052434456929,1102.43071161049,3591.10112359551,1692.46816479401,120.329588014981,1075.10112359551,855.430711610487,618.868913857678,286.310861423221,1632.64794007491,1113.89513108614,311.329588014981,234.906367041199,1001.40449438202,1033.49812734082,241.262172284644,164.838951310861,618.385767790262,1983.22471910112,490.550561797753,448.977528089888,1090.47191011236,131.756554307116,267,19.8578634936969,17.1538714703521,0.503778818923465,0.974452554744526,0.824074074074074,-0.710030698191006,50449.2996254682,35526.3071161049,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_244569,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
244904,2996.64824120603,281.743718592965,160.13567839196,654.35175879397,2077.76381909548,3372.29648241206,330.326633165829,260.502512562814,1083.0351758794,5304.21105527638,525.336683417085,115.773869346734,1064.20603015075,761.743718592965,506.231155778895,271.201005025126,1331.97487437186,1093.22110552764,331.844221105528,236.462311557789,983.095477386935,1057.65326633166,238.974874371859,122.72864321608,580.603015075377,1963.48743718593,498.402010050251,219.914572864322,1033.69346733668,129.321608040201,199,20.5380950100984,12.3852635887052,0.797712024904808,0.961352657004831,0.698245614035088,-0.548583491553912,50161.216080402,34480.3366834171,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_244904,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
245244,3736.89235127479,922.498583569405,123.968838526912,667.776203966006,3231.58640226629,3869.75354107649,1706.81019830028,271.725212464589,1351.45042492918,6223.60339943343,1592.98300283286,125.00283286119,1087.46458923513,3497.4447592068,867.643059490085,484.963172804533,6226.70254957507,5842.27195467422,395.951841359773,345.305949008499,3348.94900849858,6906.71954674221,282.524079320113,345.801699716714,665.478753541076,2051.78470254958,484.900849858357,411.045325779037,1066.5552407932,131.674220963173,353,22.4825422761349,20.0450447930967,0.452857996056916,0.972451790633609,0.84047619047619,0.958790798171691,50923.6940509915,35775.5410764873,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_245244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
245306,1570.4170771757,151.371100164204,54.2972085385878,620.407224958949,739.338259441708,1945.55500821018,398.36288998358,265.893267651888,1090.90147783251,3414.12807881773,635.671592775041,111.448275862069,1080.67651888342,716.415435139573,498.03776683087,319.098522167488,1416.98850574713,1089.01477832512,281.684729064039,228.32183908046,1024.33990147783,989.717569786535,222.968801313629,160.891625615764,622.420361247947,1829.81773399015,491.187192118227,219.779967159278,1058.35139573071,134.080459770115,609,38.9905995879792,20.018164971805,0.858143425841248,0.963607594936709,0.634375,0.748704845663718,50070.5500821018,34998.0689655172,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_245306,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
245574,1875.0243902439,252.630081300813,86.6178861788618,630.451219512195,1185.35772357724,2175.59756097561,1217.29268292683,256.817073170732,1083.93089430894,4410.68292682927,882.59756097561,105.890243902439,1065.24796747967,1966.19512195122,554.605691056911,287.987804878049,1477.81300813008,1841.58130081301,358.260162601626,236.894308943089,1031.82113821138,1914.65447154472,230.09756097561,168.313008130081,600.764227642276,2213.08130081301,488.861788617886,280.739837398374,1055.23983739837,136.239837398374,246,18.447425427546,17.0080052504672,0.387257120792436,0.968503937007874,0.803921568627451,0.499906225767214,50563.9756097561,34869.3495934959,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_245574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
245914,3740.14957264957,1213.7735042735,146.311965811966,649.042735042735,2405.19230769231,3865.94444444444,622.995726495726,276.910256410256,1098.19658119658,6772.53846153846,537.735042735043,123.726495726496,1084.9188034188,2877.57692307692,688.923076923077,559.337606837607,1921.21794871795,2405.3547008547,367.833333333333,238.794871794872,1089.99145299145,2033.57692307692,246.064102564103,284.628205128205,663.205128205128,2762.19658119658,564.752136752137,319.700854700855,1087.13247863248,131.65811965812,234,17.8162030019848,16.9245217873548,0.312398610509019,0.959016393442623,0.764705882352941,-1.45810391987036,51171.4957264957,35780.3760683761,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_245914,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
246702,2596.09491525424,308.450847457627,163.718644067797,668.820338983051,3381.95593220339,2039.40338983051,448.033898305085,257.691525423729,1089.17966101695,2379.68813559322,614.413559322034,110.481355932203,1077.19322033898,773.762711864407,702.864406779661,355.46779661017,1680.66440677966,1128.77966101695,329.606779661017,252.237288135593,1004.06779661017,1143.00677966102,244.769491525424,156.654237288136,605.033898305085,815.04406779661,434.033898305085,230.030508474576,1008.84745762712,129.708474576271,295,22.2903403604434,16.9237578345987,0.650808658357341,0.960912052117264,0.788770053475936,0.373773760797396,51969.3186440678,34695.213559322,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_246702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
246780,2035.24060150376,671.588972431078,488.859649122807,634.71679197995,1698.97243107769,1783.99248120301,444.621553884712,265.561403508772,1103.04761904762,2082.34586466165,505.260651629073,115.731829573935,1068.46365914787,1232.87468671679,651.020050125313,1298.10025062657,1827.24561403509,1330.00501253133,300.741854636591,229.390977443609,1030.68170426065,1297.91979949875,344.137844611529,286.922305764411,792.817042606516,754.922305764411,384.323308270677,241.513784461153,998.461152882206,128.085213032581,399,28.201559409491,18.0653552806004,0.767891429510138,0.952267303102625,0.697552447552448,0.480308937974114,51252.6616541353,35789.305764411,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_246780,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
247094,5318.70982142857,212.107142857143,91.7544642857143,643.495535714286,1243.90625,6563.54017857143,357.6875,269.598214285714,1087.64285714286,11660.0133928571,595.366071428571,134.214285714286,1071.71428571429,632.125,461.410714285714,273.549107142857,1366.99553571429,942.8125,305.790178571429,234.65625,982.544642857143,914.191964285714,221.566964285714,123.058035714286,584.46875,6615.49553571429,606.392857142857,308.486607142857,1044.23214285714,130.071428571429,224,17.1133780648943,16.8651318957503,0.169710103342441,0.949152542372881,0.73202614379085,0.724763350102742,50388.4866071429,34286.3705357143,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_247094,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
247482,2874.875,710.919117647059,98.3676470588235,655.816176470588,2860.47058823529,2077.30147058824,515.838235294118,262.147058823529,1228.28676470588,4400.63235294118,524.735294117647,115.463235294118,1077.14705882353,3943.52205882353,1062.41176470588,1213.67647058824,2026.79411764706,2196.14705882353,337.75,227.816176470588,1033.23529411765,1580.88235294118,236.764705882353,702.088235294118,702.779411764706,1375.64705882353,489.713235294118,458.911764705882,1046.79411764706,131.330882352941,136,14.5823159411604,11.8907078748281,0.578870185954068,0.964539007092198,0.80952380952381,0.189718899567064,51342.8897058823,35664.4779411765,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_247482,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
247683,4563.1341991342,798.220779220779,1520.08658008658,631.203463203463,1324.25108225108,4909.32467532467,1174.48484848485,275.974025974026,1096.19480519481,6946.85714285714,706.04329004329,120.108225108225,1066.39393939394,6442.92207792208,832.510822510823,381.272727272727,10396.5800865801,6662.4329004329,446.385281385281,255.341991341991,1047.5974025974,5373.54978354978,910.199134199134,243.744588744589,666.91341991342,2168.17748917749,597.597402597403,302.168831168831,1055.64069264069,128.844155844156,231,18.6079168219106,15.8102101130288,0.527347573522059,0.96652719665272,0.754901960784314,0.597768458598518,51458.6406926407,35103.9004329004,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_247683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
247732,3995.76859504132,426.446280991736,126.0,620.231404958678,399.776859504132,4717.6694214876,601.669421487603,274.148760330579,1083.61157024793,7037.07438016529,651.123966942149,129.280991735537,1070.44628099174,5836.82644628099,625.247933884297,348.867768595041,1732.63636363636,8922.76033057851,424.02479338843,256.619834710744,1027.04132231405,10292.7768595041,281.256198347107,285.280991735537,586.04132231405,2823.72727272727,569.0,226.355371900826,1041.12396694215,129.793388429752,121,13.3945825616189,11.5004366697626,0.512665110845153,0.937984496124031,0.775641025641026,0.580067441092654,50301.5867768595,34460.0495867769,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_247732,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
248407,2481.42741935484,400.172043010753,203.201612903226,680.155913978495,4480.68548387097,2730.48387096774,416.39247311828,252.833333333333,1087.2876344086,3996.29032258064,673.887096774194,123.983870967742,1123.3252688172,3633.92204301075,1209.14784946237,1593.02956989247,2015.00268817204,4742.00537634409,410.25,248.430107526882,1067.45161290323,4708.24193548387,263.481182795699,671.586021505376,917.397849462366,1055.58064516129,478.653225806452,300.077956989247,1032.69623655914,135.034946236559,372,23.7783196184922,20.1770519692107,0.529117977344154,0.966233766233766,0.808695652173913,-0.0368965424969135,50907.4596774194,33789.9220430108,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_248407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
248660,3772.16141732283,219.661417322835,82.1338582677165,610.42125984252,734.208661417323,4453.2125984252,409.570866141732,268.287401574803,1079.03149606299,7977.13385826772,547.763779527559,117.551181102362,1070.27952755906,638.842519685039,428.133858267717,271.649606299213,1386.34251968504,1029.1062992126,313.744094488189,237.606299212598,985.125984251968,969.350393700787,222.023622047244,123.393700787402,587.744094488189,4207.60236220472,573.929133858268,273.133858267717,1037.52362204724,131.783464566929,254,19.2651536164848,16.8241090262403,0.487196752135311,0.984496124031008,0.830065359477124,-1.02687253756252,50557.5905511811,34795.3818897638,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_248660,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
248692,4243.37216828479,1059.60841423948,149.472491909385,692.812297734628,2874.53398058252,4611.28478964401,3455.0355987055,296.174757281553,1143.19417475728,5293.8996763754,1871.22330097087,148.789644012945,1085.68608414239,710.255663430421,473.922330097087,417.265372168285,1521.23300970874,920.330097087379,236.223300970874,219.304207119741,1011.50485436893,891.789644012945,180.003236245955,150.401294498382,587.495145631068,1307.40453074434,523.236245954693,479.349514563107,1079.93203883495,133.443365695793,309,21.3503086831438,18.517717161219,0.497737294245291,0.965625,0.817460317460317,-0.154504712636149,50542.4368932039,35014.6343042071,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_248692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
249818,2455.03664921466,578.82722513089,78.8638743455497,628.13612565445,1225.01570680628,2368.34031413613,1165.79581151832,262.806282722513,1273.43979057592,4666.58638743456,693.722513089005,110.272251308901,1072.46596858639,4045.93193717278,673.795811518325,342.277486910995,1786.02094240838,2975.72251308901,376.795811518325,232.298429319372,1109.43455497382,2532.10471204188,229.816753926702,234.272251308901,1645.96335078534,2214.94764397906,493.078534031414,327.277486910995,1048.37696335079,130.397905759162,191,18.9351311000474,13.0018836869116,0.726984368112621,0.955,0.773279352226721,0.24614220181761,51533.4136125654,35701.3979057592,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249818,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
249963,2668.26785714286,711.825,104.439285714286,635.357142857143,1766.98214285714,2771.91071428571,728.45,266.046428571429,1100.77142857143,3517.55714285714,842.567857142857,112.067857142857,1081.55,5815.16071428571,910.592857142857,536.167857142857,1771.11428571429,4729.59285714286,351.485714285714,244.710714285714,1019.87142857143,3678.72142857143,241.632142857143,293.035714285714,633.253571428571,901.075,442.507142857143,334.203571428571,1044.76071428571,131.042857142857,280,20.4151701628939,17.5296195598753,0.512551393337831,0.949152542372881,0.777777777777778,-0.326246905797243,50870.8142857143,35315.025,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
249966,4881.93,778.293333333333,76.69,642.04,2639.88,5240.16666666667,460.506666666667,266.976666666667,1177.56666666667,8204.92,610.866666666667,128.34,1077.45666666667,1571.27,650.183333333333,416.506666666667,1749.29666666667,1090.32,237.2,221.586666666667,999.873333333333,1169.53666666667,190.123333333333,198.693333333333,644.196666666667,2353.81666666667,574.316666666667,240.433333333333,1093.01333333333,133.59,300,23.9910297604127,16.0116430530166,0.744698316439245,0.958466453674121,0.68649885583524,-0.606997144723132,51919.95,34270.4666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
250858,3728.77911646586,320.112449799197,169.843373493976,686.839357429719,3853.24096385542,3802.99196787149,1186.90361445783,284.903614457831,1125.76706827309,5935.50200803213,3480.36947791165,123.919678714859,1081.94779116466,1672.37751004016,954.558232931727,363.072289156626,1629.58634538153,5060.79116465863,421.473895582329,249.14859437751,1024.24497991968,6215.3734939759,278.44578313253,508.530120481928,649.032128514056,1539.60240963855,511.112449799197,690.506024096386,1093.22891566265,131.321285140562,249,20.6634894171199,15.4348054021396,0.66486868764863,0.97265625,0.83,0.0553367638046295,50726.1004016064,35225.8714859438,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_250858,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
251001,3367.18309859155,195.943661971831,69.2253521126761,609.291079812207,553.539906103286,3338.0985915493,332.671361502347,251.798122065728,1081.40375586854,6294.90610328638,626.079812206573,118.455399061033,1077.76056338028,1337.83098591549,812.769953051643,297.774647887324,1784.37558685446,1895.99061032864,320.220657276995,249.615023474178,1353.9014084507,3521.59154929577,358.990610328639,1381.61502347418,2483.25821596244,1924.78873239437,509.892018779343,226.075117370892,1047.20187793427,128.765258215962,213,20.8271627545544,13.1607161980269,0.775048672654766,0.950892857142857,0.665625,-1.01415438061293,50937.3474178404,33644.7840375587,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_251001,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
252242,1542.53205128205,186.134615384615,89.7115384615385,627.583333333333,1527.02884615385,1692.23397435897,2644.26602564103,255.419871794872,1102.68269230769,2483.47435897436,2204.20192307692,107.166666666667,1073.76282051282,660.891025641026,463.282051282051,283.724358974359,1506.54166666667,970.887820512821,263.676282051282,229.580128205128,990.230769230769,809.836538461538,172.25641025641,141.445512820513,581.602564102564,1011.78525641026,474.346153846154,443.641025641026,1049.32051282051,132.602564102564,312,21.0259113790697,18.9508206057898,0.433178970045362,0.96,0.742857142857143,-1.11229522886786,51583.9391025641,34938.4198717949,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_252242,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
252462,1464.51699029126,127.907766990291,107.915048543689,652.220873786408,3134.91990291262,1583.26213592233,380.070388349515,269.696601941748,1097.59708737864,3225.43932038835,583.026699029126,115.155339805825,1071.40048543689,2451.99757281553,630.839805825243,317.616504854369,1782.46116504854,3543.3640776699,365.26213592233,238.577669902913,1061.40291262136,3176.16262135922,250.900485436893,287.854368932039,994.393203883495,1590.02669902913,452.526699029126,250.242718446602,1043.88834951456,129.097087378641,412,28.8358329482529,18.2837901311165,0.773279817634774,0.962616822429906,0.754578754578755,-0.526884610651702,51726.1601941748,35621.8155339806,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_252462,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
252936,2083.51923076923,196.698717948718,136.224358974359,655.891025641026,2315.83333333333,1871.33333333333,348.602564102564,268.102564102564,1092.42948717949,3997.08333333333,717.038461538462,122.5,1078.83974358974,1047.51923076923,509.371794871795,278.923076923077,2311.02564102564,1761.51923076923,335.01282051282,231.532051282051,1016.34615384615,1476.64743589744,229.897435897436,193.910256410256,615.705128205128,1349.10256410256,436.878205128205,212.608974358974,1050.88461538462,131.102564102564,156,17.24954916331,11.8746215447701,0.725329507043559,0.917647058823529,0.65,-0.597303777945876,50713.7179487179,35710.8461538462,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_252936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
253037,4911.22177419355,677.971774193548,125.995967741935,652.935483870968,2423.64516129032,4140.99596774194,1125.11693548387,273.887096774194,1142.15322580645,8456.98790322581,1277.56451612903,118.459677419355,1079.11290322581,893.383064516129,494.141129032258,296.560483870968,1510.42338709677,1213.75806451613,321.810483870968,236.274193548387,1005.25806451613,1161.37903225806,236.508064516129,177.758064516129,586.524193548387,2783.04435483871,541.959677419355,399.653225806452,1047.78629032258,131.443548387097,248,22.3804497542038,14.2032853521048,0.772816839623586,0.932330827067669,0.718840579710145,-0.096158608711259,51243.3669354839,35500.935483871,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_253037,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
253045,1863.95588235294,396.460084033613,121.042016806723,656.067226890756,2482.80882352941,2130.05462184874,4489.00630252101,265.743697478992,1101.93487394958,2803.50210084034,1507.15546218487,115.628151260504,1065.46218487395,594.159663865546,405.268907563025,264.004201680672,1324.59243697479,983.703781512605,274.762605042017,225.474789915966,1024.25420168067,896.308823529412,203.46218487395,113.800420168067,580.552521008403,1048.73529411765,475.586134453782,613.918067226891,1075.68067226891,131.039915966387,476,27.9030189103651,21.7964230900593,0.624344299793477,0.957746478873239,0.732307692307692,-0.704606181961271,49955.9075630252,34668.3256302521,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_253045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
253075,4259.57608695652,1652.28260869565,131.804347826087,642.152173913043,1910.4347826087,4887.25724637681,550.518115942029,275.134057971014,1194.73550724638,6717.80797101449,579.775362318841,118.659420289855,1080.00724637681,710.170289855072,461.898550724638,275.528985507246,1498.17753623188,1142.47463768116,288.394927536232,231.576086956522,995.731884057971,1138.73913043478,236.278985507246,144.286231884058,581.753623188406,2364.03985507246,600.057971014493,251.822463768116,1061.73913043478,132.597826086957,276,21.2844404010475,16.5606428151218,0.628185829989423,0.945205479452055,0.73015873015873,0.354960382913652,51511.5760869565,35087.2391304348,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_253075,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
253250,2956.28571428571,865.74358974359,78.6153846153846,636.754578754579,1833.94139194139,3769.25274725275,1150.55677655678,280.956043956044,1221.88644688645,5855.11355311355,1095.1978021978,118.479853479853,1081.83516483516,1023.32234432234,1304.71794871795,1720.23443223443,1854.38095238095,1288.37728937729,275.362637362637,230.318681318681,1033.21611721612,1036.28205128205,198.076923076923,1588.23076923077,680.589743589744,2241.8021978022,493.168498168498,289.67032967033,1060.89010989011,131.454212454212,273,21.5907759033377,16.1081167318144,0.665873407908803,0.961267605633803,0.775568181818182,-0.177869157158819,50939.63003663,35487.5531135531,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_253250,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
253761,1836.31818181818,739.95,112.309090909091,644.109090909091,2215.64545454545,2229.7,358.159090909091,255.85,1264.93636363636,4187.06818181818,502.522727272727,115.418181818182,1077.87727272727,644.490909090909,673.136363636364,290.972727272727,1466.26818181818,992.813636363636,314.168181818182,240.15,992.495454545454,940.331818181818,224.145454545455,143.227272727273,591.909090909091,2530.44545454545,580.113636363636,264.036363636364,1062.80454545455,131.681818181818,220,18.3835541285604,15.3018114440761,0.554229120819841,0.956521739130435,0.763888888888889,0.62824284285852,51225.4545454545,34874.5727272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_253761,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
254088,2775.76436781609,503.833333333333,127.787356321839,645.695402298851,2705.10344827586,2888.76436781609,2491.95402298851,271.212643678161,1094.85632183908,4789.29310344828,985.488505747126,115.586206896552,1085.70689655172,1002.2816091954,561.264367816092,277.902298850575,1563.22413793103,1306.70689655172,281.436781609195,233.057471264368,985.597701149425,1345.91954022989,210.448275862069,170.931034482759,586.770114942529,1427.05747126437,468.522988505747,409.64367816092,1062.63218390805,133.0,174,15.1054865057286,14.7248420867262,0.223076609281364,0.961325966850829,0.773333333333333,-0.933047922083879,51639.6034482759,35384.1149425287,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_254088,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
254199,3581.56,863.9,124.537142857143,646.7,1975.55142857143,3932.24,1096.07714285714,267.228571428571,1299.22857142857,6557.04571428571,622.785714285714,116.822857142857,1079.10857142857,929.434285714286,1452.69428571429,871.228571428571,2658.68857142857,1325.56857142857,294.56,234.38,1030.96571428571,1140.43428571429,207.162857142857,198.725714285714,786.897142857143,2068.14571428571,528.502857142857,268.86,1059.37714285714,132.385714285714,350,22.1480837389586,20.243011466249,0.405748468951962,0.958904109589041,0.757575757575758,1.17727212087565,51489.5457142857,34959.2742857143,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_254199,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
254851,2352.685,460.745,187.065,707.62,6231.655,2637.31,1842.86,261.465,1097.28,5403.225,5978.39,124.845,1068.145,1631.14,633.86,287.2,1984.64,1769.625,367.515,243.755,1155.74,1386.7,233.135,622.51,3606.98,2494.465,543.625,590.965,1090.17,132.065,200,18.112775956956,14.0777607286499,0.62921878896951,0.956937799043062,0.735294117647059,-0.833463793873239,51270.93,34085.71,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_254851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
256189,1846.87114845938,102.929971988796,71.0476190476191,623.929971988796,1110.06162464986,1791.44257703081,377.72268907563,257.686274509804,1081.66666666667,3628.12605042017,517.484593837535,109.546218487395,1071.91316526611,1205.23529411765,620.47619047619,419.540616246499,2008.42577030812,1380.63865546218,277.364145658263,230.03081232493,1022.36414565826,1105.0756302521,207.871148459384,187.837535014006,619.422969187675,1295.80952380952,450.831932773109,215.731092436975,1039.42016806723,129.075630252101,357,27.7908680245267,16.4296999311877,0.806531880913047,0.964864864864865,0.722672064777328,1.14100861415314,52023.1456582633,35134.2296918768,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_256189,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
256534,2311.9907727797,1135.10957324106,1385.88235294118,675.595155709343,3942.18800461361,1765.10841983852,466.82583621684,265.133794694348,1126.80161476355,2131.73702422145,700.071510957324,117.340253748558,1068.39215686275,516.055363321799,320.170703575548,253.831603229527,1823.76124567474,753.419838523645,190.316032295271,212.570934256055,989.22952710496,781.630911188005,168.652825836217,142.966551326413,581.837370242215,930.478662053056,465.733564013841,231.318339100346,1011.69204152249,129.312572087659,867,34.4895191840253,32.2957131467991,0.35095561428519,0.973063973063973,0.772727272727273,0.519616617421029,52082.7277970012,34803.6943483276,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_256534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
257196,2398.67731629393,327.642172523962,155.070287539936,650.846645367412,2766.42811501597,3000.23961661342,1296.10223642173,275.600638977636,1091.76677316294,3818.85303514377,1856.31948881789,125.830670926518,1067.29392971246,650.11821086262,501.44089456869,268.012779552716,1466.07987220447,1152.23322683706,318.389776357827,237.402555910543,995.766773162939,1159.70926517572,230.076677316294,200.022364217252,677.444089456869,1627.96485623003,543.517571884984,402.057507987221,1074.32907348243,130.948881789137,313,26.4638833224291,15.1159909685141,0.820815627940476,0.948484848484848,0.695555555555556,0.384670535382677,50977.3162939297,34685.3067092652,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_257196,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
257519,2003.93658536585,893.341463414634,176.024390243902,678.89756097561,3938.7512195122,2195.61463414634,663.224390243902,256.326829268293,1118.54634146341,3437.47317073171,514.712195121951,115.707317073171,1076.66341463415,1678.94634146341,643.239024390244,291.170731707317,1692.30243902439,5187.67804878049,438.341463414634,245.048780487805,1111.34634146341,5266.02926829268,272.517073170732,376.541463414634,2223.25853658537,1281.35609756098,433.99512195122,215.453658536585,1053.14634146341,130.248780487805,205,21.1661623546128,12.3944546606866,0.810615531835609,0.966981132075472,0.732142857142857,-1.13596949653277,50657.0341463415,35697.1463414634,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_257519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
258061,4344.58146964856,363.038338658147,182.194888178914,690.70607028754,3908.25559105431,4148.22364217252,612.261980830671,274.188498402556,1097.61980830671,7125.78274760383,839.332268370607,138.086261980831,1084.69009584665,732.255591054313,586.904153354633,285.722044728435,1545.3642172524,1020.8338658147,293.341853035144,227.961661341853,988.466453674122,970.300319488818,216.952076677316,185.594249201278,582.779552715655,2438.94568690096,498.361022364217,282.210862619808,1069.07028753994,130.974440894569,313,22.5103903696358,17.7628060080365,0.614272918136711,0.963076923076923,0.79040404040404,-0.222864017634464,50543.7603833866,35797.8498402556,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_258061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
258410,4578.06451612903,1678.19713261649,136.078853046595,639.551971326165,1795.70250896057,4494.27598566308,465.845878136201,272.304659498208,1111.71684587814,7487.93906810036,605.168458781362,121.691756272401,1104.01433691756,2016.82078853047,711.698924731183,468.623655913978,2532.04659498208,1346.56630824373,307.143369175627,235.903225806452,1006.77419354839,1292.70250896057,235.605734767025,149.881720430108,621.078853046595,1810.74193548387,531.659498207885,236.652329749104,1052.58422939068,131.272401433692,279,19.3164794801285,18.4279693747711,0.299798705174064,0.97212543554007,0.815789473684211,0.332005243644709,51628.6200716846,35047.1433691756,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_258410,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
258542,2379.91368421053,305.048421052632,96.3010526315789,627.945263157895,1402.69894736842,2484.60631578947,1021.2,265.408421052632,1087.19368421053,4376.8,954.332631578947,113.943157894737,1072.28842105263,909.848421052632,539.541052631579,277.088421052632,1515.14315789474,1624.02315789474,312.101052631579,237.926315789474,986.785263157895,1927.95368421053,248.88,155.823157894737,583.58947368421,1703.96631578947,504.93052631579,359.24,1039.75368421053,128.724210526316,475,37.4178597455741,16.4112716580559,0.898685020887863,0.957661290322581,0.75516693163752,1.42819165485913,51884.6252631579,35043.6210526316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_258542,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
260220,3177.02325581395,591.697674418605,85.5813953488372,638.244186046512,1847.74418604651,3234.6976744186,5350.29651162791,268.96511627907,1096.38372093023,4074.26162790698,2125.43023255814,117.93023255814,1074.87790697674,3933.85465116279,1239.75581395349,500.93023255814,2288.0523255814,3274.27325581395,401.412790697674,244.412790697674,1089.74418604651,2594.02906976744,251.53488372093,320.21511627907,700.06976744186,1135.47093023256,528.744186046512,400.209302325581,1036.75,131.209302325581,172,18.3706795899156,12.0719634370795,0.753775424308445,0.955555555555556,0.674509803921569,0.649428168858099,51948.3372093023,34368.8313953488,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_260220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
260976,1455.90476190476,613.625850340136,187.034013605442,685.727891156463,5601.85034013605,1337.50340136054,679.197278911565,261.231292517007,1124.91156462585,2047.74829931973,498.843537414966,114.21768707483,1067.61904761905,2927.2925170068,782.687074829932,569.69387755102,4008.07482993197,2168.50340136054,350.87074829932,240.843537414966,1025.00680272109,2392.92517006803,304.959183673469,247.367346938776,598.897959183673,915.272108843538,436.08843537415,416.068027210884,1030.9387755102,128.78231292517,147,15.1615898676458,12.4094478422224,0.57453598180942,0.954545454545455,0.753846153846154,-1.08236297481339,51121.2108843537,35726.6734693878,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_260976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261144,3011.15324675325,439.948051948052,1242.97402597403,622.8,1039.12467532468,2971.65454545455,419.412987012987,267.163636363636,1113.13766233766,5501.17662337662,516.27012987013,114.753246753247,1074.57922077922,2981.68051948052,688.090909090909,1004.77922077922,1746.84155844156,6821.11168831169,427.462337662338,251.742857142857,1073.76103896104,7126.69090909091,1022.73246753247,260.797402597403,594.337662337662,2183.90909090909,477.927272727273,298.807792207792,1039.55324675325,128.67012987013,385,25.5964081209222,19.2540857948198,0.658914013082081,0.967336683417086,0.729166666666667,0.997104476362224,51470.3142857143,35764.1558441558,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261144,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261166,2894.56299212598,1093.89763779528,182.102362204724,652.03937007874,1785.48031496063,3025.16929133858,1251.72834645669,275.122047244094,1250.46062992126,4560.12204724409,1454.75984251968,117.393700787402,1099.42519685039,5449.11811023622,994.035433070866,359.07874015748,5306.25196850394,4464.86220472441,379.188976377953,241.334645669291,1037.68897637795,3646.08267716535,243.429133858268,308.208661417323,597.98031496063,1181.48031496063,475.720472440945,650.314960629921,1052.62204724409,130.417322834646,254,19.4065737334503,16.7270023836784,0.507036552468014,0.940740740740741,0.742690058479532,-1.00097377012061,50932.4094488189,35426.1653543307,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261166,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261246,1217.61244019139,365.722488038278,115.842105263158,665.875598086124,4522.48325358852,1406.36842105263,350.736842105263,255.138755980861,1113.6985645933,2992.46889952153,502.157894736842,110.11004784689,1076.64593301435,1622.90909090909,741.172248803828,360.095693779904,1827.35885167464,3204.33971291866,362.200956937799,244.043062200957,1058.04306220096,1335.44976076555,225.224880382775,197.086124401914,758.870813397129,1793.83732057416,495.459330143541,228.937799043062,1043.96172248804,131.650717703349,209,17.3217304095744,15.393243816658,0.458553833121721,0.95,0.725694444444444,-1.24645868366867,51626.3875598086,34893.023923445,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261347,1703.62380952381,341.571428571429,203.590476190476,654.609523809524,2708.29523809524,1685.12857142857,378.295238095238,271.761904761905,1100.49523809524,3881.80476190476,541.5,113.014285714286,1088.50476190476,805.219047619048,543.638095238095,319.866666666667,1512.46666666667,1147.38095238095,286.819047619048,229.17619047619,991.109523809524,1073.60952380952,225.014285714286,164.042857142857,594.995238095238,2426.39047619048,526.647619047619,358.757142857143,1053.09523809524,129.490476190476,210,18.5324899429367,14.4786609799105,0.624207914012313,0.963302752293578,0.777777777777778,1.13105942549589,51283.380952381,35444.1428571429,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261347,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261496,3975.50825082508,442.069306930693,165.415841584158,643.983498349835,2085.9900990099,4324.30363036304,930.557755775578,267.481848184818,1098.97689768977,6760.07590759076,601.214521452145,118.227722772277,1095.44224422442,3600.10231023102,1879.60066006601,3629.49834983498,2822.52805280528,2905.46534653465,393.280528052805,256.158415841584,1056.71947194719,2600.93069306931,275.095709570957,328.924092409241,963.986798679868,1869.60396039604,496.346534653465,263.828382838284,1034.01320132013,137.217821782178,303,24.1157489926069,16.1417153316802,0.74295324821775,0.94392523364486,0.688636363636364,-0.601942014616973,51513.1353135314,34925.8118811881,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261575,3606.64640883978,963.936464088398,190.129834254144,713.165745856354,6067.04143646409,4241.56906077348,1742.36187845304,273.745856353591,1156.70994475138,6869.80110497238,866.046961325967,130.132596685083,1082.44475138122,2138.37569060773,1157.98342541436,708.939226519337,2146.11602209945,3764.33425414365,390.28453038674,241.930939226519,1089.78453038674,4051.02762430939,250.759668508287,285.790055248619,659.256906077348,2209.30939226519,572.953038674033,274.314917127072,1098.27348066298,133.524861878453,362,24.6561273682845,18.7712088195296,0.648376041583516,0.965333333333333,0.749482401656315,0.569883229057372,51954.4419889503,34387.2458563536,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261719,4363.95019157088,728.532567049808,831.973180076628,621.260536398467,1153.23754789272,4056.87739463602,1252.40996168582,274.421455938697,1124.23754789272,7866.83524904215,557.819923371648,118.685823754789,1065.12260536398,1074.51340996169,686.11877394636,318.141762452107,1675.37931034483,1137.05363984674,331.406130268199,231.268199233716,995.329501915709,1063.04214559387,239.632183908046,200.766283524904,586.11877394636,3863.45593869732,580.888888888889,325.099616858238,1069.63601532567,127.045977011494,261,24.2454060474691,13.9367376675872,0.818280075699806,0.938848920863309,0.654135338345865,0.885563358284232,51410.0727969349,35659.5708812261,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_261719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
261986,1340.63803680982,255.374233128834,103.920245398773,618.478527607362,1082.46625766871,1634.76687116564,298.147239263804,250.588957055215,1085.72392638037,2454.01840490798,481.650306748466,111.920245398773,1069.41104294479,613.435582822086,443.030674846626,268.61963190184,1405.85889570552,919.39263803681,283.871165644172,232.588957055215,976.460122699386,870.368098159509,201.398773006135,140.067484662577,585.171779141104,977.981595092025,467.625766871166,213.319018404908,1032.47852760736,132.717791411043,163,18.3676718878325,11.4092155919997,0.783685820731524,0.931428571428571,0.684873949579832,0.486740040671678,50697.5705521472,34411.7668711656,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_261986,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
262218,1534.07994389902,285.566619915849,101.502103786816,641.942496493689,1509.83870967742,1786.04488078541,1837.56241234222,264.099579242637,1096.99158485273,3420.54698457223,3030.73352033661,112.762973352034,1072.65918653576,1794.73492286115,625.099579242637,307.948106591865,2345.24684431978,2563.63394109397,315.545582047686,234.524544179523,1002.70266479663,2435.57363253857,296.0603085554,257.86255259467,696.726507713885,1911.24824684432,529.075736325386,787.859747545582,1055.4824684432,131.443197755961,713,38.9545243693676,23.6141250693089,0.795314346019043,0.970068027210884,0.754497354497354,-0.392473037916486,51826.4474053296,35176.747545582,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_262218,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
262367,4480.53488372093,884.706395348837,104.770348837209,637.645348837209,1459.07558139535,4445.38953488372,788.851744186047,269.360465116279,1217.49709302326,7128.47965116279,610.761627906977,124.441860465116,1080.43604651163,1363.5523255814,909.290697674419,833.845930232558,1785.67441860465,1349.77325581395,326.80523255814,230.15988372093,1005.85755813953,1270.34011627907,236.072674418605,206.947674418605,585.595930232558,2033.31976744186,498.296511627907,273.973837209302,1050.36918604651,130.517441860465,344,22.2299098105222,19.7457777599548,0.459355105525417,0.966292134831461,0.819047619047619,-0.396116344480431,51216.0377906977,35788.0784883721,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_262367,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
263570,3055.24343675418,839.398568019093,102.050119331742,631.114558472554,1674.54415274463,2868.45584725537,633.167064439141,269.140811455847,1116.6276849642,4631.14558472554,565.615751789976,117.045346062053,1085.52983293556,1917.59427207637,693.926014319809,344.565632458234,3811.0477326969,1715.47732696897,312.014319809069,237.868735083532,1003.69928400955,1332.84725536993,224.964200477327,150.09785202864,587.169451073986,1219.19331742243,499.980906921241,280.291169451074,1040.92601431981,130.429594272076,419,25.3061413361039,21.2437472511552,0.54340598736387,0.969907407407407,0.831349206349206,1.2113216635965,51615.369928401,35128.7565632458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_263570,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
263751,3623.54700854701,631.688034188034,205.696581196581,745.811965811966,7605.47863247863,3899.07264957265,808.987179487179,275.273504273504,1180.18376068376,6521.95726495726,778.713675213675,143.316239316239,1110.65384615385,5539.91452991453,993.24358974359,1020.41025641026,2126.26923076923,3731.82478632479,386.128205128205,241.692307692308,1070.06837606838,2849.2094017094,277.807692307692,304.457264957265,628.645299145299,2927.11538461538,537.589743589744,280.65811965812,1082.10683760684,130.299145299145,234,18.9873858006413,15.9021463963369,0.546420309723832,0.947368421052632,0.764705882352941,0.56005366663563,50898.0769230769,35877.1923076923,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_263751,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
263994,2886.61951219512,1305.47804878049,532.926829268293,627.604878048781,1326.95609756098,3423.9756097561,341.941463414634,263.009756097561,1095.02926829268,5278.5512195122,487.40487804878,127.092682926829,1077.11219512195,1079.39024390244,559.936585365854,280.346341463415,3123.82926829268,1223.12195121951,348.965853658537,240.556097560976,986.751219512195,1170.8243902439,247.70243902439,197.6,588.175609756098,2749.17073170732,533.439024390244,259.351219512195,1080.61951219512,131.531707317073,205,16.6782816230463,15.771745308047,0.325198722605509,0.957943925233645,0.753676470588235,-0.40026774333607,50560.7512195122,35805.0341463415,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_263994,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
264379,1380.1568627451,432.150326797386,136.653594771242,635.849673202614,2288.96078431373,1573.22222222222,1268.83006535948,269.882352941176,1092.02614379085,3348.69281045752,2999.51633986928,119.16339869281,1066.85620915033,1083.47058823529,723.130718954248,289.058823529412,1596.56862745098,1243.8954248366,347.477124183007,239.614379084967,1000.99346405229,996.176470588235,228.287581699346,174.385620915033,584.751633986928,2482.81699346405,585.261437908497,623.797385620915,1062.91503267974,128.248366013072,153,15.2777051861363,12.7935624097802,0.546589347670156,0.944444444444444,0.735576923076923,-1.15691730887513,50752.4705882353,35024.7712418301,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264379,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
264839,3483.2447257384,616.097046413502,82.3248945147679,612.004219409283,734.869198312236,4049.98734177215,358.464135021097,277.008438818565,1148.28270042194,7261.63713080169,570.059071729958,115.810126582278,1073.22362869198,1037.98312236287,544.746835443038,281.189873417722,1432.77215189873,1178.99156118143,337.991561181435,243.282700421941,981.911392405063,1117.60337552743,280.683544303797,137.64135021097,585.379746835443,3899.24894514768,583.839662447257,257.852320675105,1058.36708860759,131.915611814346,237,24.3072437446853,12.5520371190615,0.856353045448203,0.94047619047619,0.68695652173913,-0.391645686354403,50997.9789029536,35156.7299578059,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_264839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
264922,1642.00337837838,361.452702702703,97.8547297297297,619.513513513514,1196.14189189189,1994.04391891892,3060.30405405405,263.236486486487,1085.71959459459,2558.15202702703,1153.74662162162,112.699324324324,1056.41216216216,994.827702702703,800.476351351351,311.327702702703,1730.41891891892,1414.93243243243,345.304054054054,239.925675675676,995.983108108108,1279.42905405405,231.952702702703,156.253378378378,632.118243243243,901.320945945946,494.449324324324,307.233108108108,1023.22635135135,131.527027027027,296,22.9159259728003,16.5781799063655,0.690392634791864,0.954838709677419,0.741854636591479,-0.568750782887198,50492.4662162162,34799.4155405405,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_264922,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
266419,1230.42194744977,158.695517774343,81.757341576507,617.519319938176,877.163833075734,1349.26429675425,794.893353941267,263.129829984544,1081.64142194745,2242.81916537867,1151.57959814529,109.924265842349,1067.93663060278,727.68315301391,764.601236476043,975.251931993818,1590.48686244204,1282.78516228748,271.066460587326,228.122102009274,1007.09273570325,1178.31530139104,204.268933539413,376.510046367852,678.593508500773,1176.57032457496,464.032457496136,569.758887171561,1047.5857805255,130.632148377125,647,36.4677932650883,22.9085065301051,0.778064325342217,0.970014992503748,0.803726708074534,-1.39360886016718,50046.7202472952,35175.8531684699,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_266419,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
266767,2501.79705882353,164.555882352941,82.25,624.332352941177,881.685294117647,2362.96470588235,2634.27647058824,260.9,1103.49411764706,3838.28529411765,669.305882352941,108.002941176471,1206.07352941176,3208.2,1036.62647058824,796.020588235294,1814.93529411765,2894.76470588235,367.394117647059,241.632352941176,1043.34411764706,2045.36764705882,255.014705882353,423.788235294118,624.847058823529,1071.44411764706,436.755882352941,321.561764705882,1047.38823529412,131.373529411765,340,21.8588374721804,20.0894973198807,0.394126801074001,0.955056179775281,0.735930735930736,-0.680824032557887,51143.7294117647,35687.1911764706,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
268280,3566.96829268293,660.782926829268,1065.0487804878,630.419512195122,1385.29268292683,4296.54146341463,428.378048780488,273.668292682927,1109.81707317073,5918.52682926829,578.809756097561,117.734146341463,1078.19024390244,2392.07073170732,915.085365853659,622.863414634146,1689.08536585366,3246.27073170732,334.243902439024,240.80243902439,1000.80731707317,3129.37073170732,256.778048780488,161.729268292683,598.887804878049,1467.17317073171,517.963414634146,241.273170731707,1038.24146341463,132.075609756098,410,28.374830206193,18.4500535975822,0.75974080550314,0.951276102088167,0.68561872909699,0.926741759253667,51188.7634146341,35114.9585365854,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
268415,1895.23780487805,494.314024390244,426.350609756098,632.326219512195,1093.07317073171,1914.96951219512,1318.58536585366,261.573170731707,1131.52134146341,2759.21341463415,484.618902439024,109.298780487805,1062.18902439024,1069.64634146341,826.975609756098,2040.01829268293,2287.36280487805,3264.40243902439,342.743902439024,234.631097560976,1067.41463414634,3332.08841463415,237.765243902439,385.993902439024,618.228658536585,901.521341463415,456.615853658537,638.490853658537,1026.21036585366,129.118902439024,328,24.4962963268681,17.0935034814178,0.716293130709374,0.953488372093023,0.759259259259259,0.252414686820751,51504.8048780488,35735.6768292683,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268415,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
268793,2040.50440917108,391.971781305115,248.985890652557,712.832451499118,6110.47971781305,2748.43738977072,367.57848324515,267.059964726631,1101.97883597884,4220.56790123457,654.093474426808,129.253968253968,1086.62433862434,826.530864197531,655.899470899471,283.844797178131,1638.48148148148,1598.00352733686,408.707231040564,250.902998236332,997.938271604938,1457.44973544974,259.347442680776,1186.19400352734,585.763668430335,2032.39682539683,551.816578483245,229.758377425044,1097.00705467372,131.793650793651,567,37.5892188884708,19.390052568847,0.856684465733924,0.959390862944162,0.675,-0.396640436955335,50775.9964726631,34179.3386243386,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268793,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
268932,2054.34444444444,180.616666666667,101.494444444444,646.272222222222,1670.38333333333,2158.46666666667,1181.15,262.177777777778,1074.85555555556,4054.54444444444,862.666666666667,109.288888888889,1070.50555555556,721.061111111111,501.7,416.844444444444,1463.9,1149.77777777778,335.6,239.338888888889,996.411111111111,1089.67777777778,253.333333333333,203.138888888889,593.061111111111,2030.76666666667,461.661111111111,495.477777777778,1053.36111111111,132.105555555556,180,15.4859775732466,14.8374502762323,0.286361514835415,0.967741935483871,0.8,-0.0664134962204556,51104.2722222222,35629.85,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268932,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
269260,3092.83606557377,660.979508196721,806.438524590164,637.049180327869,1341.88524590164,2366.59016393443,1079.42213114754,263.159836065574,1118.85655737705,4228.88524590164,1687.09836065574,110.012295081967,1075.22131147541,835.918032786885,654.049180327869,721.508196721311,1641.98360655738,1233.94262295082,307.254098360656,228.397540983606,1010.73770491803,1166.24590163934,227.72131147541,446.22131147541,679.081967213115,1000.09426229508,433.950819672131,574.840163934426,1033.0737704918,129.217213114754,244,25.1288481181316,12.4376005780336,0.868919706460712,0.934865900383142,0.750769230769231,-1.51028490598345,51317.7991803279,35657.5737704918,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_269260,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
269747,3775.90277777778,945.411111111111,136.563888888889,654.272222222222,2234.04166666667,4330.66666666667,969.716666666667,270.475,1182.79166666667,7308.60555555556,1360.40277777778,120.802777777778,1078.65833333333,836.372222222222,505.333333333333,284.044444444444,1509.40555555556,1248.63611111111,307.758333333333,232.925,995.608333333333,1356.05,232.833333333333,158.691666666667,593.477777777778,3153.83333333333,607.447222222222,472.197222222222,1083.20277777778,132.241666666667,360,25.1199805164473,18.3878022126445,0.681305637042725,0.952380952380952,0.714285714285714,-0.429350225665618,51847.2861111111,35146.8583333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_269747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
269863,2604.2012195122,186.615853658537,57.609756097561,605.067073170732,316.560975609756,2357.43292682927,350.115853658537,242.676829268293,1082.0,4957.0,579.042682926829,113.713414634146,1069.40243902439,1101.87195121951,935.920731707317,291.640243902439,2112.67682926829,1460.51219512195,366.774390243902,245.292682926829,1061.90853658537,1907.34756097561,282.713414634146,201.018292682927,3379.48780487805,2414.7256097561,504.701219512195,223.707317073171,1025.2987804878,128.048780487805,164,20.3321050547486,10.3920430222893,0.859512361545393,0.942528735632184,0.650793650793651,-0.997251442917173,50993.5914634146,33740.4512195122,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_269863,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
270563,4834.89802631579,1170.42434210526,150.486842105263,668.184210526316,2903.67763157895,4787.17434210526,738.427631578947,283.565789473684,1175.08223684211,7701.21052631579,726.200657894737,127.957236842105,1083.76644736842,664.388157894737,556.891447368421,289.470394736842,1442.36184210526,1014.92763157895,309.322368421053,239.865131578947,988.384868421053,918.463815789474,224.661184210526,139.894736842105,581.269736842105,2796.28618421053,643.927631578947,256.378289473684,1075.80263157895,131.950657894737,304,21.4621408248027,18.1285648361058,0.535277219318043,0.947040498442368,0.723809523809524,-0.701436917441596,50720.2467105263,35125.5888157895,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_270563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
270747,2639.98839907193,150.410672853828,95.9466357308585,661.54060324826,3502.15313225058,3225.313225058,338.013921113689,255.303944315545,1096.74477958237,5462.64501160093,683.668213457077,122.109048723898,1066.29002320186,1355.30858468678,717.343387470998,301.559164733179,1750.81902552204,2905.47331786543,354.91879350348,238.31090487239,1047.64269141531,3095.71693735499,228.055684454756,333.758700696056,648.580046403712,1607.46635730858,517.635730858469,243.756380510441,1065.77030162413,131.348027842227,431,31.4518505192685,17.5729252826862,0.829353197416306,0.957777777777778,0.665123456790123,0.674117271776649,51272.8329466357,34189.5174013921,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_270747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
270759,4934.71487603306,745.161157024793,193.487603305785,608.607438016529,414.520661157025,4848.33884297521,859.326446280992,289.892561983471,1111.13223140496,8522.16115702479,754.074380165289,124.082644628099,1067.07851239669,4151.80578512397,736.830578512397,493.309917355372,2787.88016528926,3570.45454545455,367.165289256198,231.623966942149,1062.02892561983,2581.3347107438,615.640495867769,196.694214876033,594.743801652893,5054.40909090909,641.727272727273,309.173553719008,1046.03719008264,131.326446280992,242,23.7531136665958,13.0669165203459,0.835089675059374,0.949019607843137,0.751552795031056,-0.206467866681971,51302.7561983471,35364.2355371901,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_270759,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
271455,3369.91489361702,484.617021276596,143.170212765957,632.601063829787,1687.06382978723,3293.0,2545.78191489362,279.553191489362,1107.07446808511,5780.76595744681,4126.82978723404,118.824468085106,1086.94680851064,942.292553191489,588.037234042553,302.579787234043,1482.57446808511,1368.32446808511,362.43085106383,247.590425531915,989.452127659574,1342.75,303.515957446808,141.728723404255,590.446808510638,1789.5585106383,488.797872340426,567.882978723404,1082.70212765957,131.526595744681,188,17.1752355030638,13.9757425734713,0.581264393558115,0.94949494949495,0.691176470588235,0.743159155384284,50952.2287234043,35341.9893617021,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_271455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
271797,2437.23529411765,949.607843137255,1112.18954248366,628.93137254902,1379.40849673203,2252.88562091503,988.673202614379,257.686274509804,1124.59150326797,4724.60130718954,512.071895424837,111.385620915033,1079.43464052288,841.624183006536,699.565359477124,681.552287581699,1652.75163398693,1414.10784313725,341.565359477124,234.957516339869,1034.42156862745,1379.42810457516,247.483660130719,342.699346405229,673.248366013072,2091.30065359477,516.467320261438,378.434640522876,1046.98366013072,130.764705882353,306,23.4209901889313,16.9105039213088,0.691868593772815,0.959247648902821,0.739130434782609,1.18733055514594,51478.7026143791,35694.2679738562,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_271797,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
271919,3055.18766756032,1444.02412868633,1186.88203753351,688.1581769437,3929.89544235925,2856.04289544236,875.619302949062,267.222520107239,1237.33512064343,4558.91957104558,813.1581769437,115.13672922252,1074.12868632708,1001.45576407507,652.721179624665,323.1581769437,2195.57104557641,1389.7345844504,349.423592493298,239.780160857909,999.171581769437,1246.37801608579,251.120643431635,189.434316353887,586.903485254692,1216.73726541555,463.061662198391,267.278820375335,1043.32975871314,129.680965147453,373,24.0995123052507,19.7525091963397,0.572903572750332,0.953964194373402,0.772256728778468,0.92236492163803,51322.0589812332,35441.9034852547,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_271919,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
272030,2314.05673758865,177.397163120567,107.340425531915,618.943262411348,1169.75177304965,2795.83687943262,649.652482269504,263.290780141844,1144.0,2996.54609929078,557.177304964539,107.652482269504,1076.46808510638,705.709219858156,584.851063829787,283.375886524823,1476.17730496454,1090.8085106383,320.170212765957,246.702127659574,996.333333333333,1113.78014184397,237.460992907801,146.851063829787,605.609929078014,823.503546099291,455.354609929078,257.673758865248,1019.87943262411,135.822695035461,141,15.7587837949986,11.5097949787577,0.68304819566622,0.946308724832215,0.719387755102041,0.909107181419867,51299.9929078014,35020.9787234043,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_272030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
272232,3146.85474860335,1133.68994413408,134.846368715084,644.125698324022,1551.14804469274,3220.01117318436,570.983240223464,265.435754189944,1186.03072625698,5868.0251396648,521.430167597765,114.192737430168,1084.5530726257,1162.68156424581,719.346368715084,833.371508379888,1851.43016759776,1820.64245810056,366.81843575419,246.54469273743,1005.13407821229,1920.9469273743,263.854748603352,204.745810055866,606.474860335196,1686.89944134078,489.812849162011,492.40782122905,1052.6312849162,130.586592178771,358,24.3018191155577,18.8542984350857,0.630930966710085,0.975476839237057,0.774891774891775,-0.717917496212702,51326.9525139665,35462.1061452514,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_272232,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
272653,2815.79814385151,224.415313225058,80.0649651972158,620.505800464037,1169.69837587007,2564.80046403712,504.343387470998,267.473317865429,1088.47795823666,5084.0,570.22969837587,114.890951276102,1088.15081206497,728.37819025522,536.605568445476,295.870069605568,1534.87006960557,961.269141531322,260.31090487239,223.060324825986,989.060324825986,844.22969837587,197.280742459397,170.085846867749,582.909512761021,1769.53596287703,479.584686774942,239.380510440835,1038.77958236659,129.338747099768,431,32.0543985633143,17.9731375013685,0.82801403715,0.951434878587196,0.662058371735791,-1.09896843983818,51735.7262180975,35420.3341067285,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_272653,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
273691,2778.16727272727,235.752727272727,94.3163636363636,644.552727272727,2980.11636363636,2683.19272727273,417.014545454545,268.214545454545,1089.67636363636,4705.42181818182,489.8,114.327272727273,1080.10545454545,5791.92,881.723636363636,616.094545454545,5769.90181818182,5580.43636363636,470.294545454546,249.923636363636,1062.73090909091,4617.61090909091,300.483636363636,470.436363636364,690.858181818182,1733.44363636364,448.734545454546,222.290909090909,1052.86545454545,130.578181818182,275,21.4603115789307,16.3620227131547,0.647068652283873,0.964912280701754,0.808823529411765,0.400805313511646,51365.7163636364,35729.6872727273,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_273691,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
274023,4947.36516129032,1514.44774193548,1925.40387096774,675.685161290323,4101.78838709677,5495.2735483871,722.32,287.349677419355,1168.83225806452,7503.04,1007.21161290323,132.138064516129,1083.17548387097,1102.70193548387,506.144516129032,294.152258064516,1834.65032258065,1275.42193548387,255.064516129032,224.694193548387,1010.09548387097,933.292903225806,193.305806451613,148.233548387097,589.078709677419,1620.55225806452,484.847741935484,281.125161290323,1029.15741935484,131.247741935484,775,41.363862128078,24.233175640612,0.810416763051836,0.960346964064436,0.659013605442177,1.2839025664027,52074.4361290323,34840.7341935484,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_274023,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
274161,3900.49056603774,903.943396226415,332.147798742138,656.449685534591,2858.00943396226,4059.12264150943,874.751572327044,278.823899371069,1133.05974842767,7125.33962264151,602.342767295597,121.531446540881,1090.16666666667,1751.72327044025,812.48427672956,1379.75786163522,1821.27044025157,3388.04402515723,385.85534591195,246.220125786164,1060.55031446541,2925.0251572327,353.270440251572,2183.14465408805,618.210691823899,2578.09748427673,530.003144654088,317.534591194969,1073.05974842767,131.710691823899,318,21.8644254834826,18.7115316500354,0.517310138381553,0.978461538461538,0.757142857142857,-0.576832248166043,50904.9842767296,35298.5377358491,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_274161,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
274513,3880.07443365696,624.631067961165,150.656957928803,630.572815533981,1423.71197411003,4410.18122977346,2572.39482200647,261.88996763754,1087.19741100324,6745.56634304207,1391.59223300971,129.650485436893,1071.55663430421,1016.3430420712,587.271844660194,582.359223300971,1499.83495145631,1717.54368932039,323.288025889968,238.2071197411,1010.46601941748,1561.34627831715,227.990291262136,396.388349514563,735.352750809061,2033.26213592233,557.537216828479,344.980582524272,1086.25566343042,131.844660194175,309,24.6274763109103,16.1059645831129,0.756508761235585,0.950769230769231,0.757352941176471,-0.163271645690071,50986.1294498382,33822.2038834951,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_274513,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
274562,2112.93047034765,395.478527607362,158.826175869121,682.775051124744,4131.57259713701,2816.14519427403,1758.28629856851,269.957055214724,1091.56237218814,3447.79141104294,3791.55010224949,146.449897750511,1070.8691206544,773.032719836401,567.415132924335,301.300613496932,1441.10429447853,1123.27402862986,360.631901840491,247.826175869121,985.811860940695,1035.33128834356,236.541922290389,130.867075664622,585.938650306749,1425.25357873211,534.024539877301,521.449897750511,1073.18200408998,131.460122699387,489,39.4378938441125,15.9648176861532,0.914401227812095,0.942196531791908,0.677285318559557,-0.239233450209037,50945.8098159509,34610.1308793456,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_274562,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
275339,1798.67192982456,220.133333333333,128.956140350877,684.021052631579,4735.3701754386,2239.53859649123,462.571929824561,253.375438596491,1157.55789473684,3923.92105263158,1005.98421052632,115.319298245614,1062.00877192982,1064.67719298246,826.887719298246,299.638596491228,1849.53859649123,1587.71403508772,395.421052631579,252.552631578947,1004.81228070175,1584.65263157895,283.068421052632,442.454385964912,600.308771929825,1902.71052631579,507.421052631579,236.001754385965,1067.74035087719,129.391228070175,570,33.4744525160308,21.7805609537899,0.759367302492679,0.964467005076142,0.728900255754476,0.197869440320846,51793.1578947368,34600.6245614035,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_275339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
276629,3662.02972399151,581.64118895966,115.632696390658,717.832271762208,1339.36730360934,4530.54564755839,365.072186836518,277.237791932059,1174.05520169851,6959.42675159236,559.169851380042,118.619957537155,1079.77282377919,4921.45859872611,1137.2016985138,369.016985138004,1730.45010615711,4597.991507431,375.186836518047,243.04033970276,1032.87048832272,3767.96390658174,5667.49256900212,187.428874734607,590.048832271762,2389.95116772824,554.732484076433,241.352441613588,1051.32059447983,131.070063694268,471,29.7032543609148,20.2510407617983,0.731558645153945,0.971134020618557,0.759677419354839,1.53164615566192,51149.7558386412,35119.5010615711,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_276629,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
278272,1430.32158590308,833.537444933921,544.581497797357,660.20704845815,3267.72246696035,1401.60352422907,801.079295154185,255.977973568282,1101.76211453744,2199.70925110132,2599.43171806167,111.88986784141,1059.88105726872,637.440528634361,454.621145374449,288.757709251101,1505.08370044053,979.555066079295,273.074889867841,229.074889867841,989.577092511013,928.854625550661,215.299559471366,161.515418502203,597.674008810573,821.594713656388,432.95154185022,328.101321585903,1020.51982378855,130.607929515419,227,21.6040629595262,13.4371954125261,0.783036792493114,0.974248927038627,0.709375,1.01563574684652,51699.2114537445,35180.2995594714,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_278272,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
279501,2991.28666666667,1079.24333333333,81.8433333333333,620.406666666667,1008.63,3357.02666666667,727.943333333333,276.016666666667,1126.57333333333,4474.97666666667,654.846666666667,113.906666666667,1095.93,813.523333333333,492.596666666667,321.803333333333,1548.84333333333,3004.55333333333,314.303333333333,235.203333333333,1002.81666666667,3834.94333333333,249.296666666667,213.973333333333,587.446666666667,1191.37,436.936666666667,277.703333333333,1028.39333333333,131.826666666667,300,23.8315748518193,16.0683497069349,0.738506607657467,0.949367088607595,0.68649885583524,0.480564376118989,50939.75,35729.1033333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_279501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
280123,4549.4,740.05306122449,2284.23265306122,655.551020408163,2416.10612244898,4238.2,1557.01632653061,280.465306122449,1195.91020408163,8163.68163265306,808.363265306122,118.530612244898,1081.10612244898,817.048979591837,517.257142857143,305.489795918367,1480.75510204082,1174.9387755102,340.281632653061,240.657142857143,987.359183673469,1139.80816326531,250.318367346939,162.926530612245,584.571428571429,2782.88163265306,568.89387755102,445.118367346939,1086.95918367347,131.191836734694,245,20.6472329795818,15.1333819915922,0.680282900238479,0.96078431372549,0.765625,0.258527007250446,51259.7469387755,35499.5591836735,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_280123,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
280861,1770.86416184971,258.505780346821,91.3208092485549,631.973988439306,1377.12716763006,2183.76011560694,3361.50289017341,270.995664739884,1094.71820809249,3053.74710982659,1466.36849710983,114.994219653179,1066.80924855491,2120.54335260116,559.654624277457,303.265895953757,1579.89739884393,2683.82803468208,371.101156069364,242.300578034682,1086.07080924855,2565.14739884393,251.186416184971,255.326589595376,1011.32369942197,1108.27023121387,461.067919075145,435.702312138728,1045.87138728324,131.992774566474,692,34.6904951742015,25.6019893049995,0.674787978764799,0.96513249651325,0.753812636165577,-1.32679756911803,50082.7398843931,35077.9450867052,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_280861,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
281200,3382.29022082019,428.290220820189,146.747634069401,658.365930599369,2260.15772870662,3746.2523659306,3594.94321766562,270.558359621451,1102.43533123028,5902.29337539432,3621.06624605678,124.280757097792,1082.33753943218,704.205047318612,475.864353312303,270.249211356467,1381.88643533123,1088.38485804416,288.968454258675,232.488958990536,992.315457413249,1023.68138801262,209.182965299685,134.687697160883,869.817034700316,1774.76025236593,531.526813880126,526.665615141956,1094.43848580442,131.501577287066,317,25.0399667126564,16.1620220202502,0.76380335183532,0.946268656716418,0.686147186147186,-0.907972796672632,50089.047318612,34257.8170347003,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_281200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
281399,3678.16796875,924.8671875,580.50390625,656.02734375,2464.69140625,4673.0234375,538.5859375,270.9296875,1098.1015625,7949.9921875,1142.5546875,129.48828125,1074.671875,696.85546875,648.71875,280.4140625,1423.6796875,1059.6953125,340.03125,243.3125,987.3359375,1016.140625,225.7421875,144.57421875,573.11328125,3406.23828125,577.1015625,260.55859375,1083.45703125,133.0625,256,20.2745038362849,16.1075081378597,0.607301910647772,0.96969696969697,0.8,0.0076512477979141,50528.68359375,34766.87109375,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_281399,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
281501,3281.65342960289,1137.95306859206,144.945848375451,625.86642599278,1291.7833935018,3792.97833935018,425.57761732852,274.111913357401,1118.35740072202,4793.8844765343,553.039711191336,117.682310469314,1075.25631768953,2381.62815884477,570.371841155235,292.823104693141,1705.53429602888,1558.74729241877,323.263537906137,230.285198555957,1032.1083032491,1160.94223826715,220.624548736462,316.429602888087,1639.01444043321,1516.41877256318,455.530685920578,235.891696750903,1046.27075812274,130.848375451264,277,23.0597051128511,15.3657720663799,0.745641526378327,0.955172413793104,0.694235588972431,0.594043853520338,50738.4115523466,35607.3682310469,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_281501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
282889,2419.39102564103,334.301282051282,165.551282051282,687.5,3720.37820512821,2605.6858974359,1520.42948717949,259.166666666667,1089.79487179487,4384.08333333333,3394.11538461538,118.410256410256,1060.42307692308,651.429487179487,907.089743589744,268.397435897436,1630.91666666667,1022.22435897436,340.884615384615,243.955128205128,986.173076923077,968.634615384615,232.467948717949,139.673076923077,576.487179487179,1847.89743589744,514.326923076923,514.698717948718,1070.54487179487,129.833333333333,156,18.7203900959641,10.6116672194784,0.823820504720109,0.939759036144578,0.722222222222222,-1.20646510203389,50542.5576923077,34214.5641025641,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_282889,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
283044,2535.58047493404,175.741424802111,46.4063324538259,620.598944591029,1204.27704485488,2754.94722955145,2070.06332453826,261.973614775726,1104.18205804749,4614.05013192612,964.664907651715,121.382585751979,1076.56992084433,4683.97361477573,826.094986807388,320.730870712401,1960.96042216359,4104.27176781003,406.176781002639,252.047493403694,1020.82849604222,3607.69920844327,282.0,237.298153034301,589.622691292876,1747.99208443272,467.5672823219,485.089709762533,1071.83377308707,130.720316622691,379,28.2977442165333,17.3505837297324,0.789971390064265,0.954659949622166,0.701851851851852,-0.389850630569846,51396.0290237467,35813.6490765171,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_283044,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
283710,1925.20048899756,142.080684596577,62.2224938875306,627.239608801956,1173.41809290954,2413.59657701712,366.046454767726,264.669926650367,1090.73105134474,4214.0097799511,639.229828850856,114.158924205379,1081.08312958435,660.369193154034,538.01466992665,309.066014669927,1412.8728606357,1011.42787286064,323.325183374083,241.444987775061,984.59413202934,958.430317848411,224.315403422983,151.440097799511,607.349633251834,2121.96577017115,551.364303178484,226.843520782396,1070.73594132029,130.633251833741,409,33.1629448707088,15.8028571213605,0.879162803206878,0.953379953379953,0.608630952380952,0.629693199698357,50396.7359413203,34808.6772616137,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_283710,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
285506,2685.12751677852,764.281879194631,81.8791946308725,635.765100671141,1809.3288590604,3165.54697986577,358.825503355705,264.681208053691,1115.84563758389,4191.30201342282,570.05033557047,112.855704697987,1077.5,1111.15771812081,500.38255033557,280.258389261745,1709.26510067114,1864.72818791946,313.56711409396,231.345637583893,1046.79194630872,1862.1711409396,235.530201342282,234.436241610738,2216.6677852349,1310.78859060403,429.979865771812,223.46644295302,1049.30201342282,130.718120805369,298,23.419873088577,16.2331824015295,0.720805792843063,0.94006309148265,0.730392156862745,0.142036046207372,50636.3154362416,35619.3959731544,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_285506,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
286275,3681.13839285714,430.544642857143,173.383928571429,637.642857142857,1383.93303571429,5163.41071428571,436.183035714286,294.245535714286,1091.29017857143,6377.92410714286,628.491071428571,131.651785714286,1073.9375,547.736607142857,462.950892857143,269.272321428571,1421.49553571429,911.071428571429,274.491071428571,229.799107142857,993.267857142857,981.303571428571,207.834821428571,147.044642857143,612.941964285714,2970.08482142857,590.066964285714,235.709821428571,1066.20089285714,132.415178571429,224,20.9784000944445,13.6258484060088,0.760346218374228,0.945147679324894,0.761904761904762,-1.44412917088043,50735.2366071429,34953.2901785714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_286275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
287228,2631.08038585209,308.048231511254,136.87459807074,669.662379421222,3047.48231511254,2789.11897106109,1314.54340836013,272.916398713826,1095.18971061093,5045.40192926045,540.67845659164,115.932475884244,1097.18006430868,1206.48553054662,772.848874598071,1177.27652733119,1590.12218649518,1619.50482315113,326.524115755627,235.752411575563,1017.08038585209,1381.25723472669,243.778135048232,278.929260450161,667.877813504823,1821.33440514469,495.607717041801,446.852090032154,1066.60128617363,129.581993569132,311,20.5070895635093,19.3127485381558,0.336286855292128,0.981072555205047,0.818421052631579,0.219928881863888,50920.0610932476,35313.4308681672,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_287228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
287430,3621.312,443.928,77.9173333333333,650.738666666667,2176.71733333333,3995.29333333333,541.837333333333,271.925333333333,1171.952,5526.73066666667,534.717333333333,131.477333333333,1109.96533333333,4143.91466666667,1037.71733333333,535.344,1983.536,5243.86133333333,391.754666666667,244.946666666667,1047.84533333333,4438.544,264.170666666667,286.362666666667,617.466666666667,1352.63466666667,429.896,408.728,1047.52266666667,130.154666666667,375,24.0028661252586,19.9752259894217,0.55447302085517,0.971502590673575,0.744047619047619,0.489979990693022,51221.632,35869.7306666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_287430,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
287591,2477.43434343434,167.545454545455,83.5050505050505,601.116161616162,552.181818181818,2926.70202020202,491.131313131313,264.59595959596,1102.72727272727,4715.69696969697,511.833333333333,109.090909090909,1072.32828282828,1983.70202020202,857.040404040404,377.737373737374,4015.4595959596,2991.38888888889,334.782828282828,236.025252525253,1047.43939393939,2583.29292929293,235.707070707071,549.444444444444,640.409090909091,1161.93939393939,422.015151515152,225.79797979798,1021.78282828283,129.808080808081,198,17.2108602588425,14.6601030891996,0.523877293350512,0.970588235294118,0.7734375,-0.848641076034276,50885.3686868687,35395.904040404,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_287591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
287781,1785.39759036145,278.570281124498,91.7510040160643,613.714859437751,1003.10441767068,1596.70682730924,1885.89558232932,266.586345381526,1088.03614457831,1892.10040160643,671.301204819277,110.771084337349,1068.66265060241,591.152610441767,401.674698795181,279.184738955823,1403.78313253012,908.096385542169,264.755020080321,230.353413654618,995.614457831325,832.895582329317,194.469879518072,135.33734939759,589.606425702811,944.168674698795,545.04016064257,224.927710843373,1017.16064257028,129.124497991968,249,20.7470066580315,15.419199449619,0.669068033370606,0.93609022556391,0.732352941176471,0.31406897310867,50675.1526104418,35036.734939759,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_287781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
288585,2348.47086247086,454.331002331002,127.470862470862,641.426573426573,1888.63636363636,2626.82750582751,2508.59906759907,259.589743589744,1086.1351981352,4703.15850815851,2398.51282051282,112.736596736597,1073.35431235431,874.962703962704,513.745920745921,311.312354312354,1476.32867132867,1247.25174825175,306.932400932401,230.806526806527,1006.89044289044,1210.81351981352,222.121212121212,146.902097902098,606.762237762238,1864.331002331,468.405594405594,629.386946386946,1056.662004662,130.88344988345,429,32.4265124233379,17.4221065201394,0.843404135309727,0.936681222707424,0.616379310344828,-0.561202414023498,50059.8881118881,35107.7925407925,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_288585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
288731,2254.37009803922,604.904411764706,317.598039215686,621.115196078431,1023.56617647059,2180.55147058824,1371.60539215686,268.264705882353,1093.47794117647,4427.9068627451,691.600490196078,110.830882352941,1070.34558823529,1042.58333333333,629.610294117647,406.666666666667,1720.14460784314,2096.87009803922,304.071078431373,239.661764705882,1011.08578431373,1997.55147058824,227.044117647059,169.061274509804,1214.55882352941,1988.04656862745,490.833333333333,336.852941176471,1046.31617647059,131.232843137255,408,27.5592730781784,18.8957235022082,0.727941351316114,0.964539007092198,0.784615384615385,-0.33471364757738,51130.6838235294,35481.7965686274,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_288731,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
288997,1559.90282131661,366.363636363636,112.05329153605,650.721003134796,2567.33228840125,1887.12852664577,2871.14420062696,258.100313479624,1094.15673981191,2910.73354231975,2128.35736677116,112.87460815047,1074.08463949843,538.413793103448,371.836990595611,275.724137931034,1470.20376175549,896.46394984326,273.733542319749,232.683385579937,996.843260188088,894.636363636364,198.815047021944,161.630094043887,589.811912225705,1319.18808777429,524.068965517241,367.156739811912,1067.34482758621,131.432601880878,319,24.8302012545656,16.4318548150538,0.749707897321309,0.957957957957958,0.729977116704805,1.11337727072533,51235.2978056426,34337.6677115987,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_288997,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
290364,2862.97150259067,237.461139896373,73.800518134715,641.90414507772,1666.51295336788,3466.27202072539,389.178756476684,265.432642487047,1105.51295336788,5908.01295336788,600.927461139896,122.655440414508,1082.58031088083,4049.03886010363,1330.9067357513,346.616580310881,3388.66580310881,2014.94300518135,358.523316062176,242.525906735751,999.487046632124,1514.62176165803,225.007772020725,246.476683937824,675.20207253886,2337.60362694301,541.458549222798,246.567357512953,1073.67098445596,129.766839378238,386,24.4873979355667,20.1520776761222,0.568103540531432,0.953086419753086,0.762845849802372,0.969805756157669,50615.8186528497,34273.6062176166,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_290364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
290981,1978.02482269504,883.765957446809,138.652482269504,652.031914893617,2438.32978723404,2355.74468085106,4266.62056737589,269.535460992908,1173.03546099291,2739.13120567376,639.234042553191,113.783687943262,1078.70212765957,1632.1914893617,953.276595744681,2826.31205673759,1945.47872340426,4717.23758865248,387.539007092199,244.028368794326,1068.90780141844,5160.33687943262,270.09219858156,230.716312056738,610.375886524823,1019.28014184397,483.776595744681,826.86170212766,1047.74822695035,134.024822695035,282,22.802429626409,15.9521412889826,0.714553528746666,0.95593220338983,0.801136363636364,1.393002955676,51101.8191489362,35680.8723404255,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_290981,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
291273,1870.3137254902,358.257352941176,132.022058823529,649.796568627451,2491.61764705882,1855.79166666667,865.44362745098,261.735294117647,1096.78676470588,3835.30882352941,620.303921568627,111.789215686275,1089.77941176471,3795.10294117647,897.914215686274,336.355392156863,2076.65441176471,5036.08088235294,398.997549019608,259.421568627451,1039.75490196078,3703.86274509804,270.674019607843,196.196078431373,588.291666666667,1449.79656862745,467.299019607843,249.343137254902,1052.11764705882,130.808823529412,408,26.6930327441063,19.8747296519742,0.667548643036933,0.955503512880562,0.784615384615385,-1.45431068104015,51693.5196078431,35377.8284313726,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_291273,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
291287,1838.50949367089,74.0158227848101,55.1677215189873,624.117088607595,617.316455696203,1839.30696202532,303.199367088608,261.617088607595,1094.45569620253,3425.69303797468,636.892405063291,109.041139240506,1068.0253164557,913.674050632911,638.408227848101,284.816455696203,1624.46835443038,1397.6835443038,332.914556962025,238.322784810127,1043.71202531646,1255.83544303797,269.636075949367,399.291139240506,3216.58227848101,1360.08860759494,448.674050632911,216.129746835443,1062.66139240506,129.481012658228,316,25.7292349245797,15.8098244667748,0.788940747818025,0.943283582089552,0.759615384615385,0.0446251611866382,50167.6803797468,35374.0759493671,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_291287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
291632,1212.47222222222,115.381944444444,96.4722222222222,636.326388888889,2256.09027777778,1399.82638888889,270.777777777778,238.104166666667,1066.79861111111,1993.29861111111,419.715277777778,106.729166666667,1062.55555555556,769.680555555556,584.840277777778,286.875,1459.29861111111,1291.22916666667,368.194444444444,245.604166666667,984.652777777778,1349.64583333333,254.326388888889,159.097222222222,585.972222222222,939.069444444444,463.965277777778,218.298611111111,1013.11111111111,130.875,144,16.6790798291775,11.1216114163537,0.745236661163619,0.96,0.818181818181818,1.54795508625757,51770.5833333333,34233.4791666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_291632,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
291825,2211.37149028078,373.58747300216,117.492440604752,670.943844492441,3512.36285097192,2372.93088552916,735.848812095032,266.95464362851,1121.38876889849,3890.29157667387,527.44060475162,139.002159827214,1108.31965442765,1473.80345572354,1038.49244060475,1803.88120950324,1814.60259179266,1665.08207343413,371.421166306695,245.892008639309,1037.55507559395,1564.66522678186,269.10151187905,358.235421166307,674.196544276458,1250.57019438445,450.894168466523,263.066954643628,1043.86393088553,129.658747300216,463,35.1116625777044,16.8368937338549,0.877528627310342,0.954639175257732,0.668109668109668,-0.369244712070372,50896.6479481641,35851.8920086393,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_291825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
293335,1246.77040816327,124.770408163265,87.8877551020408,605.566326530612,827.933673469388,1230.10204081633,505.423469387755,252.836734693878,1082.2193877551,3145.83163265306,522.15306122449,103.158163265306,1068.69897959184,2233.90306122449,556.586734693878,329.683673469388,1646.86734693878,3669.70918367347,357.80612244898,237.933673469388,1052.39795918367,3014.59183673469,231.362244897959,771.785714285714,717.59693877551,1799.64285714286,508.0,283.94387755102,1028.01530612245,129.290816326531,196,16.6916894841341,14.9409415277427,0.445840148624392,0.97029702970297,0.816666666666667,-1.13635704661415,51785.4693877551,35139.1632653061,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
293347,2996.2358490566,381.547169811321,234.481132075472,673.688679245283,4162.21698113208,3630.12264150943,371.911949685535,289.723270440252,1092.92452830189,5755.24213836478,594.654088050314,129.716981132075,1066.62893081761,720.339622641509,691.022012578616,297.474842767296,1515.78616352201,1221.91509433962,359.861635220126,243.691823899371,1020.60377358491,1275.7106918239,272.245283018868,295.946540880503,623.959119496855,3584.24528301887,589.477987421384,265.638364779874,1074.17295597484,130.405660377358,318,26.7636080330198,15.2736550700317,0.821167364705728,0.949253731343284,0.736111111111111,-1.40388866488951,50220.6603773585,35546.4937106918,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293347,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
293508,5240.50632911392,392.286919831224,1189.18143459916,648.282700421941,1746.96624472574,5947.09282700422,557.915611814346,277.345991561181,1110.84810126582,9088.89873417722,601.430379746835,124.054852320675,1080.26160337553,627.864978902954,401.122362869198,268.919831223629,1541.15189873418,945.738396624473,254.831223628692,225.105485232068,1000.30801687764,890.729957805907,200.455696202532,139.966244725738,584.291139240506,2169.73839662447,543.658227848101,317.164556962025,1049.16877637131,131.822784810127,237,19.1600890389838,15.8530601528512,0.561612878802967,0.94047619047619,0.774509803921569,0.605869437211622,52015.9789029536,34510.3755274262,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293508,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
293791,638.647058823529,217.329411764706,91.1843137254902,618.423529411765,1113.82352941176,791.388235294118,2213.99215686275,248.592156862745,1090.20784313725,1723.85882352941,1243.22352941176,106.313725490196,1062.52941176471,1199.56470588235,630.56862745098,283.137254901961,1519.27058823529,1201.00784313725,360.956862745098,242.650980392157,990.756862745098,1203.05490196078,712.682352941176,133.678431372549,583.188235294118,1126.96862745098,496.101960784314,324.152941176471,1047.88235294118,129.552941176471,255,18.3134119612256,17.7696234917825,0.24187849894267,0.944444444444444,0.745614035087719,-0.127015085762629,50464.2470588235,34684.9411764706,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
294042,3475.97959183673,942.561224489796,586.295918367347,638.489795918367,1447.76020408163,3080.10204081633,3183.12755102041,276.188775510204,1124.86224489796,5331.51020408163,709.591836734694,123.908163265306,1076.52040816327,1183.69387755102,464.433673469388,277.137755102041,1538.40816326531,1483.01020408163,282.65306122449,234.698979591837,999.540816326531,1578.38775510204,210.454081632653,206.647959183673,583.066326530612,1291.31632653061,537.535714285714,421.44387755102,1046.56632653061,133.474489795918,196,20.896855043721,12.0010550647766,0.818645218009549,0.942307692307692,0.687719298245614,0.970357831634433,51981.0255102041,35177.75,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_294042,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
294101,3499.77649769585,994.965437788018,721.041474654378,644.783410138249,1711.74884792627,3730.05529953917,1397.00460829493,265.366359447005,1171.12903225806,5360.00921658986,499.435483870968,135.18202764977,1094.37096774194,5092.09907834101,1140.88479262673,646.253456221198,8138.32949308756,6293.50921658986,477.866359447005,255.490783410138,1097.60599078341,5920.56451612903,341.624423963134,795.562211981567,655.214285714286,1676.70276497696,489.732718894009,671.389400921659,1071.84792626728,132.34331797235,434,31.5723464884775,17.7467236858876,0.827071263947467,0.962305986696231,0.736842105263158,0.156896617491182,51013.4953917051,35875.0069124424,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294101,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
295049,3354.02302631579,278.690789473684,116.519736842105,628.894736842105,1233.40131578947,4063.04934210526,333.1875,262.184210526316,1096.30921052632,6301.01644736842,515.355263157895,115.796052631579,1098.74013157895,2727.17763157895,563.6875,290.174342105263,1671.70723684211,3250.03947368421,364.450657894737,236.940789473684,1110.27631578947,2643.15460526316,211.865131578947,215.865131578947,1096.23355263158,2502.63157894737,515.572368421053,225.578947368421,1060.91776315789,131.733552631579,304,22.0132943562114,17.7646748781352,0.590554768710373,0.968152866242038,0.76,0.791488039277288,50560.4473684211,34493.0559210526,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_295049,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
295099,4507.37096774194,1245.41290322581,196.816129032258,649.667741935484,1574.1064516129,4400.40967741935,735.735483870968,270.903225806452,1139.93870967742,6402.67096774194,589.677419354839,117.703225806452,1073.2064516129,2398.35483870968,1108.13225806452,1644.78709677419,2570.80967741936,1185.71290322581,282.822580645161,223.438709677419,1029.00322580645,1000.9064516129,210.603225806452,450.596774193548,646.109677419355,1394.29032258065,471.416129032258,303.993548387097,1041.84193548387,131.441935483871,310,22.2762679806756,17.729022202181,0.605467021385666,0.965732087227414,0.776942355889724,0.457378478199136,51231.4709677419,35714.0516129032,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_295099,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
295601,1158.65363128492,234.54469273743,99.8016759776536,654.041899441341,2687.42737430168,1348.32402234637,2287.71787709497,253.625698324022,1084.65921787709,2060.66759776536,2343.24022346369,105.480446927374,1065.70391061453,645.312849162011,622.206703910615,487.662011173184,1821.03910614525,1007.82960893855,269.09217877095,223.167597765363,1006.82960893855,906.486033519553,197.77094972067,160.326815642458,605.212290502793,856.078212290503,426.36592178771,1382.67318435754,1034.70670391061,129.005586592179,358,25.3532042146283,18.0031891814276,0.704105656378218,0.964959568733154,0.739669421487603,0.850398424287896,50456.6508379888,35112.5363128492,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_295601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
295727,3775.86996904025,466.69040247678,143.730650154799,694.510835913313,4062.56346749226,3821.94117647059,662.956656346749,269.857585139319,1189.44891640867,5961.95046439628,530.43653250774,133.66253869969,1090.15170278638,2414.6253869969,920.30959752322,508.058823529412,3594.10526315789,3037.87616099071,369.613003095975,241.693498452012,1055.0773993808,2920.66253869969,272.94427244582,347.232198142415,595.241486068111,1963.56965944272,493.25386996904,400.321981424149,1048.04334365325,130.582043343653,323,23.1730723147108,18.0846884044449,0.625257838333422,0.952802359882006,0.702173913043478,0.996773564691999,51204.6563467492,35851.5448916409,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_295727,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
295983,3532.1469740634,1093.3976945245,123.230547550432,638.688760806916,1435.22190201729,4079.53314121038,335.596541786744,262.256484149856,1112.98847262248,6241.14409221902,504.400576368876,136.175792507205,1081.88760806916,2834.97982708934,759.28530259366,300.766570605187,6006.11527377522,3719.99423631124,403.93083573487,247.466858789625,1000.17291066282,3454.71757925072,267.769452449568,191.913544668588,593.524495677233,2576.02017291066,481.478386167147,229.878962536023,1061.01729106628,131.317002881844,347,22.358865833771,19.867264482021,0.458754302946886,0.958563535911602,0.788636363636364,0.380318060388901,50566.4841498559,35821.818443804,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_295983,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
296427,2882.02048417132,395.392923649907,87.3463687150838,739.420856610801,1851.45065176909,3641.4487895717,1641.99813780261,270.523277467412,1215.61452513966,5568.82681564246,2786.57169459963,110.80260707635,1104.51210428305,1575.69832402235,609.167597765363,304.661080074488,1869.51210428305,2341.90130353817,367.927374301676,241.664804469274,1015.97206703911,1941.80260707635,239.63687150838,320.372439478585,590.117318435754,1757.45810055866,494.212290502793,487.66852886406,1053.03538175047,131.296089385475,537,33.8136720690292,20.470547180562,0.795926999169989,0.950442477876106,0.707509881422925,-0.260860514845415,50824.2756052142,35263.7076350093,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_296427,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
296562,2540.9914893617,399.365957446809,234.668085106383,722.651063829787,5714.11914893617,3288.91063829787,967.727659574468,289.842553191489,1114.23829787234,5201.86382978723,639.170212765957,131.472340425532,1086.15744680851,714.472340425532,651.370212765957,339.068085106383,1473.89787234043,1170.69361702128,312.974468085106,241.348936170213,994.817021276596,1083.90638297872,223.11914893617,188.727659574468,678.182978723404,2205.65957446808,535.765957446809,308.6,1100.89361702128,130.889361702128,235,18.1327914156052,16.8022221327185,0.375997137663311,0.959183673469388,0.725308641975309,0.994759037787626,50450.7617021277,35303.3191489362,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_296562,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
296881,3850.95454545455,632.972027972028,1024.58391608392,621.276223776224,1157.27272727273,4528.92307692308,505.43006993007,259.066433566434,1113.93706293706,7563.96153846154,648.594405594406,117.311188811189,1065.30769230769,1244.77972027972,753.909090909091,358.800699300699,1818.23426573427,1832.12937062937,382.996503496504,251.653846153846,1105.31818181818,1209.07342657343,227.622377622378,323.27972027972,2011.69230769231,3272.25874125874,784.192307692308,427.643356643357,1110.15034965035,132.58041958042,286,22.4030679308529,16.6810570676818,0.667524238516449,0.956521739130435,0.716791979949875,0.559736058736517,51764.7412587413,34812.6573426573,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_296881,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
298112,4129.73870967742,768.577419354839,286.474193548387,624.258064516129,1192.37741935484,4937.64838709677,822.732258064516,266.522580645161,1125.17741935484,7500.62258064516,1098.07419354839,120.403225806452,1080.72903225806,925.141935483871,497.725806451613,288.316129032258,1560.37096774194,1069.96451612903,227.558064516129,219.235483870968,1275.88387096774,735.029032258064,152.748387096774,126.487096774194,615.232258064516,2394.80322580645,546.409677419355,352.558064516129,1052.7064516129,132.793548387097,310,23.1239440958208,17.1594725051264,0.670327791266976,0.95679012345679,0.776942355889724,-0.979104027911904,51340.8193548387,34282.0516129032,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_298112,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
299013,4315.21090909091,275.32,152.458181818182,658.141818181818,2580.05090909091,4544.61090909091,1039.69454545455,270.065454545455,1101.56363636364,8683.31272727273,1041.80727272727,123.44,1092.88727272727,784.367272727273,466.090909090909,281.516363636364,1952.48727272727,1041.95272727273,278.029090909091,230.447272727273,1001.92,956.632727272727,204.021818181818,139.461818181818,583.767272727273,3960.16727272727,601.963636363636,466.756363636364,1091.54545454545,132.607272727273,275,19.4289662189938,18.0692301058975,0.367521552259485,0.951557093425606,0.761772853185596,-0.72051397812097,52029.3854545455,34543.1272727273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_299013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
299139,501.539622641509,910.645283018868,249.377358490566,651.31320754717,104.796226415094,668.6,435.233962264151,278.622641509434,1129.9358490566,1448.09433962264,772.328301886792,116.298113207547,1060.87547169811,1872.84528301887,1420.10943396226,1277.38490566038,1785.59622641509,1828.81132075472,302.68679245283,232.31320754717,1063.23773584906,1169.36226415094,213.279245283019,251.705660377358,751.335849056604,630.622641509434,398.105660377359,202.377358490566,987.316981132076,130.388679245283,265,19.4687325778396,17.3956016457766,0.449033645687233,0.963636363636364,0.774853801169591,-0.438154225215558,50166.7169811321,34870.2226415094,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_299139,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
299988,2829.50853242321,531.98976109215,852.150170648464,611.754266211604,901.96928327645,3421.1638225256,368.665529010239,264.337883959044,1101.9590443686,4620.12969283276,490.006825938567,110.071672354949,1071.47781569966,2128.1843003413,630.276450511945,668.163822525597,1658.47781569966,1575.91467576792,281.761092150171,230.088737201365,1010.49829351536,1369.70307167236,216.9795221843,251.529010238908,606.921501706485,1226.66552901024,489.59385665529,259.59385665529,1024.1433447099,130.307167235495,293,19.7648912976749,19.0916219527658,0.258780712177737,0.927215189873418,0.697619047619048,0.498411463019989,51241.3242320819,35135.5563139932,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_299988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
300567,2501.81873111782,866.891238670695,71.1691842900302,626.042296072507,716.719033232628,2316.01208459215,1665.68580060423,265.700906344411,1099.53776435045,3808.26888217523,585.356495468278,107.392749244713,1071.78549848943,1087.7250755287,531.166163141994,283.045317220544,1862.16918429003,2461.80966767372,340.413897280967,247.894259818731,1023.5498489426,2581.38670694864,242.287009063444,222.981873111782,903.873111782477,800.474320241692,397.791540785499,444.809667673716,1013.52870090634,131.785498489426,331,21.0714844173401,20.0475596572087,0.307935951760494,0.959420289855072,0.716450216450216,-0.957546871149707,51041.7794561934,35503.0966767372,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_300567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
300620,3006.13043478261,708.885869565217,112.73097826087,618.633152173913,1153.60597826087,3299.20380434783,349.853260869565,266.413043478261,1119.46195652174,4995.39945652174,528.429347826087,113.26902173913,1074.53260869565,1034.92391304348,560.451086956522,296.483695652174,1481.80434782609,1136.93206521739,232.059782608696,220.665760869565,1378.96739130435,695.415760869565,157.910326086957,125.100543478261,595.179347826087,1113.80163043478,460.932065217391,222.497282608696,1039.0625,132.866847826087,368,24.0107058655252,19.5479136540161,0.580678116327154,0.963350785340314,0.761904761904762,-0.440578579198678,50276.8614130435,35043.5951086957,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_300620,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
301040,2999.92082111437,323.824046920821,144.885630498534,660.589442815249,2720.04398826979,3460.60997067449,1306.35190615836,266.454545454545,1099.5219941349,5607.80938416422,631.214076246334,118.958944281525,1093.55718475073,776.41642228739,567.08504398827,276.011730205279,1589.78885630499,1381.5073313783,343.700879765396,242.199413489736,1061.07917888563,1337.96480938416,229.363636363636,410.571847507331,1426.95601173021,2040.71260997067,552.633431085044,271.504398826979,1072.32551319648,133.087976539589,341,23.1181208898967,18.8315039842121,0.58005456173795,0.955182072829132,0.738095238095238,0.57925770053297,51212.5513196481,34457.0762463343,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_301040,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
301065,3238.73365617433,1384.0411622276,567.108958837772,650.934624697337,1940.10895883777,3174.58595641646,2890.38256658596,268.983050847458,1105.44552058111,5359.28329297821,2834.50121065375,116.208232445521,1071.61259079903,988.912832929782,643.278450363196,592.072639225182,1609.74576271186,1180.82324455206,337.646489104116,239.769975786925,997.130750605327,1131.86198547215,247.888619854722,171.406779661017,600.81598062954,1237.35351089588,462.331719128329,666.389830508475,1050.61016949153,132.099273607748,413,23.6012403724762,22.3205008547087,0.324941177894469,0.976359338061466,0.78219696969697,0.0072587662811025,51370.004842615,35494.99031477,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_301065,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
301244,3135.24216524217,611.618233618234,99.8803418803419,662.182336182336,2598.57264957265,3416.93447293447,1018.52136752137,267.433048433048,1113.76353276353,5390.61823361823,540.754985754986,130.384615384615,1080.73504273504,1642.33618233618,717.498575498576,901.478632478632,1876.37606837607,1232.60398860399,329.581196581197,227.669515669516,1035.02279202279,1105.78062678063,217.695156695157,1083.11396011396,613.589743589744,2189.84045584046,478.507122507123,424.994301994302,1073.33903133903,130.689458689459,351,27.2425819519512,16.4707452970086,0.796532582699612,0.956403269754768,0.764705882352941,-0.0979131528252684,51146.1994301994,35846.1566951567,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_301244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
301472,1655.16060606061,187.639393939394,67.1606060606061,638.815151515152,1775.62424242424,1674.56666666667,2754.74848484848,259.869696969697,1095.22121212121,2708.06060606061,1524.16363636364,113.157575757576,1068.6303030303,1015.47272727273,762.663636363636,671.545454545455,2155.18181818182,1582.12727272727,339.906060606061,244.860606060606,1003.82424242424,1579.74242424242,289.672727272727,187.842424242424,596.384848484848,1101.90606060606,510.972727272727,429.278787878788,1055.1303030303,131.745454545455,330,24.4085219928989,17.2556384082708,0.707262144066104,0.951008645533141,0.717391304347826,0.583738694966686,51927.6363636364,34811.5727272727,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_301472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
302389,5359.68944099379,705.67701863354,228.583850931677,648.583850931677,2432.77639751553,6072.72670807453,517.267080745342,286.658385093168,1114.80124223602,9240.29813664596,654.484472049689,126.124223602484,1077.60869565217,3393.33540372671,1167.14906832298,1694.27950310559,2274.96273291925,3162.66459627329,333.012422360248,231.211180124224,1074.57142857143,2758.54037267081,238.745341614907,633.521739130435,706.826086956522,3860.86335403727,588.83850931677,251.366459627329,1504.3602484472,130.739130434783,161,16.9158962991353,12.1603953005006,0.695140564660862,0.964071856287425,0.766666666666667,0.963270387743294,51494.9875776398,35036.0621118012,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_302389,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
302454,1347.17936117936,167.425061425061,114.31941031941,665.941031941032,3178.11547911548,1621.11056511057,318.783783783784,258.061425061425,1092.97297297297,2715.48402948403,521.061425061425,113.321867321867,1072.16953316953,1569.69778869779,713.081081081081,355.859950859951,1843.56265356265,1275.06388206388,399.437346437346,269.07371007371,990.093366093366,1195.60442260442,256.528255528256,149.208845208845,583.029484029484,1376.49385749386,481.823095823096,230.469287469287,1040.99508599509,129.793611793612,407,25.0345041248089,20.8140088890689,0.555655146544105,0.969047619047619,0.775238095238095,0.0553242558426414,50617.9164619165,34867.1695331695,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_302454,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
302467,1407.26984126984,672.608465608466,78.8412698412698,622.206349206349,1184.46560846561,1746.04232804233,848.941798941799,265.497354497354,1145.67195767196,2260.6455026455,689.661375661376,111.460317460317,1062.04761904762,593.354497354497,439.566137566138,269.285714285714,1372.68253968254,895.507936507937,243.037037037037,224.640211640212,983.333333333333,844.920634920635,185.862433862434,129.820105820106,602.031746031746,967.15873015873,483.677248677249,308.058201058201,1030.86243386243,131.867724867725,189,16.8454452925278,14.2831886684099,0.530162307717307,0.969230769230769,0.7875,0.495135016566323,50136.0476190476,34795.6772486772,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_302467,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
303043,2997.08060453401,213.826196473552,113.554156171285,628.589420654912,1120.12846347607,3404.3274559194,3259.86397984887,278.002518891688,1102.8362720403,5648.04282115869,1799.30730478589,113.481108312343,1074.78589420655,4492.61460957179,894.972292191436,417.123425692695,4226.07808564232,6055.56171284635,434.662468513854,254.773299748111,1075.28715365239,4847.74811083123,263.030226700252,242.476070528967,679.476070528967,1714.54659949622,487.32241813602,471.403022670025,1061.35012594458,131.848866498741,397,25.2375454822971,20.0769636544001,0.605927773919172,0.973039215686274,0.794,-0.0060113106952833,50846.2367758186,35315.5944584383,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_303043,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
303398,1780.4022556391,793.631578947368,94.0225563909774,619.503759398496,1097.5037593985,2070.42481203008,1429.65037593985,256.135338345865,1081.07518796992,4331.65413533835,846.34962406015,109.770676691729,1070.74812030075,638.669172932331,464.578947368421,327.481203007519,1469.0,1104.17293233083,311.146616541353,234.556390977444,992.308270676692,1048.49248120301,218.793233082707,164.015037593985,590.808270676692,2574.18421052632,599.928571428571,299.748120300752,1068.99248120301,130.808270676692,266,21.7903022961511,15.5502632364212,0.700520492653936,0.967272727272727,0.738888888888889,-0.610027476005039,51509.3157894737,34550.5112781955,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_303398,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
304168,2489.15040650406,275.737804878049,130.006097560976,643.227642276423,2115.15447154472,2458.35772357724,349.426829268293,274.587398373984,1101.44512195122,4255.88008130081,586.544715447154,119.538617886179,1099.42073170732,757.306910569106,499.981707317073,303.243902439024,1473.50406504065,1103.11585365854,310.264227642276,236.802845528455,987.912601626016,1070.52845528455,239.191056910569,147.776422764228,585.042682926829,1502.91056910569,544.378048780488,230.308943089431,1054.43495934959,129.752032520325,492,32.3074949705701,19.4158761826166,0.799270627740384,0.972332015810277,0.700854700854701,0.866080228198547,51784.7378048781,34989.6808943089,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_304168,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
304640,2829.14606741573,920.32808988764,2082.30561797753,629.101123595506,1155.84269662921,3315.43595505618,1017.05617977528,267.332584269663,1103.11460674157,4786.9191011236,1153.31235955056,114.687640449438,1071.10337078652,820.184269662921,530.206741573034,284.047191011236,1428.47640449438,1181.76629213483,340.501123595506,238.791011235955,986.694382022472,1153.70112359551,237.501123595506,153.570786516854,604.278651685393,1325.89662921348,495.431460674157,350.844943820225,1051.53707865169,146.750561797753,445,25.5034382235767,22.2602524186269,0.488018314057765,0.959051724137931,0.773913043478261,-1.2403630332583,50585.2202247191,34864.1146067416,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_304640,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
305152,3899.52380952381,430.709956709957,152.844155844156,632.571428571429,2070.90909090909,3485.30735930736,505.493506493507,275.536796536797,1109.83982683983,6724.29004329004,567.34632034632,122.917748917749,1094.31601731602,1049.88311688312,819.445887445887,315.077922077922,4232.98268398268,1364.40692640693,321.761904761905,239.012987012987,1196.85281385281,1186.06926406926,242.614718614719,773.805194805195,3036.52813852814,1688.90476190476,468.484848484848,222.805194805195,1035.96103896104,131.722943722944,231,18.4647831446957,16.0181339530485,0.497443361089106,0.970588235294118,0.802083333333333,1.33298031173399,51922.1341991342,35367.2943722944,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_305152,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
306425,1929.48626373626,293.129120879121,105.653846153846,623.453296703297,795.266483516484,2162.1978021978,2257.56868131868,254.038461538462,1091.30769230769,4080.25274725275,1502.24450549451,110.013736263736,1072.91483516484,908.945054945055,564.269230769231,279.994505494506,1373.74175824176,1215.37912087912,336.472527472527,240.478021978022,985.392857142857,1099.57967032967,248.126373626374,130.623626373626,582.752747252747,1750.60164835165,495.239010989011,245.986263736264,1043.48351648352,129.782967032967,364,25.8788285889743,17.9074769153493,0.721922407833168,0.973262032085562,0.758333333333333,-1.06814471395681,50137.3351648352,34212.3131868132,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_306425,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
307328,2805.28338762215,242.778501628664,134.944625407166,664.358306188925,4020.84039087948,3193.97394136808,410.260586319218,256.029315960912,1091.92182410423,5503.73615635179,849.840390879479,119.732899022801,1088.38762214984,1021.64169381107,705.5667752443,278.00651465798,1929.02931596091,1472.08794788274,328.358306188925,235.915309446254,1118.90228013029,1160.66123778502,207.446254071661,219.130293159609,2557.52442996743,1660.96091205212,518.123778501629,258.153094462541,1056.22801302932,131.208469055375,307,21.5353302024874,18.5613624738452,0.507073443824081,0.95046439628483,0.73444976076555,0.376635035084282,51254.5472312704,34080.342019544,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_307328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
307336,2259.4,355.684210526316,160.665789473684,661.921052631579,2864.18947368421,2339.32105263158,1508.44473684211,247.315789473684,1089.18684210526,3083.22368421053,2507.80263157895,107.110526315789,1075.30526315789,724.223684210526,533.218421052632,772.997368421053,1568.55789473684,935.215789473684,275.094736842105,230.247368421053,990.284210526316,922.373684210526,199.826315789474,135.321052631579,590.142105263158,910.034210526316,466.921052631579,378.289473684211,1041.43947368421,130.3,380,28.0518543365502,17.2709114527403,0.787997790515274,0.969387755102041,0.769230769230769,1.20105373183036,51149.2736842105,34247.747368421,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_307336,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
307723,1872.99163179916,190.384937238494,99.7824267782427,621.824267782427,922.18410041841,2184.32635983264,298.071129707113,249.196652719665,1088.67364016736,4027.75313807531,936.171548117155,123.690376569038,1070.51882845188,678.271966527197,459.410041841004,269.761506276151,1326.86610878661,991.556485355648,308.857740585774,230.753138075314,1013.02928870293,916.765690376569,222.129707112971,118.569037656904,582.606694560669,1623.55230125523,512.209205020921,222.602510460251,1082.61087866109,133.066945606695,239,22.488819309795,13.5641656266401,0.797626629316659,0.948412698412698,0.742236024844721,0.0134689710854138,50027.8912133891,34207.489539749,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_307723,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
308104,1620.1256281407,143.98743718593,66.8140703517588,612.06783919598,613.884422110553,1851.15577889447,377.766331658291,253.977386934673,1087.4472361809,2704.42462311558,604.713567839196,109.369346733668,1066.64070351759,740.86432160804,416.050251256281,265.138190954774,1497.18341708543,1024.6783919598,217.115577889447,217.746231155779,1299.38190954774,713.881909547739,155.922110552764,126.404522613065,593.494974874372,1068.65829145729,494.856783919598,219.256281407035,1026.57537688442,129.479899497487,398,32.6474634843784,15.7625832004081,0.875724094206141,0.949880668257756,0.709447415329768,-1.44887104263162,51351.5879396985,34243.0452261307,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_308104,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
309175,4627.07971014493,982.264492753623,601.753623188406,630.420289855072,1032.90579710145,4907.60869565217,690.213768115942,274.159420289855,1154.0,7761.66666666667,565.554347826087,120.782608695652,1071.67753623188,5951.90579710145,1031.04710144928,851.576086956522,1960.20652173913,3692.86594202899,370.981884057971,241.880434782609,1054.79710144928,2498.07246376812,4532.71739130435,310.126811594203,657.021739130435,3348.78985507246,557.561594202899,339.478260869565,1067.38405797101,130.576086956522,276,18.8471605803844,18.6715167527216,0.136205384123296,0.978723404255319,0.851851851851852,-0.0725419337023701,51052.5471014493,35760.4782608696,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_309175,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
309302,1703.69888475836,400.468401486989,198.026022304833,705.791821561338,4819.93680297398,2058.22304832714,391.431226765799,259.334572490706,1108.28252788104,3181.93680297398,535.788104089219,114.223048327138,1083.39776951673,845.31970260223,506.442379182156,276.252788104089,1466.49442379182,1042.75464684015,275.591078066915,230.89219330855,994.100371747212,956.802973977695,195.28624535316,143.401486988848,596.31970260223,1389.50185873606,507.204460966543,236.204460966543,1068.156133829,130.981412639405,269,21.6622834533782,16.0359257599818,0.672310347055373,0.943859649122807,0.719251336898396,1.25306749169764,51352.2565055762,35008.6914498141,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_309302,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
309702,4732.37086092715,385.225165562914,112.711920529801,618.721854304636,814.884105960265,4529.12913907285,499.046357615894,266.32119205298,1095.62251655629,6137.61589403974,612.476821192053,121.751655629139,1082.84105960265,944.970198675497,753.172185430464,282.466887417219,2457.6821192053,1858.7119205298,309.288079470199,234.996688741722,1037.81125827815,1826.2582781457,218.470198675497,686.953642384106,2727.91721854305,1324.13245033113,487.350993377483,230.26821192053,1024.14900662252,129.917218543046,302,23.4633610960506,16.4729732858467,0.71210577967183,0.952681388012618,0.719047619047619,0.992253941048563,51940.7284768212,34211.9072847682,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_309702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
310100,1891.42735042735,110.876068376068,49.1410256410256,626.145299145299,1489.82478632479,2069.26068376068,347.141025641026,250.102564102564,1082.67948717949,3271.24358974359,643.388888888889,118.91452991453,1083.04700854701,2373.47008547008,1270.97435897436,1616.86324786325,2172.17094017094,3280.97008547008,406.92735042735,249.363247863248,1072.5,2229.02136752137,273.679487179487,818.858974358974,687.897435897436,1177.87179487179,504.059829059829,221.132478632479,1041.57264957265,129.337606837607,234,20.5569929659724,14.6316549618807,0.702422262083839,0.955102040816326,0.73125,1.13535351255333,51477.8247863248,33959.2008547009,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_310100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
311459,1116.71745152355,113.534626038781,115.465373961219,677.052631578947,3869.20498614958,1181.08587257618,294.542936288089,254.573407202216,1097.93628808864,2559.18836565097,717.728531855956,112.08864265928,1067.16620498615,2879.6620498615,632.224376731302,318.969529085873,1568.05263157895,4858.69529085873,442.686980609418,254.096952908587,1105.87534626039,4923.46537396122,310.678670360111,778.850415512465,790.083102493075,1207.00831024931,418.700831024931,221.393351800554,1062.64265927978,130.650969529086,361,26.8449911616536,17.3980618590504,0.761560852541297,0.94750656167979,0.694230769230769,0.339696030616435,50033.2659279778,35306.0249307479,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_311459,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
311702,3715.84493670886,748.037974683544,184.759493670886,678.148734177215,3785.74050632911,4248.8670886076,2117.28164556962,273.405063291139,1112.15189873418,7614.75632911392,682.272151898734,119.411392405063,1087.57911392405,5002.56962025316,866.731012658228,304.879746835443,2944.44620253165,2686.52848101266,362.509493670886,244.009493670886,1031.99683544304,1763.28164556962,234.462025316456,250.674050632911,585.727848101266,2890.52848101266,565.835443037975,538.556962025316,1077.17088607595,130.29746835443,316,22.2443350046723,18.131898684724,0.579286047943114,0.96048632218845,0.752380952380952,0.667711943992196,51250.3797468354,35045.2626582278,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_311702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
311921,3004.77962085308,530.483412322275,92.414691943128,632.744075829384,1377.79620853081,3435.37203791469,1543.67061611374,268.957345971564,1162.55687203791,5565.87203791469,1524.31516587678,122.298578199052,1096.73222748815,1396.13744075829,591.886255924171,315.111374407583,1572.08293838863,1089.43838862559,281.774881516588,228.504739336493,1003.38388625592,1133.49763033175,823.227488151659,209.142180094787,583.514218009479,2367.65165876777,534.367298578199,343.436018957346,1061.04502369668,129.018957345972,422,27.0432359101029,20.0536682803071,0.670907550200188,0.963470319634703,0.811538461538462,0.141076553552732,51456.4478672986,35785.7582938389,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_311921,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
311967,2963.61811023622,721.905511811024,759.952755905512,658.492125984252,2773.84251968504,3111.35826771654,698.204724409449,265.700787401575,1163.55511811024,4306.13385826772,933.015748031496,116.996062992126,1076.44488188976,660.59842519685,452.177165354331,289.031496062992,1475.01968503937,987.055118110236,268.771653543307,227.759842519685,993.200787401575,787.574803149606,178.51968503937,148.716535433071,626.177165354331,1217.92519685039,496.968503937008,302.996062992126,1038.87795275591,132.42125984252,254,20.7998194892151,15.645759555248,0.658927440220305,0.965779467680608,0.742690058479532,-0.865275006662068,51563.6692913386,34933.0236220472,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_311967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
312575,4497.65482233503,870.730964467005,754.756345177665,621.786802030457,916.979695431472,3861.10659898477,398.451776649746,272.055837563452,1099.1269035533,7623.51269035533,567.857868020305,117.725888324873,1079.67005076142,740.426395939086,513.071065989848,1097.41624365482,1623.72081218274,1016.3654822335,261.05076142132,226.005076142132,1034.92385786802,985.208121827411,214.289340101523,206.812182741117,593.492385786802,3513.4923857868,538.41116751269,264.964467005076,1040.2385786802,129.979695431472,197,23.7105782201225,10.6616064844624,0.893201756790811,0.95631067961165,0.778656126482213,1.4294310038677,50927.0913705584,35622.4822335025,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_312575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
313304,1878.74587458746,378.871287128713,146.026402640264,652.244224422442,2544.26402640264,2405.87458745875,426.914191419142,260.273927392739,1123.42244224422,3092.72277227723,712.118811881188,120.046204620462,1074.50165016502,1717.18151815182,524.498349834984,287.877887788779,1572.55115511551,3706.06270627063,412.257425742574,247.349834983498,1047.52145214521,3229.37623762376,255.260726072607,161.049504950495,710.356435643564,1191.6699669967,547.092409240924,294.145214521452,1046.56105610561,130.115511551155,303,22.8997899234715,16.992041928593,0.670380653273633,0.983766233766234,0.860795454545455,1.45548290434255,51030.8349834984,33890.1419141914,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_313304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
313756,2751.09685863874,222.217277486911,105.861256544503,646.82722513089,2886.23821989529,2948.26701570681,488.782722513089,257.950261780105,1089.18062827225,5313.99738219895,571.897905759162,116.261780104712,1074.60994764398,1747.46596858639,871.397905759162,709.130890052356,1763.45811518325,3187.20942408377,329.091623036649,232.960732984293,1034.29581151832,3275.28534031414,283.61780104712,414.541884816754,712.513089005236,1991.28534031414,510.7722513089,234.562827225131,1048.69633507853,129.743455497382,382,31.1131355130494,15.8231984733774,0.861020815409254,0.950248756218906,0.6112,0.693441763200734,51996.0732984293,34353.4816753927,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_313756,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
313906,1020.93286219081,459.33038869258,186.203180212014,675.137809187279,4497.38869257951,1246.44346289753,1872.89399293286,262.567137809187,1094.96996466431,2167.46113074205,5430.31625441696,118.71554770318,1074.66961130742,2797.71554770318,793.770318021201,297.033568904594,1939.5777385159,2390.78621908127,322.881625441696,239.180212014134,1018.78268551237,2043.20141342756,974.611307420495,346.644876325088,587.731448763251,1159.03356890459,511.63074204947,423.496466431095,1062.83215547703,131.643109540636,566,37.6608416330072,19.6049779456294,0.853821040367564,0.959322033898305,0.629588431590656,0.69701299042223,51648.5883392226,34441.9081272085,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_313906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
314312,2707.01438848921,175.731414868106,75.0047961630695,611.621103117506,224.63309352518,3345.85131894484,391.690647482014,258.254196642686,1087.3860911271,4280.90167865707,697.395683453237,123.870503597122,1065.86570743405,1671.18225419664,890.328537170264,302.911270983213,1941.94244604317,2032.95443645084,407.964028776978,252.637889688249,1065.04316546763,1424.103117506,258.232613908873,221.141486810552,1967.103117506,1342.1175059952,517.947242206235,227.335731414868,1043.89928057554,130.213429256595,417,31.25487757253,17.0381594563552,0.838347614957576,0.956422018348624,0.668269230769231,-0.728848890237634,51013.2853717026,33797.1990407674,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_314312,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
314670,1069.275,265.58,130.13,647.4,2513.635,1088.485,349.2,264.225,1083.48,1742.78,477.565,113.02,1080.56,917.83,555.73,296.825,1533.945,1515.67,343.545,241.175,992.125,1523.305,245.12,163.55,587.785,1063.72,492.375,222.83,1027.325,128.995,200,17.3679530395937,14.6569371703118,0.536489490081059,0.966183574879227,0.784313725490196,1.21997479561381,51426.055,35371.25,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_314670,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
314777,5440.52173913043,986.010869565217,341.907608695652,640.483695652174,1206.07065217391,5475.47282608696,630.755434782609,282.760869565217,1096.41847826087,7916.00543478261,1029.14673913043,122.494565217391,1073.99456521739,939.875,650.364130434783,307.586956521739,1700.75543478261,1200.6902173913,310.08152173913,229.994565217391,997.923913043478,1072.10326086957,223.907608695652,191.896739130435,972.820652173913,2124.03260869565,536.266304347826,281.179347826087,1050.02173913043,130.538043478261,184,21.0651879231107,11.6472374972741,0.833238320681523,0.92,0.707692307692308,-0.0787195703920138,51889.0108695652,35169.375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_314777,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
315026,3219.09836065574,545.495901639344,847.33606557377,623.372950819672,710.598360655738,3217.50409836066,690.213114754098,275.676229508197,1110.95081967213,6824.06967213115,775.905737704918,114.487704918033,1079.31147540984,730.364754098361,458.069672131148,280.323770491803,1444.90983606557,1084.59016393443,320.147540983607,240.811475409836,996.491803278688,1008.34836065574,241.606557377049,144.97131147541,591.188524590164,3440.37704918033,569.918032786885,369.950819672131,1059.99180327869,131.58606557377,244,21.8809820046619,14.3548569141236,0.754723838004442,0.968253968253968,0.726190476190476,0.407614114163485,51198.8893442623,35420.6147540984,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315026,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
315334,3048.40104166667,808.604166666667,577.359375,613.231770833333,489.932291666667,3599.921875,896.018229166667,270.403645833333,1117.09635416667,6047.05729166667,724.255208333333,119.010416666667,1067.95052083333,610.791666666667,467.322916666667,272.140625,1454.6015625,1024.36458333333,279.502604166667,229.065104166667,1001.9375,965.380208333333,217.0234375,165.635416666667,602.5703125,2709.76041666667,546.890625,265.903645833333,1050.8671875,130.7890625,384,26.4133592289923,18.5419514557885,0.712185405191211,0.967254408060453,0.725897920604915,-0.825791642820143,50481.3255208333,35488.9479166667,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315334,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
315938,2920.68897637795,171.570866141732,165.169291338583,691.877952755906,6253.46850393701,2826.62598425197,340.149606299213,266.751968503937,1091.99606299213,5644.69291338583,578.870078740158,123.791338582677,1074.74409448819,906.913385826772,501.464566929134,288.330708661417,1603.99212598425,941.066929133858,219.05905511811,218.665354330709,1165.66929133858,704.622047244094,158.767716535433,144.405511811024,602.574803149606,2012.45275590551,712.92125984252,294.0,1089.25984251968,130.96062992126,254,23.9692340025225,13.5926210827556,0.823658471093806,0.954887218045113,0.690217391304348,1.11841619634951,51823.2559055118,34812.2992125984,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
316499,2285.79452054795,368.468493150685,81.6493150684932,628.304109589041,1034.59178082192,2777.08219178082,1877.98082191781,265.583561643836,1097.16712328767,4826.24109589041,889.819178082192,109.8,1066.91232876712,791.758904109589,526.504109589041,276.175342465753,1506.26849315068,1212.7397260274,305.635616438356,230.695890410959,1089.75342465753,1052.10684931507,219.213698630137,149.21095890411,2650.91232876712,2334.6602739726,483.038356164384,790.53698630137,1071.72328767123,130.504109589041,365,26.087312190899,17.8402131368305,0.729608086572781,0.973333333333333,0.811111111111111,0.232529946476891,50226.4301369863,35105.1643835616,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_316499,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
316575,756.89010989011,59.6227106227106,120.739926739927,676.065934065934,4051.59340659341,479.047619047619,238.771062271062,232.90293040293,1079.05128205128,1042.51831501831,486.31684981685,123.289377289377,1066.07326007326,538.239926739927,335.937728937729,255.880952380952,1439.36446886447,712.677655677656,186.921245421245,214.386446886447,992.928571428571,638.987179487179,141.998168498168,127.758241758242,584.040293040293,733.234432234432,429.0,212.899267399267,1021.12271062271,140.064102564103,546,30.384673319494,23.0400858987262,0.651929176008121,0.969804618117229,0.791304347826087,-0.132058992797673,51337.63003663,34011.0604395604,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_316575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
316841,1475.91529411765,190.04,52.5905882352941,676.171764705882,785.522352941176,1977.30823529412,699.122352941176,255.235294117647,1091.79058823529,3635.50823529412,2140.30823529412,108.985882352941,1077.47294117647,5377.70352941176,1770.46117647059,1376.38352941176,3369.80470588235,10101.8211764706,537.277647058824,269.684705882353,1029.19294117647,11141.6305882353,371.729411764706,862.207058823529,832.225882352941,2029.91529411765,503.571764705882,458.550588235294,1064.93176470588,130.654117647059,425,31.4907946185072,17.8177153680991,0.824537639421549,0.959367945823928,0.721561969439728,-0.189141222633928,50621.6705882353,34301.8070588235,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_316841,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
316879,1127.91907514451,203.277456647399,78.5028901734104,618.884393063584,745.098265895954,1130.26011560694,1020.98265895954,262.150289017341,1082.11560693642,2648.46242774566,1219.70520231214,109.49710982659,1068.50867052023,934.901734104046,518.606936416185,290.485549132948,1569.20231213873,925.751445086705,219.791907514451,215.676300578035,1234.82658959538,691.28901734104,177.011560693642,226.78612716763,587.040462427746,1345.00578034682,461.624277456647,258.57225433526,1036.27167630058,129.219653179191,173,17.3688286442929,12.6801743163974,0.683389985683929,0.977401129943503,0.772321428571429,0.969619015888947,51627.0924855491,35692.5895953757,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_316879,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
317425,1754.6985915493,204.901408450704,85.0816901408451,660.028169014084,1313.63943661972,2086.92394366197,910.416901408451,255.157746478873,1085.08732394366,3870.95211267606,509.4,109.284507042254,1075.28169014085,914.825352112676,509.870422535211,288.816901408451,1618.17464788732,1040.71549295775,217.391549295775,218.698591549296,1257.71830985915,740.797183098592,160.033802816901,151.369014084507,610.140845070423,1830.17746478873,484.501408450704,1105.89295774648,1061.50422535211,128.247887323944,355,24.5101917473745,18.5308407721123,0.654518090834008,0.964673913043478,0.771739130434783,0.96637096213675,51863.1183098592,34891.6647887324,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_317425,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
317977,4147.79179810726,691.116719242902,80.9716088328076,652.940063091483,2333.64984227129,4623.11987381704,385.05047318612,276.10094637224,1222.6309148265,7504.23974763407,564.179810725552,122.160883280757,1096.2334384858,2046.97160883281,618.135646687697,293.239747634069,2146.64984227129,3384.66561514196,393.261829652997,245.268138801262,1085.3880126183,3026.52365930599,261.410094637224,426.958990536278,674.495268138801,2974.6309148265,506.034700315457,237.463722397476,1089.21135646688,132.356466876972,317,20.3500339197686,19.8867599356716,0.212160975090279,0.949101796407186,0.718820861678005,0.165799456597473,50636.7223974763,35583.8990536278,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_317977,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
318384,4646.95486935867,1150.49643705463,681.988123515439,658.748218527316,2209.67933491686,4712.71971496437,913.698337292162,271.672209026128,1142.41805225653,7309.94536817102,560.790973871734,140.035629453682,1079.84560570071,2342.27790973872,626.463182897862,330.957244655582,1912.71258907363,2917.1377672209,352.596199524941,235.774346793349,1053.82660332542,2437.52019002375,252.375296912114,261.230403800475,1392.42517814727,2563.42280285036,535.434679334917,420.32541567696,1072.69121140143,131.377672209026,421,28.3583482822308,19.115675208258,0.738662215085093,0.952488687782805,0.715986394557823,0.271837312007132,51262.4299287411,35867.4465558195,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_318384,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
318747,1846.9011299435,254.093220338983,81.9632768361582,618.813559322034,794.420903954802,1914.78531073446,3546.82768361582,268.977401129944,1093.53389830508,2758.40395480226,1438.79943502825,114.966101694915,1065.69774011299,2147.25423728814,1231.58192090395,1159.54802259887,2235.81073446328,2803.20621468927,320.824858757062,237.079096045198,1045.97457627119,2785.93502824859,268.731638418079,503.610169491525,753.985875706215,1041.97175141243,493.709039548023,314.353107344633,1027.76271186441,128.968926553672,354,26.4002212365911,17.1539139891257,0.760135983177345,0.96195652173913,0.732919254658385,0.686258274563847,52037.0169491526,35112.709039548,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_318747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
319280,2478.50461538462,154.815384615385,161.123076923077,706.756923076923,5418.21846153846,2748.6,1868.08615384615,262.015384615385,1098.42153846154,5173.27692307692,2522.88307692308,125.356923076923,1079.32615384615,2006.96307692308,543.08,304.313846153846,2462.82769230769,3013.49230769231,347.609230769231,235.572307692308,1065.43076923077,3258.91076923077,231.956923076923,161.110769230769,591.92,1879.85846153846,517.541538461538,725.046153846154,1067.27692307692,131.547692307692,325,22.9735430975055,18.0497040355765,0.618641374174981,0.973053892215569,0.820707070707071,0.223297415570395,51947.0215384615,34283.4246153846,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_319280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
319371,3512.02362204724,508.307086614173,82.2992125984252,649.464566929134,1078.77165354331,4293.11023622047,1479.94488188976,273.913385826772,1114.07086614173,7070.8031496063,647.779527559055,119.614173228346,1090.0157480315,1389.9842519685,560.700787401575,303.385826771654,1793.86614173228,1665.02362204724,304.771653543307,237.795275590551,1006.90551181102,1262.62992125984,224.03937007874,330.692913385827,1765.55905511811,3096.77165354331,560.259842519685,824.51968503937,1052.16535433071,129.330708661417,127,14.9121641557317,10.9292010610411,0.680330893239136,0.913669064748201,0.651282051282051,0.54189242874478,52010.7559055118,35223.6771653543,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_319371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
319770,2422.30886075949,323.812658227848,146.470886075949,662.521518987342,2745.24810126582,2381.78481012658,374.711392405063,269.739240506329,1109.28607594937,3890.4582278481,501.455696202532,119.007594936709,1112.40759493671,1686.45063291139,1691.13164556962,531.607594936709,1859.75443037975,2293.96962025316,331.567088607595,238.141772151899,1019.85569620253,1436.18227848101,230.367088607595,283.967088607595,694.830379746835,1120.36708860759,498.881012658228,230.807594936709,1024.90126582278,129.863291139241,395,36.8771414957941,14.7617311169341,0.916386384110552,0.897727272727273,0.645424836601307,0.0154951479998288,50610.7949367089,35239.0962025316,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_319770,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
320200,2439.37431693989,315.571038251366,111.398907103825,684.341530054645,3204.67759562842,2686.72404371585,1944.24590163934,264.871584699454,1102.22131147541,4458.4043715847,540.956284153005,111.344262295082,1086.92896174863,937.338797814208,674.55737704918,286.743169398907,1642.89617486339,1712.6912568306,313.229508196721,236.20218579235,1018.96174863388,1636.43442622951,232.22131147541,525.571038251366,1051.04918032787,1230.49726775956,471.404371584699,1133.95355191257,1061.27868852459,130.734972677596,366,26.1008471318511,18.2662102137673,0.714307395833382,0.943298969072165,0.665454545454545,0.598042635948638,51702.3879781421,35152.2759562842,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_320200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
320461,2100.90909090909,707.090909090909,123.324675324675,612.47619047619,999.060606060606,2549.01298701299,406.861471861472,259.376623376623,1114.61904761905,5012.03463203463,661.064935064935,108.350649350649,1063.29004329004,761.051948051948,781.281385281385,340.597402597403,1504.38095238095,1318.28138528139,372.774891774892,248.121212121212,995.090909090909,1194.16017316017,243.393939393939,141.848484848485,626.077922077922,3083.64069264069,548.268398268398,242.926406926407,1040.44155844156,129.090909090909,231,19.3826573733699,15.2135873132061,0.619613337933519,0.970588235294118,0.759868421052632,1.13708573552028,51391.6233766234,34957.8744588745,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_320461,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
320783,1387.51604938272,228.745679012346,98.962962962963,643.17037037037,1731.13333333333,1758.18271604938,340.898765432099,260.854320987654,1083.84938271605,3203.07407407407,548.261728395062,122.311111111111,1070.50864197531,684.375308641975,475.745679012346,292.866666666667,1547.1950617284,1069.52345679012,302.392592592593,233.607407407407,1006.93580246914,992.444444444444,205.471604938272,150.775308641975,592.318518518519,1625.46419753086,534.414814814815,243.943209876543,1035.58024691358,132.185185185185,405,32.1856744747401,16.3830315952679,0.860756904522244,0.961995249406176,0.675,-0.415071371997141,50680.9555555556,34486.1061728395,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_320783,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
320999,2184.22289156626,254.469879518072,168.692771084337,663.855421686747,3425.35542168675,2585.28313253012,357.909638554217,261.289156626506,1079.99397590361,4564.93373493976,530.126506024096,114.343373493976,1079.5,548.897590361446,369.644578313253,260.674698795181,1413.40361445783,863.012048192771,245.457831325301,228.66265060241,985.909638554217,791.674698795181,186.367469879518,138.704819277108,581.873493975904,2320.03012048193,516.951807228916,231.740963855422,1060.6686746988,130.620481927711,166,21.6689054786479,9.73536359924653,0.893391982156401,0.959537572254335,0.691666666666667,1.16492835103737,51334.5240963855,34930.5240963855,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_320999,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
321328,3423.03179190751,180.193641618497,157.554913294798,690.057803468208,5404.6098265896,3838.15606936416,381.317919075145,265.147398843931,1112.04046242775,5657.10115606936,574.939306358381,130.341040462428,1071.84104046243,3302.7225433526,713.462427745665,330.575144508671,2283.78612716763,3104.80346820809,419.294797687861,249.332369942196,1048.26589595376,2158.08092485549,255.419075144509,158.56936416185,2423.3063583815,1083.38439306358,484.043352601156,227.57225433526,1039.67919075145,130.806358381503,346,28.1354924026137,15.7490235600582,0.82865717168049,0.953168044077135,0.692,-1.04813382150521,51311.7803468208,34100.0202312139,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_321328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
321498,1785.73469387755,160.867346938776,212.55612244898,718.716836734694,7736.73724489796,2022.29591836735,401.795918367347,273.104591836735,1110.20663265306,3752.64285714286,636.908163265306,117.303571428571,1075.43112244898,1668.37244897959,595.22193877551,282.56887755102,1606.23979591837,1289.22704081633,300.571428571429,232.515306122449,1030.7806122449,1277.31887755102,234.058673469388,439.285714285714,1176.43367346939,1540.35204081633,447.936224489796,233.336734693878,1073.70918367347,129.247448979592,392,34.582443330119,14.5054690540427,0.907780268563912,0.953771289537713,0.746666666666667,1.4916041004665,51697.8367346939,35638.8775510204,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_321498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
321832,2961.33079847909,372.144486692015,84.1825095057034,631.551330798479,971.228136882129,3094.04942965779,2023.68821292776,267.722433460076,1092.85551330798,4927.19391634981,2705.63498098859,114.51711026616,1078.86692015209,1011.39543726236,1182.49809885932,795.460076045627,1644.19771863118,1141.36501901141,271.634980988593,221.574144486692,1000.34600760456,1025.27756653992,256.908745247148,216.779467680608,699.441064638783,1248.2927756654,450.657794676806,385.950570342205,1069.44866920152,131.125475285171,263,20.8455288986915,16.0822057184453,0.636236292295506,0.963369963369963,0.769005847953216,-0.843152462487123,50193.5209125475,35259.6425855513,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_321832,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
322515,2056.52717391304,290.554347826087,118.489130434783,641.54347826087,2079.35326086957,2504.15760869565,548.907608695652,277.125,1104.03804347826,3231.40760869565,912.896739130435,123.440217391304,1067.96739130435,867.722826086957,481.858695652174,273.065217391304,1490.95652173913,3103.14130434783,396.461956521739,245.576086956522,1038.40217391304,3756.96195652174,260.777173913043,234.858695652174,588.04347826087,1521.96195652174,595.576086956522,341.445652173913,1077.27173913043,131.114130434783,184,20.6645688898499,11.4644258258041,0.831992688214597,0.938775510204082,0.657142857142857,-0.467492427667836,50744.8913043478,34727.6739130435,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_322515,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
322653,4618.16872427984,725.77366255144,142.106995884774,641.938271604938,2059.51440329218,4688.38271604938,578.740740740741,286.740740740741,1099.70781893004,7682.9670781893,977.053497942387,123.288065843621,1076.83127572016,786.098765432099,516.497942386831,281.028806584362,1478.10288065844,1099.04938271605,295.736625514403,233.547325102881,994.24279835391,969.893004115226,213.559670781893,144.0,587.111111111111,2385.48971193416,536.028806584362,414.407407407407,1070.96296296296,131.362139917695,243,22.4228179891252,13.9512244891377,0.782867289557543,0.952941176470588,0.771428571428571,1.27540245913845,50971.1769547325,35304.037037037,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_322653,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
322682,2654.82162162162,673.32972972973,1042.14054054054,630.443243243243,627.989189189189,2525.72972972973,943.340540540541,258.864864864865,1108.42702702703,3854.12432432432,565.243243243243,125.172972972973,1068.9027027027,812.05945945946,573.102702702703,299.983783783784,1682.40540540541,1071.09189189189,248.237837837838,219.340540540541,1001.55135135135,1022.34594594595,211.52972972973,257.87027027027,587.708108108108,1166.05405405405,444.372972972973,553.443243243243,1027.78378378378,129.064864864865,185,19.4110578240725,12.2404051346862,0.776116711406648,0.95360824742268,0.685185185185185,0.563727253909505,51239.4432432433,35847.2162162162,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_322682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
322702,2909.578125,379.290178571429,124.600446428571,619.479910714286,672.852678571429,2682.18973214286,1472.66964285714,269.111607142857,1097.1875,2899.83258928571,941.261160714286,111.428571428571,1069.015625,1631.26116071429,745.609375,365.988839285714,1788.03348214286,1474.24330357143,343.819196428571,246.631696428571,997.618303571429,1082.62723214286,242.261160714286,154.892857142857,595.171875,717.466517857143,414.165178571429,246.587053571429,1002.63169642857,131.350446428571,448,29.9847995186704,19.3251262963806,0.7646064738284,0.96551724137931,0.772413793103448,0.14047636001044,51994.3616071429,34691.9174107143,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_322702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
322995,2123.35031847134,942.535031847134,607.904458598726,624.847133757962,1339.50318471338,2013.45859872611,789.942675159236,262.891719745223,1114.24203821656,2949.92356687898,624.84076433121,111.426751592357,1066.92993630573,937.96178343949,669.980891719745,290.254777070064,1665.89808917197,2380.29936305732,345.197452229299,244.535031847134,1046.40127388535,2514.67515923567,252.528662420382,434.210191082803,954.656050955414,920.025477707006,493.43949044586,334.630573248408,1031.89171974522,128.076433121019,157,15.4898836444951,12.9748542475997,0.546231789979091,0.957317073170732,0.754807692307692,1.56543754321121,51685.1719745223,35117.0828025478,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_322995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
323043,3892.98695652174,200.547826086956,94.404347826087,627.934782608696,944.713043478261,4451.60434782609,1019.52608695652,276.039130434783,1087.43913043478,7048.82173913044,857.960869565217,117.239130434783,1072.55217391304,801.317391304348,449.252173913043,272.947826086957,1429.08695652174,1045.24347826087,300.582608695652,230.317391304348,989.191304347826,973.630434782609,213.208695652174,146.739130434783,580.84347826087,1807.34347826087,520.986956521739,274.395652173913,1048.06086956522,131.439130434783,230,20.8588156550383,14.0895333934828,0.737386187174955,0.950413223140496,0.71875,0.333217380342742,51053.5086956522,35097.9217391304,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_323043,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
323278,4250.40506329114,507.101265822785,159.205696202532,638.667721518987,1623.11708860759,4910.48101265823,674.186708860759,274.655063291139,1132.46835443038,6958.14556962025,1381.4082278481,120.803797468354,1076.18987341772,4045.6329113924,917.848101265823,358.683544303797,2993.53164556962,1919.46518987342,300.018987341772,238.278481012658,1005.17088607595,1649.95569620253,225.803797468354,141.48417721519,592.142405063291,1942.74050632911,560.398734177215,603.996835443038,1078.01898734177,131.882911392405,316,21.8428553433657,18.581405117229,0.525674620239853,0.957575757575758,0.755980861244019,-1.25412969241111,51447.3797468354,35013.1044303797,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_323278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
323637,2609.61206896552,725.502873563218,1155.16666666667,642.75,2726.29310344828,2236.38505747126,385.965517241379,261.991379310345,1098.49712643678,5554.09482758621,491.57183908046,110.261494252874,1075.05459770115,929.847701149425,663.020114942529,338.925287356322,1517.3908045977,1064.65804597701,284.689655172414,230.988505747126,998.183908045977,977.652298850575,216.0,162.011494252874,616.158045977012,2791.81609195402,546.583333333333,255.117816091954,1053.47701149425,130.905172413793,348,25.9759393728309,17.1211887057785,0.752040226654116,0.948228882833788,0.732631578947368,-0.374656155825202,51628.25,35424.7557471264,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_323637,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
323826,5444.78424657534,635.58904109589,163.72602739726,672.421232876712,3068.64726027397,5808.56164383562,2173.63356164384,312.373287671233,1152.77397260274,7352.38698630137,3196.12671232877,143.520547945205,1085.97260273973,9370.33219178082,1906.02739726027,1997.85273972603,2647.75342465753,8285.91095890411,580.88698630137,275.804794520548,1061.17808219178,6719.19863013699,301.938356164384,415.575342465753,701.171232876712,1920.08219178082,515.11301369863,476.068493150685,1054.40068493151,131.284246575342,292,21.1883226210249,17.7564844545268,0.545621658407236,0.944983818770226,0.731829573934837,-0.383884026776428,51739.051369863,34777.3356164384,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_323826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
324409,2669.02272727273,138.116161616162,152.891414141414,696.94696969697,5464.36363636364,3320.92424242424,345.027777777778,258.075757575758,1099.15909090909,4960.04797979798,636.762626262626,128.368686868687,1057.88131313131,3154.68939393939,936.126262626263,1350.75757575758,7454.7803030303,4225.11363636364,429.020202020202,253.74494949495,1042.38888888889,3423.2904040404,248.921717171717,461.742424242424,700.679292929293,1247.01515151515,495.830808080808,229.090909090909,1074.71212121212,132.578282828283,396,24.0510504863864,21.0273066153487,0.485425392446388,0.956521739130435,0.785714285714286,0.0563075442763925,51280.202020202,34142.3055555556,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_324409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
324555,1497.9552238806,180.243781094527,95.4925373134328,631.532338308458,1090.17412935323,1767.41293532338,319.522388059701,250.328358208955,1103.10447761194,2654.57711442786,749.024875621891,113.666666666667,1069.38308457711,545.940298507463,386.174129353234,288.910447761194,1459.42786069652,862.820895522388,255.825870646766,226.835820895522,988.701492537314,837.024875621891,195.26368159204,142.92039800995,581.432835820896,956.601990049751,458.039800995025,213.248756218905,1043.35323383085,128.990049751244,201,23.1322469153414,11.2480406959393,0.87382008530705,0.930555555555556,0.587719298245614,-0.776981528382989,51389.0447761194,34444.0049751244,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_324555,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
325107,5259.8093220339,1220.72457627119,2583.48728813559,632.779661016949,1309.06355932203,4303.9406779661,1155.75847457627,273.881355932203,1110.34745762712,7768.55084745763,1166.39406779661,122.830508474576,1083.1906779661,1177.90677966102,608.377118644068,534.902542372881,1669.8093220339,1259.37711864407,296.665254237288,231.508474576271,996.262711864407,1194.58474576271,238.724576271186,224.296610169492,582.843220338983,2292.50423728814,563.792372881356,379.029661016949,1063.44491525424,131.470338983051,236,21.9335965567099,13.8967161948998,0.773676134344253,0.955465587044534,0.621052631578947,-0.781499989037278,51005.3813559322,35725.5296610169,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_325107,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
325118,2738.49211356467,242.757097791798,150.11356466877,710.350157728707,2657.6403785489,2887.93375394322,279.173501577287,245.539432176656,1099.21451104101,5130.60252365931,633.514195583596,120.668769716088,1068.53943217666,1441.37539432177,795.365930599369,291.009463722397,1854.60252365931,2510.46687697161,404.488958990536,248.86119873817,1037.08517350158,1953.15141955836,254.725552050473,440.416403785489,1553.27444794953,1986.03470031546,504.599369085174,218.640378548896,1051.14511041009,130.466876971609,317,26.7457757266394,15.1425987377097,0.82428996644219,0.954819277108434,0.667368421052632,-0.467272820543755,50037.5331230284,34272.5425867508,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_325118,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
325937,3786.62732919255,1081.03105590062,220.236024844721,688.416149068323,4494.37888198758,4401.87888198758,939.487577639752,274.850931677019,1156.23913043478,5368.62422360248,853.260869565217,128.5,1079.20807453416,866.152173913043,569.490683229814,281.732919254658,1680.48757763975,1028.98447204969,226.94099378882,222.487577639752,1257.17080745342,739.885093167702,154.804347826087,128.319875776398,934.012422360248,1476.48757763975,567.990683229814,260.462732919255,1064.46894409938,133.922360248447,322,24.7058058188257,16.6766264112429,0.73781004493105,0.952662721893491,0.706140350877193,1.04875133323387,51365.3291925466,34292.9689440994,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_325937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
326142,1539.73404255319,227.170212765957,77.6329787234042,625.260638297872,1066.15425531915,1834.66312056738,936.452127659574,269.856382978723,1097.53368794326,2653.99468085106,749.27304964539,111.457446808511,1078.56382978723,892.148936170213,580.757092198582,287.042553191489,1531.98226950355,1277.54432624113,284.859929078014,226.212765957447,1033.85106382979,1204.59574468085,218.847517730496,212.099290780142,674.723404255319,1057.46808510638,445.152482269504,307.585106382979,1040.17021276596,129.936170212766,564,31.5194417322813,22.8823810028984,0.687719272982176,0.974093264248705,0.777931034482759,-0.462722620036765,50572.6436170213,35486.6418439716,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_326142,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
327279,2996.39427312775,522.68281938326,166.742290748899,656.107929515419,3232.63436123348,3818.90088105727,3793.13436123348,275.030837004405,1096.05066079295,5783.37004405286,1312.29295154185,497.601321585903,1073.00220264317,1349.89647577093,541.112334801762,286.654185022026,1518.359030837,1445.99779735683,380.356828193833,249.86563876652,991.649779735683,1313.66299559471,243.887665198238,186.449339207048,584.876651982379,2305.140969163,581.552863436123,495.125550660793,1077.87004405286,132.566079295154,454,32.9019875184693,17.771822749203,0.841572384465937,0.957805907172996,0.746710526315789,-0.239018805227703,50875.4779735683,34418.1894273128,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_327279,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
327605,2788.7094017094,309.440170940171,84.8717948717949,635.57264957265,1323.9188034188,2468.85897435897,2648.7264957265,268.48717948718,1082.17094017094,5107.57692307692,941.525641025641,115.32905982906,1072.88888888889,1704.13675213675,1095.82905982906,1346.67521367521,1842.96581196581,2271.02991452991,304.111111111111,230.504273504273,998.978632478632,1952.65384615385,248.867521367521,240.179487179487,589.047008547009,2306.45726495727,522.393162393162,388.286324786325,1060.74358974359,129.504273504273,234,23.2105245708652,12.863626187041,0.832373401844284,0.943548387096774,0.65,-0.633024411694085,50992.1666666667,35745.2222222222,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_327605,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
327954,4153.6936026936,262.03367003367,100.377104377104,629.3367003367,1716.63973063973,4847.06397306397,592.010101010101,268.653198653199,1096.18518518519,8109.12121212121,606.872053872054,115.811447811448,1091.21885521886,872.794612794613,647.845117845118,487.286195286195,2213.55892255892,2492.53535353535,327.848484848485,236.451178451178,1029.61279461279,2384.95622895623,221.077441077441,527.225589225589,587.872053872054,2534.94612794613,519.818181818182,259.744107744108,1057.80808080808,128.952861952862,297,21.4706701145983,17.6384249032753,0.570190436811443,0.961165048543689,0.781578947368421,-0.920811858329942,51282.5824915825,35104.0134680135,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_327954,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
327972,3581.63402061856,440.948453608247,151.510309278351,635.051546391753,1328.05670103093,4425.26804123711,947.474226804124,296.319587628866,1084.44329896907,5502.20103092783,707.592783505155,124.412371134021,1074.13402061856,2250.38659793814,557.505154639175,294.505154639175,1626.78350515464,4678.06701030928,417.479381443299,257.30412371134,1036.07216494845,4778.00515463918,276.5,219.211340206186,586.164948453608,1520.65979381443,470.587628865979,219.814432989691,1044.07216494845,131.257731958763,194,21.1403674657418,11.8230635424598,0.828989068097838,0.96039603960396,0.729323308270677,-0.443291157761469,50295.0103092784,35357.4381443299,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_327972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
328376,3673.69207317073,326.481707317073,124.335365853659,639.606707317073,2050.43902439024,4383.94207317073,349.27743902439,272.439024390244,1109.24390243902,6869.19817073171,504.253048780488,120.518292682927,1080.1493902439,768.765243902439,613.548780487805,284.018292682927,1472.91463414634,1106.68902439024,282.207317073171,234.951219512195,999.192073170732,1000.05792682927,202.59756097561,173.835365853659,620.448170731707,2736.7256097561,544.393292682927,229.414634146341,1055.80182926829,131.103658536585,328,22.0193869833624,19.0231422253264,0.503617111130783,0.967551622418879,0.822055137844611,-0.997401699096823,51083.8841463415,35010.1615853659,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_328376,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
328668,1611.01416430595,645.909348441926,155.028328611898,654.600566572238,2199.54957507082,1634.33994334278,3382.77620396601,251.164305949009,1097.62039660057,2941.67705382436,1149.77337110482,103.677053824363,1075.84135977337,443.453257790368,300.084985835694,262.104815864023,1384.09348441926,731.28045325779,194.631728045326,212.175637393768,997.71954674221,662.178470254957,152.099150141643,125.912181303116,590.371104815864,791.492917847026,412.847025495751,631.535410764872,1033.82719546742,131.028328611898,353,23.4296062606583,19.3445476714666,0.564189330157504,0.972451790633609,0.807780320366133,-1.56600364827011,50497.1501416431,34998.5184135977,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_328668,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
329072,3410.30909090909,472.585454545455,104.316363636364,655.763636363636,3073.53818181818,4032.55636363636,1110.42181818182,267.330909090909,1199.09818181818,6574.96363636364,3203.69090909091,121.781818181818,1071.96,691.36,426.029090909091,272.52,1585.37090909091,1035.16,280.76,225.858181818182,990.269090909091,1001.95272727273,212.032727272727,141.178181818182,580.883636363636,2634.32727272727,569.836363636364,642.221818181818,1107.78909090909,132.534545454545,275,21.4001860961827,16.3888858331005,0.643044126341913,0.97864768683274,0.804093567251462,-0.899309400484711,52039.2218181818,34525.6945454545,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_329072,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
329873,1818.43103448276,177.936781609195,91.8275862068966,622.137931034483,1146.23563218391,2138.29885057471,307.01724137931,258.908045977012,1083.44252873563,3474.03448275862,522.626436781609,112.85632183908,1078.55747126437,997.310344827586,536.591954022988,310.522988505747,1551.07471264368,1027.79310344828,245.109195402299,222.011494252874,1137.25862068966,828.844827586207,168.942528735632,143.862068965517,2275.55172413793,1146.56896551724,461.919540229885,217.511494252874,1040.25862068966,130.890804597701,174,19.3475415126196,11.5064773650293,0.803928799188909,0.950819672131148,0.725,1.54728775207066,50564.5287356322,34406.5344827586,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_329873,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
330018,1900.86893203884,310.004854368932,908.873786407767,618.140776699029,1019.42233009709,1891.6359223301,368.694174757282,247.533980582524,1088.50485436893,3846.52912621359,422.116504854369,101.461165048544,1071.07281553398,3467.51941747573,1060.07766990291,1088.94174757282,1661.12621359223,2651.55339805825,337.572815533981,238.834951456311,1032.0145631068,2391.78640776699,240.825242718447,406.315533980582,839.81067961165,1308.95145631068,460.470873786408,238.898058252427,1021.94174757282,130.029126213592,206,18.1786723799094,14.4883454814843,0.603983398694919,0.949308755760369,0.762962962962963,-0.0927132649580577,51633.9805825243,35073.4805825243,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
330461,3020.54716981132,439.02358490566,124.846698113208,623.455188679245,445.570754716981,4058.97641509434,921.106132075472,284.599056603774,1097.0070754717,5397.02358490566,1178.20754716981,128.375,1070.79245283019,1377.93632075472,511.658018867925,317.936320754717,1471.75943396226,1269.96933962264,318.275943396226,435.844339622641,1004.85849056604,1129.77122641509,215.318396226415,161.507075471698,592.280660377358,2639.50471698113,634.542452830189,294.129716981132,1064.23820754717,130.275943396226,424,24.7588567948046,21.8390803933835,0.471115675702313,0.961451247165533,0.737391304347826,0.328416196379057,50669.0448113208,34752.3278301887,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330461,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
330485,3733.55072463768,654.966183574879,99.2850241545894,644.028985507246,2213.0,3031.39130434783,447.512077294686,263.874396135266,1116.46859903382,5452.01449275362,517.874396135266,110.36231884058,1083.68115942029,2506.23671497585,890.594202898551,1167.51207729469,2067.24637681159,6467.961352657,395.95652173913,252.246376811594,1001.66666666667,8386.961352657,285.072463768116,210.913043478261,629.217391304348,1687.74879227053,533.570048309179,430.425120772947,1036.70048309179,131.086956521739,207,18.7012742654469,14.157865973345,0.653352837626322,0.945205479452055,0.726315789473684,-1.2784723868839,51306.7729468599,35468.8937198068,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330485,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
330628,1995.84459459459,271.429054054054,112.084459459459,625.915540540541,1133.63175675676,2333.50675675676,593.753378378378,257.820945945946,1095.79391891892,3042.38851351351,541.966216216216,113.351351351351,1074.79391891892,2960.58783783784,566.466216216216,304.537162162162,1559.80405405405,2359.26689189189,348.273648648649,241.435810810811,1045.16216216216,1943.7027027027,228.635135135135,491.510135135135,1702.62837837838,1082.00337837838,479.898648648649,221.253378378378,1023.09459459459,133.675675675676,296,22.8221926867501,16.6452250824976,0.684147352120861,0.964169381107492,0.741854636591479,-0.997201374250892,51165.4662162162,34462.527027027,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330628,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
330979,4567.09615384615,554.783653846154,214.533653846154,782.432692307692,3831.1875,5136.37980769231,3374.31730769231,295.105769230769,1203.89903846154,8605.75961538462,4326.04326923077,135.100961538462,1086.00961538462,765.783653846154,721.173076923077,291.259615384615,1618.47596153846,1338.4375,402.245192307692,254.317307692308,993.548076923077,1304.09615384615,288.278846153846,156.173076923077,610.211538461538,4198.25480769231,629.451923076923,865.456730769231,1128.66346153846,132.591346153846,208,21.0264923308356,12.7247170889981,0.796092122301283,0.945454545454545,0.684210526315789,-0.575214965386674,50727.1394230769,35163.6105769231,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330979,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
331213,3092.63525835866,255.519756838906,147.419452887538,647.313069908815,2120.14893617021,3496.1641337386,346.987841945289,266.021276595745,1104.62310030395,5338.3556231003,665.498480243161,126.547112462006,1079.94832826748,2889.90881458967,584.398176291793,310.753799392097,1726.19452887538,3844.71732522796,401.316109422492,242.516717325228,1051.04559270517,2848.4376899696,236.601823708207,167.158054711246,780.814589665653,1326.73860182371,455.231003039514,212.498480243161,1053.30699088146,131.668693009119,329,25.5791004501898,16.5262836519607,0.763265118062382,0.959183673469388,0.685416666666667,-0.98456408960026,50204.0030395137,34670.1124620061,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_331213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
332976,2374.77922077922,221.519480519481,116.703463203463,644.727272727273,2115.61038961039,2751.94588744589,1876.19047619048,262.450216450216,1092.45021645022,4613.87878787879,624.190476190476,113.997835497835,1096.65151515152,835.41341991342,536.969696969697,282.073593073593,1453.57575757576,1199.8961038961,324.88961038961,240.272727272727,984.753246753247,1130.69264069264,232.417748917749,139.757575757576,583.435064935065,1497.68181818182,480.071428571429,757.164502164502,1053.94372294372,130.203463203463,462,29.0271701688116,20.3547102624603,0.712935537178771,0.970588235294118,0.7392,0.782141430098398,51344.2748917749,35075.6385281385,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_332976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
333487,3539.14229249012,359.466403162055,115.798418972332,636.312252964427,1570.37154150198,3491.61264822134,1754.38339920949,270.509881422925,1089.46640316206,5759.1976284585,1201.85375494071,114.616600790514,1078.8814229249,663.95652173913,555.577075098814,278.683794466403,1482.32015810277,938.739130434783,269.96837944664,225.383399209486,986.339920948617,869.620553359684,199.00395256917,138.723320158103,585.209486166008,1409.52964426877,472.205533596838,385.379446640316,1036.07114624506,132.9604743083,253,18.6299036025589,17.4083964755582,0.356139007039488,0.958333333333333,0.780864197530864,-0.332790074236394,50801.4387351779,35211.7470355731,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_333487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
333523,2535.05777777778,679.537777777778,116.284444444444,632.075555555556,1911.17777777778,2388.44,1161.84888888889,271.866666666667,1117.53777777778,4239.68,672.404444444444,112.6,1075.48888888889,1524.2,1078.54222222222,1822.22666666667,2148.48444444444,4450.51111111111,359.217777777778,259.102222222222,1011.64,5758.93333333333,264.697777777778,451.16,645.591111111111,1972.28444444444,460.351111111111,286.382222222222,1030.71555555556,129.257777777778,225,18.846251086524,15.2362976363257,0.588561513896969,0.953389830508475,0.778546712802768,-0.662847776600515,50974.0355555556,35601.1555555556,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_333523,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
333547,3388.89655172414,436.362068965517,123.675862068966,632.137931034483,1372.45517241379,3307.91724137931,2433.13448275862,279.951724137931,1097.66206896552,5907.16551724138,1470.45862068966,119.979310344828,1066.38965517241,1340.08275862069,708.179310344828,279.120689655172,1745.12068965517,2241.97931034483,371.148275862069,242.255172413793,1010.06551724138,2235.41034482759,253.41724137931,215.91724137931,1655.57931034483,2185.88620689655,536.889655172414,341.655172413793,1064.03793103448,131.241379310345,290,24.2902849453875,15.2846456480672,0.777203496159395,0.96989966555184,0.69047619047619,0.806287277337422,51546.5689655172,35450.0482758621,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_333547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
334340,4040.70526315789,760.308771929825,565.775438596491,723.687719298246,6279.64210526316,4629.70175438596,1175.63157894737,275.021052631579,1143.76842105263,7757.03859649123,819.291228070175,134.435087719298,1092.96140350877,2314.54385964912,545.256140350877,1383.64561403509,3759.38245614035,2704.58596491228,260.519298245614,233.249122807018,1018.44912280702,2896.20701754386,196.838596491228,254.322807017544,632.217543859649,3438.39298245614,626.168421052632,264.954385964912,1092.2701754386,133.101754385965,285,19.5551618482079,18.6304378255854,0.303874643852667,0.95959595959596,0.75,-0.388529585998268,51926.9368421053,34305.249122807,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334340,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
334619,2378.17843137255,309.986274509804,122.86862745098,651.066666666667,2204.30392156863,2665.54705882353,3735.3568627451,260.711764705882,1092.72745098039,4485.75882352941,1432.39607843137,113.472549019608,1079.39803921569,687.282352941176,488.392156862745,324.464705882353,1460.85294117647,1045.88039215686,318.898039215686,236.080392156863,990.909803921569,990.090196078431,226.090196078431,130.421568627451,583.652941176471,1441.18039215686,484.223529411765,397.590196078431,1061.21568627451,132.450980392157,510,32.371836657012,20.4504348428538,0.775184105562316,0.949720670391062,0.708333333333333,-0.438116502714672,50540.5215686275,34956.2784313725,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334619,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
334689,2698.87124463519,677.695278969957,439.270386266094,627.111587982833,1154.27038626609,3135.87124463519,385.098712446352,258.167381974249,1120.72961373391,4871.74678111588,497.390557939914,111.008583690987,1075.08583690987,3633.24463519313,1337.02575107296,797.081545064378,2796.85407725322,2579.22746781116,297.068669527897,232.412017167382,1024.47210300429,2029.7982832618,212.68669527897,686.399141630901,1017.05150214592,1727.95278969957,493.24034334764,233.918454935622,1039.95278969957,130.579399141631,233,21.8016575416854,13.6218795407117,0.780777351446556,0.958847736625514,0.792517006802721,-1.36712626574559,51478.0901287554,34981.4206008584,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334689,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
334705,2073.8624535316,630.736059479554,321.483271375465,649.42750929368,2374.53159851301,2927.32713754647,4135.54275092937,277.345724907063,1121.52044609665,4249.02973977695,795.063197026022,113.877323420074,1090.17843866171,3902.38661710037,786.825278810409,333.531598513011,3005.22304832714,5520.11152416357,413.635687732342,246.434944237918,1047.67286245353,5041.42750929368,269.702602230483,236.486988847584,593.628252788104,2129.92936802974,491.07063197026,446.371747211896,1053.5092936803,129.955390334572,269,20.9504824963199,16.4880216134686,0.616953490455849,0.967625899280576,0.747222222222222,-0.988060416992406,50901.5427509294,35543.2713754647,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
334795,3028.53086419753,431.172839506173,117.975308641975,638.991769547325,1917.49382716049,3462.2304526749,2149.16872427984,275.172839506173,1170.82304526749,5189.69547325103,2713.74485596708,117.061728395062,1073.59670781893,1162.68312757202,461.411522633745,284.246913580247,1693.88065843621,1312.89300411523,277.242798353909,225.716049382716,1014.00411522634,1254.92592592593,213.078189300412,234.995884773663,596.510288065844,2028.41975308642,469.255144032922,466.534979423868,1057.97119341564,129.650205761317,243,21.4739882860358,14.4798239069437,0.7384611944325,0.94921875,0.771428571428571,1.33503646086851,50846.3004115226,35590.9259259259,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334795,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
335196,2279.83012820513,699.5,1248.14423076923,627.400641025641,1588.41346153846,2634.11217948718,487.599358974359,262.496794871795,1093.29487179487,3243.15384615385,675.173076923077,117.160256410256,1065.8108974359,1142.75961538462,806.352564102564,293.410256410256,2127.45512820513,1604.27564102564,295.416666666667,230.929487179487,1101.12179487179,1215.38461538462,191.830128205128,137.538461538462,3819.92948717949,1011.66025641026,536.227564102564,336.61858974359,1029.47115384615,130.480769230769,312,22.6653084479795,17.6586943622842,0.626891300289985,0.951219512195122,0.746411483253589,1.05314854661901,51347.4102564103,34301.1730769231,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335196,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
335337,2069.47387387387,383.506306306306,178.983783783784,651.171171171171,3089.6954954955,2945.71351351351,385.895495495495,272.684684684685,1090.44144144144,3858.25765765766,567.641441441441,128.288288288288,1070.41621621622,706.848648648649,614.700900900901,277.484684684685,1405.78558558559,1100.08828828829,339.237837837838,239.821621621622,991.92972972973,1074.36216216216,230.279279279279,131.075675675676,583.971171171171,1901.28288288288,537.722522522522,227.706306306306,1050.66126126126,129.702702702703,555,32.5620329593306,21.9305758239986,0.739185917895926,0.958549222797927,0.711538461538462,0.626952234916033,50677.209009009,34679.2882882883,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_335337,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
335626,3162.69014084507,504.661971830986,185.903420523139,696.112676056338,3846.96177062374,3267.5291750503,4397.50301810865,277.883299798793,1108.75855130785,5102.50905432596,3228.31589537223,120.611670020121,1086.5754527163,2463.53722334004,993.243460764588,1416.7967806841,2032.22132796781,2743.14889336016,360.090543259557,233.79476861167,1055.59959758551,2113.36016096579,229.199195171026,657.607645875251,613.187122736418,1633.53521126761,487.79476861167,1243.87323943662,1078.36217303823,132.346076458753,497,37.050929519208,17.3680408011051,0.8833248955596,0.943074003795066,0.57258064516129,0.873339195644374,51350.4446680081,35621.9899396378,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335626,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
335843,2932.76861702128,336.204787234043,196.23670212766,690.94414893617,5165.32978723404,2956.39095744681,484.502659574468,259.808510638298,1094.65159574468,5369.27393617021,649.090425531915,125.768617021277,1114.35904255319,5257.00265957447,1419.55585106383,1747.30319148936,2282.21010638298,6165.71276595745,491.952127659574,262.178191489362,1103.32446808511,5096.85372340426,321.375,278.885638297872,644.640957446809,1014.60372340426,487.138297872341,225.518617021277,1021.67553191489,134.143617021277,376,27.9040817840542,17.2194927222686,0.786888001662367,0.947103274559194,0.688644688644689,-0.543327061521494,51585.045212766,33833.1728723404,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
336036,3059.18654434251,153.969418960245,89.4556574923547,638.908256880734,2191.48929663609,3203.77675840979,317.975535168196,256.776758409786,1088.07645259939,4611.19571865443,578.795107033639,121.599388379205,1065.9755351682,782.204892966361,423.666666666667,269.718654434251,1710.06422018349,1018.53516819572,227.700305810398,218.837920489297,1108.92048929664,699.0,157.544342507645,128.308868501529,1220.63302752294,1026.36697247706,503.752293577982,222.966360856269,1032.29051987768,133.073394495413,327,23.1730472074619,18.0949456239416,0.624703902572864,0.958944281524927,0.741496598639456,-0.699440909540429,51336.3180428135,34068.0856269113,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_336036,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
336161,4467.42402826855,1278.54770318021,1302.82685512367,668.879858657244,2375.91519434629,3862.40636042403,1980.81272084806,280.282685512367,1127.47703180212,6521.20494699647,611.975265017668,121.063604240283,1070.71024734982,4160.62544169611,1105.55123674912,767.363957597173,1897.85159010601,2284.46643109541,395.328621908127,244.349823321555,1017.43462897527,1522.63250883392,267.208480565371,199.565371024735,610.996466431095,1846.20848056537,592.017667844523,1051.25088339223,1069.09187279152,130.840989399293,283,23.4780214564848,15.4587005702643,0.752639477163132,0.940199335548173,0.709273182957393,-0.549928157414179,51462.0494699647,35573.8445229682,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_336161,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
336251,1720.48181818182,691.295454545455,152.45,669.813636363636,4031.85,1211.44090909091,419.404545454545,263.145454545455,1096.84545454545,1018.14545454545,411.813636363636,106.477272727273,1065.51818181818,956.190909090909,1051.24545454545,2469.03636363636,1994.7,1703.34545454545,319.963636363636,233.004545454545,1028.27727272727,1636.21818181818,282.268181818182,251.236363636364,652.818181818182,757.531818181818,394.618181818182,213.731818181818,1002.86818181818,127.854545454545,220,19.7234506336735,15.0201310938438,0.648121814591052,0.859375,0.61624649859944,-0.3243254381908,51240.4409090909,35774.8318181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_336251,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
336499,1246.44206008584,87.8841201716738,84.2575107296137,633.648068669528,1739.44206008584,1271.32618025751,308.042918454936,255.480686695279,1091.12446351931,2726.75965665236,496.44635193133,103.648068669528,1073.41201716738,744.55364806867,432.68669527897,280.751072961373,1478.63948497854,1196.97854077253,307.884120171674,231.523605150215,1002.62660944206,1406.64806866953,227.755364806867,185.712446351931,582.609442060086,1327.69098712446,414.034334763948,213.875536480687,1033.44206008584,130.167381974249,233,18.8452000777299,15.7943316843084,0.545502808144029,0.983122362869198,0.862962962962963,-0.0135188138827578,50779.2446351931,35703.5579399142,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_336499,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
338228,1716.96951219512,604.798780487805,95.8170731707317,629.34756097561,1272.32926829268,2145.03048780488,1784.78658536585,266.518292682927,1182.73780487805,3630.38414634146,778.542682926829,111.036585365854,1074.01829268293,752.731707317073,483.871951219512,269.25,1591.57926829268,995.798780487805,222.396341463415,213.701219512195,1220.16463414634,733.810975609756,170.658536585366,181.219512195122,615.09756097561,2140.60365853659,501.780487804878,332.201219512195,1056.53048780488,132.146341463415,164,15.3581128757032,13.6273770907997,0.4611772279391,0.947976878612717,0.728888888888889,-1.29346949297871,50737.1890243902,35580.1097560976,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_338228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
338715,2501.57800511509,169.20716112532,234.50895140665,770.04347826087,8467.31202046036,3317.70588235294,346.411764705882,269.012787723785,1132.53452685422,4289.13043478261,597.608695652174,125.537084398977,1091.75959079284,792.856777493606,758.496163682864,297.994884910486,1546.75191815857,1166.46803069054,335.83631713555,243.869565217391,989.132992327366,1041.41432225064,229.667519181586,143.813299232737,592.291560102302,2420.9283887468,568.621483375959,239.455242966752,1087.68542199489,129.237851662404,391,26.4333855660836,19.1597617793749,0.688925742419293,0.953658536585366,0.751923076923077,-1.31324941978956,51895.3529411765,34585.9718670077,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_338715,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
339579,1830.13553113553,280.245421245421,79.8424908424908,611.051282051282,518.934065934066,2204.55311355311,1770.87545787546,265.923076923077,1081.38827838828,2994.33333333333,733.542124542124,114.835164835165,1068.26007326007,756.098901098901,567.113553113553,282.593406593407,1390.2380952381,1103.22710622711,364.96336996337,247.908424908425,976.930402930403,1087.2673992674,248.919413919414,124.721611721612,583.168498168498,1268.30769230769,521.586080586081,299.937728937729,1029.38461538462,133.003663003663,273,22.2604338170696,15.7357089242709,0.707322110315338,0.944636678200692,0.775568181818182,1.56864703150085,50556.8278388278,34758.1721611722,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339579,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
339599,2086.88505747126,361.718390804598,87.5919540229885,619.120689655172,1143.04885057471,1859.95114942529,2067.36206896552,258.149425287356,1099.13218390805,3605.9367816092,722.224137931035,111.747126436782,1076.54310344828,1044.95689655172,832.689655172414,348.637931034483,1715.0632183908,1241.20977011494,301.204022988506,237.316091954023,1001.54597701149,1069.45114942529,234.991379310345,168.939655172414,590.994252873563,810.229885057471,418.204022988506,287.23275862069,1006.63505747126,128.281609195402,348,25.4971126919202,17.4346078046945,0.729681169226301,0.950819672131148,0.763157894736842,0.265298854678178,51770.8563218391,35311.617816092,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339599,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
339788,3313.44871794872,350.820512820513,104.84188034188,625.529914529915,1640.31196581197,3656.70512820513,1222.6452991453,291.696581196581,1107.12820512821,6800.38461538462,673.145299145299,128.226495726496,1081.01709401709,891.854700854701,689.452991452991,392.649572649573,1679.65384615385,1176.38034188034,280.645299145299,225.965811965812,1038.77777777778,1110.62820512821,219.076923076923,856.42735042735,1262.91452991453,1333.49145299145,437.564102564103,227.717948717949,1063.61111111111,130.230769230769,234,19.6044741753713,15.7283179084007,0.596945137926816,0.947368421052632,0.724458204334365,0.384376877931994,51629.264957265,35631.3504273504,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_339788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
340408,1338.35119047619,267.815476190476,176.928571428571,693.672619047619,4717.77976190476,1732.42261904762,4984.22023809524,257.77380952381,1087.65476190476,1954.39880952381,719.904761904762,115.071428571429,1069.19642857143,1761.39285714286,1228.28571428571,1465.24404761905,1675.49404761905,1647.45238095238,334.940476190476,235.583333333333,1015.82738095238,1262.75,234.714285714286,308.196428571429,687.97619047619,855.952380952381,441.47619047619,240.666666666667,1018.69642857143,132.339285714286,168,18.0973652973396,11.8234410945935,0.757078526158827,0.943820224719101,0.777777777777778,-0.0275793949614077,50412.8333333333,35060.2738095238,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_340408,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
340420,473.578544061303,939.659003831418,219.206896551724,620.157088122605,130.486590038314,568.421455938697,371.168582375479,274.226053639847,1127.54789272031,1107.57088122605,609.022988505747,104.55938697318,1054.21072796935,3232.79310344828,1318.19540229885,418.593869731801,2044.86973180077,5723.46743295019,448.613026819923,250.022988505747,1053.35249042146,5468.46360153257,273.842911877395,468.291187739464,633.67816091954,571.026819923372,327.130268199234,193.904214559387,983.402298850575,136.39846743295,261,19.6280702144353,16.9671619796824,0.502747129268543,0.949090909090909,0.725,0.0036036194368533,50691.6091954023,35428.4482758621,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_340420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
340747,3670.66569767442,505.71511627907,807.912790697674,662.575581395349,2610.18313953488,3749.61627906977,444.479651162791,272.313953488372,1108.27906976744,5944.31976744186,524.366279069767,130.552325581395,1112.90697674419,2603.40406976744,654.06976744186,433.543604651163,1774.3226744186,2056.70348837209,332.686046511628,1112.36046511628,1037.69186046512,2015.38953488372,251.459302325581,498.444767441861,742.299418604651,1651.08720930233,487.93023255814,258.436046511628,1070.81104651163,130.05523255814,344,22.8231279654391,19.3230531807708,0.532160470313036,0.960893854748603,0.781818181818182,0.186015240293398,51358.0494186046,35817.9738372093,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_340747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
341378,3029.22289156626,1210.34638554217,678.668674698795,644.319277108434,2197.51807228916,3163.40963855422,566.978915662651,271.198795180723,1150.09638554217,5249.41265060241,975.484939759036,140.71686746988,1089.22590361446,2789.32530120482,820.10843373494,384.114457831325,2400.20180722892,4430.43373493976,409.530120481928,247.677710843373,1073.59036144578,3900.57831325301,265.927710843374,218.129518072289,613.295180722892,1337.19277108434,462.53313253012,267.150602409639,1045.36144578313,130.39156626506,332,23.7848342385757,17.7781091176726,0.664311694380305,0.973607038123167,0.752834467120181,0.74009051304065,50912.2048192771,35426.0210843373,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_341378,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
341491,1175.61838440111,132.370473537604,57.6657381615599,631.796657381616,1117.94150417827,1344.48189415042,1348.12534818942,250.58217270195,1086.21169916435,2568.356545961,1288.42618384401,102.643454038997,1066.33704735376,5260.06406685237,967.75208913649,824.445682451253,1972.22005571031,7537.38161559889,443.688022284123,260.270194986072,1053.91364902507,6325.07242339833,304.019498607242,364.701949860724,659.459610027855,801.618384401114,419.598885793872,376.643454038997,1012.99442896936,129.844011142061,359,22.9050692151318,20.0179971108051,0.486007058167764,0.954787234042553,0.815909090909091,1.2482222892248,51672.6239554318,35225.2813370474,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_341491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
341863,934.173626373626,77.1252747252747,85.843956043956,639.723076923077,2523.27032967033,1114.76923076923,302.971428571429,254.632967032967,1092.98901098901,2406.67032967033,463.694505494506,110.386813186813,1080.75164835165,1231.11648351648,497.285714285714,271.098901098901,1714.83296703297,1188.5978021978,254.272527472527,221.857142857143,1108.01098901099,940.679120879121,188.938461538462,153.61978021978,703.843956043956,1690.9978021978,518.397802197802,221.61978021978,1083.34065934066,129.69010989011,455,30.7284959571729,19.2585743080977,0.779233766769575,0.968085106382979,0.722222222222222,-1.24947644770402,51550.8813186813,35346.5230769231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_341863,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
342378,3649.86029411765,891.702205882353,1403.98161764706,674.860294117647,3326.65073529412,3944.49264705882,1137.02941176471,269.430147058824,1103.625,6918.62132352941,570.463235294118,117.386029411765,1077.27573529412,736.415441176471,642.705882352941,273.904411764706,1635.15073529412,1115.88602941176,277.132352941176,231.294117647059,1019.62867647059,954.955882352941,202.069852941176,254.356617647059,1808.63602941176,1747.80514705882,488.257352941176,452.253676470588,1054.83088235294,129.834558823529,272,21.4917331940049,16.2277755233228,0.65564351131236,0.971428571428571,0.755555555555556,-0.573039922926215,51718.9411764706,35162.5147058823,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_342378,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
343138,2592.56166982922,346.132827324478,131.510436432638,699.330170777989,3404.48766603416,3056.60531309298,2161.99620493359,267.700189753321,1102.64895635674,5110.86907020873,3024.42125237192,121.136622390892,1074.70398481973,2707.08918406072,863.709677419355,922.381404174573,1732.62239089184,2572.24857685009,299.910815939279,230.022770398482,1000.71916508539,2205.29981024668,213.017077798861,432.058823529412,654.235294117647,2106.51802656546,533.333965844402,1055.93738140417,1106.17647058824,133.024667931689,527,34.8687114153177,19.3385150109352,0.832110820023423,0.961678832116788,0.675641025641026,-0.59733988721041,50567.0265654649,34958.2903225806,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343138,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
343177,1481.9886039886,423.139601139601,261.985754985755,742.626780626781,6968.92877492878,1796.23931623932,2372.14245014245,262.011396011396,1102.02279202279,3271.39316239316,1460.36467236467,124.108262108262,1070.23646723647,3649.73219373219,536.358974358974,303.746438746439,1464.23361823362,6261.34188034188,385.720797720798,246.196581196581,1012.17378917379,7337.82621082621,251.501424501425,232.652421652422,587.729344729345,1413.13675213675,488.65811965812,554.923076923077,1081.90028490028,132.666666666667,351,27.9724277497582,16.1480090027982,0.816544092871173,0.959016393442623,0.635869565217391,0.855510260887737,50559.4415954416,34888.547008547,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
343728,4531.56393442623,1016.0393442623,749.934426229508,646.118032786885,1349.1868852459,3573.99344262295,1818.33114754098,271.688524590164,1141.27540983607,6351.4262295082,599.540983606557,119.524590163934,1089.38032786885,662.540983606557,441.518032786885,334.114754098361,1498.4,1381.12131147541,281.695081967213,229.832786885246,1028.58360655738,1422.81967213115,219.508196721311,201.918032786885,604.855737704918,1474.9606557377,490.645901639344,1226.20983606557,1051.88196721311,129.137704918033,305,22.0882427870355,17.9379362652304,0.583513604547826,0.947204968944099,0.726190476190476,-1.09310475556972,51075.8393442623,35607.737704918,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343728,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
343839,2458.2846975089,504.946619217082,181.879003558719,710.686832740214,4171.41637010676,2593.06049822064,2341.41637010676,279.29537366548,1176.71174377224,4946.16370106762,603.156583629893,117.669039145907,1075.10320284698,3352.05693950178,713.978647686833,378.035587188612,1958.62989323843,2538.01067615658,390.715302491103,260.516014234875,1093.16725978648,1844.53380782918,267.377224199288,566.032028469751,2152.75800711744,1845.66548042705,540.879003558719,1151.99288256228,1073.128113879,130.992882562278,281,21.01868325654,17.1009572099728,0.581414588091319,0.942953020134228,0.743386243386243,-0.360143056056091,51811.7829181495,35371.0818505338,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
343929,4653.67100977199,512.951140065147,86.2833876221498,660.156351791531,2864.32247557003,4623.32899022801,621.377850162866,278.257328990228,1121.69381107492,7994.37133550489,558.589576547231,149.814332247557,1106.98045602606,2342.55374592834,970.589576547231,1855.20521172638,1845.08469055375,5439.21172638436,394.065146579805,252.192182410423,1049.16286644951,5243.24429967427,314.599348534202,339.14657980456,785.700325732899,3179.34201954397,550.892508143323,346.182410423453,1084.58957654723,129.57654723127,307,25.6453442388732,15.2850546342788,0.802972003233862,0.959375,0.752450980392157,-0.326837159575209,51000.7980456026,35838.7915309446,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343929,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
344936,1858.73441108545,483.796766743649,351.401847575058,771.039260969977,8295.26327944573,1978.792147806,305.367205542725,250.757505773672,1091.01385681293,3182.11316397229,516.78752886836,125.743648960739,1068.56812933025,868.078521939954,453.445727482679,283.069284064665,1498.13163972286,971.415704387991,209.256351039261,216.80831408776,1226.80600461894,631.600461893764,146.124711316397,128.422632794457,582.422632794457,973.678983833718,466.401847575058,225.348729792148,1049.06466512702,131.581986143187,433,28.4052237277738,19.6237268093652,0.722998857383529,0.964365256124722,0.746551724137931,1.41507948089258,51430.7852193995,34209.2448036952,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_344936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
345497,907.117647058824,364.294117647059,105.120448179272,637.182072829132,1728.91596638655,1126.0056022409,2459.83473389356,257.607843137255,1087.54901960784,2274.43137254902,1774.8487394958,107.386554621849,1064.30532212885,567.43137254902,426.170868347339,264.593837535014,1404.24369747899,839.677871148459,242.789915966387,222.764705882353,979.997198879552,765.366946778712,173.002801120448,126.434173669468,579.252100840336,1387.92156862745,494.456582633053,342.680672268908,1040.01400560224,130.882352941176,357,28.2919352741106,16.2595219499563,0.818360524543124,0.952,0.722672064777328,-1.13294784115313,51021.0840336134,34917.3305322129,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_345497,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
346349,2448.71428571429,281.330922242315,98.1464737793852,655.262206148282,2204.83182640145,3261.06329113924,1254.33815551537,274.03616636528,1109.65280289331,3775.5931283906,902.808318264014,128.819168173599,1076.43037974684,1643.26039783002,610.658227848101,631.171790235081,1811.42133815552,2905.42133815552,458.690777576854,539.544303797468,1109.0452079566,2726.22061482821,261.822784810127,290.083182640145,600.882459312839,1054.60759493671,523.453887884268,251.179023508137,1032.18806509946,130.748643761302,553,28.1144591657974,25.0672178319991,0.452798214695542,0.963414634146341,0.759615384615385,-0.631152053325201,50999.8806509946,34378.6311030741,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_346349,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
347269,1668.40692640693,372.861471861472,142.099567099567,646.17316017316,2423.92207792208,2172.37229437229,389.878787878788,272.380952380952,1095.73593073593,3225.51515151515,549.372294372294,115.116883116883,1075.11255411255,702.87012987013,626.813852813853,275.034632034632,1451.25541125541,1109.47619047619,338.536796536797,238.606060606061,996.56277056277,1043.7619047619,239.246753246753,137.78354978355,586.354978354978,1574.91774891775,535.069264069264,226.17316017316,1041.25108225108,131.683982683983,231,19.8222151149629,14.8969339221694,0.65970209955064,0.95850622406639,0.77,1.38317342302848,50933.9783549784,34937.8831168831,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_347269,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
347761,1165.39100346021,476.889273356401,195.411764705882,681.262975778547,4299.2491349481,1096.48096885813,515.712802768166,274.768166089965,1092.28027681661,2532.47750865052,695.77508650519,121.574394463668,1075.35294117647,1185.07958477509,522.069204152249,290.089965397924,1671.52941176471,3131.58823529412,329.98615916955,244.204152249135,1044.95155709343,2959.41868512111,232.494809688581,242.083044982699,1402.35640138408,1381.73702422145,556.252595155709,262.19723183391,1061.276816609,132.657439446367,289,24.5564695557332,15.2446106160317,0.783970452143682,0.947540983606557,0.698067632850242,-1.09984798941239,52096.5363321799,34651.9792387543,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_347761,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
347973,2768.34841628959,312.108597285068,83.5203619909502,610.524886877828,911.932126696833,3001.49321266968,401.656108597285,268.221719457014,1087.38914027149,4003.22624434389,526.886877828054,108.072398190045,1078.44343891403,1747.77375565611,518.294117647059,282.814479638009,1704.74208144796,2903.79185520362,367.16742081448,235.153846153846,1085.90950226244,2624.41176470588,295.660633484163,246.371040723982,1921.8371040724,910.361990950226,398.343891402715,221.909502262443,1007.06334841629,130.837104072398,221,18.1498022817853,15.6343335978209,0.507918424268211,0.936440677966102,0.722222222222222,-0.670411929250438,50698.0542986425,35620.5384615385,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_347973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
348040,3741.71317829457,544.953488372093,637.093023255814,622.496124031008,965.906976744186,4425.12403100775,353.558139534884,273.496124031008,1109.72093023256,7715.99224806202,510.15503875969,113.503875968992,1067.23255813953,928.031007751938,485.147286821706,274.821705426357,1794.86821705426,1287.38759689922,285.410852713178,239.395348837209,1049.7984496124,1083.59689922481,204.038759689922,146.837209302326,593.829457364341,3356.18604651163,566.263565891473,366.317829457364,1052.16279069767,129.720930232558,129,16.7007781051496,9.93061385953616,0.804007000106052,0.914893617021277,0.614285714285714,-0.877670191051495,51152.3488372093,35286.7441860465,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_348040,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
348058,1434.69230769231,372.450549450549,96.5384615384615,607.263736263736,837.835164835165,897.516483516484,1530.37362637363,263.692307692308,1084.16483516484,1822.23076923077,3203.47252747253,112.901098901099,1285.04395604396,935.065934065934,536.582417582418,283.89010989011,1821.78021978022,1583.85714285714,326.571428571429,300.032967032967,1034.25274725275,1324.27472527473,236.153846153846,542.505494505495,852.758241758242,1005.34065934066,475.505494505494,663.692307692308,1012.03296703297,128.901098901099,91,13.447835722403,8.63708630550746,0.766481907445738,0.938144329896907,0.7,1.07562667515036,51852.9010989011,35372.5164835165,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_348058,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
348407,3499.69169960474,564.561264822134,202.581027667984,656.826086956522,2394.73517786561,4089.62450592885,892.241106719368,279.932806324111,1096.67588932806,6542.15415019763,3439.71541501976,130.395256916996,1075.41106719368,704.335968379447,493.478260869565,283.237154150198,1354.77470355731,1004.33596837945,301.549407114625,233.154150197628,982.778656126482,918.869565217391,227.067193675889,124.648221343874,579.679841897233,2975.79446640316,565.944664031621,423.913043478261,1077.60079051383,129.450592885375,253,28.8208846401676,11.2615924620586,0.920499320280186,0.951127819548872,0.554824561403509,-0.590134957924079,49903.8853754941,34595.185770751,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_348407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
348844,1496.79411764706,214.296296296296,82.0751633986928,609.570806100218,708.850762527233,1298.80610021786,876.08605664488,265.011982570806,1083.69934640523,1719.04030501089,591.667755991285,111.377995642702,1068.83769063181,2473.2614379085,1058.56753812636,330.255991285403,1663.11982570806,3053.20588235294,431.813725490196,263.596949891068,985.278867102396,2700.27233115468,291.611111111111,169.832244008715,640.355119825708,912.079520697168,518.178649237473,263.298474945534,1008.45315904139,129.006535947712,918,39.1403921696249,29.9430645099981,0.644010112003249,0.968354430379747,0.72972972972973,-1.00472823549816,51923.5239651416,34629.9226579521,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_348844,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
348857,3217.87654320988,517.069958847737,148.115226337449,639.263374485597,1754.8683127572,3819.61316872428,4640.69958847737,269.979423868313,1092.48971193416,4502.34979423868,1223.07407407407,121.781893004115,1081.15226337449,563.037037037037,415.255144032922,261.576131687243,1364.1975308642,898.131687242798,272.353909465021,227.024691358025,984.288065843621,838.115226337449,198.37037037037,118.740740740741,583.514403292181,1067.41563786008,477.218106995885,401.860082304527,1055.0,131.79012345679,243,18.5994773870233,16.6391888144829,0.446857440395199,0.979838709677419,0.794117647058823,-0.708277534750328,50430.9053497942,34280.3333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_348857,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
349080,2961.30225988701,197.906779661017,61.5932203389831,640.508474576271,1646.42655367232,3150.56779661017,1745.5,263.387005649718,1121.90395480226,5435.84745762712,1423.93220338983,118.932203389831,1073.07344632768,680.132768361582,461.449152542373,293.83615819209,1563.70903954802,1005.55084745763,287.358757062147,233.045197740113,985.587570621469,976.725988700565,216.466101694915,148.203389830508,589.505649717514,1903.53107344633,519.24011299435,634.514124293785,1084.04802259887,133.183615819209,354,21.917282942682,20.8063326874318,0.314336339857873,0.96195652173913,0.842857142857143,-0.0881277789168307,52059.581920904,34518.3644067797,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_349080,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
349125,1538.2480620155,665.06976744186,127.782945736434,654.077519379845,2436.27131782946,1890.60465116279,3067.96899224806,267.496124031008,1115.05426356589,2673.93023255814,1331.98449612403,110.085271317829,1074.54263565891,1045.50387596899,1303.27131782946,321.031007751938,1773.37984496124,1380.41085271318,349.37984496124,243.511627906977,1005.43410852713,1120.51162790698,225.720930232558,190.046511627907,656.868217054264,1181.07751937984,520.790697674419,504.604651162791,1050.7519379845,129.728682170543,129,14.0955218612828,11.6827439255958,0.559505506961649,0.928057553956834,0.716666666666667,1.43271881453259,51313.2868217054,35064.4496124031,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_349125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
350007,1622.44699140401,104.56446991404,60.8997134670487,618.704871060172,990.799426934097,1573.7106017192,1356.13753581662,248.833810888252,1085.89398280802,3102.83667621777,435.343839541547,103.375358166189,1073.78223495702,705.120343839542,499.464183381089,317.982808022923,1528.62750716332,1056.2005730659,288.541547277937,230.893982808023,986.166189111748,1005.82521489971,226.756446991404,155.166189111748,588.045845272206,927.936962750716,418.558739255014,555.518624641834,1021.34097421203,129.094555873926,349,24.058532530139,18.5006619139039,0.639266258244145,0.974860335195531,0.755411255411255,0.656022065102431,51998.8108882521,35057.8767908309,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350007,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
350472,2533.91448931116,281.524940617577,312.030878859857,773.931116389549,10390.9928741093,2882.99049881235,953.950118764846,271.857482185273,1110.96437054632,5233.30878859858,569.826603325416,126.410926365796,1073.62945368171,2771.5296912114,755.62945368171,538.691211401425,1666.04988123515,3865.13301662708,406.515439429929,244.12351543943,1024.79334916865,3320.54156769596,326.688836104513,298.733966745843,673.315914489311,2209.58669833729,517.795724465558,475.216152019002,1092.4109263658,130.821852731591,421,29.5514264912861,18.1872011120362,0.788181857876376,0.963386727688787,0.806513409961686,-0.0956344518552494,51480.9714964371,35572.0950118765,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
350535,3200.62328767123,296.109589041096,112.472602739726,613.705479452055,353.986301369863,2425.09589041096,755.63698630137,258.897260273973,1099.15068493151,3630.56164383562,1368.58219178082,118.205479452055,1062.32191780822,940.739726027397,583.390410958904,269.465753424658,1584.37671232877,1276.34931506849,302.808219178082,229.527397260274,1075.10273972603,1188.63698630137,209.945205479452,220.315068493151,1017.50684931507,736.082191780822,429.041095890411,207.815068493151,1005.37671232877,134.486301369863,146,14.0061674534088,13.2647135331091,0.321049762208787,0.954248366013072,0.802197802197802,-0.22382156558154,51326.095890411,33814.7808219178,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350535,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
350959,2610.20477137177,175.339960238569,66.6998011928429,645.703777335984,803.145129224652,3495.02186878728,401.330019880716,277.590457256461,1103.84691848907,4902.71371769384,638.642147117296,119.353876739563,1076.61033797217,2060.28429423459,744.848906560636,296.544731610338,1787.60039761431,1710.93439363817,323.582504970179,239.101391650099,1049.5606361829,1335.64015904573,231.721669980119,157.530815109344,3277.14512922465,2639.58648111332,538.423459244533,231.001988071571,1065.1550695825,130.721669980119,503,39.7310964943598,16.5550932029874,0.909053924619391,0.947269303201507,0.574857142857143,1.01148566967855,50089.958250497,35043.0079522863,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350959,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
350979,3665.03058103976,179.868501529052,80.2140672782875,627.376146788991,1050.49541284404,4584.88073394495,627.694189602446,274.480122324159,1107.35779816514,7218.16819571865,996.957186544343,117.122324159021,1088.09174311927,644.709480122324,438.819571865443,277.467889908257,1437.03975535168,952.850152905199,274.146788990826,227.363914373089,991.584097859327,890.984709480122,204.565749235474,135.11620795107,585.837920489297,2351.58103975535,512.470948012232,314.626911314985,1053.00305810398,129.987767584098,327,22.3776503594142,18.6903258507473,0.549911557048228,0.961764705882353,0.778571428571429,0.464574268735748,51037.6666666667,35100.996941896,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350979,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
351801,2091.95238095238,261.587301587302,132.23544973545,661.335978835979,2590.58994708995,2385.51058201058,316.298941798942,257.526455026455,1097.13492063492,4153.39682539683,542.227513227513,120.783068783069,1069.87037037037,3208.06084656085,755.526455026455,757.492063492063,1557.33597883598,4080.35978835979,361.391534391534,238.293650793651,1013.46825396825,3663.25925925926,226.854497354497,333.039682539683,658.550264550265,1192.10582010582,468.52380952381,216.018518518519,1028.7380952381,128.708994708995,378,41.3956358920241,11.8193690786596,0.958372123874169,0.942643391521197,0.7875,-0.0763656932469946,50518.0767195767,34354.3624338624,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_351801,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
352614,1166.26258992806,387.309352517986,565.075539568345,609.158273381295,384.205035971223,1280.28057553957,414.751798561151,247.809352517986,1085.75539568345,2266.09352517986,377.287769784173,100.334532374101,1058.55035971223,5328.88848920863,905.143884892086,478.413669064748,2179.5,6680.59352517986,482.140287769784,245.003597122302,1054.35251798561,5583.93165467626,274.812949640288,531.41726618705,652.539568345324,751.910071942446,405.615107913669,244.086330935252,996.618705035971,129.690647482014,278,22.2724765687744,16.0962869783021,0.691163349839457,0.9553264604811,0.789772727272727,-0.008981490981337,51728.3597122302,35256.2697841727,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_352614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
354041,3775.28656716418,834.889552238806,84.2268656716418,633.2,1672.45671641791,3640.4447761194,2572.82089552239,271.567164179104,1151.50149253731,6667.82686567164,579.934328358209,116.364179104478,1087.55820895522,1670.39402985075,717.292537313433,392.316417910448,1679.20895522388,3791.57313432836,370.411940298507,245.620895522388,1036.85671641791,4043.09850746269,258.388059701493,228.146268656716,592.25671641791,2075.97313432836,477.128358208955,383.220895522388,1044.6776119403,130.635820895522,335,23.4780504902206,18.2607591986423,0.62853655382149,0.949008498583569,0.766590389016018,-1.43818508488991,51085.2537313433,35579.2537313433,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_354041,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
354403,2309.96378830084,318.364902506964,193.303621169916,686.674094707521,4230.60724233983,2959.13091922006,396.323119777159,267.721448467967,1098.85236768802,4792.60724233983,591.490250696379,123.064066852368,1116.66295264624,1079.77994428969,515.217270194986,277.259052924791,1928.04735376045,1488.356545961,303.506963788301,239.008356545961,1012.96100278552,1406.54038997214,202.027855153203,167.523676880223,890.412256267409,2267.87465181058,593.866295264624,237.052924791086,1116.44289693593,131.473537604457,359,31.2438297086943,14.8986321499873,0.878984478036602,0.947229551451187,0.747916666666667,-0.0398158033993066,51356.2729805014,34539.7966573816,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_354403,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
355555,2336.6137667304,221.439770554493,93.9311663479924,643.235181644359,2040.36711281071,2459.66921606119,1924.77055449331,268.330783938815,1087.80497131931,4671.34799235182,2143.22562141491,111.158699808795,1066.39770554493,1155.16443594646,622.885277246654,281.130019120459,1678.49521988528,1714.62523900574,348.214149139579,235.940726577438,1047.10898661568,1673.72275334608,254.896749521989,382.799235181644,1744.2982791587,2431.87571701721,475.051625239006,886.57552581262,1068.13575525813,130.527724665392,523,36.8852294934408,18.3134100907889,0.868038370781827,0.96316758747698,0.726388888888889,-1.29568007713468,50188.604206501,35441.793499044,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_355555,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
355652,3127.12171052632,1343.13157894737,281.467105263158,634.299342105263,1770.14802631579,3362.09868421053,1248.41776315789,275.1875,1130.88157894737,5133.90131578947,1430.00986842105,116.460526315789,1198.19736842105,1705.24013157895,513.207236842105,308.243421052632,1560.45394736842,2498.42763157895,360.578947368421,242.223684210526,998.434210526316,2989.61513157895,264.519736842105,428.141447368421,639.667763157895,1817.14144736842,545.200657894737,311.164473684211,1060.47039473684,132.375,304,23.7097646500483,16.572830011448,0.715133849138376,0.944099378881988,0.695652173913043,0.935006433181556,50909.2236842105,35706.6052631579,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_355652,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
355954,5228.72093023256,1789.62790697674,163.833887043189,693.867109634552,3221.18936877076,5965.79069767442,3102.18604651163,298.800664451827,1189.82059800664,7252.08637873754,1375.67441860465,142.624584717608,1092.57142857143,3438.19601328904,1177.87707641196,2134.63455149502,1910.73089700997,2630.42857142857,308.428571428571,227.112956810631,1042.55813953488,2086.68106312292,209.863787375415,225.777408637874,734.720930232558,1819.1196013289,552.847176079734,326.265780730897,1114.37873754153,134.016611295681,301,22.7976024490285,16.9859805753362,0.666977903034683,0.929012345679012,0.769820971867008,-0.0595252648646664,50544.0764119601,35035.0564784053,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_355954,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
356358,1400.9347826087,125.797101449275,66.9927536231884,625.576086956522,1293.10869565217,1474.98550724638,441.93115942029,256.152173913043,1083.72101449275,2928.04347826087,639.170289855072,107.260869565217,1074.23188405797,1163.99275362319,646.409420289855,376.471014492754,1684.97826086957,1883.03260869565,300.079710144928,248.528985507246,1030.82971014493,1609.80434782609,229.923913043478,520.615942028986,723.855072463768,1247.52536231884,470.467391304348,256.369565217391,1038.34057971014,130.014492753623,276,21.657622412347,16.2445895580932,0.661365950013627,0.971830985915493,0.773109243697479,-1.19873584680727,51646.8043478261,35241.9710144928,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_356358,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
356821,1208.36218678815,97.248291571754,84.6765375854214,630.100227790433,1922.40774487472,1554.94988610478,303.596810933941,260.462414578588,1082.71981776765,2816.33485193622,580.389521640091,114.289293849658,1065.02050113895,600.854214123007,510.489749430524,398.888382687927,1633.9271070615,961.339407744875,239.990888382688,222.476082004556,1000.12528473804,1051.66742596811,271.21867881549,249.384965831435,643.574031890661,1602.4145785877,508.533029612756,251.378132118451,1076.28246013667,131.624145785877,439,26.1764936213895,21.438396268997,0.573801805359385,0.966960352422908,0.804029304029304,-0.0315442728091629,51194.6446469248,35151.7107061503,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_356821,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
357386,1973.58401305057,183.781402936378,110.417618270799,634.515497553018,2086.4942903752,2693.01957585644,346.306688417618,262.296900489396,1091.36704730832,4645.31973898858,562.515497553018,120.433931484502,1080.38499184339,763.119086460033,455.510603588907,267.792822185971,1435.79608482871,997.84339314845,304.437194127243,234.624796084829,987.831973898858,952.15986949429,211.099510603589,127.84013050571,578.644371941272,3064.0163132137,582.701468189233,235.575856443719,1075.26101141925,129.845024469821,613,37.3678540302887,22.8161137542869,0.791953564239716,0.944530046224962,0.637214137214137,0.26967836692981,51103.4290375204,34645.1549755302,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_357386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
357494,2476.69590643275,502.011695906433,90.921052631579,654.827485380117,2359.4649122807,2364.65789473684,606.356725146199,270.801169590643,1318.04385964912,4627.40350877193,748.830409356725,111.80701754386,1088.26608187135,977.134502923977,921.25730994152,1015.24561403509,1883.67251461988,1438.52923976608,318.953216374269,237.397660818713,1009.31286549708,1566.58479532164,240.409356725146,208.24269005848,604.078947368421,2137.02339181287,502.616959064327,323.152046783626,1058.10526315789,130.619883040936,342,24.6869551263323,17.7122529800938,0.696585095707513,0.957983193277311,0.743478260869565,-0.51811904948626,50969.5614035088,35671.8625730994,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_357494,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
358685,4375.54421768707,1585.38095238095,309.568027210884,657.21768707483,2187.11224489796,4771.32993197279,613.173469387755,281.795918367347,1165.42176870748,6376.00340136054,580.659863945578,135.5,1088.86394557823,2920.2380952381,959.207482993197,644.676870748299,1973.34353741497,5438.40476190476,437.312925170068,252.585034013605,1192.59183673469,4748.57823129252,303.013605442177,249.530612244898,622.057823129252,1685.57823129252,502.418367346939,343.751700680272,1057.2074829932,132.224489795918,294,20.8386938877473,18.0445079639313,0.500193639705307,0.963934426229508,0.814404432132964,-0.820352823466903,51023.0612244898,35809.8197278912,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_358685,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
358886,3727.1862745098,447.779411764706,138.137254901961,645.563725490196,1497.59803921569,4102.08823529412,1583.1862745098,286.053921568627,1088.41176470588,6727.54901960784,1633.33823529412,125.882352941176,1072.27941176471,3142.52450980392,779.799019607843,1133.63725490196,1763.73039215686,2717.20588235294,336.838235294118,346.225490196078,1003.54411764706,2290.57352941176,516.039215686274,214.372549019608,627.877450980392,2623.07352941176,515.093137254902,608.367647058824,1059.60784313725,130.661764705882,204,19.7102488081341,13.4316637307451,0.731859254012842,0.953271028037383,0.708333333333333,-0.941529608005203,50374.3480392157,35510.9068627451,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_358886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
358930,405.708933717579,725.587896253602,203.337175792507,609.126801152738,121.158501440922,462.184438040346,316.746397694524,242.463976945245,1087.32853025937,1237.27089337176,955.097982708934,111.420749279539,1064.4553314121,858.368876080692,485.109510086455,371.368876080692,1731.19884726225,1105.1613832853,239.665706051873,331.680115273775,1031.81268011527,1022.25360230548,181.936599423631,238.815561959654,1772.86167146974,667.706051873199,396.700288184438,205.478386167147,993.00288184438,131.844380403458,347,23.5132856840324,18.9041667655359,0.59465890524734,0.963888888888889,0.751082251082251,0.835474333676956,51310.5821325648,33836.7752161383,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_358930,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
359182,3881.58630952381,290.877976190476,141.363095238095,676.833333333333,3457.71726190476,4404.4255952381,426.348214285714,270.776785714286,1127.55357142857,7077.35416666667,558.895833333333,122.488095238095,1092.75297619048,1621.10714285714,1621.46726190476,1459.00892857143,2442.5625,2095.7380952381,311.794642857143,236.482142857143,1027.38095238095,1660.30952380952,218.497023809524,349.901785714286,879.235119047619,1877.08035714286,507.366071428571,236.425595238095,1075.80654761905,133.154761904762,336,21.4918531210829,19.9312642542633,0.374103505758662,0.96551724137931,0.8,0.310805462671269,51468.1696428571,34965.8898809524,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_359182,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
360025,3996.64242424242,983.19696969697,180.257575757576,639.060606060606,1703.79090909091,4657.20303030303,608.030303030303,277.433333333333,1115.70909090909,7009.39090909091,641.154545454545,118.484848484848,1086.88484848485,4658.96363636364,1064.69393939394,1319.06060606061,3613.51212121212,5027.4696969697,412.360606060606,247.281818181818,1063.36666666667,4301.90909090909,275.724242424242,540.763636363636,722.315151515152,1736.16363636364,526.166666666667,239.727272727273,1041.77878787879,132.033333333333,330,21.9659050614303,19.1495882026443,0.48988529990703,0.964912280701754,0.789473684210526,-0.107889414120814,50900.8545454546,35376.3818181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_360025,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
360391,1622.89252336449,563.710280373832,152.579439252336,674.336448598131,3659.42990654206,1706.52336448598,3288.93925233645,258.663551401869,1094.27102803738,2584.01401869159,2639.60280373832,121.359813084112,1066.56542056075,3763.66355140187,545.570093457944,321.546728971963,1569.67757009346,2533.83644859813,359.873831775701,245.070093457944,1088.34579439252,6824.49065420561,364.672897196262,1382.15887850467,1310.72429906542,1238.6261682243,543.018691588785,614.107476635514,1105.23831775701,132.855140186916,214,18.6358920595334,14.7106802136872,0.613913188927046,0.963963963963964,0.792592592592593,1.22158103104205,50935.0934579439,33698.7570093458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_360391,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
361078,1510.99609375,246.359375,57.77734375,615.77734375,870.33984375,1676.08984375,4268.53515625,247.640625,1103.73046875,3162.5546875,762.80078125,105.35546875,1071.04296875,3634.1328125,1378.46484375,1969.953125,2161.4609375,3704.58203125,380.75,251.53515625,1030.4921875,3034.62109375,260.64453125,215.421875,717.921875,1088.6171875,444.6328125,343.9765625,1027.078125,132.6875,256,19.8311012331542,16.526386987153,0.552735121176637,0.966037735849057,0.792569659442725,1.22511981949273,51492.14453125,34938.35546875,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_361078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
362259,3243.46357615894,867.635761589404,281.28476821192,618.278145695364,593.211920529801,3387.03311258278,343.437086092715,259.185430463576,1097.35761589404,3905.81456953642,503.741721854305,136.059602649007,1071.49668874172,4385.13907284768,644.788079470199,331.291390728477,2096.76158940397,6816.37086092715,441.046357615894,247.264900662252,1001.7417218543,6021.5761589404,284.211920529801,1041.03311258278,702.894039735099,822.960264900662,397.986754966887,216.245033112583,1014.78145695364,129.145695364238,151,18.3309278022618,10.5276051185344,0.81863905686957,0.932098765432099,0.762626262626263,-0.0520205956863853,50599.5165562914,35825.5430463576,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_362259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
362869,1821.19026548673,150.393805309735,84.0221238938053,631.163716814159,1683.71238938053,1721.93362831858,315.513274336283,265.03982300885,1092.8982300885,3309.23451327434,525.637168141593,114.137168141593,1071.65044247788,5548.21681415929,608.296460176991,401.491150442478,1787.03097345133,6283.2389380531,384.955752212389,245.907079646018,1020.23008849558,6103.86725663717,262.41592920354,186.862831858407,592.013274336283,1356.07522123894,504.87610619469,224.535398230089,1054.28318584071,129.097345132743,226,20.7411617881962,13.8911950871277,0.742595263865411,0.969957081545064,0.738562091503268,-0.932905748268512,51162.4646017699,35371.3053097345,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_362869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
363122,529.227488151659,686.36018957346,171.317535545024,609.047393364929,94.6137440758294,660.0,412.094786729858,264.900473933649,1123.55213270142,1343.3317535545,1129.77488151659,122.0663507109,1066.33412322275,1035.93838862559,585.362559241706,299.796208530806,1590.64928909953,864.74644549763,200.452606635071,215.670616113744,1087.94786729858,689.518957345972,145.068720379147,127.732227488152,586.706161137441,565.481042654028,376.094786729858,200.85308056872,982.981042654028,130.068720379147,422,24.9436382360921,21.5518812347637,0.503452055086168,0.963470319634703,0.767272727272727,1.41114055629758,51190.9312796208,33809.2014218009,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_363122,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
363210,3552.56084656085,208.862433862434,103.478835978836,640.12962962963,1757.38095238095,4099.95238095238,569.687830687831,271.0,1167.95502645503,5908.97619047619,706.568783068783,126.574074074074,1083.61111111111,682.230158730159,474.597883597884,277.206349206349,1514.8544973545,1040.23015873016,321.595238095238,234.285714285714,989.857142857143,999.42328042328,235.322751322751,185.875661375661,582.661375661376,2324.54497354497,505.121693121693,341.050264550265,1087.07936507937,131.388888888889,378,23.7869822781853,20.2934029986062,0.521697365276917,0.956962025316456,0.78099173553719,0.899228750772124,50559.9920634921,35777.0555555556,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_363210,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
363287,2735.31818181818,709.734265734266,377.524475524476,657.611888111888,3483.3041958042,2914.77622377622,365.146853146853,266.552447552448,1091.4020979021,6061.33916083916,534.472027972028,124.590909090909,1071.84265734266,814.076923076923,882.454545454545,306.223776223776,2215.55594405594,2228.91608391608,355.513986013986,244.244755244755,1017.92307692308,2644.22727272727,261.867132867133,367.27972027972,656.905594405594,3524.58741258741,567.342657342657,251.723776223776,1058.06643356643,130.807692307692,286,21.1733785789861,17.6748368931602,0.550603415001857,0.959731543624161,0.752631578947368,-0.843591535446131,51965.6118881119,34936.7342657343,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_363287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
363400,2310.25405405405,438.362162162162,107.362162162162,631.551351351351,1279.75135135135,2251.05405405405,3490.57837837838,265.027027027027,1092.4,4709.7027027027,1654.29189189189,109.594594594595,1068.18918918919,2277.63243243243,1429.91351351351,1352.84864864865,2231.27027027027,3938.37297297297,426.854054054054,246.464864864865,1099.78918918919,3972.74594594595,282.762162162162,423.108108108108,752.794594594595,2086.1027027027,475.243243243243,524.864864864865,1059.82702702703,130.318918918919,185,19.3268924206282,12.17910870388,0.776462193098137,0.958549222797927,0.790598290598291,0.358587960353532,50228.9189189189,35272.5135135135,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_363400,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
363676,3597.09375,193.7375,99.259375,637.3625,1294.028125,3647.91875,351.9125,271.853125,1099.375,5997.103125,642.340625,114.559375,1068.709375,6164.171875,914.60625,413.659375,2076.1,3838.153125,373.325,240.7875,1037.159375,3025.765625,245.13125,399.309375,726.61875,1611.465625,481.134375,220.140625,1050.7125,130.203125,320,28.4945514732825,14.5562778153089,0.859673281455708,0.955223880597015,0.689655172413793,1.37764987307885,51129.034375,35369.659375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_363676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
364003,3922.36551724138,1502.67931034483,148.834482758621,649.220689655172,2312.12068965517,4723.13793103448,482.775862068966,269.741379310345,1148.88620689655,7355.79655172414,571.196551724138,117.234482758621,1070.74827586207,1092.66206896552,1110.03793103448,315.18275862069,1689.53793103448,1637.43793103448,375.91724137931,250.575862068966,996.444827586207,1485.24827586207,251.337931034483,192.479310344828,627.110344827586,2725.8724137931,544.968965517241,260.875862068965,1054.30344827586,131.610344827586,290,20.1450254765839,18.3403668004264,0.413692525990439,0.963455149501661,0.763157894736842,1.1476315090556,51321.2862068966,35001.6103448276,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_364003,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
366364,1250.44372990354,170.212218649518,88.4083601286174,657.665594855305,2425.01286173633,1392.60128617363,3244.88745980707,250.726688102894,1088.1961414791,2504.94533762058,488.508038585209,109.446945337621,1074.3729903537,1131.52411575563,503.836012861736,286.848874598071,1649.29260450161,1347.86495176849,230.559485530547,220.167202572347,1166.26688102894,1204.88424437299,179.360128617363,154.649517684887,989.826366559486,1038.27974276527,461.800643086817,889.112540192926,1029.35691318328,130.379421221865,311,23.6997816789251,16.8901357811374,0.701498914488281,0.96583850931677,0.744019138755981,0.973772248157845,51870.8006430868,34845.5466237942,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_366364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
366707,1309.5,187.289855072464,65.9166666666667,619.692028985507,1253.90942028986,1240.38768115942,2814.40942028986,251.507246376812,1087.79347826087,2594.41666666667,477.108695652174,103.833333333333,1066.23913043478,2726.05072463768,1352.80434782609,3938.59057971014,3105.69565217391,2751.53985507246,365.06884057971,241.56884057971,1070.77173913043,2367.01086956522,261.311594202899,479.376811594203,727.905797101449,1278.61594202899,409.996376811594,607.235507246377,1027.05797101449,129.351449275362,276,21.1325215936348,16.650389685957,0.615798610461319,0.951724137931034,0.726315789473684,1.12106329554917,51088.6413043478,35657.0471014493,FAAGSCC_12,AG,1,dendritic cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_366707,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
366999,2125.05283018868,875.860377358491,192.233962264151,667.162264150943,2984.90188679245,2247.76226415094,342.230188679245,258.467924528302,1165.51698113208,4356.65660377358,459.083018867925,114.08679245283,1076.41132075472,889.196226415094,758.909433962264,1186.83396226415,1597.52830188679,1285.38490566038,303.305660377358,234.056603773585,1022.62264150943,1216.40377358491,215.622641509434,166.169811320755,697.784905660377,1367.07169811321,478.905660377359,225.166037735849,1039.18867924528,129.754716981132,265,20.5984134965402,16.4336139321918,0.602909358839983,0.963636363636364,0.734072022160665,-0.806995018360024,51143.2188679245,35071.0867924528,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_366999,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
367141,3541.06631299735,237.188328912467,90.1140583554377,651.557029177719,2447.7824933687,3596.5225464191,1363.73474801061,265.159151193634,1190.1299734748,6158.8275862069,575.575596816976,128.893899204244,1091.92042440318,4314.80106100796,1089.8275862069,479.997347480106,2108.10079575597,6905.24933687003,476.864721485411,273.697612732095,2362.22546419098,7268.18302387268,338.021220159151,400.976127320955,659.273209549072,1954.00530503979,456.822281167109,283.429708222812,1056.85411140584,131.618037135279,377,23.4832446755231,20.5437545009182,0.484437156276188,0.947236180904523,0.745059288537549,0.556347628063735,50925.3421750663,35799.4535809019,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_367141,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
367640,1216.36206896552,213.784482758621,59.0603448275862,616.758620689655,764.737068965517,1648.87068965517,2403.43534482759,255.047413793103,1099.90948275862,2160.90517241379,1737.4525862069,100.336206896552,1072.59482758621,631.047413793103,429.073275862069,293.728448275862,1485.40086206897,1421.95689655172,251.827586206897,222.823275862069,989.047413793104,1512.73275862069,209.090517241379,147.129310344828,588.577586206897,886.793103448276,406.176724137931,409.0,1045.89224137931,130.556034482759,232,21.1477257248211,14.0186803730801,0.748714101873132,0.974789915966386,0.773333333333333,-1.13222668189292,50193.6939655172,35230.0905172414,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_367640,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
367716,653.603524229075,844.356828193833,216.555066079295,626.903083700441,536.665198237885,737.370044052863,381.806167400881,268.819383259912,1131.80616740088,1631.61674008811,762.440528634361,121.533039647577,1061.11013215859,1841.49339207048,752.726872246696,289.092511013216,1773.38325991189,1993.42290748899,344.74449339207,240.594713656388,1069.12775330396,2252.76651982379,236.669603524229,275.396475770925,2383.67400881057,851.938325991189,425.237885462555,214.321585903084,1044.32158590308,130.140969162996,227,17.1279476460891,16.9177363529558,0.15619018058312,0.961864406779661,0.785467128027682,-0.992920053201954,50390.9735682819,34905.59030837,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_367716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
367834,1341.91489361702,302.347517730496,99.7198581560284,618.843971631206,928.989361702128,1288.39716312057,1225.19503546099,262.13475177305,1091.41843971631,1857.1170212766,890.035460992908,109.670212765957,1064.52836879433,692.63829787234,421.017730496454,276.86524822695,1479.8865248227,1085.51418439716,277.152482269504,228.163120567376,992.893617021277,1060.54255319149,216.570921985816,162.368794326241,730.205673758865,935.0,471.54609929078,254.312056737589,1019.98226950355,130.354609929078,282,23.0161623382101,15.6634620523693,0.732709198397112,0.95593220338983,0.801136363636364,-0.3222607637875,51849.7021276596,35209.3475177305,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_367834,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368126,2103.59455370651,313.152798789713,189.888048411498,678.813918305598,3777.04841149773,2527.94099848714,352.854765506808,265.409984871407,1094.23903177005,3346.57942511346,584.546142208775,127.998487140696,1084.39183055976,540.043872919818,385.347957639939,263.930408472012,1397.29349470499,852.145234493192,263.084720121029,227.087745839637,987.518910741301,792.134644478064,186.435703479576,119.695915279879,579.532526475038,1215.34947049924,498.357034795764,219.612708018154,1043.77155824508,129.564296520424,661,29.8583241815418,28.2521979570763,0.323557742371596,0.960755813953488,0.759770114942529,0.701145639890558,50527.6323751891,34154.1588502269,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_368126,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368295,1881.83870967742,1010.36559139785,665.236559139785,658.440860215054,2795.45161290323,2302.0752688172,882.784946236559,276.784946236559,1099.87096774194,2764.93548387097,1801.76344086022,121.204301075269,1076.79569892473,570.731182795699,409.41935483871,260.236559139785,1428.54838709677,945.462365591398,284.021505376344,232.709677419355,1004.01075268817,895.569892473118,197.655913978495,126.774193548387,582.731182795699,1610.45161290323,607.05376344086,400.172043010753,1045.1935483871,129.311827956989,93,12.542134971052,9.50904761019788,0.652059057877776,0.93,0.704545454545455,0.967463951973757,51304.5268817204,34912.9462365591,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368295,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368382,1107.50306748466,347.441717791411,127.441717791411,638.153374233129,1645.46012269939,1374.85889570552,373.981595092025,266.085889570552,1097.36809815951,2818.42331288344,797.539877300614,116.042944785276,1065.8527607362,680.337423312883,542.018404907975,526.644171779141,1485.76687116564,1060.67484662577,291.239263803681,233.104294478528,1010.22085889571,1017.69938650307,207.251533742331,410.429447852761,679.067484662577,1137.61349693252,451.233128834356,234.128834355828,1064.88957055215,128.981595092025,163,17.3895171458769,11.9591484439293,0.725974415162029,0.953216374269006,0.799019607843137,1.42007948891778,50314.7791411043,34822.4171779141,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_368382,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368591,2242.78983833718,138.584295612009,163.424942263279,710.198614318707,5635.02309468822,2471.78521939954,348.339491916859,270.355658198614,1096.79676674365,4011.92609699769,548.018475750577,126.21247113164,1076.68591224018,3720.27020785219,770.547344110855,357.272517321016,5148.38799076212,4182.17551963048,385.833718244804,246.226327944573,1047.09468822171,3339.57043879908,253.29792147806,860.103926096998,797.942263279446,1348.27713625866,453.94688221709,272.632794457275,1072.94688221709,130.903002309469,433,31.2635889825814,17.7883130072713,0.822352330673188,0.957964601769912,0.666153846153846,-0.770457455260514,50637.0,35552.0600461894,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368682,2957.29166666667,675.258928571429,84.7470238095238,616.511904761905,602.452380952381,3395.38988095238,341.866071428571,255.779761904762,1081.15476190476,6023.67261904762,483.324404761905,112.407738095238,1065.3005952381,1093.92261904762,518.416666666667,308.401785714286,1881.40773809524,1979.35119047619,244.315476190476,223.872023809524,1008.46428571429,2041.08928571429,183.565476190476,200.520833333333,632.247023809524,2924.86011904762,532.571428571429,241.041666666667,1044.09523809524,128.973214285714,336,26.9846204828266,15.8915787616714,0.808196841697153,0.957264957264957,0.666666666666667,-0.906693037307066,51478.3571428571,35000.0238095238,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
368873,2029.93846153846,294.241025641026,56.4410256410256,602.676923076923,655.54358974359,2540.26153846154,334.779487179487,244.994871794872,1175.9641025641,4475.65128205128,473.112820512821,108.887179487179,1078.75897435897,1925.27179487179,680.651282051282,311.969230769231,1937.84615384615,2912.24615384615,352.841025641026,240.292307692308,1040.78461538462,2794.72307692308,247.620512820513,674.333333333333,946.235897435897,1492.05128205128,464.323076923077,241.25641025641,1029.06666666667,131.061538461538,195,18.0397831889626,14.0357209458198,0.628211441402798,0.919811320754717,0.674740484429066,-0.815183744475129,51924.7538461538,34203.9948717949,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368873,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
369061,3305.45797101449,211.866666666667,113.576811594203,646.715942028986,1537.24637681159,4132.97101449275,355.434782608696,266.536231884058,1098.84637681159,5552.68115942029,853.64347826087,127.301449275362,1070.39420289855,776.124637681159,502.944927536232,280.608695652174,1341.5652173913,1083.55072463768,303.539130434783,232.724637681159,985.342028985507,1039.47826086957,222.965217391304,118.56231884058,584.631884057971,1569.21449275362,496.16231884058,216.327536231884,1069.06376811594,130.973913043478,345,26.1300217143329,16.8898270691029,0.763018783019223,0.950413223140496,0.709876543209877,-0.256532187308555,50079.6463768116,34212.8637681159,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_369061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
369466,3492.34733893557,1001.6218487395,105.204481792717,615.002801120448,657.50700280112,3319.79271708683,665.372549019608,277.596638655462,1091.42016806723,6182.53221288515,572.212885154062,113.901960784314,1077.0056022409,1528.73949579832,543.3081232493,283.635854341737,1886.64705882353,2300.52661064426,338.985994397759,241.72268907563,1022.41736694678,2030.95518207283,243.963585434174,201.529411764706,749.254901960784,2137.51260504202,520.848739495798,399.12324929972,1031.85434173669,131.204481792717,357,24.9644538333587,18.7485321808505,0.660291845444059,0.952,0.737603305785124,0.805863365653925,51092.6386554622,35435.9131652661,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_369466,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
369871,3395.70528967254,250.362720403023,88.1889168765743,635.216624685139,1019.71788413098,4113.39294710327,1768.79848866499,267.612090680101,1092.48362720403,6945.19395465995,1582.40554156171,128.256926952141,1070.88916876574,2848.0201511335,743.120906801008,397.544080604534,1689.73803526448,2546.42065491184,403.929471032746,389.39798488665,1029.72292191436,2424.78337531486,236.768261964736,235.83879093199,594.612090680101,3069.00503778337,614.513853904282,820.921914357683,1161.95465994962,132.304785894207,397,28.677466503385,17.8160811668008,0.783606757930561,0.945238095238095,0.689236111111111,0.865183007787536,50609.7884130982,34212.2544080605,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_369871,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
370341,1891.14393939394,240.666666666667,87.5227272727273,620.359848484848,1250.60227272727,2408.39393939394,934.818181818182,275.939393939394,1085.56818181818,3368.41666666667,1215.5303030303,115.469696969697,1074.77651515152,1371.83333333333,607.337121212121,292.212121212121,1520.23106060606,1682.79545454545,411.784090909091,250.05303030303,993.67803030303,1653.93560606061,273.143939393939,251.185606060606,584.412878787879,1973.84090909091,624.011363636364,358.590909090909,1059.14393939394,130.431818181818,264,22.6951445492287,15.0618169358295,0.748036029509778,0.953068592057762,0.661654135338346,-0.918803977888176,50721.5265151515,34724.5871212121,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_370341,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
370385,1563.71573604061,490.131979695431,386.842639593909,633.928934010152,1646.18274111675,1772.52284263959,759.446700507614,262.502538071066,1137.53299492386,2279.08121827411,524.94923857868,126.609137055838,1071.22842639594,1516.18274111675,566.857868020305,353.97461928934,1665.58883248731,1720.54822335025,313.030456852792,230.020304568528,992.502538071066,1702.36040609137,228.644670050761,282.477157360406,593.451776649746,969.142131979696,464.776649746193,387.218274111675,1020.54822335025,128.289340101523,197,16.4794489964479,15.2795697608616,0.374592967799823,0.970443349753695,0.820833333333333,0.49936084826313,51144.8274111675,35871.0659898477,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
370952,2925.75,352.041666666667,114.083333333333,636.291666666667,1885.29583333333,2687.94166666667,3559.67083333333,275.729166666667,1104.125,5149.05416666667,1066.46666666667,116.3625,1071.81666666667,743.945833333333,502.35,729.983333333333,1470.7125,1104.71666666667,289.25,233.504166666667,992.8375,1032.36666666667,221.15,158.720833333333,607.670833333333,2206.18333333333,503.808333333333,654.279166666667,1067.34166666667,131.0875,240,20.5016086849744,14.9708007354822,0.683206034300127,0.952380952380952,0.75,-0.342956056344905,51004.675,35483.4875,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
370967,1200.90972222222,311.083333333333,71.2847222222222,621.034722222222,899.25,1161.51388888889,1429.95138888889,255.916666666667,1074.02083333333,2620.29166666667,2237.58333333333,114.625,1065.61111111111,2235.47222222222,557.680555555556,487.409722222222,1669.99305555556,1859.48611111111,305.347222222222,229.659722222222,1013.56944444444,1960.79166666667,229.256944444444,214.451388888889,942.965277777778,1690.86805555556,448.576388888889,315.368055555556,1050.45833333333,129.263888888889,144,13.9644702448463,13.169557457269,0.332577151092597,0.929032258064516,0.685714285714286,-1.30271239593118,50796.1041666667,35811.3055555556,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
371239,2214.9765625,568.03515625,140.7109375,664.62890625,3305.59765625,2607.94921875,1171.91015625,269.66015625,1109.98828125,4495.8671875,1367.03125,113.58203125,1073.9921875,3858.375,1347.7890625,743.9609375,1643.328125,3940.63671875,372.73046875,245.453125,1018.8828125,3528.04296875,243.109375,832.953125,736.1484375,1880.65234375,497.71484375,299.76171875,1058.03125,131.30078125,256,20.7935536499012,15.7473088489328,0.653047599309638,0.973384030418251,0.8,-1.30415155435109,50718.1640625,35262.6171875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_371239,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
371406,2117.53191489362,206.718085106383,91.6276595744681,646.718085106383,2770.26595744681,2039.54787234043,367.0,259.622340425532,1082.79255319149,3333.37234042553,463.393617021277,111.590425531915,1078.13829787234,993.521276595745,693.404255319149,455.335106382979,1852.64893617021,1205.83510638298,296.207446808511,228.797872340426,1017.66489361702,1420.37765957447,234.984042553192,224.462765957447,604.239361702128,1537.31914893617,461.675531914894,250.946808510638,1046.87765957447,127.005319148936,188,20.5247518425095,11.7640267552137,0.819441434124466,0.94,0.746031746031746,-0.0279308780184227,51248.7340425532,35741.4042553191,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_371406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
371447,3553.89367816092,602.399425287356,1418.86206896552,625.048850574713,1262.32183908046,3336.20977011494,1694.74425287356,267.01724137931,1108.71551724138,5572.00862068965,1446.89655172414,114.528735632184,1076.98850574713,4604.85632183908,631.948275862069,358.698275862069,1548.97701149425,2388.00287356322,340.448275862069,238.17816091954,989.264367816092,2028.06896551724,247.048850574713,162.534482758621,583.198275862069,1224.84770114943,451.086206896552,577.965517241379,1028.3908045977,131.060344827586,348,27.7942960545001,15.9933358331881,0.817859538811327,0.950819672131148,0.669230769230769,-1.04109935338662,51370.5747126437,35517.0977011494,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_371447,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
371735,3279.47191011236,351.966292134831,128.131086142322,646.868913857678,1796.05243445693,4529.03745318352,1792.20973782772,271.595505617978,1092.79775280899,6715.02621722846,1507.30337078652,122.063670411985,1072.37453183521,706.209737827715,615.378277153558,274.621722846442,1452.02621722846,1088.60674157303,333.662921348315,239.561797752809,981.823970037453,1056.92509363296,225.602996254682,136.172284644195,573.595505617978,2689.2808988764,534.576779026217,351.052434456929,1073.04868913858,130.87265917603,267,19.1430145117408,17.7739839491844,0.371372238059005,0.963898916967509,0.780701754385965,1.15094090538483,50509.202247191,34741.4456928839,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_371735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
371917,3666.81140350877,876.184210526316,193.482456140351,681.945175438596,3718.88815789474,4311.44298245614,4647.98684210526,268.489035087719,1183.74561403509,6751.22149122807,3781.78289473684,128.076754385965,1087.12719298246,884.570175438596,471.638157894737,277.491228070175,1543.93859649123,1074.14473684211,212.160087719298,218.129385964912,1356.88377192982,650.800438596491,147.723684210526,128.298245614035,593.355263157895,2436.88815789474,568.065789473684,774.980263157895,1102.34429824561,130.697368421053,456,30.8676725204025,19.1074591638199,0.785381541321819,0.955974842767296,0.8,-0.181055093116693,51452.6600877193,34263.6140350877,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_371917,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
372167,2102.19902120718,328.853181076672,106.584013050571,660.566068515498,2485.7748776509,2477.74061990212,2151.94616639478,259.499184339315,1096.80261011419,3051.72593800979,942.05220228385,120.557911908646,1077.93311582382,2006.11908646003,1312.49265905383,945.975530179445,1754.09461663948,1516.03262642741,331.146818923328,240.557911908646,1002.0766721044,1130.17781402936,230.867862969005,368.942903752039,632.215334420881,1041.91517128874,514.862969004894,378.884176182708,1051.4779771615,131.176182707993,613,30.8621118816463,25.617125162893,0.557687571177508,0.959311424100156,0.760545905707196,0.0832574132734388,51473.4339314845,33886.8287112561,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_372167,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
372204,2056.54495912807,204.569482288828,102.089918256131,634.117166212534,1734.29155313351,2545.27520435967,342.544959128065,258.070844686649,1095.8174386921,3809.76839237057,503.634877384196,114.133514986376,1089.82016348774,667.098092643052,410.66757493188,261.354223433243,1612.48228882834,976.645776566758,235.689373297003,226.765667574932,1008.74931880109,846.41961852861,174.675749318801,124.125340599455,585.822888283379,1323.50408719346,474.33242506812,224.485013623978,1036.47411444142,129.212534059946,367,25.536307372363,18.3396106348344,0.695859582370592,0.963254593175853,0.742914979757085,1.56998221155624,50270.9673024523,34703.1580381471,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_372204,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
372238,2604.35784313725,382.098039215686,161.313725490196,702.102941176471,4067.45098039216,3212.74019607843,4730.95588235294,275.96568627451,1103.38235294118,4648.86764705882,2431.56862745098,122.416666666667,1091.0637254902,595.960784313726,398.328431372549,363.299019607843,1407.26960784314,1018.44117647059,285.455882352941,227.519607843137,999.563725490196,971.71568627451,230.323529411765,136.916666666667,595.039215686274,1533.49019607843,477.210784313726,843.03431372549,1121.76470588235,132.107843137255,204,21.8071790981641,12.0480501910527,0.833525549783316,0.948837209302326,0.747252747252747,0.22456734328696,50208.1078431373,35166.112745098,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_372238,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
373240,863.473404255319,532.414893617021,361.861702127659,626.377659574468,1596.13829787234,944.38829787234,439.93085106383,266.106382978723,1095.09042553191,1782.16489361702,636.265957446809,112.047872340426,1062.6329787234,1845.47340425532,683.803191489362,327.335106382979,1816.64893617021,4961.48936170213,445.436170212766,254.101063829787,1038.09042553191,4961.8829787234,1164.79255319149,280.867021276596,590.702127659574,965.728723404255,470.031914893617,231.175531914894,1011.32978723404,129.409574468085,188,16.4254854113012,14.5970996000964,0.45851621640057,0.959183673469388,0.783333333333333,1.13041700325097,51456.5,35594.7553191489,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_373240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
374779,4620.27857142857,1570.87142857143,2479.26785714286,636.503571428571,1509.70714285714,4957.24642857143,678.271428571429,279.7,1106.71785714286,7468.65714285714,619.685714285714,123.239285714286,1082.4,480.325,332.735714285714,254.689285714286,1473.65,875.167857142857,217.707142857143,214.410714285714,1002.96071428571,742.160714285714,172.464285714286,168.185714285714,585.457142857143,1783.67857142857,495.721428571429,304.639285714286,1066.61071428571,131.314285714286,280,19.6304102194115,18.4877249603477,0.336201587804748,0.955631399317406,0.775623268698061,-0.888933923977633,51715.7321428571,35375.0535714286,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_374779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
374912,1015.9,169.822222222222,180.85,702.561111111111,5405.48055555556,1318.70833333333,303.488888888889,250.158333333333,1089.95277777778,2485.01666666667,666.819444444444,122.980555555556,1068.79166666667,2109.84166666667,562.522222222222,296.541666666667,1838.66388888889,3427.84444444444,331.902777777778,236.383333333333,1074.075,2840.675,218.919444444444,147.158333333333,5037.48888888889,1012.23055555556,480.491666666667,247.261111111111,1050.45555555556,131.244444444444,360,27.9253788882952,16.5303388602305,0.805977033157655,0.935064935064935,0.666666666666667,1.16712258650003,51324.75,34215.6916666667,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_374912,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
374934,1841.42175066313,372.763925729443,209.114058355438,724.397877984085,5590.27320954907,1612.50663129973,2907.99204244032,264.493368700265,1103.90981432361,2840.19098143236,765.350132625995,114.700265251989,1070.77984084881,1255.85676392573,1052.00795755968,1724.16710875332,4344.57824933687,1722.59151193634,313.275862068966,232.400530503979,1058.75596816976,1526.69230769231,235.655172413793,723.079575596817,604.490716180371,931.596816976127,423.273209549072,763.496021220159,1037.24137931034,129.084880636605,377,25.1950612535557,19.3073448611936,0.642465437231457,0.954430379746835,0.712665406427221,-0.808594271329402,51214.3023872679,35577.6366047745,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_374934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
375215,1095.36363636364,343.748051948052,105.119480519481,638.890909090909,1754.10909090909,1134.2961038961,1956.54285714286,264.916883116883,1080.29350649351,1718.54545454545,2858.13766233766,110.706493506494,1068.47792207792,2938.87532467532,786.425974025974,429.812987012987,2472.52207792208,5017.71168831169,552.012987012987,376.607792207792,1250.4025974026,3612.5974025974,274.8,306.903896103896,590.454545454545,979.909090909091,457.750649350649,686.690909090909,1041.98701298701,131.748051948052,385,25.8697210256584,19.0347869284191,0.677205366939528,0.967336683417086,0.733333333333333,0.50044967647516,49986.1714285714,35190.3480519481,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_375215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
375849,4129.06628242075,751.256484149856,313.792507204611,665.262247838617,2958.23631123919,5042.08069164265,1177.7204610951,273.233429394813,1142.70028818444,7140.87608069164,1850.92795389049,122.936599423631,1073.93948126801,1424.90778097983,507.861671469741,287.798270893372,1630.87319884726,1872.44668587896,335.685878962536,240.043227665706,999.953890489914,1666.70317002882,222.432276657061,280.365994236311,585.873198847262,2365.08645533141,548.455331412104,480.579250720461,1074.08645533141,131.043227665706,347,29.5091234519799,15.3116455991926,0.854848084113248,0.948087431693989,0.628623188405797,-0.75420435026634,51423.1959654179,34951.3515850144,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_375849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
376121,4119.52173913043,359.33850931677,113.55900621118,699.549689440994,2245.29192546584,5487.74844720497,3545.07142857143,282.093167701863,1130.94720496894,8637.91925465839,1900.45962732919,141.006211180124,1104.74223602484,2913.81677018634,647.773291925466,963.515527950311,1953.26397515528,2303.4751552795,366.487577639752,800.680124223602,1039.54037267081,1563.00621118012,230.981366459627,246.16149068323,611.208074534161,2586.60869565217,592.503105590062,436.44099378882,1112.90062111801,132.108695652174,322,23.4825572769721,17.5008683932329,0.666761705215496,0.966966966966967,0.731818181818182,-0.571013672332647,51010.5652173913,34400.9534161491,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_376121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
376614,4427.42577030812,493.495798319328,103.966386554622,656.778711484594,2755.70588235294,4674.38095238095,481.140056022409,268.943977591036,1187.75630252101,8234.64425770308,972.644257703081,124.288515406162,1077.02240896359,648.798319327731,397.260504201681,267.512605042017,1538.16806722689,992.313725490196,253.504201680672,223.708683473389,988.52380952381,1074.9243697479,202.557422969188,139.350140056022,587.420168067227,3023.6106442577,614.980392156863,398.268907563025,1080.86834733894,132.075630252101,357,25.5486227692578,18.1910324699017,0.70216307021394,0.9296875,0.714,-0.611450594664907,52034.756302521,34509.756302521,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_376614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
377238,2583.03463203463,152.064935064935,69.9134199134199,634.246753246753,1494.19913419913,3034.24242424242,477.380952380952,267.813852813853,1097.7316017316,5202.30735930736,577.4329004329,114.515151515152,1078.90476190476,643.961038961039,627.649350649351,439.974025974026,1751.68398268398,971.593073593074,254.199134199134,218.220779220779,1012.51515151515,845.670995670996,187.95670995671,141.935064935065,611.264069264069,2278.09956709957,485.099567099567,220.809523809524,1063.2380952381,131.285714285714,231,21.5178608540374,13.6762877297067,0.772036325698437,0.96652719665272,0.715170278637771,0.89048095615901,50157.1948051948,35211.1471861472,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_377238,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
378244,2684.68859649123,264.526315789474,132.565789473684,644.109649122807,1883.91666666667,3044.49561403509,344.390350877193,262.55701754386,1097.45175438596,5426.93421052632,525.587719298246,117.179824561404,1080.63596491228,665.175438596491,455.385964912281,266.328947368421,1334.81578947368,1049.61403508772,304.517543859649,234.021929824561,982.635964912281,1010.24561403509,227.59649122807,139.245614035088,584.245614035088,2872.25438596491,535.671052631579,225.530701754386,1044.80263157895,129.127192982456,228,25.6692548779197,11.3479796619849,0.896973408996833,0.962025316455696,0.730769230769231,-1.29242213402402,50123.8859649123,34542.1929824561,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_378244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
378553,2189.96654275093,222.089219330855,150.089219330855,685.159851301115,4609.81412639405,2565.71003717472,371.401486988848,277.197026022305,1102.73605947955,4574.47583643123,616.446096654275,120.133828996283,1078.91821561338,1864.19330855019,979.706319702602,1288.92936802974,1769.24907063197,4348.0185873606,378.066914498141,242.773234200744,1047.40520446097,4383.7843866171,268.089219330855,1551.87360594796,692.82156133829,1609.30483271375,466.773234200744,239.940520446097,1089.19330855019,129.985130111524,269,22.465404566611,15.300284456262,0.732227777119937,0.95729537366548,0.815151515151515,-1.46965579115334,50698.9330855019,35370.0557620818,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_378553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
379085,4211.49777777778,235.344444444444,105.968888888889,642.537777777778,2261.23111111111,4345.20666666667,479.611111111111,296.5,1085.97333333333,8546.18444444445,588.442222222222,122.3,1108.76444444444,533.242222222222,394.62,367.013333333333,1503.97777777778,780.026666666667,196.971111111111,265.608888888889,995.775555555556,693.222222222222,173.075555555556,177.62,591.764444444444,4692.67333333333,553.777777777778,309.368888888889,1056.88,127.875555555556,450,28.0588471357876,20.7974723328388,0.671274233438478,0.957446808510638,0.76530612244898,0.0989637607542088,51758.1111111111,35387.06,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_379085,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
379217,4381.74203821656,1029.71974522293,787.550955414013,652.082802547771,2163.45222929936,4159.13375796178,514.96178343949,284.512738853503,1171.15605095541,7370.96815286624,596.111464968153,118.458598726115,1080.07961783439,682.257961783439,570.302547770701,346.980891719745,1538.38535031847,1297.79936305732,273.531847133758,226.837579617834,1004.88853503185,1155.16878980892,237.414012738854,183.751592356688,593.315286624204,2800.89808917197,615.143312101911,325.140127388535,1092.16878980892,130.257961783439,314,23.3558638358489,17.1651641221016,0.678131880114283,0.960244648318043,0.713636363636364,-0.614787226403698,51437.3184713376,35499.4458598726,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_379217,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
379341,2509.046875,208.59375,94.865625,640.75625,1956.26875,2891.2375,323.8375,268.04375,1087.275,4516.41875,570.621875,120.5125,1078.9375,1297.31875,677.1375,776.5625,1803.06875,1849.578125,362.428125,780.80625,1013.39375,1555.221875,265.390625,338.41875,617.015625,1604.475,446.0,212.55625,1033.221875,128.009375,320,23.3720090137618,17.6234655618762,0.656826737357212,0.941176470588235,0.732265446224256,-1.30709835709643,50683.703125,35761.2625,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_379341,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
379406,3907.33793103448,193.875862068966,93.9620689655172,628.168965517241,1596.91379310345,4509.78965517241,347.431034482759,260.855172413793,1097.46206896552,7369.57586206897,625.465517241379,134.755172413793,1074.30689655172,2373.36896551724,524.1,283.775862068966,1628.44827586207,1636.87931034483,325.462068965517,235.08275862069,1022.36896551724,1413.39310344828,220.9,248.486206896552,898.344827586207,2438.56206896552,544.762068965517,230.344827586207,1060.34482758621,129.489655172414,290,21.7166783316284,17.0647409249339,0.618493844848982,0.957095709570957,0.763157894736842,-0.735875798419371,51032.4379310345,33829.0310344828,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_379406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
380158,5045.46613545817,1044.67330677291,1138.31474103586,651.677290836653,2070.80876494024,5899.48207171315,630.91235059761,289.840637450199,1110.35856573705,8425.29083665339,703.633466135458,125.358565737052,1082.89243027888,1510.37051792829,561.374501992032,332.247011952191,1575.69721115538,1472.88446215139,323.948207171315,235.243027888446,1005.67330677291,1308.27888446215,241.163346613546,176.131474103586,692.764940239044,2285.17529880478,528.812749003984,278.824701195219,1076.67729083665,131.657370517928,251,19.7047225314627,16.2397759391776,0.566362073157177,0.954372623574144,0.784375,-1.53787331992016,50934.0119521912,35334.4262948207,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_380158,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
381430,2491.25165562914,701.149006622517,576.566225165563,609.708609271523,488.44701986755,2267.47682119205,382.483443708609,269.188741721854,1097.34768211921,4535.6059602649,511.562913907285,119.576158940397,1082.88741721854,3771.19536423841,1094.91059602649,613.533112582781,2306.51324503311,2507.58609271523,354.423841059603,241.960264900662,1768.88741721854,2560.77814569536,621.23178807947,236.417218543046,597.417218543046,2371.42715231788,529.496688741722,260.188741721854,1047.99337748344,130.062913907285,302,21.2207845231267,18.2461316415352,0.510591179645115,0.937888198757764,0.798941798941799,-1.33861199089551,50964.6523178808,35778.8741721854,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_381430,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
381443,4236.2950310559,772.037267080745,139.826086956522,647.900621118012,1807.86335403727,4215.3602484472,1440.6149068323,276.223602484472,1137.67080745342,6761.68633540373,624.189440993789,133.034161490683,1088.36335403727,692.574534161491,508.083850931677,300.776397515528,1514.02795031056,1099.19254658385,320.347826086957,232.192546583851,1000.42857142857,1064.24223602484,237.44099378882,225.459627329193,605.490683229814,1974.54658385093,501.276397515528,353.866459627329,1058.33229813665,129.605590062112,322,22.1934823709814,18.4860606207627,0.553348295871163,0.972809667673716,0.813131313131313,0.19696392716044,50854.6459627329,35798.5217391304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_381443,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
382169,1874.5668202765,349.502304147465,134.866359447005,637.709677419355,867.838709677419,2378.56221198157,377.917050691244,267.695852534562,1096.59447004608,2948.34101382488,902.502304147466,131.230414746544,1066.73271889401,597.783410138249,412.552995391705,266.009216589862,1369.17511520737,908.58064516129,262.101382488479,224.493087557604,1004.98156682028,837.036866359447,189.857142857143,124.806451612903,585.285714285714,1213.17511520737,524.806451612903,222.566820276498,1048.87557603687,130.912442396313,217,17.9771190303287,15.411179530114,0.514873164061287,0.960176991150442,0.797794117647059,-1.19418343389327,50034.6958525346,34166.6912442396,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_382169,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
382461,3143.06403940887,486.864532019704,197.088669950739,703.896551724138,4500.68226600985,3659.75123152709,591.472906403941,274.15763546798,1219.97783251232,6446.68472906404,808.327586206897,122.524630541872,1082.83004926108,2675.0960591133,667.746305418719,693.953201970443,1908.82512315271,2643.15517241379,435.5,244.633004926108,1127.07881773399,1945.80541871921,277.546798029557,192.238916256158,590.997536945813,3085.19458128079,534.118226600985,429.002463054187,1079.7315270936,130.302955665025,406,27.2857991021615,19.0123050674582,0.717281130002038,0.955294117647059,0.706086956521739,-0.723141585568828,50440.1256157635,35554.1428571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_382461,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
382598,1604.48684210526,243.190789473684,144.177631578947,665.723684210526,2501.34868421053,1661.45394736842,317.171052631579,257.105263157895,1091.63815789474,3495.81578947368,628.263157894737,113.447368421053,1068.11184210526,1038.59210526316,952.58552631579,293.230263157895,1638.24342105263,1282.15131578947,326.164473684211,239.855263157895,1001.88157894737,1137.65789473684,228.361842105263,146.289473684211,591.651315789474,2443.15789473684,530.565789473684,227.894736842105,1058.45394736842,131.342105263158,152,16.4657537955792,11.7707560120717,0.699264669028446,0.95,0.723809523809524,0.896725942102064,50379.9934210526,34165.1644736842,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_382598,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
382630,2057.12416107383,94.0805369127517,141.570469798658,681.01677852349,4911.8322147651,2316.08053691275,333.291946308725,265.808724832215,1088.31543624161,4339.30872483222,762.694630872483,117.89932885906,1077.6711409396,1121.47315436242,901.979865771812,1260.21812080537,1721.98322147651,3638.73825503356,361.164429530201,241.308724832215,1052.8288590604,4045.55369127517,397.372483221477,363.714765100671,861.345637583893,1262.71812080537,469.848993288591,257.137583892617,1044.88926174497,128.288590604027,298,30.7881356147922,12.5134039206656,0.91367929326107,0.937106918238994,0.70952380952381,-1.42417118671839,51536.8187919463,35148.9966442953,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_382630,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
383100,1734.58562367865,181.3044397463,101.53488372093,646.23467230444,2329.27906976744,2037.32558139535,368.124735729387,267.902748414376,1104.25369978858,3962.75052854123,770.186046511628,114.374207188161,1076.67019027484,1210.1289640592,557.792811839323,413.900634249471,1584.7399577167,2232.97463002114,282.625792811839,227.739957716702,1016.71458773784,2618.45877378436,226.103594080338,299.505285412262,646.894291754757,1628.38477801269,500.338266384778,291.22198731501,1077.89852008457,130.786469344609,473,28.9135559692877,20.9719388527393,0.688398804528202,0.95748987854251,0.741379310344828,-1.51673878760065,51625.5961945032,35170.733615222,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_383100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
383230,1982.92207792208,379.191558441558,165.324675324675,655.327922077922,2624.3474025974,2508.12337662338,1907.4512987013,286.269480519481,1093.9025974026,4524.65584415584,1908.69805194805,133.064935064935,1087.75649350649,705.837662337662,511.344155844156,318.071428571429,1362.14285714286,1084.42532467532,350.675324675325,256.431818181818,989.49025974026,1105.76623376623,236.74025974026,194.175324675325,595.659090909091,2440.32467532468,622.412337662338,363.386363636364,1103.87337662338,131.831168831169,308,26.5211070117904,14.8710911305662,0.828000989816317,0.959501557632399,0.63768115942029,0.864155630039597,50404.1201298701,34634.3538961039,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_383230,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
383509,1075.71153846154,745.891025641026,81.0064102564103,635.634615384615,1892.02564102564,995.987179487179,858.807692307692,258.98717948718,1139.28205128205,2289.88461538462,1339.95512820513,102.128205128205,1066.96794871795,1888.57051282051,737.173076923077,300.179487179487,4394.58333333333,1783.23717948718,318.378205128205,234.512820512821,1010.87179487179,1607.9358974359,232.647435897436,251.794871794872,582.179487179487,1413.59615384615,446.673076923077,361.205128205128,1026.82692307692,131.564102564103,156,16.7367394168479,11.9597957662649,0.699550282570379,0.951219512195122,0.696428571428571,0.435790689348326,51015.4615384615,35633.6602564103,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_383509,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
383767,2972.80769230769,376.519230769231,114.641025641026,621.935897435897,781.185897435897,3238.74358974359,1095.16025641026,280.198717948718,1095.25641025641,4031.16666666667,586.474358974359,121.621794871795,1067.21794871795,2850.60897435897,655.955128205128,305.064102564103,2309.88461538462,2889.73076923077,312.185897435897,229.320512820513,1018.82051282051,2313.92307692308,224.423076923077,219.051282051282,629.019230769231,1123.89102564103,467.205128205128,244.980769230769,1027.37179487179,129.570512820513,156,17.2532620517669,11.6857619660944,0.735700138248931,0.934131736526946,0.666666666666667,-0.292651108411389,50690.1346153846,35661.2820512821,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_383767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
384955,2113.1875,498.308333333333,169.829166666667,711.175,4295.425,2687.59166666667,789.645833333333,268.033333333333,1189.52916666667,3983.69166666667,1354.42916666667,129.9875,1077.67916666667,760.791666666667,525.091666666667,279.416666666667,1379.67083333333,1135.45416666667,341.533333333333,243.529166666667,986.491666666667,1054.87916666667,236.45,133.041666666667,587.375,1511.92916666667,539.529166666667,456.283333333333,1104.5,132.804166666667,240,23.4890992929184,13.0226189108148,0.832242909126667,0.952380952380952,0.666666666666667,0.671866156957446,50366.7833333333,34268.0875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_384955,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
385183,3968.80322580645,1153.32580645161,1051.47419354839,653.841935483871,1771.47419354839,3763.14193548387,1534.98709677419,271.7,1114.3064516129,7257.8064516129,666.477419354839,124.451612903226,1086.08387096774,800.516129032258,494.696774193548,291.770967741935,1610.71935483871,1320.30322580645,295.970967741936,232.348387096774,998.790322580645,1128.53870967742,215.370967741935,260.170967741935,870.4,2189.89032258065,513.68064516129,424.322580645161,1055.95161290323,131.154838709677,310,25.0087556893894,15.8466734939775,0.773623932464998,0.950920245398773,0.673913043478261,0.973682943382885,51994.335483871,35239.2774193548,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_385183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
385412,1743.46862745098,228.056862745098,107.796078431373,642.578431372549,1745.28823529412,2314.5137254902,747.074509803922,266.066666666667,1085.50980392157,4126.98039215686,1588.43333333333,120.894117647059,1082.10588235294,580.721568627451,411.586274509804,266.686274509804,1353.8568627451,915.009803921569,277.547058823529,233.041176470588,990.407843137255,859.41568627451,197.145098039216,125.535294117647,581.913725490196,2675.87647058824,553.543137254902,317.617647058824,1080.8137254902,133.637254901961,510,30.9242233395831,21.0225952717199,0.733388306236076,0.973282442748092,0.758928571428571,0.551810913227718,50600.4274509804,34650.2882352941,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_385412,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386341,2176.8587196468,121.072847682119,135.333333333333,684.759381898455,4554.69315673289,2562.54746136865,358.348785871965,266.540838852097,1094.54304635762,4436.19426048565,722.156732891832,121.207505518764,1079.60706401766,4994.34657836645,882.770419426049,940.039735099338,2009.94922737307,3732.68432671082,333.958057395143,238.317880794702,1026.66445916115,2702.80573951435,220.986754966887,180.894039735099,607.189845474614,1504.33333333333,502.823399558499,285.730684326711,1074.23841059603,130.695364238411,453,28.0910711066176,20.6040698701694,0.679717524555794,0.96588486140725,0.798941798941799,-1.19502933314478,51649.408388521,35186.944812362,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_386341,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386424,3398.12275449102,529.616766467066,153.437125748503,637.619760479042,1865.95808383234,4004.40119760479,2899.13473053892,266.419161676647,1096.62874251497,6087.95209580838,1586.65568862275,124.197604790419,1072.72754491018,772.937125748503,472.715568862275,281.781437125748,1481.7874251497,1169.5119760479,311.556886227545,235.817365269461,1030.29341317365,1084.96706586826,210.622754491018,169.982035928144,700.218562874251,1773.35329341317,540.392215568862,446.904191616766,1089.10179640719,134.329341317365,334,22.6815197040584,18.81528476907,0.558443573994148,0.968115942028986,0.799043062200957,-1.29638508249127,51233.7065868263,34118.9940119761,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386583,3382.36036036036,508.995495495496,118.463963963964,628.481981981982,864.707207207207,4004.55405405405,4155.06756756757,291.418918918919,1108.23423423423,6817.27477477477,1298.80630630631,127.648648648649,1073.83783783784,567.864864864865,384.40990990991,268.603603603604,1414.9009009009,877.490990990991,252.734234234234,223.036036036036,989.779279279279,828.45045045045,478.626126126126,127.400900900901,581.558558558559,3666.95045045045,560.472972972973,388.684684684685,1059.02702702703,131.238738738739,222,22.4836467425971,12.7072173844378,0.824970360929493,0.94468085106383,0.616666666666667,-0.944132538521473,50338.3198198198,35365.1621621622,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_386583,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386704,3138.32225063939,444.058823529412,124.953964194373,639.97442455243,1570.18158567775,3638.31713554987,3999.09974424552,265.125319693095,1097.87212276215,6517.04603580563,1919.48849104859,122.109974424552,1072.21227621483,865.143222506394,475.358056265985,273.383631713555,1629.20716112532,1053.72122762148,221.437340153453,217.757033248082,1375.41943734015,750.79283887468,154.25831202046,127.176470588235,611.383631713555,2460.25063938619,557.987212276215,356.404092071611,1093.09462915601,131.53452685422,391,30.345752940002,16.463425654445,0.840037612438755,0.953658536585366,0.74904214559387,-0.206919009991506,51469.9846547315,34266.1867007673,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386775,876.014598540146,41.4087591240876,36.1605839416058,608.759124087591,1420.40145985401,931.116788321168,247.649635036496,240.175182481752,1078.5401459854,2078.24087591241,413.43795620438,98.1824817518248,1065.9197080292,1905.80291970803,542.744525547445,314.379562043796,1559.90510948905,2541.74452554745,304.970802919708,234.51094890511,1006.09489051095,2487.0802919708,230.51094890511,158.394160583942,586.467153284672,942.751824817518,421.92700729927,219.350364963504,1024.92700729927,128.613138686131,137,14.1014252348702,12.4020005538014,0.475925481974008,0.938356164383562,0.752747252747253,0.0964224194339245,51753.102189781,35072.1459854015,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_386775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386853,3488.77397260274,1181.18493150685,175.643835616438,696.818493150685,4274.95890410959,3807.77739726027,410.876712328767,272.602739726027,1198.18835616438,6524.94520547945,553.304794520548,145.243150684931,1092.61643835616,948.917808219178,789.993150684931,395.818493150685,1749.46232876712,1446.01369863014,332.808219178082,237.513698630137,1020.72260273973,1415.54452054795,242.962328767123,220.328767123288,722.253424657534,3146.45890410959,552.294520547945,235.202054794521,1081.3801369863,130.702054794521,292,22.049924217525,16.8921534004716,0.642737261593594,0.973333333333333,0.817927170868347,1.24125811736394,50752.1130136986,35874.7157534247,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386853,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386936,2684.03703703704,183.26936026936,89.3602693602694,624.686868686869,1162.7037037037,3053.00336700337,514.47138047138,269.356902356902,1110.03703703704,5696.28282828283,684.845117845118,116.828282828283,1074.37037037037,736.639730639731,512.121212121212,323.851851851852,1519.80471380471,1208.90572390572,326.814814814815,274.430976430976,1001.01683501683,1199.65993265993,262.744107744108,173.558922558923,632.89898989899,3056.2861952862,483.659932659933,375.346801346801,1056.7138047138,131.393939393939,297,23.6539264986841,16.113430469348,0.732082589783633,0.961165048543689,0.759590792838875,-0.237775601578991,50400.0437710438,35495.2457912458,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
386944,4014.88,1099.88923076923,119.064615384615,648.867692307692,2771.55692307692,4098.48,697.898461538462,270.8,1115.72,6239.68307692308,671.609230769231,118.981538461538,1075.11384615385,2491.70153846154,997.067692307692,393.092307692308,2087.82461538462,3160.40307692308,380.550769230769,248.504615384615,1012.11384615385,3040.63076923077,258.218461538462,191.375384615385,602.993846153846,1767.40615384615,517.6,267.569230769231,1056.23384615385,132.710769230769,325,22.5709678772429,18.5308863130183,0.57092043888203,0.964391691394659,0.773809523809524,0.530946931437087,51681.0061538462,34901.6092307692,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386944,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
387449,3806.73106060606,643.685606060606,137.848484848485,656.30303030303,2629.36742424242,3769.80303030303,1269.02651515152,265.590909090909,1165.77651515152,6603.83333333333,597.693181818182,117.371212121212,1076.58333333333,558.640151515152,397.82196969697,270.284090909091,1659.35984848485,855.655303030303,211.704545454545,214.003787878788,1010.0,860.359848484848,179.375,163.348484848485,584.549242424242,2426.86363636364,544.791666666667,234.935606060606,1047.28409090909,131.246212121212,264,25.297197614098,13.4036678792097,0.84809266437351,0.946236559139785,0.6875,0.362249625780473,52040.3068181818,34959.2992424242,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_387449,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
387887,2859.37073170732,522.360975609756,150.248780487805,631.409756097561,1442.31707317073,2862.80487804878,2035.65365853658,285.736585365854,1103.1756097561,4735.96585365854,2117.69756097561,130.312195121951,1075.10731707317,3720.11707317073,652.092682926829,306.312195121951,1576.30243902439,4303.81463414634,362.551219512195,243.687804878049,1010.36097560976,4014.85853658537,265.551219512195,140.40487804878,585.268292682927,1897.04390243902,580.721951219512,577.741463414634,1080.33658536585,131.960975609756,205,20.1388974032879,13.1201691583801,0.758662385846447,0.953488372093023,0.770676691729323,-0.294983800963844,50439.3804878049,35245.3073170732,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_387887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
388020,2972.05970149254,558.820895522388,249.914179104478,722.227611940299,6482.41417910448,3200.23880597015,2608.52611940298,276.671641791045,1098.97388059701,5220.88432835821,4499.47388059701,142.470149253731,1073.48134328358,868.347014925373,822.179104477612,367.223880597015,1845.80223880597,1154.45895522388,294.865671641791,230.951492537313,1003.14179104478,1068.38059701493,197.514925373134,267.126865671642,717.80223880597,697.880597014925,401.123134328358,216.917910447761,1017.58582089552,130.276119402985,268,23.5718894018977,14.5038852906129,0.788289666577228,0.957142857142857,0.761363636363636,-1.19802590509202,50707.6641791045,33762.5932835821,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_388020,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
388319,4853.24066390041,797.170124481328,2413.86307053942,652.419087136929,1709.60580912863,4498.42738589212,672.394190871369,273.228215767635,1112.02489626556,8344.7468879668,800.087136929461,124.663900414938,1090.32365145228,4401.65145228216,553.630705394191,349.535269709544,1751.89626556017,4086.22821576763,423.269709543568,241.970954356846,1075.59751037344,3076.50622406639,247.402489626556,433.369294605809,772.273858921162,2487.29875518672,546.352697095436,398.190871369295,1073.67219917012,131.572614107884,241,22.2613180394891,14.2143255994959,0.769604156160031,0.948818897637795,0.675070028011205,1.07362531575107,51985.2157676349,35203.6473029046,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_388319,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
389215,1800.69781931464,422.183800623053,113.735202492212,650.01246105919,2429.32398753894,1704.14953271028,2687.48286604361,260.803738317757,1103.41121495327,2673.79127725857,3760.07165109034,118.034267912773,1066.18068535826,800.336448598131,672.760124610592,507.990654205607,1607.54517133956,1144.91900311526,311.638629283489,236.996884735202,1008.67289719626,1107.89408099688,239.666666666667,158.280373831776,601.13707165109,869.88785046729,450.021806853583,540.563862928349,1025.75700934579,130.588785046729,321,21.8284737797406,18.7497181959044,0.512047890211873,0.966867469879518,0.767942583732057,-0.33754070643759,52013.9190031153,35022.6074766355,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_389215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
389683,4658.75675675676,1067.375,135.574324324324,648.628378378378,2064.89527027027,5510.16891891892,1097.53378378378,273.625,1266.34121621622,8465.48986486487,1020.86824324324,129.64527027027,1078.24662162162,967.233108108108,471.172297297297,279.456081081081,1612.15878378378,1082.375,222.817567567568,220.41554054054,1277.22297297297,691.179054054054,146.195945945946,130.25,616.033783783784,3319.53716216216,624.219594594595,346.033783783784,1076.59459459459,132.47972972973,296,23.9301686483004,15.870413918984,0.748444959699028,0.964169381107492,0.741854636591479,-0.715863362579265,51433.5405405405,34275.7162162162,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_389683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
390558,4533.54545454545,939.028571428572,461.52987012987,654.436363636364,2195.87272727273,5109.19220779221,1130.23376623377,290.649350649351,1111.17142857143,7619.18181818182,940.150649350649,129.051948051948,1089.17402597403,717.974025974026,530.831168831169,496.623376623377,1930.26753246753,946.646753246753,271.545454545455,226.166233766234,994.831168831169,886.467532467532,212.727272727273,162.649350649351,599.844155844156,2658.92727272727,624.306493506494,391.257142857143,1089.29350649351,132.849350649351,385,27.3474511913934,18.9898612959397,0.719596584288055,0.939024390243902,0.663793103448276,-0.0713351059313662,50653.3792207792,35295.6883116883,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_390558,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
390638,1460.36465324385,503.051454138702,131.080536912752,643.852348993289,2031.23713646532,1948.79865771812,1659.73601789709,262.355704697987,1090.31991051454,3444.43400447427,4061.774049217,118.903803131991,1069.37583892617,706.997762863535,519.203579418344,275.34451901566,1459.32662192394,1009.82326621924,299.270693512304,234.787472035794,984.624161073826,955.809843400447,209.091722595078,130.680089485459,583.194630872483,1837.28187919463,533.644295302013,460.832214765101,1085.49888143177,132.167785234899,447,29.2398122133011,19.5639228763335,0.743185790979644,0.965442764578834,0.719806763285024,-0.552036021217437,50767.4653243848,34394.0760626398,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_390638,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
390901,4310.94249201278,990.038338658147,101.207667731629,625.11821086262,1318.20447284345,4902.79233226837,446.833865814696,272.367412140575,1098.61661341853,7230.39616613419,689.460063897764,122.290734824281,1080.58146964856,841.610223642173,792.699680511182,301.779552715655,1529.0,1256.00958466454,395.635782747604,256.945686900958,989.814696485623,1168.79552715655,275.760383386581,137.450479233227,599.565495207668,2225.80191693291,524.022364217252,230.345047923323,1030.89776357827,130.233226837061,313,24.9930111142204,16.580647489974,0.748254881457521,0.912536443148688,0.648033126293996,-0.648249957608331,51874.8913738019,34616.2076677316,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_390901,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
391531,2665.16955017301,393.463667820069,122.010380622837,643.328719723183,2020.86505190311,2870.26297577855,1844.01038062284,255.961937716263,1089.84083044983,4665.63667820069,2755.97923875433,116.702422145329,1067.74394463668,644.062283737024,470.615916955017,277.737024221453,1418.79930795848,988.43598615917,335.813148788927,239.190311418685,986.21107266436,952.743944636678,232.498269896194,131.916955017301,587.799307958477,1809.22837370242,517.176470588235,819.162629757785,1065.54671280277,129.439446366782,289,26.8195185018459,14.1132168586395,0.850342700145038,0.932258064516129,0.597107438016529,-0.83530615609283,51497.8685121107,34410.6366782007,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_391531,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
391560,3153.50294117647,322.447058823529,179.285294117647,660.988235294118,4088.22941176471,3951.33823529412,397.997058823529,269.270588235294,1089.53823529412,5883.59705882353,568.179411764706,120.708823529412,1081.67647058824,1057.54411764706,564.297058823529,275.579411764706,1754.91764705882,2437.68235294118,367.623529411765,248.444117647059,1001.85,2276.36470588235,238.297058823529,251.973529411765,1607.43529411765,1500.01176470588,522.979411764706,264.455882352941,1035.85294117647,129.711764705882,340,29.5662958112491,15.0378472848892,0.860994350946373,0.9366391184573,0.594405594405594,-0.671763018367483,51328.3147058824,34577.1705882353,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_391560,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
391775,4244.7212543554,885.358885017422,91.3693379790941,628.466898954704,1194.90940766551,4553.33449477352,485.351916376307,264.885017421603,1104.02787456446,7579.18466898955,639.118466898955,115.104529616725,1086.62369337979,4946.87804878049,847.222996515679,455.0,5542.38327526132,4762.48432055749,397.979094076655,243.898954703833,1045.56445993031,4783.61672473868,250.689895470383,165.275261324042,613.693379790941,2511.25783972125,501.191637630662,250.94425087108,1050.5818815331,130.222996515679,287,22.3966893571918,16.3485309574007,0.683497325235763,0.959866220735786,0.755263157894737,-0.69020320966009,51593.0522648084,34903.5156794425,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_391775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
391882,1304.59107806691,199.576208178439,76.8104089219331,639.702602230483,1885.96282527881,1708.31226765799,1272.74721189591,268.947955390335,1086.54646840149,3019.44609665428,633.460966542751,112.442379182156,1067.2936802974,4554.40892193309,654.802973977695,299.765799256506,1638.98513011152,7397.94795539033,390.739776951673,249.524163568773,992.64312267658,7338.82156133829,266.60594795539,205.89219330855,592.28624535316,1680.4312267658,471.315985130112,913.910780669145,1084.03345724907,131.524163568773,269,18.8241349251509,18.3016903884816,0.233960815987267,0.96415770609319,0.786549707602339,-0.590646504016112,51592.9256505576,35523.2081784387,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_391882,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
391968,1438.36330935252,98.7625899280576,118.708633093525,796.859712230216,2137.63309352518,1588.44964028777,294.428057553957,258.107913669065,1106.45323741007,2888.09352517986,440.251798561151,106.71582733813,1116.58273381295,958.021582733813,722.176258992806,423.338129496403,1688.94244604317,1283.85251798561,326.129496402878,230.071942446043,1036.77338129496,1222.18345323741,232.776978417266,266.363309352518,645.21582733813,1205.68345323741,405.931654676259,209.902877697842,1024.25539568345,128.755395683453,278,21.2758871789782,16.7054804573816,0.619262876258617,0.952054794520548,0.735449735449735,-0.347891984182728,50773.5143884892,35726.7877697842,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_391968,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
392179,2951.6715542522,871.328445747801,177.175953079179,665.360703812317,2182.9706744868,3365.75073313783,383.00293255132,276.422287390029,1124.63636363636,5535.29032258064,553.935483870968,115.950146627566,1083.19941348974,892.548387096774,477.568914956012,276.425219941349,1789.57478005865,1348.35190615836,300.592375366569,233.390029325513,1039.99413489736,1114.82697947214,215.472140762463,142.422287390029,589.870967741935,1919.99120234604,554.023460410557,246.284457478006,1039.1642228739,130.469208211144,341,22.9729503962357,18.962917267762,0.564481901367086,0.977077363896848,0.815789473684211,1.25528562477362,51138.5395894428,35276.6129032258,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_392179,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
392519,4428.70847457627,1103.76610169492,171.281355932203,640.606779661017,1234.86440677966,5459.44745762712,1005.11186440678,279.715254237288,1144.02033898305,7198.15593220339,936.31186440678,130.301694915254,1080.06101694915,566.149152542373,413.013559322034,350.850847457627,1441.57288135593,873.691525423729,238.616949152542,223.705084745763,996.996610169492,801.532203389831,183.738983050847,134.332203389831,587.352542372881,1317.99322033898,533.51186440678,382.145762711864,1065.48813559322,132.769491525424,295,23.6443660041728,15.957768091617,0.737902027096977,0.939490445859873,0.705741626794258,0.434185286232459,50526.7694915254,35019.793220339,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_392519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
392732,2994.47696476965,617.517615176152,118.831978319783,640.677506775068,1268.0243902439,3817.63143631436,2090.39295392954,271.571815718157,1106.66937669377,5567.37669376694,1241.0108401084,119.978319783198,1074.21951219512,781.341463414634,739.192411924119,286.021680216802,1535.63956639566,1227.38482384824,345.962059620596,240.208672086721,993.140921409214,1173.87533875339,238.420054200542,138.132791327913,623.840108401084,2012.69105691057,533.341463414634,340.466124661247,1084.18157181572,131.192411924119,369,27.082819394212,17.4324142935236,0.765302668033463,0.968503937007874,0.834841628959276,1.49723505158221,50342.2059620596,34741.0108401084,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_392732,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393026,1205.1797235023,176.47465437788,99.2903225806452,642.806451612903,2300.52534562212,1351.34562211982,433.594470046083,263.26267281106,1083.26267281106,2657.22119815668,1565.92165898618,123.10599078341,1068.46543778802,1012.71428571429,520.207373271889,293.31797235023,2006.34101382488,2033.13824884793,345.350230414747,244.092165898618,1038.34562211982,2243.27649769585,248.626728110599,212.184331797235,937.216589861751,1850.1797235023,467.972350230415,282.539170506912,1058.27188940092,129.672811059908,217,20.4961801512438,13.4892954510014,0.752898153270131,0.947598253275109,0.713815789473684,1.08119613098037,50723.1889400922,35820.331797235,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_393026,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393207,1211.42574257426,109.069306930693,189.782178217822,746.049504950495,7292.9900990099,1257.04455445545,323.737623762376,263.262376237624,1093.92079207921,2633.5198019802,565.009900990099,119.935643564356,1073.39108910891,585.480198019802,352.480198019802,257.341584158416,1544.05445544554,1056.4702970297,246.445544554455,221.549504950495,1028.68316831683,947.519801980198,196.30198019802,152.876237623762,633.955445544554,1183.24752475248,456.158415841584,215.113861386139,1052.40099009901,131.554455445545,202,19.9406993471909,12.9222038069026,0.761613427307444,0.961904761904762,0.748148148148148,0.480574037506998,50062.2772277228,35385.5594059406,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_393207,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393232,3771.60124610592,217.305295950156,119.258566978193,637.869158878505,1842.73831775701,3453.01557632399,728.95015576324,273.348909657321,1091.14018691589,6622.93457943925,648.246105919003,118.093457943925,1085.19003115265,983.473520249221,576.208722741433,280.582554517134,1726.13395638629,1257.29595015576,276.560747663551,227.246105919003,1215.81931464174,1009.44236760125,201.744548286604,170.451713395639,3381.71651090343,2045.19626168224,461.654205607477,237.635514018692,1057.23364485981,131.277258566978,321,24.1730162571078,16.9418441488081,0.713301134951644,0.958208955223881,0.767942583732057,-0.530784734182791,50785.015576324,35526.3956386293,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_393232,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393269,3985.64971751412,1132.86440677966,749.666666666667,650.446327683616,2035.76836158192,4115.39548022599,465.474576271186,273.19209039548,1174.4406779661,6169.49152542373,530.728813559322,131.564971751412,1116.29378531073,1071.12994350282,634.723163841808,297.28813559322,2020.4011299435,1791.86440677966,329.056497175141,249.971751412429,1032.78531073446,1714.06214689266,256.858757062147,309.757062146893,1024.00564971751,1700.11299435028,524.322033898305,241.994350282486,1095.14124293785,132.322033898305,177,18.6055888103312,12.2569977134322,0.752335264996871,0.941489361702128,0.694117647058824,0.414000696334156,51345.0395480226,35823.9604519774,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_393269,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393317,2586.53846153846,207.221153846154,53.8317307692308,624.1875,1191.09134615385,2264.23076923077,469.894230769231,264.548076923077,1152.1875,4337.16346153846,498.346153846154,122.625,1082.66346153846,958.913461538462,580.081730769231,1011.10576923077,1544.32211538462,1270.69230769231,327.105769230769,237.192307692308,994.317307692308,1281.16346153846,246.201923076923,230.961538461538,622.649038461538,1458.10576923077,457.644230769231,243.682692307692,1028.52403846154,129.197115384615,208,19.3009139266885,13.8828526367676,0.694715394321737,0.941176470588235,0.77037037037037,0.44130004753034,50875.4807692308,35802.1634615385,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393317,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
393541,5321.86787564767,1409.74093264249,1716.71243523316,639.080310880829,1706.68393782383,5074.39896373057,788.422279792746,278.927461139896,1160.98186528497,8596.63212435233,581.971502590674,122.212435233161,1076.84455958549,3708.93005181347,1517.44300518135,2162.87305699482,1975.59067357513,2441.25129533679,442.230569948187,245.386010362694,1027.47409326425,1978.79015544041,268.274611398964,769.108808290155,672.080310880829,2073.96373056995,491.774611398964,302.272020725389,1045.27461139896,129.878238341969,386,27.3661209622941,18.0012956101518,0.753197072931513,0.965,0.781376518218624,0.289769968967206,51458.2720207254,35652.0803108808,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
394193,3325.91711229947,421.155080213904,119.208556149733,637.267379679144,1418.91978609626,4005.74331550802,3678.66844919786,264.70320855615,1093.56417112299,5278.02941176471,929.264705882353,115.438502673797,1083.31016042781,1779.30748663102,589.588235294118,293.478609625668,1616.64171122995,1943.13368983957,354.804812834225,242.310160427807,1035.6577540107,1540.91176470588,229.633689839572,483.844919786096,1862.59090909091,1438.33155080214,513.326203208556,356.802139037433,1048.29946524064,134.211229946524,374,28.9596914707345,16.9549078935695,0.810697131563448,0.946835443037975,0.729044834307992,1.22885221513103,51189.7219251337,34457.1844919786,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_394193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
394601,3982.36363636364,1317.89225589226,153.969696969697,651.154882154882,2664.16161616162,4530.9898989899,792.087542087542,273.52861952862,1303.85858585859,6944.77777777778,597.454545454545,120.979797979798,1068.0404040404,663.377104377104,430.16835016835,267.053872053872,1472.65656565657,1042.79797979798,273.683501683502,227.434343434343,990.228956228956,954.548821548822,199.882154882155,131.373737373737,582.057239057239,2065.44107744108,520.690235690236,249.888888888889,1067.45791245791,132.0,297,24.2769307854303,15.6386303941828,0.764876804413059,0.961165048543689,0.707142857142857,-0.727159386695919,51054.9191919192,35039.0202020202,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_394601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
394679,3377.25129533679,623.528497409326,143.059585492228,645.875647668394,1126.36787564767,3893.63471502591,3403.53626943005,277.556994818653,1107.34974093264,5255.24093264249,1815.82383419689,122.616580310881,1081.20725388601,3654.04404145078,690.088082901554,330.663212435233,1848.92487046632,4280.55440414508,429.790155440414,247.821243523316,1086.31088082902,4098.65025906736,262.145077720207,164.0,2651.46113989637,1483.45077720207,507.619170984456,425.113989637306,1094.42487046632,135.204663212435,386,25.446407238107,19.5254919418468,0.64126651805231,0.965,0.812631578947368,0.192200000147873,50429.6943005181,34965.7668393782,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_394679,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
394784,1424.96031746032,306.142857142857,170.039682539683,646.404761904762,2785.9126984127,1403.09523809524,309.396825396825,254.15873015873,1083.80158730159,2591.71428571429,603.031746031746,116.253968253968,1073.94444444444,545.928571428571,447.896825396825,262.452380952381,1437.50793650794,787.769841269841,218.865079365079,218.095238095238,1005.07142857143,775.269841269841,167.388888888889,128.825396825397,624.126984126984,1100.88095238095,494.571428571429,218.793650793651,1032.54761904762,129.619047619048,126,16.6387201171197,10.1618823070647,0.791833501999399,0.940298507462687,0.646153846153846,0.590090062439763,50698.8888888889,33688.3571428571,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_394784,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
394839,1819.4331797235,662.013824884793,250.064516129032,708.516129032258,4679.60368663594,1856.34101382488,2159.44239631336,262.248847926267,1113.3732718894,2836.61751152074,5818.02304147465,115.709677419355,1064.04147465438,3155.57603686636,590.663594470046,472.511520737327,1834.21198156682,4652.65898617512,429.654377880184,242.225806451613,1153.866359447,4161.03225806452,246.115207373272,231.907834101382,609.304147465438,1056.866359447,496.976958525346,610.391705069124,1341.58525345622,133.73732718894,217,19.3848103056217,14.364366119553,0.671492406390273,0.939393939393939,0.723333333333333,-0.0058658509719889,51552.4101382489,35042.3087557604,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_394839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396018,1114.57142857143,145.541666666667,98.7916666666667,649.809523809524,1561.68452380952,1281.6130952381,321.130952380952,248.178571428571,1088.8869047619,2754.32738095238,835.291666666667,116.25,1070.50595238095,554.797619047619,391.0,266.988095238095,1482.80357142857,881.107142857143,279.904761904762,230.333333333333,983.988095238095,814.517857142857,198.946428571429,130.720238095238,582.369047619048,1023.64880952381,461.845238095238,214.785714285714,1037.35714285714,130.136904761905,168,15.8529588122936,13.5429325169536,0.519806190242321,0.93854748603352,0.7,-0.806722001841212,51331.4464285714,34462.869047619,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_396018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396168,3090.69428571429,261.028571428571,118.642857142857,634.52,1570.48,3574.32571428571,336.391428571429,262.828571428571,1089.26857142857,6535.68571428571,538.948571428571,119.251428571429,1085.63142857143,1897.71428571429,640.028571428571,298.251428571429,1697.08285714286,3003.26571428571,382.834285714286,242.988571428571,1085.68285714286,3352.50571428571,239.86,803.194285714286,1312.82571428571,2970.54,586.617142857143,239.614285714286,1056.68571428571,130.365714285714,350,25.5300518748643,17.8169310168327,0.716214003535935,0.964187327823691,0.723140495867769,0.854054948013526,51219.6514285714,34415.6428571429,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_396168,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396322,2536.12367491166,105.116607773852,66.1908127208481,647.243816254417,1996.3074204947,3559.72791519435,395.250883392226,272.943462897527,1103.1554770318,4624.13427561837,756.908127208481,144.862190812721,1067.69964664311,591.321554770318,418.833922261484,266.028268551237,1384.07067137809,933.802120141343,272.363957597173,226.681978798587,994.385159010601,883.968197879859,193.243816254417,120.159010600707,590.257950530035,1718.92932862191,526.840989399293,236.0,1087.36395759717,132.183745583039,283,23.5247298429623,15.3905002795923,0.756298726665052,0.946488294314381,0.769021739130435,0.0634524555496777,50427.5477031802,34872.9399293286,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396480,1757.51145038168,592.389312977099,254.81679389313,698.221374045802,4990.38167938931,2414.98473282443,383.274809160305,269.206106870229,1107.09160305344,3825.6641221374,950.57251908397,138.870229007634,1075.67175572519,1945.48091603053,664.251908396947,346.358778625954,1862.84732824427,1439.12213740458,342.992366412214,254.809160305344,1033.12977099237,1258.41221374046,221.36641221374,144.801526717557,737.351145038168,1256.34351145038,519.145038167939,227.404580152672,1039.28244274809,129.564885496183,131,14.3532255713054,12.3176475581943,0.513349309549156,0.885135135135135,0.671794871794872,-0.0009617024032785,51062.8549618321,34016.5038167939,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396480,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396506,3571.13091922006,1150.78272980501,541.849582172702,635.172701949861,1191.19498607242,4129.81615598886,607.161559888579,270.512534818942,1182.3147632312,7176.99164345404,753.618384401114,120.128133704735,1086.87186629526,787.50139275766,686.91922005571,302.696378830084,1457.37325905292,1261.17548746518,347.941504178273,241.448467966574,989.125348189415,1185.61559888579,242.097493036212,136.949860724234,593.24791086351,2853.74373259053,591.055710306407,303.389972144847,1058.18105849582,132.214484679666,359,27.7331569845209,16.5045406693028,0.803637268961201,0.962466487935657,0.678638941398866,-0.747635366313599,51450.3203342618,34926.1894150418,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396506,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
396628,3192.28518518519,600.62962962963,349.455555555556,729.322222222222,7016.35925925926,3958.51481481482,383.940740740741,282.774074074074,1113.67777777778,5467.43333333333,639.059259259259,138.0,1085.04444444444,577.474074074074,380.362962962963,265.2,1339.2037037037,1046.76296296296,270.87037037037,227.996296296296,1005.08148148148,965.585185185185,196.725925925926,124.422222222222,587.185185185185,2181.01111111111,546.503703703704,226.148148148148,1096.46296296296,129.655555555556,270,22.5098409291886,15.3760742526234,0.730341393396304,0.96085409252669,0.756302521008403,-1.10566749208913,50080.4518518519,34380.6259259259,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396628,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
397922,2055.04833836858,324.824773413897,88.2447129909366,642.755287009063,932.196374622356,2258.76737160121,1724.01510574018,272.912386706949,1178.40181268882,4001.65256797583,592.842900302115,112.208459214502,1069.93051359517,1345.13897280967,827.404833836858,1433.15407854985,1664.57703927492,1552.59214501511,327.009063444109,234.111782477341,1016.10271903323,1243.56797583082,230.033232628399,297.015105740181,686.29003021148,1708.07854984894,516.003021148036,990.779456193353,1037.77341389728,129.453172205438,331,20.7862788993456,20.2943512862328,0.216268067267665,0.962209302325581,0.788095238095238,1.08773356341403,51324.1963746224,35485.3081570997,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_397922,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
398326,1637.97583081571,504.791540785499,87.0332326283988,638.353474320242,1659.98791540786,1759.29305135952,2281.19033232628,267.688821752266,1102.32628398792,2924.68580060423,2576.60120845921,114.716012084592,1069.00302114804,880.12084592145,786.63746223565,489.419939577039,1592.32024169184,1312.6586102719,316.918429003021,236.607250755287,1008.09365558912,1227.57401812689,243.468277945619,375.888217522659,611.549848942598,1329.99093655589,513.181268882175,558.987915407855,1046.78549848943,130.36253776435,331,23.1518053220218,18.4931489276025,0.60162610530072,0.965014577259475,0.791866028708134,1.05001124363338,51995.003021148,34996.746223565,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_398326,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
398396,4354.01171875,1419.5078125,183.671875,647.49609375,1358.33203125,4139.0703125,1256.92578125,270.5703125,1148.5703125,6490.60546875,592.75,120.08984375,1074.91796875,900.80859375,518.26171875,416.40234375,1502.5859375,1775.95703125,340.09375,238.1015625,993.7578125,1986.93359375,242.99609375,268.1171875,1085.75,1220.76171875,482.515625,265.3671875,1038.9921875,130.59765625,256,21.9977309869573,14.8727669470019,0.736805659498374,0.951672862453532,0.673684210526316,0.782116147338116,51980.1875,35246.42578125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_398396,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
398681,1117.66438356164,172.332191780822,120.181506849315,658.304794520548,2967.7397260274,1469.56849315068,367.071917808219,271.996575342466,1105.64383561644,2110.93835616438,622.102739726027,150.164383561644,1069.89726027397,1262.38356164384,670.921232876712,291.859589041096,1579.60616438356,1271.77397260274,273.702054794521,230.366438356164,1290.04452054795,998.496575342466,186.472602739726,133.708904109589,1134.06164383562,968.36301369863,473.239726027397,216.633561643836,1048.10273972603,130.356164383562,292,25.8601654482293,14.4503801619827,0.82930975709313,0.941935483870968,0.634782608695652,-0.901220662623902,50378.1130136986,34930.448630137,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_398681,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
399228,3053.08011049724,163.78453038674,75.6381215469613,641.013812154696,1152.59668508287,3768.91988950276,362.422651933702,268.541436464088,1094.38674033149,5713.26795580111,717.096685082873,125.555248618785,1075.60497237569,722.381215469613,519.574585635359,281.359116022099,1339.09944751381,1152.93922651934,323.919889502762,236.546961325967,979.867403314917,1104.49447513812,239.792817679558,126.919889502762,588.140883977901,1806.34806629834,563.096685082873,228.093922651934,1070.22928176796,131.839779005525,362,31.7056900238458,14.6404828466709,0.887003864178854,0.952631578947368,0.5829307568438,-0.887172615355695,50083.044198895,34618.4640883978,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_399228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
399444,2683.7492795389,280.132564841498,108.853025936599,646.302593659942,2219.12391930836,2648.66858789625,1461.12391930836,276.463976945245,1143.6916426513,3895.10086455331,767.515850144092,122.740634005764,1072.52737752161,672.956772334294,600.625360230548,297.233429394813,1546.87031700288,1072.81556195965,273.530259365994,228.815561959654,998.959654178674,1036.91930835735,218.083573487032,174.461095100865,606.317002881844,1044.89337175793,491.057636887608,274.71757925072,1023.56484149856,130.221902017291,347,26.762167808886,16.7419656157644,0.780157367332459,0.953296703296703,0.660952380952381,0.593345157412406,51774.6340057637,35337.6974063401,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_399444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
400276,4643.78991596639,1010.83753501401,2761.64705882353,641.960784313726,1527.08963585434,4725.58823529412,449.59943977591,288.882352941176,1112.91036414566,7728.25770308123,612.616246498599,131.15406162465,1084.39215686275,3249.43977591036,815.59943977591,373.725490196078,4235.98879551821,3207.8431372549,405.254901960784,242.605042016807,1057.18767507003,2257.6862745098,246.935574229692,429.022408963586,601.229691876751,2237.60224089636,525.201680672269,259.787114845938,1043.58823529412,131.03081232493,357,21.844489686786,20.9848221967837,0.277775473507881,0.964864864864865,0.80952380952381,-1.55378221545774,50598.4677871148,35502.4369747899,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_400276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
401283,2117.21661721068,447.100890207715,127.991097922849,664.640949554896,2392.06231454006,2446.6824925816,2995.39465875371,264.771513353116,1283.6824925816,3862.44510385757,544.860534124629,108.326409495549,1072.21364985163,2391.09792284866,867.445103857567,336.851632047478,1847.37685459941,1730.07121661721,286.421364985163,225.097922848665,1041.28486646884,1297.45697329377,208.314540059347,196.124629080119,622.925816023739,1207.77448071217,427.032640949555,916.525222551929,1042.46290801187,129.80118694362,337,24.0346947346186,18.0180258914423,0.661814827188623,0.936111111111111,0.739035087719298,-1.24592570181691,51331.5786350148,35526.7744807122,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_401283,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
401352,3681.05693950178,463.5871886121,81.0071174377224,615.462633451957,899.946619217082,3562.07117437722,1154.37722419929,271.455516014235,1104.03558718861,7179.42704626334,789.103202846975,114.483985765125,1075.20284697509,1249.01067615658,637.857651245552,337.135231316726,2943.871886121,1203.128113879,292.327402135231,312.555160142349,1016.92170818505,1071.13879003559,215.181494661922,345.629893238434,620.907473309609,3058.07473309609,496.078291814947,233.149466192171,1053.0462633452,130.725978647687,281,22.0649691342096,16.3734568299863,0.67033718744984,0.959044368600682,0.704260651629073,-0.579091327169373,50866.2526690391,35473.8291814947,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_401352,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
401788,2578.70979020979,145.671328671329,107.520979020979,640.108391608392,1915.16083916084,2660.78321678322,338.272727272727,261.839160839161,1097.36363636364,5099.54545454545,501.192307692308,113.206293706294,1074.55594405594,664.524475524476,429.699300699301,276.832167832168,1495.86013986014,948.555944055944,255.451048951049,224.409090909091,992.65034965035,897.940559440559,200.293706293706,159.048951048951,580.297202797203,2100.71678321678,506.989510489511,222.653846153846,1037.22727272727,130.671328671329,286,25.3782663412605,14.3810481101562,0.82394631262022,0.956521739130435,0.744791666666667,1.27358026800673,51939.6363636364,35133.4090909091,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_401788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
402458,1875.89010989011,316.168498168498,114.025641025641,674.772893772894,1703.60073260073,2123.60805860806,3149.78021978022,266.479853479853,1101.99267399267,3555.30036630037,1728.23443223443,109.710622710623,1073.15384615385,960.344322344322,1023.99267399267,582.479853479853,1848.22344322344,1030.17582417582,267.897435897436,222.981684981685,1099.98534798535,927.575091575092,205.263736263736,149.326007326007,597.52380952381,1289.4652014652,432.732600732601,413.74358974359,1077.90476190476,131.974358974359,273,20.7734527539943,16.7832976550707,0.589291539583237,0.947916666666667,0.718421052631579,0.64602302181846,50210.2783882784,35235.2747252747,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_402458,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
402630,3398.49069767442,467.262790697674,94.7883720930233,649.251162790698,2306.61395348837,3683.75348837209,990.627906976744,274.355813953488,1178.1,5896.21627906977,560.258139534884,132.902325581395,1101.01395348837,2188.30465116279,1000.87906976744,1439.22093023256,2179.08604651163,2615.37674418605,344.318604651163,238.544186046512,1036.25813953488,2349.86511627907,251.255813953488,265.548837209302,634.788372093023,2479.98837209302,497.553488372093,357.776744186047,1084.09534883721,132.390697674419,430,27.7771518322158,19.7782455692881,0.702146117276408,0.966292134831461,0.758377425044092,1.15733504571761,51194.7720930233,35868.1255813953,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_402630,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
402657,1828.14417177914,160.923312883436,101.424846625767,667.30981595092,3792.89110429448,2066.48466257669,598.303680981595,272.334355828221,1098.0,3425.85122699387,649.226993865031,121.024539877301,1072.6226993865,696.984662576687,449.414110429448,277.055214723926,1430.21625766871,1026.98619631902,284.239263803681,229.651840490798,989.196319018405,980.467791411043,213.745398773006,160.391104294479,597.860429447853,1405.81595092025,492.51226993865,304.771472392638,1066.16411042945,130.825153374233,652,38.9704456627013,21.3732176560982,0.83618542626611,0.958823529411765,0.684873949579832,0.980155244209497,51587.504601227,35492.6104294479,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_402657,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
404524,1866.0,786.961832061069,80.9083969465649,624.557251908397,1802.28244274809,1964.62595419847,508.030534351145,257.900763358779,1155.83969465649,2678.12977099237,550.916030534351,106.343511450382,1053.74045801527,1711.29770992366,562.412213740458,332.335877862595,1689.12977099237,1472.0,312.18320610687,229.770992366412,995.992366412214,1151.64122137405,214.496183206107,137.702290076336,577.511450381679,914.709923664122,459.793893129771,225.75572519084,1042.2213740458,129.832061068702,131,15.4587649111095,10.852377449641,0.712156253476936,0.949275362318841,0.744318181818182,-1.30654591627311,51054.9083969466,35072.9847328244,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_404524,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
405248,472.758957654723,742.302931596091,194.889250814332,609.547231270358,124.553745928339,620.794788273616,380.179153094463,260.537459283388,1104.65146579805,1372.19218241042,737.527687296417,115.644951140065,1068.93159609121,963.482084690554,544.107491856677,299.182410423453,1593.34201954397,991.70684039088,222.586319218241,220.498371335505,1143.45602605863,632.589576547231,138.71009771987,119.087947882736,582.755700325733,564.185667752443,373.980456026059,200.296416938111,984.384364820847,129.680781758958,307,22.1895578324222,17.6615806477733,0.605374095577616,0.959375,0.775252525252525,-1.26921206351922,51200.0,33970.2084690554,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_405248,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
405521,5011.544,719.72,194.432,658.528,2652.04,6596.192,2310.232,311.92,1182.04,8135.56,3867.648,145.184,1087.2,10438.208,2357.032,3078.824,2698.216,10442.096,682.344,289.576,1101.136,13262.272,404.728,846.04,900.44,3280.368,584.664,753.704,1091.632,130.048,125,13.6241272667183,12.2076351608435,0.443992267279441,0.905797101449275,0.641025641025641,-0.10144198947232,51731.68,34790.88,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_405521,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406332,2959.86440677966,447.353510895884,169.474576271186,642.64406779661,2015.46489104116,2811.14769975787,657.28813559322,268.8401937046,1108.72397094431,4906.33414043584,577.065375302663,119.980629539952,1093.60532687651,2245.71428571429,1063.11138014528,4353.9588377724,2000.68523002421,3216.97578692494,377.46004842615,255.944309927361,1089.94430992736,3064.23486682809,300.624697336562,436.709443099274,755.779661016949,1662.59322033898,491.438256658596,290.283292978208,1057.82566585956,129.554479418886,413,29.9611829072113,17.8194241203692,0.803910453476664,0.958236658932715,0.67816091954023,0.44741848916864,51154.3607748184,35771.2348668281,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406332,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406539,2431.42222222222,214.475925925926,285.05,856.922222222222,9907.06851851852,3090.79259259259,311.562962962963,267.696296296296,1245.10740740741,5234.0462962963,564.083333333333,131.975925925926,1069.12037037037,732.368518518518,494.440740740741,490.687037037037,1545.35185185185,992.109259259259,236.909259259259,222.233333333333,1011.59814814815,877.244444444444,185.942592592593,156.074074074074,601.703703703704,2349.18703703704,528.048148148148,259.57037037037,1088.46851851852,131.046296296296,540,38.2988915376384,18.0446514916361,0.882051307974302,0.978260869565217,0.858505564387917,1.53307245007377,51225.9240740741,35160.9407407407,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406539,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406692,1268.52941176471,154.070588235294,194.552941176471,742.658823529412,6118.28235294118,1501.80784313725,367.035294117647,258.83137254902,1093.29019607843,3054.18039215686,574.486274509804,117.996078431373,1067.79607843137,947.682352941176,681.435294117647,284.666666666667,1933.41568627451,1620.15294117647,285.094117647059,230.462745098039,1095.96078431373,1598.99607843137,206.976470588235,301.61568627451,1690.07450980392,1568.87058823529,499.972549019608,248.827450980392,1044.58039215686,128.372549019608,255,25.7204767242802,12.8261767590856,0.866788639339686,0.958646616541353,0.754437869822485,-1.53217318795991,51870.4705882353,34823.5137254902,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_406692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406824,2071.20656370656,148.351351351351,106.372586872587,702.055984555985,2167.26640926641,2512.73938223938,1160.98455598456,263.776061776062,1156.2972972973,4609.10424710425,1939.62548262548,113.76833976834,1072.44208494208,957.305019305019,636.436293436293,287.857142857143,1886.85907335907,1608.32625482625,314.009652509652,236.6138996139,1002.87644787645,1474.92857142857,233.722007722008,169.135135135135,593.656370656371,2679.89189189189,543.739382239382,414.629343629344,1055.39189189189,129.413127413127,518,37.4078440606571,17.9780883830785,0.876941709147389,0.95045871559633,0.685185185185185,0.291730463373338,51648.9111969112,34987.9111969112,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406824,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406902,2731.10185185185,330.844907407407,108.810185185185,622.157407407407,921.44212962963,3283.3587962963,2440.57175925926,264.206018518519,1088.45138888889,5334.52777777778,893.263888888889,124.053240740741,1069.35648148148,1719.96064814815,673.108796296296,328.722222222222,1796.10416666667,1858.4212962963,363.328703703704,243.3125,998.962962962963,1434.82407407407,230.210648148148,277.270833333333,589.747685185185,2183.65972222222,531.273148148148,249.717592592592,1042.30787037037,130.548611111111,432,31.6739092739388,17.8789658116521,0.825453708130325,0.943231441048035,0.617142857142857,-0.640884483022975,50910.3541666667,33922.5787037037,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406902,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
406987,2492.84487534626,287.551246537396,88.9861495844875,636.321329639889,1863.08864265928,2915.56232686981,736.698060941828,272.296398891967,1109.93905817175,4633.31578947368,782.390581717451,116.556786703601,1090.71468144044,763.238227146814,413.146814404432,279.839335180055,1531.2216066482,817.90027700831,200.941828254848,214.288088642659,1068.63711911357,694.520775623269,181.113573407202,225.94459833795,620.274238227147,1631.95290858726,474.168975069252,283.963988919668,1050.52908587258,130.592797783934,361,27.1244551665147,17.1382039232393,0.775102202489897,0.957559681697613,0.687619047619048,-1.01326425282072,51639.487534626,35674.9806094183,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406987,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
407516,2309.89498806683,131.016706443914,102.992840095465,679.011933174224,3139.17661097852,2597.21479713604,1963.63007159905,260.532219570406,1109.68973747017,4580.43914081146,655.257756563246,114.923627684964,1087.21479713604,6252.33651551313,1469.22673031026,585.634844868735,3460.43914081146,6926.77565632458,472.770883054893,268.36276849642,1055.15035799523,7027.05727923628,317.646778042959,306.560859188544,750.968973747017,1770.39618138425,499.81861575179,1054.02863961814,1065.83770883055,130.751789976134,419,28.9490346498797,18.4567352548152,0.770401027452136,0.961009174311927,0.76043557168784,1.5089680683367,51663.5178997613,34947.4272076372,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_407516,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
407576,2276.27705627706,128.246753246753,130.311688311688,694.727272727273,4617.28571428571,2524.24242424242,410.748917748918,276.333333333333,1113.5367965368,4420.22943722944,570.606060606061,128.805194805195,1077.46753246753,1631.95670995671,715.194805194805,376.454545454545,1894.39393939394,2397.33766233766,383.372294372294,248.943722943723,1032.62337662338,1431.15151515152,221.108225108225,226.207792207792,1531.51948051948,4002.91774891775,835.030303030303,516.458874458874,1201.93506493506,133.82683982684,231,26.5355976565532,11.1885051259539,0.906762689421016,0.950617283950617,0.5775,0.785239684140751,51776.3333333333,34790.658008658,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_407576,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
407866,2845.90151515152,409.181818181818,274.863636363636,730.015151515152,5145.17424242424,3477.99242424242,389.810606060606,270.643939393939,1095.18181818182,4735.09848484848,619.939393939394,124.181818181818,1094.81060606061,772.780303030303,462.325757575758,350.916666666667,1372.37878787879,990.174242424242,274.007575757576,231.128787878788,993.916666666667,885.318181818182,202.363636363636,116.378787878788,587.022727272727,1881.25757575758,518.462121212121,223.212121212121,1053.81818181818,129.689393939394,132,16.238406275861,10.5357462279893,0.760944889695698,0.936170212765958,0.676923076923077,-0.978260794039541,50010.3636363636,34637.2196969697,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_407866,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
407958,2087.54966887417,130.059602649007,68.682119205298,626.761589403974,1218.93377483444,2127.71523178808,442.53642384106,260.165562913907,1092.70198675497,4019.33112582782,511.748344370861,126.092715231788,1097.76821192053,1261.26490066225,571.423841059603,741.470198675497,1553.43046357616,1318.56953642384,322.701986754967,233.092715231788,997.218543046358,1083.72185430464,239.470198675497,198.867549668874,592.072847682119,1204.93377483444,429.384105960265,220.735099337748,1029.97350993377,128.377483443709,151,15.1113093452726,12.8112434196671,0.530329280562083,0.967948717948718,0.770408163265306,-0.984161185747872,50877.0662251656,35818.642384106,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_407958,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
408223,3547.12307692308,342.255384615385,164.32,651.246153846154,2568.21230769231,3850.98153846154,863.766153846154,263.495384615385,1086.33846153846,6907.31384615385,2230.61538461538,124.433846153846,1064.31384615385,3220.74153846154,687.070769230769,653.938461538462,1557.31076923077,3303.98461538462,308.433846153846,233.892307692308,1003.75384615385,3762.44307692308,247.827692307692,422.956923076923,719.723076923077,2827.52307692308,584.298461538462,300.28,1061.43384615385,131.043076923077,325,32.4824451223001,12.7681283699698,0.919505212503805,0.944767441860465,0.637254901960784,-0.374269895108898,51575.8030769231,34220.7169230769,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_408223,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
408266,3489.51063829787,525.208510638298,1057.80425531915,624.744680851064,691.485106382979,2646.25957446808,858.497872340425,268.391489361702,1098.13617021277,6697.62978723404,558.310638297872,113.740425531915,1071.35744680851,3901.01276595745,1050.2170212766,771.36170212766,2623.33191489362,4192.12765957447,393.736170212766,244.697872340426,1012.17446808511,4601.00425531915,264.042553191489,218.187234042553,621.148936170213,3080.95744680851,525.634042553192,563.28085106383,1061.4170212766,130.323404255319,235,22.7838324307479,13.2182403485319,0.814503403290739,0.955284552845528,0.699404761904762,-1.16304925021345,51395.9872340425,35533.229787234,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_408266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
409429,2058.27619047619,624.461904761905,80.2666666666667,611.061904761905,668.323809523809,2173.3,1547.15238095238,254.547619047619,1128.4,3292.51428571429,906.309523809524,109.080952380952,1062.28095238095,893.738095238095,721.204761904762,540.547619047619,1606.19523809524,1180.23333333333,335.166666666667,237.914285714286,1002.48095238095,1133.75238095238,249.695238095238,160.233333333333,610.333333333333,752.780952380952,399.17619047619,319.171428571429,1014.6619047619,129.166666666667,210,18.7309937897762,14.3893426641026,0.640197555376565,0.9375,0.736842105263158,-0.0344673899769026,52025.5571428571,35036.6666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409429,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
409550,3387.19565217391,1176.66459627329,115.357142857143,633.291925465839,1558.32608695652,3886.69254658385,676.916149068323,275.267080745342,1141.15838509317,6907.73602484472,878.236024844721,118.624223602484,1080.34472049689,1007.32919254658,508.512422360248,277.254658385093,2199.46894409938,1773.70186335404,331.704968944099,244.869565217391,1046.26397515528,1779.23291925466,238.773291925466,216.236024844721,699.400621118012,3064.8602484472,557.428571428571,315.369565217391,1066.90062111801,131.5,322,21.9973519428741,18.8401546966462,0.516190566473613,0.947058823529412,0.766666666666667,-1.25873289393647,51366.0869565217,35285.0062111801,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409550,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
409585,3440.59871244635,235.328326180258,122.579399141631,649.476394849785,2360.48712446352,3601.7339055794,630.356223175966,267.257510729614,1128.669527897,6008.08798283262,796.12017167382,114.497854077253,1093.52789699571,5582.85193133047,778.957081545064,334.785407725322,1635.95493562232,6922.98927038627,391.442060085837,248.036480686695,1006.90987124464,6018.81759656652,253.227467811159,196.038626609442,613.615879828326,1887.97639484979,510.403433476395,302.036480686695,1042.38197424893,130.487124463519,466,33.2782400290957,18.2695597705255,0.835826178750842,0.962809917355372,0.616402116402116,0.840236601282718,51375.4420600858,35062.2145922747,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
409840,4236.54469273743,1160.1312849162,299.622905027933,653.815642458101,2918.3156424581,5155.46368715084,1091.60055865922,276.111731843575,1137.97765363128,7191.42458100559,1556.18715083799,130.117318435754,1074.34357541899,590.675977653631,406.075418994413,271.787709497207,1419.34357541899,911.840782122905,262.581005586592,225.692737430168,986.016759776536,867.27374301676,194.494413407821,132.513966480447,581.201117318436,2709.03910614525,577.72905027933,299.916201117318,1076.17039106145,131.72625698324,358,24.8073749822595,18.4360327113481,0.669105518516408,0.972826086956522,0.828703703703704,-0.129693923866038,51806.6229050279,34278.8770949721,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
410371,2139.27631578947,428.385338345865,137.998120300752,648.778195488722,2684.15037593985,2312.00751879699,333.53007518797,264.015037593985,1168.81766917293,4384.90789473684,482.87969924812,110.110902255639,1088.27067669173,1324.5469924812,564.248120300752,320.751879699248,1599.27255639098,1372.21616541353,303.59022556391,232.462406015038,997.729323308271,1204.97368421053,225.701127819549,327.398496240602,891.813909774436,2346.63533834586,533.471804511278,234.712406015038,1069.22744360902,133.509398496241,532,32.439585389691,21.2536708733225,0.755475395338594,0.95169946332737,0.686451612903226,-0.495278700022722,51410.1804511278,35355.4360902256,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_410371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
411559,3649.79545454546,1071.54772727273,542.479545454545,639.938636363636,1522.90227272727,4551.49772727273,2497.39090909091,291.820454545455,1119.09772727273,5450.78181818182,999.536363636364,124.634090909091,1082.98181818182,711.006818181818,423.106818181818,289.327272727273,1544.00227272727,1131.99772727273,305.797727272727,235.05,1003.47272727273,1107.61136363636,238.422727272727,207.572727272727,585.827272727273,1761.28181818182,573.911363636364,536.077272727273,1083.425,133.484090909091,440,24.8524993286658,22.5939080744643,0.416533961861509,0.962800875273523,0.797101449275362,-1.1893106962521,50901.7295454546,35729.5522727273,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_411559,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
411731,2527.16438356164,137.041095890411,57.5424657534247,615.194520547945,1032.24657534247,3002.26301369863,379.682191780822,253.424657534247,1090.8904109589,4895.19178082192,664.682191780822,114.583561643836,1066.11232876712,887.493150684931,482.430136986301,283.002739726027,1503.78082191781,1028.77808219178,214.679452054794,221.413698630137,1318.61095890411,706.265753424658,148.720547945205,124.449315068493,584.147945205479,1583.04657534247,494.156164383562,220.821917808219,1061.35342465753,131.457534246575,365,30.5818849666981,15.264704565916,0.866520178702548,0.948051948051948,0.620748299319728,-1.03333997673286,51175.1205479452,34036.6164383562,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_411731,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
412079,2595.90128755365,220.158798283262,108.31330472103,632.214592274678,1467.16738197425,2218.07296137339,329.145922746781,264.502145922747,1087.63090128755,4787.1330472103,510.613733905579,112.103004291845,1066.51072961373,2849.60944206009,771.201716738197,342.072961373391,1644.95278969957,1136.96995708155,321.892703862661,234.343347639485,1022.84120171674,1083.64806866953,231.223175965665,198.124463519313,589.44635193133,1766.48927038627,444.321888412017,215.300429184549,1039.5364806867,129.510729613734,233,20.0388884783251,14.9936205766704,0.66344375308065,0.962809917355372,0.721362229102167,-1.03099839297219,50779.0729613734,35664.8111587983,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_412079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
412102,4585.90681003584,1640.95340501792,192.752688172043,683.810035842294,3742.98924731183,5327.82795698925,1036.69892473118,265.064516129032,1107.229390681,8033.37275985663,748.089605734767,127.247311827957,1090.54121863799,997.741935483871,604.064516129032,343.813620071685,1641.09677419355,1149.43369175627,235.344086021505,223.046594982079,1372.59856630824,679.111111111111,147.440860215054,125.362007168459,1081.72043010753,2008.94982078853,544.888888888889,249.537634408602,1093.6523297491,133.885304659498,279,22.0526275703733,16.2722856831051,0.674927323472014,0.933110367892977,0.745989304812834,0.232164060469788,51205.6200716846,34074.1505376344,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_412102,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
412371,2007.09764309764,158.841750841751,91.4915824915825,641.606060606061,2161.68686868687,2206.59932659933,421.501683501683,263.56228956229,1097.82154882155,3871.79124579125,541.511784511785,113.538720538721,1082.91582491582,2151.56228956229,517.946127946128,289.707070707071,1704.9898989899,3080.15824915825,331.400673400673,234.737373737374,1023.58585858586,2582.87878787879,222.252525252525,180.949494949495,808.37037037037,1628.14814814815,492.835016835017,231.791245791246,1034.80808080808,130.62962962963,297,24.0173197591565,15.9917734994147,0.746091539937921,0.933962264150943,0.7734375,-0.0313472195356529,51579.6565656566,35352.6498316498,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_412371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
412726,2998.34033613445,445.936974789916,116.90756302521,641.693277310924,1937.35294117647,3147.16806722689,4685.01260504202,260.978991596639,1096.0,5378.88235294118,1493.16386554622,117.571428571429,1075.94117647059,658.575630252101,483.911764705882,264.084033613445,1441.74789915966,1006.78151260504,274.306722689076,222.470588235294,990.483193277311,969.739495798319,208.59243697479,134.025210084034,576.966386554622,1759.23949579832,500.478991596639,290.449579831933,1043.89075630252,131.609243697479,238,22.9689463349034,13.3374075734421,0.814138108234188,0.926070038910506,0.636363636363636,1.06112746387132,51839.0798319328,34251.3025210084,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_412726,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
413057,864.959758551308,164.370221327968,152.845070422535,689.708249496982,4861.89134808853,978.915492957746,308.084507042254,257.38430583501,1098.96378269618,1523.99798792757,883.696177062374,113.10060362173,1067.85915492958,4893.98189134809,1134.46680080483,921.700201207244,3954.78873239437,6641.64386317907,431.883299798793,251.132796780684,1057.6861167002,5858.64386317907,278.774647887324,276.533199195171,844.43661971831,937.169014084507,447.893360160966,223.857142857143,1067.8490945674,132.261569416499,497,26.7521898550561,24.1218866439569,0.432406126967799,0.959459459459459,0.764615384615385,-1.44249997890959,51273.1207243461,35179.7907444668,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_413057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
413617,4029.38487972509,687.718213058419,1443.84192439863,641.295532646048,2105.4295532646,3499.92439862543,617.704467353952,268.439862542955,1096.78350515464,6738.39518900344,795.993127147766,117.79381443299,1073.85910652921,1122.27835051546,546.735395189003,329.006872852234,1603.92783505155,1097.18900343643,286.357388316151,231.099656357388,996.13058419244,1019.76288659794,221.223367697595,170.398625429553,592.965635738832,2458.2852233677,561.711340206186,378.477663230241,1053.47422680412,131.137457044674,291,22.3816235619379,16.6706169189654,0.667248679726938,0.947882736156352,0.734848484848485,0.115596171397929,51268.4673539519,35451.0240549828,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_413617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
414732,1491.37265917603,272.041198501873,82.3408239700374,620.574906367041,885.12734082397,1810.30337078652,527.88202247191,258.756554307116,1096.61423220974,2980.10112359551,767.563670411985,129.237827715356,1078.4456928839,640.185393258427,507.176029962547,273.713483146067,1461.91198501873,1032.37453183521,297.659176029963,232.50936329588,1008.11797752809,974.295880149813,203.906367041199,147.352059925094,588.782771535581,1076.88951310861,472.653558052435,239.842696629213,1053.58988764045,130.084269662921,534,39.5668141359765,17.3016316328896,0.899327194804555,0.953571428571429,0.760683760683761,-0.152809751330458,50567.6479400749,34250.6142322097,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_414732,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
414805,1638.29437229437,446.904761904762,125.095238095238,649.290043290043,2287.45021645022,1945.77922077922,730.727272727273,259.415584415584,1129.36796536797,2943.00432900433,701.30303030303,123.411255411255,1077.60606060606,3624.02597402597,691.926406926407,1026.5670995671,1648.86147186147,2002.4329004329,318.562770562771,231.341991341991,1038.29437229437,1734.96536796537,246.030303030303,307.402597402597,754.147186147186,1613.36363636364,492.463203463203,351.948051948052,1082.87445887446,131.926406926407,231,17.8991186680141,16.4928665485947,0.388533589488258,0.94672131147541,0.754901960784314,0.678266674865624,51100.8701298701,35829.5714285714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_414805,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
416521,6375.20294117647,501.423529411765,170.85,676.664705882353,2979.98823529412,7147.77352941176,3208.09411764706,312.029411764706,1120.65,10761.8558823529,2646.91764705882,147.917647058824,1093.89705882353,802.7,567.470588235294,283.308823529412,1524.78529411765,1165.45294117647,307.679411764706,237.75,992.670588235294,1153.38235294118,239.923529411765,136.038235294118,585.020588235294,2703.93529411765,555.541176470588,272.791176470588,1073.48529411765,131.017647058824,340,25.5830246718925,16.9710660811705,0.74828964348618,0.96045197740113,0.708333333333333,0.559158194685016,51675.0970588235,34844.6382352941,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416521,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
416698,3254.50518134715,712.852331606218,197.90414507772,672.502590673575,3138.04404145078,3736.9378238342,2380.77720207254,256.753886010363,1093.60362694301,5339.16580310881,4958.84715025907,128.704663212435,1072.15544041451,1186.60621761658,800.362694300518,719.585492227979,1680.58808290155,1462.75906735751,324.756476683938,237.170984455958,1000.01813471503,1292.30310880829,233.344559585492,201.976683937824,867.769430051814,1899.29533678756,515.139896373057,485.670984455959,1061.90932642487,132.751295336788,386,25.099498019385,19.5865477647313,0.62533532723218,0.972292191435768,0.804166666666667,-1.21260489346813,50659.4611398964,33750.7435233161,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
417046,2581.88630490956,332.785529715762,49.937984496124,605.860465116279,597.723514211886,3360.88888888889,420.421188630491,265.201550387597,1085.95865633075,5389.9173126615,494.46511627907,107.950904392765,1090.48320413437,5129.92248062015,870.922480620155,404.201550387597,7223.09302325581,7323.80620155039,444.087855297158,246.498708010336,1102.23514211886,6882.47286821705,281.147286821705,365.248062015504,658.325581395349,1880.51937984496,482.359173126615,230.547803617571,1032.39793281654,130.25322997416,387,24.2873143906671,20.462451012114,0.538671316206046,0.965087281795511,0.764822134387352,-0.592960671591654,50846.3720930233,35344.8372093023,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_417046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
417535,2131.2027027027,376.505405405405,262.343243243243,713.654054054054,6223.71351351351,2960.13783783784,391.413513513514,281.354054054054,1095.28108108108,3569.50810810811,640.310810810811,131.410810810811,1077.58378378378,868.878378378378,571.124324324324,284.651351351351,1735.9972972973,2041.1,420.645945945946,248.245945945946,1053.41351351351,2102.78648648649,257.286486486486,310.721621621622,590.237837837838,1671.13243243243,605.921621621622,236.413513513514,1066.36216216216,132.367567567568,370,25.3449792425997,18.7721878503326,0.671872387880132,0.95360824742268,0.804347826086957,-0.403635526343645,50790.0621621622,34290.3513513514,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_417535,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
418203,481.316239316239,400.773504273504,170.012820512821,644.435897435897,4009.30341880342,500.393162393162,1002.26923076923,256.5,1080.9358974359,966.547008547008,1638.53846153846,109.017094017094,1067.72222222222,737.811965811966,478.311965811966,279.166666666667,1395.59401709402,1060.39743589744,317.636752136752,239.538461538462,982.474358974359,990.371794871795,208.594017094017,132.059829059829,579.764957264957,953.029914529914,529.504273504274,268.57264957265,1025.9188034188,130.807692307692,234,18.2362753644371,16.3459887205448,0.443357850621584,0.970954356846473,0.8125,-1.45339329473083,51119.2393162393,34773.4145299145,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_418203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
418304,4161.81428571429,1204.93142857143,490.648571428571,630.645714285714,1192.57142857143,4645.89714285714,1791.57142857143,273.348571428571,1113.06857142857,7619.44285714286,1112.92857142857,122.017142857143,1082.13714285714,972.422857142857,587.574285714286,287.082857142857,1544.04571428571,1356.41428571429,360.277142857143,241.997142857143,1027.09714285714,1218.09142857143,242.334285714286,133.948571428571,1006.30857142857,2288.64,534.222857142857,312.308571428571,1067.06571428571,132.002857142857,350,27.0915761856999,16.5337522988746,0.792177108966253,0.945945945945946,0.7,0.445894634075791,50439.3514285714,34945.4771428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_418304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
420780,2117.1015037594,411.462406015038,1309.05639097744,624.124060150376,1261.65789473684,2733.08646616541,461.804511278195,259.116541353383,1091.98872180451,4563.78195488722,501.390977443609,111.654135338346,1072.57518796992,1976.37969924812,577.454887218045,290.695488721805,1641.44360902256,1789.07894736842,287.605263157895,227.552631578947,1014.45488721805,1556.87593984962,203.593984962406,345.582706766917,2000.78947368421,1757.36842105263,523.578947368421,303.210526315789,1033.52255639098,130.669172932331,266,20.6683190049247,17.0758342362946,0.563400405332888,0.94661921708185,0.7,-0.297708055452269,51760.2330827068,35178.6315789474,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_420780,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
420988,1998.14900662252,593.764900662252,78.8145695364238,623.400662251656,1150.93708609272,2141.91390728477,437.996688741722,271.092715231788,1120.05298013245,4270.85430463576,522.933774834437,114.102649006623,1069.3642384106,943.145695364238,503.05298013245,316.831125827815,1513.13245033113,1729.2582781457,297.741721854305,232.413907284768,997.940397350993,1676.49337748344,248.115894039735,178.569536423841,595.96357615894,2334.80463576159,542.735099337748,330.480132450331,1043.34437086093,129.066225165563,302,22.1904253224984,17.411690675141,0.61994052569609,0.967948717948718,0.798941798941799,1.1495473555563,51287.4105960265,35475.9602649007,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_420988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
422510,3075.28148148148,1557.98148148148,470.385185185185,670.551851851852,3241.45555555556,2277.01851851852,682.907407407407,261.314814814815,1093.28518518519,5299.73333333333,622.82962962963,116.455555555556,1080.29259259259,1740.15555555556,723.237037037037,318.018518518519,2257.25925925926,3752.15555555556,392.414814814815,244.096296296296,1090.7,3416.27037037037,245.666666666667,444.674074074074,1137.78148148148,1571.6962962963,481.407407407407,246.959259259259,1064.93333333333,132.52962962963,270,25.4648166608808,13.7491403377512,0.841711891283016,0.950704225352113,0.652173913043478,-1.00625537656093,51899.1777777778,35362.6518518518,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_422510,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
422664,3058.22699386503,998.073619631902,128.036809815951,678.576687116564,3775.90797546012,3152.23312883436,1610.24539877301,273.901840490798,1181.31288343558,5002.14110429448,1201.32515337423,137.877300613497,1086.18404907975,5620.73006134969,772.601226993865,409.042944785276,2325.8527607362,3378.10429447853,417.656441717791,241.705521472393,1111.23926380368,2539.9018404908,290.521472392638,266.80981595092,586.981595092025,1606.98159509202,520.177914110429,457.957055214724,1060.95705521472,131.717791411043,163,19.6579553494743,11.5473144020718,0.809288211417461,0.848958333333333,0.626923076923077,-0.304012926958686,50885.4110429448,35893.1411042945,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_422664,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
423051,3517.78445229682,165.201413427562,82.9611307420495,654.996466431095,2410.0035335689,4353.88339222615,464.575971731449,269.229681978799,1101.48056537102,5982.74911660777,839.833922261484,139.272084805654,1074.34982332155,1258.19787985866,664.978798586572,310.703180212014,1910.18021201413,2027.87632508834,306.858657243816,232.349823321555,1088.18374558304,1411.89045936396,188.123674911661,140.540636042403,1153.72791519435,1118.27208480565,504.328621908127,221.678445229682,1037.62190812721,129.08480565371,283,20.0422852207778,18.011535395597,0.438611593922962,0.969178082191781,0.786111111111111,-0.145129908579351,51072.7526501767,33891.4628975265,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_423051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
423311,2050.69711538462,686.076923076923,58.5673076923077,622.600961538462,933.336538461538,1700.91346153846,383.326923076923,259.653846153846,1113.59615384615,3434.91826923077,484.490384615385,111.673076923077,1069.27884615385,3899.78365384615,800.413461538462,306.043269230769,1812.5,5695.67307692308,419.149038461538,249.211538461538,1020.95673076923,5039.68269230769,273.480769230769,433.653846153846,606.759615384615,1061.00480769231,504.432692307692,309.466346153846,1028.24519230769,130.004807692308,208,18.60723207427,14.2694323137932,0.641795769538364,0.941176470588235,0.722222222222222,0.98711963427818,51869.6971153846,35235.5961538462,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_423311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
423700,2542.25941422594,821.564853556485,92.4267782426778,647.439330543933,2541.75732217573,2487.37656903766,2168.49372384937,272.004184100418,1202.21757322176,3758.10878661088,1395.89539748954,117.414225941423,1073.09205020921,4682.26778242678,850.305439330544,752.606694560669,10070.0251046025,2354.7949790795,336.648535564854,241.941422594142,1259.81171548117,2041.0,243.65690376569,205.857740585774,651.058577405858,1039.03347280335,461.213389121339,477.121338912134,1051.47280334728,131.92050209205,239,23.934545955074,12.8367339632016,0.844010523810811,0.940944881889764,0.742236024844721,-0.210147531994668,50908.7824267782,35757.8535564854,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_423700,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
424135,1541.47435897436,350.641025641026,307.794871794872,607.288461538462,476.115384615385,1399.53846153846,338.346153846154,257.74358974359,1088.15384615385,3326.16666666667,495.76282051282,104.333333333333,1062.03846153846,1659.32051282051,1087.13461538462,1090.33974358974,1947.03205128205,2384.83333333333,546.50641025641,233.25641025641,1056.96794871795,1817.10256410256,231.980769230769,414.269230769231,613.115384615385,1636.83974358974,526.666666666667,272.346153846154,1049.20512820513,128.788461538462,156,18.8765763645689,10.5669484991784,0.828633445795549,0.957055214723926,0.787878787878788,0.277126874154407,51270.75,35374.6858974359,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_424135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
424457,3897.58333333333,1110.44252873563,217.011494252874,637.175287356322,1577.85344827586,4169.1091954023,435.675287356322,275.488505747126,1100.87931034483,6339.73563218391,609.787356321839,119.683908045977,1081.0775862069,2078.02873563218,573.772988505747,287.974137931034,3021.05172413793,2634.23850574713,309.152298850575,226.902298850575,1108.67816091954,2160.50574712644,396.459770114943,235.281609195402,936.58908045977,1920.79022988506,490.413793103448,250.224137931034,1062.9683908046,130.902298850575,348,22.7811038599234,19.673112307917,0.504226381169105,0.966666666666667,0.753246753246753,0.688500507106226,50679.2040229885,35622.2385057471,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_424457,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
424504,3369.71808510638,257.25,96.6941489361702,679.890957446809,3663.65425531915,4094.00531914894,556.218085106383,281.502659574468,1126.54521276596,5633.52393617021,541.98670212766,143.840425531915,1112.32446808511,1180.05585106383,958.095744680851,921.369680851064,1740.20744680851,4073.07180851064,389.327127659574,244.178191489362,1072.04787234043,4597.5079787234,282.962765957447,248.396276595745,719.906914893617,1774.67819148936,504.406914893617,353.425531914894,1073.50531914894,131.234042553192,376,26.559948729959,18.7081319934224,0.709829240735779,0.919315403422983,0.716190476190476,0.318984733230902,51015.7712765957,35831.3989361702,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_424504,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
425827,1989.31168831169,312.473098330241,136.111317254174,655.903525046382,2503.16141001855,2385.7680890538,391.155844155844,266.729128014842,1092.98886827458,3040.76994434137,613.816326530612,120.673469387755,1091.28014842301,697.703153988868,499.178107606679,292.270871985158,1523.01484230056,1042.48608534323,319.161410018553,236.150278293135,996.460111317254,963.497217068646,212.500927643785,125.881261595547,587.029684601113,1161.70315398887,528.250463821892,227.536178107607,1037.12987012987,130.814471243043,539,31.784912017679,21.6604019273618,0.731847867020986,0.96078431372549,0.755960729312763,0.243142395570237,50986.2244897959,34266.3098330241,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_425827,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
425897,1354.8772845953,70.2402088772846,61.5509138381201,615.164490861619,978.603133159269,1438.63446475196,373.318537859008,253.54046997389,1107.53785900783,2115.57702349869,464.172323759791,100.981723237598,1075.19582245431,809.712793733681,541.402088772846,304.080939947781,2335.2088772846,1715.49869451697,336.973890339426,236.655352480418,1019.5091383812,1342.97911227154,225.98955613577,302.77545691906,635.467362924282,724.731070496084,418.206266318538,210.671018276762,1010.64490861619,128.629242819843,383,25.6983349025373,19.2021486203125,0.664583813385704,0.948019801980198,0.72952380952381,1.26359939870693,50750.3577023499,35305.1279373368,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_425897,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
425934,3070.31563421829,647.268436578171,1115.85250737463,620.991150442478,1080.12684365782,3274.14159292035,448.153392330383,265.542772861357,1089.8790560472,5711.17699115044,578.336283185841,111.504424778761,1068.13569321534,4306.93805309734,1422.598820059,2438.46607669617,1922.71681415929,3368.25958702065,356.766961651917,241.825958702065,1036.84660766962,2412.28613569322,256.327433628319,323.663716814159,729.477876106195,1883.2802359882,517.613569321534,238.88790560472,1039.94395280236,130.46017699115,339,24.0093956483069,18.2025093064435,0.652090555631748,0.965811965811966,0.770454545454546,0.597857555322476,50916.5604719764,35366.209439528,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_425934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
426028,2357.05797101449,168.067632850242,71.1449275362319,627.057971014493,1376.19323671498,3030.1884057971,391.028985507246,269.729468599034,1091.13043478261,4643.30434782609,555.555555555556,115.227053140097,1077.38647342995,1681.89371980676,1004.06763285024,325.400966183575,2096.83574879227,1512.52657004831,262.193236714976,221.101449275362,1020.15458937198,868.314009661836,188.36231884058,149.75845410628,587.995169082126,2252.23671497585,494.347826086957,222.845410628019,1063.32850241546,130.714975845411,207,22.4173873556816,11.7905193429475,0.850512883468917,0.94954128440367,0.758241758241758,1.36671937967933,50133.7536231884,35196.5169082126,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_426028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
426112,2607.21739130435,328.489130434783,99.8586956521739,639.474637681159,1536.17028985507,2778.15217391304,4668.5652173913,273.449275362319,1113.28260869565,4201.96376811594,1424.65217391304,116.615942028986,1067.75362318841,1233.32608695652,618.56884057971,837.268115942029,1461.95289855072,1939.98913043478,351.960144927536,250.891304347826,996.847826086956,1300.47826086957,269.869565217391,238.86231884058,617.949275362319,1889.13405797101,582.217391304348,359.974637681159,1077.07971014493,130.88768115942,276,21.4178226520292,16.4802504223886,0.638689795229281,0.955017301038062,0.726315789473684,0.846911422094834,50693.0833333333,35136.4891304348,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_426112,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
427046,2772.40639269406,436.205479452055,182.684931506849,675.986301369863,3656.67123287671,3810.18264840183,1498.28310502283,262.616438356164,1096.23744292237,6140.74429223744,2787.91780821918,131.534246575342,1087.18721461187,836.356164383562,691.123287671233,599.13698630137,1652.03196347032,1568.22831050228,381.465753424658,248.073059360731,1041.91780821918,1598.02283105023,274.639269406393,374.689497716895,723.351598173516,3009.11872146119,573.360730593607,430.237442922374,1178.98173515982,131.86301369863,219,20.1665551371561,14.0417718923286,0.717760511548821,0.931914893617021,0.678018575851393,-0.636760942435229,50961.6666666667,33788.7534246575,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_427046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
427402,1801.50267379679,244.839572192513,206.112299465241,730.604278074866,6879.03743315508,1708.12299465241,311.92513368984,262.727272727273,1084.01604278075,2962.72727272727,467.909090909091,120.197860962567,1061.86096256684,866.582887700535,477.491978609626,282.256684491979,1531.52406417112,1008.79144385027,217.566844919786,213.497326203209,1288.51871657754,685.860962566845,158.224598930481,153.620320855615,596.026737967914,955.299465240642,399.941176470588,226.989304812834,1051.43315508021,128.973262032086,187,23.564151401889,10.1992478929506,0.901476047320367,0.958974358974359,0.584375,-0.960686515596822,50709.1390374332,35515.4064171123,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_427402,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
427455,3065.23664122137,730.5,158.572519083969,645.259541984733,2401.76717557252,2833.3893129771,351.645038167939,266.56106870229,1122.0572519084,5664.90839694656,530.778625954198,119.576335877863,1089.70992366412,1381.08015267176,939.484732824428,869.614503816794,1690.19847328244,2782.17557251908,411.007633587786,248.606870229008,995.980916030534,3332.36641221374,273.660305343511,398.786259541985,620.286259541985,2371.95419847328,547.56106870229,248.12213740458,1058.30534351145,130.003816793893,262,21.6344131937764,15.4401331241785,0.700467873593854,0.952727272727273,0.779761904761905,1.31616129119826,51867.8015267176,35139.2442748092,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_427455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
427658,1835.37900874636,166.967930029155,102.116618075802,635.699708454811,1906.90379008746,2018.20408163265,1656.81632653061,251.947521865889,1094.18950437318,3557.89795918367,458.443148688047,107.623906705539,1080.99708454811,681.775510204082,486.620991253644,321.104956268222,1493.527696793,1058.78425655977,293.609329446064,232.612244897959,993.857142857143,1032.08746355685,225.483965014577,155.851311953353,595.909620991254,1273.59475218659,451.979591836735,730.571428571429,1038.65597667638,129.00583090379,343,22.9027008672598,19.5673207327417,0.519669476908274,0.922043010752688,0.677865612648221,0.700439245863694,52014.5218658892,35071.8688046647,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_427658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
428207,2105.18792866941,414.561042524005,142.644718792867,670.787379972565,2571.14403292181,2555.83813443073,4702.71879286694,268.799725651577,1102.6378600823,3307.25514403292,1608.74485596708,126.065843621399,1071.52263374486,650.294924554184,561.79012345679,269.205761316872,1514.96296296296,1280.89300411523,248.333333333333,222.251028806584,1007.58299039781,1284.02880658436,174.621399176955,279.987654320988,619.422496570645,1135.37037037037,524.463648834019,349.59670781893,1047.74211248285,132.078189300412,729,35.5939604550793,27.4346042093482,0.637118685932514,0.951697127937337,0.675,1.41035141622006,50658.2386831276,33860.3374485597,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428207,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
428854,2100.30111524164,182.973977695167,78.7174721189591,636.159851301115,1653.62081784387,1947.52788104089,986.345724907063,254.208178438662,1091.2936802974,4288.20817843866,763.843866171004,109.223048327138,1089.62453531599,1049.84758364312,671.754646840149,289.762081784387,1721.91078066914,1132.66171003717,299.791821561338,234.171003717472,984.379182156134,989.765799256506,228.866171003717,147.650557620818,580.122676579926,1774.81412639405,489.780669144981,363.449814126394,1057.08921933086,130.561338289963,269,22.3461358452441,15.6236565807238,0.714959452826961,0.971119133574007,0.745152354570637,-0.752517267496814,52088.3011152416,34971.2230483271,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
429255,3036.92946058091,191.547717842324,106.340248962656,647.128630705394,2508.01659751037,2803.30290456432,649.879668049792,270.439834024896,1099.377593361,4480.80082987552,545.622406639004,114.605809128631,1075.5601659751,929.954356846473,525.207468879668,415.734439834025,1576.43153526971,1404.11618257261,327.331950207469,237.796680497925,999.917012448133,1775.03319502075,260.45643153527,182.352697095436,595.842323651452,1406.29460580913,508.485477178423,386.929460580913,1027.41493775934,130.253112033195,241,20.0395885719043,15.4503918793749,0.636843052207919,0.960159362549801,0.746130030959752,0.617785533862487,51266.6514522822,35478.4564315353,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_429255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
429837,3958.4613003096,720.164086687307,80.3498452012384,625.15479876161,1428.66253869969,4828.37151702786,592.780185758514,277.238390092879,1107.92569659443,6652.2786377709,689.28173374613,116.705882352941,1083.57585139319,5443.86687306502,590.179566563467,345.034055727554,1734.18885448916,3727.47678018576,368.956656346749,239.882352941176,1007.20123839009,2760.8947368421,231.303405572755,164.448916408669,580.631578947368,1905.13931888545,521.424148606811,262.59133126935,1059.31888544892,130.69040247678,323,26.3457934550143,15.6425490448171,0.804657019371819,0.952802359882006,0.68,-1.05859591411295,51086.9442724458,35097.9009287926,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_429837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
429990,4464.25170068027,314.557823129252,1582.00340136054,648.826530612245,1345.51700680272,4940.63265306122,1420.05102040816,284.214285714286,1108.37414965986,6957.92176870748,1178.42857142857,120.374149659864,1078.39455782313,632.982993197279,462.438775510204,634.462585034014,1549.18367346939,1030.49659863946,266.380952380952,223.517006802721,1022.85714285714,975.863945578231,204.292517006803,303.921768707483,612.904761904762,2082.71088435374,524.418367346939,837.928571428571,1061.25850340136,130.285714285714,294,26.1246421169279,14.8970458076438,0.821485321945258,0.921630094043887,0.607438016528926,0.760480701631016,51370.1972789116,35644.0986394558,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_429990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
430215,2273.69565217391,804.90635451505,211.829431438127,723.672240802676,5474.66555183946,2610.85953177258,763.327759197324,269.217391304348,1144.03678929766,4221.50501672241,1080.86287625418,116.886287625418,1076.51170568562,4705.12040133779,1325.28762541806,936.046822742475,1697.12040133779,2605.59197324415,376.698996655518,245.521739130435,1019.04347826087,2033.48494983278,250.57525083612,720.953177257525,710.71906354515,1407.84615384615,509.180602006689,267.719063545151,1076.11036789298,131.351170568562,299,21.7074418174923,17.7488421213375,0.575731826507984,0.931464174454829,0.715311004784689,1.44655480458399,50723.9899665552,35247.9732441472,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_430215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
430249,3964.1,502.702857142857,208.045714285714,696.36,5155.32,5141.30285714286,895.64,283.154285714286,1113.87142857143,7636.41714285714,943.945714285714,128.94,1089.18857142857,919.731428571428,585.185714285714,302.04,1522.82571428571,1464.99142857143,329.837142857143,239.791428571429,987.077142857143,1531.97428571429,256.114285714286,187.651428571429,582.865714285714,2999.74,560.254285714286,291.52,1060.88,132.711428571429,350,24.1661458363838,18.635777952756,0.636650762551977,0.961538461538462,0.729166666666667,0.550830084070634,51975.9,35002.4085714286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_430249,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
431008,3025.21551724138,289.353448275862,97.4568965517241,616.198275862069,653.008620689655,2974.41379310345,889.439655172414,272.922413793103,1081.09482758621,4092.78448275862,568.73275862069,118.077586206897,1090.39655172414,1238.31034482759,514.353448275862,296.275862068966,3469.06034482759,1420.0,329.724137931034,237.844827586207,1019.41379310345,1541.72413793103,248.51724137931,267.629310344828,610.775862068965,1033.85344827586,448.655172413793,214.672413793103,1014.12068965517,131.862068965517,116,14.7967341735808,11.1698405511929,0.655856564578639,0.828571428571429,0.644444444444444,-1.41140030569041,50687.5862068966,35650.25,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_431008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
431113,2667.98954703833,215.891986062718,96.2543554006969,638.470383275261,2031.44599303136,2890.28919860627,514.787456445993,267.06968641115,1123.88153310105,4438.37282229965,608.783972125436,112.386759581882,1081.17770034843,815.529616724739,552.703832752613,482.219512195122,1590.8606271777,1162.70731707317,325.114982578397,235.020905923345,1017.08362369338,1067.45644599303,239.703832752613,223.724738675958,615.968641114983,1522.48780487805,456.397212543554,228.763066202091,1039.45644599303,129.222996515679,287,24.783908877007,14.8700878889567,0.80000779034999,0.953488372093023,0.747395833333333,-1.29141752883764,51277.5052264808,35700.4355400697,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_431113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
431540,3802.71974522293,907.343949044586,1090.62738853503,632.964968152866,1578.33439490446,4297.76433121019,2440.22292993631,273.528662420382,1131.71974522293,7598.47770700637,1014.52229299363,121.200636942675,1090.01910828025,784.544585987261,616.375796178344,382.949044585987,1660.72929936306,1064.19108280255,251.652866242038,227.503184713376,1006.75159235669,987.984076433121,203.582802547771,189.114649681529,619.987261146497,2108.65605095541,572.643312101911,495.917197452229,1047.41401273885,131.662420382166,314,21.0931048973474,19.1164247396521,0.422661008893208,0.948640483383686,0.712018140589569,0.679656277904853,51666.1878980892,35127.7197452229,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_431540,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
431966,2289.1179245283,321.693396226415,106.900943396226,642.415094339623,1966.54716981132,2438.56132075472,2369.91037735849,274.792452830189,1093.94339622642,3870.96226415094,1122.20283018868,112.75,1075.02358490566,821.27358490566,447.745283018868,261.830188679245,1859.72169811321,1214.16037735849,264.396226415094,229.316037735849,1057.29245283019,1008.81603773585,200.47641509434,160.603773584906,647.193396226415,1492.11320754717,487.25,564.778301886792,1064.6179245283,133.141509433962,212,24.4143968344603,11.0779572157443,0.891130595492988,0.946428571428571,0.770909090909091,-1.53733314210964,50149.8773584906,35436.9339622641,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_431966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
433163,2361.20779220779,232.311688311688,88.3376623376623,622.344155844156,1175.02597402597,2139.66883116883,389.402597402597,262.902597402597,1088.20779220779,3986.88311688312,870.181818181818,125.487012987013,1064.93506493506,1365.58441558442,843.0,299.818181818182,1877.86363636364,1786.07792207792,363.798701298701,244.058441558442,1309.72077922078,4290.25974025974,365.461038961039,2161.7012987013,3262.03896103896,1640.29220779221,565.422077922078,232.012987012987,1059.68831168831,131.727272727273,154,18.0131408561132,11.02117849055,0.790980761571332,0.911242603550296,0.641666666666667,-0.93598950707509,50957.0844155844,33670.461038961,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_433163,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
434013,2707.49796747967,263.5,102.298780487805,675.018292682927,1493.86788617886,2571.41056910569,1110.41056910569,266.067073170732,1092.09349593496,4780.64227642276,551.392276422764,115.922764227642,1083.40853658537,1773.78455284553,499.709349593496,281.477642276423,1525.13617886179,2541.34552845528,338.658536585366,237.252032520325,1000.80081300813,2478.4512195122,240.904471544715,324.085365853659,957.168699186992,1781.66463414634,521.172764227642,917.184959349593,1061.27032520325,130.589430894309,492,34.8390364899973,18.0980562334652,0.85448481573137,0.955339805825243,0.657754010695187,1.21295263865421,51899.5467479675,35213.162601626,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
434183,3956.14736842105,821.75,306.728947368421,665.521052631579,2584.06052631579,4921.76842105263,3934.82368421053,286.039473684211,1121.65789473684,5277.48421052632,1178.14210526316,127.463157894737,1065.85,661.652631578947,490.934210526316,284.628947368421,1400.26052631579,1001.68157894737,320.731578947368,239.176315789474,983.521052631579,921.313157894737,219.010526315789,131.35,587.918421052632,1324.72368421053,530.463157894737,232.626315789474,1063.6,131.526315789474,380,25.7765286280435,18.8477480856132,0.682165212152076,0.95959595959596,0.71969696969697,0.98311106867929,50459.7815789474,34242.9315789474,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
434795,2237.13725490196,1107.24369747899,132.53781512605,665.616246498599,3281.3137254902,2930.2324929972,1111.44817927171,270.647058823529,1240.79271708683,2644.53221288515,1276.88795518207,114.375350140056,1083.02240896359,512.913165266106,434.072829131653,257.672268907563,1489.3137254902,756.963585434174,203.464985994398,216.675070028011,996.162464985994,722.817927170868,170.168067226891,143.635854341737,582.322128851541,584.929971988796,377.775910364146,202.204481792717,983.717086834734,127.728291316527,357,29.853104027239,16.1890160868923,0.840191892837434,0.937007874015748,0.7,-0.222210033912687,51616.8655462185,34737.4257703081,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434795,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
434881,2903.32989690722,411.896907216495,128.59793814433,632.13058419244,1665.09965635739,2850.80756013746,2152.78350515464,275.536082474227,1101.43642611684,5074.30927835052,3495.97250859106,117.567010309278,1077.85223367698,1097.32302405498,699.068728522337,738.766323024055,1779.22336769759,2182.35738831615,358.735395189003,228.848797250859,1043.7147766323,1594.0824742268,497.398625429553,219.079037800687,593.814432989691,1841.35738831615,527.295532646048,557.79381443299,1074.69759450172,131.298969072165,291,23.8252941873838,15.9539686244667,0.742701038392343,0.957236842105263,0.744245524296675,0.327456383117049,51304.4639175258,35403.9828178694,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434881,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
435431,2874.24378109453,189.298507462687,79.3233830845771,644.084577114428,2174.41293532338,2397.43781094527,367.134328358209,267.661691542289,1094.60199004975,5616.02985074627,548.358208955224,117.179104477612,1089.05472636816,814.407960199005,443.134328358209,270.004975124378,1867.28855721393,1217.39303482587,268.567164179104,224.55223880597,1035.44776119403,1006.13930348259,205.850746268657,168.383084577114,676.89552238806,2225.9552238806,482.228855721393,219.601990049751,1068.35820895522,131.039800995025,201,19.4955685355205,13.2143399513098,0.735234807096268,0.961722488038278,0.697916666666667,0.863282837152813,50059.7213930348,35416.4626865672,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_435431,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
437337,3810.4,854.796774193548,340.264516129032,660.312903225807,3791.71290322581,4177.75806451613,476.906451612903,269.212903225806,1131.45806451613,7287.17741935484,723.151612903226,125.806451612903,1079.05161290323,1362.2,735.158064516129,328.5,1772.68387096774,1866.75806451613,343.764516129032,245.029032258064,997.206451612903,1154.2935483871,238.3,158.635483870968,601.858064516129,2437.7064516129,556.251612903226,278.787096774194,1047.93548387097,130.938709677419,310,23.2914313398815,17.4748210812347,0.661133553526871,0.930930930930931,0.641821946169772,0.854026086305664,51707.0129032258,34908.1225806452,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_437337,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
438247,2292.68613138686,689.874087591241,812.717153284672,621.248175182482,961.540145985401,2767.30474452555,579.405109489051,256.39598540146,1088.5602189781,4520.29562043796,785.815693430657,115.355839416058,1076.21897810219,754.138686131387,495.669708029197,276.111313868613,1434.53284671533,1142.63321167883,334.92700729927,241.527372262774,973.184306569343,1090.92883211679,242.709854014599,134.768248175182,583.447080291971,1826.09489051095,538.242700729927,238.136861313869,1054.54744525547,131.109489051095,548,33.0732440138016,21.3786922879756,0.762994940956214,0.963093145869947,0.778409090909091,0.159788580989385,51654.8795620438,34361.1058394161,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_438247,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
438485,3399.24423963134,164.3133640553,89.1244239631336,619.216589861751,1354.47004608295,4220.82488479263,479.84331797235,272.391705069124,1097.84792626728,6124.24884792627,668.6866359447,117.341013824885,1116.18433179724,595.672811059908,398.290322580645,274.470046082949,1399.30414746544,905.47465437788,269.880184331797,230.382488479263,991.244239631336,845.161290322581,211.433179723502,140.032258064516,577.571428571429,1958.44239631336,511.479262672811,260.082949308756,1037.61751152074,129.94930875576,217,17.0660749490523,16.2099495605044,0.312752476517748,0.960176991150442,0.797794117647059,1.45539441034571,51023.0967741935,35112.4193548387,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_438485,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
438774,763.202090592334,641.97212543554,207.344947735192,650.12543554007,1982.03484320557,910.783972125436,364.010452961672,272.202090592335,1116.60975609756,1891.99651567944,541.623693379791,115.390243902439,1065.36933797909,2054.2787456446,886.668989547038,1218.33449477352,3231.54355400697,4865.21602787456,413.933797909408,244.048780487805,1074.14982578397,5116.88153310105,270.425087108014,1135.85017421603,732.101045296167,955.313588850174,395.149825783972,217.787456445993,1055.37282229965,130.770034843206,287,23.0566452048827,15.8714635613754,0.725361351083998,0.956666666666667,0.683333333333333,-0.75684329126052,50684.2508710801,35388.0766550523,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_438774,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
438858,1928.03614457831,156.078313253012,66.9698795180723,621.686746987952,623.674698795181,1575.01204819277,325.084337349398,263.277108433735,1091.19879518072,3740.63855421687,772.246987951807,113.373493975904,1072.72891566265,844.578313253012,518.831325301205,409.096385542169,1454.70481927711,1211.9156626506,308.44578313253,235.885542168675,1082.70481927711,1104.3734939759,232.066265060241,251.963855421687,680.439759036145,1565.10240963855,450.036144578313,216.530120481928,1064.65060240964,129.138554216867,166,20.5014410195385,10.4986898322506,0.858928688248605,0.922222222222222,0.658730158730159,0.249049293305718,50141.5542168675,35263.2771084337,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_438858,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
438964,2117.46929824561,535.412280701754,128.710526315789,670.175438596491,1831.2149122807,2540.46929824561,2504.7149122807,274.447368421053,1142.58333333333,3832.73684210526,805.210526315789,116.644736842105,1068.64035087719,1429.23684210526,681.679824561404,357.456140350877,1916.60087719298,3565.18859649123,419.561403508772,259.59649122807,1084.3201754386,3470.76315789474,277.0,372.201754385965,1660.26754385965,1421.74561403509,483.627192982456,1361.83771929825,1071.05263157895,130.074561403509,228,19.9197387196477,14.8336505547622,0.667431787735972,0.942148760330578,0.7125,0.181650089307875,51823.2587719298,35383.2280701754,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_438964,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
440324,2742.03347280335,1653.78242677824,157.121338912134,636.108786610879,2024.56485355649,4127.42677824268,719.518828451883,273.958158995816,1158.20920502092,3555.23012552301,630.979079497908,116.062761506276,1086.49790794979,3301.3179916318,758.836820083682,383.284518828452,2035.64853556485,4787.96652719665,427.748953974895,247.794979079498,1043.70711297071,4648.92887029289,280.937238493724,369.401673640167,1260.56066945607,859.234309623431,433.188284518828,269.087866108787,1033.96652719665,133.238493723849,239,17.9441259205871,17.114668140012,0.300519959145193,0.971544715447154,0.826989619377163,-0.528790487727255,50663.2426778243,35681.4518828452,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_440324,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
440348,2227.75494071146,339.094861660079,111.260869565217,628.750988142292,1878.21343873518,2634.02766798419,2296.46640316206,262.296442687747,1108.1581027668,3622.09486166008,1031.35968379447,111.339920948617,1068.49407114625,740.494071146245,486.126482213439,274.0,1484.46640316206,1317.55335968379,319.99604743083,235.833992094862,987.727272727273,1228.99209486166,220.509881422925,178.541501976285,580.916996047431,1074.50197628458,468.537549407115,378.177865612648,1046.9209486166,130.557312252964,253,22.6923024951439,14.2972811567661,0.776554712368584,0.947565543071161,0.708683473389356,-1.13832707143306,51037.3557312253,35053.2608695652,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_440348,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
440444,1239.70731707317,234.613821138211,373.792682926829,863.516260162602,11953.1463414634,1174.10569105691,347.321138211382,263.089430894309,1108.26422764228,2370.62601626016,574.89837398374,126.516260162602,1070.5162601626,697.219512195122,440.569105691057,287.028455284553,1449.52032520325,1116.60975609756,321.243902439024,235.849593495935,985.975609756098,1096.68699186992,243.939024390244,175.325203252033,584.678861788618,929.780487804878,430.873983739837,245.89837398374,1086.23983739837,129.991869918699,246,23.4787405008692,13.3804831500926,0.821715564427264,0.972332015810277,0.822742474916388,1.47987813743544,51942.6138211382,35269.7520325203,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_440444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
440746,2570.84550561798,433.570224719101,105.606741573034,641.393258426966,1235.15449438202,3333.85674157303,2186.81460674157,278.794943820225,1095.60112359551,3923.68258426966,846.626404494382,121.073033707865,1062.12640449438,752.401685393258,511.210674157303,278.205056179775,1397.11797752809,1070.21629213483,335.421348314607,241.761235955056,981.983146067416,1015.86516853933,231.542134831461,126.837078651685,581.38202247191,1456.2106741573,538.769662921348,414.921348314607,1058.15730337079,131.845505617978,356,27.4803015654576,16.5256813448692,0.798974707648857,0.970027247956403,0.794642857142857,0.0282640816727595,50841.5,34903.9831460674,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_440746,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
441257,1145.60695187166,336.307486631016,80.8395721925134,653.467914438503,2612.19518716578,1362.02139037433,6375.19786096257,256.941176470588,1098.8128342246,1699.18181818182,970.762032085562,106.930481283422,1067.93315508021,1262.83155080214,1013.5614973262,1465.95989304813,1867.89304812834,2231.83422459893,358.914438502674,239.213903743316,1038.82887700535,1908.24598930481,245.029411764706,436.927807486631,801.914438502674,882.802139037433,436.050802139037,389.655080213904,1050.55882352941,131.826203208556,374,27.1878453495054,17.5373578049485,0.764145389886301,0.96640826873385,0.769547325102881,0.21598954599986,50432.4117647059,35072.9090909091,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441257,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
441275,2234.11925042589,215.175468483816,147.672913117547,709.526405451448,5503.39352640545,2801.13628620102,347.436115843271,270.098807495741,1107.68654173765,4513.60136286201,656.081771720613,132.086882453152,1069.84497444634,1295.20102214651,560.131175468484,283.298126064736,1588.67461669506,1254.17206132879,302.647359454855,236.028960817717,1060.97103918228,1111.51277683135,224.664395229983,138.045996592845,658.933560477002,1569.33219761499,462.127768313458,221.807495741056,1069.89097103918,131.79727427598,587,29.0141061062115,25.9105161245278,0.449993784300673,0.960720130932897,0.722906403940887,0.541415279194285,50091.5502555366,34971.0681431005,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_441275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
441435,3081.00882352941,650.988235294118,93.6058823529412,628.082352941177,1774.95882352941,3586.49705882353,366.620588235294,260.558823529412,1095.14411764706,5954.53823529412,511.923529411765,109.452941176471,1089.32647058824,787.867647058824,581.561764705882,280.479411764706,1546.84705882353,1363.59411764706,358.402941176471,249.523529411765,999.167647058824,1254.67941176471,244.726470588235,157.508823529412,590.302941176471,1646.63235294118,483.602941176471,232.155882352941,1035.00588235294,132.097058823529,340,27.7685690504214,15.6287729911954,0.826577844696462,0.96045197740113,0.671936758893281,-0.699077415131069,51259.4147058824,35010.7617647059,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
441563,3477.25912408759,290.339416058394,89.2700729927007,612.78102189781,716.85401459854,3679.69708029197,534.989051094891,269.799270072993,1116.68248175182,5054.18613138686,558.507299270073,113.795620437956,1077.7299270073,3821.3503649635,639.92700729927,284.726277372263,1754.19343065693,5381.47080291971,354.985401459854,242.503649635037,1017.44890510949,4868.28102189781,243.014598540146,190.624087591241,585.857664233577,1372.20072992701,563.821167883212,278.244525547445,1039.71167883212,130.496350364963,274,21.4260893194925,16.3192516961805,0.647984757799807,0.96140350877193,0.761111111111111,-0.586724512592618,51491.503649635,35083.9124087591,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
443369,1969.45586107091,377.115774240232,136.736613603473,689.140376266281,3882.03473227207,2252.6005788712,3256.4500723589,278.334298118669,1106.51085383502,2968.71490593343,1244.32706222865,121.800289435601,1070.3994211288,815.483357452967,566.866859623734,394.775687409551,1496.497829233,1386.06946454414,318.070911722142,294.600578871201,1004.77424023155,1360.21273516643,226.147612156295,181.114327062229,592.808972503618,1028.61215629522,479.296671490593,386.626628075253,1049.36179450072,130.325615050651,691,35.4179390572858,24.9099518543668,0.710878783182666,0.96373779637378,0.767777777777778,1.53085903909414,50669.9348769899,35224.5383502171,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_443369,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
443411,2918.71906354515,781.632107023411,116.167224080268,646.234113712375,3034.35451505017,2657.13712374582,513.33110367893,272.280936454849,1172.5652173913,3879.82943143813,522.05016722408,117.260869565217,1071.47826086957,6863.16387959866,971.759197324415,550.571906354515,7113.14715719064,5337.127090301,455.404682274247,251.822742474916,1081.84615384615,4014.76923076923,285.785953177258,274.505016722408,635.755852842809,1133.52508361204,454.71237458194,259.561872909699,1029.17391304348,128.458193979933,299,20.9649131590112,18.3196728260742,0.486239896647875,0.955271565495208,0.74937343358396,0.607194642337376,50914.8695652174,35566.4347826087,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_443411,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
443803,759.813114754098,149.819672131148,154.488524590164,658.767213114754,4466.50819672131,831.229508196721,302.226229508197,249.750819672131,1086.7868852459,1209.66885245902,481.013114754098,108.281967213115,1077.61967213115,843.901639344262,668.291803278689,286.019672131148,1494.66229508197,1163.61639344262,340.12131147541,242.455737704918,1000.01639344262,1158.0131147541,231.367213114754,164.44262295082,590.288524590164,873.259016393443,470.045901639344,219.511475409836,1020.34098360656,129.127868852459,305,22.5823366322649,17.2471705787987,0.645516815579093,0.962145110410095,0.7625,0.894640893055096,51130.606557377,34725.393442623,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_443803,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
444124,2243.50993377483,473.701986754967,134.655629139073,648.261589403974,1894.21854304636,2579.25496688742,2097.19205298013,261.662251655629,1102.18543046358,4655.26490066225,1542.51324503311,128.423841059603,1071.73509933775,666.37417218543,448.784768211921,270.009933774834,1382.98675496689,911.139072847682,284.94701986755,227.013245033113,988.301324503311,866.470198675497,201.016556291391,126.788079470199,590.264900662252,645.827814569536,407.311258278146,209.456953642384,997.519867549669,130.480132450331,302,21.170019644926,18.2918294421481,0.503416214884864,0.958730158730159,0.719047619047619,0.5341274599985,50693.9006622517,33783.1456953642,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_444124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
444477,1777.20740740741,836.014814814815,87.037037037037,634.155555555556,1188.05925925926,1921.62962962963,650.637037037037,260.718518518519,1132.01481481481,3007.25925925926,479.807407407407,107.962962962963,1074.68888888889,2820.76296296296,594.807407407407,474.948148148148,1842.02222222222,1327.04444444444,305.496296296296,233.066666666667,1015.62222222222,1252.03703703704,223.940740740741,216.474074074074,603.103703703704,1163.77037037037,500.577777777778,285.762962962963,1040.16296296296,130.437037037037,135,14.8135131030975,11.7363232569232,0.610168809539351,0.978260869565217,0.803571428571429,-0.466703716330634,51487.5037037037,35718.9851851852,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_444477,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
444711,1682.60615384615,478.904615384615,75.2276923076923,645.424615384615,2156.12307692308,1877.41230769231,2333.87384615385,263.92,1098.96615384615,3233.70461538462,3573.78769230769,115.092307692308,1078.12923076923,5367.54769230769,1322.83384615385,386.086153846154,2221.27384615385,8078.27384615385,518.489230769231,270.64,1070.92,7223.88307692308,406.495384615385,264.916923076923,629.84,1353.40615384615,498.172307692308,490.390769230769,1048.59692307692,132.252307692308,325,21.815920030761,19.0549134840858,0.486930448633408,0.964391691394659,0.81453634085213,-0.521949101339731,52090.8338461538,34933.8215384615,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_444711,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
444739,2932.65818181818,318.563636363636,117.901818181818,642.883636363636,2416.76363636364,3506.68363636364,1846.93454545455,272.305454545454,1100.99272727273,5388.93090909091,2255.72727272727,119.112727272727,1073.44363636364,665.585454545455,535.443636363636,270.229090909091,1407.46909090909,1006.46545454545,298.025454545455,233.156363636364,984.814545454546,1029.42545454545,234.414545454545,143.829090909091,581.010909090909,2264.69090909091,534.541818181818,521.930909090909,1061.07272727273,130.021818181818,275,24.0389691253705,14.7030711274742,0.791140201089718,0.945017182130584,0.654761904761905,0.697630266899972,51087.9418181818,34888.0327272727,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_444739,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
445190,1157.4,228.2,92.5444444444444,612.744444444444,1502.7,1089.13333333333,365.155555555556,268.611111111111,1071.14444444444,2803.6,560.1,118.533333333333,1075.7,3610.77777777778,798.544444444444,861.1,1689.38888888889,5708.18888888889,438.711111111111,244.3,1110.54444444444,4574.91111111111,384.377777777778,998.233333333333,762.366666666667,2017.45555555556,503.522222222222,219.644444444444,1065.25555555556,128.3,90,13.4185911563418,8.5630661994971,0.769912536813648,0.927835051546392,0.692307692307692,-1.09914590666286,50201.8888888889,35346.2,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_445190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
445338,3609.74774774775,477.141141141141,102.951951951952,689.381381381381,2772.86786786787,2951.0960960961,2251.22822822823,280.477477477477,1102.14414414414,6358.62162162162,690.204204204204,118.654654654655,1077.6036036036,2551.68168168168,908.339339339339,524.996996996997,1744.51951951952,2772.36936936937,363.678678678679,238.681681681682,1021.60660660661,2107.86486486487,243.966966966967,215.123123123123,588.843843843844,2145.68468468468,534.705705705706,1801.90690690691,1109.03903903904,133.207207207207,333,25.4412850543805,16.8128830631144,0.750517665725218,0.954154727793696,0.723913043478261,-0.513461536632276,51463.1741741742,35545.7507507508,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_445338,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
445747,1727.82972136223,243.343653250774,102.730650154799,626.399380804954,1476.83591331269,1920.40866873065,606.597523219814,267.266253869969,1092.34055727554,2647.15479876161,621.396284829721,114.727554179567,1076.06501547988,670.777089783282,508.068111455108,275.674922600619,1479.01238390093,997.136222910217,297.637770897833,235.377708978328,989.275541795666,934.021671826625,200.814241486068,137.674922600619,583.269349845201,1348.84520123839,542.040247678019,238.959752321981,1042.58823529412,129.71826625387,323,25.515996952236,16.4446677963267,0.764617266774546,0.955621301775148,0.702173913043478,-1.02905793037788,51476.4674922601,34571.5882352941,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_445747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
445778,3840.39263803681,684.687116564417,1803.47034764826,628.047034764826,1459.91615541922,3305.00613496933,648.022494887526,269.560327198364,1091.17382413088,6612.38445807771,617.740286298569,117.842535787321,1072.46625766871,699.993865030675,513.815950920245,377.533742331288,1509.82208588957,991.621676891616,265.746421267894,227.286298568507,992.742331288344,876.775051124744,202.224948875256,169.875255623722,583.766871165644,2195.0899795501,527.746421267894,256.961145194274,1041.55623721881,130.335378323108,489,35.5477825650461,17.9599618819025,0.862982167453899,0.940384615384615,0.581450653983353,-0.757909105305307,51703.2024539877,35414.1840490798,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_445778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
445907,4754.91538461538,744.911538461538,834.453846153846,673.346153846154,3717.42307692308,5747.93846153846,665.542307692308,278.196153846154,1149.15384615385,8224.51538461538,658.692307692308,126.238461538462,1072.79615384615,765.573076923077,532.969230769231,285.476923076923,1397.16538461538,1124.59230769231,353.988461538462,242.553846153846,984.173076923077,1049.16153846154,232.992307692308,134.915384615385,585.973076923077,3108.66538461538,600.969230769231,258.842307692308,1081.81153846154,131.165384615385,260,19.5121421343734,17.2920435711477,0.463265313072838,0.962962962962963,0.722222222222222,-1.03695022907205,51119.4884615385,34905.7923076923,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_445907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446116,1632.70930232558,236.821705426357,131.728682170543,647.515503875969,2770.53488372093,2030.36434108527,325.670542635659,261.333333333333,1096.48449612403,3401.40697674419,491.43023255814,109.957364341085,1098.17441860465,686.437984496124,587.96511627907,280.740310077519,1543.17054263566,1261.40310077519,360.837209302326,245.484496124031,997.313953488372,1173.46899224806,251.0,203.162790697674,588.813953488372,1935.88759689922,522.317829457364,225.236434108527,1052.7984496124,130.441860465116,258,26.9912701247301,12.7503675193103,0.881390400527541,0.924731182795699,0.682539682539683,0.134689574879743,50889.1240310078,34956.988372093,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_446116,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446168,3507.55392156863,367.710784313725,113.004901960784,606.857843137255,184.774509803922,2915.50980392157,695.588235294118,281.019607843137,1088.05882352941,5921.26470588235,722.710784313726,140.622549019608,1077.95588235294,1341.72549019608,614.686274509804,1020.67647058824,1515.21568627451,1086.79901960784,298.632352941176,231.343137254902,1350.61274509804,986.436274509804,232.450980392157,210.75,656.210784313726,2013.17156862745,523.156862745098,233.289215686275,1061.94117647059,129.56862745098,204,20.578220233748,12.6888555740518,0.787264227979751,0.940092165898618,0.784615384615385,0.0649154030879137,50257.5196078431,35241.2205882353,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446168,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446349,2411.72122302158,220.041366906475,123.557553956835,662.154676258993,2703.5071942446,2002.96043165468,1098.89028776978,271.13309352518,1094.40287769784,2919.47122302158,2393.63309352518,117.059352517986,1071.89208633094,1217.91366906475,645.064748201439,282.724820143885,1615.79676258993,1649.87410071942,326.356115107914,241.307553956835,1004.03057553957,2065.96402877698,236.553956834532,155.415467625899,583.624100719424,595.012589928058,376.807553956835,203.940647482014,984.764388489209,128.215827338129,556,28.2784707047479,25.3791558868969,0.441069977846014,0.96695652173913,0.735449735449735,1.14094317336506,51661.3237410072,34809.1169064748,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446349,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446414,3360.11832061069,440.274809160305,168.690839694656,637.675572519084,1657.53435114504,3851.48473282443,360.454198473282,271.847328244275,1086.82442748092,5947.24045801527,581.160305343511,132.5,1067.6641221374,713.202290076336,495.515267175573,273.980916030534,1369.62977099237,1015.23664122137,335.190839694656,239.580152671756,997.362595419847,956.110687022901,222.954198473282,126.812977099237,583.160305343511,2954.93511450382,564.942748091603,229.572519083969,1069.37022900763,128.660305343511,262,24.2861356065907,14.4938034065046,0.802395001063021,0.932384341637011,0.632850241545894,1.08346169118459,50448.034351145,33884.7900763359,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446414,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446504,2556.15272727273,548.141818181818,69.92,604.370909090909,268.232727272727,2177.20727272727,1532.73090909091,263.16,1090.56363636364,5195.73454545455,549.963636363636,109.418181818182,1069.79272727273,2292.52,838.061818181818,1246.11272727273,1727.74545454545,1819.72727272727,288.130909090909,227.029090909091,1002.16363636364,1622.07636363636,252.152727272727,373.276363636364,599.203636363636,3366.56363636364,502.229090909091,310.538181818182,1035.32,129.469090909091,275,20.7202635334721,17.1183880090704,0.563426021637246,0.951557093425606,0.808823529411765,-1.50472705885584,51098.1490909091,35744.9345454545,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446504,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446527,2023.67391304348,1059.47826086957,162.775362318841,629.521739130435,1891.77536231884,1665.45652173913,930.782608695652,265.094202898551,1090.25362318841,2975.29710144928,2064.81884057971,110.95652173913,1070.05072463768,461.072463768116,303.760869565217,256.159420289855,1454.39855072464,743.036231884058,192.905797101449,209.521739130435,996.550724637681,669.927536231884,165.202898550725,170.021739130435,584.144927536232,977.050724637681,468.884057971014,354.572463768116,1054.96376811594,130.217391304348,138,14.9022588152614,11.9087926578824,0.601162660468911,0.951724137931034,0.766666666666667,-1.50706071677137,51721.7391304348,35397.0,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446527,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446567,1570.91789473684,232.166315789474,85.4042105263158,639.705263157895,1560.80210526316,2082.64842105263,784.8,255.082105263158,1088.55789473684,3789.01052631579,2384.39578947368,111.425263157895,1067.56421052632,543.04,378.570526315789,261.273684210526,1395.58526315789,891.532631578947,263.917894736842,227.764210526316,986.406315789474,864.776842105263,194.76,132.376842105263,594.711578947368,2043.29263157895,511.85052631579,430.456842105263,1077.72210526316,131.978947368421,475,33.6958968607291,18.0531815049851,0.844365268281971,0.961538461538462,0.659722222222222,0.545096053415019,50667.8442105263,34442.0505263158,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_446567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
446799,2974.44390243902,326.741463414634,148.117073170732,640.565853658537,2302.09756097561,3400.1756097561,344.936585365854,262.863414634146,1087.6,5348.35121951219,539.346341463415,118.326829268293,1087.45853658537,674.990243902439,457.253658536585,300.99512195122,1328.00487804878,1055.36585365854,295.00487804878,228.287804878049,979.926829268293,1016.66341463415,227.078048780488,112.721951219512,584.731707317073,1799.99512195122,498.312195121951,218.4,1039.39024390244,128.112195121951,205,24.1797713987553,11.7651973492708,0.873640535112966,0.895196506550218,0.594202898550725,-0.384460157814897,49999.2634146341,34592.1268292683,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
448060,2892.60784313725,546.186274509804,982.362745098039,630.098039215686,1399.75980392157,3322.13235294118,986.377450980392,269.088235294118,1096.8137254902,4576.62745098039,752.519607843137,112.632352941176,1071.98529411765,4317.61764705882,726.073529411765,322.509803921569,4812.5931372549,2291.39705882353,334.651960784314,234.794117647059,1034.68137254902,1715.32352941176,420.553921568627,225.671568627451,1185.25980392157,1080.90196078431,427.397058823529,325.367647058824,1032.29411764706,130.127450980392,204,19.1279953843498,13.7331012579765,0.696086211526858,0.931506849315068,0.708333333333333,1.01102536490634,50668.6617647059,35634.7107843137,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448060,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
448305,3248.39259259259,337.074074074074,95.2925925925926,627.781481481481,1109.4037037037,3178.34074074074,2142.18888888889,276.807407407407,1098.03333333333,5678.11481481481,1139.42592592593,117.355555555556,1083.77777777778,4964.30740740741,697.459259259259,380.018518518518,2259.96666666667,5787.61111111111,437.448148148148,293.122222222222,1043.06296296296,5223.51851851852,270.637037037037,300.733333333333,629.411111111111,1946.54444444444,490.181481481482,361.437037037037,1077.27407407407,131.377777777778,270,23.1882698961788,15.0009655607298,0.762557509736997,0.944055944055944,0.767045454545455,0.233347754548376,50973.6925925926,35459.0962962963,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448305,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
448488,2442.26,536.024,67.292,625.988,1159.348,1670.764,1565.312,262.308,1117.816,3328.448,681.448,109.1,1070.576,780.696,683.868,387.184,1563.96,1447.552,319.312,236.776,1035.552,1254.68,237.584,237.4,610.684,958.42,453.128,399.88,1034.692,129.808,250,21.7178096639094,15.2333982880447,0.712744011442112,0.925925925925926,0.710227272727273,1.31907147441405,51788.436,35319.632,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
448900,1994.66363636364,265.515151515152,122.121212121212,623.954545454545,1315.96363636364,2177.78787878788,379.284848484849,268.042424242424,1086.08484848485,3855.76666666667,539.309090909091,113.651515151515,1144.33636363636,646.872727272727,487.939393939394,277.533333333333,1425.60606060606,1033.05151515152,318.984848484848,233.49696969697,998.336363636364,1041.09393939394,286.160606060606,143.421212121212,586.869696969697,2028.89393939394,478.078787878788,231.709090909091,1048.01212121212,130.824242424242,330,25.3589085919548,17.1815217552885,0.735491490961189,0.94017094017094,0.723684210526316,-0.368360200827517,50287.296969697,35268.2575757576,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448900,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
449402,1588.35906040268,131.010067114094,66.3657718120805,630.812080536913,992.285234899329,1562.74496644295,321.238255033557,262.221476510067,1093.41946308725,2936.15100671141,658.053691275168,111.607382550336,1070.67785234899,794.026845637584,442.58389261745,263.728187919463,1854.57046979866,1213.12751677852,273.946308724832,227.697986577181,1032.13758389262,1000.65771812081,207.852348993289,145.328859060403,601.906040268456,1047.35570469799,412.48322147651,213.96644295302,1063.35234899329,132.637583892617,298,24.721468283966,15.4700778551431,0.780003587643588,0.952076677316294,0.70952380952381,0.882858133557833,50123.6812080537,35397.9060402685,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_449402,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
450372,2271.68604651163,151.003875968992,165.577519379845,688.767441860465,4761.74031007752,2353.84108527132,356.112403100775,275.670542635659,1105.50775193798,4242.94186046512,975.135658914729,122.600775193798,1071.41085271318,2700.10852713178,560.670542635659,315.135658914729,1724.01937984496,4259.71705426357,336.531007751938,229.922480620155,1037.71317829457,3468.03875968992,212.31007751938,166.616279069767,608.22480620155,1221.98449612403,434.666666666667,258.333333333333,1076.93798449612,130.949612403101,258,20.1604653990025,16.4074218753735,0.581087029672067,0.962686567164179,0.758823529411765,0.121084129715626,50762.3100775194,35419.5581395349,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_450372,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451541,1833.68897637795,488.110236220472,254.5,678.299212598425,4490.20472440945,2260.16535433071,915.496062992126,255.070866141732,1130.95669291339,3993.32283464567,2286.56692913386,116.255905511811,1070.33464566929,602.346456692913,483.094488188976,276.023622047244,2103.31102362205,936.311023622047,254.370078740157,227.814960629921,1000.88582677165,820.086614173228,183.322834645669,152.503937007874,581.779527559055,1552.95669291339,500.334645669291,371.566929133858,1068.32677165354,132.653543307087,254,18.4420799208411,17.5851520007385,0.301285127871173,0.965779467680608,0.783950617283951,-1.10734472281592,51789.5275590551,34662.7834645669,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451548,4188.61428571429,1564.77714285714,575.78,652.008571428571,2325.97428571429,4677.05142857143,1125.24857142857,279.474285714286,1146.08285714286,6570.26285714286,859.337142857143,119.242857142857,1078.33714285714,3713.64,902.785714285714,524.325714285714,1829.94285714286,3724.04571428571,349.957142857143,235.58,1040.91142857143,3434.61714285714,243.871428571429,279.78,599.448571428571,2488.10857142857,552.668571428571,378.645714285714,1062.15428571429,133.171428571429,350,26.8131775395668,16.7308779679552,0.781440565679121,0.958904109589041,0.791855203619909,0.231160490341798,51384.8028571429,35697.2571428571,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451548,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451604,3033.82967032967,695.695054945055,141.637362637363,635.785714285714,1344.50274725275,3297.06593406593,465.010989010989,265.574175824176,1251.06043956044,5099.69230769231,493.357142857143,118.769230769231,1087.97252747253,3453.29945054945,947.71978021978,819.631868131868,1902.31318681319,3676.3021978022,337.434065934066,235.162087912088,1024.01923076923,3055.05769230769,388.42032967033,261.260989010989,620.151098901099,1620.0521978022,505.104395604396,295.351648351648,1047.57967032967,129.554945054945,364,21.90301265443,21.1926853427603,0.252605244030925,0.968085106382979,0.787878787878788,-1.38797127197963,51482.9505494506,35783.5274725275,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451737,2923.98854961832,463.019083969466,171.576335877863,644.477099236641,2415.58015267176,3340.47328244275,881.446564885496,277.431297709924,1088.30534351145,5711.86641221374,2133.93511450382,123.06106870229,1074.11450381679,640.412213740458,653.908396946565,277.103053435115,1595.83969465649,990.729007633588,264.961832061069,222.675572519084,993.022900763359,906.843511450382,214.679389312977,144.916030534351,589.74427480916,2552.76335877863,507.13358778626,427.045801526718,1065.99618320611,129.992366412214,262,26.0970821921365,12.9610336756719,0.867952709527241,0.952727272727273,0.594104308390023,-0.802685850912911,50558.7022900763,35536.7404580153,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451737,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451740,1751.0715835141,87.7548806941432,64.3731019522777,637.622559652928,1190.9284164859,1937.41214750542,308.180043383948,260.303687635575,1097.39479392625,3210.72017353579,686.472885032538,110.173535791757,1072.62039045553,920.127982646421,604.715835140998,287.084598698482,1549.54663774403,1421.284164859,336.373101952278,236.229934924078,1094.37744034707,1311.11496746204,244.932754880694,383.403470715835,828.032537960954,961.872017353579,388.683297180043,208.594360086768,1045.73101952278,129.14967462039,461,36.6333863667922,16.1290030408622,0.8978597791087,0.950515463917526,0.548809523809524,0.84004213853346,50162.9848156182,35331.3665943601,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_451740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451828,663.94425087108,830.177700348432,257.393728222997,629.560975609756,94.3101045296167,669.400696864112,410.045296167247,267.651567944251,1114.68641114983,1506.11149825784,2316.18118466899,127.376306620209,1060.55052264808,1024.54355400697,537.299651567944,282.498257839721,1556.53658536585,1163.0487804878,230.912891986063,304.686411149826,1275.35540069686,659.292682926829,140.149825783972,122.163763066202,587.97212543554,572.390243902439,374.062717770035,200.923344947735,975.756097560976,129.390243902439,287,21.8565038347122,16.8258485122787,0.638245888816176,0.972881355932203,0.759259259259259,0.543507137070151,51255.0278745645,33862.6236933798,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451828,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451861,2918.98516320475,433.145400593472,223.415430267062,669.614243323442,2821.55192878338,3419.59940652819,1648.50148367953,271.382789317507,1115.35608308605,5776.58160237389,1457.78931750742,119.949554896142,1075.18694362018,700.044510385757,524.833827893175,293.59940652819,1489.22551928783,1111.79821958457,311.774480712166,235.548961424332,993.362017804154,1045.59050445104,227.462908011869,139.40059347181,594.724035608309,2106.66765578635,534.827893175074,331.026706231454,1110.63798219585,131.486646884273,337,22.2522719588481,19.4263540592629,0.487710502398306,0.954674220963173,0.764172335600907,-0.815458883895886,51563.5459940653,34952.234421365,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451861,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
451946,4371.61073825503,759.124161073825,1156.11409395973,662.093959731544,2556.70805369128,4759.57718120805,790.191275167785,273.956375838926,1196.64429530201,7252.02348993289,624.758389261745,121.751677852349,1081.21140939597,1869.75503355705,563.828859060403,348.560402684564,1690.46644295302,1590.46644295302,302.738255033557,235.61744966443,1006.15436241611,1368.74832214765,227.560402684564,188.929530201342,585.651006711409,2503.52684563758,534.812080536913,570.060402684564,1065.57382550336,130.795302013423,298,23.4441433549552,16.2408840210757,0.721179709243485,0.958199356913183,0.745,0.849049911232675,51891.8053691275,35015.2852348993,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451946,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
452195,2056.00340136054,245.520408163265,77.5034013605442,625.993197278912,1239.02721088435,2123.16326530612,3511.46598639456,255.704081632653,1091.30612244898,3670.84693877551,3608.1768707483,108.969387755102,1070.10884353741,2709.55442176871,777.47619047619,416.091836734694,2349.54421768707,4464.71768707483,429.874149659864,244.649659863946,1071.58163265306,4083.24829931973,257.289115646258,223.744897959184,586.666666666667,1330.08163265306,477.316326530612,547.377551020408,1042.41156462585,129.908163265306,294,24.7245839321618,15.1403466530254,0.790579033864908,0.954545454545455,0.703349282296651,0.945901838571205,51612.5714285714,34983.119047619,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452195,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
452853,2931.47932330827,1287.78383458647,128.210526315789,647.877819548872,2541.56390977444,3201.40977443609,853.513157894737,267.357142857143,1144.48496240602,4770.7462406015,792.101503759398,116.199248120301,1073.6015037594,721.142857142857,486.218045112782,278.462406015038,1608.45676691729,1087.41541353383,298.78007518797,231.018796992481,990.088345864662,1053.35714285714,222.357142857143,155.204887218045,585.828947368421,1334.24812030075,508.364661654135,338.176691729323,1051.22932330827,132.234962406015,532,28.6681686089847,23.6846981989966,0.5634251462128,0.96551724137931,0.730769230769231,1.15851735835382,51406.9266917293,35406.045112782,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452853,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
453123,3123.16302186879,592.996023856859,210.089463220676,652.75745526839,1949.84095427435,3329.51292246521,3424.00397614314,269.510934393638,1096.42147117296,5111.18489065606,3732.80516898608,116.013916500994,1074.81312127237,590.471172962227,504.900596421471,373.246520874751,1518.53677932406,894.065606361829,242.176938369781,219.554671968191,993.554671968191,788.564612326044,177.936381709742,141.707753479125,592.673956262425,1676.39562624254,481.664015904573,721.001988071571,1058.44135188867,130.578528827038,503,33.2887490074172,19.2777265036583,0.815251995128474,0.969171483622351,0.714488636363636,0.369070701076569,50482.7415506958,35113.2564612326,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_453123,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
453692,2397.03759398496,116.315789473684,96.609022556391,662.748120300752,3117.03007518797,2321.59022556391,336.394736842105,261.195488721805,1094.10902255639,3979.27819548872,507.65037593985,122.097744360902,1074.6954887218,2985.60902255639,716.015037593985,661.642857142857,1792.48872180451,2265.33834586466,323.59022556391,234.40977443609,1008.21428571429,1905.31203007519,320.951127819549,218.488721804511,630.09022556391,1286.62406015038,444.218045112782,307.345864661654,1065.6992481203,129.740601503759,266,27.6230748086364,12.2944975127301,0.89549046291646,0.95,0.578260869565217,0.651061512548968,51263.9398496241,35771.3609022556,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_453692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
454385,2620.80991735537,900.301652892562,974.413223140496,629.690082644628,1310.26446280992,2494.09504132231,1468.82644628099,267.938016528926,1101.94628099174,4262.65289256198,3504.63223140496,117.814049586777,1064.36363636364,820.46694214876,458.731404958678,274.02479338843,1520.92148760331,1369.46280991736,276.293388429752,229.669421487603,1104.32231404959,1194.97520661157,220.210743801653,210.45041322314,2378.28925619835,1140.17768595041,483.359504132231,565.504132231405,1051.00826446281,130.454545454545,242,22.7443487582587,13.5931085370235,0.801758806577403,0.941634241245136,0.677871148459384,1.08424663239668,51770.8140495868,35552.5289256198,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_454385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
454788,4248.10666666667,370.486666666667,119.033333333333,616.946666666667,529.473333333333,3860.04666666667,1434.84666666667,272.713333333333,1093.29333333333,6246.14,597.1,142.94,1084.14,733.966666666667,431.926666666667,289.32,1491.55333333333,1079.89333333333,310.58,229.666666666667,995.753333333333,1222.68666666667,243.253333333333,191.686666666667,588.573333333333,1198.58,429.826666666667,229.926666666667,1035.00666666667,130.46,150,14.0537557239654,13.6438327559865,0.239761642386298,0.9375,0.714285714285714,1.06702145579343,50835.8333333333,35862.6,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_454788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
455553,2274.1320754717,159.528301886792,100.811320754717,646.157232704403,2346.30188679245,2208.35849056604,345.081761006289,264.679245283019,1097.29559748428,4355.57232704402,675.050314465409,111.138364779874,1065.43396226415,2806.37735849057,664.100628930818,297.949685534591,1744.47169811321,1479.67924528302,309.276729559748,232.559748427673,1062.22641509434,1243.88050314465,220.094339622642,171.106918238994,2132.35220125786,1494.47798742138,466.37106918239,218.930817610063,1054.25157232704,132.641509433962,159,16.6752083487744,12.3061755073605,0.674809122863714,0.957831325301205,0.764423076923077,1.37573612954037,51139.3459119497,35342.8679245283,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_455553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
455938,3392.9387755102,1363.71173469388,284.058673469388,640.173469387755,2122.52295918367,3667.34183673469,485.02806122449,274.727040816327,1122.99489795918,5499.82397959184,555.099489795918,118.112244897959,1081.27551020408,1146.17602040816,628.022959183673,454.308673469388,1665.21683673469,1693.29846938776,321.602040816327,236.426020408163,1013.50510204082,1926.89540816327,241.47193877551,242.492346938776,589.836734693878,1848.66071428571,556.984693877551,233.609693877551,1053.64285714286,130.198979591837,392,26.6572721571153,18.7531672580316,0.710703564995895,0.958435207823961,0.710144927536232,0.786536350030489,51400.4515306122,35721.887755102,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_455938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
456366,1686.14166666667,147.4,91.2222222222222,634.658333333333,1916.06944444444,1992.32222222222,381.894444444445,258.869444444444,1087.125,3218.38611111111,456.422222222222,111.605555555556,1073.86666666667,2115.76666666667,861.997222222222,325.158333333333,5447.26944444444,2489.075,317.669444444444,236.575,1020.08611111111,2476.15555555556,236.141666666667,160.733333333333,593.019444444444,1174.925,471.227777777778,220.941666666667,1023.64444444444,129.797222222222,360,26.1565386275868,17.8600956852912,0.73059064885687,0.947368421052632,0.685714285714286,0.524987779099457,51776.0888888889,35041.6694444444,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_456366,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
457126,2586.04683195592,129.154269972452,69.4517906336088,624.611570247934,1284.68595041322,2886.69421487603,316.520661157025,257.396694214876,1090.15702479339,5371.8870523416,490.889807162534,113.404958677686,1076.34710743802,1042.60606060606,603.32782369146,307.556473829201,2653.59228650138,1617.34435261708,341.107438016529,243.826446280992,998.95041322314,1765.7217630854,244.730027548209,170.823691460055,609.534435261708,2475.64187327824,509.305785123967,234.380165289256,1041.96143250689,130.146005509642,363,33.6657195854091,13.8170333267746,0.9118972938502,0.955263157894737,0.53698224852071,0.775306871149584,51750.1212121212,34949.2506887052,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_457126,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
457169,2255.55710306407,291.771587743733,134.701949860724,630.690807799443,1895.45961002786,2901.87465181058,321.454038997214,263.211699164345,1088.62116991643,4509.14206128134,494.311977715878,117.83008356546,1075.9860724234,777.256267409471,546.654596100279,362.682451253482,1514.80501392758,1732.45682451253,307.818941504178,232.938718662953,1023.83008356546,1593.63509749304,208.671309192201,150.518105849582,592.8356545961,2325.90529247911,525.442896935933,227.378830083565,1040.55988857939,130.119777158774,359,25.9119551259791,17.6522888503273,0.732059124468202,0.967654986522911,0.747916666666667,-0.483417791902572,51119.7103064067,34564.6378830084,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_457169,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
457246,525.291443850267,281.122994652406,140.935828877005,637.770053475936,2617.8449197861,574.270053475936,312.114973262032,258.401069518716,1080.83957219251,1007.41711229947,579.422459893048,115.516042780749,1060.48128342246,2024.74598930481,698.737967914439,296.983957219251,1702.8422459893,2580.07754010695,401.350267379679,244.048128342246,1024.55614973262,2160.42245989305,237.032085561497,242.35294117647,588.371657754011,888.465240641711,527.066844919786,228.711229946524,1020.05614973262,130.085561497326,374,24.4222459272186,19.5207620819958,0.6009288833715,0.961439588688946,0.774327122153209,-0.904177084957344,50931.8449197861,34054.1443850267,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_457246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
457380,2424.16430594901,430.929178470255,165.609065155807,664.382436260623,2477.49575070822,2572.61473087819,2293.33144475921,268.626062322946,1122.09348441926,5095.59206798867,1002.9433427762,116.912181303116,1125.1954674221,1051.18413597734,586.470254957507,411.558073654391,1680.84702549575,1331.61473087819,312.85269121813,236.960339943343,997.453257790368,1315.45325779037,233.127478753541,277.181303116147,593.810198300283,2239.18130311615,545.118980169972,785.560906515581,1089.15580736544,130.988668555241,353,30.4329808216425,14.8373004836755,0.873100559932058,0.956639566395664,0.630357142857143,1.04756731696595,51905.3711048159,35005.8016997167,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_457380,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
458079,2951.97247706422,527.940366972477,193.811926605505,691.100917431193,3214.72018348624,3109.36697247706,4435.33486238532,293.665137614679,1094.88990825688,4532.6376146789,3647.04128440367,127.100917431193,1067.26605504587,659.683486238532,559.399082568807,283.302752293578,1525.79357798165,1113.22935779817,339.43119266055,242.481651376147,1003.22935779817,939.174311926606,233.004587155963,184.674311926605,582.307339449541,1709.37614678899,580.284403669725,883.559633027523,1114.93119266055,132.518348623853,218,22.0668697430369,12.862247178964,0.812561168520819,0.919831223628692,0.637426900584795,-0.833343612796295,50731.6055045872,35175.1834862385,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_458079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
458113,1900.23099415205,387.377192982456,123.988304093567,669.888888888889,2696.14035087719,2430.58771929825,4347.91228070175,260.470760233918,1115.59356725146,4810.6783625731,1769.53801169591,118.485380116959,1076.09064327485,4245.23976608187,1320.88304093567,1206.88888888889,2374.55555555556,3851.70760233918,525.684210526316,305.005847953216,1097.38888888889,2988.86257309942,295.0,305.476608187135,681.824561403509,2175.8216374269,559.002923976608,688.383040935673,1099.36257309942,133.722222222222,342,24.3711953690975,17.926495017547,0.677458756348099,0.963380281690141,0.75,0.270129411721493,51027.0058479532,34387.2426900585,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_458113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
458488,4164.43231441048,788.28384279476,2786.65502183406,626.685589519651,1072.29257641921,4556.37991266376,776.384279475983,283.353711790393,1114.51091703057,7447.00873362445,671.64192139738,118.25327510917,1074.49344978166,721.834061135371,455.087336244542,272.340611353712,1430.74672489083,1027.68995633188,278.275109170306,225.986899563319,982.314410480349,973.921397379913,218.873362445415,155.021834061135,579.008733624454,2757.30131004367,571.646288209607,325.288209606987,1079.87336244541,132.441048034935,229,19.2033893917522,15.2409402985777,0.608363049699873,0.96218487394958,0.795138888888889,1.02409132657947,51467.1310043668,35492.7161572052,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_458488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
458750,2719.22727272727,165.465909090909,67.25,617.25,793.75,2843.5,441.329545454545,252.590909090909,1086.94318181818,5621.42045454545,569.988636363636,119.954545454545,1067.56818181818,651.488636363636,512.102272727273,275.943181818182,1396.57954545455,1108.84090909091,337.477272727273,240.977272727273,980.829545454546,1062.59090909091,241.045454545455,128.636363636364,581.511363636364,3264.82954545455,547.420454545455,233.522727272727,1030.97727272727,130.102272727273,88,12.4598430079264,8.98887272570847,0.692490028342904,0.977777777777778,0.727272727272727,-0.728535641370517,50395.7159090909,34322.8636363636,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_458750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
459010,3499.24509803922,331.978758169935,179.089869281046,682.348039215686,3485.33823529412,4417.37091503268,399.748366013072,279.287581699346,1091.74836601307,5693.72549019608,697.983660130719,138.848039215686,1073.57516339869,2735.17320261438,684.21568627451,454.727124183007,1778.32843137255,4668.00490196078,377.933006535948,239.625816993464,1033.29901960784,4531.32843137255,229.97385620915,228.519607843137,625.957516339869,2178.56535947712,560.462418300654,230.692810457516,1084.61274509804,130.705882352941,612,32.529012305797,24.4731537369858,0.658765306382617,0.959247648902821,0.753694581280788,0.92254022189827,50411.0784313726,33828.8137254902,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
461501,2978.74881516588,212.620853080569,205.995260663507,725.317535545024,6000.71563981043,2380.23222748815,447.39336492891,280.663507109005,1101.23696682464,4615.50710900474,737.834123222749,128.056872037915,1076.05687203791,832.905213270142,677.947867298578,328.900473933649,1643.55450236967,1146.3981042654,310.654028436019,239.028436018957,1024.43601895735,1041.99526066351,229.251184834123,212.336492890995,614.658767772512,1253.20379146919,493.421800947867,256.957345971564,1059.48815165877,129.21327014218,211,23.7736944806506,11.4567562088647,0.876221296997663,0.95475113122172,0.62797619047619,0.576574261724833,51820.1990521327,35317.4928909953,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_461501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
462585,1562.00602409639,180.560240963855,65.2469879518072,606.102409638554,846.144578313253,1451.09638554217,536.319277108434,265.78313253012,1086.59638554217,2274.66265060241,505.656626506024,109.433734939759,1073.70481927711,1940.53012048193,1070.59638554217,1574.56626506024,2185.83734939759,1816.60240963855,283.415662650602,228.030120481928,1031.49397590361,1711.67469879518,223.120481927711,199.066265060241,627.198795180723,915.927710843374,440.373493975904,211.578313253012,1016.6686746988,132.55421686747,166,16.0637935197631,13.5046043050164,0.54152309295157,0.937853107344633,0.691666666666667,0.919344887041447,50842.6325301205,35389.5662650602,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_462585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
462638,4418.14507772021,1126.70466321244,99.8316062176166,644.062176165803,1659.34974093264,5206.09585492228,624.080310880829,285.69170984456,1137.4896373057,7720.94041450777,640.341968911917,123.725388601036,1077.92227979275,1862.24611398964,732.051813471503,428.440414507772,1966.67098445596,2993.73056994819,333.810880829016,237.080310880829,1041.4274611399,2866.60621761658,230.769430051813,403.844559585492,597.121761658031,2399.44041450777,533.670984455959,259.945595854922,1091.80051813472,131.813471502591,386,27.5764781624221,17.83375842447,0.76274292198012,0.962593516209476,0.699275362318841,0.78375407442335,50919.292746114,35482.2331606218,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_462638,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
462892,2037.72566371681,226.787610619469,142.004424778761,673.444690265487,4060.49778761062,2398.03982300885,2573.05973451327,275.026548672566,1089.30973451327,3700.0796460177,3497.77433628319,120.471238938053,1068.67256637168,1795.45796460177,577.973451327434,344.446902654867,1620.50663716814,1476.32079646018,332.21017699115,235.637168141593,994.108407079646,1368.5796460177,249.360619469026,322.814159292035,624.553097345133,1494.42256637168,455.444690265487,347.163716814159,1065.98672566372,132.800884955752,452,36.9859645392947,15.8279814294942,0.903804485802982,0.957627118644068,0.763513513513513,-0.0582125952455616,50470.7853982301,35524.6238938053,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_462892,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
463013,2774.5951417004,364.943319838057,123.194331983806,688.582995951417,2426.25506072874,3286.15384615385,2113.01214574899,276.595141700405,1109.6963562753,4632.94331983806,706.048582995951,115.619433198381,1072.47368421053,3061.7004048583,836.327935222672,677.449392712551,2286.65182186235,2924.85425101215,344.493927125506,238.82995951417,1060.97165991903,2111.74089068826,1592.91497975709,776.591093117409,593.02024291498,1507.95141700405,497.105263157895,1628.42914979757,1085.72469635628,132.919028340081,247,21.391825269768,15.5566410550559,0.686400594644538,0.953667953667954,0.69187675070028,0.449460821782668,51182.9473684211,35572.6518218623,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
463588,2051.42692307692,795.388461538462,100.884615384615,637.880769230769,2209.2,2060.36923076923,446.65,262.234615384615,1125.22307692308,3735.8,497.261538461538,109.75,1081.52692307692,2632.60769230769,707.865384615385,350.807692307692,1979.77307692308,1899.28461538462,367.607692307692,237.557692307692,1013.90769230769,1496.80384615385,253.392307692308,297.223076923077,589.088461538462,2116.06153846154,492.373076923077,237.161538461538,1032.80384615385,130.673076923077,260,21.7164215957763,15.4879641358863,0.700969394241101,0.945454545454545,0.687830687830688,0.56377557494284,51418.4192307692,35718.7538461538,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463588,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
463817,927.739130434783,110.550724637681,91.9420289855072,672.355072463768,2905.43115942029,1168.36231884058,359.905797101449,258.126811594203,1095.07608695652,2079.3152173913,440.398550724638,105.130434782609,1073.17028985507,1029.09057971014,647.644927536232,626.365942028986,2573.72463768116,2044.52173913043,366.347826086957,239.028985507246,1025.46739130435,1994.69202898551,321.394927536232,612.554347826087,680.04347826087,1287.5,433.141304347826,213.384057971014,1043.13405797101,128.449275362319,276,21.3154968672321,16.6398884671457,0.624971635137297,0.951724137931034,0.726315789473684,-1.02324347721461,51391.0217391304,35747.2826086957,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463817,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
464734,2949.49528301887,306.783018867925,130.561320754717,628.438679245283,1655.28301886792,3676.17452830189,365.47641509434,266.679245283019,1094.59433962264,5099.89150943396,503.004716981132,112.009433962264,1136.44811320755,674.594339622642,637.0,279.141509433962,1459.32547169811,1054.62264150943,322.38679245283,237.650943396226,991.122641509434,993.377358490566,227.27358490566,143.981132075472,588.853773584906,2078.45283018868,529.88679245283,227.047169811321,1065.57075471698,129.849056603774,212,24.9679390217387,10.9070162538987,0.899538799921545,0.963636363636364,0.588888888888889,-0.739377009387802,51063.4905660377,34968.6320754717,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_464734,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
465325,2422.96315789474,1260.3,212.778947368421,629.447368421053,1425.20526315789,1820.61052631579,502.768421052632,270.026315789474,1104.12105263158,3297.01578947368,589.357894736842,116.473684210526,1078.79473684211,655.68947368421,458.778947368421,278.705263157895,1482.25263157895,999.578947368421,268.973684210526,223.821052631579,992.205263157895,944.521052631579,223.357894736842,198.142105263158,577.031578947368,997.426315789474,478.278947368421,244.952631578947,1021.45789473684,128.884210526316,190,16.1923483359669,15.0506288497827,0.368846846343438,0.95959595959596,0.7421875,0.984581034274309,51447.1052631579,35482.7894736842,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_465325,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
465779,548.718894009217,799.101382488479,228.456221198157,616.336405529954,90.7373271889401,503.248847926267,342.718894009217,260.907834101382,1103.74193548387,1245.19815668203,691.663594470046,109.783410138249,1066.76958525346,1021.67741935484,567.63133640553,305.101382488479,1522.24423963134,1183.26267281106,227.718894009217,220.912442396313,1465.95391705069,810.230414746544,169.552995391705,125.718894009217,1349.66359447005,565.405529953917,361.359447004608,194.548387096774,979.235023041475,129.903225806452,217,17.5186892372624,15.8501654604491,0.42592706883158,0.931330472103004,0.709150326797386,0.239239422882171,50201.6451612903,34930.1797235023,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_465779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
465904,1627.68115942029,425.188405797101,205.449275362319,684.579710144928,3544.79710144928,1356.20289855072,484.333333333333,255.659420289855,1085.36231884058,2592.52173913043,1333.3768115942,125.992753623188,1061.61594202899,930.702898550725,1533.70289855072,1192.70289855072,2092.65217391304,2672.14492753623,382.855072463768,239.913043478261,1047.07246376812,2347.04347826087,266.775362318841,733.231884057971,838.101449275362,994.884057971014,487.384057971014,217.695652173913,1031.70289855072,130.753623188406,138,17.2787793494326,10.2942821314115,0.803150640859134,0.965034965034965,0.707692307692308,-0.638145001000431,50703.4130434783,33750.3115942029,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_465904,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
466079,5237.33463035019,671.077821011673,264.552529182879,685.093385214008,3414.82101167315,5298.41245136187,541.295719844358,283.311284046693,1135.25680933852,8615.59922178988,587.669260700389,122.43579766537,1098.62645914397,3161.33852140078,906.455252918288,476.346303501945,1886.63813229572,1733.13229571984,307.451361867704,238.163424124514,1009.31906614786,1267.52918287938,223.027237354086,190.743190661479,589.821011673152,3372.76653696498,593.354085603113,261.280155642023,1087.71984435798,131.229571984436,257,20.6102871063225,15.8905198442944,0.636835819888928,0.973484848484848,0.803125,0.306378666383585,51059.5486381323,35582.1011673152,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_466079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
466231,3376.14864864865,1165.7972972973,119.972972972973,658.797297297297,2468.56756756757,3883.64864864865,2123.18243243243,272.452702702703,1274.57432432432,5378.5472972973,2177.32432432432,124.837837837838,1082.31756756757,1174.56756756757,687.804054054054,283.135135135135,1827.18243243243,1435.60135135135,326.047297297297,236.972972972973,1016.04054054054,1440.33108108108,237.054054054054,291.75,892.844594594595,1813.58783783784,525.52027027027,544.506756756757,1087.83783783784,132.317567567568,148,17.1905149787329,11.1791180892075,0.759671219684564,0.948717948717949,0.79144385026738,-0.0920203988277006,50599.6959459459,35712.9256756757,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_466231,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
467125,1770.88268156425,257.927374301676,269.932960893855,719.391061452514,6731.46368715084,1778.46927374302,314.642458100559,263.340782122905,1110.46927374302,3338.18994413408,544.094972067039,146.525139664804,1065.01117318436,938.68156424581,524.754189944134,284.882681564246,1452.26815642458,1135.36312849162,231.486033519553,218.849162011173,1500.62569832402,744.983240223464,157.067039106145,131.072625698324,580.77094972067,967.22905027933,440.675977653631,214.083798882682,1035.56983240223,133.262569832402,179,18.4583732272152,12.4130777962309,0.740105894232633,0.952127659574468,0.752100840336134,-1.09484669394152,50197.6368715084,35011.4413407821,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_467125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
467388,2172.73728813559,316.327683615819,112.19209039548,638.638418079096,1891.99152542373,2179.77401129944,1671.20903954802,271.83615819209,1088.66666666667,3457.36723163842,2805.24011299435,113.838983050847,1071.75988700565,670.536723163842,540.274011299435,273.949152542373,1571.05084745763,1004.31920903955,276.237288135593,229.827683615819,988.423728813559,940.223163841808,220.853107344633,138.209039548023,582.793785310735,1266.54237288136,481.358757062147,770.576271186441,1043.17231638418,131.282485875706,354,28.8836533699316,15.6593152981916,0.840280772952388,0.954177897574124,0.655555555555556,0.493182184651893,50951.4943502825,35276.6638418079,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_467388,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
467747,2653.54325259516,777.166089965398,104.314878892734,666.595155709343,3093.62629757785,2984.8615916955,589.058823529412,268.152249134948,1144.35294117647,4563.29411764706,809.660899653979,113.764705882353,1069.82006920415,1078.74394463668,492.854671280277,280.449826989619,1583.17301038062,1999.60207612457,361.80276816609,240.269896193772,995.993079584775,2008.33910034602,248.57785467128,242.0,585.934256055363,937.948096885813,449.43598615917,326.629757785467,1032.36332179931,132.339100346021,289,20.1873057449533,18.369154478829,0.414748881496991,0.944444444444444,0.760526315789474,-0.127537850658402,50779.6020761246,35288.9065743945,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_467747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
467944,2627.18586387435,299.793193717277,152.520942408377,671.259162303665,4181.07068062827,2500.86910994764,382.937172774869,265.539267015707,1099.01308900524,4592.66753926702,533.311518324607,122.659685863874,1083.89528795812,734.905759162304,546.698952879581,287.510471204188,1749.97382198953,1077.21989528796,269.772251308901,227.633507853403,1044.91623036649,942.476439790576,197.497382198953,568.989528795812,1218.33507853403,1683.56544502618,522.185863874346,234.089005235602,1044.15706806283,130.701570680628,382,24.7884974425941,19.829642542598,0.600062142692971,0.969543147208122,0.754940711462451,-0.769532225960734,51922.4869109948,34879.719895288,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_467944,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
467968,2306.97486033519,132.346368715084,70.586592178771,627.114525139665,1751.04748603352,2891.68156424581,342.706703910615,251.600558659218,1086.9217877095,4698.61452513966,627.946927374302,118.905027932961,1084.4748603352,992.659217877095,549.941340782123,282.142458100559,1573.1061452514,1113.55027932961,238.45530726257,239.608938547486,1120.31843575419,791.522346368715,157.494413407821,133.743016759777,587.670391061453,2056.80726256983,516.184357541899,223.117318435754,1084.33240223464,129.608938547486,358,32.4833247511958,14.0562675884788,0.901527138919499,0.954666666666667,0.608843537414966,-0.567505974465227,51145.0893854749,34048.6117318436,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_467968,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
468067,1707.393728223,134.463414634146,74.8501742160279,617.076655052265,1146.91986062718,1962.22299651568,342.459930313589,264.0,1082.01742160279,3645.07665505226,504.599303135888,111.975609756098,1075.85365853659,586.149825783972,376.334494773519,312.912891986063,1967.16027874564,1009.31010452962,4776.35888501742,225.648083623693,1038.06620209059,1227.36933797909,187.400696864111,236.965156794425,625.93031358885,1776.21254355401,459.648083623693,247.515679442509,1060.04529616725,128.770034843206,287,20.2599466301046,18.2274624218031,0.436550641581491,0.956666666666667,0.755263157894737,1.30764209882067,50826.0278745645,35424.3205574913,FAAGSCC_12,AG,1,tumor cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,tumor cells,Tumor,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_468067,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
468546,1626.30523255814,180.470930232558,93.8081395348837,624.787790697674,1540.16569767442,1815.06104651163,470.526162790698,262.497093023256,1082.59011627907,2781.65988372093,501.819767441861,108.328488372093,1078.13081395349,1021.02325581395,529.59011627907,276.933139534884,1789.90988372093,1535.43895348837,326.84011627907,238.540697674419,1026.93023255814,1266.26744186047,229.918604651163,143.212209302326,607.046511627907,1161.08720930233,480.412790697674,227.287790697674,1008.01453488372,129.517441860465,344,26.9143050889623,16.4988112022079,0.790073042660361,0.958217270194986,0.749455337690632,1.54431217804435,51204.1162790698,35297.1162790698,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_468546,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
468980,2843.0351758794,1135.73869346734,1376.77889447236,644.773869346734,2251.05527638191,2792.80904522613,761.256281407035,271.090452261306,1115.66331658291,3930.81407035176,1152.21608040201,119.095477386935,1070.8040201005,1518.34170854271,1355.69849246231,1106.59798994975,1833.62311557789,1569.36180904523,381.331658291457,237.311557788945,1027.99497487437,1310.64824120603,231.206030150754,1122.05025125628,621.195979899498,1301.27638190955,543.391959798995,486.170854271357,1037.81407035176,131.663316582915,199,17.644690689709,14.8333012431205,0.541553092660214,0.938679245283019,0.737037037037037,0.0194922050582651,51886.9296482412,34978.7236180905,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_468980,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
469687,2153.91007194245,371.514388489209,118.482014388489,649.636690647482,2185.52158273381,1670.64748201439,3959.72302158273,260.712230215827,1092.04676258993,3628.08992805755,4733.4964028777,108.960431654676,1082.28776978417,790.140287769784,536.525179856115,383.410071942446,1467.97482014388,1249.20503597122,362.507194244604,244.611510791367,992.312949640288,1225.96402877698,263.960431654676,196.73381294964,606.992805755396,1033.02877697842,426.723021582734,632.762589928058,1027.75539568345,129.895683453237,278,22.1589812582013,16.0415424507228,0.689873853291654,0.965277777777778,0.778711484593838,0.370323163843406,51351.9892086331,35496.964028777,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_469687,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
469712,2107.73279352227,142.202429149798,59.6477732793522,622.886639676113,490.886639676113,1983.38056680162,555.283400809717,248.643724696356,1080.44939271255,3903.1983805668,678.558704453441,113.716599190283,1067.61133603239,1121.17813765182,729.906882591093,288.757085020243,1824.94736842105,1551.67206477733,354.060728744939,243.631578947368,1144.3967611336,3775.58299595142,352.028340080972,1088.34817813765,1848.47773279352,1478.72469635628,505.206477732794,234.226720647773,1047.0971659919,129.655870445344,247,27.2707714194465,11.7232041450959,0.902885246962983,0.95,0.560090702947846,-0.750042953796035,50934.7125506073,33674.9311740891,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_469712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
470519,1473.6130952381,262.107142857143,78.9761904761905,614.934523809524,1011.54166666667,1334.72023809524,3359.1130952381,251.630952380952,1082.11904761905,2591.78571428571,1377.53571428571,111.982142857143,1074.53571428571,1017.97619047619,1127.2619047619,818.791666666667,2112.56547619048,1303.2619047619,315.738095238095,238.065476190476,1016.35714285714,1148.8869047619,234.809523809524,235.714285714286,619.89880952381,1050.19047619048,478.910714285714,323.172619047619,1032.42857142857,129.755952380952,168,17.5177198615394,13.3379120935735,0.648287727560635,0.852791878172589,0.549019607843137,0.754290755316761,52023.0178571429,35099.0714285714,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_470519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
470598,3239.35897435897,256.291666666667,145.580128205128,639.695512820513,2438.55128205128,3586.05448717949,388.083333333333,269.958333333333,1091.375,5727.35576923077,525.560897435897,117.705128205128,1097.79807692308,1964.13141025641,782.320512820513,1380.39102564103,1927.73076923077,2231.47756410256,347.833333333333,241.262820512821,1054.30448717949,2063.18269230769,243.871794871795,413.445512820513,707.378205128205,2482.67307692308,526.330128205128,237.88141025641,1049.59935897436,129.932692307692,312,28.8841956134971,13.864509053068,0.87726668538262,0.939759036144578,0.590909090909091,0.693446931908034,51876.5256410256,34933.0448717949,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_470598,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
471367,3400.81818181818,477.636363636364,172.967272727273,666.865454545455,2504.35272727273,3538.83636363636,366.930909090909,283.647272727273,1100.72,6029.47272727273,557.236363636364,124.483636363636,1107.46181818182,619.618181818182,437.589090909091,272.472727272727,1408.92,984.298181818182,295.865454545454,231.2,990.16,958.578181818182,219.650909090909,135.283636363636,589.676363636364,2837.82181818182,509.207272727273,221.581818181818,1069.02181818182,130.007272727273,275,27.4740016562674,12.7657100076605,0.885496046247529,0.958188153310104,0.705128205128205,-0.329775060686933,50419.0690909091,35409.5090909091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_471367,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
471500,2595.74939759036,114.0,118.568674698795,684.41686746988,4932.64578313253,3165.6313253012,341.472289156627,265.761445783133,1088.96626506024,5474.71325301205,516.166265060241,118.38313253012,1088.06746987952,1080.11084337349,999.653012048193,871.481927710843,1775.52289156627,1182.5156626506,281.865060240964,232.30843373494,1019.55421686747,993.414457831325,210.8,281.920481927711,670.706024096386,3028.18313253012,549.877108433735,249.41686746988,1054.14698795181,129.860240963855,415,29.7444650697972,17.8622630075152,0.799606785610853,0.945330296127563,0.668276972624799,-0.890937488901638,51939.1855421687,34886.9253012048,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_471500,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
471619,3354.1843003413,572.98976109215,66.1399317406143,625.436860068259,1383.81911262799,3338.04436860068,1093.54948805461,267.9795221843,1108.10580204778,6244.75767918089,570.672354948805,112.105802047782,1107.78498293515,2255.91126279863,902.361774744027,2240.91467576792,1725.27645051195,3510.42662116041,361.737201365188,245.252559726962,1018.07167235495,3063.81911262799,239.692832764505,447.034129692833,661.259385665529,2452.09897610922,488.576791808874,534.836177474403,1050.03071672355,131.341296928328,293,20.7887839899774,18.1475500148486,0.487811326832022,0.963815789473684,0.775132275132275,-1.38097759854703,50994.2252559727,35501.6962457338,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_471619,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
472571,1900.62078651685,354.27808988764,220.011235955056,672.415730337079,5154.02528089888,2311.36797752809,418.424157303371,265.502808988764,1091.14325842697,3189.08146067416,587.404494382022,121.064606741573,1085.75,781.634831460674,548.839887640449,281.733146067416,1538.41292134831,1078.53370786517,313.943820224719,238.747191011236,996.376404494382,954.671348314607,202.536516853933,206.769662921348,585.85393258427,1285.20786516854,495.438202247191,221.120786516854,1039.37359550562,129.109550561798,356,36.6268485847834,12.6629575332314,0.938334468953799,0.936842105263158,0.513708513708514,1.0952717016135,51371.6516853933,34751.893258427,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_472571,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
472585,2857.05609756098,246.143902439024,130.09756097561,662.958536585366,3032.92195121951,2889.19024390244,399.339024390244,271.685365853659,1107.00731707317,4937.50243902439,528.539024390244,113.143902439024,1106.82195121951,835.851219512195,630.951219512195,300.341463414634,1742.11707317073,1377.0756097561,354.012195121951,237.065853658537,1020.57073170732,1168.85365853659,236.578048780488,155.607317073171,586.375609756098,1227.75853658537,450.592682926829,226.985365853658,1030.3756097561,130.970731707317,410,30.4603452428776,17.30888547555,0.822860627695931,0.951276102088167,0.665584415584416,-0.56023194776092,50792.1317073171,35238.643902439,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_472585,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
472613,1742.8025210084,268.478991596639,165.718487394958,676.096638655462,3705.66806722689,2081.87394957983,362.302521008403,256.663865546218,1100.61344537815,2745.42857142857,534.36974789916,115.344537815126,1076.26470588235,1692.13445378151,766.840336134454,321.256302521008,1754.41176470588,1620.40336134454,386.764705882353,245.319327731092,1021.71428571429,952.676470588235,219.31512605042,138.53781512605,591.067226890756,1010.83613445378,482.088235294118,218.210084033613,1039.75630252101,128.957983193277,238,21.2344696834655,14.4174617608139,0.734170637820759,0.955823293172691,0.74375,-0.631063582592846,51400.3277310924,34749.1176470588,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_472613,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
472963,4510.44852941176,278.422794117647,139.470588235294,622.827205882353,1537.98161764706,5258.99632352941,446.555147058824,277.643382352941,1184.62132352941,6323.09926470588,659.363970588235,123.841911764706,1080.72794117647,3336.82720588235,1042.16176470588,440.404411764706,2505.92647058824,4264.03308823529,481.470588235294,264.3125,1061.99632352941,1773.06617647059,263.246323529412,308.882352941176,1713.63970588235,2330.70955882353,715.360294117647,299.378676470588,1069.74632352941,132.055147058824,272,23.0221335860389,15.0959219071299,0.755009876253072,0.964539007092198,0.71957671957672,0.608908006910303,51747.7683823529,34822.7426470588,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_472963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
473006,883.878260869565,208.313043478261,101.826086956522,648.773913043478,1329.61739130435,783.026086956522,1353.11304347826,253.739130434783,1084.74782608696,1356.41739130435,452.086956521739,107.486956521739,1069.06956521739,1391.1652173913,554.991304347826,281.991304347826,1619.06086956522,2907.04347826087,509.173913043478,316.095652173913,1029.91304347826,3035.85217391304,239.208695652174,460.878260869565,815.634782608696,911.052173913044,480.860869565217,568.286956521739,1007.00869565217,128.286956521739,115,13.9599552691489,10.6154339130878,0.649431219292003,0.950413223140496,0.746753246753247,1.40318552245152,51474.5652173913,35362.4434782609,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_473006,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
473023,4275.36918604651,964.65988372093,818.014534883721,689.03488372093,4163.0726744186,4674.6511627907,790.433139534884,278.316860465116,1297.72674418605,7330.09593023256,579.811046511628,122.119186046512,1110.6511627907,734.296511627907,540.802325581395,653.872093023256,1651.38662790698,1145.39534883721,308.316860465116,230.375,1013.91279069767,1086.40406976744,238.453488372093,315.09011627907,589.813953488372,2602.61627906977,549.598837209302,386.53488372093,1156.98255813953,131.662790697674,344,24.4846199570112,17.9137333961129,0.681699714955335,0.960893854748603,0.754385964912281,0.3561033934125,51132.5872093023,35655.6773255814,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_473023,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
473417,2385.41116751269,109.284263959391,60.3705583756345,620.94923857868,1212.06598984772,2553.05076142132,287.710659898477,254.583756345178,1081.84263959391,4513.6192893401,457.862944162437,117.517766497462,1081.32994923858,4068.56345177665,1296.57868020305,401.822335025381,2323.60406091371,4905.29441624366,439.274111675127,248.086294416244,1078.68527918782,3947.18781725888,769.106598984772,282.233502538071,610.142131979695,2158.97461928934,458.857868020305,223.53807106599,1019.79187817259,128.664974619289,197,22.9660909165808,11.0913523758429,0.875650841499962,0.95631067961165,0.746212121212121,-1.38861319211578,50663.807106599,35771.3096446701,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_473417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
473487,3256.43636363636,531.409090909091,504.545454545455,629.827272727273,1135.52727272727,3258.78181818182,956.354545454546,272.227272727273,1102.79090909091,6268.61818181818,637.9,111.118181818182,1072.59090909091,1102.36363636364,675.136363636364,364.463636363636,4516.67272727273,1871.24545454545,318.781818181818,235.418181818182,1063.38181818182,1905.03636363636,227.781818181818,178.754545454545,614.7,2449.29090909091,510.554545454546,346.436363636364,1067.36363636364,131.581818181818,110,13.0669815915107,10.7598477064331,0.567406421228581,0.948275862068966,0.763888888888889,-0.850541364744797,50858.5181818182,35328.1818181818,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_473487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
473860,4895.90909090909,375.516363636364,234.789090909091,637.541818181818,1224.03272727273,5180.71636363636,1006.30181818182,287.181818181818,1117.20363636364,8306.58909090909,867.989090909091,125.178181818182,1084.26545454545,2027.01090909091,859.363636363636,1169.98909090909,2569.02545454545,1541.40727272727,316.534545454545,229.887272727273,1030.18545454545,1116.47272727273,227.876363636364,301.174545454545,624.749090909091,2499.36727272727,564.84,361.829090909091,1107.16,131.876363636364,275,22.0891272067195,15.8635939485469,0.695874916787295,0.96830985915493,0.78125,-0.248853100513083,50668.7636363636,35304.3018181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_473860,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
474418,3087.16666666667,777.968599033816,183.42270531401,663.900966183575,2564.961352657,3589.13526570048,3376.1231884058,269.900966183575,1102.10869565217,4981.77777777778,1249.09420289855,120.927536231884,1064.75120772947,841.234299516908,495.519323671498,268.171497584541,1828.13285024155,1269.93719806763,286.384057971014,233.253623188406,1032.28743961353,1089.22222222222,208.410628019324,128.485507246377,600.012077294686,1225.16666666667,474.601449275362,360.995169082126,1040.89130434783,131.091787439614,414,25.2970434463495,20.9395662956635,0.561100665456088,0.958333333333333,0.788571428571429,1.46409131510487,50175.9057971014,34750.309178744,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_474418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
474686,2356.96464646465,1110.66161616162,339.060606060606,747.40404040404,5730.17676767677,3905.31818181818,1404.37373737374,283.808080808081,1337.91919191919,3623.61616161616,589.838383838384,119.59595959596,1086.26262626263,979.055555555556,681.818181818182,613.722222222222,1604.28282828283,1118.21212121212,301.0,229.560606060606,1011.42424242424,1032.32828282828,229.318181818182,426.348484848485,617.227272727273,1329.01515151515,524.530303030303,788.712121212121,1078.4898989899,131.267676767677,198,18.7543694097239,13.5995981310153,0.688598395757527,0.925233644859813,0.694736842105263,-0.149898598427426,51147.1060606061,35663.1313131313,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_474686,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
475592,1978.61849710983,227.040462427746,290.28323699422,759.578034682081,9940.73988439306,1776.83815028902,377.080924855491,265.28901734104,1098.37572254335,3597.20809248555,510.208092485549,119.768786127168,1228.61849710983,3278.67630057803,939.231213872832,1000.54913294798,2383.47976878613,2662.5549132948,383.838150289017,239.07514450867,1061.04046242775,1796.95953757225,251.387283236994,889.260115606936,658.872832369942,1352.7225433526,431.78612716763,269.757225433526,1079.90751445087,130.64161849711,173,24.2924045402685,9.11903351162856,0.926868490295742,0.920212765957447,0.626811594202899,1.2077654584932,51324.8208092486,35717.6994219653,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX+,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_475592,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
476286,2149.24600638978,202.746006389776,94.4169329073482,653.891373801917,2256.08146964856,2409.56549520767,1355.79712460064,259.161341853035,1089.36581469649,4081.11980830671,2320.31150159744,113.495207667732,1077.55271565495,1637.05910543131,627.23482428115,313.683706070288,3182.07827476038,1678.62619808307,294.20607028754,232.552715654952,1033.94568690096,1784.03514376997,253.650159744409,883.913738019169,694.543130990415,1493.34185303514,504.512779552716,517.937699680511,1041.36261980831,130.536741214058,626,39.3901296774297,20.4062507806749,0.855347351620463,0.964560862865948,0.634888438133874,0.878222961384218,51897.9936102236,34838.5303514377,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_476286,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
477495,3145.35144927536,1055.02173913043,99.9094202898551,625.04347826087,851.094202898551,2996.69202898551,1208.3768115942,264.050724637681,1128.53623188406,5186.82608695652,823.351449275362,115.31884057971,1080.58695652174,6638.19927536232,925.61231884058,328.054347826087,6095.91304347826,7154.59420289855,458.014492753623,247.514492753623,1046.99637681159,6065.99275362319,279.554347826087,293.764492753623,767.731884057971,1462.86956521739,458.086956521739,272.800724637681,1051.14855072464,130.086956521739,276,21.1456542404732,16.7152391231976,0.612486487939699,0.955017301038062,0.773109243697479,-0.258108757140597,50649.6014492754,35666.2717391304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_477495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
478145,4056.11785714286,1136.84642857143,686.664285714286,622.296428571429,1027.075,4240.35,441.964285714286,272.221428571429,1132.65,6291.61785714286,608.757142857143,118.117857142857,1070.73571428571,1382.97857142857,499.25,281.057142857143,1855.98928571429,1309.44642857143,245.8,214.917857142857,1068.26428571429,942.085714285714,186.717857142857,204.307142857143,828.832142857143,1930.22857142857,491.678571428571,244.55,1045.13214285714,130.285714285714,280,25.251974724062,14.1947251299533,0.827053394254826,0.96551724137931,0.760869565217391,1.2049713974846,50717.1142857143,35596.225,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_478145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
478380,1996.68088737201,411.853242320819,166.392491467577,653.4795221843,2612.31058020478,2277.44539249147,421.441979522184,275.870307167235,1127.5614334471,3031.05119453925,928.196245733788,155.692832764505,1064.41638225256,1106.03412969283,1060.97781569966,1611.89078498294,1751.14846416382,1456.89419795222,328.378839590444,239.049488054608,1040.00682593857,1628.81911262799,292.134812286689,1443.92662116041,802.534129692833,925.972696245734,462.716723549488,219.172354948805,1064.00682593857,132.540955631399,586,35.7843386712607,20.9968537246727,0.809760180028308,0.963815789473684,0.761038961038961,1.42683304841505,51457.6774744027,33984.5358361775,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_478380,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
479277,2958.72207792208,509.716883116883,759.342857142857,650.254545454545,2827.3012987013,2732.15324675325,416.566233766234,268.745454545454,1094.14805194805,4459.5038961039,510.644155844156,115.548051948052,1070.81038961039,912.857142857143,619.574025974026,396.649350649351,1579.06753246753,1374.80519480519,364.142857142857,241.431168831169,1009.38701298701,1259.98701298701,259.620779220779,221.072727272727,594.132467532468,1018.22337662338,442.945454545455,253.077922077922,1018.89090909091,129.163636363636,385,23.6171525290168,21.025965767592,0.455406352927022,0.972222222222222,0.797101449275362,0.0100925590912764,51441.6623376623,35660.6545454545,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_479277,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
479335,3882.3,952.883333333333,860.545833333333,637.795833333333,1539.03333333333,4213.65833333333,1892.06666666667,262.575,1115.12083333333,8674.93333333333,973.270833333333,131.441666666667,1095.88333333333,639.070833333333,505.4375,271.925,1412.52083333333,983.725,318.0875,238.758333333333,993.066666666667,896.925,215.133333333333,126.9625,584.0625,3833.85833333333,652.441666666667,272.8375,1106.45416666667,132.141666666667,240,20.6448479838869,14.947546307374,0.689765583016039,0.956175298804781,0.701754385964912,0.826575627009244,50446.05,34250.9416666667,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_479335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
479669,5308.40546697039,431.346241457859,144.104783599089,642.706150341686,1534.34396355353,6561.10250569476,1782.46013667426,287.824601366743,1116.44646924829,9823.77676537586,2867.55125284738,141.806378132118,1076.78815489749,3228.59453302961,566.387243735763,786.922551252847,1935.3576309795,4397.20501138952,427.346241457859,1261.72665148064,1046.08656036446,3621.10478359909,361.678815489749,599.059225512528,608.227790432802,3145.98177676538,644.453302961276,689.567198177677,1117.58314350797,132.054669703872,439,30.0092203231939,19.0338810470564,0.773113448777021,0.95021645021645,0.675384615384615,0.90762795459289,50618.0182232346,34197.6537585421,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_479669,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
479854,1675.64197530864,143.320987654321,79.6502057613169,655.724279835391,2597.46913580247,2075.95473251029,363.341563786008,271.127572016461,1098.05349794239,2718.39917695473,506.19341563786,114.58024691358,1079.04526748971,780.744855967078,442.679012345679,267.353909465021,1843.12757201646,1181.62962962963,271.037037037037,227.024691358025,1039.58436213992,978.164609053498,211.189300411523,148.493827160494,612.56378600823,1169.90534979424,457.753086419753,212.037037037037,1046.87242798354,130.82304526749,243,19.9575123858071,15.8761354420945,0.605957906481096,0.952941176470588,0.759375,1.34319989300219,50073.6378600823,35411.7983539095,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_479854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
480669,2444.48666666667,403.365,115.131666666667,642.968333333333,1703.16333333333,2796.505,3272.73333333333,256.143333333333,1088.61166666667,3720.62,2527.09,119.501666666667,1067.31,1244.68833333333,915.853333333333,976.085,1806.56333333333,2043.385,363.823333333333,244.553333333333,1025.97833333333,1977.71,245.185,259.278333333333,726.343333333333,1072.23666666667,499.061666666667,275.928333333333,1049.57833333333,132.668333333333,600,31.7447240489865,24.1258792712152,0.649927161437877,0.963081861958266,0.75,0.18365803009617,50948.8066666667,33819.605,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_480669,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
480972,4830.7012987013,915.56277056277,402.0,615.52380952381,836.471861471861,4369.76623376623,506.363636363636,276.670995670996,1091.9696969697,8378.38095238095,620.147186147186,121.402597402597,1075.38528138528,2312.02164502164,681.978354978355,296.294372294372,1795.15151515152,3392.69264069264,348.454545454545,235.060606060606,1027.30303030303,2923.99134199134,254.341991341991,222.341991341991,4163.82683982684,4100.36363636364,545.91341991342,314.874458874459,1060.28571428571,130.008658008658,231,19.0392160655715,15.7957329112268,0.558295786558089,0.96652719665272,0.802083333333333,-1.07939210483725,50774.4199134199,35587.7489177489,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_480972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
481346,2085.00233100233,406.724941724942,176.801864801865,650.794871794872,2058.82750582751,2561.69696969697,381.317016317016,275.913752913753,1091.337995338,4424.44289044289,653.825174825175,122.536130536131,1082.17715617716,591.053613053613,415.165501165501,281.272727272727,1365.27272727273,965.909090909091,272.755244755245,230.678321678322,986.487179487179,1089.37762237762,205.060606060606,171.004662004662,612.34965034965,2570.76923076923,571.5337995338,231.072261072261,1077.22144522145,135.398601398601,429,29.2532182021228,18.8623238902011,0.764355693226448,0.938730853391685,0.666149068322981,0.650754245131823,50540.9160839161,34582.3076923077,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_481346,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
481943,2351.74838709677,243.348387096774,68.7129032258065,637.567741935484,1558.32580645161,2618.69677419355,2425.25806451613,266.832258064516,1288.8935483871,4122.5935483871,3241.72258064516,109.822580645161,1074.56774193548,2374.84838709677,708.677419354839,323.567741935484,2887.42903225806,2764.16774193548,308.916129032258,234.38064516129,1011.82258064516,3031.64516129032,233.651612903226,212.309677419355,583.683870967742,1676.76451612903,460.561290322581,709.354838709677,1055.53225806452,130.409677419355,310,28.6053980450095,13.907241609313,0.873861232789281,0.953846153846154,0.675381263616558,-0.39035941550125,50985.7612903226,35674.6451612903,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_481943,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
482018,2263.08682634731,644.167664670659,71.4071856287425,622.72754491018,950.017964071856,2085.03892215569,998.544910179641,258.347305389222,1119.50598802395,4328.03293413174,764.464071856287,106.104790419162,1093.01497005988,857.691616766467,637.110778443114,574.52994011976,4036.5,1477.40119760479,302.976047904192,231.988023952096,1039.12275449102,1354.2874251497,227.766467065868,229.75748502994,605.889221556886,1834.35628742515,455.721556886228,266.634730538922,1043.52095808383,129.586826347305,334,27.2950594202694,15.8027999175144,0.815354584857787,0.954285714285714,0.668,-0.520300213757743,51267.7125748503,35685.9910179641,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_482018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
483106,3238.55789473684,1087.96842105263,133.743859649123,662.375438596491,2394.17543859649,4063.64210526316,768.459649122807,280.354385964912,1216.3298245614,5599.02807017544,755.301754385965,119.452631578947,1080.64210526316,1109.04912280702,791.322807017544,1028.27719298246,1727.30526315789,1429.7649122807,331.161403508772,237.021052631579,1007.20701754386,1280.43157894737,239.445614035088,500.421052631579,698.58947368421,1802.95087719298,507.00350877193,275.585964912281,1046.12280701754,130.449122807018,285,21.7916957160759,16.9627732364948,0.627761945874377,0.962837837837838,0.71969696969697,1.23806934962547,50958.8140350877,35555.9824561404,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_483106,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
485287,2390.04918032787,508.603825136612,230.928961748634,707.833333333333,5547.70765027322,2785.69945355191,2119.51092896175,259.508196721311,1095.40710382514,3876.20491803279,1161.80054644809,128.404371584699,1096.87704918033,2024.39890710382,601.103825136612,333.254098360656,1562.7131147541,2038.02459016393,379.256830601093,243.158469945355,1067.14207650273,1700.59016393443,303.207650273224,839.915300546448,1748.60928961749,1264.96448087432,522.874316939891,468.303278688525,1072.33606557377,131.879781420765,366,25.2771554910979,18.4863957562806,0.682004531853131,0.953125,0.726190476190476,0.451945304298751,51493.0519125683,33812.2213114754,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
485390,4329.42641509434,211.62641509434,122.694339622642,656.215094339623,2029.8679245283,4826.44905660377,1317.32075471698,285.4,1113.16226415094,5444.03018867924,1198.98113207547,147.120754716981,1073.48679245283,687.547169811321,447.524528301887,275.37358490566,1460.37735849057,963.354716981132,283.750943396226,232.91320754717,991.422641509434,922.162264150943,199.290566037736,133.037735849057,614.28679245283,928.290566037736,460.924528301887,226.939622641509,1065.40377358491,131.192452830189,265,23.4419866363549,14.5133217854485,0.785299116970735,0.94306049822064,0.664160401002506,0.616679856114451,51065.4679245283,33956.4905660377,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
485478,2677.26356589147,336.751937984496,139.813953488372,636.201550387597,1524.07364341085,2710.19379844961,379.302325581395,273.759689922481,1094.2519379845,4751.82945736434,543.259689922481,118.391472868217,1108.88759689922,915.771317829457,676.205426356589,283.736434108527,1620.88372093023,1596.99224806202,352.279069767442,237.949612403101,1006.98837209302,1558.8992248062,263.081395348837,191.232558139535,583.395348837209,2156.01162790698,505.003875968992,219.027131782946,1066.77519379845,130.453488372093,258,32.3990541689994,10.6358390087119,0.944581771949097,0.905263157894737,0.460714285714286,-0.557951404599538,50461.2286821705,35705.2248062015,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_485478,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
485614,2395.19371727749,225.11780104712,157.774869109948,633.086387434555,1643.18586387435,3133.77748691099,989.408376963351,277.767015706806,1097.85602094241,4062.87958115183,561.526178010471,115.604712041885,1072.87958115183,3144.74083769633,540.879581151832,288.782722513089,1484.21989528796,1778.57068062827,293.562827225131,228.751308900524,990.874345549738,1481.16753926702,221.662303664921,171.070680628272,586.96335078534,1425.68848167539,474.486910994764,358.853403141361,1054.79581151832,130.986910994764,382,29.8731590257488,16.744662200825,0.828137282665192,0.950248756218906,0.682142857142857,1.17989839862224,51564.8010471204,35513.2827225131,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
485859,3307.3838028169,671.718309859155,119.394366197183,643.644366197183,1997.25352112676,3574.53169014085,574.778169014084,276.580985915493,1178.89436619718,5646.74295774648,820.327464788732,116.915492957746,1082.33450704225,766.246478873239,643.978873239437,364.742957746479,1616.67605633803,1276.75,305.021126760563,231.81338028169,1031.45774647887,1153.94718309859,222.806338028169,506.933098591549,671.943661971831,1802.15845070423,476.87676056338,316.542253521127,1055.54225352113,130.816901408451,284,24.9498717248262,14.5710073777688,0.811745517242435,0.940397350993378,0.696078431372549,0.336551431992596,50843.5387323944,35571.0492957746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
486045,1897.96162528217,200.099322799097,82.5756207674944,627.878103837472,1442.54627539503,2338.84875846501,2272.21670428894,250.255079006772,1084.40406320542,4194.79232505643,901.252821670429,106.367945823928,1066.89164785553,1932.38600451467,745.110609480813,317.422121896163,1714.60948081264,2247.84650112867,423.943566591422,253.194130925508,1024.78781038375,1815.64334085779,237.056433408578,282.681715575621,2038.92550790068,1817.20541760722,473.638826185102,273.620767494357,1043.71783295711,132.266365688488,443,25.5787143730497,22.5896080751511,0.469107879946114,0.958874458874459,0.709935897435897,-0.11961047315969,50337.2257336343,34697.1128668172,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_486045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
486339,2536.90265486726,658.244837758112,160.268436578171,640.834808259587,1897.17994100295,2830.33333333333,4723.51032448378,264.625368731563,1096.90855457227,5205.27138643068,890.6401179941,119.058997050147,1079.88495575221,4462.68731563422,1089.35398230089,513.702064896755,1995.71681415929,5954.74631268437,402.268436578171,248.690265486726,1043.95280235988,5719.65486725664,270.513274336283,197.053097345133,708.852507374631,1794.68731563422,523.979351032448,341.306784660767,1051.55162241888,131.938053097345,339,25.1384846653732,17.3136107206668,0.725018595419348,0.949579831932773,0.701863354037267,0.914113182537828,51594.7463126844,35064.6755162242,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
486433,3157.55191256831,675.808743169399,281.081967213115,715.289617486339,5658.37704918033,3767.67759562842,3458.53005464481,263.251366120219,1104.01639344262,5946.8306010929,1904.98907103825,126.338797814208,1071.60655737705,2213.87431693989,633.415300546448,369.404371584699,1652.7650273224,1821.49726775956,360.098360655738,243.710382513661,1040.34426229508,1451.13114754098,289.120218579235,1053.45355191257,1698.27868852459,1957.46448087432,590.311475409836,681.382513661202,1100.42076502732,132.224043715847,183,16.8899795662563,14.3230139358723,0.529966738816447,0.943298969072165,0.635416666666667,-0.0305912079942209,51479.6885245902,33818.7540983607,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
486698,4336.23214285714,349.151785714286,109.098214285714,616.625,630.4375,4182.0,1521.74107142857,273.741071428571,1113.32142857143,6304.21428571429,563.714285714286,140.357142857143,1100.77678571429,702.491071428571,424.5625,302.133928571429,1489.04464285714,1052.07142857143,301.758928571429,232.223214285714,992.044642857143,1046.66964285714,243.276785714286,186.410714285714,586.196428571429,1416.52678571429,442.839285714286,231.053571428571,1042.77678571429,131.008928571429,112,14.2071397592544,11.1770439971432,0.617309734828565,0.823529411764706,0.615384615384615,1.00870038188421,50834.7678571429,35873.2232142857,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
488239,2400.51688843398,400.842374616172,183.712384851586,672.645854657114,3047.45445240532,2839.52814738997,512.413510747185,274.835209825998,1108.02149437052,4372.73387922211,659.500511770727,129.102354145343,1097.72466734903,915.747185261003,627.539406345957,384.327533265097,1491.8812691914,1152.7011258956,301.840327533265,277.809621289662,1006.30501535312,996.624360286592,232.063459570113,157.894575230297,589.277379733879,1371.8505629478,509.048106448311,223.124872057318,1063.11668372569,131.437052200614,977,61.4643347183004,20.3078048948718,0.943841067894,0.960668633235005,0.636897001303781,-0.274167841607774,49974.7993858751,35100.1729785056,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_488239,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
489166,4703.15969581749,1351.01901140684,1096.16730038023,661.973384030418,2309.55513307985,4478.98859315589,1256.71102661597,279.574144486692,1134.29657794677,8796.12547528517,1076.26996197719,124.543726235741,1436.53992395437,1179.37642585551,651.942965779468,300.80608365019,1568.1102661597,1829.37642585551,342.072243346008,240.790874524715,999.627376425856,1879.36121673004,255.456273764259,259.501901140684,589.403041825095,3049.86692015209,633.570342205323,327.220532319392,1078.30798479087,133.22433460076,263,25.3270156240834,13.3707865990838,0.849290458208156,0.942652329749104,0.730555555555556,1.2699151114334,51897.0076045627,35244.1673003802,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_489166,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
489333,3291.39737991266,283.572052401747,90.4192139737991,620.53711790393,953.724890829694,3498.62445414847,2997.92139737991,258.655021834061,1085.3056768559,6763.34497816594,1561.0,117.781659388646,1080.4672489083,1333.8384279476,569.489082969432,297.56768558952,1518.68995633188,1636.62008733624,302.829694323144,230.03056768559,1021.00873362445,1363.44541484716,209.384279475983,256.917030567686,595.956331877729,2678.31004366812,528.384279475983,342.655021834061,1070.73362445415,130.318777292576,229,20.1950824272292,14.6148636683457,0.69013119342504,0.954166666666667,0.763333333333333,-0.142615495014428,51892.5938864629,34150.4716157205,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_489333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
489491,3125.90358126722,816.190082644628,127.738292011019,621.187327823691,1151.88429752066,3797.2479338843,391.831955922865,266.997245179063,1104.88980716253,6692.80716253444,598.082644628099,120.247933884298,1067.49862258953,2937.53994490358,618.98347107438,286.851239669421,1854.54545454545,2200.33333333333,353.997245179063,243.046831955923,1016.57575757576,1741.26446280992,228.443526170799,212.074380165289,1183.50413223141,3811.09917355372,592.187327823691,240.834710743802,1050.50137741047,130.776859504132,363,29.7335999968217,15.8582482660201,0.845898208485517,0.968,0.631304347826087,-0.706873571932924,51428.1873278237,34485.6143250689,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_489491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
490322,2187.87084870849,371.19557195572,160.745387453875,660.564575645756,3078.73431734317,2673.80442804428,1622.82656826568,258.110701107011,1112.9667896679,4860.13653136531,1492.67527675277,125.937269372694,1070.54612546125,723.051660516605,526.970479704797,339.040590405904,1589.32472324723,1183.26199261993,317.520295202952,241.859778597786,1029.85608856089,1135.77121771218,220.409594095941,154.505535055351,659.837638376384,2230.46494464945,550.077490774908,317.169741697417,1209.0405904059,131.708487084871,271,21.5304759442062,16.018495506626,0.668188852743198,0.967857142857143,0.806547619047619,-0.188968372961186,50976.4907749077,33793.0885608856,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_490322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
491627,2823.77288135593,278.471186440678,120.857627118644,665.24406779661,2168.49152542373,2675.82711864407,1593.68813559322,271.027118644068,1109.42372881356,4419.16949152542,580.254237288136,112.186440677966,1078.54915254237,732.559322033898,577.677966101695,418.898305084746,1507.58644067797,1071.11525423729,301.383050847458,235.338983050847,997.95593220339,1038.97288135593,233.35593220339,183.081355932203,583.657627118644,1413.65423728814,446.928813559322,1293.14915254237,1050.59661016949,130.267796610169,295,22.1733480487742,17.0433443493218,0.639680402896492,0.954692556634304,0.744949494949495,1.47876845528359,51102.5220338983,35613.0101694915,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_491627,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
491633,2201.12610619469,262.130530973451,112.577433628319,636.287610619469,1807.78318584071,2156.35619469027,1568.03539823009,266.477876106195,1091.26769911504,4054.84734513274,2558.94690265487,113.980088495575,1080.11283185841,1067.03982300885,504.095132743363,284.599557522124,1558.00221238938,1791.63053097345,258.896017699115,225.119469026549,1325.92256637168,1959.36504424779,204.466814159292,239.497787610619,1263.21681415929,1521.72345132743,464.194690265487,779.048672566372,1070.5,129.504424778761,452,31.6955809581746,18.3917222275201,0.814430295330553,0.961702127659574,0.753333333333333,1.30479490951539,51559.5597345133,35649.8716814159,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_491633,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
491649,2107.64024390244,314.890243902439,460.024390243902,605.591463414634,670.091463414634,1832.90243902439,370.926829268293,257.268292682927,1118.87804878049,4149.48170731707,587.914634146341,106.219512195122,1069.51829268293,6052.42682926829,1051.81097560976,532.676829268293,2392.64634146341,3842.19512195122,454.042682926829,251.219512195122,1041.57926829268,2616.85975609756,271.164634146341,217.865853658537,586.225609756098,2266.63414634146,500.59756097561,265.926829268293,1024.2743902439,129.871951219512,164,19.3865861850565,10.8677470663236,0.82809976467589,0.942528735632184,0.784688995215311,-0.0478587028290766,51454.2256097561,35716.6280487805,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_491649,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
491877,3234.50595238095,841.580357142857,1450.01488095238,708.636904761905,4925.6369047619,2477.47619047619,409.080357142857,264.60119047619,1109.53273809524,4747.05654761905,538.696428571429,120.214285714286,1080.1130952381,878.0625,471.46130952381,291.282738095238,1457.0505952381,1477.23511904762,335.520833333333,241.732142857143,979.77380952381,1740.92261904762,247.559523809524,175.66369047619,612.360119047619,1133.21130952381,505.580357142857,284.714285714286,1041.5119047619,131.985119047619,336,30.2338513894921,14.1878433559278,0.883054667383102,0.949152542372881,0.6,-1.05989286263974,51933.3363095238,35242.8363095238,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_491877,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
492740,1673.82178217822,734.118811881188,421.727722772277,651.519801980198,2809.9702970297,1705.05940594059,407.821782178218,256.019801980198,1114.76732673267,3484.35643564356,480.262376237624,105.80198019802,1067.61881188119,1144.79702970297,776.722772277228,1109.51485148515,6355.17821782178,1933.67326732673,325.747524752475,236.663366336634,1020.95544554455,1511.20297029703,269.158415841584,302.193069306931,667.950495049505,1946.41089108911,494.430693069307,232.163366336634,1064.39108910891,129.732673267327,202,19.2999983759321,13.3206190995701,0.723630506316534,0.966507177033493,0.817813765182186,-0.122493232191043,51383.8415841584,35727.9801980198,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_492740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
492874,3235.86184210526,437.013157894737,238.526315789474,699.210526315789,4184.84210526316,3334.71052631579,372.394736842105,267.671052631579,1081.61184210526,5986.6447368421,741.032894736842,124.703947368421,1067.125,2090.68421052632,654.467105263158,304.118421052632,1834.23684210526,1740.53289473684,384.105263157895,245.940789473684,1036.66447368421,1356.58552631579,229.66447368421,142.625,588.289473684211,1756.74342105263,510.118421052632,291.901315789474,1091.47368421053,129.631578947368,152,20.3602844521542,9.52873376508498,0.883725327153566,0.938271604938272,0.666666666666667,0.406238238961263,50532.6447368421,34232.5263157895,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_492874,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
493154,2201.84168865435,668.366754617414,73.7651715039578,616.891820580475,887.071240105541,2497.96042216359,650.20580474934,252.055408970976,1156.61213720317,3763.39577836412,612.656992084433,109.02110817942,1071.27176781003,1447.49604221636,1035.81794195251,667.514511873351,1716.58575197889,2049.01055408971,373.976253298153,245.941952506596,1016.2981530343,1791.44591029024,269.598944591029,1131.59102902375,688.54617414248,1069.74406332454,456.308707124011,278.691292875989,1035.45646437995,130.498680738786,379,25.114871838913,19.356314234319,0.637184566059851,0.964376590330789,0.689090909090909,-0.896975250836204,50496.7150395778,34287.5013192612,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_493154,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
493294,2993.97805642633,825.319749216301,95.0689655172414,634.05329153605,1711.91222570533,3384.58934169279,529.363636363636,259.084639498433,1094.66457680251,6239.85893416928,530.689655172414,113.416927899687,1092.3605015674,3361.20062695925,829.909090909091,586.479623824451,1657.20689655172,1842.03134796238,293.435736677116,234.420062695925,1006.80564263323,1845.1473354232,226.225705329154,194.996865203762,609.213166144201,2072.13479623824,502.228840125392,253.426332288401,1049.6394984326,129.109717868339,319,23.7790641901234,17.6402914249925,0.670575510085991,0.943786982248521,0.729977116704805,1.18458066546239,51337.8777429467,35111.8181818182,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_493294,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
494109,2173.81716417911,177.714552238806,97.2164179104478,639.253731343284,2121.11380597015,2773.28917910448,359.582089552239,255.345149253731,1089.73134328358,4635.05970149254,581.184701492537,115.807835820896,1075.44402985075,2017.96082089552,974.897388059702,1502.01305970149,1873.68656716418,2454.75186567164,354.035447761194,235.779850746269,1042.76679104478,2046.70335820896,318.914179104478,1761.76305970149,643.319029850746,1951.78731343284,540.477611940299,232.578358208955,1048.04850746269,129.886194029851,536,37.1742853518135,18.709223075105,0.864121064490198,0.945326278659612,0.66583850931677,0.342661154995164,51209.2742537314,34310.6492537313,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_494109,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
495335,4401.70714285714,1079.375,1121.73214285714,680.921428571429,4964.52857142857,4618.80714285714,407.014285714286,278.196428571429,1125.44285714286,6501.39285714286,542.228571428571,143.892857142857,1103.08214285714,3268.88214285714,1375.60714285714,2001.43571428571,2608.21071428571,2951.08214285714,385.15,243.035714285714,1047.58214285714,2147.01071428571,258.978571428571,339.446428571429,657.585714285714,1791.51071428571,537.625,239.467857142857,1063.41428571429,132.703571428571,280,25.8294233481432,14.0835869051403,0.838271123372365,0.952380952380952,0.636363636363636,-0.927320240014694,50915.0607142857,35848.7035714286,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_495335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
495611,1292.54368932039,257.495145631068,105.255663430421,614.715210355987,1287.35922330097,1547.26860841424,555.799352750809,257.757281553398,1081.88349514563,2974.60841423948,711.974110032362,106.46925566343,1072.91262135922,1542.88673139159,1593.3074433657,1513.28155339806,1765.79611650485,3138.20388349515,348.766990291262,242.11003236246,1047.56957928803,3376.53398058252,246.381877022654,900.26213592233,650.611650485437,1390.70226537217,481.666666666667,277.708737864078,1012.92556634304,129.135922330097,309,27.6478246493912,14.2429066171029,0.85709721873586,0.962616822429906,0.673202614379085,0.415402002213427,51677.8381877023,35051.8058252427,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_495611,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
495876,1268.87878787879,156.683982683983,95.8939393939394,645.668831168831,2386.53896103896,1246.65151515152,365.073593073593,251.188311688312,1092.7619047619,2406.76623376623,456.493506493507,108.383116883117,1080.68181818182,1112.69047619048,546.147186147186,283.562770562771,1620.170995671,1695.14285714286,333.136363636364,236.835497835498,985.71645021645,1564.84415584416,238.61038961039,156.915584415584,590.541125541126,850.829004329004,397.733766233766,210.84632034632,1019.36147186147,129.238095238095,462,30.9248353174107,19.1359967656182,0.785555993406871,0.960498960498961,0.717391304347826,-1.09280687172586,51436.2878787879,35438.1515151515,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_495876,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
496009,1532.11082474227,307.324742268041,98.9072164948454,635.698453608247,1503.81958762887,1704.99484536082,1980.11855670103,261.80412371134,1090.2293814433,2665.76030927835,3963.47422680412,111.94587628866,1066.55412371134,700.523195876289,493.824742268041,380.298969072165,1488.12628865979,1088.21391752577,304.871134020619,230.525773195876,1021.59536082474,1035.26804123711,230.381443298969,185.881443298969,601.755154639175,1006.28608247423,424.229381443299,589.479381443299,1056.13659793814,130.981958762887,388,29.5596073372778,16.7665142305029,0.823572982173946,0.958024691358025,0.743295019157088,0.276325562864532,50220.0231958763,35217.6417525773,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_496009,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
496190,1278.14634146341,406.570731707317,123.829268292683,656.536585365854,3987.02926829268,1349.90731707317,589.975609756098,266.892682926829,1089.77073170732,2081.13658536585,571.409756097561,111.6,1066.5512195122,1901.19024390244,1036.79512195122,409.663414634146,2121.2487804878,1669.70243902439,296.434146341463,227.268292682927,1043.51707317073,1282.72682926829,212.575609756098,615.434146341463,644.282926829268,1079.56097560976,472.380487804878,230.2,1050.56097560976,128.682926829268,205,17.2279658369845,15.5960046446833,0.424831262733874,0.940366972477064,0.753676470588235,-0.853111124233899,50792.1219512195,35400.7609756098,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_496190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
496200,1838.24712643678,502.925287356322,126.258620689655,653.247126436782,2442.86781609195,2016.86206896552,483.781609195402,271.770114942529,1137.54597701149,3051.86781609195,638.477011494253,117.149425287356,1075.35057471264,1050.94252873563,652.597701149425,279.948275862069,1734.52298850575,1501.95977011494,294.471264367816,229.172413793103,1074.99425287356,1535.21264367816,214.172413793103,216.264367816092,6688.95402298851,1245.74712643678,455.862068965517,253.522988505747,1055.41954022989,130.166666666667,174,17.3270308357175,12.8671239247627,0.669730669048155,0.940540540540541,0.743589743589744,-0.0440730752046328,50825.0977011494,35530.8505747126,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_496200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
496241,1354.68181818182,133.609090909091,71.5,630.068181818182,1125.10454545455,1415.98181818182,1200.76818181818,251.481818181818,1094.84545454545,3181.39090909091,1309.79545454545,105.540909090909,1069.88636363636,1380.61363636364,476.877272727273,272.627272727273,2346.50454545455,1276.56818181818,292.531818181818,226.15,1062.40909090909,1103.9,219.654545454545,137.004545454545,2604.77272727273,1753.75909090909,514.7,624.468181818182,1089.60454545455,129.004545454545,220,21.141376641394,13.2754621835196,0.778263808849443,0.936170212765958,0.748299319727891,0.138511943705686,50268.7409090909,35086.2636363636,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_496241,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
496398,1454.72666666667,90.16,213.953333333333,704.133333333333,6112.24666666667,1216.65333333333,662.6,269.52,1084.04,3083.12,668.3,112.033333333333,1083.12,779.393333333333,483.333333333333,338.273333333333,1512.97333333333,1147.66,265.426666666667,228.433333333333,1003.81333333333,1181.86666666667,221.52,198.446666666667,580.106666666667,2013.46666666667,483.84,365.833333333333,1056.22666666667,128.546666666667,150,14.37800143698,13.3737058443625,0.367178386199426,0.949367088607595,0.714285714285714,0.831081532393908,51178.62,35618.3,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_496398,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
497418,1914.48780487805,276.443902439024,235.858536585366,616.673170731707,1084.16097560976,1826.45853658537,472.146341463415,249.775609756098,1082.76585365854,3625.51707317073,436.068292682927,111.975609756098,1066.29756097561,6028.27317073171,1005.43902439024,541.30243902439,2918.17073170732,6026.25365853659,448.336585365854,263.019512195122,1046.21951219512,6159.54634146342,296.278048780488,421.843902439024,695.590243902439,1591.96585365854,431.946341463415,224.034146341463,1021.50731707317,128.658536585366,205,20.19538377405,13.0667508618472,0.762475816588589,0.962441314553991,0.719298245614035,-0.41977520921401,51382.7707317073,35794.156097561,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_497418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
497597,1871.08435852373,372.898066783831,220.497363796134,699.906854130053,5797.9086115993,2280.5553602812,366.905096660808,264.731107205624,1093.80492091388,3098.32864674868,705.583479789104,132.539543057996,1070.56239015817,623.314586994728,492.142355008787,280.059753954306,1458.61159929701,924.929701230228,293.862917398946,233.91388400703,988.637961335677,984.108963093146,228.702987697715,150.497363796134,608.681898066784,1291.26362038664,530.425307557118,226.128295254833,1046.77680140598,133.015817223199,569,30.1460737840174,24.7701994872751,0.569959928773179,0.956302521008403,0.700738916256158,-0.515636634310084,50815.6555360281,33739.5623901582,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
498045,1469.33798882682,127.472067039106,131.821229050279,671.075418994413,3848.46089385475,1434.71787709497,435.608938547486,263.804469273743,1090.98603351955,2638.18156424581,609.231843575419,117.298882681564,1067.88826815642,1635.19273743017,515.435754189944,437.016759776536,1727.29888268156,2483.44413407821,271.675977653631,225.59217877095,1015.47206703911,2264.6061452514,231.784916201117,161.891061452514,586.829608938547,1124.24301675978,500.648044692737,293.583798882682,1038.80446927374,129.268156424581,358,32.2123086489662,14.1590903538215,0.898215539642628,0.96236559139785,0.602693602693603,0.922304760185767,51649.9832402235,35165.4581005587,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_498045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
498591,2864.50636942675,274.216560509554,101.968152866242,633.694267515924,1312.04458598726,3588.18789808917,350.643312101911,266.006369426752,1086.52229299363,5486.14331210191,618.509554140127,125.085987261146,1071.36305732484,615.398089171975,438.18152866242,266.168789808917,1460.77070063694,929.694267515924,298.910828025478,236.449044585987,989.06050955414,870.050955414013,207.920382165605,134.624203821656,588.194267515924,2049.63057324841,541.649681528662,228.71974522293,1053.84713375796,129.894904458599,314,30.7140607218621,13.4565275791111,0.898915173559207,0.931750741839763,0.590225563909774,-1.06409657352833,51299.1242038217,34495.4267515924,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_498591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
498636,2396.29612756264,217.578587699317,152.261958997722,680.093394077449,3687.22323462415,2664.13895216401,347.936218678815,272.917995444191,1099.37357630979,4706.75170842825,600.692482915718,123.047835990888,1066.97494305239,718.949886104784,488.061503416857,325.924829157175,1490.74715261959,1066.86332574032,286.949886104784,229.177676537585,993.904328018223,1044.96583143508,215.086560364465,161.854214123007,602.656036446469,1566.69703872437,469.485193621868,251.911161731207,1079.35307517084,130.50569476082,439,27.3370883638069,20.6066618666423,0.657105401786588,0.956427015250545,0.746598639455782,-1.47977708677684,50729.264236902,35375.1845102506,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_498636,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
499309,2498.795221843,161.965870307167,70.2525597269625,618.58361774744,672.945392491468,2641.2662116041,1685.46416382253,261.59385665529,1095.44709897611,4211.71672354949,762.255972696246,130.40614334471,1071.99317406143,1165.56313993174,540.501706484642,297.303754266212,1521.77815699659,2747.35153583618,336.522184300341,241.19795221843,997.081911262799,3112.21160409556,253.453924914676,187.266211604096,580.18771331058,1311.92832764505,431.047781569966,280.552901023891,1025.99317406143,129.245733788396,293,26.6700920384687,14.0474871037244,0.85004311682345,0.942122186495177,0.606625258799172,0.820864741777999,50867.2252559727,35857.6040955631,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499309,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
499866,2760.7,721.28,176.38,641.276,2017.6,2652.356,475.528,258.52,1112.108,5347.844,494.812,113.684,1083.116,1200.42,557.18,338.688,1640.988,1324.516,330.752,236.508,1014.292,1155.868,234.44,207.936,592.944,2489.18,509.988,233.78,1050.76,129.28,250,22.9921647983445,13.878581119328,0.797270492721956,0.954198473282443,0.700280112044818,1.02602941533099,51473.0,35708.172,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_499866,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
500040,3191.87566137566,378.846560846561,95.7619047619048,638.140211640212,2031.10317460317,3930.73544973545,2900.51058201058,267.084656084656,1099.87037037037,5755.7037037037,1512.03439153439,130.256613756614,1080.41798941799,543.740740740741,420.791005291005,260.031746031746,1448.20105820106,902.010582010582,258.251322751323,227.933862433862,981.719576719577,958.134920634921,204.457671957672,133.198412698413,584.849206349206,1865.14814814815,528.706349206349,390.230158730159,1059.28042328042,131.185185185185,378,24.8965603887298,19.3937373686942,0.627058012906171,0.964285714285714,0.78099173553719,0.860952234938507,50845.2566137566,34465.6375661376,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500040,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
500113,1312.91079812207,585.676056338028,322.845070422535,603.107981220657,483.835680751174,1186.73708920188,609.49765258216,267.399061032864,1086.97183098592,1759.90610328638,533.323943661972,172.328638497653,1067.34272300469,696.056338028169,504.018779342723,338.408450704225,1503.58215962441,1018.54929577465,276.291079812207,228.169014084507,995.774647887324,963.286384976526,212.765258215962,145.49765258216,595.830985915493,968.62441314554,539.516431924883,238.929577464789,1005.32394366197,131.93896713615,213,21.8826288353727,12.4312790966049,0.8229671761467,0.950892857142857,0.744755244755245,-1.38211051033456,51608.2394366197,35092.6948356807,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
500603,831.793349168646,472.714964370546,150.365795724466,645.023752969121,1414.57957244656,715.534441805226,332.809976247031,250.577197149644,1108.83610451306,1553.73634204276,638.679334916865,119.591448931116,1066.72921615202,693.733966745843,424.66270783848,268.788598574822,1476.34441805226,826.957244655582,204.472684085511,220.173396674584,1105.45605700713,637.479809976247,141.95486935867,121.589073634204,584.581947743468,715.225653206651,421.406175771972,210.593824228028,1023.80285035629,131.137767220903,421,31.1404781660334,18.0410571096503,0.815082961858333,0.935555555555556,0.623703703703704,-0.726817743498507,51300.567695962,33972.8527315914,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
500851,1604.62334217507,300.62599469496,203.742705570292,691.010610079576,4513.2599469496,1996.0,383.994694960212,274.798408488064,1108.19893899204,2895.25198938992,599.644562334218,123.827586206897,1082.63395225464,1829.58620689655,561.801061007958,1124.76923076923,1512.80636604775,2915.53580901857,409.114058355438,2318.6976127321,1020.50132625995,1983.67374005305,313.082228116711,429.681697612732,617.941644562334,1160.20689655172,516.519893899204,222.145888594164,1037.05039787798,129.06100795756,377,24.6437458696911,19.6712017344792,0.602362215136864,0.971649484536082,0.748015873015873,0.493378106760645,50684.8567639257,35096.3846153846,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
501057,1310.18272425249,115.883720930233,171.85049833887,714.169435215947,6285.66777408638,1391.2292358804,327.382059800664,264.883720930233,1102.78405315615,3018.55481727575,744.950166112957,127.299003322259,1068.97674418605,1516.34551495017,705.843853820598,368.395348837209,3792.3122923588,1517.58803986711,252.059800664452,219.425249169435,1009.8073089701,998.647840531561,177.159468438538,145.910299003322,602.823920265781,1565.46179401993,452.847176079734,258.598006644518,1065.45514950166,130.09634551495,301,26.2038046533724,14.6924323968099,0.828020083779341,0.949526813880126,0.696759259259259,0.441750463856901,50747.3920265781,35397.9335548173,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_501057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
501240,3629.3038869258,610.876325088339,255.86925795053,612.636042402827,621.335689045936,3404.47349823322,1677.36749116608,276.04593639576,1088.55477031802,7111.04946996466,1064.55830388693,115.780918727915,1076.21908127208,2150.64664310954,1128.71024734982,1563.47703180212,1843.6925795053,4693.16961130742,413.904593639576,286.826855123675,1039.14134275618,4524.3851590106,286.897526501767,332.689045936396,940.363957597173,3492.7667844523,570.049469964664,279.424028268551,1046.32862190813,130.098939929329,283,27.0354232008204,13.5184112926213,0.866010461113722,0.943333333333333,0.612554112554113,0.849835330838195,51867.0989399293,35438.1554770318,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_501240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
501917,2329.46979865772,723.073825503356,300.758389261745,634.93288590604,1436.22147651007,2849.22818791946,1556.61073825503,268.020134228188,1110.72483221477,5413.30201342282,797.89932885906,111.040268456376,1069.18120805369,767.03355704698,634.147651006711,286.912751677852,1603.61073825503,1425.44295302013,353.758389261745,240.402684563758,995.536912751678,1301.70469798658,237.51677852349,205.630872483221,583.020134228188,2287.93288590604,538.234899328859,255.671140939597,1057.27516778523,131.469798657718,149,14.6722126413478,12.9663627736159,0.467985737652192,0.955128205128205,0.760204081632653,1.02752464213877,51060.6979865772,35085.2953020134,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_501917,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
501928,1787.37201365188,173.167235494881,104.0204778157,634.477815699659,1791.40273037543,1825.32764505119,349.559726962457,260.98976109215,1090.46416382253,3303.40273037543,488.327645051195,109.870307167235,1080.19795221843,780.587030716724,440.102389078498,279.18771331058,1473.37542662116,1279.67576791809,319.819112627986,234.587030716724,987.174061433447,1475.61433447099,230.440273037543,178.327645051195,581.286689419795,1187.31740614334,425.122866894198,299.918088737201,1025.60068259386,130.030716723549,293,23.318296666237,16.0698377256885,0.72461734229696,0.942122186495177,0.749360613810742,-0.239373573594259,50794.9829351536,35704.1501706485,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_501928,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
502092,1831.10067114094,115.812080536913,81.7919463087248,649.926174496644,2356.03355704698,1900.44295302013,808.791946308725,257.812080536913,1101.94630872483,2839.26174496644,537.523489932886,120.624161073826,1067.51006711409,2813.80536912752,823.577181208054,340.41610738255,1948.81208053691,2640.6644295302,346.127516778523,612.744966442953,1040.09395973154,2273.68456375839,250.389261744966,525.637583892617,636.476510067114,1088.1610738255,463.691275167785,356.436241610738,1037.48993288591,130.328859060403,149,15.4784117972885,12.3718512435062,0.600935922219419,0.973856209150327,0.827777777777778,-0.215351574563624,51377.9261744966,35817.255033557,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_502092,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
502403,4290.29113924051,828.832278481013,151.775316455696,641.901898734177,1958.1582278481,4689.83544303797,1079.99367088608,288.094936708861,1115.51898734177,6674.95569620253,1125.21518987342,122.243670886076,1092.81012658228,804.784810126582,556.471518987342,299.76582278481,1465.29430379747,1193.67405063291,343.949367088608,244.993670886076,996.455696202532,1127.3417721519,257.813291139241,155.477848101266,666.841772151899,1605.36392405063,501.231012658228,456.411392405063,1176.05063291139,133.835443037975,316,24.6309629952078,16.6685073036243,0.736231446292892,0.943283582089552,0.774509803921569,0.164384928170761,50945.25,35320.8417721519,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_502403,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
503413,3300.08080808081,261.313131313131,118.535353535354,641.888888888889,1951.14141414141,4384.13131313131,974.09595959596,281.040404040404,1108.64646464646,5313.40909090909,1191.94444444444,143.383838383838,1074.39393939394,695.984848484848,456.222222222222,272.929292929293,1481.11111111111,1050.28787878788,281.59595959596,232.338383838384,1001.87373737374,1043.22727272727,205.267676767677,130.767676767677,917.106060606061,1071.59090909091,472.656565656566,225.979797979798,1067.93939393939,130.590909090909,198,19.086491474788,13.3375757294055,0.715320406487701,0.970588235294118,0.801619433198381,0.14919087198991,51070.5757575758,33932.095959596,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_503413,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
503662,3221.12432432432,465.908108108108,132.924324324324,623.691891891892,797.540540540541,4076.5027027027,1296.56216216216,293.405405405405,1093.65405405405,4942.68108108108,818.421621621622,123.837837837838,1066.22702702703,716.967567567568,545.556756756757,277.221621621622,1466.33513513514,1015.19459459459,275.708108108108,227.475675675676,1002.48648648649,954.145945945946,215.4,134.648648648649,581.654054054054,1671.24324324324,544.032432432432,439.145945945946,1051.48648648649,130.054054054054,185,21.619322230801,10.9639890229183,0.861864616989718,0.939086294416244,0.764462809917355,-0.063295335049331,50428.9891891892,35255.7945945946,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_503662,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
503887,2438.20338983051,315.118644067797,163.576271186441,637.966101694915,2144.30508474576,2215.9406779661,310.279661016949,262.991525423729,1093.29661016949,4661.00847457627,489.78813559322,117.322033898305,1066.21186440678,655.254237288136,475.28813559322,273.64406779661,1466.65254237288,1124.16101694915,348.381355932203,241.78813559322,977.313559322034,1227.87288135593,291.508474576271,178.432203389831,589.576271186441,2921.26271186441,487.703389830508,213.364406779661,1038.4406779661,128.745762711864,118,14.7637727081285,10.3523387574807,0.712965870863914,0.951612903225806,0.766233766233766,-0.323222212098183,50405.7711864407,35683.4406779661,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_503887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
504563,4143.8277027027,510.962837837838,144.543918918919,682.760135135135,4214.44932432432,4924.69256756757,1623.25337837838,282.608108108108,1129.98986486486,7991.6722972973,3132.68581081081,122.996621621622,1091.63513513514,678.621621621622,456.722972972973,270.239864864865,1412.73986486486,1076.98648648649,295.60472972973,231.675675675676,987.175675675676,1033.19594594595,220.41554054054,134.658783783784,602.449324324324,3265.52364864865,548.016891891892,397.293918918919,1084.84121621622,132.652027027027,296,26.442543383335,14.3414446467425,0.840144564600163,0.936708860759494,0.711538461538462,1.41497788782694,50834.6486486486,35234.7668918919,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_504563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
504632,1494.48238482385,156.872628726287,195.029810298103,712.653116531165,6692.59891598916,1671.49593495935,315.514905149052,266.907859078591,1097.56097560976,3236.55826558266,569.468834688347,119.227642276423,1073.48238482385,826.330623306233,565.932249322493,291.894308943089,2012.59349593496,1210.31436314363,319.476964769648,235.070460704607,1012.0352303523,1111.9918699187,229.027100271003,203.59891598916,2067.79674796748,1512.12737127371,439.040650406504,238.978319783198,1074.0460704607,129.246612466125,369,26.6567258478945,17.7814821920546,0.745009148503541,0.958441558441558,0.698863636363636,-0.895173333098536,50778.2059620596,35488.6151761518,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_504632,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
505057,518.629573170732,787.205792682927,187.987804878049,612.591463414634,100.949695121951,531.137195121951,376.943597560976,257.788109756098,1115.48780487805,989.38262195122,1685.75457317073,106.408536585366,1061.84908536585,2524.9862804878,742.280487804878,321.658536585366,2078.75,2637.56554878049,366.352134146341,242.018292682927,1058.75,1486.56707317073,3352.80335365854,174.846036585366,3946.11432926829,571.690548780488,375.317073170732,202.3125,985.048780487805,129.989329268293,656,38.4902767515978,21.8132266875888,0.823910152632921,0.968980797636632,0.784688995215311,0.0977161288735002,51448.1036585366,34068.3597560976,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_505057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
505320,3397.90058479532,700.754385964912,136.397660818713,668.06432748538,4033.49707602339,3412.66081871345,456.847953216374,274.163742690058,1264.53801169591,4310.97076023392,568.280701754386,116.865497076023,1083.98830409357,3954.39766081871,927.280701754386,840.543859649123,2136.70175438596,3589.57894736842,407.169590643275,234.426900584795,1091.30994152047,2539.44444444444,316.345029239766,975.602339181286,751.216374269006,1166.4269005848,483.245614035088,366.982456140351,1033.36257309942,130.33918128655,171,16.7391462315178,13.2213784408731,0.613302857240646,0.93956043956044,0.763392857142857,-0.252688976828822,51354.1403508772,35665.4444444444,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_505320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
506307,1996.52960526316,283.197368421053,144.296052631579,641.865131578947,2158.6875,2254.09868421053,340.496710526316,257.654605263158,1102.22039473684,3700.01644736842,487.289473684211,110.013157894737,1110.73355263158,3549.55263157895,794.177631578947,335.384868421053,1608.81578947368,3459.55592105263,324.907894736842,235.25,997.832236842105,3312.25328947368,229.690789473684,145.154605263158,595.746710526316,1640.75,496.842105263158,234.342105263158,1037.10855263158,129.598684210526,304,29.0665052882749,13.6478936700367,0.882911076750895,0.947040498442368,0.748768472906404,-0.103080484025974,51395.0394736842,35046.7302631579,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_506307,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
506485,1337.98662207358,159.301003344482,49.3478260869565,615.020066889632,778.301003344482,1305.40468227425,1632.6889632107,255.321070234114,1093.11036789298,2231.30434782609,488.080267558528,101.725752508361,1068.5652173913,4276.18394648829,870.518394648829,579.063545150502,2750.83946488294,5269.05351170569,474.729096989967,247.792642140468,1065.6889632107,4877.35785953177,276.56856187291,240.347826086957,600.789297658863,953.274247491639,414.321070234114,973.722408026756,1013.4347826087,129.76254180602,299,21.8244939889532,17.5548384100127,0.594136745559854,0.958333333333333,0.711904761904762,0.792374652859959,51040.8695652174,35647.6889632107,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_506485,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
506786,1684.78163771712,271.275434243176,133.493796526055,637.684863523573,2137.38461538462,1999.60049627792,578.260545905707,262.560794044665,1095.32754342432,2920.25558312655,738.627791563275,116.870967741935,1088.3746898263,2401.66004962779,1237.84367245658,1731.07692307692,2354.40446650124,1793.40694789082,345.652605459057,240.29776674938,1023.62034739454,1319.57320099256,231.786600496278,182.109181141439,680.446650124069,1234.24813895782,507.292803970223,253.285359801489,1026.19106699752,130.320099255583,403,28.4666251541708,18.1264783866252,0.771060026144282,0.9618138424821,0.799603174603175,-0.205772335457139,51959.4243176179,34452.9305210918,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_506786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
507487,3547.99090909091,919.569696969697,97.6030303030303,639.224242424242,1612.28484848485,4509.67878787879,591.712121212121,276.315151515152,1141.01515151515,6737.75151515152,685.457575757576,118.260606060606,1077.48484848485,717.248484848485,477.727272727273,276.442424242424,1460.16363636364,1047.13333333333,288.606060606061,232.909090909091,987.930303030303,968.618181818182,213.257575757576,160.09696969697,614.845454545455,2753.03939393939,546.193939393939,248.245454545454,1078.45757575758,132.272727272727,330,28.6962431942194,14.8475128717161,0.855742061727327,0.951008645533141,0.705128205128205,-1.18016886238897,51547.9848484848,35490.9939393939,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_507487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
508194,1716.78761061947,193.522123893805,80.4955752212389,628.864306784661,1661.02359882006,1970.16519174041,1759.26548672566,259.0,1110.74336283186,3186.1592920354,2561.71386430678,111.171091445428,1080.74631268437,2518.64896755162,742.150442477876,649.646017699115,2339.50737463127,3040.53982300885,371.899705014749,248.079646017699,1013.24778761062,2859.63126843658,247.238938053097,188.486725663717,662.77581120944,1442.6784660767,509.109144542773,509.194690265487,1052.82890855457,129.525073746313,339,23.0991907153354,18.7467390017715,0.584247451867534,0.963068181818182,0.811004784688995,0.296065674586865,51701.1474926254,34930.5221238938,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_508194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
509314,2212.29597701149,238.715517241379,142.419540229885,666.433908045977,3566.90804597701,2534.0316091954,353.758620689655,268.114942528736,1097.0,4420.13505747126,613.224137931035,120.735632183908,1125.55747126437,503.264367816092,522.548850574713,258.408045977012,1530.49712643678,856.620689655172,241.479885057471,223.26724137931,996.57183908046,800.454022988506,183.152298850575,141.727011494253,580.324712643678,2029.73563218391,556.591954022988,231.591954022988,1072.69540229885,131.227011494253,348,24.3899663887534,18.5067304832451,0.651341658525273,0.969359331476323,0.805555555555556,1.31187123511573,51553.5833333333,34772.9281609195,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_509314,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
509799,3616.55805892548,1347.09358752166,167.415944540728,720.324090121317,4474.96360485269,4095.57712305026,1632.71750433276,285.530329289428,1134.20103986135,5023.9445407279,1011.58232235702,130.622183708839,1090.88388214905,3643.30155979203,1722.55285961872,1713.80589254766,1812.3431542461,3583.79202772964,382.584055459272,240.956672443674,1039.11958405546,3345.89428076256,243.538994800693,358.726169844021,890.78856152513,1771.57712305026,577.461005199307,297.459272097054,1090.76949740035,133.129982668977,577,29.0115604420752,25.9147568620513,0.449547909175574,0.969747899159664,0.792582417582418,0.877900955519064,50564.8180242634,35040.7590987868,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_509799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
510801,2556.54042553191,798.089361702128,475.544680851064,617.978723404255,1108.22978723404,2498.88510638298,1730.28510638298,268.434042553191,1106.76595744681,5862.85531914894,627.965957446808,118.83829787234,1073.02978723404,828.697872340426,931.182978723404,283.123404255319,1725.3914893617,1167.73617021277,321.621276595745,236.906382978723,994.846808510638,1084.71914893617,231.251063829787,192.936170212766,589.306382978723,3312.64680851064,588.56170212766,287.36170212766,1057.05531914894,129.263829787234,235,22.7916010031942,13.3810991894329,0.80950963534825,0.94758064516129,0.762987012987013,-1.36214114094567,51658.1957446809,35387.8085106383,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_510801,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
511255,5005.72509960159,1027.46215139442,2191.25099601594,641.772908366534,1841.08764940239,5454.19920318725,646.796812749004,282.96812749004,1109.23505976096,7987.3187250996,623.450199203187,120.067729083665,1074.20717131474,2143.41832669323,939.553784860558,1332.47410358566,1771.38645418327,1397.72111553785,300.358565737052,232.362549800797,1026.26294820717,1069.74103585657,220.00796812749,230.685258964143,739.972111553785,2584.59760956175,536.115537848606,304.227091633466,1059.23505976096,129.179282868526,251,21.3224059378379,15.1574220511709,0.703325164755082,0.943609022556391,0.733918128654971,0.530153884206393,51045.8247011952,35586.1394422311,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_511255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
511709,2328.88141025641,208.480769230769,123.740384615385,665.387820512821,2378.07051282051,2734.52884615385,1482.71153846154,267.278846153846,1151.38782051282,4141.52243589744,541.192307692308,131.983974358974,1082.08333333333,1640.32692307692,589.333333333333,352.778846153846,1729.29487179487,2066.09615384615,372.24358974359,240.294871794872,1002.20833333333,1853.99679487179,257.833333333333,316.240384615385,586.871794871795,1770.36217948718,460.076923076923,1274.62820512821,1072.63782051282,131.173076923077,312,21.558855265713,18.6437971064349,0.502140520444354,0.96,0.746411483253589,-1.4740024937813,51079.3205128205,35884.3782051282,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_511709,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
511838,1661.47639484979,162.047210300429,76.8412017167382,640.343347639485,2376.87982832618,1934.36480686695,411.755364806867,250.75965665236,1087.36909871245,3108.12875536481,504.356223175966,109.25321888412,1068.48927038627,1279.95278969957,978.06008583691,703.261802575107,2338.0,1002.59656652361,218.175965665236,216.605150214592,1015.00429184549,806.961373390558,169.854077253219,166.854077253219,638.163090128755,1445.22317596567,482.274678111588,221.892703862661,1034.27467811159,130.738197424893,233,23.5661003722456,12.6168592795119,0.844610216098148,0.947154471544715,0.779264214046823,0.10755626040986,51976.5836909871,34331.9871244635,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_511838,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
512935,1011.8303030303,199.69696969697,197.278787878788,690.945454545455,4857.52727272727,989.993939393939,343.042424242424,266.733333333333,1103.4303030303,1853.72727272727,589.054545454545,124.824242424242,1062.13939393939,950.357575757576,690.721212121212,347.775757575758,1740.4303030303,3419.69696969697,362.775757575758,268.169696969697,1042.92727272727,3722.62424242424,259.527272727273,601.757575757576,778.69696969697,1002.78787878788,474.787878787879,233.012121212121,1030.04848484848,129.854545454545,165,18.7273724589739,11.2369165685822,0.799980251763646,0.953757225433526,0.6875,-0.748150689457175,51629.2545454545,35237.1212121212,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_512935,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
513430,3539.21212121212,458.752525252525,156.015151515152,631.272727272727,1572.62626262626,4090.80303030303,1634.78282828283,272.727272727273,1091.70202020202,6021.42929292929,1961.26767676768,116.540404040404,1065.22727272727,790.79797979798,532.020202020202,277.090909090909,1418.24747474747,1233.5303030303,355.530303030303,244.676767676768,982.090909090909,1115.13131313131,236.116161616162,133.106060606061,578.5,1754.38888888889,516.489898989899,289.015151515152,1043.76262626263,131.272727272727,198,23.7916153336408,10.6583633374687,0.894039460681623,0.951923076923077,0.55,0.87590307624875,51362.4646464646,34960.6767676768,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_513430,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
514214,3393.82833787466,712.531335149864,125.901907356948,614.803814713896,605.850136239782,2874.65667574932,491.41961852861,268.877384196185,1095.94822888283,5937.96730245232,596.433242506812,116.550408719346,1076.53678474114,756.49591280654,541.822888283379,287.795640326976,1476.00544959128,1167.31607629428,341.384196185286,241.119891008174,986.803814713896,1120.88555858311,245.212534059946,156.520435967302,588.99727520436,2065.65667574932,484.923705722071,222.850136239782,1042.18528610354,129.653950953678,367,25.8506046320092,18.7395972108729,0.688834006936687,0.950777202072539,0.728174603174603,-0.598537413734722,51513.8610354223,35492.4604904632,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_514214,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
514958,3389.24255319149,209.251063829787,116.995744680851,642.829787234043,1854.0,3804.05957446808,355.974468085106,273.157446808511,1091.4170212766,6238.32765957447,594.029787234043,133.753191489362,1072.5829787234,800.829787234043,790.255319148936,321.663829787234,1616.28510638298,1397.18723404255,354.217021276596,244.540425531915,999.336170212766,1322.90638297872,345.642553191489,259.710638297872,619.221276595745,2776.0170212766,475.744680851064,268.502127659574,1051.68936170213,129.63829787234,235,25.8974129344739,11.8351358506478,0.889466334268487,0.928853754940711,0.601023017902813,-0.500178262372565,50387.5659574468,35483.2680851064,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_514958,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
515953,3052.78402366864,194.399408284024,119.139053254438,650.476331360947,2487.64792899408,3323.04733727811,474.869822485207,266.781065088757,1101.7573964497,5004.54437869823,574.514792899408,114.467455621302,1078.37278106509,786.85798816568,429.58875739645,273.804733727811,2192.08579881657,2032.68639053254,286.792899408284,230.828402366864,1039.12130177515,2362.01775147929,268.355029585799,218.576923076923,655.044378698225,1489.85798816568,489.076923076923,254.150887573964,1048.00887573964,130.896449704142,338,25.3259970155516,17.0161956526018,0.740654118122163,0.957507082152974,0.698347107438017,-0.87495031488585,51611.4408284024,34915.073964497,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_515953,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
516242,3117.81115879828,183.360515021459,115.055793991416,645.223175965665,2406.66094420601,3029.330472103,865.742489270386,268.030042918455,1082.8025751073,4949.32188841202,512.609442060086,125.497854077253,1081.75107296137,723.969957081545,606.836909871245,619.364806866953,1627.57510729614,1846.27896995708,326.437768240343,236.789699570815,1029.12017167382,2019.18884120172,5099.92274678112,247.635193133047,592.223175965665,2366.74248927039,505.223175965665,521.515021459227,1040.24463519313,128.841201716738,233,23.9908455653244,12.5482015516089,0.852307376444697,0.928286852589641,0.622994652406417,0.506462236578334,51066.5493562232,35792.9785407725,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_516242,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
516705,3394.58536585366,321.623306233062,122.024390243902,622.216802168022,779.813008130081,3636.47967479675,853.688346883469,274.80487804878,1089.42005420054,6074.23848238482,675.785907859079,123.907859078591,1071.50406504065,1067.31978319783,491.658536585366,281.078590785908,1542.39024390244,1719.08130081301,290.344173441734,230.972899728997,1049.70460704607,1909.11382113821,225.444444444444,187.008130081301,687.292682926829,1916.89701897019,515.986449864499,244.024390243902,1046.18970189702,130.975609756098,369,25.1915102767146,18.9288115497837,0.659851017668795,0.971052631578947,0.732142857142857,0.446698964839395,50267.6449864499,35115.2574525745,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_516705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
517432,1915.78260869565,93.0186335403727,69.6832298136646,613.44099378882,1002.26708074534,2312.24844720497,334.472049689441,261.950310559006,1080.73913043478,3500.85093167702,474.186335403727,107.478260869565,1066.16770186335,913.478260869565,1162.3850931677,304.11801242236,1572.80745341615,1379.90062111801,305.981366459627,235.583850931677,997.869565217391,1564.84472049689,214.751552795031,166.527950310559,616.621118012422,1367.9751552795,485.223602484472,219.521739130435,1024.04347826087,129.900621118012,161,16.4225553443705,12.5094245564992,0.647903796809103,0.941520467836257,0.774038461538462,0.301938895219419,51088.6335403727,34992.5838509317,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517432,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
517505,1931.19642857143,438.346428571429,120.892857142857,646.471428571429,1914.96785714286,2594.64285714286,2091.77857142857,266.089285714286,1091.53928571429,4233.51785714286,3830.20714285714,110.921428571429,1072.18214285714,665.453571428571,517.735714285714,275.285714285714,1480.34642857143,1015.81785714286,291.539285714286,232.896428571429,993.2,940.196428571429,205.389285714286,146.171428571429,606.439285714286,1674.23571428571,515.142857142857,813.525,1065.62857142857,131.942857142857,280,20.1674309546015,17.9887786484467,0.452091141400499,0.962199312714777,0.777777777777778,0.0850280276842597,51328.925,35044.1,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517505,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
517537,3258.42258064516,329.332258064516,140.270967741935,636.309677419355,2031.70322580645,3722.32903225806,372.364516129032,263.629032258065,1092.61612903226,4191.96774193548,538.767741935484,120.751612903226,1113.12258064516,1328.73548387097,557.261290322581,275.01935483871,1895.59032258065,1461.64193548387,301.435483870968,239.325806451613,1042.01935483871,1278.17741935484,202.035483870968,353.590322580645,1512.91290322581,1065.67096774194,483.658064516129,225.396774193548,1017.51612903226,132.461290322581,310,25.2871287840083,16.2315514188076,0.766796853502829,0.906432748538012,0.662393162393162,1.22214806789531,51199.0580645161,34417.4516129032,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_517537,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
517743,3977.06474820144,239.0,95.1223021582734,649.892086330935,2203.36690647482,4343.53956834532,786.410071942446,273.690647482014,1091.97841726619,6365.88489208633,1025.52517985612,150.064748201439,1075.41007194245,699.424460431655,448.73381294964,280.913669064748,1472.58992805755,1460.86330935252,329.402877697842,243.323741007194,1027.73381294964,1638.21582733813,234.575539568345,147.496402877698,1297.46762589928,1128.87050359712,492.36690647482,226.057553956835,1052.07913669065,129.575539568345,139,17.8534144430271,10.5590810780118,0.806354858871564,0.852760736196319,0.594017094017094,-0.177767214779991,51060.7050359712,33928.381294964,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517743,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
517749,2152.87577639751,371.180124223602,138.39751552795,644.378881987578,2092.92857142857,2257.93167701863,692.655279503106,270.562111801242,1107.47204968944,4242.3602484472,885.326086956522,116.673913043478,1100.39130434783,676.841614906832,488.518633540373,271.003105590062,1519.22360248447,1514.46894409938,312.409937888199,232.624223602484,1015.80745341615,1715.88198757764,228.10248447205,288.891304347826,645.288819875776,1807.39751552795,516.214285714286,280.645962732919,1072.89751552795,130.763975155279,322,28.2741171281186,14.5552833284539,0.857315236277874,0.952662721893491,0.766666666666667,0.0156323528756274,50812.0683229814,35181.9627329193,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517749,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
519705,1866.70472440945,292.704724409449,81.8346456692913,608.889763779528,417.334645669291,1946.53149606299,374.88188976378,264.204724409449,1089.29921259843,4070.85826771654,525.929133858268,112.275590551181,1063.38188976378,3936.04330708661,854.909448818898,742.858267716535,1757.8937007874,4418.03937007874,408.070866141732,248.562992125984,1064.20866141732,3636.65354330709,270.358267716535,478.830708661417,680.925196850394,2530.26377952756,553.566929133858,297.842519685039,1017.46456692913,127.972440944882,254,24.0203651857643,13.5212298237151,0.826520294702079,0.944237918215613,0.636591478696742,0.695389474122901,51901.7992125984,34933.2165354331,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_519705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
520075,1405.35675675676,274.302702702703,103.481081081081,618.32972972973,962.448648648649,1467.63783783784,366.767567567568,252.313513513514,1091.70810810811,2394.03243243243,522.389189189189,110.572972972973,1066.65945945946,708.513513513514,655.572972972973,286.151351351351,1417.58378378378,1089.76756756757,325.675675675676,235.589189189189,984.594594594595,1083.54594594595,240.945945945946,140.113513513514,600.605405405405,1151.36756756757,504.043243243243,224.410810810811,1030.11891891892,129.951351351351,185,21.4217926811155,11.2716638878492,0.8503748048793,0.92964824120603,0.616666666666667,-0.533432620274899,51840.1783783784,34194.4540540541,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_520075,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
520133,3211.50993377483,563.602649006623,201.847682119205,686.496688741722,3714.54304635762,3397.11920529801,2761.80794701987,289.668874172185,1109.99337748344,5607.59602649007,3639.96688741722,127.986754966887,1094.74834437086,638.788079470199,437.390728476821,281.198675496689,1423.72847682119,1089.23178807947,326.834437086093,239.370860927152,988.46357615894,1096.76821192053,243.271523178808,131.483443708609,585.986754966887,1771.11258278146,504.112582781457,498.496688741722,1046.3642384106,131.562913907285,151,16.6002747188732,11.5966835755456,0.71552821428968,0.949685534591195,0.786458333333333,0.196180056104835,50544.3377483444,35392.6556291391,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_520133,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
521589,1627.10849056604,185.264150943396,118.896226415094,642.099056603774,1868.44339622642,1726.18396226415,325.806603773585,263.051886792453,1091.64150943396,3559.74528301887,523.561320754717,110.334905660377,1069.92452830189,1532.66509433962,747.952830188679,349.622641509434,1552.39150943396,3248.96698113208,339.132075471698,238.188679245283,1006.79716981132,4230.13679245283,250.566037735849,259.811320754717,592.528301886792,1549.66509433962,502.377358490566,221.452830188679,1033.08490566038,128.72641509434,212,23.9012340109747,11.4041022208014,0.878830309879422,0.942222222222222,0.588888888888889,0.822454391178091,51898.4622641509,35119.3160377359,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521589,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
521815,2981.86925795053,457.579505300353,64.1519434628975,687.52296819788,3367.02120141343,3333.7703180212,2473.6148409894,286.070671378092,1114.98233215548,4588.84098939929,1809.3109540636,132.212014134276,1081.2332155477,1141.84098939929,864.802120141343,1005.42756183746,1741.98586572438,1339.67491166078,347.208480565371,244.657243816254,1002.46643109541,908.466431095406,214.961130742049,147.978798586572,598.660777385159,597.279151943463,379.339222614841,203.03886925795,988.148409893993,130.342756183746,283,23.6994703876978,15.3546723023619,0.761733103764533,0.946488294314381,0.769021739130435,-0.066764461070731,51754.851590106,34693.9116607774,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
522199,2306.27647058824,997.788235294118,88.0941176470588,638.629411764706,1512.65882352941,2139.31764705882,1113.37058823529,270.617647058824,1081.38823529412,3689.40588235294,1506.50588235294,114.958823529412,1083.63529411765,493.641176470588,367.382352941176,281.070588235294,1526.15882352941,745.582352941177,186.541176470588,209.529411764706,988.0,654.035294117647,164.429411764706,162.952941176471,577.194117647059,1131.50588235294,475.341176470588,399.917647058824,1063.15882352941,131.558823529412,170,19.2453904479944,11.3429580519942,0.807851773910289,0.913978494623656,0.745614035087719,1.42069008602853,51742.3764705882,35398.4882352941,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_522199,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
522243,2303.2912371134,127.829896907216,189.628865979381,715.613402061856,7627.7706185567,2832.89948453608,431.590206185567,277.247422680412,1128.58505154639,3838.76030927835,1472.40206185567,172.211340206186,1070.88659793814,1427.23969072165,794.286082474227,296.329896907216,1759.66494845361,1725.33762886598,292.75,238.734536082474,1457.07216494845,3394.45103092783,281.474226804124,601.118556701031,1593.53092783505,1106.0412371134,525.868556701031,226.20618556701,1089.58762886598,130.703608247423,388,23.7406391472979,20.9196615381301,0.472789947548912,0.962779156327543,0.801652892561983,-0.842402394999225,51016.2783505155,33693.7190721649,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_522243,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
522344,1355.49344978166,107.406113537118,72.7729257641921,658.877729257642,1606.6768558952,1555.63755458515,1160.15283842795,260.14847161572,1084.53711790393,3232.93449781659,540.069868995633,112.318777292576,1090.59825327511,748.580786026201,631.397379912664,448.842794759825,1772.12227074236,1160.10043668122,297.279475982533,231.7903930131,987.454148471616,1145.45414847162,223.131004366812,147.541484716157,591.729257641921,1970.15283842795,561.834061135371,440.882096069869,1036.93449781659,129.615720524017,229,18.6345628055418,15.7075976051549,0.538026141655437,0.96218487394958,0.753289473684211,0.0249788947081211,52005.5676855895,34538.9082969432,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_522344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
523030,2939.70676691729,211.575187969925,139.766917293233,658.052631578947,2882.59022556391,3369.43609022556,1226.75563909774,284.774436090226,1090.30827067669,5144.38721804511,1088.94360902256,119.315789473684,1072.71804511278,2380.78571428571,923.691729323308,986.567669172932,3381.62406015038,3167.47744360902,382.481203007519,249.03007518797,1054.95864661654,2583.95488721805,298.360902255639,595.691729323308,661.03007518797,1714.28571428571,495.81954887218,371.808270676692,1046.04511278195,129.770676691729,266,22.6517435730725,15.0334652193283,0.748018337550198,0.953405017921147,0.806060606060606,-0.0789142103312674,50663.0037593985,35335.0939849624,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_523030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
523687,2604.36220472441,688.622047244094,243.291338582677,630.275590551181,1670.13779527559,2375.29921259843,793.236220472441,261.893700787402,1127.05905511811,4859.55511811024,633.814960629921,112.854330708661,1086.11023622047,903.736220472441,561.96062992126,318.259842519685,1604.67322834646,1263.50787401575,313.01968503937,233.208661417323,1002.47637795276,1154.0157480315,239.452755905512,200.822834645669,584.106299212598,1608.47637795276,443.874015748031,242.944881889764,1041.37007874016,130.846456692913,254,21.7891544385688,15.0334551715914,0.723855800586959,0.944237918215613,0.703601108033241,-0.801690995783925,51215.7244094488,35769.3070866142,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_523687,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
523751,2421.86178861789,158.231707317073,167.154471544715,744.272357723577,5232.03658536585,2483.86991869919,331.711382113821,259.463414634146,1088.65853658537,5048.0243902439,528.581300813008,110.223577235772,1079.30487804878,3064.04471544715,946.373983739837,340.467479674797,7042.5406504065,8307.86585365854,476.30081300813,256.207317073171,1045.32113821138,8198.91463414634,297.560975609756,225.890243902439,599.430894308943,1753.69512195122,538.186991869919,349.951219512195,1038.5162601626,129.634146341463,246,29.5960190637791,10.5930578911478,0.933751597673166,0.942528735632184,0.517894736842105,-0.614607945336804,52041.7195121951,34578.9878048781,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_523751,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
523942,2714.04241071429,303.805803571429,176.573660714286,733.526785714286,6091.49330357143,3435.91964285714,405.095982142857,285.459821428571,1240.15401785714,4809.18080357143,602.839285714286,135.227678571429,1077.45535714286,5021.66741071429,1158.25223214286,2711.42857142857,2348.01339285714,3600.07142857143,439.879464285714,253.928571428571,1087.58705357143,3023.078125,324.551339285714,306.535714285714,675.926339285714,1522.51339285714,454.837053571429,225.03125,1064.484375,131.075892857143,448,31.4641535114157,18.1898456425239,0.815956500966163,0.947145877378436,0.663703703703704,-0.672330048694569,50452.2053571429,35567.8236607143,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_523942,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
524030,1770.19947506562,179.616797900262,118.944881889764,638.745406824147,2861.02362204724,2271.50131233596,335.343832020997,254.154855643045,1096.51443569554,2866.00787401575,485.45406824147,110.41469816273,1076.5905511811,777.845144356955,584.448818897638,343.57217847769,1486.90026246719,1089.02099737533,312.419947506562,383.01312335958,1010.23097112861,984.955380577428,204.204724409449,183.283464566929,595.926509186352,1115.8188976378,480.351706036745,221.952755905512,1031.07349081365,131.496062992126,381,30.5005922936978,16.0735386106362,0.84987084439412,0.945409429280397,0.647959183673469,-1.04118291972629,51164.7637795276,34729.845144357,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_524030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
524334,2327.23756906077,826.281767955801,88.4972375690608,618.78453038674,1310.45303867403,2718.77900552486,3910.90607734807,266.475138121547,1164.76795580111,3851.2817679558,2377.01104972376,117.878453038674,1072.4861878453,1100.64640883978,594.939226519337,293.381215469613,1615.77900552486,1130.02209944751,228.983425414365,220.828729281768,1482.45856353591,775.182320441989,163.325966850829,137.972375690608,661.220994475138,2445.61878453039,794.441988950276,373.187845303867,1094.38674033149,132.480662983425,181,18.8892998560796,12.2078622900746,0.763096524405746,0.957671957671958,0.773504273504274,1.18201817929878,51781.4419889503,34831.044198895,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_524334,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
524855,3164.14757709251,267.092511013216,94.3898678414097,684.077092511013,2291.76651982379,3951.85242290749,421.502202643172,274.870044052863,1169.64537444934,6333.48237885463,575.431718061674,120.76872246696,1069.80837004405,5180.23348017621,1100.28193832599,350.563876651982,2707.92290748899,8237.24669603524,535.343612334802,271.955947136564,1109.42070484581,7889.33259911894,441.687224669604,362.86563876652,619.977973568282,3160.59251101322,508.592511013216,261.920704845815,1069.75110132159,130.198237885463,454,25.450130223867,23.3068044213399,0.401672670869271,0.961864406779661,0.756666666666667,0.917078352590199,50622.372246696,35598.8017621145,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_524855,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
525130,2406.33608815427,512.501377410468,168.677685950413,669.245179063361,3907.39944903581,3157.12121212121,3753.02479338843,293.330578512397,1095.39944903581,3902.14876033058,789.187327823691,127.454545454545,1075.36363636364,619.168044077135,515.190082644628,303.716253443526,1494.37741046832,909.157024793388,240.922865013774,224.201101928375,1004.43250688705,891.573002754821,204.239669421488,161.201101928375,653.853994490358,1344.02479338843,533.275482093664,416.236914600551,1073.0303030303,131.986225895317,363,23.9802878563373,19.320337258931,0.592356757711334,0.970588235294118,0.796052631578947,-1.53981177109143,50453.7603305785,35285.2672176309,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_525130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
525158,1560.28899082569,152.43119266055,166.678899082569,689.422018348624,5943.00917431193,2003.21100917431,332.990825688073,254.344036697248,1086.87155963303,2545.77064220184,571.889908256881,120.724770642202,1061.90825688073,1060.23853211009,713.876146788991,275.316513761468,1949.32110091743,1323.56422018349,349.435779816514,242.252293577982,1020.67889908257,1237.01376146789,235.646788990826,137.747706422018,1162.3623853211,1098.9128440367,508.330275229358,233.440366972477,1052.51834862385,131.45871559633,218,19.973342773621,13.9492754577185,0.715712883978123,0.956140350877193,0.764912280701754,1.19127277469218,51299.5733944954,34218.0550458716,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_525158,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
525544,3024.71147540984,164.944262295082,85.2491803278689,627.032786885246,1182.54754098361,3471.69180327869,703.377049180328,273.796721311475,1095.04590163934,5823.79672131148,1295.48852459016,118.019672131148,1083.97704918033,712.76393442623,427.740983606557,266.937704918033,1398.34754098361,1017.23278688525,281.865573770492,227.032786885246,985.885245901639,949.629508196721,220.540983606557,133.518032786885,582.04262295082,2185.77704918033,509.914754098361,382.537704918033,1071.28524590164,129.531147540984,305,26.5998973590252,14.7840551840933,0.831320257738199,0.950155763239875,0.706018518518518,-1.08676478529362,50883.3278688525,35195.5639344262,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_525544,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
526018,3881.44690265487,779.318584070796,853.287610619469,663.398230088496,2960.67256637168,3867.28318584071,855.730088495575,278.761061946903,1109.53982300885,5158.74336283186,569.544247787611,123.238938053097,1240.85398230089,2349.28318584071,566.216814159292,347.96017699115,1585.24336283186,3155.05309734513,296.995575221239,235.128318584071,994.061946902655,3543.74336283186,222.699115044248,163.278761061947,598.061946902655,1040.05752212389,444.761061946903,229.429203539823,1036.31415929204,129.061946902655,226,20.8539870784304,13.850530672438,0.747584213026721,0.957627118644068,0.753333333333333,-0.364023847008557,50997.9778761062,35534.7566371681,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_526018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
526624,1454.47647058824,723.505882352941,119.617647058824,616.676470588235,926.258823529412,1633.74705882353,1062.47058823529,267.811764705882,1120.83529411765,3591.8,2349.39411764706,111.911764705882,1057.31764705882,769.794117647059,474.882352941176,274.741176470588,1428.96470588235,2623.8,350.329411764706,240.382352941176,999.882352941176,3888.25294117647,251.747058823529,167.423529411765,581.9,2311.53529411765,549.752941176471,350.429411764706,1043.07058823529,130.635294117647,170,17.2482079161236,12.5670939215767,0.684936381509497,0.944444444444444,0.726495726495726,1.37439748726037,50820.5117647059,35117.0941176471,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_526624,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
527683,2251.29347826087,319.684782608696,112.782608695652,619.271739130435,534.760869565217,2809.96739130435,997.521739130435,280.195652173913,1087.9347826087,3330.53260869565,649.467391304348,121.652173913043,1073.32608695652,681.760869565217,458.739130434783,282.195652173913,1389.39130434783,1125.72826086957,349.304347826087,235.510869565217,976.70652173913,1096.80434782609,246.413043478261,127.70652173913,585.010869565217,1090.33695652174,506.304347826087,222.652173913043,1039.83695652174,133.413043478261,92,11.8283607955017,10.6428128336649,0.436362959614493,0.901960784313726,0.766666666666667,0.365088988549033,50673.4565217391,35002.5217391304,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_527683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
528182,2100.00977198697,369.723127035831,113.488599348534,642.530944625407,2032.73615635179,2032.02931596091,3390.72638436482,259.794788273616,1094.73615635179,4339.00651465798,1734.57654723127,113.628664495114,1071.55374592834,1388.94462540717,683.42996742671,526.084690553746,1794.29641693811,3389.65146579805,349.557003257329,242.045602605863,998.827361563518,3761.41042345277,259.234527687296,183.052117263844,598.615635179153,1666.57654723127,492.28664495114,448.325732899023,1054.87947882736,129.801302931596,307,24.1097318440797,16.3334972818095,0.73555509482339,0.971518987341772,0.73444976076555,-0.62430848969068,52036.5016286645,35006.9087947883,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_528182,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
528268,1578.77777777778,260.142857142857,107.849206349206,623.571428571429,1010.94444444444,1616.79365079365,325.222222222222,261.468253968254,1090.12698412698,3643.12698412698,564.126984126984,113.087301587302,1077.23015873016,889.063492063492,709.968253968254,273.587301587302,1353.50793650794,1082.47619047619,316.809523809524,235.706349206349,984.015873015873,1025.5873015873,233.563492063492,127.007936507937,583.269841269841,2830.5873015873,542.134920634921,218.31746031746,1051.3253968254,129.325396825397,126,17.9068852444974,9.16738052707978,0.859016891944113,0.940298507462687,0.65625,-0.537859040195923,50167.7619047619,34430.7063492063,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_528268,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
528336,1428.39043824701,310.310756972112,227.450199203187,684.529880478088,4383.95219123506,1688.09163346614,348.143426294821,269.537848605578,1090.78486055777,3167.32270916335,526.665338645418,117.533864541833,1068.22709163347,575.159362549801,426.302788844621,274.99203187251,1385.3984063745,886.139442231076,296.517928286853,232.537848605578,981.820717131474,867.872509960159,223.788844621514,134.780876494024,581.151394422311,2181.95219123506,492.470119521912,217.505976095618,1057.08366533865,129.764940239044,251,23.6479775682413,13.6914723798371,0.815348760743385,0.958015267175572,0.74702380952381,0.0312232112611608,50365.0796812749,35266.2509960159,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_528336,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
528865,544.546925566343,904.495145631068,221.705501618123,609.63430420712,138.805825242718,508.588996763754,349.245954692557,251.647249190939,1118.21359223301,970.598705501618,486.572815533981,111.11003236246,1060.89644012945,530.375404530744,331.834951456311,255.660194174757,1443.58252427184,704.834951456311,181.957928802589,215.854368932039,994.666666666667,631.873786407767,148.381877022654,123.708737864078,585.239482200647,575.482200647249,379.582524271845,204.521035598706,984.184466019418,130.851132686084,309,22.2465556101857,17.7984734081442,0.59992633838751,0.965625,0.78030303030303,1.2334295287572,51364.8867313916,34038.8705501618,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_528865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529125,3439.64622641509,645.853773584906,180.405660377358,684.061320754717,3538.07547169811,3964.82075471698,4112.14622641509,270.783018867925,1120.71698113208,5730.77358490566,1752.70283018868,128.957547169811,1089.16037735849,858.504716981132,476.825471698113,279.669811320755,1541.43867924528,1039.80660377358,222.844339622642,221.457547169811,1310.30660377358,709.02358490566,149.462264150943,129.830188679245,595.490566037736,2120.46226415094,557.169811320755,354.349056603774,1084.00471698113,132.292452830189,212,21.5172826992823,12.6184862943446,0.80999633720854,0.938053097345133,0.688311688311688,-1.55930790925676,51378.7264150943,34283.2028301887,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_529125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529249,2253.64539007092,312.386524822695,75.9148936170213,619.333333333333,871.581560283688,1889.04255319149,1413.8865248227,272.393617021277,1088.46453900709,3534.05673758865,899.514184397163,117.347517730496,1076.56737588652,883.783687943262,667.262411347518,360.400709219858,1610.1914893617,1615.62765957447,347.748226950355,237.312056737589,1022.28014184397,1519.14893617021,244.489361702128,262.709219858156,636.936170212766,1113.67021276596,463.843971631206,259.914893617021,1021.63829787234,130.124113475177,282,20.7839427987534,17.5813287427301,0.533326916208266,0.952702702702703,0.746031746031746,0.21484417301243,50883.4787234043,35722.4290780142,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_529249,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529289,1552.2268907563,294.487394957983,197.53781512605,694.63025210084,5470.83193277311,2079.67226890756,373.579831932773,275.445378151261,1097.3781512605,2532.0,688.873949579832,219.966386554622,1065.94957983193,544.168067226891,521.44537815126,421.008403361345,1470.80672268908,784.689075630252,214.714285714286,220.310924369748,986.44537815126,670.420168067227,154.554621848739,126.109243697479,589.27731092437,1467.34453781513,575.974789915966,252.714285714286,1084.83193277311,129.201680672269,119,15.7986067416695,9.68685390846754,0.789969540948912,0.952,0.772727272727273,0.443127998672175,50924.7731092437,34584.731092437,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_529289,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529444,2332.51794871795,207.741025641026,163.841025641026,701.489743589744,5351.75641025641,2369.94615384615,346.082051282051,267.561538461538,1100.17948717949,3834.77692307692,516.689743589744,121.45641025641,1073.35128205128,4445.11538461538,1016.65384615385,562.420512820513,2131.11538461538,3301.27948717949,418.589743589744,248.512820512821,1029.1641025641,2435.17692307692,341.707692307692,314.251282051282,613.584615384615,1167.35641025641,420.438461538462,241.723076923077,1049.96923076923,128.623076923077,390,32.6618514462073,15.5875382806985,0.878773059798358,0.942028985507246,0.641447368421053,0.322316385669617,51361.6615384615,35761.6538461538,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_529444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529676,1209.11805555556,284.236111111111,119.444444444444,637.236111111111,1727.64583333333,1543.25,337.451388888889,263.284722222222,1088.59722222222,1840.55555555556,492.534722222222,109.152777777778,1063.52777777778,793.138888888889,1584.56944444444,317.472222222222,1581.40277777778,1056.80555555556,296.805555555556,231.819444444444,1000.72916666667,933.354166666667,200.854166666667,171.069444444444,670.819444444444,1006.0,495.541666666667,220.041666666667,1025.375,131.402777777778,144,14.4617343232942,12.6902278284419,0.479569555960343,0.966442953020134,0.791208791208791,-0.577738881561612,51050.2430555556,34984.2013888889,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_529676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529847,3085.00340136054,565.258503401361,789.183673469388,616.744897959184,884.384353741497,3142.79591836735,446.0,254.43537414966,1081.7380952381,5932.59183673469,545.091836734694,117.309523809524,1069.71088435374,832.748299319728,586.704081632653,383.84693877551,1657.2925170068,1504.28911564626,313.554421768707,240.785714285714,1008.52040816327,1904.58163265306,236.884353741497,174.506802721088,592.904761904762,2076.25170068027,564.860544217687,251.921768707483,1056.45578231293,130.455782312925,294,24.1494000401797,15.7597292921256,0.757708640101781,0.954545454545455,0.765625,-1.53969387982277,51957.7278911565,34811.7721088435,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_529847,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
529991,2218.92142857143,110.760714285714,66.9214285714286,614.978571428571,921.871428571429,2068.28571428571,435.796428571429,256.8,1084.11785714286,2538.25357142857,580.775,110.825,1070.81428571429,3318.41071428571,920.285714285714,556.675,2258.27857142857,3647.54642857143,365.160714285714,242.603571428571,1083.36428571429,2768.22142857143,234.414285714286,280.3,589.978571428571,836.45,466.285714285714,223.2,1003.21428571429,128.275,280,22.5903166632145,15.985109180255,0.706604303101098,0.952380952380952,0.740740740740741,-0.532817697646838,51920.9464285714,34375.1321428571,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_529991,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
530037,2346.22033898305,376.553672316384,170.683615819209,688.40395480226,4284.84745762712,2751.96892655367,1489.08474576271,271.248587570621,1102.79378531073,4518.20056497175,563.757062146893,113.912429378531,1107.79661016949,2888.39265536723,512.988700564972,669.161016949153,1497.72316384181,2486.29943502825,309.909604519774,235.838983050847,991.042372881356,2311.09322033898,228.059322033898,348.641242937853,615.358757062147,1668.17231638418,462.036723163842,412.06779661017,1048.03672316384,129.697740112994,354,29.7947209511933,15.5099996689613,0.853823868970174,0.944,0.615652173913043,-0.862482879746567,50992.290960452,35520.4209039548,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_530037,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
530593,1148.89711934156,345.720164609053,88.6502057613169,648.485596707819,2608.99588477366,1301.42798353909,5928.43209876543,261.123456790123,1095.12345679012,2437.09465020576,2146.15637860082,120.19341563786,1072.85185185185,819.222222222222,414.526748971193,1038.76543209877,1766.50205761317,919.971193415638,249.181069958848,224.551440329218,987.761316872428,843.251028806584,188.255144032922,146.839506172839,603.514403292181,1211.98765432099,528.674897119342,369.839506172839,1039.21399176955,130.559670781893,243,22.2480082149479,13.9816763268441,0.777853050186039,0.956692913385827,0.788961038961039,-3.52853680944964e-05,51901.3209876543,34313.8353909465,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_530593,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
530643,4438.47348484848,1668.14015151515,186.848484848485,638.681818181818,1403.83712121212,4207.52272727273,867.969696969697,268.57196969697,1113.66287878788,8168.01515151515,666.371212121212,122.121212121212,1102.57575757576,776.655303030303,353.287878787879,268.916666666667,1524.11363636364,1140.95833333333,207.07196969697,217.185606060606,997.356060606061,942.727272727273,175.223484848485,159.151515151515,584.704545454545,2483.12878787879,547.522727272727,288.477272727273,1063.08712121212,133.125,264,21.5123932380331,15.6666445278712,0.685299501679913,0.967032967032967,0.733333333333333,-0.641409524408683,51727.6287878788,35360.2121212121,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_530643,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
530988,1061.79591836735,440.278911564626,502.748299319728,615.65306122449,1069.20408163265,680.496598639456,449.061224489796,254.292517006803,1086.08843537415,1721.84353741497,1409.20408163265,102.707482993197,1064.19727891156,944.965986394558,508.231292517007,284.340136054422,1568.0612244898,1234.91156462585,313.122448979592,235.965986394558,991.183673469388,1106.40136054422,228.952380952381,171.054421768707,1392.90476190476,945.69387755102,470.952380952381,375.482993197279,1002.85034013605,129.068027210884,147,17.1912592199662,10.9541158138968,0.770705921631876,0.954545454545455,0.706730769230769,-0.956222953336907,51480.2176870748,35426.619047619,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_530988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
531893,2326.76373626374,186.115384615385,83.1703296703297,626.203296703297,1136.40659340659,2814.85714285714,379.274725274725,271.06043956044,1085.84065934066,5282.86263736264,563.236263736264,116.697802197802,1075.23626373626,668.137362637363,604.565934065934,275.543956043956,1517.35714285714,1043.77472527473,299.181318681319,235.532967032967,1000.66483516484,963.505494505494,282.56043956044,158.181318681319,609.153846153846,2118.70879120879,530.912087912088,241.357142857143,1015.92307692308,128.32967032967,182,19.663538542779,11.7918183000429,0.800240376147524,0.957894736842105,0.7109375,-0.746581163652275,51007.5659340659,35130.543956044,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_531893,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
532576,996.335294117647,264.908823529412,137.067647058824,660.655882352941,3117.88235294118,1004.16470588235,343.255882352941,268.679411764706,1089.34411764706,1762.47352941176,603.185294117647,122.108823529412,1066.73823529412,2134.87647058824,786.308823529412,381.652941176471,1644.08529411765,4272.89705882353,403.208823529412,252.408823529412,1013.06764705882,4375.91176470588,280.161764705882,205.923529411765,607.597058823529,1073.70882352941,507.111764705882,291.982352941176,1065.24411764706,131.161764705882,340,21.8257191332103,19.9958626748287,0.400811502989971,0.952380952380952,0.772727272727273,1.37957857573241,51814.0117647059,35252.1411764706,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_532576,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
532935,3742.47619047619,556.325396825397,189.813492063492,664.198412698413,2717.87301587302,4984.36904761905,4942.56746031746,282.734126984127,1103.05158730159,6473.2380952381,1574.63492063492,127.496031746032,1077.11111111111,786.428571428571,445.531746031746,276.130952380952,1730.87301587302,1225.11904761905,268.956349206349,235.349206349206,1016.80158730159,1085.79761904762,201.623015873016,131.448412698413,613.575396825397,2192.45238095238,555.84126984127,488.027777777778,1115.00396825397,131.944444444444,252,19.9940825098625,16.1570719964466,0.589055343874285,0.958174904942966,0.741176470588235,-0.255618678953074,50055.9444444444,34767.5396825397,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_532935,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
533090,3747.17874396135,479.429951690821,106.048309178744,609.502415458937,519.304347826087,4230.71980676329,720.24154589372,276.173913043478,1102.86956521739,7187.78743961353,1090.47342995169,117.009661835749,1076.78743961353,1092.21256038647,555.07729468599,280.734299516908,1949.38164251208,1453.41062801932,309.429951690821,237.685990338164,1045.7922705314,1190.42512077295,218.371980676328,154.676328502415,722.797101449275,3667.28985507246,571.507246376812,370.777777777778,1053.62801932367,130.260869565217,207,19.0408787761983,13.9744602213478,0.679237140716281,0.953917050691244,0.71875,0.558912571887837,51339.5603864734,35320.2077294686,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_533090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
533675,851.332432432432,367.22972972973,268.532432432432,730.116216216216,9279.3054054054,939.510810810811,1188.78108108108,262.345945945946,1097.52972972973,1503.4027027027,2983.24864864865,127.605405405405,1069.82432432432,725.081081081081,636.9,522.340540540541,1465.53243243243,1022.84054054054,312.359459459459,236.483783783784,989.748648648649,1002.32702702703,243.524324324324,135.789189189189,583.0,584.856756756757,365.297297297297,201.308108108108,978.275675675676,129.278378378378,370,25.1551606988063,18.9333414467693,0.658406745038461,0.971128608923884,0.734126984126984,0.568566287428569,50618.3540540541,35140.8540540541,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_533675,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
533904,1974.04,292.260952380952,128.424761904762,636.013333333333,1628.4,2550.87619047619,406.424761904762,272.615238095238,1094.46666666667,3792.51619047619,616.175238095238,132.049523809524,1107.0780952381,1001.00380952381,1286.22095238095,328.577142857143,1605.50857142857,1643.25142857143,362.474285714286,244.241904761905,1002.34095238095,1609.69714285714,245.826666666667,359.727619047619,673.081904761905,1524.04571428571,568.405714285714,231.832380952381,1064.68380952381,131.502857142857,525,35.5823354589534,19.5166399640423,0.836155551276844,0.951086956521739,0.625,-0.737916279354974,50839.7276190476,34631.8780952381,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_533904,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
534497,1733.4119047619,344.535714285714,139.607142857143,651.819047619048,2699.15714285714,2183.08333333333,2670.22380952381,254.957142857143,1088.54761904762,3114.06904761905,948.157142857143,126.319047619048,1060.83571428571,935.064285714286,657.828571428571,383.935714285714,1551.66904761905,1619.85238095238,438.292857142857,258.295238095238,1002.81666666667,1557.04761904762,391.45,171.759523809524,596.333333333333,1018.69285714286,480.788095238095,279.219047619048,1022.72142857143,130.859523809524,420,28.1860511322812,20.0615931396502,0.702426714250756,0.9375,0.676328502415459,0.953991377095331,51011.8357142857,34539.7261904762,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_534497,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
534799,3628.69607843137,327.632352941176,173.352941176471,675.892156862745,3371.50980392157,3955.85784313725,412.700980392157,265.867647058824,1098.37254901961,6275.43137254902,551.294117647059,118.357843137255,1072.88725490196,2305.55392156863,954.602941176471,1591.53921568627,1917.82352941176,1673.8431372549,270.926470588235,226.220588235294,1015.58823529412,1341.24019607843,212.019607843137,272.024509803922,650.220588235294,2827.30882352941,552.5,235.539215686275,1343.53431372549,131.774509803922,204,18.2322538070294,14.3832768969942,0.614532024443406,0.966824644549763,0.80952380952381,1.56941815627377,51497.3480392157,35022.2647058823,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_534799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
534907,3626.62939297125,604.488817891374,119.338658146965,617.779552715655,1409.79872204473,3695.84345047923,399.450479233227,269.185303514377,1087.74121405751,5764.18849840256,525.038338658147,116.418530351438,1071.66773162939,719.779552715655,492.869009584665,388.744408945687,1503.53674121406,1057.30670926518,292.05750798722,239.447284345048,990.485623003195,1133.54632587859,224.041533546326,142.638977635783,588.70607028754,2390.31629392971,538.900958466454,233.198083067093,1022.27476038339,130.038338658147,313,28.5541820231568,13.9915046125841,0.871723310444697,0.957186544342508,0.621031746031746,0.8875160025069,51829.2651757189,34977.9361022364,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_534907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
535086,903.271428571429,263.407142857143,130.357142857143,640.821428571429,1844.25,1048.59285714286,298.078571428571,253.264285714286,1075.6,1507.22142857143,476.835714285714,110.314285714286,1064.9,722.257142857143,600.771428571429,279.778571428571,1366.26428571429,1035.3,324.785714285714,239.9,985.0,968.021428571429,212.778571428571,133.714285714286,583.921428571429,1014.82857142857,490.528571428571,214.942857142857,1010.57857142857,130.928571428571,140,15.768530743905,11.3835886801898,0.691978447732207,0.952380952380952,0.714285714285714,0.792093640724047,50381.7571428571,34434.9071428571,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_535086,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
535962,5342.85650224215,638.448430493274,1240.03587443946,649.515695067265,2073.31390134529,4556.94170403587,1144.08520179372,276.896860986547,1087.14798206278,8472.04035874439,971.520179372197,121.358744394619,1083.41255605381,719.188340807175,596.85201793722,880.533632286995,1529.87892376682,1081.82062780269,290.910313901345,232.044843049327,987.251121076233,1061.86098654709,229.058295964126,191.578475336323,604.865470852018,2668.57847533632,567.0,449.0,1052.00448430493,130.919282511211,223,21.7555498632899,13.1811075790281,0.795561122946017,0.940928270042194,0.655882352941176,-0.974328429070684,51034.3946188341,35574.2421524664,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_535962,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
536253,5590.95480225989,1227.37853107345,363.406779661017,659.994350282486,2509.25988700565,6756.14689265537,1195.42937853107,306.237288135593,1286.19209039548,9943.66101694915,1363.88700564972,143.146892655367,1083.34463276836,7199.41807909605,1747.63276836158,1039.16949152542,5617.93785310734,11175.3107344633,684.694915254237,302.502824858757,1076.96610169492,9866.65536723164,402.225988700565,755.079096045198,845.169491525424,3656.44632768362,729.971751412429,523.361581920904,1123.33333333333,134.632768361582,177,15.8167174021368,14.2742296236281,0.430737257696017,0.967213114754098,0.842857142857143,0.46588565114761,51735.6214689266,34805.7175141243,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_536253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
536481,4818.87072243346,920.520912547528,1335.12927756654,634.330798479087,1483.10266159696,5477.63117870722,425.543726235741,282.798479087452,1118.39543726236,8643.01140684411,572.098859315589,120.821292775665,1094.26235741445,975.893536121673,535.847908745247,278.007604562738,1727.36882129278,1367.01901140684,296.946768060837,237.201520912548,1127.68060836502,1062.56273764259,213.878326996198,141.091254752852,592.319391634981,2449.43726235741,564.262357414449,253.083650190114,1043.09505703422,129.380228136882,263,23.2242441691632,14.5409195029187,0.779735157389745,0.952898550724638,0.76231884057971,1.34304327973206,51123.8935361217,35286.2015209125,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_536481,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
536710,3112.91946308725,225.855704697987,108.5,618.906040268456,979.255033557047,3126.80872483221,535.697986577181,273.580536912752,1135.11744966443,4351.86241610738,519.902684563758,113.127516778523,1087.68456375839,2202.02684563758,843.05033557047,359.634228187919,5250.45973154362,3838.94630872483,344.003355704698,234.875838926175,1043.76845637584,4184.80872483222,248.835570469799,247.597315436242,592.241610738255,1062.20469798658,441.211409395973,260.479865771812,1013.34899328859,128.798657718121,298,22.2334056989257,17.1043024660952,0.638879943402713,0.952076677316294,0.746867167919799,0.594642787672115,51185.2147651007,35757.4395973154,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_536710,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
536937,4013.60750853242,946.20819112628,2084.55631399317,627.03071672355,1463.46075085324,3586.33105802048,1357.90443686007,275.232081911263,1103.1023890785,6605.79180887372,910.259385665529,120.883959044369,1080.81911262799,1169.13651877133,688.658703071672,337.262798634812,1753.53924914676,1703.46075085324,328.795221843003,237.836177474403,1083.03754266212,1395.23890784983,236.665529010239,729.79180887372,1030.14675767918,1816.29351535836,526.634812286689,466.01023890785,1044.84641638225,133.262798634812,293,25.7297716646732,14.9570263916222,0.813680709459253,0.904320987654321,0.718137254901961,1.28759363771336,51807.4505119454,35394.8293515358,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_536937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
538095,3731.70990990991,1356.69189189189,108.385585585586,632.372972972973,1302.40540540541,3817.69369369369,1045.86846846847,285.888288288288,1167.45945945946,6550.21621621622,609.113513513514,120.2,1089.05045045045,1986.91711711712,977.801801801802,1120.66126126126,1698.46306306306,1357.12612612613,342.661261261261,235.322522522522,1009.04324324324,1240.6018018018,241.592792792793,244.136936936937,597.987387387387,1860.3963963964,492.203603603604,244.863063063063,1036.71171171171,131.531531531532,555,35.5123113128423,20.2668814321435,0.821158533740364,0.948717948717949,0.777310924369748,1.38776501172846,51455.7837837838,35627.4432432432,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_538095,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
538529,2804.64227642276,474.79674796748,219.821138211382,696.487804878049,4755.29268292683,3488.17886178862,385.569105691057,287.756097560976,1114.67479674797,6149.05691056911,634.682926829268,126.861788617886,1090.78048780488,679.178861788618,481.463414634146,279.382113821138,1434.33333333333,1138.0,349.056910569106,242.829268292683,983.715447154472,994.707317073171,215.650406504065,141.69918699187,582.032520325203,4573.52032520325,660.325203252033,435.569105691057,1076.27642276423,129.471544715447,123,16.9244735075231,9.40524431258128,0.831370473729126,0.931818181818182,0.627551020408163,-0.874967527849303,51292.9430894309,34905.1707317073,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_538529,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
538989,393.179836512262,650.839237057221,179.534059945504,608.130790190736,112.828337874659,588.297002724796,411.16348773842,271.806539509537,1141.01634877384,1345.02179836512,666.354223433243,108.25340599455,1058.12534059946,936.634877384196,546.673024523161,300.66485013624,1506.63215258856,1497.6348773842,316.021798365123,240.016348773842,1029.40054495913,1277.30245231608,235.58038147139,255.00272479564,751.147138964578,587.297002724796,374.891008174387,198.411444141689,985.261580381471,131.016348773842,367,25.829328025317,18.1275077330281,0.712355519701541,0.95822454308094,0.784188034188034,-1.41706314827251,50156.3269754768,34903.3923705722,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_538989,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
539155,496.706739526412,97.5318761384335,71.7850637522769,611.95810564663,1407.73770491803,393.48087431694,271.92349726776,241.832422586521,1077.32422586521,817.072859744991,482.225865209472,103.435336976321,1065.9635701275,841.327868852459,690.120218579235,283.59927140255,1942.2349726776,1226.51001821494,347.014571948998,243.535519125683,993.777777777778,1009.29326047359,220.081967213115,172.047358834244,577.989071038251,575.213114754098,376.40072859745,199.617486338798,983.808743169399,128.670309653916,549,29.3483318140701,23.8776784952275,0.581430933114873,0.968253968253968,0.782051282051282,-1.00298083470775,51659.7285974499,34611.2349726776,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_539155,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
540710,2694.34296028881,188.115523465704,103.72202166065,645.314079422383,1879.72202166065,3183.83754512635,345.137184115523,272.021660649819,1104.42238267148,5418.14440433213,635.97833935018,116.797833935018,1080.17328519856,1966.10469314079,692.967509025271,300.310469314079,1855.38628158845,1468.72924187726,300.057761732852,235.490974729242,1049.7725631769,1281.40072202166,220.902527075812,189.841155234657,2117.58844765343,1607.09386281588,474.826714801444,220.205776173285,1059.18772563177,132.5559566787,277,21.3921675945631,16.6748647979239,0.626421413831582,0.958477508650519,0.775910364145658,0.213723726062915,51128.642599278,35352.4584837545,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_540710,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
540952,2903.70135746606,175.316742081448,102.556561085973,764.886877828054,2605.48868778281,3281.47058823529,319.27149321267,270.045248868778,1218.18552036199,6518.2036199095,539.262443438914,118.552036199095,1082.65610859729,962.696832579186,523.552036199095,278.923076923077,1812.96380090498,1468.7149321267,318.651583710407,236.710407239819,1027.92760180995,1171.23076923077,217.873303167421,138.348416289593,598.475113122172,3120.22171945701,535.886877828054,229.009049773756,1053.76470588235,129.257918552036,221,21.8742790067996,13.0111632733295,0.803862148670669,0.936440677966102,0.690625,-1.04698924944114,51139.2805429864,35260.7375565611,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_540952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
540969,3363.79801324503,421.950331125828,87.8708609271523,632.387417218543,1600.71523178808,2698.48013245033,2654.22185430464,269.490066225166,1091.50331125828,5707.07284768212,1014.49337748344,116.377483443709,1083.99668874172,2378.86092715232,563.44701986755,298.725165562914,1640.08609271523,3259.97350993377,308.298013245033,233.665562913907,1001.96357615894,2840.86092715232,238.344370860927,174.347682119205,590.102649006623,1597.76158940397,498.129139072848,509.698675496689,1066.57284768212,133.523178807947,302,23.2401891023627,16.6785607186387,0.696393363209991,0.958730158730159,0.772378516624041,1.4777383859125,51645.1026490066,35368.4701986755,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_540969,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
541003,4661.57703081232,935.067226890756,627.862745098039,694.997198879552,4299.64425770308,5013.7731092437,924.624649859944,276.137254901961,1149.48459383753,6662.60504201681,979.120448179272,128.21568627451,1079.88795518207,3631.66386554622,860.263305322129,347.887955182073,2084.68067226891,4102.55742296919,378.848739495798,244.885154061625,1039.08403361345,4897.00840336134,298.072829131653,254.179271708683,589.675070028011,1484.18207282913,478.840336134454,257.075630252101,1053.8431372549,131.06162464986,357,26.1666634651597,17.5433310708259,0.741958459030974,0.970108695652174,0.84,1.50298026824516,52066.7731092437,34936.6246498599,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_541003,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
541977,1689.32183908046,402.310344827586,128.82183908046,654.494252873563,2209.29885057471,1593.10344827586,2750.39655172414,263.735632183908,1111.40804597701,2482.50574712644,3780.81609195402,111.5,1624.98275862069,1874.29885057471,953.287356321839,2072.76436781609,1864.9367816092,4857.07471264368,479.793103448276,261.488505747126,1071.59195402299,4002.24137931034,328.344827586207,464.120689655172,864.224137931035,1040.72988505747,468.810344827586,703.218390804598,1043.68390804598,133.706896551724,174,16.5017971694148,13.4408606827193,0.58015105759249,0.961325966850829,0.773333333333333,-0.783261843163989,51543.2528735632,34926.2126436782,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_541977,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
542465,2449.89597315436,303.469798657718,130.104026845638,627.298657718121,1990.22483221477,2951.35234899329,399.456375838926,270.852348993289,1087.93959731544,3601.22483221476,592.577181208054,120.318791946309,1078.12080536913,988.328859060403,1171.11409395973,289.895973154362,1592.36577181208,1448.87248322148,358.892617449664,248.020134228188,992.711409395973,1328.43624161074,233.140939597315,170.194630872483,632.942953020134,1436.8355704698,524.023489932886,226.406040268456,1026.3322147651,130.036912751678,298,32.0144039984257,11.9430982621924,0.927809672198563,0.937106918238994,0.498327759197324,-0.686868749654113,50936.1610738255,34729.4429530201,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_542465,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
543130,2079.18461538462,149.030769230769,251.087179487179,759.882051282051,8607.73846153846,2387.68205128205,395.551282051282,265.564102564103,1105.86923076923,3800.88461538462,684.110256410256,151.479487179487,1068.41538461538,667.771794871795,549.292307692308,317.958974358974,1349.83076923077,1001.99743589744,328.538461538462,240.620512820513,975.717948717949,979.297435897436,242.476923076923,154.44358974359,601.051282051282,910.569230769231,447.017948717949,216.220512820513,1048.86666666667,130.982051282051,390,35.1300024656119,14.2972135971029,0.913437003445486,0.951219512195122,0.738636363636364,-1.35579308543023,50225.4692307692,34815.2820512821,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
543223,1218.35751295337,543.678756476684,688.963730569948,619.658031088083,1070.9274611399,1462.18652849741,345.59067357513,266.331606217617,1089.99481865285,1718.27979274611,527.943005181347,111.497409326425,1075.07772020725,559.777202072539,400.725388601036,259.59585492228,1426.30051813472,936.40414507772,282.984455958549,230.103626943005,991.777202072539,879.383419689119,200.777202072539,137.870466321244,579.917098445596,987.564766839378,500.906735751295,225.61139896373,1038.9585492228,129.989637305699,193,19.5027737735977,12.6663899280812,0.760390569274573,0.946078431372549,0.781376518218624,-0.296629694586082,51239.103626943,34838.7772020725,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_543223,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
543413,2016.24615384615,104.179487179487,56.6871794871795,623.912820512821,1551.4,2260.78974358974,526.271794871795,272.210256410256,1085.27692307692,4650.70769230769,831.94358974359,111.482051282051,1074.40512820513,783.374358974359,537.610256410256,322.687179487179,1483.02051282051,1315.77948717949,320.912820512821,250.717948717949,982.215384615385,1175.48717948718,232.164102564103,140.641025641026,585.379487179487,2724.51794871795,513.538461538462,325.953846153846,1029.52820512821,130.676923076923,195,18.237476179195,14.0883830246434,0.635019254326866,0.933014354066986,0.722222222222222,-0.290537352905121,50933.9025641026,35263.2820512821,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543413,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
545037,2116.12643678161,593.099616858238,1150.74712643678,616.770114942529,981.32183908046,1663.74712643678,572.551724137931,264.674329501916,1096.68199233716,3537.04214559387,792.04214559387,110.436781609195,1065.73180076628,664.739463601533,504.858237547893,319.455938697318,1607.09195402299,1009.87356321839,278.735632183908,224.858237547893,993.360153256705,931.226053639847,217.314176245211,188.038314176245,596.750957854406,1151.7969348659,492.348659003831,287.045977011494,1017.13026819923,128.789272030651,261,24.0613637399847,13.9329605125715,0.815285306669355,0.952554744525547,0.69047619047619,-0.589450122057271,51459.9042145594,35446.7701149425,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_545037,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
545342,3331.74019607843,889.299019607843,803.823529411765,624.25,935.063725490196,3104.0637254902,1566.25490196078,265.872549019608,1096.03921568627,6563.62254901961,697.519607843137,111.808823529412,1082.63235294118,783.455882352941,539.117647058824,295.411764705882,1492.67647058824,1271.97549019608,345.705882352941,244.897058823529,985.073529411765,1198.22058823529,253.617647058824,156.328431372549,595.240196078431,2568.17647058824,488.196078431372,430.573529411765,1043.61764705882,129.186274509804,204,18.9004847134598,13.8107733305437,0.682687984839448,0.940092165898618,0.708333333333333,-0.610167561921517,51207.4754901961,35455.6274509804,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_545342,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
547875,2177.40520446097,771.832713754647,105.033457249071,655.263940520446,1503.94795539033,2282.74349442379,778.825278810409,263.237918215613,1146.19330855019,3309.72118959108,510.505576208178,112.17843866171,1079.56505576208,4310.14498141264,801.144981412639,356.951672862454,1800.87732342007,5460.10408921933,401.442379182156,249.873605947955,1014.10037174721,4966.91821561338,273.256505576208,359.226765799256,603.802973977695,985.966542750929,448.520446096654,403.200743494424,1023.75836431227,132.126394052045,269,25.6314647304467,13.9902272427243,0.837900902642056,0.930795847750865,0.6725,0.307068085809934,51206.3494423792,35506.5390334573,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_547875,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
548041,1360.69325153374,99.8895705521472,48.9815950920245,626.01226993865,1030.67484662577,1253.33128834356,1105.0,253.871165644172,1083.50920245399,3028.38650306748,1998.68711656442,105.693251533742,1066.93865030675,719.423312883436,342.680981595092,267.085889570552,1470.94478527607,886.220858895706,195.846625766871,213.699386503067,1166.22699386503,755.251533742331,160.282208588957,163.055214723926,614.006134969325,1328.42944785276,449.717791411043,434.128834355828,1035.8773006135,129.374233128834,163,20.0255838400405,10.3779767943413,0.855237706648088,0.947674418604651,0.714912280701754,1.26036728862458,51746.773006135,35143.2208588957,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_548041,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
548309,5931.60606060606,358.536796536797,126.056277056277,639.848484848485,1779.42424242424,7559.62337662338,427.056277056277,284.424242424242,1092.96536796537,10364.316017316,636.835497835498,137.316017316017,1086.45021645022,637.982683982684,463.709956709957,267.917748917749,1351.32467532468,980.181818181818,313.380952380952,235.857142857143,984.415584415584,922.805194805195,223.484848484848,123.034632034632,581.264069264069,4025.8961038961,588.865800865801,272.337662337662,1053.15584415584,131.770562770563,231,24.9448449084593,11.8700645191413,0.879525147857757,0.935222672064777,0.77,-0.0349572931888299,50402.2813852814,34291.5497835498,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_548309,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
548367,1736.56779661017,674.067796610169,546.737288135593,614.457627118644,1133.78813559322,328.135593220339,815.567796610169,248.838983050847,1081.82627118644,885.838983050847,606.601694915254,107.444915254237,1057.65677966102,2017.94915254237,909.822033898305,366.521186440678,2346.28389830508,1543.50847457627,302.563559322034,239.228813559322,1011.98305084746,1219.68220338983,250.228813559322,156.919491525424,614.330508474576,1006.86440677966,493.995762711864,299.779661016949,1009.56779661017,129.656779661017,236,23.2926489508033,12.983340367164,0.830243570328229,0.955465587044534,0.653739612188366,-0.73383757224123,52097.3347457627,34869.3601694915,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_548367,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
549126,1119.26543209877,168.413580246914,78.1296296296296,612.302469135802,907.487654320988,1397.86419753086,430.814814814815,257.407407407407,1085.54320987654,2120.75925925926,608.925925925926,111.543209876543,1064.77160493827,1326.00617283951,664.722222222222,304.975308641975,1634.02469135802,1796.58641975309,292.679012345679,233.216049382716,1321.51851851852,2019.91975308642,201.006172839506,140.388888888889,1287.71604938272,1019.54938271605,486.030864197531,223.907407407407,1035.46296296296,132.586419753086,162,18.8784914674823,10.9744156310444,0.813676130503248,0.936416184971098,0.635294117647059,-0.899812081396078,50398.0185185185,34944.1358024691,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_549126,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
549365,2052.65369649805,342.498054474708,126.143968871595,621.093385214008,984.389105058366,2534.90272373541,372.143968871595,268.284046692607,1082.85992217899,3483.12840466926,562.035019455253,120.513618677043,1075.75875486381,1792.46303501946,543.47859922179,282.077821011673,1551.51750972763,1348.4046692607,291.922178988327,235.871595330739,1003.84824902724,1109.9766536965,197.385214007782,256.727626459144,642.155642023346,1212.82879377432,514.910505836576,224.140077821012,1034.68482490272,129.910505836576,257,25.948944890303,12.89804274801,0.86771925884051,0.937956204379562,0.584090909090909,0.894173435349458,50518.9299610895,34434.4319066148,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_549365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
549491,3993.1228668942,325.163822525597,96.9863481228669,650.221843003413,1920.43686006826,2990.67576791809,1501.68259385666,273.061433447099,1090.27303754266,6753.67576791809,1695.27645051195,116.887372013652,1072.23549488055,935.82252559727,695.286689419795,477.918088737201,1552.58361774744,1327.61092150171,310.860068259386,232.027303754266,994.163822525597,1134.83959044369,225.423208191126,173.259385665529,594.829351535836,1880.10580204778,498.098976109215,302.433447098976,1079.22866894198,132.699658703072,293,25.2588323579998,14.8303057464969,0.809490145153357,0.957516339869281,0.665909090909091,-0.858891005333963,51494.5597269625,35515.4675767918,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_549491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
549973,2946.96120689655,292.995689655172,121.521551724138,635.818965517241,1502.03017241379,3207.87068965517,506.905172413793,273.810344827586,1085.15517241379,5651.9525862069,560.905172413793,117.698275862069,1075.61206896552,926.875,520.935344827586,287.728448275862,1584.22844827586,1155.20689655172,254.375,225.474137931034,1311.46120689655,832.150862068965,187.909482758621,146.086206896552,585.181034482759,2588.90517241379,523.952586206897,302.452586206897,1036.43103448276,130.85775862069,232,20.1712335990415,15.3357215450376,0.649599215843695,0.943089430894309,0.814035087719298,-1.5034995500877,51076.2413793103,35305.7327586207,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_549973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
550253,3733.39142857143,785.817142857143,115.954285714286,638.24,1298.64,4030.93428571429,2951.23428571429,275.52,1134.96285714286,5886.48571428571,706.302857142857,139.245714285714,1079.96285714286,2626.70857142857,676.777142857143,347.888571428571,3638.65142857143,2386.16857142857,317.368571428571,234.162857142857,1020.91714285714,2447.83714285714,247.105714285714,221.111428571428,596.245714285714,1557.63142857143,478.92,669.28,1075.43714285714,131.957142857143,350,23.5131874485643,19.6035055093107,0.552181598345873,0.964187327823691,0.760869565217391,0.154915821583026,50954.8171428571,35870.44,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_550253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
551716,2009.8025751073,373.098712446352,450.347639484979,635.755364806867,2502.59656652361,1957.14592274678,909.223175965665,267.141630901288,1092.30901287554,3873.62660944206,881.682403433476,115.304721030043,1074.52789699571,664.948497854077,554.648068669528,372.841201716738,1572.76824034335,1006.38626609442,287.68669527897,231.214592274678,993.763948497854,999.523605150215,237.12017167382,195.729613733906,580.291845493562,2269.80686695279,566.467811158798,345.974248927039,1043.330472103,129.656652360515,233,19.8164519585491,14.9951975186469,0.653757114516001,0.951020408163265,0.776666666666667,0.151691853306181,51157.9442060086,35618.6223175966,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_551716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
552719,4366.62337662338,253.896103896104,118.334415584416,659.292207792208,2944.48376623377,4837.01623376623,389.327922077922,277.782467532468,1113.41883116883,7333.04545454545,555.555194805195,120.782467532468,1087.39935064935,974.782467532468,497.204545454545,306.61038961039,1632.63636363636,1590.61038961039,315.733766233766,233.477272727273,1017.65584415584,1295.16883116883,216.448051948052,172.788961038961,586.892857142857,1915.33441558442,495.37012987013,258.522727272727,1044.19480519481,131.301948051948,308,24.2495819395819,16.3194034842484,0.739663686651809,0.950617283950617,0.754901960784314,-0.285897850429039,50774.288961039,35242.3896103896,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_552719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
552773,466.132727272727,551.24,152.081818181818,609.9,150.267272727273,478.392727272727,320.343636363636,248.603636363636,1103.77090909091,1072.33818181818,864.945454545455,112.329090909091,1062.51272727273,2371.99818181818,597.510909090909,286.66,1752.91636363636,2105.35636363636,345.181818181818,241.810909090909,1032.01090909091,1435.37818181818,237.630909090909,161.287272727273,1143.58,745.1,418.86,209.003636363636,1022.50909090909,131.707272727273,550,39.574436366237,17.7454157836884,0.893829980984146,0.946643717728055,0.742240215924426,1.46724540942482,51514.2072727273,34078.9290909091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_552773,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
553437,2528.34090909091,177.833333333333,118.643939393939,642.431818181818,2486.57575757576,2757.84848484848,342.537878787879,276.780303030303,1079.73484848485,4960.55303030303,582.909090909091,119.121212121212,1070.09848484848,928.439393939394,566.780303030303,278.333333333333,1585.87121212121,1227.62878787879,254.068181818182,224.984848484848,1324.75757575758,872.939393939394,196.204545454545,148.757575757576,585.742424242424,1369.56818181818,484.090909090909,228.522727272727,1047.37121212121,129.560606060606,132,20.366517174101,8.56414361107821,0.907292011702194,0.910344827586207,0.66,-1.34148859346404,51088.8939393939,35274.3181818182,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_553437,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
553673,1368.31297709924,435.709923664122,187.412213740458,677.36641221374,3531.17557251908,1610.20610687023,1348.85496183206,270.900763358779,1090.51145038168,3539.59541984733,4177.20610687023,113.908396946565,1077.23664122137,2825.10687022901,1811.69465648855,373.396946564886,1990.96183206107,3172.40458015267,425.06106870229,253.12213740458,1045.63358778626,1913.00763358779,236.167938931298,192.961832061069,662.854961832061,2324.6641221374,536.274809160305,526.236641221374,1078.71755725191,136.343511450382,131,13.8529989682536,12.0827043709699,0.489134149934223,0.929078014184397,0.71978021978022,0.954249232813587,50952.6564885496,35101.0076335878,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_553673,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
554246,1804.75840978593,309.868501529052,160.7125382263,669.039755351682,4392.83180428135,2012.76146788991,656.067278287462,269.348623853211,1108.2752293578,4093.29663608563,811.149847094801,121.966360856269,1099.11314984709,1090.03975535168,587.204892966361,290.079510703364,1623.0122324159,1419.2874617737,335.82874617737,243.452599388379,985.62996941896,1201.03669724771,253.574923547401,137.77370030581,587.522935779817,2829.99694189602,675.345565749235,372.064220183486,1134.46788990826,131.477064220183,327,26.7320888652054,15.6102927815104,0.811787218310441,0.967455621301775,0.717105263157895,1.06709234941398,51692.626911315,34867.373088685,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_554246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
554437,992.204651162791,230.958139534884,97.7581395348837,612.660465116279,924.023255813954,1270.11627906977,619.027906976744,255.060465116279,1078.01860465116,2658.18604651163,896.106976744186,115.511627906977,1066.70697674419,811.646511627907,559.874418604651,271.120930232558,1547.23720930233,1109.5488372093,320.488372093023,236.93488372093,984.441860465116,985.748837209302,216.66976744186,135.260465116279,689.195348837209,1580.60930232558,529.748837209302,273.33023255814,1046.85581395349,130.144186046512,215,21.3379891465516,12.8596176024804,0.797995770133054,0.951327433628319,0.66358024691358,-0.817097119586852,51309.4744186047,34530.4325581395,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_554437,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
554699,2660.98333333333,165.833333333333,76.7416666666667,641.4875,2060.05833333333,2869.425,868.591666666667,270.45,1111.95833333333,4239.8625,623.333333333333,129.170833333333,1070.27083333333,633.975,450.7875,340.391666666667,1396.52916666667,1113.1,315.291666666667,238.225,1054.02916666667,949.6,234.366666666667,136.05,594.779166666667,904.441666666667,463.666666666667,231.1125,1054.35833333333,131.391666666667,240,21.4589757912571,14.2900168023856,0.746020844286937,0.952380952380952,0.701754385964912,0.659592347122662,50121.825,34876.9666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_554699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
554897,3889.45214521452,800.194719471947,99.2970297029703,667.247524752475,2958.27722772277,4313.84488448845,772.257425742574,274.960396039604,1225.31683168317,7266.87788778878,812.069306930693,116.339933993399,1079.44554455446,1342.75577557756,547.353135313531,297.376237623762,1651.92079207921,1067.98349834983,283.260726072607,229.887788778878,1004.41584158416,939.118811881188,210.19801980198,152.63696369637,584.574257425743,2473.89768976898,520.46204620462,250.594059405941,1052.58415841584,131.356435643564,303,24.1191905006705,16.3650275683365,0.734594396432141,0.94392523364486,0.731884057971015,-0.273381348677491,50810.1716171617,35254.297029703,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_554897,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
555196,1528.42857142857,113.789346246973,110.414043583535,671.566585956416,2904.19370460048,1564.07021791768,1907.75060532688,253.033898305085,1102.99273607748,3030.46246973366,455.910411622276,107.893462469734,1079.87167070218,1711.78934624697,639.317191283293,631.123486682809,2042.89830508475,1763.33656174334,327.980629539952,235.215496368039,1015.28813559322,1408.79176755448,237.953995157385,264.852300242131,655.200968523002,1133.38983050847,402.98789346247,875.360774818402,1036.82082324455,129.314769975787,413,32.079049448979,16.4238309908089,0.858997382658864,0.956018518518518,0.61094674556213,0.787837266064485,51529.6610169492,35736.5278450363,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_555196,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
555688,3033.01181102362,281.767716535433,632.444881889764,622.606299212598,1243.5905511811,3198.9094488189,1821.31102362205,268.744094488189,1107.29527559055,6269.29921259843,1060.45275590551,113.740157480315,1074.77165354331,958.224409448819,578.405511811024,309.507874015748,1496.52755905512,1126.63385826772,296.354330708661,230.295275590551,989.633858267716,1044.89763779528,226.236220472441,172.295275590551,585.838582677165,2903.09448818898,511.622047244094,270.204724409449,1079.79133858268,131.074803149606,254,18.4704908142009,17.8784031354923,0.251165610620628,0.940740740740741,0.786377708978328,1.10177877584099,51544.9133858268,35512.3070866142,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_555688,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
555767,1596.8347826087,159.069565217391,149.017391304348,674.617391304348,2888.48695652174,1483.6,335.886956521739,262.834782608696,1092.55652173913,3108.93043478261,697.139130434783,116.4,1066.08695652174,916.0,513.617391304348,275.130434782609,1592.74782608696,1161.77391304348,254.55652173913,223.808695652174,1303.51304347826,865.234782608696,184.95652173913,152.617391304348,615.017391304348,1055.01739130435,461.84347826087,214.817391304348,1029.21739130435,129.608695652174,115,20.0110500894967,7.37863306598584,0.929537365591102,0.912698412698413,0.71875,1.4923919545595,51084.6260869565,35338.5391304348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_555767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
555908,3118.13962264151,551.656603773585,142.649056603774,641.181132075472,2031.36981132075,3675.35849056604,4414.96226415094,271.090566037736,1103.67169811321,5559.45283018868,2276.5320754717,114.11320754717,1081.12830188679,774.411320754717,640.977358490566,539.169811320755,1741.72830188679,1920.2,294.554716981132,233.705660377358,1027.57358490566,1853.04528301887,233.252830188679,414.060377358491,694.075471698113,1865.69811320755,513.498113207547,302.743396226415,1090.07547169811,132.301886792453,265,18.6888502664996,18.1197247894706,0.244904030052152,0.967153284671533,0.817901234567901,0.716278447928036,51516.7018867925,35048.9471698113,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_555908,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
555994,2156.95422535211,292.901408450704,91.3732394366197,626.943661971831,1199.65492957746,2074.04577464789,3569.72183098592,269.112676056338,1090.96830985915,3441.53169014085,1078.73591549296,109.669014084507,1077.25,675.207746478873,496.683098591549,476.718309859155,2208.98943661972,1055.32746478873,310.570422535211,238.700704225352,999.771126760563,1013.91549295775,238.725352112676,191.848591549296,603.943661971831,1303.03169014085,474.176056338028,532.845070422535,1049.01056338028,128.545774647887,284,27.2859378937047,13.5229205649028,0.868550681311665,0.949832775919732,0.587991718426501,0.77020559234766,51237.3838028169,35476.6021126761,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_555994,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
556819,3152.84233261339,630.423326133909,108.822894168467,641.732181425486,2055.07559395248,3417.24406047516,448.215982721382,277.075593952484,1102.28509719222,4835.79265658747,548.462203023758,116.051835853132,1074.51403887689,1251.89632829374,607.63282937365,496.684665226782,1646.25701943845,2196.38012958963,316.377969762419,233.645788336933,1043.78617710583,2105.46436285097,255.747300215983,1159.03887688985,609.801295896328,1206.04103671706,482.365010799136,240.300215982721,1040.32181425486,130.561555075594,463,27.658003288597,21.4069228522325,0.63320202403077,0.970649895178197,0.81657848324515,0.0313089691125834,50904.8423326134,35327.8725701944,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_556819,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
557845,1484.5668202765,135.930875576037,65.7327188940092,607.6866359447,537.52534562212,1562.64976958525,330.898617511521,256.801843317972,1079.06451612903,3465.95391705069,557.760368663594,107.21198156682,1064.90783410138,550.921658986175,667.889400921659,335.801843317972,1457.35023041475,916.290322580645,265.078341013825,227.709677419355,983.188940092166,861.824884792627,209.142857142857,126.506912442396,596.433179723502,2264.69124423963,485.299539170507,221.806451612903,1030.42857142857,130.248847926267,217,22.9281440972464,12.0922313230238,0.849619059648633,0.931330472103004,0.725752508361204,1.39339859481284,50186.4423963134,34795.4377880184,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_557845,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
558168,1620.34432234432,320.25641025641,298.78021978022,616.600732600733,1172.92307692308,1684.48717948718,441.604395604396,260.194139194139,1086.88278388278,3760.75824175824,506.223443223443,110.424908424908,1077.95604395604,810.131868131868,457.351648351648,266.391941391941,1710.06593406593,952.838827838828,234.644688644689,219.637362637363,998.838827838828,854.311355311355,194.553113553114,156.157509157509,582.791208791209,2008.73626373626,530.868131868132,295.728937728938,1022.72893772894,129.263736263736,273,20.4923884031657,16.9671128794675,0.560770229741199,0.97153024911032,0.764705882352941,0.0513631498689745,52065.0622710623,34974.4395604396,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_558168,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
559014,1644.91050583658,685.352140077821,115.642023346304,636.381322957198,2221.49416342412,1750.31906614786,771.470817120623,270.727626459144,1095.66926070039,2492.1439688716,1976.08949416342,118.964980544747,1077.32684824903,962.822957198444,759.550583657588,369.173151750973,1666.87937743191,1342.49416342412,304.054474708171,235.540856031128,1008.13035019455,1129.98638132296,220.714007782101,153.31906614786,608.898832684825,1058.01167315175,547.161478599222,253.665369649805,1023.01167315175,131.023346303502,514,31.7358054376664,20.6527245213522,0.759274532594666,0.964352720450281,0.67989417989418,0.805556590939405,51641.3035019455,34868.9824902724,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_559014,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
560079,5383.94932432432,442.030405405405,200.648648648649,671.027027027027,3524.36824324324,5636.97635135135,429.297297297297,274.540540540541,1133.38851351351,9140.04391891892,611.47972972973,128.851351351351,1101.73986486486,810.280405405405,483.452702702703,272.564189189189,1658.75,1140.03040540541,249.881756756757,221.631756756757,1005.71621621622,1147.82432432432,196.293918918919,158.25,585.695945945946,2434.36824324324,541.425675675676,236.584459459459,1067.63175675676,134.081081081081,296,21.8350558451413,17.336385949867,0.607956540156803,0.948717948717949,0.783068783068783,0.17234136423821,52018.4189189189,34492.0743243243,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_560079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
560119,2918.07692307692,820.935897435897,427.288461538462,617.00641025641,741.301282051282,3396.49358974359,389.429487179487,270.358974358974,1101.83333333333,4694.03846153846,502.532051282051,110.660256410256,1073.48076923077,1099.03205128205,894.211538461538,1298.98717948718,1617.08974358974,1236.16025641026,290.25,235.897435897436,1008.64102564103,993.653846153846,210.397435897436,175.576923076923,606.602564102564,1110.95512820513,492.0,235.865384615385,1029.11538461538,129.544871794872,156,15.6162694105428,12.8571775534703,0.567578335044627,0.928571428571429,0.696428571428571,-0.440102419490197,51228.4615384615,35116.0448717949,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_560119,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
560468,2501.75,337.4625,160.5975,692.535,3889.495,2674.42,2083.435,271.135,1108.3875,4591.72,1291.94,240.51,1085.3225,1706.18,972.2575,583.595,2077.1925,2532.3675,351.305,236.94,1037.22,2376.03,247.5625,440.96,644.7425,1956.57,526.3025,325.8275,1077.2775,132.25,400,31.8699860970111,16.0852101688576,0.86328694426402,0.950118764845606,0.615384615384615,-0.750494360575357,50554.345,34991.71,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_560468,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
560706,4160.57831325301,987.281124497992,230.232931726908,661.622489959839,3025.64257028112,4038.62248995984,1864.26907630522,283.951807228916,1194.86345381526,5978.95582329317,3141.65863453815,123.132530120482,1075.69477911647,918.309236947791,521.433734939759,510.160642570281,1612.53012048193,1065.16465863454,277.650602409639,227.642570281125,997.413654618474,932.437751004016,208.072289156627,215.168674698795,636.136546184739,1543.74698795181,543.265060240964,809.208835341365,1065.79919678715,132.510040160643,249,20.6705941039053,15.4465047587811,0.664521088572736,0.961389961389961,0.778125,-0.343953243076694,51474.4297188755,35448.0763052209,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_560706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
561033,1487.58823529412,215.843137254902,77.8235294117647,619.071895424837,745.627450980392,1645.92156862745,340.516339869281,258.40522875817,1079.26797385621,3657.83660130719,594.908496732026,106.895424836601,1062.66666666667,2549.72549019608,647.980392156863,561.555555555556,1645.8954248366,4627.2091503268,343.562091503268,240.771241830065,1021.70588235294,5003.15032679739,281.346405228758,266.281045751634,652.745098039216,2484.92156862745,522.790849673203,223.346405228758,1059.35294117647,131.947712418301,153,15.7096792503991,12.4026022817218,0.613766075457371,0.968354430379747,0.85,-1.44300934792411,50342.0980392157,34795.4248366013,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561033,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
561253,3451.07575757576,386.875,159.280303030303,635.367424242424,1673.18181818182,3729.7196969697,559.844696969697,281.348484848485,1095.29545454545,6362.56439393939,576.651515151515,121.924242424242,1105.86363636364,827.431818181818,493.659090909091,275.318181818182,1528.20075757576,1058.03787878788,305.325757575758,238.310606060606,986.69696969697,1057.14015151515,243.299242424242,134.791666666667,583.265151515152,2677.10227272727,492.397727272727,220.738636363636,1052.93939393939,130.488636363636,264,24.3038960095352,14.5467857852655,0.80109501572793,0.871287128712871,0.55,-0.615251721427112,50304.3636363636,35340.3333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_561253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
561565,2772.39318885449,75.2693498452012,104.538699690402,653.600619195046,3318.45820433437,3256.21981424149,407.46439628483,272.167182662539,1090.92569659443,5754.53560371517,799.879256965944,117.517027863777,1073.83900928793,953.554179566563,690.148606811146,627.222910216718,1608.58204334365,1096.61609907121,290.476780185759,226.43653250774,987.482972136223,969.798761609907,232.458204334365,150.8173374613,584.94427244582,2163.76470588235,497.613003095975,264.012383900929,1041.96904024768,131.213622291022,323,24.3885035774228,17.0901837325486,0.713409345334991,0.955621301775148,0.702173913043478,-1.05802913816096,51036.5170278638,35131.73374613,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561565,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
561823,4572.26225490196,1262.69117647059,253.333333333333,648.877450980392,2107.12254901961,4492.64705882353,675.30637254902,269.365196078431,1140.53921568627,8003.57598039216,820.259803921569,118.68137254902,1089.21078431373,888.205882352941,781.171568627451,462.963235294118,2335.28676470588,1010.54656862745,265.958333333333,223.651960784314,1010.32843137255,922.053921568627,209.188725490196,180.796568627451,628.75,2274.73284313725,505.522058823529,339.94362745098,1063.11029411765,130.264705882353,408,25.1001767896211,20.7746153516137,0.561217903142927,0.946635730858469,0.741818181818182,1.31965162251485,51383.2426470588,35477.5147058823,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561823,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
561833,4828.58208955224,791.179104477612,257.014925373134,620.761194029851,1266.64179104478,5870.16417910448,564.298507462687,279.537313432836,1314.25373134328,7331.97014925373,800.955223880597,128.65671641791,1086.23880597015,6172.68656716418,1505.50746268657,511.44776119403,5195.07462686567,7695.91044776119,576.925373134328,286.208955223881,1074.4776119403,7260.4328358209,356.671641791045,384.835820895522,824.865671641791,4538.65671641791,735.044776119403,350.298507462687,1111.49253731343,132.65671641791,67,10.6822409013682,8.88428363137977,0.55524436686193,0.8375,0.676767676767677,-1.18218083390842,51735.2537313433,34816.6268656716,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561833,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
562266,2102.84444444444,263.688888888889,132.792592592593,652.244444444444,1627.73333333333,2653.25185185185,319.911111111111,260.325925925926,1094.22222222222,4225.73333333333,575.022222222222,118.962962962963,1073.14814814815,925.0,572.303703703704,288.977777777778,1674.71851851852,1212.51111111111,303.977777777778,232.074074074074,1039.22962962963,1147.94074074074,208.718518518518,859.762962962963,1542.8962962963,1472.54074074074,469.548148148148,212.214814814815,1048.52592592593,130.622222222222,135,17.3320432581729,10.4427501624325,0.798110427967452,0.882352941176471,0.75,1.45745330039021,50548.3851851852,34406.4148148148,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_562266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
562448,1501.11740890688,206.202429149798,79.7327935222672,629.153846153846,1147.36032388664,1987.3036437247,362.635627530364,268.627530364372,1103.4979757085,3184.02834008097,989.894736842105,129.04048582996,1071.4979757085,626.971659919028,585.291497975708,273.210526315789,1673.21457489879,1163.45748987854,299.85020242915,232.016194331984,995.546558704453,984.801619433198,209.894736842105,152.643724696356,592.991902834008,1414.43724696356,558.421052631579,239.344129554656,1072.004048583,131.02024291498,247,22.7399789892883,14.213919759175,0.780574295674162,0.95,0.686111111111111,0.74386750154879,50396.1255060729,34832.4331983806,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_562448,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
563519,2522.97872340426,308.997340425532,162.178191489362,662.11170212766,3711.43617021277,3315.14627659574,360.904255319149,270.837765957447,1091.34308510638,4002.58244680851,559.327127659574,190.170212765957,1145.09840425532,900.731382978723,614.632978723404,303.154255319149,1393.06914893617,1430.0079787234,458.952127659574,258.186170212766,980.587765957447,1434.21276595745,300.922872340426,135.170212765957,584.095744680851,1628.76063829787,529.56914893617,229.816489361702,1060.51861702128,131.563829787234,376,25.1292942124173,19.2060292659114,0.644874537163254,0.959183673469388,0.776859504132231,-0.820942557540646,50964.9574468085,34549.7579787234,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_563519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
564133,2353.03184713376,479.095541401274,224.089171974522,679.267515923567,4475.02547770701,2357.43949044586,1474.68789808917,271.426751592357,1097.33121019108,4749.24203821656,2351.79617834395,121.127388535032,1076.17197452229,699.273885350318,593.12101910828,289.496815286624,1457.01910828025,1123.82165605096,345.165605095541,246.031847133758,988.821656050955,1066.68789808917,262.445859872611,170.12101910828,578.292993630573,2357.63694267516,508.254777070064,561.433121019108,1071.27388535032,134.267515923567,157,21.0829547534361,9.57086817096825,0.89102085488866,0.940119760479042,0.577205882352941,-0.693240801420722,50572.4522292994,35316.3949044586,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564133,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
565534,1972.5763546798,241.965517241379,108.034482758621,653.28078817734,2296.16256157635,2350.70935960591,380.512315270936,262.832512315271,1098.89655172414,4813.09852216749,864.448275862069,173.975369458128,1068.93103448276,1014.22660098522,722.679802955665,285.251231527094,1814.22167487685,1345.18226600985,323.458128078818,233.270935960591,1062.04926108374,1157.00492610837,206.369458128079,196.591133004926,3934.52709359606,1355.32019704433,519.487684729064,229.226600985222,1037.26600985222,130.07881773399,203,19.5951801639812,13.4260589244098,0.728381781674762,0.935483870967742,0.704861111111111,-1.02370524709468,51064.4482758621,33909.354679803,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_565534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
566210,1343.99481865285,188.269430051813,140.663212435233,648.60621761658,2478.59585492228,1660.15544041451,321.953367875648,263.917098445596,1085.56476683938,3342.9792746114,574.715025906736,119.041450777202,1082.21761658031,756.735751295337,503.901554404145,280.60621761658,1361.25388601036,1195.30051813472,363.849740932642,244.300518134715,990.647668393782,1173.47150259067,253.963730569948,126.243523316062,587.321243523316,2495.26943005181,582.253886010363,233.435233160622,1090.99481865285,131.658031088083,193,21.6900544932941,11.5344057484559,0.846880551965177,0.955445544554455,0.765873015873016,-1.3756832256267,50729.9792746114,34631.9689119171,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_566210,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
566751,1260.65789473684,416.09649122807,207.991228070175,628.640350877193,1734.75438596491,981.859649122807,606.035087719298,262.210526315789,1084.93859649123,2543.07894736842,823.254385964912,102.245614035088,1062.88596491228,2856.93859649123,587.640350877193,342.701754385965,1842.9649122807,1617.9649122807,306.184210526316,229.561403508772,1024.38596491228,1521.71929824561,234.017543859649,231.482456140351,675.833333333333,1499.0350877193,472.061403508772,270.640350877193,1039.0,129.043859649123,114,16.0786065184176,9.02381108534951,0.827659264104961,0.982758620689655,0.74025974025974,-1.01359991301791,50991.2456140351,35645.8684210526,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_566751,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
566941,2512.48945147679,317.198312236287,150.966244725738,640.654008438819,2012.60337552743,2891.45569620253,349.126582278481,261.928270042194,1097.59915611814,4179.8776371308,461.472573839662,113.092827004219,1108.53164556962,676.316455696203,465.206751054852,269.168776371308,1457.71729957806,1029.94936708861,305.548523206751,228.004219409283,991.751054852321,971.915611814346,220.814345991561,179.814345991561,579.616033755274,1146.78481012658,411.995780590717,206.497890295359,1031.0970464135,129.417721518987,237,21.6785436495919,14.0159063385046,0.762885532491937,0.944223107569721,0.697058823529412,-0.974081755246124,50485.0084388186,35736.0886075949,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_566941,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
567964,1199.58787878788,249.2,67.0787878787879,623.169696969697,1467.36363636364,1100.04242424242,1543.08484848485,260.945454545455,1086.18181818182,2554.69090909091,1519.24242424242,105.624242424242,1065.78181818182,2176.80606060606,972.163636363636,1428.69090909091,9445.62424242424,2638.09696969697,333.339393939394,239.187878787879,1062.90303030303,2104.38181818182,299.0,291.181818181818,753.466666666667,1586.27272727273,461.224242424243,728.412121212121,1065.80606060606,131.69696969697,165,19.2862250392751,10.8896096823017,0.825343139521345,0.970588235294118,0.833333333333333,-1.35572594510101,51031.4484848485,35608.0242424242,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_567964,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
568216,1815.07299270073,302.57299270073,92.6496350364964,669.675182481752,2453.8102189781,1858.32846715328,1363.8503649635,257.835766423358,1197.89416058394,3323.17518248175,596.653284671533,126.094890510949,1072.93065693431,1611.49270072993,661.671532846715,505.306569343066,1662.03284671533,1739.16423357664,322.598540145985,236.704379562044,1024.58759124088,1847.71532846715,292.832116788321,250.368613138686,604.467153284672,1545.40510948905,522.642335766423,985.773722627737,1109.07299270073,131.689781021898,274,20.7362160271964,16.8966441777843,0.579689593977743,0.96140350877193,0.805882352941176,-0.295019476591493,51118.5255474453,35822.4124087591,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_568216,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
568358,1346.25438596491,115.16081871345,80.1461988304094,629.514619883041,1610.27192982456,1768.86549707602,350.690058479532,251.12865497076,1087.73684210526,3015.06725146199,556.356725146199,111.926900584795,1073.80994152047,926.038011695906,475.16081871345,293.602339181287,1635.02923976608,1304.18128654971,260.777777777778,385.286549707602,1171.44444444444,1013.29824561404,186.488304093567,283.184210526316,1509.11695906433,1618.8918128655,503.055555555556,226.763157894737,1041.83040935673,129.134502923977,342,27.7033069751969,15.7672744650176,0.822235278839968,0.94475138121547,0.647727272727273,0.923656987488341,51938.6549707602,34180.514619883,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_568358,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
569354,988.24513618677,292.264591439689,100.210116731518,642.665369649805,2280.87937743191,981.634241245136,1348.89494163424,263.953307392996,1092.01945525292,1808.13618677043,3120.50972762646,106.062256809339,1069.77042801556,1222.92996108949,572.031128404669,299.591439688716,1673.00389105058,2978.12840466926,382.311284046693,240.249027237354,1025.47081712062,2912.4513618677,241.56420233463,415.887159533074,695.342412451362,1034.73540856031,442.346303501945,407.525291828794,1051.61478599222,129.677042801556,257,21.2489429002684,15.446616002111,0.686705491398098,0.948339483394834,0.755882352941176,-0.326817621764416,50825.8910505837,35476.4708171206,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_569354,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
569934,1945.89399293286,143.445229681979,167.236749116608,690.95406360424,4246.05653710247,2232.86925795053,375.459363957597,270.671378091873,1111.43109540636,3948.55477031802,522.328621908127,117.932862190813,1073.81272084806,722.547703180212,498.936395759717,367.26148409894,1584.26148409894,1110.42756183746,307.590106007067,231.413427561837,1001.68197879859,1004.62190812721,225.088339222615,160.003533568905,608.95406360424,1259.65371024735,426.554770318021,226.420494699647,1053.48409893993,130.272084805654,283,27.6014989845145,13.1383890581426,0.879443798374403,0.943333333333333,0.620614035087719,-0.583100832279612,50633.0636042403,35506.5689045936,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_569934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
570363,2983.42542787286,479.273838630807,119.117359413203,639.41564792176,1406.48899755501,3487.39364303178,2867.99755501222,273.342298288509,1101.8239608802,5159.39119804401,1251.50366748166,119.951100244499,1073.12224938875,1167.00488997555,662.894865525672,301.860635696822,1545.61369193154,1345.59657701711,243.687041564792,224.677261613692,1648.68948655257,769.982885085575,167.249388753056,124.083129584352,601.777506112469,1566.36674816626,552.034229828851,350.601466992665,1079.79217603912,132.496332518337,409,31.3469002918468,17.2439846944654,0.835097638069136,0.919101123595506,0.605029585798817,-0.891480854867913,50309.2029339853,35031.5452322738,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_570363,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
570573,1779.94816053512,417.807692307692,169.095317725752,663.864548494983,4048.61705685619,900.560200668896,477.844481605351,273.61872909699,1096.30267558528,1334.15384615385,679.372909698997,112.578595317726,1071.8143812709,481.157190635452,333.419732441472,253.423076923077,1469.94481605351,758.869565217391,204.729096989967,215.6872909699,990.78762541806,759.112040133779,175.809364548495,145.637123745819,579.157190635451,577.622073578595,372.782608695652,201.602006688963,982.230769230769,129.028428093645,598,34.7384037565144,22.9920898820951,0.749624164339127,0.904689863842663,0.621621621621622,-0.414087586682594,51629.4331103679,34711.5819397993,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_570573,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
570737,2623.89406779661,102.330508474576,227.055084745763,741.703389830509,7664.85593220339,3318.00423728814,356.110169491525,274.313559322034,1095.58050847458,5761.83898305085,726.885593220339,128.449152542373,1077.42796610169,1652.82203389831,807.326271186441,300.546610169492,1764.56355932203,2666.71610169492,349.266949152542,238.483050847458,1006.89830508475,2774.50423728814,233.762711864407,174.330508474576,591.161016949153,2350.00847457627,516.716101694915,234.457627118644,1068.38983050847,130.453389830508,236,26.5086368994994,11.3361076999849,0.903949947492716,0.936507936507936,0.756410256410256,-1.48234251701765,51076.5254237288,35117.0423728814,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_570737,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
571656,2116.47802197802,126.126373626374,81.771978021978,633.552197802198,977.255494505494,2383.43681318681,324.796703296703,256.425824175824,1095.84615384615,4564.0467032967,1051.81318681319,118.972527472527,1069.21978021978,876.884615384615,489.92032967033,278.593406593407,1383.65934065934,1330.71978021978,324.953296703297,239.980769230769,990.706043956044,1182.27472527473,228.186813186813,123.005494505495,612.392857142857,1728.83516483516,487.901098901099,218.876373626374,1056.14835164835,131.483516483516,364,33.147917816864,14.2302385374747,0.903164282492294,0.928571428571429,0.735353535353535,0.0856846817712455,50065.760989011,34220.4093406593,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_571656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
571721,1148.40548780488,75.8262195121951,46.405487804878,609.05487804878,703.719512195122,1425.40853658537,370.378048780488,245.966463414634,1083.40548780488,2568.69512195122,502.743902439024,100.701219512195,1064.92682926829,1028.39634146341,795.780487804878,294.378048780488,2085.12804878049,1210.30792682927,309.317073170732,234.490853658537,1000.97256097561,994.378048780488,198.734756097561,149.34756097561,707.09756097561,1421.70426829268,459.771341463415,231.225609756098,1043.16768292683,128.47256097561,328,27.9713105867249,15.0150098014484,0.843709289677906,0.942528735632184,0.706896551724138,0.138567799520121,50633.4634146341,34265.9085365854,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_571721,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
571865,2695.3285198556,424.28880866426,152.068592057762,630.974729241877,935.981949458484,3436.42599277978,938.620938628159,281.58844765343,1098.14801444043,4606.28880866426,793.43321299639,126.212996389892,1073.07220216606,649.025270758123,530.126353790614,268.27797833935,1382.72924187726,1000.80505415162,305.241877256318,231.014440433213,984.31046931408,995.15523465704,222.592057761733,126.292418772563,584.259927797834,1695.35740072202,571.285198555957,229.826714801444,1068.54151624549,132.610108303249,277,21.128773253643,17.0698792298212,0.589323276879251,0.942176870748299,0.732804232804233,0.399542835963734,50416.3718411552,34531.0397111913,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_571865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
572933,1359.68027210884,163.850340136054,140.224489795918,671.336734693878,3432.70408163265,1573.89455782313,2975.81632653061,262.544217687075,1092.89795918367,3183.7074829932,2071.70068027211,113.06462585034,1073.04761904762,2112.74149659864,964.84693877551,325.80612244898,2264.4387755102,2538.02721088435,339.166666666667,238.149659863946,1026.76530612245,2467.63945578231,273.62925170068,360.765306122449,639.843537414966,1578.40136054422,452.469387755102,727.472789115646,1069.62585034014,131.829931972789,294,25.7503606714753,14.5888680622999,0.824027331855852,0.97029702970297,0.710144927536232,-1.04997472983515,50655.3367346939,35356.887755102,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_572933,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
573941,2475.2331838565,749.484304932735,86.2600896860987,623.461883408072,1112.52466367713,2314.33183856502,3666.24215246637,262.367713004484,1106.0,3740.04035874439,971.443946188341,114.461883408072,1068.16591928251,569.233183856502,398.959641255605,288.816143497758,1484.47533632287,1150.00896860987,222.681614349776,249.910313901345,998.70403587444,1235.40358744395,191.708520179372,172.479820627803,579.910313901345,1167.78475336323,492.887892376682,487.533632286995,1062.59192825112,131.57399103139,223,22.3532201536573,13.1547152434952,0.808502258362086,0.921487603305785,0.758503401360544,-1.38751621055384,51747.0224215247,35360.5560538117,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573941,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
573960,1942.72452830189,1079.67924528302,117.433962264151,693.954716981132,3204.89056603774,1732.96226415094,3158.39245283019,261.943396226415,1282.8641509434,4600.53962264151,635.377358490566,113.856603773585,1074.97358490566,820.090566037736,489.68679245283,273.422641509434,1590.28301886792,1155.96603773585,247.562264150943,226.754716981132,1280.60754716981,920.611320754717,195.796226415094,218.630188679245,650.188679245283,2330.42641509434,507.143396226415,455.007547169811,1071.47169811321,131.464150943396,265,23.0447032621756,14.8282179691521,0.765484362349681,0.94306049822064,0.701058201058201,0.538367129159162,51891.8452830189,35407.1660377358,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573960,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
574045,1897.85746606335,189.260180995475,159.076923076923,674.610859728507,4362.592760181,1844.69230769231,339.938914027149,262.12443438914,1103.84841628959,3898.42986425339,535.031674208145,120.319004524887,1074.59954751131,2599.64479638009,633.825791855204,363.538461538462,1681.29185520362,2341.78054298643,327.481900452489,237.257918552036,1100.92307692308,2307.81221719457,235.902714932127,221.380090497738,642.581447963801,1277.15384615385,421.506787330317,282.352941176471,1048.7443438914,128.730769230769,442,35.2726944896707,16.1151342052927,0.889532044002443,0.952586206896552,0.637806637806638,-1.14099282185374,51818.463800905,35513.5248868778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_574045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
574153,2833.0,577.919540229885,317.82183908046,716.770114942529,6205.97701149425,3497.78735632184,383.086206896552,278.097701149425,1101.2183908046,5240.31034482759,621.137931034483,135.959770114943,1086.25862068966,810.787356321839,678.586206896552,296.850574712644,1408.29885057471,1228.0,319.626436781609,238.120689655172,986.936781609195,2302.26436781609,244.568965517241,166.011494252874,588.833333333333,1388.68965517241,613.471264367816,238.718390804598,1055.95402298851,130.431034482759,174,18.9122277199959,11.9082119953959,0.77687345618668,0.940540540540541,0.704453441295547,-0.104371227522514,51723.316091954,33993.5862068966,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_574153,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
575809,1598.96774193548,342.051612903226,66.6129032258064,620.693548387097,926.890322580645,1607.38387096774,1740.46451612903,261.364516129032,1120.20322580645,3383.83548387097,2297.60967741935,108.68064516129,1066.59677419355,715.8,535.525806451613,344.829032258065,1507.8935483871,1171.83225806452,297.232258064516,236.783870967742,1005.67096774194,1069.55806451613,223.335483870968,227.374193548387,1415.07741935484,1880.12903225806,502.609677419355,752.512903225806,1061.28709677419,131.5,310,26.5748750124455,14.9463596355748,0.82684867462224,0.962732919254658,0.640495867768595,-0.807370064962172,51616.4129032258,35353.2258064516,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_575809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
576250,1719.4512195122,173.548780487805,129.752032520325,644.878048780488,2231.43902439024,1978.0081300813,336.768292682927,274.146341463415,1090.06910569106,2873.58536585366,576.756097560976,117.593495934959,1069.09756097561,1027.21951219512,530.227642276423,281.69512195122,1688.26016260163,1390.30487804878,280.394308943089,231.813008130081,1112.9918699187,1314.19105691057,203.638211382114,181.434959349593,1397.64634146341,1134.84146341463,489.105691056911,218.166666666667,1027.73170731707,131.715447154472,246,22.413256808868,14.0695916127043,0.778426902220888,0.957198443579767,0.745454545454545,-0.309558811305256,51061.7520325203,35337.4756097561,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_576250,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
576393,2019.9375,182.3984375,164.390625,703.6796875,4265.71875,2390.62109375,496.9609375,271.1484375,1098.46875,3633.078125,554.41796875,120.5859375,1075.1953125,1275.01171875,713.80078125,310.63671875,1651.0234375,1804.01171875,353.36328125,238.2734375,1018.31640625,1936.328125,395.8984375,228.90234375,592.265625,1087.296875,443.1640625,261.69921875,1030.8671875,128.453125,256,19.0906435644714,17.3151288102682,0.421140199300453,0.951672862453532,0.709141274238227,1.0251932630429,51489.9296875,35591.54296875,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_576393,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
576427,1113.28205128205,442.820512820513,82.7948717948718,620.076923076923,977.051282051282,846.290598290598,462.358974358974,254.615384615385,1078.08547008547,2719.57264957265,485.863247863248,105.538461538462,1067.59829059829,1689.46153846154,745.521367521368,282.452991452991,1720.67521367521,1748.63247863248,345.521367521367,240.717948717949,993.982905982906,1494.11965811966,244.735042735043,159.247863247863,861.213675213675,1985.73504273504,496.555555555556,220.717948717949,1029.79487179487,130.675213675214,117,13.5641724651711,10.9870690889683,0.586420773544919,0.975,0.818181818181818,-1.28480348170916,51552.0598290598,35427.8888888889,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_576427,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
577019,1743.93820224719,135.039325842697,57.0393258426966,661.455056179775,1057.55617977528,2402.12921348315,355.865168539326,259.38202247191,1130.29775280899,4642.02808988764,614.921348314607,107.174157303371,1076.48876404494,872.224719101124,500.331460674157,369.005617977528,1424.94943820225,1234.83146067416,298.814606741573,229.404494382022,997.522471910112,1681.73595505618,263.741573033708,207.050561797753,673.825842696629,2361.39887640449,498.202247191011,227.022471910112,1036.92134831461,128.741573033708,178,18.3826392837842,12.5023637529451,0.733102662881419,0.951871657754011,0.720647773279352,-1.43944911258862,51132.202247191,35109.8426966292,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_577019,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
578283,2107.31818181818,278.801652892562,147.157024793388,656.652892561983,3268.52066115702,2319.2479338843,492.144628099174,266.884297520661,1094.16115702479,4580.19421487603,828.603305785124,114.04132231405,1085.53719008264,750.739669421488,535.942148760331,274.297520661157,1463.53719008264,1405.49173553719,296.950413223141,235.590909090909,990.078512396694,1404.23140495868,223.132231404959,155.198347107438,640.301652892562,2304.82231404959,528.582644628099,388.169421487603,1082.60330578512,131.082644628099,242,27.8680171015346,11.1310539844776,0.916767887705402,0.941634241245136,0.560185185185185,0.576271527906567,50788.5702479339,35080.5743801653,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578283,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
578333,3898.57333333333,1369.82933333333,131.258666666667,665.744,2114.10133333333,3660.312,1230.32533333333,281.008,1142.352,6532.83733333333,782.797333333333,121.682666666667,1084.368,2354.54666666667,749.093333333333,340.834666666667,2099.048,1938.82133333333,302.768,234.210666666667,1012.944,1662.93866666667,350.805333333333,341.232,591.346666666667,2155.184,529.170666666667,461.314666666667,1065.94133333333,132.122666666667,375,28.4413342756632,16.9165864089389,0.803882025945763,0.954198473282443,0.686813186813187,0.531025775432863,51164.7946666667,35582.9226666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
578372,5578.95626822157,1468.98833819242,241.6472303207,746.825072886297,5639.22740524781,6403.61516034985,2454.54227405248,303.860058309038,1148.10495626822,8436.80174927114,1170.2332361516,149.390670553936,1083.75510204082,3118.32069970845,1077.81924198251,2913.12536443149,1795.52186588921,2258.02915451895,378.99416909621,493.183673469388,1021.33236151604,1561.21282798834,279.087463556851,250.00583090379,682.927113702624,2060.71428571429,596.507288629738,445.01166180758,1081.55685131195,132.180758017493,343,24.7641912680213,17.6839877863866,0.700048698099747,0.958100558659218,0.762222222222222,-0.0370559124119402,51004.8279883382,34423.0758017493,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578372,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
578554,4509.14285714286,319.510822510822,90.4588744588745,612.904761904762,451.74025974026,5182.0303030303,514.329004329004,283.65367965368,1109.38961038961,6450.37229437229,811.203463203463,123.597402597403,1086.21645021645,735.181818181818,491.281385281385,284.246753246753,1427.92207792208,1101.22510822511,329.909090909091,236.61038961039,991.575757575758,1100.38528138528,242.285714285714,145.948051948052,587.658008658009,1243.95670995671,464.385281385281,243.051948051948,1010.86147186147,130.320346320346,231,19.4949183501397,15.146412057672,0.629572735805608,0.978813559322034,0.855555555555556,-1.22254105070261,50528.1774891775,35387.9177489177,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578554,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
579010,2410.29945054945,329.576923076923,148.038461538462,656.535714285714,1815.28571428571,2959.01098901099,421.398351648352,274.159340659341,1091.75824175824,4241.5521978022,574.10989010989,124.239010989011,1093.18406593407,1417.24725274725,532.348901098901,282.258241758242,1752.5,1293.13736263736,284.818681318681,231.120879120879,1020.38736263736,1118.28296703297,209.381868131868,126.398351648352,594.752747252747,1739.67582417582,520.271978021978,224.678571428571,1049.40659340659,130.535714285714,364,38.5552471717392,12.3179648725188,0.947590093814331,0.926208651399491,0.52,-0.474251311062194,50082.3021978022,34772.6263736264,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
579262,2039.44166666667,840.591666666667,158.591666666667,636.9,1936.96666666667,2032.49166666667,1189.75,252.575,1185.225,2983.88333333333,520.15,104.125,1067.35833333333,787.275,1274.01666666667,1489.95833333333,1855.075,993.65,246.716666666667,226.675,1003.325,839.1,177.783333333333,135.875,648.566666666667,1173.48333333333,477.558333333333,228.583333333333,1041.325,133.258333333333,120,14.4503859998589,10.6924017679001,0.672674157305383,0.930232558139535,0.714285714285714,-0.361217623987225,51475.9833333333,34950.3583333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579262,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
579635,4576.22222222222,1226.79738562092,1941.99346405229,633.562091503268,1644.72549019608,4857.67647058824,499.326797385621,273.859477124183,1140.43790849673,6869.20588235294,601.496732026144,116.918300653595,1073.3137254902,576.205882352941,434.411764705882,263.823529411765,1464.27450980392,904.43137254902,251.666666666667,229.774509803922,993.153594771242,854.009803921569,187.369281045752,158.111111111111,707.24183006536,1867.47385620915,576.316993464052,240.173202614379,1038.01633986928,132.029411764706,306,24.4874518987015,16.0481638307725,0.755314282379142,0.977635782747604,0.88695652173913,-0.0788415474037574,51521.7581699346,34787.7745098039,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579635,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
580100,3354.992,939.44,188.288,679.504,3802.496,4462.992,424.352,276.328,1210.64,6940.448,615.348,124.456,1076.428,665.764,500.604,341.48,1571.408,920.228,264.808,226.896,989.564,869.036,201.836,138.272,588.676,2896.616,585.552,234.404,1083.708,132.52,250,18.3033534520594,17.4422930949168,0.303108216734065,0.968992248062015,0.816993464052288,1.15531723983521,51979.152,34510.8,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_580100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
580335,1316.2864321608,189.400753768844,60.2072864321608,638.899497487437,1726.58417085427,1268.00125628141,1825.23492462312,260.159547738693,1097.90577889447,2107.92085427136,2082.04271356784,113.709798994975,1067.22738693467,554.552763819096,363.016331658291,261.758793969849,1547.2675879397,816.342964824121,225.39824120603,219.579145728643,993.9108040201,786.866834170854,174.639447236181,136.611809045226,582.206030150754,579.486180904523,373.777638190955,203.790201005025,986.061557788945,128.625628140704,796,33.7050982479088,30.1839814852379,0.444997870047674,0.963680387409201,0.780392156862745,0.0559236907659198,51738.783919598,34623.108040201,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_580335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
580429,1592.604,623.78,1008.424,616.024,1055.304,1681.86,341.768,250.768,1123.124,3271.752,509.16,105.488,1075.984,670.676,466.26,342.744,1589.624,1155.496,293.04,231.02,1014.528,1024.644,279.56,179.348,660.0,1893.612,481.1,256.492,1042.508,129.62,250,21.5586379172704,14.7881740303539,0.727647524996016,0.950570342205323,0.735294117647059,0.538268139394384,50518.076,35571.608,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_580429,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
582208,4062.93014705882,758.408088235294,134.242647058824,656.643382352941,2493.80882352941,4466.4375,445.080882352941,274.341911764706,1117.08455882353,7739.07352941176,565.0625,117.669117647059,1088.54044117647,1572.39705882353,734.25,590.485294117647,5573.52205882353,1320.83455882353,264.551470588235,227.441176470588,1006.98161764706,1026.23529411765,189.628676470588,235.033088235294,642.099264705882,2386.00367647059,550.794117647059,266.294117647059,1057.02941176471,129.720588235294,272,23.9136055666337,15.2915149351226,0.768834081205821,0.87741935483871,0.657004830917874,-0.324329560058138,51297.6102941177,35105.7095588235,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_582208,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
582306,2802.38289962825,189.343866171004,143.258364312268,778.256505576208,5267.04089219331,2764.3624535316,1276.26579925651,261.154275092937,1266.08921933086,5651.02973977695,735.176579925651,122.970260223048,1076.2063197026,1652.09851301115,656.447955390335,293.724907063197,2039.91821561338,1596.8717472119,276.644981412639,223.92936802974,1025.73605947955,969.131970260223,184.596654275093,165.888475836431,583.347583643123,1803.78252788104,513.100371747212,315.10594795539,1067.72676579926,130.85687732342,538,32.5836482755655,21.1780111517523,0.759969912347625,0.962432915921288,0.747222222222222,-0.479316890854445,52046.4107806691,34926.2267657993,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_582306,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
582453,4518.17081850534,917.612099644128,910.996441281139,648.782918149466,2714.43416370107,5130.27758007117,559.487544483986,276.181494661922,1161.69395017794,8446.30604982206,746.113879003559,122.188612099644,1077.98220640569,1843.23131672598,517.565836298932,310.918149466192,1871.86832740214,2274.30960854093,287.302491103203,228.672597864769,1097.91103202847,1609.04270462633,200.590747330961,178.135231316726,970.010676156584,3760.95729537367,574.430604982206,515.010676156584,1066.43416370107,131.099644128114,281,21.4671974151953,16.7828095455026,0.623543609973278,0.95578231292517,0.743386243386243,-0.498358958312777,51904.7117437722,34889.7508896797,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_582453,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
583193,2142.10305343511,327.862595419847,114.713740458015,624.381679389313,521.839694656489,1955.27480916031,690.725190839695,259.019083969466,1079.34351145038,4285.6679389313,938.213740458015,123.141221374046,1121.84732824427,2177.18702290076,646.129770992366,283.164122137405,1678.74809160305,2175.84732824427,373.843511450382,245.992366412214,1031.75954198473,6489.74045801527,322.732824427481,735.248091603053,2243.27099236641,1333.56106870229,596.156488549618,356.610687022901,1064.54198473282,130.286259541985,262,21.9010993621087,15.6897741532533,0.697697918837714,0.952727272727273,0.733893557422969,-0.352625291407842,50878.8625954199,33651.2442748092,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_583193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
584978,2370.11895910781,333.505576208178,182.416356877323,661.460966542751,2999.22304832714,3106.47955390335,499.312267657993,278.018587360595,1086.03345724907,4259.32713754647,820.609665427509,124.717472118959,1073.07063197026,672.118959107807,509.501858736059,280.847583643123,1342.75836431227,1028.63568773234,356.133828996283,244.24907063197,979.312267657993,990.579925650558,248.579925650558,128.130111524164,582.546468401487,2331.00371747212,591.122676579926,296.28624535316,1103.30855018587,133.438661710037,269,27.3989104599279,13.0450456043518,0.879382762384902,0.924398625429553,0.566315789473684,0.524577893246219,50409.8550185874,34654.5390334573,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_584978,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
585299,813.277533039648,184.704845814978,88.3127753303965,620.903083700441,994.779735682819,995.850220264317,298.506607929515,256.625550660793,1088.11013215859,2271.19823788546,510.969162995595,113.339207048458,1066.11013215859,906.577092511013,533.321585903084,281.400881057269,1498.17621145374,1161.20704845815,245.977973568282,225.092511013216,1334.78854625551,888.823788546256,171.810572687225,171.810572687225,4289.35682819383,1836.99559471366,530.656387665198,224.220264317181,1012.94273127753,130.105726872247,227,18.7176714665957,15.4585758150224,0.563843943484449,0.953781512605042,0.746710526315789,0.511815002729847,50547.422907489,34428.0440528634,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_585299,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
585566,2480.29977628635,301.841163310962,212.720357941834,746.964205816555,5919.62863534676,2775.79865771812,716.816554809843,271.740492170022,1119.26845637584,3701.63982102908,840.668903803132,131.335570469799,1078.7225950783,2069.68680089485,611.953020134228,820.06711409396,1664.56375838926,2668.0581655481,420.7225950783,942.563758389262,1024.92617449664,2287.26845637584,466.373601789709,324.23937360179,637.474272930649,1121.26845637584,515.246085011186,239.854586129754,1030.53914988814,130.134228187919,447,31.6208185446383,18.313557008093,0.815212912153372,0.943037974683544,0.6984375,-0.108161641647733,50991.0425055928,34410.4899328859,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_585566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
585775,2309.27894736842,184.384210526316,96.3605263157895,625.389473684211,1181.27894736842,2551.95526315789,366.61052631579,252.189473684211,1089.47631578947,4412.99473684211,542.284210526316,112.192105263158,1087.73684210526,2549.70526315789,615.471052631579,289.276315789474,1661.62631578947,1774.52894736842,345.160526315789,239.897368421053,1087.68157894737,1507.38157894737,227.686842105263,745.555263157895,707.355263157895,1846.67894736842,518.66052631579,229.181578947368,1045.47894736842,131.2,380,39.7479035093944,12.2894144194943,0.951002247946788,0.935960591133005,0.625,-1.31063002348555,51168.5157894737,34373.3921052632,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_585775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
585985,2551.82043343653,342.575851393189,90.2167182662539,640.730650154799,1481.91950464396,3311.79256965944,1194.64086687307,262.427244582043,1084.27244582043,5416.6346749226,3252.79876160991,117.33746130031,1075.08359133127,1091.12074303406,1591.82043343653,744.582043343653,1758.49226006192,3162.93808049536,416.904024767802,255.291021671827,1015.11455108359,3521.95665634675,279.876160990712,741.647058823529,929.222910216718,2245.13003095975,540.049535603715,515.321981424149,1087.71826625387,129.876160990712,323,23.6925125360853,17.4623940513384,0.675846149974809,0.95,0.747685185185185,0.146725083366747,50635.2043343653,34312.5665634675,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_585985,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
586130,1499.73983739837,487.894308943089,125.174796747967,644.361788617886,1925.93902439024,1873.08536585366,3495.02032520325,261.939024390244,1096.36991869919,2521.81707317073,2254.4918699187,112.447154471545,1070.79268292683,650.943089430894,594.357723577236,303.60162601626,1412.16666666667,997.813008130081,264.662601626016,228.146341463415,988.987804878049,969.581300813008,200.430894308943,125.80487804878,619.414634146341,1046.60975609756,480.707317073171,556.073170731707,1062.4756097561,132.020325203252,246,21.1462499258506,14.8768704713939,0.710672617410066,0.953488372093023,0.780952380952381,-1.49607279997122,50157.2317073171,34787.1666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_586130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
587034,2078.98026315789,614.394736842105,37.8881578947368,608.769736842105,893.434210526316,2100.27631578947,428.572368421053,262.789473684211,1085.29605263158,3736.69078947368,483.684210526316,113.953947368421,1076.48026315789,1630.10526315789,743.355263157895,332.302631578947,1978.30921052632,2654.61842105263,344.434210526316,230.546052631579,1084.05921052632,2412.75657894737,228.421052631579,223.230263157895,593.164473684211,1944.56578947368,481.625,243.322368421053,1032.43421052632,129.230263157895,152,16.7497440256294,12.0550196556707,0.694271013961463,0.910179640718563,0.678571428571429,0.790127516779893,51184.7434210526,35777.3157894737,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_587034,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
587279,1160.95348837209,645.895348837209,84.0,659.790697674419,1500.91860465116,1005.77906976744,2866.41860465116,265.162790697674,1107.88372093023,2292.73255813953,613.56976744186,119.883720930233,1073.51162790698,745.209302325581,603.53488372093,960.732558139535,1692.36046511628,1366.5,421.372093023256,235.872093023256,1038.79069767442,1216.09302325581,244.093023255814,1157.94186046512,681.186046511628,1527.17441860465,552.662790697674,1859.37209302326,1062.67441860465,128.488372093023,86,11.0804473463217,9.87401976796899,0.453765678800326,0.955555555555556,0.781818181818182,0.980871579905061,51147.2441860465,35808.6279069767,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_587279,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
587374,2224.61196581197,147.623931623932,63.1213675213675,637.408547008547,1486.12991452991,2599.75555555556,909.181196581197,255.796581196581,1099.06153846154,4420.18803418803,754.993162393162,116.420512820513,1078.64273504274,697.369230769231,559.398290598291,294.760683760684,1503.88717948718,1134.17606837607,312.044444444444,236.155555555556,1005.48547008547,1164.12307692308,234.193162393162,393.222222222222,650.507692307692,1312.41538461538,461.017094017094,313.304273504274,1045.25982905983,129.989743589744,585,36.2911545899342,20.8284594549065,0.818906736009426,0.951219512195122,0.748081841432225,-0.313611280628113,50519.7076923077,34303.0683760684,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_587374,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
588445,1148.63722397476,107.16403785489,69.0504731861199,626.98738170347,1731.31861198738,1376.44164037855,296.621451104101,250.173501577287,1092.33753943218,2554.64668769716,435.003154574133,108.930599369085,1070.96214511041,3762.89905362776,697.422712933754,305.880126182965,1706.94952681388,5682.39432176656,423.16403785489,244.779179810726,1011.52050473186,6065.24921135647,258.993690851735,183.81072555205,583.293375394322,958.946372239748,433.091482649842,214.305993690852,1027.3880126183,129.624605678233,317,27.8535410510732,14.5175219494989,0.853428946106016,0.963525835866261,0.704444444444444,0.470879842764503,51756.3470031546,35045.1798107256,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_588445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
588886,3654.38152610442,559.393574297189,79.7389558232932,634.421686746988,1520.63453815261,3807.1124497992,544.028112449799,258.570281124498,1129.45381526104,6164.51807228916,643.449799196787,119.903614457831,1076.09638554217,716.95983935743,464.116465863454,276.104417670683,3677.0281124498,1165.04819277108,265.518072289157,225.63453815261,995.0,1226.06827309237,200.991967871486,139.385542168675,588.927710843373,1635.81124497992,528.879518072289,303.168674698795,1051.98393574297,132.028112449799,249,24.0432756068933,13.2086232432003,0.83558005197983,0.946768060836502,0.655263157894737,-0.759316966151342,51983.297188755,34292.8152610442,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_588886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
589727,2277.84955752212,183.713864306785,75.4896755162242,653.601769911504,2332.83480825959,2654.07079646018,2523.48377581121,268.011799410029,1099.36873156342,4905.74336283186,1394.21828908555,116.525073746313,1073.60766961652,676.675516224189,488.958702064897,286.982300884956,1421.53982300885,1068.26548672566,334.463126843658,239.008849557522,986.572271386431,1039.07669616519,244.690265486726,149.12389380531,587.053097345133,2255.35693215339,524.368731563422,897.946902654867,1099.56932153392,132.386430678466,339,31.0336950566314,14.2184126508608,0.888869491968859,0.963068181818182,0.597883597883598,-0.602043747843482,50686.6165191741,35277.4837758112,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_589727,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
589763,1274.34657039711,97.1516245487365,75.0180505415162,638.198555956679,1611.71119133574,1368.51263537906,325.837545126354,256.617328519856,1096.35379061372,2986.57400722022,485.310469314079,103.462093862816,1069.62815884477,1218.8880866426,1059.0036101083,746.985559566787,1595.47292418773,1208.08303249097,279.382671480144,230.85559566787,1016.48736462094,1137.35379061372,220.960288808664,314.563176895307,758.346570397112,1874.68231046931,456.754512635379,215.801444043321,1050.12274368231,131.750902527076,277,27.4629087675365,12.8622544026099,0.883543004396529,0.965156794425087,0.651764705882353,-0.501789761201718,50219.0469314079,35355.6498194946,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_589763,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
589890,884.884422110553,149.758793969849,63.2211055276382,596.346733668342,201.361809045226,1016.81407035176,504.91959798995,254.562814070352,1077.03015075377,2319.09045226131,651.045226130653,106.065326633166,1069.2864321608,925.211055276382,841.829145728643,426.753768844221,1738.12060301508,1190.16582914573,322.94472361809,238.587939698492,1004.10552763819,1116.77386934673,220.27135678392,148.653266331658,599.70351758794,1712.27135678392,536.542713567839,263.311557788945,1033.62814070352,134.366834170854,199,18.5895748341824,13.6232032940267,0.68039989335003,0.956730769230769,0.731617647058823,-0.856635632241166,50521.3366834171,34808.6984924623,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_589890,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
590364,3013.16292134831,221.601123595506,68.8539325842697,617.455056179775,703.758426966292,2883.01685393258,331.365168539326,252.078651685393,1081.20786516854,5948.84831460674,615.314606741573,122.662921348315,1072.08426966292,1262.61235955056,793.123595505618,293.685393258427,1939.8202247191,1392.30337078652,292.0,235.286516853933,1195.19101123596,1272.60112359551,231.943820224719,162.297752808989,5740.37640449438,2779.53370786517,543.921348314607,228.140449438202,1058.65168539326,130.769662921348,178,24.6875610899657,9.35430338075882,0.925434528050434,0.931937172774869,0.565079365079365,-1.03592764653434,51018.0449438202,33748.8202247191,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_590364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
590385,3040.01324503311,823.41059602649,146.741721854305,664.271523178808,2649.81456953642,2361.62913907285,507.019867549669,263.927152317881,1198.05960264901,5961.82781456954,644.880794701987,121.370860927152,1066.07947019868,524.827814569536,362.092715231788,320.960264900662,1558.4701986755,1075.64900662252,235.05298013245,219.662251655629,1012.37086092715,1433.77483443709,189.774834437086,153.662251655629,597.87417218543,2480.86092715232,570.933774834437,259.258278145695,1085.48344370861,133.317880794702,151,20.7278618187657,10.0046945880766,0.87580289897481,0.82967032967033,0.722488038277512,1.52260299017912,51980.4635761589,34499.119205298,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_590385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
591368,1079.56505576208,138.044609665428,140.31970260223,672.014869888476,5263.03345724907,1050.0780669145,297.988847583643,253.676579925651,1093.20074349442,1689.01115241636,793.873605947955,111.446096654275,1065.64312267658,3999.66171003717,551.847583643123,374.256505576208,2154.11152416357,3726.17843866171,340.297397769517,237.159851301115,1041.73234200743,3074.34200743494,231.412639405204,676.104089219331,661.773234200743,1088.5873605948,482.817843866171,310.39405204461,1086.03345724907,132.330855018587,269,31.499609947021,11.3268391750046,0.933111698621415,0.902684563758389,0.619815668202765,1.39900347144308,51270.6208178439,35225.9553903346,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_591368,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
592177,1486.15333333333,88.2466666666667,64.74,616.666666666667,1067.58666666667,1468.51333333333,421.906666666667,247.0,1086.4,3261.96,470.173333333333,106.626666666667,1064.80666666667,6543.85333333333,1083.71333333333,339.133333333333,6316.04,3830.4,380.066666666667,249.186666666667,1026.82666666667,3231.82666666667,268.253333333333,172.113333333333,653.02,1517.37333333333,470.826666666667,226.186666666667,1020.70666666667,129.966666666667,150,16.3612761214005,11.6588249508621,0.701584235571262,0.955414012738854,0.769230769230769,1.0197682868772,51781.0066666667,35026.98,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_592177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
592591,1208.69322709163,270.762948207171,140.268924302789,647.49203187251,2625.9780876494,1560.09163346614,355.141434262948,253.081673306773,1084.78685258964,1916.07768924303,628.715139442231,117.043824701195,1069.29482071713,563.288844621514,435.874501992032,264.440239043825,1480.13545816733,864.083665338645,246.334661354582,227.402390438247,999.92828685259,861.386454183267,188.790836653386,139.810756972112,594.051792828685,945.573705179283,492.888446215139,221.972111553785,1025.80278884462,130.348605577689,502,30.7419012401391,20.9107091461463,0.733024525008082,0.972868217054264,0.743703703703704,-0.970688986732529,50905.9402390438,33830.5517928287,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
592665,3858.30622009569,312.019138755981,143.976076555024,657.129186602871,2033.32057416268,4550.38277511962,2167.80861244019,285.822966507177,1103.10526315789,7754.96172248804,2231.6985645933,124.961722488038,1083.18660287081,2370.57894736842,1318.11483253589,2247.54545454545,7218.82775119617,2003.85645933014,331.516746411483,237.028708133971,1041.23923444976,1309.3014354067,225.468899521531,676.387559808612,650.645933014354,2951.77511961722,553.244019138756,733.928229665072,1139.01913875598,132.038277511962,209,20.9295866045149,13.6225019647764,0.759186664259707,0.881856540084388,0.653125,-0.405919006797061,50655.8660287081,35321.8421052632,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592665,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
592715,2814.48501872659,210.215355805243,67.6573033707865,621.374531835206,1191.40262172285,2400.5074906367,1152.53558052434,275.020599250936,1095.14419475655,3759.89700374532,1326.77153558052,120.046816479401,1069.57303370787,984.975655430712,619.140449438202,287.895131086142,1567.734082397,1493.70411985019,318.093632958801,238.09925093633,1003.45131086142,1396.30898876404,228.837078651685,148.252808988764,587.10861423221,813.816479400749,398.23595505618,226.368913857678,1000.3595505618,128.780898876405,534,31.262661086702,21.8494503382014,0.715220134300585,0.960431654676259,0.712,0.502923450975484,51688.1329588015,34829.1741573034,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592715,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
593032,1705.14285714286,230.809523809524,150.0,640.821428571429,1955.7619047619,2428.83333333333,2376.63095238095,274.142857142857,1186.625,2736.21428571429,2121.94047619048,109.0,1080.16666666667,2943.7619047619,563.410714285714,301.22619047619,2442.08928571429,5195.96428571429,399.910714285714,251.636904761905,1057.42261904762,4403.14285714286,269.482142857143,305.178571428571,592.27380952381,1243.17857142857,443.309523809524,710.505952380952,1044.75,133.940476190476,168,17.6006388229471,12.7868158826369,0.687169361163765,0.870466321243523,0.736842105263158,0.0069061895104547,50981.2202380952,35694.8214285714,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_593032,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
593252,4995.84444444444,718.78024691358,241.824691358025,637.274074074074,1688.59259259259,5067.31358024691,1025.53333333333,288.933333333333,1135.4962962963,8148.72592592593,766.57037037037,121.444444444444,1083.97777777778,2485.10864197531,833.911111111111,366.745679012346,1980.03703703704,4439.50617283951,440.074074074074,254.323456790123,1041.5975308642,4256.74074074074,273.38024691358,244.227160493827,588.669135802469,1625.88641975309,464.827160493827,235.459259259259,1047.73086419753,133.555555555556,405,24.8365966921632,20.9426659152164,0.537571733617121,0.964285714285714,0.771428571428571,-0.394343558047435,50875.2222222222,35447.7283950617,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_593252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
593360,1843.10404624277,435.098265895954,288.450867052023,718.317919075144,6572.50867052023,2184.23121387283,369.473988439306,263.190751445087,1091.22543352601,2822.90751445087,536.485549132948,117.589595375723,1066.19653179191,887.50289017341,498.895953757225,274.254335260116,1793.3063583815,1342.88439306358,296.132947976879,242.838150289017,1033.14450867052,1157.09826589595,218.826589595376,127.520231213873,594.965317919075,1051.66473988439,481.924855491329,213.670520231214,1050.70520231214,130.589595375723,173,21.9495861934698,10.2773536958857,0.883609064112488,0.925133689839572,0.600694444444444,-0.686913046824448,50131.9132947977,34746.7803468208,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_593360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
593676,2198.90015600624,256.424336973479,117.322932917317,635.017160686427,1458.51950078003,3035.80811232449,403.96879875195,278.241809672387,1099.87987519501,4335.30889235569,655.048361934477,131.823712948518,1066.98907956318,931.801872074883,738.897035881435,353.421216848674,1715.46801872075,1857.78627145086,356.176287051482,238.694227769111,1013.17472698908,1908.1856474259,231.358814352574,299.588143525741,595.720748829953,2655.96723868955,604.121684867395,240.81903276131,1056.25429017161,130.620904836193,641,45.5755550763794,18.1538937047502,0.917244246008333,0.948224852071006,0.511164274322169,-0.90813324814968,50990.0031201248,34647.7956318253,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_593676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
594160,3291.45569620253,384.018987341772,111.303797468354,609.253164556962,445.26582278481,4624.67088607595,1978.70886075949,276.835443037975,1086.36075949367,6690.8417721519,995.639240506329,122.316455696203,1071.15189873418,1560.94303797468,819.474683544304,278.632911392405,1723.74050632911,3069.8164556962,318.354430379747,240.879746835443,1040.63291139241,2748.34810126582,217.670886075949,186.525316455696,2757.36075949367,3861.83544303797,599.341772151899,320.03164556962,1107.20253164557,131.544303797468,158,15.1402426291302,13.4535146223863,0.458696372907715,0.951807228915663,0.806122448979592,0.835047368132434,50528.9240506329,34461.746835443,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_594160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
594863,1153.53164556962,356.113924050633,325.373417721519,786.196202531646,10544.7911392405,1483.4746835443,374.506329113924,258.677215189873,1095.72784810127,2124.74050632911,715.056962025316,160.664556962025,1075.51898734177,904.645569620253,533.76582278481,282.23417721519,1526.13924050633,1003.32911392405,228.411392405063,218.398734177215,1199.53797468354,630.006329113924,141.70253164557,124.613924050633,586.018987341772,1107.24050632911,515.917721518987,225.563291139241,1089.74050632911,132.607594936709,158,17.0069232066384,12.1276501072788,0.70106154200538,0.929411764705882,0.663865546218487,-1.10373116991951,51267.9493670886,33997.7025316456,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_594863,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
594965,2612.99607843137,257.996078431372,49.556862745098,654.96862745098,3280.5568627451,2310.63529411765,463.145098039216,267.741176470588,1087.14117647059,4371.70980392157,563.054901960784,126.258823529412,1083.91764705882,2134.59215686275,608.705882352941,317.549019607843,1892.07843137255,2970.45882352941,365.439215686275,255.141176470588,1045.61568627451,2268.32156862745,247.478431372549,290.039215686275,2457.32156862745,1766.68235294118,490.43137254902,259.274509803922,1057.05098039216,128.874509803922,255,27.1035987496305,12.0576250873358,0.895594292382004,0.944444444444444,0.754437869822485,-1.37019625631669,51331.5568627451,35812.2509803922,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_594965,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
595680,2313.66666666667,260.886075949367,100.253164556962,619.691983122363,1020.4135021097,3009.45991561181,2548.99578059072,264.472573839662,1093.75105485232,4244.74261603376,1193.25316455696,113.35864978903,1077.02953586498,649.708860759494,421.396624472574,351.95358649789,1487.64556962025,1068.10970464135,280.400843881857,225.316455696202,998.675105485232,1023.83122362869,255.080168776371,209.599156118143,617.493670886076,1372.12658227848,439.286919831224,255.177215189873,1065.03797468354,131.523206751055,237,21.5856538643738,14.0540857564445,0.759005209021256,0.94047619047619,0.73374613003096,-0.976265596448672,50161.6708860759,35176.9113924051,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_595680,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
596051,1449.11646586345,334.915662650602,160.281124497992,673.393574297189,3555.43775100402,1577.53012048193,3891.58634538153,267.831325301205,1098.10441767068,2582.92771084337,1613.86345381526,121.020080321285,1073.36947791165,805.06827309237,678.184738955823,443.939759036145,1589.16064257028,1276.08835341365,349.987951807229,244.55421686747,995.606425702811,1257.22489959839,266.253012048193,272.309236947791,602.983935742972,1100.69477911647,498.144578313253,316.570281124498,1040.62248995984,129.746987951807,249,23.2303749630443,13.7024937064566,0.807511040872303,0.943181818181818,0.689750692520776,0.78234373732872,51996.0481927711,35016.9076305221,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_596051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
596095,2365.67052023121,355.589595375723,231.109826589595,715.514450867052,5641.12716763006,3003.63583815029,350.398843930636,269.346820809249,1101.54913294798,4069.79768786127,566.433526011561,130.50289017341,1100.37572254335,3006.9710982659,691.121387283237,321.895953757225,1696.1676300578,3930.79190751445,466.508670520231,256.537572254335,1011.36994219653,3248.61849710983,284.208092485549,260.959537572254,581.479768786127,1785.45086705202,561.537572254335,230.728323699422,1073.1387283237,133.115606936416,173,16.2030912077062,13.6753616805907,0.536347767274542,0.95054945054945,0.772321428571429,-0.574901044216028,50845.710982659,34731.6069364162,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_596095,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
596856,3958.51523545706,1050.37950138504,414.85595567867,636.961218836565,1648.7783933518,4212.76731301939,720.783933518006,270.340720221607,1137.75346260388,6661.51523545706,840.606648199446,118.16620498615,1083.39889196676,1243.75069252078,796.227146814404,863.451523545706,1708.86426592798,1117.67313019391,291.204986149584,228.797783933518,997.307479224377,1043.53739612188,217.714681440443,244.601108033241,604.030470914127,2423.58725761773,530.002770083103,322.905817174515,1054.23822714681,132.90027700831,361,24.0266200521548,19.2290438673225,0.599569801259692,0.955026455026455,0.752083333333333,1.48096546040474,50861.0886426593,35631.4265927978,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_596856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
597683,910.135714285714,263.285714285714,484.907142857143,596.935714285714,309.528571428571,997.107142857143,328.942857142857,249.371428571429,1085.68571428571,1319.11428571429,486.65,104.092857142857,1066.92142857143,703.335714285714,541.471428571429,638.107142857143,1635.47857142857,1231.32142857143,266.457142857143,226.142857142857,1032.45,986.657142857143,188.978571428571,162.15,630.778571428571,874.392857142857,495.778571428571,222.535714285714,999.542857142857,127.421428571429,140,14.9309241148161,11.9370694697895,0.600684305915844,0.958904109589041,0.769230769230769,0.929169836514922,51886.4428571429,34406.1214285714,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_597683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
598104,2422.81696428571,486.946428571429,99.7232142857143,643.522321428571,1875.21875,2113.59375,1218.94642857143,263.004464285714,1090.70982142857,4476.15178571429,3078.17857142857,112.191964285714,1076.3125,872.933035714286,507.459821428571,272.205357142857,1546.31696428571,1087.64732142857,285.165178571429,227.151785714286,985.008928571429,1032.78571428571,213.276785714286,195.897321428571,598.361607142857,1828.05803571429,463.857142857143,577.290178571429,1034.15625,130.625,224,23.3179133676947,12.2498716300292,0.850891371523443,0.941176470588235,0.749163879598662,0.172618838647875,50588.6428571429,35710.1696428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_598104,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
598952,2727.95698924731,453.745519713262,122.448028673835,658.508960573477,2006.65949820788,3547.37992831541,4062.17562724014,276.52688172043,1100.37275985663,4472.54838709677,1507.05017921147,121.336917562724,1072.63440860215,597.874551971326,437.645161290323,277.086021505376,1390.40143369176,979.254480286738,278.928315412186,232.358422939068,987.121863799283,920.007168458781,216.964157706093,135.469534050179,607.512544802867,1584.89247311828,524.838709677419,394.591397849462,1087.67741935484,132.175627240143,279,27.1580891873093,13.1210425041824,0.875545482971785,0.962068965517241,0.656470588235294,-0.479235220245448,50009.0788530466,34866.1792114695,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_598952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
598978,1011.11744966443,141.94966442953,144.956375838926,695.107382550336,4736.26510067114,1223.4932885906,362.872483221477,266.379194630872,1096.67785234899,2112.76174496644,541.308724832215,113.05033557047,1066.55704697987,2988.90939597315,719.704697986577,320.812080536913,1905.20134228188,2946.87248322148,384.93288590604,244.244966442953,1060.0033557047,2297.12416107383,253.570469798658,183.61744966443,3985.68120805369,1062.32214765101,420.751677852349,219.969798657718,1050.23489932886,130.040268456376,298,20.8238400548067,18.4219092243039,0.466246668353074,0.952076677316294,0.746867167919799,-1.44689590398847,50767.1577181208,35507.0704697987,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_598978,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
599000,2517.63402061856,130.917525773196,131.324742268041,676.5,4121.55154639175,2308.81958762887,373.907216494845,269.814432989691,1101.0824742268,4719.99484536082,570.484536082474,119.216494845361,1068.71649484536,1580.37113402062,606.422680412371,342.046391752577,1660.36597938144,1403.49484536082,305.932989690722,232.149484536082,1009.65979381443,1826.76804123711,243.041237113402,206.963917525773,641.154639175258,1241.78865979381,430.128865979381,264.010309278351,1047.50515463918,128.90206185567,194,27.1803835630426,9.15634843326023,0.941549949386605,0.93719806763285,0.798353909465021,1.51702297292858,51710.1804123711,35531.0515463918,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_599000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
599143,2386.34615384615,197.5,189.119230769231,706.815384615385,6713.51923076923,2964.97692307692,336.834615384615,256.95,1093.91538461538,4223.46923076923,669.776923076923,160.630769230769,1067.81153846154,1046.06538461538,582.088461538462,288.35,1546.71923076923,1148.43076923077,229.296153846154,220.519230769231,1308.80384615385,631.1,140.923076923077,123.538461538462,586.076923076923,1044.07307692308,490.965384615385,232.592307692308,1077.70769230769,131.430769230769,260,20.6553591266736,16.1276908309122,0.624781870992047,0.966542750929368,0.728291316526611,-1.16213774916626,51227.2269230769,33996.4384615385,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_599143,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
599694,1657.49172576832,157.8463356974,100.718676122931,644.06146572104,2495.54609929078,1966.13002364066,333.096926713948,251.683215130024,1091.44680851064,3090.26713947991,712.929078014184,114.335697399527,1065.19621749409,594.141843971631,401.869976359338,275.60756501182,1475.03546099291,883.898345153664,268.094562647754,226.472813238771,979.848699763593,814.151300236407,191.278959810875,132.434988179669,587.394799054373,1052.14893617021,456.009456264775,213.312056737589,1045.41607565012,129.981087470449,423,31.8538405577624,17.0857767996709,0.843976321235139,0.963553530751708,0.656832298136646,-0.996052177410518,51347.8865248227,34472.5555555556,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_599694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
600245,1827.3568627451,528.470588235294,807.435294117647,647.325490196078,2245.0431372549,1862.76078431373,829.050980392157,259.486274509804,1120.78823529412,3184.39215686275,2148.43921568627,112.654901960784,1068.61960784314,916.811764705882,449.411764705882,290.494117647059,1546.23137254902,990.807843137255,287.576470588235,228.878431372549,1024.42745098039,945.376470588235,240.137254901961,147.749019607843,581.972549019608,1196.16862745098,466.501960784314,713.21568627451,1062.34117647059,131.843137254902,255,22.476863295857,14.6135768876498,0.759796584191383,0.940959409594096,0.708333333333333,-0.920961368072103,50424.2862745098,35548.4549019608,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_600245,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
600498,2158.25412541254,103.957095709571,113.379537953795,688.03300330033,4287.9900990099,1838.72607260726,348.326732673267,261.207920792079,1094.0396039604,3653.59735973597,465.09900990099,116.719471947195,1073.9504950495,2174.92739273927,609.577557755776,430.937293729373,1851.57095709571,1168.74257425743,295.811881188119,228.729372937294,1013.38943894389,1155.20462046205,233.808580858086,193.782178217822,592.46204620462,1283.24752475248,430.273927392739,269.250825082508,1056.6303630363,129.564356435644,303,30.200474224838,12.9871815115114,0.902813469436577,0.94392523364486,0.590643274853801,-0.513112060154117,51265.9636963696,35727.102310231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_600498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
600561,1111.73684210526,132.861842105263,57.6118421052632,631.519736842105,1922.60526315789,1336.98684210526,2095.15131578947,250.25,1071.21710526316,1805.96052631579,1637.41447368421,108.940789473684,1061.76315789474,1077.31578947368,661.276315789474,728.309210526316,1657.38157894737,2307.32236842105,329.980263157895,235.171052631579,1011.73684210526,1951.56578947368,221.16447368421,219.177631578947,665.223684210526,1009.40789473684,490.052631578947,385.75,1055.38157894737,132.144736842105,152,14.7702578205101,13.1850040409963,0.450705756347808,0.938271604938272,0.723809523809524,0.431628264032176,51184.4276315789,34553.8157894737,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_600561,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
600651,1476.21705426357,141.197674418605,83.3914728682171,632.604651162791,1569.59302325581,1664.75968992248,331.794573643411,252.352713178294,1091.25968992248,2796.50775193798,480.468992248062,107.286821705426,1063.78294573643,1926.69379844961,595.589147286822,708.414728682171,1746.26356589147,1845.10465116279,298.813953488372,229.038759689922,1029.50387596899,1327.37984496124,196.329457364341,563.93023255814,591.984496124031,1003.88372093023,442.248062015504,215.031007751938,1018.72093023256,130.686046511628,258,27.0189232696419,12.2289133161512,0.891710861222303,0.95910780669145,0.763313609467456,1.39415559672093,52014.9031007752,35149.488372093,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_600651,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
600763,1735.94761904762,236.290476190476,164.052380952381,697.814285714286,4589.74761904762,2201.97619047619,354.895238095238,261.685714285714,1089.48095238095,3067.25714285714,684.747619047619,124.171428571429,1067.11904761905,529.809523809524,374.104761904762,266.076190476191,1577.06666666667,826.933333333333,221.019047619048,218.5,1001.68095238095,800.804761904762,174.809523809524,141.019047619048,584.461904761905,1842.54761904762,645.704761904762,335.233333333333,1127.5380952381,134.828571428571,210,24.8290322627982,10.8053850047808,0.900337889841146,0.967741935483871,0.583333333333333,0.706183645611888,51852.7761904762,34716.1142857143,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_600763,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
601003,2990.59166666667,194.769444444444,128.902777777778,656.075,2755.73333333333,3532.8,314.769444444444,253.244444444444,1093.21111111111,6180.86944444444,594.269444444444,123.416666666667,1079.80833333333,755.347222222222,565.738888888889,295.855555555556,1432.69722222222,1141.48333333333,341.019444444444,241.741666666667,990.480555555556,1398.67777777778,251.563888888889,141.636111111111,608.347222222222,2483.16944444444,525.438888888889,224.980555555556,1064.43333333333,131.711111111111,360,33.3531664352488,13.8070072512626,0.910293293206908,0.954907161803714,0.535714285714286,-0.84544692830232,51476.2111111111,34389.6388888889,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_601003,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
602159,2071.76567656766,325.293729372937,104.0,653.389438943894,1157.12211221122,1926.38943894389,1436.83828382838,265.19801980198,1095.81848184818,3802.26402640264,504.643564356436,109.844884488449,1076.91089108911,2065.47524752475,694.726072607261,391.435643564356,1874.54125412541,1586.08910891089,250.772277227723,223.250825082508,1005.19801980198,1247.52805280528,186.333333333333,172.90099009901,603.346534653465,1627.71287128713,506.485148514851,773.323432343234,1047.90099009901,129.924092409241,303,27.6154888241186,14.4876425315416,0.851336404607296,0.929447852760736,0.660130718954248,1.22513303884076,51685.8415841584,35348.3069306931,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_602159,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
603327,1566.66871165644,573.024539877301,528.625766871166,636.822085889571,1883.72392638037,1552.50920245399,552.411042944785,269.38036809816,1092.85889570552,2416.87116564417,1936.07975460123,109.226993865031,1064.07975460123,1135.72392638037,586.754601226994,300.901840490798,1621.49079754601,1292.03680981595,270.834355828221,225.472392638037,1363.96319018405,974.846625766871,205.018404907975,148.521472392638,610.447852760736,1057.41104294479,488.533742331288,350.036809815951,1043.9509202454,130.773006134969,163,21.0391950107932,9.90766310216212,0.882178827847381,0.947674418604651,0.679166666666667,1.18661324129657,51105.8159509202,35313.282208589,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_603327,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
603407,500.189368770764,539.923588039867,145.970099667774,623.548172757475,96.249169435216,644.983388704319,438.906976744186,282.85049833887,1122.60797342193,1294.06644518272,1974.85049833887,112.637873754153,1057.37541528239,1077.86378737542,474.186046511628,335.740863787375,1413.39867109635,1526.1926910299,299.435215946844,235.584717607973,1043.21926910299,1457.23588039867,223.764119601329,242.900332225914,729.717607973422,597.478405315615,378.514950166113,197.199335548173,987.817275747508,129.71096345515,301,23.9531117319945,16.0440334175713,0.742532547142454,0.95859872611465,0.737745098039216,-1.30346740415622,50176.0431893688,34888.2458471761,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_603407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
603492,1478.98015873016,344.900793650794,109.472222222222,644.710317460317,1602.87698412698,1567.06349206349,3125.32142857143,248.456349206349,1094.15873015873,3059.4246031746,1308.28571428571,105.095238095238,1078.62698412698,674.880952380952,440.587301587302,270.186507936508,1392.39285714286,1062.2380952381,311.805555555556,232.34126984127,992.996031746032,1016.79761904762,230.289682539683,128.519841269841,617.210317460317,1235.28174603175,476.706349206349,373.400793650794,1065.05952380952,132.90873015873,252,20.4882353365649,15.689419580304,0.64310619041069,0.950943396226415,0.705882352941177,0.418326665660718,50458.4444444444,34950.1071428571,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_603492,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
603993,807.259541984733,217.839694656488,90.8473282442748,617.916030534351,968.396946564886,972.946564885496,303.763358778626,249.740458015267,1079.61832061069,1992.74809160305,503.770992366412,109.427480916031,1061.26717557252,609.374045801527,427.267175572519,264.114503816794,1436.30534351145,934.549618320611,307.770992366412,237.75572519084,987.625954198473,904.320610687023,213.847328244275,124.801526717557,580.931297709924,1323.82442748092,508.419847328244,220.396946564885,1021.47328244275,129.81679389313,131,16.8440014983451,9.96244462356071,0.806339065331195,0.935714285714286,0.744318181818182,0.257666038074642,50850.251908397,34205.3282442748,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_603993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
604843,1009.34131736527,263.85628742515,211.854291417166,701.367265469062,6797.29740518962,1262.13972055888,532.095808383234,267.11377245509,1096.45908183633,1890.36127744511,580.50499001996,121.938123752495,1076.67664670659,666.884231536926,522.894211576846,272.2375249501,1414.25548902196,1041.89820359281,319.465069860279,239.345309381238,991.223552894212,1000.57684630739,230.249500998004,130.97005988024,581.668662674651,1021.18163672655,503.646706586826,268.764471057884,1037.41916167665,130.554890219561,501,33.276089444426,19.3630987059109,0.813265887774472,0.954285714285714,0.668,0.526076218526062,50860.123752495,34898.0119760479,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_604843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
605275,2469.98901098901,247.785714285714,93.6318681318681,618.285714285714,617.32967032967,3295.38461538462,1008.43406593407,271.379120879121,1090.88461538462,5464.3956043956,775.450549450549,118.258241758242,1076.08791208791,1637.82417582418,600.769230769231,340.318681318681,1886.28021978022,2633.33516483516,326.401098901099,235.93956043956,1023.3021978022,1987.57692307692,221.637362637363,174.351648351648,590.104395604396,1736.45604395604,527.373626373626,221.923076923077,1080.19230769231,133.752747252747,182,18.5140602777862,12.5460729754761,0.73538358110275,0.962962962962963,0.764705882352941,1.06740393593236,51410.9395604396,35187.543956044,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_605275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
605325,2710.24242424242,375.121212121212,118.863636363636,642.914141414141,1604.13636363636,2936.76262626263,2731.39898989899,264.252525252525,1108.73232323232,4538.18686868687,1317.80303030303,116.055555555556,1076.32323232323,540.131313131313,466.60101010101,312.656565656566,1629.27777777778,908.535353535354,252.085858585859,221.479797979798,992.368686868687,884.924242424242,237.20202020202,163.459595959596,594.227272727273,1298.18686868687,442.984848484848,256.646464646465,1062.91919191919,130.747474747475,198,20.7604628951199,12.6465137431995,0.793044750769228,0.895927601809955,0.673469387755102,-1.3150655272733,50168.3181818182,35187.0303030303,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_605325,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
605477,3316.91777188329,413.915119363395,127.450928381963,642.864721485411,1371.06100795756,3917.66312997347,1313.75862068966,268.026525198939,1099.53050397878,5269.06896551724,687.320954907162,129.273209549072,1069.37931034483,536.119363395225,627.883289124668,268.689655172414,1521.34217506631,851.464190981432,261.615384615385,225.602122015915,1002.3474801061,799.472148541114,190.214854111406,133.092838196286,604.737400530504,1047.32625994695,463.641909814324,216.928381962865,1021.69230769231,131.790450928382,377,28.3517881001292,17.3421163511136,0.79110816280902,0.944862155388471,0.634680134680135,-0.450232065628374,50606.6710875332,34099.2228116711,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_605477,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
606016,2693.47083333333,520.629166666667,153.4625,665.483333333333,3360.84583333333,3075.99166666667,634.345833333333,265.958333333333,1106.37083333333,5994.8625,534.654166666667,118.908333333333,1068.3375,919.25,715.091666666667,289.004166666667,1582.27083333333,1419.1625,347.1125,244.6875,1002.37083333333,1329.575,237.658333333333,186.766666666667,633.729166666667,3107.72916666667,563.425,244.4375,1075.77916666667,131.6,240,21.8394307773319,15.7033908931909,0.694970271715786,0.816326530612245,0.631578947368421,-0.656131581708391,51100.0125,35009.1041666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606016,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
606096,2758.09830508475,166.179661016949,151.552542372881,690.003389830508,4468.95254237288,3356.14237288136,391.166101694915,272.338983050847,1150.16949152542,5104.45762711864,572.196610169492,125.725423728814,1082.86440677966,851.291525423729,440.779661016949,279.413559322034,1570.83050847458,1463.90169491525,261.359322033898,220.569491525424,1053.52542372881,1368.50508474576,205.033898305085,230.779661016949,1810.07118644068,1772.28813559322,465.749152542373,281.427118644068,1068.14237288136,130.183050847458,295,28.5321903845694,13.2404261062867,0.885807847713126,0.960912052117264,0.597165991902834,-0.547472940670277,50654.2372881356,35593.8644067797,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606096,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
606114,732.915492957746,808.021126760563,334.598591549296,649.056338028169,2307.92253521127,735.028169014084,1779.38028169014,261.852112676056,1098.1338028169,1250.20422535211,3309.14788732394,108.788732394366,1069.6338028169,746.718309859155,516.654929577465,322.859154929577,1498.68309859155,1159.19014084507,301.366197183099,231.683098591549,997.021126760563,1119.91549295775,230.802816901408,181.204225352113,586.253521126761,976.112676056338,467.091549295775,400.922535211268,1052.97887323944,129.323943661972,142,14.0200385229486,12.9288224210145,0.386791020015038,0.986111111111111,0.78021978021978,1.25073222040125,51825.4225352113,35221.7676056338,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606114,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
606231,3127.53663793103,153.262931034483,81.1185344827586,647.987068965517,993.765086206896,3811.20474137931,402.073275862069,260.665948275862,1099.64655172414,6997.77155172414,591.243534482759,121.133620689655,1079.4525862069,532.633620689655,368.122844827586,297.0,1474.00862068966,926.825431034483,297.993534482759,236.683189655172,990.875,912.614224137931,215.075431034483,140.178879310345,584.980603448276,3129.96336206897,578.301724137931,245.959051724138,1064.32327586207,133.252155172414,464,37.6342514214254,15.8527660642271,0.906952735723902,0.950819672131148,0.554360812425329,-0.692086475830257,51113.6939655172,34292.3340517241,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_606231,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
606339,2276.09132420091,439.433789954338,170.424657534247,681.89497716895,3036.68493150685,3213.21461187215,1338.28310502283,272.534246575342,1105.24657534247,4372.83561643836,2467.47488584475,125.127853881279,1089.93150684932,760.415525114155,673.351598173516,285.520547945205,1443.51141552511,1191.26484018265,387.356164383562,253.853881278539,985.616438356164,1161.88127853881,256.744292237443,143.7899543379,570.315068493151,1924.33333333333,545.75799086758,471.182648401826,1117.0,132.228310502283,219,23.9231931969889,11.6950544692489,0.872363137400002,0.964757709251101,0.760416666666667,0.0356705404085344,50523.9223744292,34741.5570776256,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
607543,2681.42715231788,247.115894039735,161.450331125828,706.019867549669,5004.80132450331,2822.18874172185,1724.73509933775,270.384105960265,1126.63245033113,4211.08609271523,588.645695364238,132.602649006623,1139.18874172185,864.380794701987,409.337748344371,279.208609271523,1700.64238410596,2120.8642384106,292.115894039735,225.973509933775,1030.01655629139,2148.88410596027,237.834437086093,241.14238410596,874.413907284768,1532.7417218543,447.668874172185,1332.98675496689,1080.87748344371,129.496688741722,302,21.778522173765,17.6931060143308,0.583085531787534,0.952681388012618,0.756892230576441,1.06198211478923,51277.3443708609,35834.8278145695,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_607543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
608190,4028.65544554455,354.512871287129,146.485148514851,641.992079207921,1887.40594059406,4759.34455445545,427.108910891089,281.639603960396,1100.3801980198,7469.53465346535,589.154455445544,123.287128712871,1100.18613861386,660.241584158416,530.326732673267,277.611881188119,1416.87524752475,1028.3504950495,331.053465346535,238.340594059406,989.473267326733,986.251485148515,232.611881188119,135.522772277228,585.134653465347,3353.8297029703,555.722772277228,229.728712871287,1055.97623762376,131.059405940594,505,34.4316965012204,18.940500985637,0.835105969681409,0.961904761904762,0.62192118226601,0.706176061886849,50811.2396039604,35010.4257425743,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_608190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
609427,1177.87628865979,282.762886597938,38.360824742268,617.30412371134,1322.79381443299,1193.56701030928,336.422680412371,240.319587628866,1077.88659793814,2182.40206185567,424.463917525773,98.0463917525773,1063.78865979381,2223.37113402062,770.329896907216,411.938144329897,1809.24742268041,2130.01030927835,348.489690721649,244.247422680412,1019.20103092784,1423.30927835052,253.783505154639,163.298969072165,604.788659793814,752.262886597938,419.376288659794,216.438144329897,1011.02577319588,128.824742268041,194,19.5770537127222,12.731824988845,0.759639593265302,0.915094339622642,0.673611111111111,1.03939961286588,51983.4845360825,34874.824742268,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_609427,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
609914,1184.34497816594,325.489082969432,105.938864628821,657.589519650655,2938.91703056769,1390.62008733624,1942.97379912664,259.323144104803,1087.00873362445,2339.17467248908,4486.93886462882,107.122270742358,1064.59388646288,1566.75545851528,634.078602620087,289.174672489083,1771.24890829694,3248.28820960699,366.449781659389,246.489082969432,1023.41484716157,3435.93013100437,253.637554585153,159.161572052402,2008.96943231441,1134.29694323144,479.266375545852,435.532751091703,1047.68122270742,129.244541484716,229,21.7707778810098,13.7008527554807,0.777143792706297,0.94238683127572,0.726984126984127,-1.26595751639466,51201.1222707424,35253.0349344978,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_609914,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
611413,1123.2614379085,231.59477124183,150.261437908497,650.954248366013,3002.50980392157,1430.39215686275,305.986928104575,259.254901960784,1082.3660130719,1952.47058823529,451.712418300654,108.549019607843,1067.45751633987,698.150326797386,500.705882352941,278.588235294118,1403.66013071895,1040.98692810458,314.483660130719,238.300653594771,990.790849673203,988.856209150327,226.065359477124,134.0,582.464052287582,1007.8431372549,484.091503267974,216.091503267974,1026.75816993464,129.457516339869,153,18.9657365172968,10.4406938325485,0.834833220502988,0.932926829268293,0.642857142857143,-0.647191343895915,51030.0261437908,34951.5294117647,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_611413,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
611877,1322.91056910569,498.276422764228,86.5934959349593,607.406504065041,758.089430894309,1163.84552845528,934.439024390244,264.479674796748,1110.39024390244,1997.50406504065,870.691056910569,107.30081300813,1077.29268292683,745.170731707317,527.861788617886,321.959349593496,1682.71544715447,1047.9837398374,293.894308943089,225.869918699187,992.040650406504,1000.84552845528,221.333333333333,188.19512195122,583.048780487805,952.853658536585,439.967479674797,316.365853658537,1020.39837398374,131.219512195122,123,13.2561399536311,11.8630471984565,0.446247429120153,0.931818181818182,0.727810650887574,1.13995715271624,50869.9837398374,35607.0406504065,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_611877,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
612068,2137.77099236641,267.129770992366,100.297709923664,623.450381679389,868.526717557252,2843.5572519084,342.656488549618,263.053435114504,1089.09923664122,3649.89312977099,619.984732824428,129.374045801527,1063.11450381679,602.793893129771,510.351145038168,262.114503816794,1358.06106870229,945.587786259542,272.190839694656,229.809160305344,1000.77099236641,993.114503816794,196.679389312977,123.221374045802,585.916030534351,1599.77099236641,547.793893129771,222.213740458015,1035.67175572519,129.12213740458,131,17.6256668861694,9.60921903812707,0.838316874306687,0.942446043165468,0.682291666666667,-0.546616781536049,50315.0076335878,34576.7786259542,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_612068,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
612248,2300.12437810945,188.741293532338,70.3333333333333,624.47263681592,759.92039800995,3107.23383084577,918.512437810945,277.820895522388,1114.592039801,4148.42288557214,623.661691542289,117.52736318408,1068.76616915423,693.621890547264,457.756218905473,315.73631840796,1371.45771144279,1040.44278606965,283.044776119403,231.208955223881,1042.62686567164,870.980099502488,207.761194029851,133.412935323383,591.432835820896,810.318407960199,465.10447761194,223.094527363184,1044.82089552239,128.875621890547,201,20.1562256226477,13.1775587929185,0.756692331274721,0.926267281105991,0.661184210526316,0.950075358008902,50130.7910447761,34868.4676616915,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_612248,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
612282,3045.15884476534,786.332129963899,898.963898916968,632.046931407942,1717.50541516245,3616.31046931408,2789.67509025271,268.13357400722,1105.30324909747,6279.87364620939,683.703971119134,115.805054151625,1081.64981949458,2830.74729241877,902.007220216606,1925.75451263538,1725.13718411552,1611.1119133574,342.552346570397,240.859205776173,1006.61732851986,1367.03610108303,232.72202166065,163.653429602888,613.682310469314,1917.23104693141,516.137184115523,337.328519855596,1057.06137184116,132.126353790614,277,19.1483952480535,18.5115881567335,0.255747633825693,0.971929824561404,0.809941520467836,0.195363586339846,51123.238267148,35076.6353790614,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_612282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
612709,533.627906976744,1167.66976744186,284.818604651163,634.339534883721,150.697674418605,592.753488372093,370.46976744186,275.153488372093,1125.99069767442,1258.2511627907,433.995348837209,111.66511627907,1053.2976744186,4424.3488372093,850.172093023256,370.981395348837,2007.68837209302,2970.59069767442,363.055813953488,240.53023255814,1018.16279069767,1814.39534883721,224.325581395349,171.297674418605,596.116279069767,563.813953488372,325.651162790698,193.302325581395,982.06976744186,137.655813953488,215,18.4729298422274,14.8410541378453,0.59544683878731,0.951327433628319,0.743944636678201,0.853676878561624,50699.823255814,35406.9302325581,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_612709,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
613846,2976.2684729064,916.024630541872,1126.74137931034,712.189655172414,2346.95566502463,2716.63054187192,1269.48768472906,263.532019704433,1234.56157635468,4647.59113300493,603.581280788177,119.524630541872,1083.45566502463,745.450738916256,565.748768472906,676.152709359606,1559.68965517241,1079.99014778325,283.470443349754,229.285714285714,995.07881773399,1054.60591133005,227.650246305419,196.110837438424,587.334975369458,1406.22413793103,486.467980295567,717.923645320197,1058.07142857143,131.812807881773,406,29.7546805858777,17.5257187453305,0.80812784355163,0.944186046511628,0.716049382716049,-1.11094598295742,51230.8965517241,35634.7610837438,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_613846,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
614399,1716.63662790698,379.906976744186,134.982558139535,642.183139534884,1475.18895348837,2262.98546511628,1654.86046511628,261.822674418605,1085.76744186047,3142.10174418605,2257.11918604651,114.337209302326,1069.99418604651,891.28488372093,1143.83139534884,307.05523255814,1495.08430232558,1341.21220930233,324.316860465116,234.633720930233,1002.875,1226.26744186047,217.43023255814,212.616279069767,715.372093023256,1481.09302325581,498.895348837209,373.776162790698,1037.375,129.662790697674,344,23.1994442771418,18.9785633375323,0.575131294701464,0.945054945054945,0.747826086956522,0.304345550510553,50354.4186046512,34475.4215116279,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_614399,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
614484,1548.55251141553,589.287671232877,95.4566210045662,622.849315068493,1175.43378995434,1956.90867579909,708.022831050228,259.529680365297,1162.31506849315,3975.99086757991,664.415525114155,110.584474885845,1080.67579908676,666.461187214612,551.03196347032,298.662100456621,1521.46118721461,1215.7397260274,313.511415525114,490.65296803653,1000.64840182648,1196.62100456621,233.639269406393,182.337899543379,598.735159817352,2304.85844748858,525.753424657534,253.529680365297,1038.18264840183,130.077625570776,219,21.7315471922622,12.9401037387655,0.803390527879374,0.960526315789474,0.684375,-1.00340389642027,51180.3378995434,35021.904109589,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_614484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
615420,2286.48314606742,168.059925093633,88.0374531835206,636.348314606742,2168.68539325843,2579.56179775281,355.936329588015,269.827715355805,1084.97003745318,4099.02996254682,549.49063670412,118.438202247191,1062.14981273408,1206.76029962547,556.996254681648,569.097378277154,1499.56928838951,2732.0936329588,316.438202247191,235.674157303371,1011.14981273408,3113.40823970037,268.865168539326,338.49063670412,735.501872659176,1403.70786516854,474.520599250936,234.168539325843,1056.92134831461,129.026217228464,267,24.8846327056473,14.1019343731291,0.823929381817073,0.943462897526502,0.741666666666667,-1.37081970672587,50719.2134831461,35360.8202247191,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_615420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
615445,4160.59363957597,694.696113074205,1060.1519434629,621.82332155477,1106.51236749117,3727.70671378092,474.533568904594,268.756183745583,1106.06007067138,7247.04946996466,556.579505300353,120.593639575972,1079.62897526502,910.353356890459,496.805653710247,286.918727915194,1607.31802120141,1850.7667844523,274.272084805654,227.551236749117,1130.08127208481,1777.22261484099,217.685512367491,213.583038869258,1423.72791519435,1971.79858657244,525.208480565371,231.667844522968,1051.87985865724,130.462897526502,283,19.9026410869309,18.4829799229716,0.370907764884556,0.962585034013605,0.786111111111111,-0.251363303712315,51716.371024735,35552.7067137809,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_615445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
615724,1985.70823529412,148.32,70.6494117647059,617.308235294118,923.531764705882,2242.23764705882,2233.00235294118,247.809411764706,1087.08941176471,3664.78352941176,1521.45647058824,108.202352941176,1073.12235294118,3351.47529411765,1029.12235294118,1997.95764705882,2158.66352941177,2186.40705882353,351.054117647059,237.63294117647,1014.79529411765,1775.79764705882,298.670588235294,242.169411764706,689.597647058824,1030.98588235294,459.821176470588,315.955294117647,1050.07058823529,131.64,425,26.6550383058508,20.8566106131852,0.622695695342311,0.959367945823928,0.743006993006993,1.36914340919924,51202.0517647059,34161.6376470588,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_615724,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
615883,569.876865671642,644.19776119403,188.705223880597,619.757462686567,83.4776119402985,609.238805970149,397.559701492537,273.220149253731,1108.02611940299,1447.15671641791,933.940298507463,117.652985074627,1061.91791044776,946.559701492537,567.757462686567,309.041044776119,1548.42164179104,1959.4552238806,336.708955223881,238.268656716418,1048.5447761194,2122.85074626866,225.936567164179,179.652985074627,724.541044776119,592.246268656716,371.940298507463,198.876865671642,984.011194029851,128.742537313433,268,19.3677240601854,17.664057010886,0.410110674230419,0.964028776978417,0.742382271468144,0.850131606039682,50360.6940298507,34888.5970149254,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_615883,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
616337,1421.20205479452,149.770547945205,108.527397260274,642.5,2411.59931506849,1544.82191780822,333.760273972603,258.099315068493,1087.36301369863,2417.95890410959,519.205479452055,113.541095890411,1079.92123287671,1041.26712328767,608.455479452055,732.455479452055,1451.20205479452,1600.35273972603,377.099315068493,596.705479452055,993.506849315068,2496.34931506849,341.267123287671,477.369863013699,622.760273972603,1049.58904109589,500.407534246575,221.482876712329,1023.1198630137,129.342465753425,292,25.9442171817124,14.9361139231522,0.817660237076834,0.906832298136646,0.608333333333333,0.632847866909149,50675.7397260274,35108.7465753425,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_616337,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
616433,1237.82258064516,163.535483870968,186.074193548387,708.306451612903,5468.46129032258,1251.14193548387,316.029032258064,257.541935483871,1092.57419354839,2800.70967741935,583.003225806452,122.174193548387,1073.42580645161,4806.11290322581,1034.6,392.593548387097,1861.09677419355,4673.63548387097,387.448387096774,250.5,1025.80322580645,3462.99677419355,254.81935483871,316.861290322581,603.177419354839,1210.37419354839,447.387096774194,241.970967741935,1062.18387096774,130.316129032258,310,31.1502954707442,12.8566768222412,0.910853193295769,0.94224924012158,0.628803245436105,1.18125103650999,51890.2064516129,35336.7225806452,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_616433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
616713,3095.61516034985,455.206997084548,2180.58309037901,653.807580174927,2360.59766763848,2878.15451895044,773.69387755102,266.096209912536,1120.47813411079,4957.81341107872,634.997084548105,116.513119533528,1085.27405247813,2309.10787172012,950.268221574344,714.833819241982,1937.36734693878,3174.75218658892,404.037900874636,242.36443148688,1041.26822157434,2590.79300291545,251.991253644315,705.361516034985,672.521865889213,1285.08454810496,491.215743440233,397.209912536443,1044.55685131195,131.626822157434,343,27.3809548045897,16.1378027807536,0.807855520731935,0.950138504155125,0.776018099547511,1.36975563007647,51387.889212828,35606.6151603499,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_616713,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
617186,2764.60962566845,229.978609625668,95.1229946524064,690.024064171123,1741.5935828877,3396.07486631016,1680.16844919786,278.085561497326,1200.91978609626,5797.60427807487,1719.99465240642,121.251336898396,1070.88770053476,718.868983957219,452.791443850267,288.053475935829,1457.00267379679,1092.81818181818,308.604278074866,232.320855614973,993.628342245989,1031.86631016043,225.379679144385,156.46256684492,588.540106951872,2471.88235294118,525.75935828877,299.70320855615,1067.69786096257,132.179144385027,374,32.1121278097489,14.9261103600116,0.885409268539235,0.949238578680203,0.623333333333333,-1.15679640930531,51520.8983957219,35511.9385026738,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_617186,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
617906,4151.3777173913,831.557065217391,650.122282608696,638.358695652174,1303.50543478261,4563.04891304348,477.059782608696,267.179347826087,1135.69293478261,7696.16304347826,590.119565217391,121.722826086957,1096.76358695652,3417.23097826087,676.842391304348,314.953804347826,1679.46195652174,2081.58967391304,316.016304347826,234.836956521739,1002.95923913043,1657.91847826087,229.39402173913,352.9375,628.285326086957,2342.21195652174,559.788043478261,253.959239130435,1109.2527173913,132.350543478261,368,26.9085253188483,17.4979786449259,0.75969771586535,0.973544973544974,0.727272727272727,-0.857449449148678,52036.5081521739,34472.972826087,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_617906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
618050,2045.07518796992,64.3383458646616,47.0225563909774,629.624060150376,1519.54887218045,2051.42857142857,365.345864661654,255.172932330827,1085.88721804511,3135.40601503759,681.436090225564,123.962406015038,1066.2030075188,2943.45864661654,746.676691729323,320.210526315789,2206.88721804511,1299.39097744361,297.669172932331,237.766917293233,1031.05263157895,1022.6015037594,205.330827067669,138.165413533835,884.12030075188,935.300751879699,476.796992481203,219.954887218045,1018.25563909774,131.894736842105,133,16.6714649981298,11.2681439555493,0.736998803619886,0.841772151898734,0.59375,-1.11882361836392,51067.1503759398,33879.7518796993,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_618050,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
618233,542.462389380531,601.829646017699,142.778761061947,612.329646017699,95.4469026548673,580.70796460177,375.41814159292,256.980088495575,1110.12168141593,1360.47566371681,1688.26769911504,119.847345132743,1064.78097345133,1041.50663716814,577.446902654867,296.652654867257,1668.31415929204,1011.59292035398,224.964601769911,257.988938053097,1130.36946902655,641.491150442478,137.349557522124,123.108407079646,592.287610619469,571.559734513274,373.91814159292,200.141592920354,983.371681415929,129.194690265487,452,25.9372802117771,22.20177787711,0.51700990841911,0.959660297239915,0.760942760942761,-1.48337181463282,51136.7522123894,33841.6084070796,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_618233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
618529,3366.97350993377,288.788079470199,98.5099337748344,638.523178807947,1455.43046357616,3731.93377483444,370.801324503311,273.278145695364,1089.3642384106,5517.60927152318,586.490066225166,127.278145695364,1073.18543046358,694.801324503311,495.87417218543,281.026490066225,1350.72847682119,1062.8940397351,335.41059602649,236.443708609272,976.384105960265,1014.15231788079,240.271523178808,120.774834437086,587.192052980132,1880.43046357616,545.953642384106,272.298013245033,1040.45695364238,130.854304635762,151,16.1580327150147,12.3445926176229,0.645226822937192,0.915151515151515,0.683257918552036,-1.53173647707139,50392.3509933775,34303.5099337748,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_618529,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
619985,3753.97916666667,357.757575757576,161.706439393939,667.856060606061,2885.20643939394,4522.23674242424,378.998106060606,281.299242424242,1098.20454545455,6943.51136363636,646.138257575758,130.429924242424,1093.32954545455,1144.57196969697,553.306818181818,288.556818181818,1462.60606060606,1865.91666666667,382.465909090909,254.99053030303,988.0625,1869.14204545455,264.195075757576,280.109848484848,586.50946969697,3277.60795454545,579.668560606061,234.664772727273,1072.16098484848,130.079545454545,528,39.4677100871079,17.6054620474772,0.894996804965898,0.967032967032967,0.733333333333333,0.130220522070452,50458.2992424242,34623.2689393939,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_619985,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
620004,2914.55042016807,705.285714285714,129.058823529412,636.840336134454,2069.07983193277,2649.1218487395,759.521008403361,267.445378151261,1089.28151260504,4227.18907563025,1343.77731092437,118.81512605042,1074.34033613445,1699.84033613445,545.021008403361,282.054621848739,1534.13025210084,6095.26890756303,381.508403361345,242.084033613445,1010.3487394958,6962.26470588235,272.600840336134,227.22268907563,592.033613445378,1453.73109243697,487.0,363.193277310924,1059.00420168067,131.176470588235,238,25.6830791314724,11.8740576378543,0.886707946977404,0.922480620155039,0.569377990430622,-0.690604811251842,50829.4117647059,35701.4915966387,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_620004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
620815,4084.51800554017,1047.56509695291,2766.70360110803,642.778393351801,1857.73684210526,3908.3351800554,689.95567867036,271.905817174515,1110.10249307479,6299.08033240997,644.91135734072,120.542936288089,1082.86980609418,1222.84487534626,616.108033240997,277.180055401662,1633.8891966759,1503.09972299169,285.684210526316,227.903047091413,1011.01939058172,1386.37673130194,212.980609418283,430.008310249307,2919.24653739612,1479.37673130194,510.83379501385,287.94459833795,1039.41828254848,132.445983379501,361,28.6796554521572,16.3737312226459,0.821007094713527,0.952506596306069,0.758403361344538,0.188418606936728,51769.7257617728,35162.5512465374,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_620815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
621219,2420.14935064935,1130.81818181818,117.558441558442,651.844155844156,2120.61688311688,2631.14285714286,2821.48701298701,270.233766233766,1128.31818181818,3824.99350649351,1682.95454545455,116.11038961039,1074.1038961039,637.506493506493,465.136363636364,495.487012987013,1516.26623376623,978.227272727273,263.883116883117,228.318181818182,997.928571428571,919.74025974026,208.207792207792,168.954545454545,645.474025974026,1314.63636363636,532.519480519481,351.714285714286,1085.0974025974,130.766233766234,154,15.9514417414593,12.3032937657793,0.636475812207903,0.956521739130435,0.78974358974359,0.328932061265617,51532.512987013,35041.0974025974,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_621219,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
621932,1493.51925465839,282.362732919255,187.114285714286,691.383850931677,4505.15527950311,1963.48198757764,362.480745341615,266.541614906832,1093.71180124224,2894.72670807453,612.331677018634,129.434782608696,1084.83850931677,524.182608695652,406.151552795031,256.068322981366,1393.64347826087,814.024844720497,228.370186335404,219.894409937888,990.472049689441,754.924223602485,178.365217391304,137.782608695652,582.407453416149,1124.24099378882,547.113043478261,228.804968944099,1034.38757763975,130.8,805,53.8295884040518,19.3239052358964,0.933344111798074,0.949292452830189,0.468023255813953,-0.842031541633101,51742.5627329193,34132.9068322981,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_621932,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
622213,2410.28434504792,535.626198083067,454.134185303514,673.990415335463,3712.58466453674,3057.42172523962,672.523961661342,273.386581469649,1119.97444089457,4207.08945686901,568.182108626198,120.092651757188,1075.11182108626,997.188498402556,674.792332268371,304.054313099042,1667.0607028754,1200.60383386581,296.083067092652,230.686900958466,1168.20766773163,1027.15335463259,216.185303514377,266.546325878594,2150.02236421725,1476.97444089457,474.003194888179,383.463258785943,1072.17571884984,130.421725239617,313,25.6972260973566,15.6968672487106,0.791754852631629,0.954268292682927,0.7825,0.134831335801853,51579.1341853035,35711.1980830671,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_622213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
622557,2113.55405405405,221.900900900901,82.1036036036036,628.445945945946,956.662162162162,1653.22972972973,2825.93693693694,265.54954954955,1105.57657657658,3670.12612612613,2250.48648648649,113.216216216216,1073.4009009009,656.900900900901,484.432432432433,388.220720720721,1483.40540540541,999.972972972973,267.432432432432,326.247747747748,994.936936936937,914.887387387387,203.783783783784,184.103603603604,591.878378378378,1412.62162162162,493.783783783784,654.513513513514,1043.81531531532,129.45045045045,222,20.0766756062482,14.2068351800417,0.70658431122381,0.956896551724138,0.687306501547988,-1.00323014379575,51471.3693693694,35474.7522522523,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_622557,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
623247,1687.3738317757,144.028037383178,60.2928348909657,614.330218068536,610.981308411215,1944.79439252336,1046.84423676012,263.691588785047,1091.47663551402,3750.47040498442,1584.47663551402,109.102803738318,1064.70404984424,666.267912772586,470.333333333333,276.249221183801,1446.33333333333,964.084112149533,276.127725856698,227.18691588785,986.738317757009,928.738317757009,212.482866043614,153.97507788162,591.869158878505,2065.753894081,496.06230529595,398.006230529595,1029.70404984424,129.420560747664,321,22.1381647453827,18.501043604961,0.54917389867152,0.966867469879518,0.764285714285714,0.837320194226686,51603.1713395639,35374.5140186916,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623247,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
623971,3795.29142857143,459.611428571429,123.291428571429,630.205714285714,1398.26857142857,4059.86285714286,506.6,279.434285714286,1120.33714285714,5648.33714285714,597.931428571429,125.257142857143,1080.43428571429,1441.92571428571,692.32,307.56,3701.13714285714,3781.96571428571,372.794285714286,245.142857142857,1012.18285714286,5255.74857142857,262.874285714286,157.948571428571,597.114285714286,1730.64,601.525714285714,287.628571428571,1042.98285714286,131.045714285714,175,17.835893854406,13.4012686197406,0.659886693734794,0.897435897435897,0.614035087719298,-0.353929421040671,51754.2228571429,34925.1428571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623971,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
624330,1848.66666666667,135.794326241135,93.5354609929078,647.287234042553,2461.81560283688,2156.45390070922,448.382978723404,255.826241134752,1089.5,3131.39361702128,763.414893617021,112.329787234043,1075.82269503546,2114.91489361702,518.812056737589,378.943262411348,1733.91489361702,1726.72695035461,326.393617021277,233.840425531915,991.574468085106,1417.52482269504,214.290780141844,137.404255319149,587.141843971631,1126.98581560284,495.159574468085,230.744680851064,1023.07446808511,130.439716312057,282,24.3644723545343,14.8572392813942,0.792562155380493,0.952702702702703,0.721227621483376,-0.358547550429567,51172.4503546099,34541.634751773,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_624330,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
624562,1804.94270833333,83.1458333333333,60.2135416666667,642.119791666667,1773.859375,2431.05729166667,380.921875,269.114583333333,1109.97395833333,3026.86979166667,835.833333333333,158.828125,1062.890625,1520.25,517.713541666667,298.614583333333,1521.296875,3499.90625,389.145833333333,239.005208333333,1106.18229166667,3485.36458333333,246.604166666667,469.932291666667,828.375,1090.74479166667,485.635416666667,225.083333333333,1075.515625,132.333333333333,192,24.4364977308506,10.1693742383753,0.909293624692532,0.932038834951456,0.53185595567867,-0.762038068040149,50411.625,34904.609375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_624562,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
624615,3022.83241758242,1023.26923076923,548.126373626374,653.582417582418,2228.92857142857,3408.14835164835,1139.3489010989,269.131868131868,1116.67032967033,5260.30769230769,1022.7032967033,118.313186813187,1078.23076923077,1680.76098901099,637.629120879121,321.337912087912,3243.48626373626,1206.23351648352,300.063186813187,233.868131868132,990.653846153846,1108.64285714286,222.653846153846,150.291208791209,582.217032967033,1724.33516483516,489.903846153846,266.953296703297,1060.44230769231,129.931318681319,364,28.5942097290086,16.7143531168501,0.811367568956292,0.93573264781491,0.722222222222222,0.207374922806021,51572.6978021978,34971.010989011,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624615,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
625051,4422.04597701149,791.080459770115,140.885057471264,664.241379310345,2377.31417624521,3884.83524904215,1237.31800766284,279.662835249042,1341.38314176245,6210.4214559387,865.92337164751,127.938697318008,1110.21455938697,1162.10344827586,902.95785440613,645.885057471264,2097.16475095785,2829.09195402299,350.245210727969,244.76245210728,1020.89272030651,3447.2030651341,258.651340996169,467.157088122605,677.60153256705,1367.94252873563,475.164750957854,295.325670498084,1060.65900383142,130.777777777778,261,21.7283577415326,15.4294195401809,0.704095606579375,0.952554744525547,0.686842105263158,-0.784009303168452,50893.5172413793,35789.1111111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_625051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
625371,3006.85081585082,261.456876456876,102.102564102564,648.797202797203,2318.53146853147,3213.2331002331,2004.42657342657,279.191142191142,1117.15384615385,5710.60839160839,1638.9020979021,117.174825174825,1076.98601398601,1034.89743589744,643.778554778555,836.37296037296,1695.59207459207,2413.3006993007,285.151515151515,232.121212121212,1013.71328671329,2358.24708624709,210.937062937063,261.636363636364,598.307692307692,2085.02331002331,497.356643356643,439.638694638695,1102.7668997669,132.156177156177,429,26.2687594478929,21.0011029892286,0.600705111657257,0.955456570155902,0.78,1.1561891273553,50936.2237762238,35466.8065268065,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_625371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
625422,3766.54372623574,397.847908745247,170.114068441065,684.406844106464,4239.95437262357,4349.77186311787,518.490494296578,298.722433460076,1222.17490494297,6615.79847908745,597.80608365019,121.51711026616,1089.19391634981,4451.61216730038,1077.20912547529,709.190114068441,3139.61977186312,6816.47148288973,470.334600760456,254.433460076046,1081.03041825095,6653.29657794677,305.250950570342,669.916349809886,647.950570342205,2245.65399239544,502.429657794677,256.349809885932,1064.93536121673,129.965779467681,263,26.9470248485037,12.5217027413499,0.885479476626309,0.942652329749104,0.569264069264069,-0.749367778531827,50930.1977186312,35579.6768060836,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_625422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
625893,2497.35357142857,262.510714285714,114.607142857143,651.575,2454.46785714286,2933.025,2438.93571428571,266.135714285714,1101.81785714286,5091.28928571429,995.882142857143,110.053571428571,1071.175,673.121428571429,429.767857142857,277.214285714286,1401.41785714286,1026.72142857143,302.639285714286,235.75,983.796428571429,1000.50357142857,222.032142857143,141.517857142857,577.9,1481.56071428571,480.439285714286,444.735714285714,1069.96428571429,130.210714285714,280,25.3820814959186,14.0880445825188,0.831824339920837,0.955631399317406,0.669856459330144,-0.948494041548605,51203.2178571429,35091.0142857143,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_625893,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
626780,2669.9211469534,799.503584229391,108.97311827957,637.324372759857,2317.42652329749,2559.59318996416,715.066308243728,263.718637992832,1103.72043010753,4348.23835125448,1378.65591397849,114.652329749104,1078.94802867384,1584.41397849462,773.408602150538,302.030465949821,1972.50716845878,1806.99462365591,311.200716845878,235.89605734767,1021.16845878136,1352.58781362007,278.729390681004,157.320788530466,592.301075268817,1475.01612903226,508.200716845878,311.068100358423,1037.01433691756,132.362007168459,558,36.7052055563588,19.5497524280208,0.846357483471404,0.950596252129472,0.754054054054054,-1.47360035970109,52076.9068100358,34897.6774193548,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_626780,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
627057,1147.68347338936,162.834733893557,79.4481792717087,627.078431372549,1679.70868347339,1475.83193277311,346.896358543417,249.593837535014,1080.99719887955,2652.43417366947,608.977591036415,110.014005602241,1065.44817927171,799.56862745098,785.324929971989,275.663865546218,1586.22128851541,1318.17927170868,348.546218487395,243.935574229692,1001.92156862745,1269.37535014006,235.593837535014,355.887955182073,584.565826330532,1552.53781512605,489.532212885154,239.039215686275,1049.55462184874,131.190476190476,357,22.2126991226663,20.5416675105208,0.380523285174648,0.962264150943396,0.739130434782609,-0.403563289454702,50782.4173669468,34407.5014005602,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_627057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
627103,2333.41706161137,326.232227488152,124.355450236967,621.194312796209,1024.51658767773,2458.01421800948,508.952606635071,268.236966824645,1082.36492890995,4499.58293838863,932.407582938389,115.156398104265,1085.98578199052,656.710900473934,454.431279620853,279.369668246445,1432.94312796209,1028.34597156398,312.81990521327,234.417061611374,989.018957345972,1050.96682464455,249.957345971564,194.056872037915,586.530805687204,2844.55450236967,509.805687203791,381.142180094787,1061.68246445498,128.464454976303,211,30.506525399901,8.88773105884472,0.956619971243818,0.925438596491228,0.422,-0.630403919153907,50326.1327014218,35659.355450237,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_627103,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
627371,2144.99411764706,285.094117647059,158.905882352941,662.829411764706,3609.47647058824,3013.53529411765,344.770588235294,272.047058823529,1094.3,3544.47058823529,554.311764705882,125.982352941176,1086.62352941176,3593.94705882353,678.811764705882,300.417647058824,1615.56470588235,1549.74117647059,375.141176470588,244.288235294118,1001.07647058824,1209.09411764706,236.941176470588,143.123529411765,581.029411764706,2465.62352941176,579.041176470588,229.247058823529,1064.05882352941,130.911764705882,170,16.7839163359567,13.2258873828672,0.615662937799377,0.904255319148936,0.708333333333333,-1.20184031611399,50843.2235294118,34719.2529411765,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_627371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
627699,2030.92307692308,278.83110367893,204.667224080268,710.968227424749,5762.67558528428,2441.2508361204,360.138795986622,266.923076923077,1124.18227424749,4469.51337792642,598.265886287625,124.147157190635,1066.64882943144,590.714046822742,399.596989966555,264.872909698997,1432.32943143813,884.235785953177,257.463210702341,224.814381270903,973.85618729097,841.864548494983,196.07525083612,136.690635451505,580.255852842809,2558.05518394649,575.155518394649,231.994983277592,1082.65719063545,130.382943143813,598,41.617405657218,18.9670538821067,0.890108792331973,0.952229299363057,0.622916666666667,-0.354895563637357,51725.3428093645,34291.110367893,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_627699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
627706,2293.82456140351,426.25,126.587719298246,627.083333333333,1945.98684210526,2297.02631578947,524.561403508772,268.745614035088,1126.67543859649,3170.23245614035,537.710526315789,114.355263157895,1073.85526315789,830.052631578947,582.197368421053,344.232456140351,3506.89035087719,1167.60964912281,278.267543859649,230.456140350877,1012.27631578947,1087.3201754386,209.232456140351,151.688596491228,596.956140350877,959.232456140351,520.907894736842,237.276315789474,1026.53070175439,129.90350877193,228,22.2050179474256,13.2340008480794,0.80299077908476,0.942148760330578,0.723809523809524,-0.356427664436803,51615.1271929825,35040.8771929825,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_627706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
628050,2650.81451612903,214.407258064516,109.923387096774,643.012096774194,2027.35080645161,3355.85483870968,4370.02419354839,267.629032258065,1092.99193548387,4043.02822580645,1218.14919354839,110.512096774194,1068.33870967742,1671.95161290323,537.653225806452,320.508064516129,1545.12903225806,1838.97177419355,323.197580645161,235.233870967742,1002.15725806452,1425.57661290323,216.782258064516,141.415322580645,581.350806451613,1048.42338709677,474.911290322581,454.709677419355,1061.88306451613,132.528225806452,248,20.1339261381783,15.7905579260246,0.620411905291849,0.953846153846154,0.765432098765432,0.603656744200027,51103.625,35077.5080645161,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_628050,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
628974,2091.10817941953,135.218997361478,117.168865435356,653.97889182058,2875.98416886544,2138.36675461741,335.707124010554,262.406332453826,1093.45118733509,4346.58311345646,587.158311345646,113.108179419525,1074.69920844327,851.683377308707,481.002638522427,276.406332453826,1654.56464379947,1095.72031662269,260.65963060686,226.387862796834,1086.24802110818,944.313984168865,198.134564643799,164.269129287599,815.184696569921,1447.14511873351,476.688654353562,258.266490765172,1050.53298153034,129.047493403694,379,37.8799930820351,13.1990804123552,0.937329363370595,0.917675544794189,0.601587301587302,-1.24415558175159,51562.7625329815,35265.1767810026,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_628974,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
629258,4741.33603238866,1054.41700404858,1319.45344129555,641.012145748988,1887.92712550607,5126.90688259109,677.348178137652,279.623481781377,1115.2955465587,7647.44939271255,585.165991902834,125.862348178138,1100.17813765182,829.716599190283,468.17004048583,290.36032388664,1546.74493927126,1120.68016194332,251.882591093117,223.63967611336,1084.71659919028,1023.68421052632,210.032388663968,212.497975708502,1706.57894736842,1783.14574898785,506.109311740891,238.344129554656,1054.61538461538,130.02024291498,247,20.6193158875463,15.4816872267813,0.660490747531726,0.942748091603053,0.764705882352941,-0.548270088424368,51731.7530364373,35552.8259109312,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_629258,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
629823,780.837313432836,222.94328358209,131.768656716418,643.350746268657,2270.12537313433,1025.44925373134,388.007462686567,277.991044776119,1091.28358208955,1485.71194029851,579.970149253731,117.34776119403,1063.71791044776,598.228358208955,440.837313432836,272.408955223881,1431.43134328358,1033.70298507463,305.874626865672,235.513432835821,984.708955223881,1096.03134328358,392.129850746269,150.377611940299,580.282089552239,1011.41194029851,472.188059701492,220.771641791045,1031.34179104478,129.168656716418,670,36.9974541855661,23.1494676261544,0.780060305238291,0.964028776978417,0.744444444444444,-0.328913037093168,50365.2223880597,35383.2567164179,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_629823,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
630592,1756.58762886598,189.675257731959,106.618556701031,641.742268041237,1869.18556701031,2513.89175257732,1499.59793814433,267.149484536082,1096.41237113402,3608.31958762887,1942.95360824742,109.649484536082,1080.12371134021,4455.27835051546,1306.96391752577,322.60824742268,2219.95360824742,7190.45360824742,428.850515463918,253.917525773196,1022.34536082474,7886.5412371134,303.731958762887,285.541237113402,582.865979381443,1424.21134020619,458.365979381443,559.814432989691,1063.38659793814,129.453608247423,194,18.8381925589902,13.1453511345661,0.716289527911617,0.96039603960396,0.76984126984127,0.345076795296087,51406.3144329897,35448.118556701,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_630592,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
630935,1796.65605095541,114.197452229299,103.350318471338,646.108280254777,3784.76433121019,1621.53503184713,554.203821656051,271.095541401274,1107.49681528662,3762.96815286624,866.815286624204,113.146496815287,1078.85350318471,4280.03821656051,596.554140127389,366.178343949045,1954.79617834395,2134.91719745223,346.40127388535,238.044585987261,1031.43312101911,1495.15923566879,239.56050955414,269.407643312102,1984.14012738854,1925.35031847134,452.146496815287,230.929936305732,1052.17197452229,129.044585987261,157,21.831951788109,9.2609747830312,0.905571514567512,0.923529411764706,0.67965367965368,-1.33847937893181,51673.2802547771,35655.8025477707,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_630935,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
631056,3358.79948586118,537.976863753213,247.897172236504,664.120822622108,3231.75835475578,3604.37017994859,580.40616966581,273.498714652956,1130.5706940874,6596.91259640103,612.431876606684,119.94087403599,1122.35475578406,3914.91516709512,869.156812339332,455.082262210797,1753.84318766067,4941.16452442159,420.753213367609,247.789203084833,1021.96915167095,4154.31105398458,276.272493573265,316.637532133676,598.259640102828,2329.27763496144,530.501285347044,300.627249357326,1075.24935732648,130.946015424165,389,29.7974466362738,16.682356870644,0.828588162930811,0.962871287128713,0.68006993006993,-0.988226300709096,51415.1542416452,35599.3316195373,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_631056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
632090,2163.65882352941,222.735294117647,99.8176470588235,630.676470588235,1559.11764705882,2462.10588235294,332.105882352941,261.223529411765,1080.02352941176,3902.87058823529,649.9,115.035294117647,1061.6,2342.05294117647,504.0,351.705882352941,1830.6,2627.43529411765,347.105882352941,232.170588235294,1097.2,2549.47058823529,218.647058823529,218.923529411765,611.605882352941,1118.04117647059,456.794117647059,239.123529411765,1038.98823529412,131.882352941176,170,29.3375952185178,7.48318795368051,0.96692216254483,0.899470899470899,0.732758620689655,1.55393018441773,51398.5176470588,35134.9411764706,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_632090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
632136,2600.79527559055,436.490813648294,135.385826771654,643.307086614173,2248.14960629921,2029.62467191601,2551.97900262467,273.918635170604,1090.22834645669,3919.61942257218,1106.87926509186,120.482939632546,1073.70866141732,1532.76902887139,735.45406824147,297.251968503937,1948.2125984252,3462.65091863517,377.587926509186,243.396325459318,1035.25459317585,3647.92650918635,276.98687664042,288.606299212598,598.97375328084,1578.20472440945,556.11811023622,344.771653543307,1043.1312335958,129.997375328084,381,25.6893923512071,19.0168790820446,0.672318584917542,0.967005076142132,0.762,1.25804072657056,51969.5853018373,34976.3832020997,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_632136,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
634702,2881.77914110429,296.963190184049,93.5337423312883,652.070552147239,2593.90797546012,2444.76380368098,951.506134969325,267.306748466258,1103.27300613497,4798.84969325153,920.067484662577,113.773006134969,1099.68711656442,3170.14110429448,883.840490797546,497.782208588957,7514.53067484663,4152.0736196319,369.061349693252,239.527607361963,1027.70552147239,4300.24539877301,258.895705521472,184.79754601227,621.567484662577,1456.50920245399,465.914110429448,290.331288343558,1047.65030674847,130.981595092025,326,24.6445716478818,17.0988796989756,0.720149126849706,0.953216374269006,0.740909090909091,-0.588204599502321,51272.990797546,35558.8159509202,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_634702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
634909,2673.03225806452,149.411290322581,127.745967741935,628.899193548387,1126.22580645161,2768.36693548387,466.778225806452,267.709677419355,1102.89516129032,5156.0,474.532258064516,111.467741935484,1100.28629032258,975.491935483871,521.717741935484,275.721774193548,1822.20161290323,1407.20967741935,307.790322580645,238.463709677419,1057.0564516129,1114.39516129032,215.008064516129,150.504032258065,633.637096774194,2165.625,510.862903225806,389.274193548387,1055.33064516129,131.104838709677,248,22.1849078512121,14.2994672900032,0.764555133020674,0.950191570881226,0.725146198830409,-0.83916975727114,51167.6975806452,35282.4032258065,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_634909,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
635452,2742.34134615385,658.216346153846,141.947115384615,651.072115384615,2594.06730769231,2900.75480769231,3671.21634615385,277.355769230769,1117.44230769231,5298.20192307692,692.495192307692,116.471153846154,1085.55769230769,3962.24038461538,858.480769230769,364.341346153846,3998.52884615385,6663.53365384615,467.600961538462,254.947115384615,1085.72115384615,5673.55769230769,277.923076923077,292.375,631.153846153846,2155.96634615385,479.466346153846,1940.36538461538,1106.02884615385,130.903846153846,208,19.172093714047,14.2472869882348,0.669151184858242,0.920353982300885,0.693333333333333,1.24774272766823,50877.0336538462,35550.4134615385,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635452,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
635554,2076.58011049724,567.038674033149,244.939226519337,710.994475138122,6656.33701657459,2019.78453038674,598.298342541436,258.718232044199,1111.24309392265,4407.94475138122,730.403314917127,117.480662983425,1064.71270718232,2829.23204419889,1108.17679558011,1171.72375690608,3370.75138121547,6769.61878453039,446.044198895028,248.049723756906,1049.74585635359,6790.07182320442,271.469613259669,335.276243093923,668.408839779006,2066.36464088398,521.28729281768,228.977900552486,1031.12154696133,129.883977900552,181,17.3222365288728,13.3682962084725,0.635935843653513,0.93298969072165,0.709803921568627,-1.0380706068754,51518.9392265193,35026.6740331492,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635554,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
635747,1820.7247706422,371.700305810398,100.030581039755,607.079510703364,347.247706422018,1965.07339449541,1018.23547400612,267.975535168196,1100.64525993884,1952.05504587156,847.522935779817,119.067278287462,1435.89296636086,654.495412844037,606.960244648318,272.599388379205,1563.79204892966,1121.95412844037,317.880733944954,237.60244648318,1016.09480122324,1001.21406727829,219.100917431193,177.394495412844,596.596330275229,860.840978593272,518.443425076453,223.262996941896,1041.59327217125,132.211009174312,327,23.7122231116432,17.6320234997118,0.668642822777874,0.964601769911504,0.782296650717703,-0.444964058566451,50256.0856269113,33976.0366972477,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
635924,1001.3660130719,256.16339869281,104.722222222222,637.669934640523,1586.38562091503,1222.92483660131,1044.91176470588,261.676470588235,1084.94444444444,2591.12745098039,2193.93790849673,109.66339869281,1065.56862745098,709.823529411765,551.352941176471,274.898692810458,1435.00326797386,1019.93464052288,314.898692810458,235.957516339869,983.111111111111,964.33660130719,225.039215686275,127.535947712418,581.549019607843,1571.99019607843,526.624183006536,465.150326797386,1074.27450980392,131.83660130719,306,27.5435530244019,14.1555969070478,0.857829108316193,0.965299684542587,0.6375,-0.944050285751928,50766.3366013072,34982.2614379085,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635924,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
636233,1617.21393034826,240.800995024876,100.333333333333,628.089552238806,1584.64179104478,1401.80099502488,300.467661691542,259.621890547264,1080.77114427861,3211.95024875622,525.860696517413,108.980099502488,1059.77114427861,1212.13930348259,520.477611940299,270.995024875622,1508.56218905473,1401.95024875622,287.756218905473,228.766169154229,990.467661691542,1388.33333333333,224.975124378109,170.661691542289,588.611940298507,1386.50248756219,449.154228855721,220.432835820896,1024.4328358209,128.258706467662,201,22.4738162166438,11.6682199348635,0.85465778437198,0.94811320754717,0.652597402597403,-0.376643773308364,50586.6567164179,35645.7661691542,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_636233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
636845,2371.96578947368,242.5,183.168421052632,701.534210526316,4358.07894736842,3148.96315789474,294.473684210526,260.539473684211,1105.25789473684,5306.98157894737,483.621052631579,120.557894736842,1076.37368421053,733.818421052632,543.378947368421,280.810526315789,1392.87105263158,1208.40789473684,366.189473684211,244.834210526316,980.834210526316,1197.40263157895,259.205263157895,123.555263157895,583.852631578947,2860.60526315789,511.518421052632,221.447368421053,1062.46578947368,131.115789473684,380,30.1491653934518,16.1403440782628,0.844630564206953,0.945273631840796,0.664335664335664,-0.588065957294007,50760.9763157895,34677.7210526316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_636845,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
636869,1712.29457364341,161.077519379845,57.7984496124031,604.395348837209,287.193798449612,1685.57364341085,753.294573643411,246.829457364341,1084.12403100775,1654.17054263566,440.279069767442,98.1705426356589,1057.17829457364,863.023255813953,565.84496124031,277.457364341085,1446.93023255814,1151.81395348837,334.751937984496,241.868217054264,983.193798449612,1078.61240310078,231.139534883721,120.22480620155,582.147286821705,702.612403100775,407.782945736434,208.046511627907,1003.70542635659,130.744186046512,129,16.7108741594327,10.0185801255706,0.800356330309658,0.941605839416058,0.708791208791209,-0.680314369589407,50745.4496124031,34444.0387596899,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_636869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
637076,2356.08270676692,289.635338345865,106.432330827068,617.398496240602,1225.7030075188,2290.20676691729,1423.65789473684,268.639097744361,1086.11654135338,4303.85714285714,1798.72932330827,114.360902255639,1085.57518796992,829.09022556391,474.996240601504,315.864661654135,1596.92481203008,2434.32330827068,320.443609022556,245.842105263158,1009.60902255639,2580.95488721805,226.203007518797,178.958646616541,586.011278195489,1770.38721804511,489.067669172932,633.203007518797,1044.14661654135,129.473684210526,266,24.8691153487185,13.7397882014475,0.833523506089331,0.963768115942029,0.666666666666667,-0.705238426011999,50980.537593985,35408.6503759398,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_637076,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
637160,2241.088,386.624,172.192,648.336,3064.056,2547.44,382.184,270.304,1094.384,4470.288,674.464,125.208,1085.464,732.336,552.048,281.152,1417.336,1116.096,343.04,246.392,983.136,1106.2,245.888,139.8,587.544,1411.2,547.752,244.072,1054.256,131.408,125,20.0888401538596,8.22997285977769,0.91222981907583,0.932835820895522,0.730994152046784,1.36850137529141,50746.448,34845.368,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_637160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
637444,1859.21374045802,158.251908396947,71.0114503816794,656.828244274809,2969.00381679389,1714.9427480916,338.36641221374,262.919847328244,1094.18702290076,3832.58396946565,492.091603053435,114.309160305344,1075.5572519084,3205.25572519084,740.496183206107,915.988549618321,1656.49618320611,2800.20229007634,341.591603053435,235.919847328244,1015.20992366412,2864.90839694657,257.835877862595,267.893129770992,623.324427480916,1964.29770992366,458.839694656489,222.240458015267,1089.90458015267,129.87786259542,262,22.604145880808,14.8471761208369,0.754035033086837,0.956204379562044,0.693121693121693,-0.575149191092185,51402.1603053435,35758.6984732824,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_637444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
638274,1025.73287671233,179.404109589041,68.3424657534247,641.267123287671,2044.17123287671,986.938356164384,430.0,254.047945205479,1096.18493150685,2348.19863013699,736.150684931507,113.732876712329,1067.05479452055,703.801369863014,534.616438356164,281.315068493151,1527.64383561644,1171.06849315068,356.143835616438,239.719178082192,994.58904109589,1122.1095890411,249.246575342466,182.157534246575,585.506849315069,1434.19863013699,457.815068493151,259.253424657534,1040.13698630137,130.397260273973,146,15.8698021017392,11.8679167688022,0.663890081352522,0.929936305732484,0.695238095238095,0.727452948563152,50533.2465753425,35774.1095890411,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_638274,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
638690,442.035143769968,676.127795527157,176.076677316294,608.29392971246,211.741214057508,254.290734824281,221.523961661342,225.709265175719,1080.98722044728,690.207667731629,484.968051118211,97.7476038338658,1059.63897763578,642.929712460064,378.830670926518,258.913738019169,1516.2268370607,969.351437699681,200.386581469648,216.623003194888,998.38338658147,840.939297124601,157.594249201278,131.130990415335,705.722044728435,572.875399361022,375.150159744409,201.130990415335,986.054313099042,130.916932907348,313,21.2291294345258,18.7998517252933,0.464508500289469,0.966049382716049,0.784461152882206,1.41920050098406,51389.9424920128,34002.3322683706,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_638690,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
638763,2488.13274336283,1064.08407079646,135.20796460177,670.269911504425,3652.07079646018,2773.79203539823,1053.9203539823,263.455752212389,1124.29646017699,3815.77876106195,546.796460176991,110.41592920354,1077.37168141593,740.296460176991,420.615044247788,308.12389380531,1498.86283185841,1305.24778761062,274.314159292035,228.411504424779,995.318584070796,1666.09292035398,221.101769911504,355.079646017699,605.274336283186,1157.98672566372,447.946902654867,383.464601769911,1032.44247787611,130.619469026549,226,18.334998836317,15.7756845204638,0.509596147623351,0.978354978354978,0.830882352941177,0.560895433890829,51105.3628318584,35578.4336283186,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_638763,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
639259,1742.16393442623,1257.89344262295,104.549180327869,635.459016393443,1157.64754098361,2999.90163934426,1844.73770491803,269.008196721311,1217.65573770492,3629.0737704918,1766.13114754098,112.254098360656,1145.14754098361,1127.23770491803,1292.81147540984,1144.13114754098,1764.2131147541,1073.49180327869,289.655737704918,226.934426229508,1010.31147540984,1003.90983606557,218.713114754098,265.122950819672,665.393442622951,1479.26229508197,459.729508196721,391.05737704918,1060.64754098361,133.44262295082,122,15.6243061139204,9.98366602749669,0.769220854461029,0.924242424242424,0.693181818181818,-1.43777506333319,51333.8196721311,35697.8278688525,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_639259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
639776,1860.85454545454,516.733333333333,294.036363636364,616.812121212121,840.375757575758,2562.03636363636,370.575757575758,270.266666666667,1129.30909090909,3576.31515151515,485.133333333333,107.975757575758,1065.66666666667,3308.36363636364,1153.23636363636,1951.16363636364,2010.79393939394,3649.09696969697,318.636363636364,278.836363636364,1014.0,3922.98787878788,250.775757575758,573.551515151515,610.927272727273,1773.52121212121,446.763636363636,236.509090909091,1028.82424242424,129.933333333333,165,15.1268652057062,14.2731064259523,0.331201359012589,0.942857142857143,0.6875,-1.46447126489665,50988.1151515152,35602.8060606061,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_639776,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
639945,3058.6880733945,278.241590214067,148.449541284404,642.34250764526,2603.4006116208,3453.52599388379,372.681957186544,283.113149847095,1108.17737003058,6173.43119266055,584.519877675841,121.862385321101,1077.27217125382,1079.01834862385,593.180428134557,277.795107033639,1586.49235474006,1774.84097859327,290.412844036697,231.795107033639,1284.47400611621,1765.31498470948,208.917431192661,174.993883792049,1218.09174311927,1905.09480122324,517.978593272171,235.984709480122,1045.21712538226,129.097859327217,327,33.2510016392887,12.6832136588515,0.92439419999809,0.945086705202312,0.50462962962963,0.920307596687452,51040.2905198777,35257.7155963303,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_639945,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
640509,3776.10144927536,260.43961352657,93.6618357487923,623.840579710145,1044.1690821256,4338.74396135266,406.95652173913,265.130434782609,1091.2270531401,7103.13526570048,711.777777777778,120.492753623188,1079.05797101449,791.289855072464,743.942028985507,410.275362318841,1669.01449275362,1221.85990338164,326.724637681159,236.004830917874,1014.14492753623,952.835748792271,207.183574879227,167.888888888889,605.371980676328,2458.77777777778,517.840579710145,235.502415458937,1042.55555555556,129.579710144928,207,23.4482990159117,11.3775305494386,0.874393360663465,0.940909090909091,0.608823529411765,0.936702506971538,50516.0531400966,34252.4782608696,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_640509,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
640826,2468.375,214.775862068966,107.931034482759,655.14224137931,2450.91379310345,2403.64655172414,979.01724137931,258.176724137931,1092.65086206897,4588.26724137931,494.806034482759,117.974137931034,1091.69827586207,4637.27586206897,1522.9525862069,733.909482758621,2366.21551724138,3479.7974137931,398.487068965517,249.612068965517,1047.89224137931,2567.91810344828,254.568965517241,287.073275862069,730.310344827586,1938.63793103448,501.931034482759,342.344827586207,1051.9224137931,130.155172413793,232,23.3089294496007,13.093689308557,0.827310005229662,0.909803921568627,0.581453634085213,-0.927908292113095,52080.4956896552,35010.2715517241,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_640826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
641818,1131.51968503937,103.464566929134,109.88188976378,674.897637795276,3566.1811023622,1320.70866141732,293.196850393701,246.307086614173,1097.27559055118,2783.11811023622,812.047244094488,106.952755905512,1069.29921259843,606.653543307087,686.393700787402,628.44094488189,1576.67716535433,875.181102362205,239.291338582677,217.968503937008,998.330708661417,770.0,172.157480314961,130.51968503937,598.07874015748,1105.08661417323,465.850393700787,219.834645669291,1054.28346456693,131.779527559055,127,14.6100947806329,11.0839362646105,0.651499377089,0.933823529411765,0.697802197802198,0.997189568802502,51149.5984251968,34300.9763779528,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_641818,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642607,3892.48228882834,510.242506811989,99.5640326975477,653.514986376022,2447.9863760218,3319.08719346049,551.512261580382,266.367847411444,1104.08174386921,6856.98365122616,570.103542234332,119.754768392371,1093.43051771117,592.681198910082,418.539509536785,308.395095367847,1489.04359673025,1018.13079019074,295.005449591281,231.130790190736,994.634877384196,991.021798365123,229.155313351499,190.863760217984,588.49863760218,2783.36784741144,563.351498637602,363.782016348774,1169.6621253406,130.673024523161,367,27.8600095058538,16.8017223884656,0.797683209581498,0.968337730870712,0.664855072463768,-0.786936819162511,51139.9073569482,35627.9945504087,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_642607,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642681,484.095823095823,560.550368550369,135.749385749386,608.872235872236,99.5577395577396,599.314496314496,391.515970515971,258.299754299754,1107.41277641278,1244.15724815725,992.525798525799,121.628992628993,1062.32186732187,1022.2457002457,576.882063882064,284.894348894349,1636.16953316953,956.479115479116,214.420147420147,217.619164619165,1129.01965601966,634.019656019656,136.361179361179,126.0,590.348894348894,561.609336609337,374.97542997543,202.208845208845,982.53316953317,128.486486486486,407,25.7143688974242,20.8271070685685,0.586512144507937,0.922902494331066,0.706597222222222,1.00998057033708,51147.1842751843,33824.9459459459,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_642681,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642712,1153.64901960784,436.009803921569,126.772549019608,633.78431372549,1753.14509803922,1400.67254901961,1872.69607843137,274.566666666667,1099.81568627451,1980.96862745098,1513.1862745098,112.009803921569,1069.13725490196,594.092156862745,432.492156862745,269.860784313726,1432.41764705882,1046.20392156863,295.337254901961,231.347058823529,991.694117647059,1037.00784313725,229.960784313725,195.913725490196,639.405882352941,961.352941176471,446.370588235294,345.51568627451,1045.71568627451,131.221568627451,510,29.6005626112452,22.3766404186875,0.654625648323489,0.96045197740113,0.700549450549451,-0.54165568627902,50499.5117647059,35457.437254902,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_642712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642825,1237.48235294118,115.711764705882,80.8176470588235,618.758823529412,964.729411764706,1131.16470588235,374.441176470588,259.488235294118,1090.15294117647,1856.04117647059,509.441176470588,105.770588235294,1061.67647058824,778.8,526.735294117647,275.658823529412,1490.87647058824,1114.09411764706,297.8,229.170588235294,993.94705882353,976.205882352941,205.594117647059,146.270588235294,584.047058823529,743.629411764706,417.329411764706,218.505882352941,1017.6,129.870588235294,170,18.2099278599408,12.2908431327394,0.737860839686946,0.944444444444444,0.833333333333333,0.0487748868448792,50743.2470588235,35201.8235294118,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_642825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642890,2709.8431372549,484.703431372549,192.313725490196,675.862745098039,4160.09803921569,3380.40441176471,1625.02696078431,268.262254901961,1098.12990196078,4771.90441176471,1708.69607843137,130.600490196078,1076.5318627451,830.301470588235,463.835784313726,270.450980392157,1482.52696078431,1145.57598039216,299.575980392157,236.208333333333,1014.64950980392,2773.15931372549,318.269607843137,385.401960784314,1196.22058823529,1523.19362745098,518.593137254902,292.46568627451,1067.23774509804,132.264705882353,408,26.1961307998285,20.0453384955516,0.643789951025643,0.962264150943396,0.739130434782609,0.961507210786283,50927.943627451,33713.4240196078,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_642890,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642904,1012.64646464646,206.737373737374,172.868686868687,662.333333333333,3134.83838383838,965.070707070707,308.131313131313,257.282828282828,1087.39393939394,1729.46464646465,492.333333333333,113.484848484848,1070.73737373737,738.353535353535,633.919191919192,397.070707070707,1534.33333333333,1320.16161616162,350.414141414141,289.747474747475,1009.21212121212,1134.67676767677,238.444444444444,751.757575757576,659.0,1011.40404040404,442.191919191919,218.333333333333,1070.56565656566,130.979797979798,99,14.6293404599769,8.65824200214034,0.806054806371898,0.951923076923077,0.785714285714286,-0.035143500322073,50286.303030303,35397.3737373737,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_642904,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
642928,1692.78616352201,326.433962264151,113.949685534591,661.716981132075,2212.62893081761,1899.8679245283,1240.22641509434,269.314465408805,1138.88050314465,3583.77358490566,859.748427672956,117.987421383648,1059.59748427673,2640.7106918239,752.62893081761,312.427672955975,1738.33333333333,4021.77358490566,381.358490566038,243.716981132075,1020.86163522013,3499.69182389937,258.729559748428,745.861635220126,854.276729559748,1928.4465408805,496.477987421384,417.698113207547,1054.61006289308,131.88679245283,159,18.3170604855727,11.1389396226148,0.793846419181157,0.940828402366864,0.668067226890756,0.972472537215136,50599.7987421384,35697.5283018868,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_642928,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
643008,5064.53156146179,1006.01993355482,2546.43521594684,638.398671096346,1852.03322259136,4932.18604651163,703.063122923588,273.797342192691,1121.68438538206,8604.41196013289,565.581395348837,122.56146179402,1079.86378737542,989.827242524917,673.647840531561,305.332225913621,1749.96013289037,1276.16279069767,313.847176079734,232.358803986711,1105.60132890365,1138.12624584718,226.694352159468,359.481727574751,3079.12624584718,2785.14285714286,548.116279069767,627.823920265781,1074.35880398671,130.757475083056,301,24.842323122468,15.5708634926036,0.7791900491559,0.970967741935484,0.836111111111111,0.0244835406680922,51564.9534883721,35711.3222591362,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_643008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
643899,2157.65957446808,954.170212765957,124.446808510638,626.957446808511,1940.63829787234,1492.48936170213,471.617021276596,271.904255319149,1201.58510638298,3147.86170212766,664.042553191489,115.170212765957,1074.48936170213,876.595744680851,650.053191489362,277.457446808511,1597.96808510638,1081.39361702128,294.148936170213,231.191489361702,990.797872340426,1061.85106382979,220.521276595745,175.914893617021,586.585106382979,1160.01063829787,509.468085106383,276.340425531915,1036.27659574468,131.202127659574,94,13.5277361440601,8.85172316974603,0.756201483140854,0.959183673469388,0.803418803418803,0.169554162914713,50584.9574468085,35687.0638297872,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_643899,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
643958,3075.55365853659,366.59756097561,244.912195121951,628.085365853659,1292.38536585366,3167.84878048781,816.50243902439,274.50487804878,1092.58292682927,5744.74634146341,819.065853658537,113.546341463415,1075.76341463415,2416.29024390244,549.578048780488,289.226829268293,1616.09512195122,3600.67073170732,354.748780487805,235.590243902439,1039.68048780488,3410.83658536585,229.351219512195,321.251219512195,1216.03658536585,2559.47804878049,489.882926829268,250.7,1052.56341463415,128.807317073171,410,30.9260195915702,18.2999898551912,0.806132986488689,0.936073059360731,0.607407407407407,0.669098571116554,50832.6926829268,35508.6975609756,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_643958,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
644500,2167.67048710602,224.621776504298,96.458452722063,632.209169054441,1219.56446991404,2559.44699140401,382.034383954155,266.627507163324,1083.8223495702,4704.81375358166,659.902578796562,126.501432664756,1082.31232091691,1502.50716332378,1665.76217765043,340.730659025788,1786.12607449857,2092.72492836676,352.41547277937,238.885386819484,1023.33524355301,1914.61031518625,219.065902578797,411.220630372493,751.318051575931,2656.39828080229,591.873925501433,242.252148997135,1088.0229226361,131.409742120344,349,26.5145247433642,16.8368523145884,0.77250813341138,0.94579945799458,0.789592760180995,-0.0682916982883635,50605.7793696275,34139.2206303725,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_644500,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
645875,2482.83333333333,295.992424242424,104.54797979798,689.391414141414,1862.61616161616,3041.14646464646,366.338383838384,270.901515151515,1176.27272727273,5043.07323232323,513.396464646465,112.388888888889,1095.77272727273,837.305555555556,676.217171717172,400.318181818182,1548.69949494949,1168.18939393939,303.699494949495,236.580808080808,1002.55808080808,1049.10101010101,233.010101010101,199.590909090909,602.840909090909,2137.10353535354,521.575757575758,248.489898989899,1076.57575757576,131.424242424242,396,26.1711544768661,19.2994903156699,0.675419567676834,0.963503649635036,0.801619433198381,-0.13279240342677,50977.148989899,35371.3712121212,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_645875,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
646145,873.359872611465,204.503184713376,123.643312101911,676.101910828025,4202.22929936306,1095.54777070064,364.646496815287,264.592356687898,1088.1847133758,2114.42038216561,498.385350318471,116.608280254777,1064.02229299363,2812.69426751592,882.200636942675,332.592356687898,7367.75477707006,1728.77070063694,289.56050955414,226.525477707006,1056.99681528662,1385.09554140127,206.528662420382,375.745222929936,644.108280254777,1360.16242038217,459.468152866242,224.955414012739,1052.48089171975,129.761146496815,314,24.4323346931043,16.4886376671821,0.737937089888248,0.957317073170732,0.758454106280193,-0.348799510145275,50807.2133757962,35399.2834394904,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_646145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
646362,2278.98792270531,639.219806763285,162.272946859903,612.56038647343,610.756038647343,2571.72946859903,1758.93961352657,255.963768115942,1096.88164251208,4110.59420289855,1009.39371980676,114.746376811594,1070.05555555556,799.381642512077,481.454106280193,275.364734299517,1617.56038647343,842.289855072464,203.425120772947,213.427536231884,1030.25362318841,759.18115942029,159.393719806763,130.425120772947,758.306763285024,1637.57246376812,543.171497584541,302.857487922705,1058.94444444444,131.42270531401,414,31.7081265774479,16.6698454461685,0.850652819900913,0.960556844547564,0.713793103448276,-0.359370247508738,51515.9082125604,34226.8574879227,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_646362,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
647012,2209.06477732794,778.380566801619,1786.88259109312,611.720647773279,354.080971659919,2198.25506072874,1969.19433198381,265.578947368421,1118.7975708502,3130.31174089069,585.838056680162,113.441295546559,1074.74493927126,4476.67206477733,897.437246963563,390.137651821862,2124.7004048583,7526.74089068826,582.898785425101,257.672064777328,1081.46963562753,6973.72874493927,312.882591093117,325.668016194332,595.80971659919,1077.14979757085,479.862348178138,234.914979757085,1025.94331983806,129.323886639676,247,20.8240634999713,15.1153890156971,0.687840730376058,0.96484375,0.771875,0.427442743465254,51422.6842105263,35692.6518218623,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_647012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
647029,959.847750865052,137.235294117647,85.5432525951557,629.59169550173,1310.15570934256,1088.21453287197,520.837370242215,248.743944636678,1080.43598615917,2229.21453287197,447.43598615917,105.896193771626,1068.84429065744,4344.33564013841,712.16955017301,352.550173010381,1643.48442906574,4245.52595155709,385.747404844291,246.77508650519,1050.78892733564,3732.10380622837,259.584775086505,1155.27335640138,856.173010380623,1165.97923875433,466.685121107266,285.159169550173,1021.09688581315,128.733564013841,289,23.1525129401465,15.9082971618343,0.726554465540578,0.956953642384106,0.772727272727273,-0.330090149355523,51739.6678200692,35198.6020761246,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_647029,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
647856,1710.47787610619,360.212389380531,74.929203539823,620.778761061947,453.203539823009,1889.65486725664,1683.77876106195,262.58407079646,1090.78761061947,4183.53982300885,1276.59292035398,113.176991150442,1062.97345132743,2372.21238938053,667.769911504425,300.159292035398,1752.13274336283,2856.69911504425,426.690265486726,247.814159292035,1008.54867256637,2373.25663716814,255.619469026549,305.87610619469,795.982300884956,1800.42477876106,530.407079646018,431.115044247788,1025.69026548673,130.867256637168,113,14.7688349479613,9.70762600485564,0.753624846005989,0.974137931034483,0.807142857142857,-0.327601127364192,51311.5309734513,34569.4424778761,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_647856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648304,934.754966887417,149.715231788079,81.2913907284768,649.814569536424,1841.8940397351,1292.81456953642,2225.39735099338,253.198675496689,1105.11920529801,2125.59602649007,432.688741721854,105.364238410596,1068.55629139073,1054.31125827815,551.576158940397,569.397350993377,1813.44370860927,1882.56953642384,317.662251655629,235.582781456954,1020.81456953642,1869.90728476821,241.562913907285,337.94701986755,629.774834437086,1036.98675496689,395.920529801325,1117.01324503311,1040.13245033113,129.490066225166,151,15.1183207924355,13.1635253974618,0.491814099793027,0.915151515151515,0.671111111111111,-0.70821174055831,51544.1390728477,35751.8940397351,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648381,2880.76439790576,253.816753926702,79.7696335078534,617.602094240838,1093.20942408377,3020.97382198953,2281.24607329843,269.062827225131,1092.58115183246,5239.34031413613,1963.01570680628,116.356020942408,1077.9057591623,2036.14136125654,766.82722513089,341.418848167539,2457.86910994764,2945.64397905759,315.706806282723,236.96335078534,1031.48691099476,2738.50785340314,219.937172774869,175.764397905759,587.916230366492,2285.26701570681,542.062827225131,433.926701570681,1058.13089005236,131.094240837696,191,18.9449460005484,14.8316989143038,0.622167443447538,0.799163179916318,0.606349206349206,-1.20708322584967,51628.6282722513,34988.8534031414,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648381,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648429,670.148936170213,564.989361702128,83.1489361702128,637.095744680851,1500.23404255319,594.968085106383,561.265957446809,251.808510638298,1107.02127659574,1598.37234042553,479.648936170213,104.808510638298,1069.67021276596,2204.06382978723,649.904255319149,280.202127659574,1702.5,1860.1170212766,320.531914893617,234.265957446808,992.882978723404,2356.91489361702,232.074468085106,199.563829787234,582.393617021277,1273.29787234043,445.712765957447,508.255319148936,1016.98936170213,130.308510638298,94,12.2368310140094,9.75824259582292,0.603387008614506,0.959183673469388,0.776859504132231,-0.861807424835646,50699.0212765957,35680.1382978723,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_648429,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648440,2310.33333333333,563.774451097804,140.916167664671,647.708582834331,2355.60079840319,2649.71457085828,4471.90818363273,254.445109780439,1093.49301397206,3416.66467065868,1196.29540918164,113.067864271457,1073.35129740519,1988.79840319361,980.161676646707,379.656686626746,4114.03992015968,3908.68463073852,430.477045908184,246.435129740519,1037.26147704591,3518.08383233533,246.5249500998,550.85628742515,705.656686626746,834.11377245509,438.666666666667,330.848303393214,1032.20758483034,132.221556886228,501,30.8767689155835,20.8097299544469,0.738767165020715,0.956106870229008,0.759090909090909,-1.36117435615602,51166.6906187625,34197.2634730539,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648440,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648545,2675.96501457726,342.868804664723,179.355685131195,714.798833819242,4787.68513119534,2995.09620991254,3944.92419825073,275.638483965015,1130.80758017493,4367.11370262391,2638.21282798834,123.314868804665,1070.40816326531,684.259475218659,611.008746355685,284.854227405248,1522.63848396501,1282.22740524781,325.865889212828,245.766763848396,1015.10787172012,1138.97667638484,223.096209912536,148.734693877551,660.31778425656,1450.87755102041,539.755102040816,512.075801749271,1076.77551020408,130.443148688047,343,24.1694245177825,18.8167992398937,0.627598299288091,0.942307692307692,0.75219298245614,-1.52766837845998,51512.2711370262,34857.4781341108,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648545,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
648775,1472.328,209.368,281.208,766.392,9427.24,1324.256,317.4,259.712,1097.72,2796.664,476.408,115.144,1069.336,934.504,717.048,527.96,1546.64,1362.992,380.976,241.76,1004.584,1289.792,269.648,229.28,599.36,1285.448,429.304,295.24,1072.408,130.232,125,18.8694044744758,8.51949146244266,0.892272316674463,0.93984962406015,0.771604938271605,-1.42409117232181,51288.072,35715.584,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
649551,1210.90990990991,96.009009009009,72.036036036036,629.09009009009,1595.27027027027,1305.47747747748,309.135135135135,247.054054054054,1081.91891891892,1562.06306306306,437.882882882883,102.108108108108,1071.96396396396,832.765765765766,567.504504504505,296.990990990991,1630.89189189189,1451.18018018018,353.756756756757,242.486486486486,1039.35135135135,1431.00900900901,238.711711711712,554.828828828829,845.684684684685,832.099099099099,453.981981981982,217.423423423423,1012.05405405405,132.972972972973,111,12.6831128642723,11.3625401845805,0.444297209101586,0.965217391304348,0.776223776223776,1.47509012182941,51225.018018018,34445.5225225225,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_649551,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
649796,3257.41954022989,547.080459770115,100.66091954023,672.683908045977,2340.16666666667,2793.59195402299,1115.28735632184,266.988505747126,1109.59195402299,6378.28735632184,540.385057471264,115.885057471264,1087.28735632184,756.752873563218,540.235632183908,790.109195402299,1519.25862068966,1081.59195402299,280.304597701149,227.609195402299,1000.3908045977,1033.55747126437,222.166666666667,191.183908045977,595.413793103448,3119.17816091954,548.247126436782,750.626436781609,1091.7816091954,133.109195402299,174,15.9909816933725,13.9228746370519,0.491866884156218,0.966666666666667,0.776785714285714,0.162231341601152,51192.0459770115,35557.3448275862,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_649796,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
650008,1153.81761006289,307.301886792453,179.220125786164,718.522012578616,6054.74842767296,1371.08805031447,556.949685534591,255.949685534591,1089.05031446541,2936.24528301887,721.528301886792,111.817610062893,1080.16352201258,783.056603773585,524.446540880503,277.666666666667,1454.61635220126,1235.14465408805,344.238993710692,246.496855345912,996.559748427673,1162.78616352201,232.962264150943,141.081761006289,599.880503144654,1889.41509433962,496.138364779874,320.867924528302,1066.45283018868,129.025157232704,159,16.3574173063338,12.4551530190177,0.648238181577646,0.940828402366864,0.764423076923077,-1.51286314573524,51275.5597484277,34991.3773584906,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_650008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
651117,2760.91847826087,502.782608695652,327.6875,631.127717391304,1402.92934782609,2579.00543478261,1154.25543478261,268.959239130435,1119.9972826087,5636.75815217391,3013.40760869565,111.366847826087,1073.13586956522,1905.0597826087,869.682065217391,1194.91032608696,1778.9402173913,3548.53532608696,337.676630434783,237.529891304348,1029.57608695652,3866.38858695652,236.29347826087,283.595108695652,620.453804347826,2914.57880434783,505.211956521739,496.141304347826,1047.70108695652,130.847826086957,368,32.350780108427,15.2971564411585,0.88114144414828,0.910891089108911,0.571428571428571,-0.950930741304576,50968.8967391304,35494.6548913043,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_651117,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
651282,1032.70731707317,95.6463414634146,52.5670731707317,599.15243902439,364.262195121951,1028.67682926829,258.280487804878,240.542682926829,1068.57317073171,1719.21951219512,404.317073170732,98.7073170731707,1065.82926829268,711.939024390244,668.40243902439,290.493902439024,1584.20731707317,961.512195121951,319.359756097561,237.207317073171,988.158536585366,879.396341463415,209.060975609756,131.225609756098,583.939024390244,772.268292682927,433.646341463415,212.926829268293,990.634146341463,129.865853658537,164,16.3522430939435,13.1467163411876,0.594669571089429,0.953488372093023,0.732142857142857,-0.229488621861763,50578.2621951219,34206.2256097561,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_651282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
651343,2706.48979591837,645.15306122449,136.862244897959,658.448979591837,2561.37244897959,2025.09693877551,827.84693877551,249.586734693878,1087.65306122449,3646.20408163265,774.459183673469,112.857142857143,1074.45918367347,1209.35204081633,729.790816326531,344.168367346939,1684.6887755102,2813.85204081633,329.372448979592,236.362244897959,1038.31632653061,3433.17857142857,241.525510204082,503.989795918367,648.729591836735,846.464285714286,456.418367346939,438.076530612245,1018.77551020408,130.566326530612,196,20.8831741480621,12.0375848836014,0.817150017886789,0.95609756097561,0.687719298245614,-1.01099632546431,52005.7908163265,34462.4846938776,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_651343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
651727,1435.66666666667,245.100456621005,238.223744292237,716.182648401826,5558.18721461187,1365.60730593607,327.301369863014,262.205479452055,1086.22831050228,2843.26484018265,530.981735159817,127.707762557078,1073.63470319635,856.65296803653,518.305936073059,277.260273972603,1494.51598173516,1285.99543378995,327.881278538813,233.315068493151,1047.51598173516,1151.62557077626,228.972602739726,147.721461187215,1802.97716894977,1306.99543378995,471.62100456621,226.684931506849,1040.84474885845,129.310502283105,219,18.8305385604579,14.8157327349653,0.61721717553732,0.973333333333333,0.805147058823529,0.678386917807454,50190.5251141553,35128.6575342466,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_651727,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
653258,1993.21487603306,546.677685950413,145.04132231405,633.595041322314,1370.90082644628,1702.95867768595,2567.84297520661,286.107438016529,1091.65289256198,2475.04958677686,1570.2479338843,117.98347107438,1070.05785123967,626.760330578512,426.090909090909,267.404958677686,1409.59504132231,1012.11570247934,301.231404958678,230.900826446281,995.429752066116,967.090909090909,226.809917355372,138.495867768595,586.925619834711,1242.14876033058,540.132231404959,243.636363636364,1034.06611570248,132.347107438017,121,18.7979488035965,8.1791885134678,0.900376968632907,0.96031746031746,0.840277777777778,0.106123513598833,50923.4876033058,35214.4545454545,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_653258,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
653552,2115.32665330661,99.5050100200401,65.6533066132264,622.637274549098,1011.85170340681,2255.35470941884,541.032064128256,263.693386773547,1087.84368737475,4659.4368737475,555.957915831663,110.300601202405,1071.74549098196,929.470941883768,531.833667334669,278.741482965932,1554.12424849699,1717.65731462926,344.03006012024,239.725450901804,1132.43687374749,1752.23246492986,243.436873747495,519.03006012024,1243.04208416834,2740.13627254509,467.486973947896,250.587174348697,1060.71743486974,129.923847695391,499,41.1847731842614,15.6388091074587,0.925100199495742,0.961464354527938,0.504040404040404,-0.88151785805628,50202.8857715431,35411.8577154309,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_653552,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
654108,1396.66839378238,436.082901554404,124.435233160622,642.886010362694,1741.51813471503,1792.81347150259,329.466321243523,257.948186528497,1096.58549222798,3215.63730569948,748.471502590674,114.481865284974,1075.81347150259,4350.41968911917,1057.79792746114,1110.07772020725,1796.90155440415,2096.33678756477,380.253886010363,245.139896373057,1010.08808290155,1520.85492227979,252.435233160622,608.932642487047,641.937823834197,996.554404145078,468.782383419689,231.575129533679,1065.31088082902,132.020725388601,193,20.0122694731666,12.434647404487,0.78353219565034,0.965,0.804166666666667,1.51682206244131,50344.2124352332,34823.3471502591,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_654108,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
654125,2579.40287769784,227.273381294964,116.352517985612,635.503597122302,1816.89208633094,2803.21582733813,803.244604316547,274.158273381295,1094.79856115108,4284.70503597122,545.647482014389,124.712230215827,1074.21582733813,805.906474820144,451.136690647482,381.892086330935,1541.38848920863,1145.25899280576,285.920863309353,224.079136690647,985.748201438849,1133.47482014388,221.230215827338,203.129496402878,596.330935251799,1822.53956834532,463.208633093525,236.043165467626,1028.11510791367,129.561151079137,139,15.3698784511008,11.5710541364271,0.658203949825476,0.965277777777778,0.842424242424242,-0.20679780391612,50701.0503597122,35652.381294964,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_654125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
654478,2353.79166666667,214.28947368421,272.469298245614,787.135964912281,8823.67105263158,2925.29605263158,357.173245614035,264.495614035088,1095.91666666667,4542.87061403509,533.554824561404,191.381578947368,1064.09210526316,685.423245614035,660.548245614035,378.611842105263,1661.27631578947,1288.63377192982,338.914473684211,243.864035087719,1066.22587719298,1087.06359649123,236.719298245614,444.565789473684,593.508771929825,1149.39473684211,499.877192982456,226.230263157895,1062.15131578947,130.366228070175,456,41.0176762859115,14.2822772106798,0.937420971984561,0.938271604938272,0.571428571428571,-0.376685360678542,50101.4495614035,34877.0328947368,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_654478,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
654911,2394.68376068376,519.952991452991,244.491452991453,703.820512820513,2426.6452991453,3323.71794871795,679.504273504274,279.645299145299,1150.94017094017,4565.77777777778,985.871794871795,114.747863247863,1106.12820512821,753.294871794872,495.252136752137,559.051282051282,1522.0,1144.97863247863,297.08547008547,236.641025641026,999.320512820513,1104.00854700855,229.252136752137,172.944444444444,637.786324786325,1743.8547008547,466.098290598291,309.837606837607,1046.41025641026,130.448717948718,234,20.1111492704578,14.8721043031162,0.673161504786154,0.951219512195122,0.78,0.132773999352129,51039.9658119658,35551.4658119658,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_654911,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
655455,1173.83698296837,291.47201946472,150.948905109489,650.082725060827,2726.00486618005,1347.98540145985,367.462287104623,270.498783454988,1084.66423357664,1894.11435523114,594.401459854015,122.968369829684,1071.12165450122,694.625304136253,450.912408759124,268.671532846715,1405.86131386861,1152.54744525547,334.953771289538,238.934306569343,985.043795620438,1077.55474452555,228.970802919708,129.501216545012,580.257907542579,1234.68369829684,565.328467153285,233.408759124088,1050.31143552311,130.661800486618,411,28.725954945474,18.5101389552856,0.76471400598413,0.958041958041958,0.761111111111111,1.21899998032709,51054.6374695864,34693.9513381995,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_655455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
655561,1643.94980694981,324.953667953668,147.003861003861,629.725868725869,1427.37837837838,1772.92277992278,328.714285714286,263.872586872587,1087.94980694981,3482.6332046332,607.926640926641,117.142857142857,1068.99613899614,631.521235521236,439.034749034749,283.003861003861,1348.17760617761,999.447876447876,282.544401544402,226.254826254826,1010.46332046332,958.266409266409,215.293436293436,133.324324324324,598.629343629344,1588.18532818533,483.108108108108,216.791505791506,1032.0193050193,132.490347490347,259,30.9769968826712,10.7283631999393,0.938111559442637,0.931654676258993,0.470909090909091,-0.70589013056203,49981.8223938224,34711.8532818533,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_655561,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
655761,2010.68484848485,611.987878787879,91.5333333333333,624.054545454545,627.769696969697,2431.9696969697,1328.92727272727,275.393939393939,1119.25454545455,3052.81212121212,593.012121212121,109.563636363636,1066.90909090909,3745.40606060606,1410.65454545455,820.466666666667,7565.07272727273,6684.52121212121,492.775757575758,261.830303030303,1056.37575757576,6200.52121212121,282.69696969697,250.206060606061,612.121212121212,857.266666666667,425.418181818182,964.812121212121,1028.56363636364,130.921212121212,165,14.8695125705265,14.2417266738065,0.287501021330792,0.953757225433526,0.785714285714286,0.367471206164987,50957.0121212121,35417.4060606061,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_655761,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
655929,1349.7947761194,299.067164179104,87.7238805970149,616.884328358209,731.940298507463,1757.60447761194,2738.18656716418,265.082089552239,1094.91791044776,2312.35074626866,1224.33955223881,115.902985074627,1065.08208955224,952.522388059702,718.19776119403,290.164179104478,1668.52611940299,1192.03731343284,305.10447761194,230.111940298507,985.902985074627,1061.34701492537,219.309701492537,140.64552238806,585.440298507463,921.388059701493,489.317164179104,274.041044776119,1030.9776119403,131.473880597015,268,22.1304066789872,15.5945599360447,0.709538502834641,0.960573476702509,0.761363636363636,-1.38937027363494,51854.5149253731,34271.8619402985,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_655929,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
656663,1372.62007168459,367.114695340502,117.336917562724,644.379928315412,2174.47311827957,1470.34050179211,3124.11827956989,254.512544802867,1088.82437275986,2251.81003584229,1884.3835125448,114.003584229391,1066.229390681,788.759856630824,447.498207885305,262.856630824373,1522.85663082437,997.057347670251,209.197132616487,218.939068100358,1254.87813620072,663.634408602151,150.204301075269,123.541218637993,590.620071684588,1034.86379928315,509.47311827957,325.78853046595,1029.55913978495,129.910394265233,279,25.9779063835183,14.9278274852023,0.818409451661223,0.885714285714286,0.631221719457014,-1.50208064238634,51373.0716845878,34272.7455197133,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_656663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
656963,1466.60301507538,213.371859296482,133.165829145729,658.884422110553,2588.22110552764,1742.27638190955,295.407035175879,252.884422110553,1092.55778894472,2371.27638190955,588.236180904523,114.693467336683,1061.1256281407,934.276381909548,642.859296482412,291.452261306533,1628.8040201005,1179.24120603015,294.56783919598,234.29648241206,1029.9648241206,1090.0,196.035175879397,248.768844221106,2668.1256281407,882.180904522613,445.663316582915,214.748743718593,1054.61306532663,131.633165829146,199,26.3432416255595,9.84103520371671,0.927602138058878,0.925581395348837,0.576811594202899,-0.438927244266788,50600.6733668342,34378.2010050251,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_656963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
657067,1208.03389830508,454.367231638418,90.954802259887,621.350282485876,1104.61581920904,1280.42937853107,2256.61581920904,269.079096045198,1108.88700564972,1975.84745762712,1218.86440677966,109.090395480226,1063.9604519774,578.966101694915,403.16384180791,274.649717514124,1373.80225988701,892.655367231638,252.372881355932,222.960451977401,986.621468926554,853.45197740113,196.225988700565,127.214689265537,597.005649717514,999.141242937853,495.898305084746,357.64406779661,1033.82485875706,131.457627118644,177,17.4575340533622,14.6789727086606,0.541285546311444,0.811926605504587,0.582236842105263,0.866158711652981,50150.3276836158,34798.4745762712,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_657067,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
657113,3031.56956521739,775.326086956522,799.14347826087,650.2,1958.69565217391,3181.05217391304,1329.52173913043,269.978260869565,1105.79782608696,5603.4847826087,1211.83913043478,118.997826086957,1089.46086956522,1408.23695652174,1266.35652173913,1456.05869565217,1724.6652173913,1986.38695652174,297.560869565217,224.423913043478,1051.71086956522,1593.81086956522,207.280434782609,524.563043478261,750.454347826087,1854.9152173913,545.00652173913,473.713043478261,1066.94130434783,133.782608695652,460,28.3253257116865,21.1171940730696,0.666479414869809,0.940695296523517,0.657142857142857,-0.498411294310487,50496.1543478261,35094.1282608696,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_657113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
657736,937.506944444444,293.979166666667,98.5763888888889,627.006944444444,926.673611111111,1021.59722222222,304.506944444444,253.833333333333,1077.69444444444,1377.54861111111,521.9375,120.486111111111,1065.54861111111,433.458333333333,291.763888888889,249.048611111111,1424.79861111111,709.930555555556,190.743055555556,214.909722222222,997.208333333333,616.909722222222,141.013888888889,109.305555555556,584.715277777778,842.965277777778,451.784722222222,211.777777777778,1024.43055555556,129.354166666667,144,16.109398056604,11.4392360502953,0.704103812255704,0.972972972972973,0.872727272727273,-0.213092871555346,50555.7430555556,34081.9097222222,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_657736,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
658130,564.089686098655,702.506726457399,172.77130044843,604.565022421525,98.4125560538117,519.892376681614,366.609865470852,257.775784753363,1116.63228699552,1030.69955156951,548.587443946188,111.300448430493,1063.42152466368,839.600896860986,469.784753363229,277.878923766816,1569.0,928.233183856502,210.040358744395,217.533632286996,1014.71748878924,1155.07623318386,177.72197309417,136.52466367713,1018.09865470852,574.704035874439,376.704035874439,201.300448430493,983.67264573991,127.188340807175,223,19.5462572564565,14.6119495921949,0.664197190497271,0.957081545064378,0.782456140350877,0.267323896926091,51493.4843049327,34108.9955156951,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_658130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
658860,1576.84951456311,421.257281553398,197.868932038835,710.878640776699,4532.40776699029,2009.57281553398,633.203883495146,269.71359223301,1103.45145631068,2794.44660194175,1638.78155339806,121.660194174757,1067.4854368932,610.553398058252,640.058252427184,265.339805825243,1424.26213592233,1072.71844660194,277.68932038835,224.04854368932,1037.45145631068,923.47572815534,196.723300970874,162.466019417476,622.941747572816,1247.59223300971,485.805825242718,367.077669902913,1091.9854368932,130.0,206,17.9534964975827,14.6280682556773,0.579776646584446,0.962616822429906,0.807843137254902,0.216651093118036,49931.4854368932,34667.9514563107,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_658860,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
658926,3707.0,225.134057971014,82.6195652173913,633.449275362319,2152.61594202899,3185.95289855072,636.63768115942,255.971014492754,1109.22826086957,4729.55434782609,542.666666666667,116.771739130435,1064.80072463768,2641.45652173913,804.322463768116,402.619565217391,4562.32971014493,3370.76086956522,323.38768115942,234.550724637681,1013.84057971014,3585.30072463768,227.75,157.028985507246,629.826086956522,1087.80797101449,476.884057971014,225.246376811594,1035.85507246377,130.572463768116,276,20.0480462772036,18.7485269404633,0.354173448932054,0.849230769230769,0.597402597402597,1.26243417853772,51930.4166666667,34255.152173913,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_658926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
658995,5417.60833333333,1999.6,879.041666666667,650.75,2508.48333333333,6351.575,602.35,298.3,1305.97083333333,8500.54583333333,698.375,138.675,1094.85833333333,844.3,612.066666666667,352.633333333333,4688.98333333333,2114.10416666667,371.766666666667,240.175,1048.725,1577.64166666667,249.5,190.154166666667,632.954166666667,2431.70833333333,591.966666666667,295.595833333333,1073.8125,136.145833333333,240,21.429928009346,14.4068605170833,0.740299150260825,0.956175298804781,0.761904761904762,-0.231437825775306,50615.4958333333,35508.6291666667,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_658995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
659105,1458.86315789474,391.073684210526,253.231578947368,722.547368421053,6067.65263157895,1722.44210526316,368.536842105263,267.989473684211,1091.66315789474,3434.68421052632,592.915789473684,124.084210526316,1081.58947368421,4708.30526315789,613.147368421053,344.663157894737,1896.28421052632,6267.65263157895,488.442105263158,255.505263157895,1027.83157894737,4653.07368421053,260.242105263158,252.294736842105,628.936842105263,1338.32631578947,514.536842105263,226.178947368421,1072.56842105263,129.578947368421,95,15.0787362105566,8.14386720288411,0.841607583533988,0.94059405940594,0.7421875,-1.56422413178233,51363.9789473684,34514.3578947368,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_659105,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
659216,510.6,859.474725274725,220.120879120879,615.861538461538,112.283516483516,538.415384615385,351.27032967033,256.301098901099,1111.02857142857,1201.83516483516,605.092307692308,113.382417582418,1068.12087912088,1850.12087912088,719.628571428571,340.958241758242,2183.0989010989,1880.39340659341,361.131868131868,243.182417582418,1034.25274725275,1226.9956043956,251.967032967033,191.087912087912,2011.19340659341,570.501098901099,378.841758241758,203.114285714286,987.178021978022,129.276923076923,455,30.6726862243851,19.0589371653161,0.783521151849064,0.953878406708595,0.653735632183908,0.564726507205785,51471.0923076923,34073.9186813187,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_659216,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
660129,2460.56349206349,243.666666666667,206.373015873016,705.035714285714,5183.92063492064,2502.05952380952,323.015873015873,264.019841269841,1089.25793650794,4828.53174603175,575.900793650794,118.111111111111,1070.69841269841,1031.16666666667,562.047619047619,290.031746031746,1684.9880952381,1161.15079365079,247.154761904762,224.623015873016,1205.52777777778,822.349206349206,179.269841269841,148.02380952381,597.309523809524,1402.83333333333,470.829365079365,244.230158730159,1037.69047619048,128.757936507937,252,32.5953009042228,9.8789919483751,0.952965037150933,0.929889298892989,0.7875,-1.5081480383192,51510.1984126984,35271.630952381,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_660129,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
660770,1142.50909090909,168.648484848485,71.5757575757576,618.066666666667,1067.1696969697,1436.56363636364,463.927272727273,259.612121212121,1078.72121212121,1913.89090909091,532.387878787879,109.70303030303,1068.09696969697,1145.40606060606,578.781818181818,295.381818181818,1466.26666666667,2212.92121212121,424.987878787879,253.163636363636,993.727272727273,1909.29696969697,257.418181818182,174.375757575758,1531.81818181818,908.612121212121,485.254545454546,226.357575757576,1027.83636363636,129.642424242424,165,17.3556217738159,12.1452710401438,0.71434972534048,0.953757225433526,0.736607142857143,0.506562145898685,50339.7575757576,34718.6121212121,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_660770,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
661719,2962.3893129771,312.93893129771,114.526717557252,639.450381679389,1735.1679389313,3220.80916030534,3580.24427480916,263.923664122137,1097.32061068702,3872.93893129771,1356.54198473282,113.87786259542,1078.17557251908,620.312977099237,435.06106870229,271.015267175573,1494.92366412214,938.358778625954,282.725190839695,227.908396946565,987.480916030534,854.442748091603,196.358778625954,133.511450381679,590.419847328244,1488.74809160305,532.007633587786,341.748091603053,1072.03816793893,129.580152671756,131,21.062687073396,8.16597359016495,0.92178621238521,0.916083916083916,0.693121693121693,1.42928798735956,51487.3282442748,34553.3969465649,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_661719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
662038,1413.34579439252,195.707165109034,79.0249221183801,627.158878504673,1033.49221183801,1905.0062305296,367.339563862928,266.289719626168,1089.98442367601,3158.56697819315,613.566978193146,118.09968847352,1076.3769470405,510.364485981308,377.78816199377,256.781931464174,1470.64174454829,779.694704049844,227.984423676012,220.595015576324,996.579439252336,750.940809968847,171.984423676012,125.168224299065,591.663551401869,1821.7445482866,548.429906542056,231.651090342679,1062.32710280374,130.654205607477,321,24.535162604895,17.9200624582946,0.683037967070626,0.881868131868132,0.703947368421053,1.3958441701488,50613.7725856698,34122.9283489097,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_662038,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
662098,988.010526315789,157.368421052632,61.4947368421053,606.694736842105,790.915789473684,1138.90526315789,313.694736842105,254.884210526316,1079.34736842105,1926.08421052632,513.884210526316,105.8,1068.75789473684,1052.04210526316,601.263157894737,302.073684210526,1543.98947368421,1231.86315789474,234.884210526316,220.926315789474,1462.70526315789,759.431578947368,171.936842105263,114.263157894737,583.210526315789,963.073684210526,503.736842105263,217.8,1023.32631578947,131.705263157895,95,13.9397947264726,8.70658781959161,0.780956769918547,0.913461538461538,0.753968253968254,-1.48442730719833,50298.6842105263,34994.0842105263,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_662098,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665062,3017.21603563474,519.429844097996,145.360801781737,667.229398663697,3254.68819599109,3528.59465478842,5111.83073496659,274.971046770601,1102.51670378619,4705.70378619154,2011.72383073497,118.986636971047,1068.44988864143,1391.87527839644,1044.73273942094,373.031180400891,1809.36080178174,1785.87527839644,345.149220489978,271.167037861915,1047.90200445434,1496.30734966592,219.681514476615,179.427616926503,669.924276169265,1502.75055679287,538.173719376392,448.739420935412,1065.32739420935,130.993318485523,449,32.6626073570713,18.5199834184003,0.823711784238344,0.921971252566735,0.619310344827586,-0.624139555929598,51490.3875278396,34842.0111358575,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665062,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665103,2454.07391304348,108.269565217391,59.3782608695652,686.247826086956,2386.01739130435,2543.35652173913,393.673913043478,263.126086956522,1160.66956521739,5153.79130434783,541.260869565217,111.74347826087,1074.20869565217,843.0,459.391304347826,279.321739130435,1601.06086956522,915.326086956522,223.265217391304,218.6,1087.75217391304,741.304347826087,160.695652173913,142.678260869565,608.317391304348,2408.79130434783,799.095652173913,373.117391304348,1093.35217391304,130.747826086957,230,28.0709948957063,10.5412055734349,0.926814499060803,0.954356846473029,0.575,1.0655217555689,51800.7086956522,34812.8391304348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665103,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665227,1835.97967479675,688.390243902439,818.747967479675,626.40243902439,1229.69918699187,1809.40243902439,645.528455284553,274.260162601626,1091.69918699187,4170.05691056911,579.532520325203,115.174796747967,1071.58130081301,645.439024390244,411.272357723577,274.959349593496,1437.18292682927,956.788617886179,279.544715447154,231.056910569106,995.59756097561,896.178861788618,225.731707317073,142.353658536585,586.243902439024,2396.65447154472,521.90243902439,248.552845528455,1046.32113821138,131.520325203252,246,22.1494142063106,14.2892158911054,0.764074186496109,0.942528735632184,0.723529411764706,-0.529000784304564,50990.256097561,35350.7398373984,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665227,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665479,2417.03829787234,270.336170212766,165.43829787234,683.165957446809,4071.74468085106,2164.01276595745,321.736170212766,265.157446808511,1102.55319148936,4054.60425531915,503.434042553191,125.553191489362,1071.97446808511,745.957446808511,436.910638297872,272.553191489362,1567.10638297872,992.348936170213,218.893617021277,214.863829787234,1393.08510638298,715.936170212766,167.063829787234,164.089361702128,657.982978723404,1217.2,423.110638297872,224.727659574468,1057.54468085106,129.923404255319,235,33.2255706908902,9.18668284621255,0.961015540897676,0.910852713178294,0.441729323308271,-0.997860084207304,50681.7191489362,35528.2510638298,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665479,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665658,2312.56967213115,1095.94262295082,84.2909836065574,658.081967213115,1135.44262295082,2411.10245901639,2018.54098360656,273.418032786885,1318.8237704918,4132.29918032787,692.286885245902,112.254098360656,1087.19262295082,5742.18852459016,1209.30327868852,730.475409836066,5246.22950819672,5525.90163934426,420.909836065574,256.553278688525,1054.64754098361,4138.02868852459,248.5,220.139344262295,647.258196721311,1227.48360655738,446.717213114754,1104.67213114754,1047.31557377049,132.184426229508,244,24.6283115725526,13.9131908323122,0.825141091799763,0.844290657439446,0.6524064171123,0.334207210675073,50945.7663934426,35417.5532786885,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
665662,2781.51578947368,416.778947368421,267.642105263158,738.512280701754,7036.09473684211,2320.79649122807,381.835087719298,281.814035087719,1092.48070175439,2687.26666666667,559.038596491228,124.119298245614,1069.3649122807,680.277192982456,447.736842105263,263.185964912281,1408.5649122807,1036.70877192982,306.445614035088,234.957894736842,984.105263157895,921.614035087719,199.943859649123,123.526315789474,579.536842105263,1537.90526315789,546.884210526316,229.273684210526,1058.77543859649,131.950877192982,285,25.1717710951193,14.7281398998229,0.810957235703037,0.956375838926174,0.791666666666667,0.0537941897796296,51036.750877193,34772.9368421053,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_665662,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
666149,782.420814479638,182.755656108597,92.7647058823529,630.217194570136,1485.8778280543,896.565610859729,490.837104072398,247.266968325792,1076.93665158371,2014.42986425339,1090.5520361991,102.099547511312,1064.71945701357,852.153846153846,1021.28959276018,372.257918552036,1498.11312217195,1157.66968325792,282.628959276018,230.466063348416,988.447963800905,1075.54298642534,199.538461538462,240.171945701357,713.79185520362,1213.64253393665,480.746606334842,259.171945701357,1030.5520361991,130.004524886878,221,21.9806546923931,12.8798207464223,0.81033878212031,0.956709956709957,0.751700680272109,0.341697315640513,50651.1085972851,34505.3122171946,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_666149,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
666943,1179.54581673307,181.988047808765,54.7211155378486,626.669322709163,1456.9561752988,1248.62549800797,2412.77689243028,256.498007968127,1088.41035856574,1913.05179282868,634.219123505976,118.621513944223,1069.17131474104,4130.42629482072,781.183266932271,375.948207171315,2484.26693227092,3798.14741035857,406.270916334661,239.338645418327,1073.27490039841,3278.37848605578,261.729083665339,253.948207171315,596.852589641434,852.270916334661,399.199203187251,391.697211155379,1019.66932270916,129.888446215139,251,23.8169212295123,13.4785718596298,0.824457282676209,0.947169811320755,0.713068181818182,0.458544179324284,51196.2669322709,35822.5697211155,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_666943,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
667576,4613.26607142857,798.623214285714,267.201785714286,708.803571428571,5126.48571428571,5394.29642857143,1463.19821428571,289.653571428571,1207.3,8044.48392857143,930.519642857143,133.948214285714,1100.975,2189.38392857143,1257.69464285714,815.45,2260.47321428571,3329.68214285714,406.880357142857,243.1625,1071.26785714286,3161.03392857143,249.760714285714,415.048214285714,633.164285714286,2603.97321428571,556.778571428571,334.821428571429,1094.74107142857,131.875,560,31.2489521959266,23.4219138389924,0.661974481593663,0.947546531302876,0.689655172413793,0.84570244384821,50632.3107142857,35336.2928571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_667576,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
668220,2507.02777777778,388.005555555556,132.472222222222,648.0,1474.27222222222,2468.83888888889,1569.68333333333,267.011111111111,1090.91666666667,5071.98888888889,1330.02222222222,116.394444444444,1077.26111111111,674.9,410.288888888889,287.05,1438.01666666667,1141.58888888889,285.522222222222,230.9,987.972222222222,1231.38333333333,265.127777777778,153.255555555556,583.922222222222,2736.40555555556,503.138888888889,397.394444444445,1088.75555555556,130.205555555556,180,22.6999931600288,10.1715016756187,0.893991504574023,0.947368421052632,0.779220779220779,-0.183827927628959,50351.9611111111,35538.7666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_668220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
668634,2495.34857142857,549.562857142857,117.302857142857,687.222857142857,3973.62857142857,2679.02285714286,450.628571428571,264.28,1133.65142857143,3714.38285714286,500.977142857143,112.625714285714,1089.03714285714,1253.97142857143,765.305714285714,847.411428571429,4056.27142857143,2237.75428571429,316.602857142857,232.637142857143,1068.3,1862.84285714286,226.805714285714,273.545714285714,601.46,1069.43142857143,415.048571428571,224.925714285714,1051.32285714286,128.874285714286,350,25.8456175189642,17.3683232058186,0.740548750454366,0.958904109589041,0.729166666666667,-0.441608219899757,51212.0828571429,35749.0828571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_668634,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
670609,658.373271889401,139.562211981567,90.7235023041475,637.230414746544,1737.58064516129,891.119815668203,361.539170506912,258.428571428571,1088.67741935484,1777.56221198157,572.142857142857,111.087557603687,1073.43778801843,796.783410138249,593.115207373272,309.253456221198,1576.29953917051,1759.01843317972,304.322580645161,229.829493087558,1003.3732718894,2144.06912442396,226.216589861751,189.912442396313,615.898617511521,1230.2534562212,442.783410138249,263.299539170507,1056.85253456221,129.294930875576,217,20.9827561413192,13.1814384761523,0.778049165918741,0.951754385964912,0.713815789473684,1.01183068349903,51650.5852534562,35531.7465437788,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_670609,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
670975,2173.88174807198,423.94087403599,157.750642673522,656.221079691517,2285.6940874036,2578.76349614396,2617.72750642674,274.681233933162,1093.42673521851,3113.529562982,3082.56812339332,115.853470437018,1073.48329048843,766.480719794345,524.259640102828,275.164524421594,1445.49871465296,1077.66323907455,319.105398457584,236.398457583548,991.424164524422,1013.20822622108,221.467866323907,137.254498714653,582.922879177378,996.005141388175,485.028277634962,318.624678663239,1028.31876606684,130.308483290488,389,27.7456206170114,18.810248546189,0.735104525801893,0.941888619854722,0.623397435897436,-0.902094679486322,50942.0179948586,35007.9742930591,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_670975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
671356,1634.74675324675,615.266233766234,176.103896103896,622.142857142857,1271.81168831169,1969.35714285714,476.974025974026,261.935064935065,1114.49350649351,2886.32467532468,429.149350649351,103.422077922078,1076.68181818182,1925.48701298701,1335.98701298701,636.337662337662,4764.55194805195,1882.62337662338,302.733766233766,227.253246753247,1044.17532467532,1135.02597402597,204.902597402597,230.928571428571,611.019480519481,1222.71428571429,420.181818181818,281.266233766234,1023.53246753247,130.824675324675,154,17.0558619522743,11.4909125453701,0.73898472264092,0.968553459119497,0.78974358974359,-0.559082208276506,51247.0779220779,35716.961038961,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_671356,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
671370,3506.04573170732,240.30487804878,83.6615853658537,622.725609756098,1185.07012195122,3663.3993902439,2182.01219512195,268.661585365854,1090.88109756098,6566.61280487805,1385.81402439024,119.246951219512,1078.99390243902,4393.4237804878,611.167682926829,301.579268292683,1715.55792682927,6628.38414634146,426.850609756098,251.463414634146,1056.35365853659,7077.36280487805,294.262195121951,257.576219512195,581.509146341463,2475.48170731707,542.932926829268,366.30487804878,1047.96036585366,132.015243902439,328,24.3751068116407,17.3506434532655,0.702363809121677,0.942528735632184,0.743764172335601,0.725126809747442,51950.0884146341,34980.2591463415,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_671370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672146,2773.74262734584,1057.86058981233,136.241286863271,665.769436997319,2224.37801608579,3412.98391420912,1734.76943699732,262.008042895442,1114.41018766756,6056.37801608579,956.276139410188,126.817694369973,1079.24128686327,736.131367292225,496.605898123324,278.198391420912,1504.19302949062,1115.4745308311,308.02144772118,234.042895442359,1021.60321715818,1546.20107238606,277.190348525469,450.324396782842,1182.2091152815,2610.99731903485,557.209115281501,266.892761394102,1088.18766756032,132.064343163539,373,23.2250216345188,20.6386413143179,0.458608937557784,0.961340206185567,0.772256728778468,-1.05477988298759,50906.908847185,33697.3806970509,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_672146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672442,1937.23762376238,848.930693069307,116.990099009901,647.623762376238,2114.33663366337,1528.9504950495,317.19801980198,260.693069306931,1123.25742574257,4433.50495049505,483.049504950495,109.891089108911,1058.10891089109,1076.86138613861,517.663366336634,279.732673267327,1573.86138613861,832.940594059406,203.762376237624,207.693069306931,1096.64356435644,700.831683168317,167.663366336634,172.306930693069,630.950495049505,2440.9900990099,492.069306930693,211.326732673267,1031.23762376238,129.366336633663,101,12.6990417776118,10.1956210830226,0.59616035712334,0.935185185185185,0.765151515151515,0.453532496188161,50700.9405940594,35595.4158415842,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_672442,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672453,2697.13461538462,280.682692307692,84.2596153846154,636.543269230769,1829.90384615385,2571.16826923077,353.764423076923,275.966346153846,1099.70192307692,4442.84134615385,525.725961538462,117.081730769231,1078.46634615385,920.725961538462,517.168269230769,276.475961538462,1656.77403846154,1117.46634615385,237.951923076923,217.043269230769,1353.52403846154,767.480769230769,174.461538461538,155.581730769231,595.649038461538,1678.55769230769,465.995192307692,267.475961538462,1054.94711538462,128.379807692308,208,24.0527907158146,11.2685030571096,0.883468554136229,0.908296943231441,0.666666666666667,-1.43151093799995,50732.2211538462,35524.5240384615,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_672453,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672463,1641.66821345708,327.016241299304,129.981438515081,645.371229698376,1951.13225058005,1889.22273781903,2120.22041763341,261.510440835267,1086.53596287703,2336.32482598608,1513.94199535963,110.974477958237,1069.96983758701,1796.27146171694,695.498839907193,301.772621809745,1811.09048723898,1609.86310904872,309.661252900232,233.15313225058,1162.24593967517,1188.66821345708,201.756380510441,133.248259860789,2112.37587006961,750.703016241299,412.979118329466,246.30626450116,1015.44547563805,133.914153132251,431,25.5822566121885,21.6038403545672,0.535578688481662,0.970720720720721,0.816287878787879,0.478322372549696,50412.3201856149,34982.0696055684,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_672463,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672480,3477.65803108808,776.943005181347,119.20207253886,674.458549222798,3004.72538860104,3077.59844559586,498.79792746114,272.681347150259,1092.83160621762,6311.56735751295,603.961139896373,121.370466321244,1084.27979274611,684.922279792746,454.264248704663,273.681347150259,1506.16839378238,1210.53886010363,317.821243523316,235.559585492228,996.860103626943,1160.01554404145,231.613989637306,163.056994818653,1112.51813471503,2208.48704663212,529.129533678757,243.349740932642,1061.18652849741,132.10103626943,386,28.7712519328656,17.2239723046518,0.801009103229449,0.957816377171216,0.674825174825175,-0.96368297113731,51544.0051813472,35475.8264248705,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_672480,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
672507,1417.28996282528,266.133828996283,208.925650557621,696.2156133829,6040.77695167286,838.947955390335,310.747211895911,259.219330855019,1083.3717472119,1485.73234200743,483.747211895911,113.293680297398,1066.156133829,1914.68029739777,707.223048327138,312.550185873606,1669.47211895911,1691.52416356877,354.118959107807,240.208178438662,990.323420074349,1144.83271375465,212.371747211896,134.304832713755,579.732342007435,1201.74721189591,523.765799256506,224.706319702602,1051.85501858736,128.947955390335,269,22.7944213154139,15.156680124022,0.746906244198369,0.960714285714286,0.753501400560224,-0.460811402720809,51051.1078066914,34775.1375464684,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_672507,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
673213,3483.85240963855,216.710843373494,107.10843373494,631.963855421687,1899.26506024096,3244.6265060241,343.418674698795,269.430722891566,1088.05421686747,6237.15662650602,520.795180722892,116.394578313253,1087.76807228916,725.972891566265,491.64156626506,279.644578313253,1484.15662650602,1075.05722891566,301.174698795181,235.963855421687,985.394578313253,1044.48192771084,230.963855421687,133.954819277108,583.593373493976,2170.95180722892,535.093373493976,232.072289156627,1054.81626506024,130.506024096386,332,35.0115226067276,12.5166142378362,0.933913194055144,0.924791086350975,0.457931034482759,0.913578615268871,51759.2469879518,34979.8313253012,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_673213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
674148,985.487364620939,729.379061371841,202.429602888087,634.884476534296,1301.53068592058,1067.79422382671,364.833935018051,271.389891696751,1097.74368231047,2143.47653429603,727.083032490975,115.274368231047,1060.32490974729,3416.04332129964,983.916967509025,1168.14079422383,2017.79061371841,5500.15884476534,425.42238267148,252.747292418773,1033.29963898917,5047.75451263538,380.241877256318,1668.42238267148,763.98916967509,869.617328519856,462.671480144404,217.397111913357,1047.17328519856,130.823104693141,277,27.3331261190377,13.745565334439,0.864350216543861,0.876582278481013,0.760989010989011,-1.52949315039841,50348.1624548736,34833.8592057762,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_674148,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
674451,1297.13880126183,78.4668769716088,80.9526813880126,651.08832807571,3135.71924290221,1670.17665615142,309.1261829653,257.839116719243,1083.66246056782,2972.85488958991,485.104100946372,111.504731861199,1070.04100946372,3922.44479495268,1139.73186119874,1148.11356466877,2779.93375394322,2603.26498422713,339.545741324921,241.96214511041,1027.99684542587,1662.1261829653,244.675078864353,212.652996845426,740.145110410095,2192.39432176656,535.394321766561,263.738170347003,1032.56466876972,129.514195583596,317,24.0363242375604,17.0674071066865,0.704133846354597,0.97239263803681,0.776960784313726,-1.39335060345225,51947.7350157729,34901.832807571,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_674451,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
674717,2710.80985915493,179.341549295775,87.4542253521127,636.12676056338,1869.04225352113,2946.15845070423,378.922535211268,269.183098591549,1093.54577464789,4781.55985915493,527.355633802817,117.869718309859,1072.70070422535,933.714788732394,636.746478873239,275.457746478873,1707.79929577465,1418.74647887324,305.394366197183,238.911971830986,1006.62323943662,1289.83098591549,241.12323943662,417.070422535211,1681.98591549296,1538.3838028169,518.845070422535,228.781690140845,1036.3661971831,130.704225352113,284,27.0272275944453,13.7082527447902,0.861827447647576,0.925081433224756,0.62280701754386,0.583321510062542,51731.6161971831,35103.9471830986,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_674717,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
674807,1825.27222222222,206.783333333333,103.361111111111,624.5,1179.29444444444,1725.01111111111,350.883333333333,270.227777777778,1086.89444444444,4084.21666666667,680.472222222222,117.177777777778,1078.85,660.494444444444,527.355555555556,275.677777777778,1554.95,1000.07222222222,280.466666666667,228.611111111111,988.25,922.861111111111,210.3,151.783333333333,586.577777777778,1720.2,490.877777777778,222.588888888889,1042.81666666667,127.944444444444,180,22.537589148109,10.309664114629,0.889238905947387,0.942408376963351,0.743801652892562,0.214406776890396,51024.8222222222,35401.7,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_674807,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
675061,2277.20622568093,337.293774319066,162.017509727626,699.727626459144,5769.71206225681,2192.953307393,752.429961089494,266.167315175097,1140.41050583658,3788.89299610895,600.933852140078,118.34046692607,1085.87159533074,1618.91050583658,863.422178988327,584.682879377432,1727.75680933852,2616.74902723735,341.575875486381,238.52140077821,1029.90272373541,2810.62256809339,253.719844357977,273.25486381323,702.130350194553,1165.37937743191,454.231517509728,344.77626459144,1038.22373540856,130.233463035019,514,28.0834820021478,23.3478446747488,0.555715009841541,0.957169459962756,0.761481481481482,-0.47832496031357,51169.9513618677,35699.3482490272,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_675061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
675344,2941.33913043478,433.756521739131,100.94347826087,629.878260869565,1411.3,3272.14782608696,2097.64347826087,272.221739130435,1098.78695652174,5371.3347826087,1535.95217391304,118.034782608696,1079.91739130435,891.234782608696,476.24347826087,284.2,1595.65652173913,1010.46086956522,224.504347826087,218.813043478261,1306.62608695652,723.291304347826,163.286956521739,145.534782608696,588.217391304348,2508.6652173913,793.878260869565,356.55652173913,1107.05217391304,131.230434782609,230,22.221701087796,13.3688521834956,0.798788114547691,0.934959349593496,0.638888888888889,0.959529545828235,51797.5608695652,34828.452173913,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_675344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
676244,427.636842105263,618.421052631579,155.205263157895,605.594736842105,98.6526315789474,319.726315789474,250.910526315789,237.752631578947,1088.17894736842,1032.30526315789,490.926315789474,102.747368421053,1063.27894736842,942.931578947368,524.457894736842,285.347368421053,1508.65789473684,1117.44736842105,223.8,219.673684210526,1513.84210526316,642.073684210526,149.442105263158,118.8,591.352631578947,577.5,369.068421052632,198.526315789474,993.757894736842,128.515789473684,190,18.1264223324069,13.3939463780024,0.673794959791531,0.95959595959596,0.753968253968254,1.22145658613814,50218.3684210526,34945.1473684211,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_676244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
677134,2267.96052631579,70.6052631578947,43.1315789473684,614.263157894737,838.223684210526,2624.91447368421,393.427631578947,281.552631578947,1113.88815789474,4740.43421052632,739.486842105263,121.111842105263,1065.06578947368,1596.86842105263,667.638157894737,309.513157894737,1521.38157894737,2118.98026315789,346.467105263158,241.651315789474,997.53947368421,1759.59868421053,283.763157894737,156.289473684211,585.480263157895,1769.22368421053,544.730263157895,355.368421052632,1049.48684210526,131.421052631579,152,24.8666022397698,8.19434228011294,0.944144391252943,0.904761904761905,0.575757575757576,-0.279344072083295,51012.2434210526,35159.1578947368,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_677134,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
677551,2267.77317073171,399.636585365854,174.056097560976,730.726829268293,6434.08536585366,2527.08536585366,574.80243902439,264.468292682927,1148.4243902439,3886.63414634146,861.714634146341,126.092682926829,1102.51707317073,3431.0756097561,869.948780487805,332.287804878049,3031.86585365854,4392.41707317073,310.185365853659,230.741463414634,1015.26829268293,3914.36585365854,229.512195121951,199.553658536585,596.846341463415,1376.84390243902,521.314634146342,264.875609756098,1087.01707317073,131.885365853659,410,29.705475313089,18.1665495584633,0.791201464333627,0.957943925233645,0.683333333333333,-0.829762129708898,51927.7658536585,34286.0658536585,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_677551,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
677609,1828.26605504587,199.669724770642,150.032110091743,636.311926605505,1516.73394495413,2112.80733944954,620.651376146789,258.981651376147,1117.71100917431,4487.70183486239,537.876146788991,107.256880733945,1074.1376146789,946.509174311927,469.266055045872,280.940366972477,1417.43119266055,1022.8623853211,299.389908256881,231.793577981651,977.614678899083,998.596330275229,232.532110091743,137.165137614679,581.926605504587,1895.05504587156,492.545871559633,249.284403669725,1048.09633027523,130.52752293578,218,19.0990604878399,14.7109134288919,0.637750782987236,0.951965065502183,0.807407407407407,-1.37595795301066,51182.4678899083,35097.3623853211,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_677609,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
678598,1667.83783783784,921.114864864865,1034.43918918919,624.702702702703,863.513513513514,2067.48648648649,1074.02027027027,271.993243243243,1125.62162162162,2546.64864864865,535.47972972973,112.709459459459,1071.60810810811,6317.99324324324,998.533783783784,442.972972972973,2043.02702702703,5063.83108108108,483.182432432433,255.783783783784,1025.72972972973,3329.02027027027,292.067567567568,375.648648648649,594.891891891892,1113.5472972973,507.452702702703,235.22972972973,1041.2972972973,129.425675675676,148,16.2948585441564,12.1663600533209,0.665230596467193,0.925,0.822222222222222,1.51500501145239,51421.8108108108,35678.5540540541,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_678598,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
680510,5181.87841191067,1462.23325062035,341.374689826303,669.471464019851,2653.66501240695,5038.27791563275,452.935483870968,281.267990074442,1161.83622828784,8208.30024813896,600.622828784119,152.057071960298,1092.36972704715,4290.81141439206,692.66253101737,578.563275434243,1760.43920595533,1763.81885856079,327.928039702233,236.101736972705,1012.80893300248,1454.54342431762,260.518610421836,206.101736972705,596.655086848635,2644.7047146402,556.414392059553,245.570719602978,1075.158808933,133.535980148883,403,28.1989848782578,18.4325977589824,0.756786838325157,0.952718676122932,0.699652777777778,-0.79402693017351,51002.6277915633,35811.2158808933,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_680510,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
681331,2382.35223880597,155.913432835821,273.402985074627,763.179104477612,9227.05373134328,2450.07462686567,371.883582089552,272.388059701493,1111.89850746269,4788.47164179104,542.107462686567,128.516417910448,1071.32835820896,1291.59701492537,682.579104477612,335.262686567164,1765.94925373134,1750.38208955224,307.680597014925,231.773134328358,1018.25970149254,1812.59402985075,238.444776119403,633.146268656716,1354.35820895522,1450.30149253731,432.316417910448,234.785074626866,1064.39701492537,128.69552238806,335,34.7601455878184,12.4027156529608,0.934177546977899,0.946327683615819,0.531746031746032,1.03386332836564,51608.1820895522,35636.9910447761,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_681331,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
681646,1154.47959183673,463.821428571429,193.423469387755,686.081632653061,3206.31632653061,1413.82653061224,2008.38775510204,259.882653061225,1087.94387755102,1955.07653061224,4487.25510204082,117.428571428571,1058.27551020408,457.214285714286,316.469387755102,252.484693877551,1372.4693877551,780.811224489796,226.795918367347,222.75,988.862244897959,752.90306122449,166.107142857143,151.94387755102,579.494897959184,1132.07142857143,493.198979591837,490.117346938775,1050.96428571429,130.719387755102,196,21.3039567858215,11.8283848464197,0.83170346244817,0.933333333333333,0.777777777777778,-1.55392898922875,50324.4591836735,34420.6428571429,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_681646,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
682663,1549.54128440367,844.110091743119,70.9724770642202,657.064220183486,2052.04587155963,1147.96330275229,2311.15596330275,265.688073394495,1109.59633027523,1987.56880733945,677.51376146789,111.183486238532,1067.95412844037,1726.62385321101,717.477064220183,329.669724770642,1862.79816513761,1708.04587155963,361.559633027523,247.853211009174,1029.42201834862,1271.48623853211,255.321100917431,354.174311926606,1579.39449541284,935.633027522936,469.467889908257,891.385321100917,1046.24770642202,131.853211009174,109,12.0979995360836,11.4999695027436,0.310516904060936,0.931623931623932,0.756944444444444,0.447804145355709,51817.4495412844,35347.4587155963,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_682663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
682976,773.11013215859,238.704845814978,83.8766519823789,613.726872246696,775.854625550661,1160.85022026432,1209.37004405286,261.938325991189,1089.19823788546,2055.33039647577,727.594713656388,109.929515418502,1061.31718061674,688.925110132159,415.740088105727,283.722466960352,1506.4845814978,1030.81938325991,273.863436123348,228.418502202643,989.145374449339,996.991189427313,221.814977973568,147.837004405286,582.039647577093,1532.71365638767,515.167400881057,390.25550660793,1033.51982378855,131.47577092511,227,19.2982240108572,15.1078016108528,0.622198288573145,0.930327868852459,0.709375,1.51456657288023,51904.2070484581,35056.5154185022,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_682976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
683543,2181.06513409962,269.984674329502,97.7892720306514,617.647509578544,959.072796934866,2425.41379310345,743.773946360153,266.724137931034,1099.15708812261,4232.2337164751,760.302681992337,111.375478927203,1069.36781609195,757.475095785441,654.130268199234,279.080459770115,1582.79310344828,1182.36398467433,352.524904214559,242.980842911877,986.854406130268,1159.969348659,267.51724137931,160.394636015326,581.463601532567,1858.06513409962,472.942528735632,245.045977011494,1064.92337164751,130.459770114943,261,21.2133056019481,15.825017680499,0.665951662629899,0.96309963099631,0.815625,-0.264168870683952,50380.2222222222,35425.5440613027,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_683543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
684183,980.263565891473,128.06976744186,69.7984496124031,641.263565891473,1720.07751937984,1241.72093023256,347.286821705426,264.837209302326,1096.83720930233,2379.85271317829,533.705426356589,109.348837209302,1069.68992248062,877.449612403101,460.457364341085,272.387596899225,1821.48837209302,1751.6511627907,302.713178294574,233.325581395349,1050.88372093023,1645.96124031008,217.333333333333,365.84496124031,1250.36434108527,1439.11627906977,467.0,216.356589147287,1058.81395348837,129.906976744186,129,15.009334259135,11.0923098159748,0.673675328778607,0.955555555555556,0.732954545454545,-1.38748488079168,50050.023255814,35404.5813953488,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_684183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
684260,927.806282722513,167.44502617801,170.764397905759,752.664921465969,5650.35078534031,1164.87434554974,1092.80104712042,253.471204188482,1104.0942408377,2145.5497382199,448.235602094241,110.565445026178,1067.48691099476,775.424083769634,526.643979057592,334.434554973822,1531.50785340314,1364.01570680628,271.34554973822,228.858638743455,996.905759162304,1431.83246073298,211.193717277487,220.874345549738,604.471204188482,1060.31937172775,442.225130890052,342.099476439791,1023.30890052356,128.905759162304,191,18.4195383734241,13.2385803688806,0.695294583363861,0.945544554455446,0.749019607843137,1.03971852412759,51689.0209424084,35163.2356020942,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_684260,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
684342,2835.51361867704,491.003891050584,122.552529182879,641.918287937743,2098.43190661479,3168.0233463035,414.673151750973,263.466926070039,1136.68871595331,5846.00778210117,514.36186770428,117.015564202335,1083.19844357977,898.447470817121,489.264591439689,276.346303501945,1847.13618677043,1406.60311284047,306.793774319066,238.610894941634,1034.59922178988,1174.52529182879,217.007782101167,149.443579766537,772.291828793774,1726.03501945525,471.303501945525,300.311284046693,1035.89883268482,130.470817120623,257,21.8140908847389,15.8502479688121,0.687054445346601,0.921146953405018,0.719887955182073,-0.237433970292661,51318.9961089494,35274.1673151751,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_684342,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
684529,1256.71428571429,175.687074829932,79.0272108843537,613.034013605442,945.891156462585,1519.55102040816,336.040816326531,259.571428571429,1083.80952380952,2326.39455782313,567.299319727891,106.496598639456,1061.00680272109,684.238095238095,533.08843537415,272.231292517007,1500.78911564626,964.530612244898,252.993197278912,224.52380952381,1008.65306122449,881.136054421769,194.646258503401,147.421768707483,597.285714285714,1150.31972789116,481.605442176871,220.054421768707,1054.81632653061,132.401360544218,147,21.6798750505879,8.72713299246122,0.915400042274244,0.91875,0.6125,-1.1682794646291,50132.0068027211,34822.2176870748,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_684529,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
684799,3900.9238410596,903.271523178808,207.344370860927,744.692052980132,6700.10264900662,3192.23841059603,1773.88741721854,275.619205298013,1129.30463576159,8031.87417218543,2864.38079470199,136.400662251656,1085.35761589404,8973.15231788079,1427.67218543046,386.526490066225,2523.70198675497,9723.50993377483,534.794701986755,268.966887417219,1071.07284768212,7996.41390728477,317.44701986755,197.480132450331,593.387417218543,2547.28145695364,558.403973509934,386.890728476821,1094.50662251656,133.778145695364,302,28.2141582458638,14.3181090267328,0.861663786680498,0.885630498533724,0.634453781512605,1.31513588284868,52071.1026490066,34923.1158940397,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_684799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
685039,2821.10546875,158.90234375,120.52734375,651.51171875,2301.4921875,3017.34765625,1289.359375,266.4765625,1096.75390625,5387.71484375,1430.09375,114.9921875,1077.41796875,1511.875,746.08203125,286.11328125,1684.60546875,2688.78125,333.4140625,238.11328125,996.9765625,3149.9921875,246.10546875,197.71484375,582.1484375,1642.86328125,487.08984375,540.765625,1068.8671875,130.171875,256,19.4033870186536,17.1770004275694,0.46510059296596,0.941176470588235,0.752941176470588,1.3042231294926,51393.453125,35453.63671875,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_685039,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
685167,1157.60802469136,217.12962962963,133.651234567901,660.293209876543,2937.23765432099,1221.36728395062,380.824074074074,254.95987654321,1094.80864197531,2681.66358024691,446.947530864198,110.077160493827,1068.43827160494,4217.19135802469,1300.72530864198,1593.31481481481,3079.3487654321,3173.49691358025,395.913580246914,251.925925925926,1019.16049382716,2260.76543209877,277.549382716049,260.768518518519,769.416666666667,1366.97222222222,457.83024691358,222.901234567901,1032.5987654321,128.737654320988,324,27.4115436012555,15.1134073287572,0.834272770093894,0.944606413994169,0.723214285714286,-0.0917772798483669,51979.6975308642,35070.75,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_685167,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
686028,431.862170087977,517.768328445748,127.208211143695,606.826979472141,88.5718475073314,506.659824046921,404.269794721408,253.33431085044,1125.91495601173,1086.41055718475,1112.05278592375,120.284457478006,1059.80058651026,992.941348973607,565.41642228739,299.777126099707,1623.33431085044,842.873900293255,202.387096774194,221.935483870968,1047.36070381232,664.876832844575,149.551319648094,127.404692082111,583.815249266862,567.070381231672,373.988269794721,200.202346041056,983.035190615836,129.102639296188,341,23.3163112093211,18.6457469406185,0.600417336424848,0.955182072829132,0.74780701754386,-1.2809291996131,51176.7536656891,33786.0586510264,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_686028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
686906,2618.99099099099,261.174174174174,109.957957957958,640.306306306306,2003.87387387387,3090.60660660661,1234.5975975976,268.585585585586,1099.87387387387,4978.16516516517,657.162162162162,112.477477477477,1078.85885885886,3121.57657657658,763.003003003003,312.546546546546,1718.35435435435,1561.95495495495,333.036036036036,242.960960960961,994.168168168168,1238.07807807808,238.255255255255,174.828828828829,592.945945945946,1557.30630630631,504.444444444444,1913.74474474474,1078.5975975976,132.141141141141,333,23.5174170352953,18.1723337499962,0.634749353502426,0.951428571428571,0.723913043478261,1.10595353923021,51323.3603603604,35081.4714714715,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_686906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
687766,1380.60089686099,169.502242152466,74.3542600896861,605.156950672646,385.533632286995,1477.92376681614,363.941704035874,258.121076233184,1081.61434977578,2893.95964125561,467.354260089686,129.318385650224,1073.40807174888,652.843049327354,532.031390134529,425.013452914798,3264.87443946188,998.273542600897,263.219730941704,221.430493273543,1006.54260089686,1009.55156950673,211.080717488789,198.112107623318,587.977578475336,1879.12556053812,456.686098654708,228.708520179372,1025.43946188341,127.869955156951,223,23.1721835456474,12.4208163505982,0.844203569562989,0.965367965367965,0.745819397993311,-0.212496698114374,50804.8161434978,35865.2062780269,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_687766,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
687989,741.337606837607,262.726495726496,135.384615384615,644.679487179487,2578.62393162393,843.495726495726,320.008547008547,262.504273504273,1089.40598290598,2009.33333333333,507.970085470086,116.294871794872,1069.47863247863,3746.50427350427,1012.30341880342,882.025641025641,1995.53418803419,6811.5641025641,369.508547008547,246.059829059829,1029.79487179487,7987.33333333333,283.119658119658,277.128205128205,647.897435897436,1235.46153846154,504.713675213675,223.196581196581,1025.0811965812,128.495726495727,234,22.0072530897093,13.5828790593646,0.786806216576627,0.932270916334661,0.65546218487395,1.00184627979832,51955.2222222222,35061.4188034188,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_687989,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
688704,1785.42365591398,521.354838709677,84.3806451612903,638.118279569892,2168.44946236559,1659.6623655914,1841.87956989247,269.634408602151,1108.95268817204,3042.89677419355,1067.3247311828,111.131182795699,1074.87956989247,1978.81720430108,720.643010752688,299.38064516129,1833.09462365591,1821.76989247312,330.034408602151,242.989247311828,1033.21720430108,1414.24086021505,230.752688172043,670.617204301075,2463.78494623656,1059.64301075269,462.075268817204,339.316129032258,1048.39139784946,130.832258064516,465,25.6483356812981,23.2739413624926,0.420214045602691,0.972803347280335,0.808695652173913,-0.384505161872874,51870.1827956989,35351.2688172043,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_688704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
689228,2133.62244897959,170.268707482993,237.965986394558,750.823129251701,8341.08163265306,2131.65646258503,320.724489795918,261.921768707483,1089.01700680272,4287.23469387755,583.58843537415,119.085034013605,1068.17006802721,1000.98639455782,551.887755102041,280.850340136054,1787.73469387755,1438.89455782313,308.775510204082,240.278911564626,1034.70068027211,1177.71768707483,218.251700680272,146.095238095238,866.309523809524,1450.32993197279,472.585034013605,268.357142857143,1057.70408163265,129.809523809524,294,31.9905430939406,11.8845167828634,0.928432578427603,0.933333333333333,0.563218390804598,1.11438896490316,51463.7925170068,35259.2414965986,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_689228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
689639,1345.9477124183,657.248366013072,67.8758169934641,612.934640522876,821.065359477124,1411.51633986928,282.555555555556,251.993464052288,1078.27450980392,3123.99346405229,454.346405228758,104.627450980392,1067.58169934641,1012.11111111111,541.614379084967,278.013071895425,1517.96732026144,1289.8954248366,327.294117647059,234.078431372549,1024.77124183007,1182.72549019608,247.43137254902,154.986928104575,648.228758169935,1210.05882352941,457.771241830065,220.392156862745,1019.67973856209,131.352941176471,153,17.712324885439,11.0223472224758,0.782780299614521,0.980769230769231,0.728571428571429,0.722863888106759,51010.1764705882,35279.1503267974,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_689639,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
689995,1330.05357142857,207.913265306122,82.2015306122449,635.352040816327,1978.51530612245,1399.66326530612,1083.79081632653,255.813775510204,1093.00255102041,2127.32908163265,1811.18112244898,102.239795918367,1073.14285714286,693.321428571429,480.382653061225,290.637755102041,1426.70918367347,1058.76275510204,298.576530612245,234.464285714286,988.043367346939,1002.55357142857,226.885204081633,144.242346938776,583.599489795918,871.834183673469,427.632653061225,325.290816326531,1028.07653061224,129.446428571429,392,26.2267364300022,19.3034479449111,0.676957909725218,0.96078431372549,0.784,-0.332356499386338,50861.5816326531,35255.7142857143,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_689995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
690535,1729.63414634146,400.634146341463,102.219512195122,629.040650406504,1239.27642276423,1822.78048780488,2180.09756097561,245.959349593496,1088.80487804878,2679.65040650406,1764.26016260163,112.747967479675,1059.74796747967,4390.50406504065,677.227642276423,457.073170731707,1487.74796747967,2867.56910569106,373.463414634146,243.943089430894,1094.32520325203,2889.24390243902,260.528455284553,943.089430894309,951.414634146341,932.845528455285,462.0,367.821138211382,1030.62601626016,130.479674796748,123,14.6109212596048,10.9182236776559,0.664526654210252,0.911111111111111,0.683333333333333,-0.0163256285919944,51549.7235772358,33798.9756097561,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690535,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
690620,1445.96875,400.125,107.604166666667,615.479166666667,1323.40625,1657.85416666667,385.614583333333,265.291666666667,1128.1875,2743.16666666667,541.84375,109.760416666667,1061.86458333333,770.208333333333,467.885416666667,289.885416666667,1431.55208333333,1212.08333333333,322.96875,231.635416666667,975.09375,1113.1875,219.510416666667,130.1875,585.5625,1333.54166666667,523.229166666667,238.21875,1040.90625,129.53125,96,14.6069214422825,8.58023804261144,0.809290178065021,0.923076923076923,0.64,1.35289779791238,51381.9895833333,34985.96875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690620,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
690674,3798.54035087719,703.614035087719,906.042105263158,643.705263157895,1884.80350877193,3187.64210526316,748.624561403509,267.982456140351,1141.35438596491,5971.44210526316,600.459649122807,114.301754385965,1088.87719298246,910.866666666667,459.126315789474,306.484210526316,1518.0,1562.65614035088,315.789473684211,235.140350877193,996.473684210526,1557.44210526316,234.361403508772,177.831578947368,603.8,1639.30877192982,469.835087719298,274.887719298246,1038.58245614035,131.564912280702,285,21.829070195034,16.6823286998532,0.644949317487785,0.953177257525084,0.798319327731092,-0.261291052888847,51024.9754385965,35543.1298245614,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690674,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
693079,2265.80228136882,184.695817490494,78.3269961977186,618.965779467681,883.77566539924,2627.5855513308,592.072243346008,254.239543726236,1090.59695817491,4374.95817490494,652.764258555133,115.273764258555,1075.88593155894,737.296577946768,561.494296577947,519.376425855513,1558.26615969582,1176.81368821293,304.74144486692,233.950570342205,1021.42205323194,1231.11406844106,284.836501901141,161.25855513308,603.608365019011,1992.42585551331,535.71102661597,234.315589353612,1047.05703422053,130.235741444867,263,30.8591924002851,11.1329953708791,0.932655762723882,0.929328621908127,0.497164461247637,0.807047532104013,51231.6197718631,34186.1558935361,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_693079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
693626,3668.4188034188,953.957264957265,1366.22222222222,649.344729344729,1870.68091168091,2955.79202279202,610.450142450142,280.307692307692,1110.48148148148,5515.2735042735,662.655270655271,119.190883190883,1073.58974358974,3185.76353276353,673.096866096866,355.706552706553,1575.1452991453,1434.150997151,333.105413105413,233.219373219373,1012.93732193732,1319.82051282051,235.193732193732,211.410256410256,661.230769230769,1516.20512820513,531.732193732194,327.239316239316,1041.66096866097,130.65811965812,351,28.6721170343052,15.6310716014074,0.83832793038136,0.956403269754768,0.710526315789474,-1.12151289960378,51416.7264957265,35582.056980057,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_693626,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
694008,1558.15503875969,102.387596899225,88.2945736434109,636.821705426357,2272.48062015504,2086.82170542636,389.53488372093,269.899224806202,1101.22480620155,2734.06976744186,541.333333333333,111.426356589147,1065.54263565891,5519.99224806202,883.565891472868,436.906976744186,1722.17054263566,2011.86821705426,348.325581395349,234.596899224806,1015.5503875969,1559.90697674419,265.558139534884,216.852713178294,589.472868217054,940.527131782946,427.736434108527,225.279069767442,1037.27131782946,130.193798449612,129,15.4206639802116,11.232357946266,0.685155831012403,0.883561643835616,0.583710407239819,0.0414761999369655,51501.2015503876,35600.5658914729,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_694008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
694182,2867.41455696203,476.094936708861,106.351265822785,656.215189873418,2558.55379746835,3173.18037974684,416.325949367089,266.569620253165,1182.34493670886,4634.19936708861,487.20253164557,113.104430379747,1080.63607594937,3258.71518987342,1279.55063291139,678.974683544304,9738.33227848101,3930.7753164557,372.101265822785,238.819620253164,1064.49050632911,3690.88924050633,248.79746835443,285.686708860759,631.699367088608,1107.54113924051,424.028481012658,216.962025316456,1044.64873417722,130.658227848101,316,24.1035770523544,16.85123783131,0.715006582950003,0.954682779456193,0.763285024154589,0.300771536454844,51197.0949367089,35734.0379746835,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_694182,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
696699,1792.325,115.1975,74.8575,637.4525,1717.195,2058.305,361.6,265.8325,1094.2725,3981.895,536.8475,108.385,1068.7725,1536.9225,716.07,307.305,1557.385,1363.725,310.7175,232.8675,1066.49,1240.0675,232.8975,314.5675,744.9375,2401.24,468.38,218.2375,1069.1875,130.56,400,37.5900039650621,13.6396334960518,0.931846519640869,0.943396226415094,0.492610837438424,-0.750384474745687,50205.74,35389.87,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_696699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
697618,1278.56763925729,109.148541114058,61.5411140583554,666.32625994695,858.297082228117,1560.87533156499,288.185676392573,250.2175066313,1097.76657824934,3070.44562334218,508.068965517241,100.575596816976,1082.27055702918,914.400530503979,524.116710875332,286.917771883289,1485.13527851459,1085.93899204244,230.599469496021,219.320954907162,1347.97877984085,658.344827586207,154.175066312997,117.111405835544,584.838196286472,1490.76127320955,457.013262599469,212.395225464191,1040.57824933687,131.161803713528,377,37.6199576831286,12.7917794901248,0.940415883772039,0.944862155388471,0.598412698412698,-1.20914650793201,50254.700265252,35012.7108753316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_697618,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
698439,901.080745341615,268.801242236025,145.459627329193,630.111801242236,2160.80124223602,1049.29192546584,317.67701863354,264.55900621118,1087.52173913043,2323.19875776398,509.913043478261,127.167701863354,1065.73913043478,710.95652173913,502.155279503106,272.149068322981,1422.7701863354,1085.57763975155,312.801242236025,230.217391304348,990.608695652174,1014.65838509317,219.360248447205,135.472049689441,581.378881987578,1640.75776397516,526.136645962733,229.515527950311,1032.16770186335,129.459627329193,161,18.0117861147282,11.3912469697441,0.774615109455387,0.952662721893491,0.74537037037037,-0.212516234618377,51002.2857142857,35073.3664596273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_698439,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
698778,375.345029239766,657.865497076023,161.22514619883,605.295321637427,111.558479532164,402.959064327485,295.210526315789,241.830409356725,1102.8567251462,906.900584795322,487.309941520468,106.634502923977,1067.11988304094,881.739766081871,514.921052631579,311.005847953216,1556.7865497076,1109.73976608187,250.137426900585,430.163742690058,1098.53801169591,877.690058479532,171.640350877193,162.850877192982,643.406432748538,562.760233918129,373.342105263158,199.982456140351,977.608187134503,131.002923976608,342,22.1453557999859,19.7072369111169,0.456148195133345,0.968838526912181,0.777272727272727,-1.07157314277635,51315.4532163743,33883.514619883,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_698778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
698886,3529.12601626016,1178.48780487805,74.8536585365854,645.321138211382,1489.41463414634,3271.88617886179,1665.86991869919,268.439024390244,1136.32520325203,5440.40650406504,687.40243902439,140.650406504065,1081.47154471545,2567.20325203252,827.313008130081,296.365853658537,2073.77235772358,3716.24390243902,351.581300813008,240.227642276423,1012.76016260163,3622.74796747967,260.959349593496,217.426829268293,585.926829268293,1335.64634146341,429.166666666667,312.406504065041,1047.29674796748,130.142276422764,246,21.928198686796,14.6207581361932,0.745276076923161,0.938931297709924,0.689075630252101,1.15755853722901,50986.3617886179,35890.256097561,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_698886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
699171,1833.0,224.535353535354,56.1313131313131,618.878787878788,786.340067340067,1653.47138047138,1628.24579124579,265.228956228956,1090.73737373737,2762.37037037037,883.397306397306,107.107744107744,1066.54882154882,986.838383838384,511.494949494949,316.400673400673,1544.78114478114,1286.77441077441,305.080808080808,237.56228956229,996.464646464646,1292.20875420875,225.188552188552,160.841750841751,600.6632996633,870.265993265993,414.188552188552,334.188552188552,1016.09764309764,132.531986531987,297,24.7560625701778,15.3671626862941,0.784013787842971,0.964285714285714,0.792,-0.0391648236161433,51020.4983164983,35512.8215488216,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_699171,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
699216,1780.43950617284,174.034567901235,94.6913580246914,627.449382716049,1381.58271604938,2010.39259259259,1011.31851851852,261.56049382716,1084.83703703704,3602.87160493827,2355.37777777778,107.41975308642,1082.32098765432,782.251851851852,474.703703703704,304.387654320988,1608.32839506173,1085.45679012346,296.738271604938,231.604938271605,1006.81481481481,1079.58024691358,229.274074074074,215.767901234568,594.246913580247,2103.51851851852,457.340740740741,382.575308641975,1040.24197530864,128.012345679012,405,29.7858126930484,17.5234892394252,0.808630651935696,0.959715639810426,0.677257525083612,0.709322033420503,50875.7283950617,35683.2395061728,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_699216,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
699228,879.267716535433,122.622047244094,114.314960629921,634.385826771654,2422.92125984252,918.03937007874,300.086614173228,256.212598425197,1083.84251968504,1391.74015748032,452.795275590551,109.685039370079,1060.68503937008,952.488188976378,588.015748031496,504.220472440945,1501.11811023622,929.59842519685,243.48031496063,221.740157480315,991.897637795276,861.551181102362,220.464566929134,138.897637795276,600.622047244094,792.472440944882,442.905511811024,209.614173228346,1003.81102362205,128.992125984252,127,14.6566501053714,11.0275197817046,0.658717693333962,0.947761194029851,0.76969696969697,-0.0547480272555984,50306.188976378,35105.2677165354,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_699228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
699450,3804.99143468951,1190.08565310493,107.901498929336,635.914346895075,1818.89721627409,4276.59743040685,473.880085653105,287.297644539615,1121.40899357602,6010.55246252677,615.267665952891,119.899357601713,1088.73233404711,1826.64668094218,780.23982869379,434.925053533191,3713.18415417559,2213.00214132762,303.145610278373,232.775160599572,1062.38115631692,1873.80728051392,217.428265524625,240.584582441113,619.689507494647,1768.68308351178,520.809421841542,227.65096359743,1057.48394004283,132.58244111349,467,29.4566656258445,20.3131228241561,0.724196736755502,0.968879668049792,0.786195286195286,-0.454395425634998,50866.1284796574,35348.3554603854,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_699450,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
700124,1890.38916256158,221.23645320197,53.5862068965517,603.881773399015,308.748768472906,2306.97044334975,380.172413793103,252.901477832512,1088.2118226601,4451.66502463054,508.369458128079,105.802955665025,1069.07389162562,968.812807881773,520.911330049261,279.024630541872,1877.23645320197,1381.89655172414,303.822660098522,239.448275862069,1045.39408866995,1148.61083743842,220.689655172414,148.56157635468,758.71921182266,1898.27093596059,474.724137931034,664.581280788177,1016.26600985222,130.374384236453,203,18.4774444018903,14.4365319440899,0.624148589180796,0.939814814814815,0.704861111111111,-0.486631199269835,51327.0591133005,35314.1280788177,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_700124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
700498,1191.94444444444,116.1,156.044444444444,669.0,3933.44444444444,1400.4,323.077777777778,257.844444444444,1091.88888888889,2091.53333333333,474.355555555556,108.222222222222,1055.92222222222,2220.6,863.844444444444,340.866666666667,1596.26666666667,6376.4,442.6,254.866666666667,1029.78888888889,7291.8,278.188888888889,499.733333333333,626.777777777778,1122.61111111111,477.688888888889,220.811111111111,1033.91111111111,130.8,90,13.6990860173805,8.44720599973689,0.787256611035209,0.9375,0.625,0.771801447943115,51098.4,34984.3888888889,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_700498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
701091,1135.39766081871,159.883040935673,73.953216374269,613.573099415205,766.040935672515,1144.97076023392,334.608187134503,255.315789473684,1081.30409356725,2919.14619883041,444.140350877193,103.678362573099,1067.56725146199,754.33918128655,435.415204678363,270.40350877193,1549.33333333333,834.818713450292,198.824561403509,216.362573099415,1093.90058479532,706.549707602339,163.304093567251,153.561403508772,593.584795321637,2112.37426900585,512.280701754386,220.497076023392,1016.63742690058,129.877192982456,171,16.7398527257487,13.0224883654402,0.628346900903542,0.977142857142857,0.76,0.705923244130006,51619.1695906433,35291.8011695906,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701091,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
701234,543.369863013699,650.717808219178,184.4,612.282191780822,101.035616438356,610.12602739726,400.087671232877,267.268493150685,1116.60821917808,1334.14520547945,732.4,109.641095890411,1061.35890410959,2024.68767123288,615.542465753425,303.493150684931,1754.02191780822,2256.93150684932,316.408219178082,234.827397260274,1133.38630136986,1727.72328767123,212.980821917808,154.241095890411,2998.24657534247,593.284931506849,369.276712328767,198.676712328767,988.676712328767,130.021917808219,365,29.5045398112409,15.853381711376,0.843378403158133,0.960526315789474,0.64373897707231,0.550206250188774,50353.5205479452,34911.5232876712,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_701234,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
701410,3224.10576923077,547.442307692308,168.168269230769,633.216346153846,1689.14423076923,3875.42307692308,439.932692307692,274.908653846154,1103.84134615385,5232.73076923077,700.480769230769,134.471153846154,1080.625,591.451923076923,441.548076923077,271.192307692308,1413.65865384615,925.995192307692,295.855769230769,230.971153846154,982.451923076923,874.057692307692,209.096153846154,131.341346153846,587.394230769231,2272.58653846154,570.538461538462,233.552884615385,1070.70192307692,131.509615384615,208,27.4197664562509,9.7796341834837,0.934232859431959,0.912280701754386,0.472727272727273,-0.843705485243427,50859.2692307692,33998.7740384615,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701410,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
701503,2605.04347826087,310.253623188406,181.13768115942,660.739130434783,3499.84782608696,2575.46376811594,331.467391304348,256.992753623188,1086.95652173913,4438.84420289855,541.355072463768,123.329710144928,1087.01449275362,2759.61594202899,1506.23913043478,364.630434782609,1643.22826086957,4290.22101449275,439.11231884058,253.547101449275,1009.04710144928,3043.28985507246,247.514492753623,166.170289855072,586.735507246377,948.492753623188,534.264492753623,230.938405797101,1033.76086956522,129.61231884058,276,27.6124096549835,13.3290049695412,0.875775889823943,0.884615384615385,0.581052631578947,-0.552111996204139,51724.847826087,33972.5797101449,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701503,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
703012,1373.375,333.586538461538,117.875,631.384615384615,1972.88461538462,2177.45192307692,2728.89423076923,273.163461538462,1082.28846153846,2431.80769230769,1168.875,110.509615384615,1068.48076923077,787.375,434.826923076923,269.221153846154,1815.125,1128.80769230769,256.884615384615,224.682692307692,1038.96153846154,932.096153846154,188.740384615385,148.182692307692,615.307692307692,1222.93269230769,468.548076923077,520.576923076923,1047.77884615385,132.355769230769,104,14.1846139021951,9.43935708475227,0.746429495070282,0.904347826086956,0.693333333333333,-1.4794614989641,50131.2980769231,35438.5865384615,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_703012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
703105,875.293103448276,923.810344827586,75.1120689655172,619.379310344828,761.879310344828,867.224137931035,347.01724137931,259.146551724138,1168.33620689655,2229.60344827586,495.922413793103,105.853448275862,1073.66379310345,3750.75862068966,1079.06034482759,1229.12931034483,1701.01724137931,1955.05172413793,356.775862068966,241.086206896552,1016.77586206897,1358.26724137931,239.275862068966,193.387931034483,659.258620689655,1497.37931034483,495.112068965517,241.698275862069,1026.46551724138,132.043103448276,116,12.275316509333,12.0025395878392,0.209641027405695,0.966666666666667,0.805555555555556,-0.0114922287207259,50709.5689655172,35294.5689655172,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_703105,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
706212,1015.96617336152,189.934460887949,75.8583509513742,600.293868921776,130.672304439746,749.120507399577,414.824524312896,250.00422832981,1072.92811839323,1243.87526427061,537.906976744186,98.0105708245243,1064.82241014799,704.179704016913,533.071881606765,306.080338266385,1439.56025369979,1063.90063424947,350.395348837209,248.725158562368,983.183932346723,969.00422832981,241.097251585624,138.298097251586,587.403805496829,752.186046511628,440.302325581395,211.08245243129,1002.24312896406,129.488372093023,473,30.0211964618208,20.1867851370683,0.740171858584464,0.963340122199593,0.729938271604938,-0.849532308579761,50646.5517970402,35098.0824524313,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_706212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707266,1870.71808510638,186.808510638298,88.5,628.042553191489,694.510638297872,1979.44680851064,304.324468085106,249.590425531915,1095.8670212766,3895.60638297872,730.085106382979,113.877659574468,1079.51595744681,673.63829787234,481.93085106383,268.952127659574,1368.6914893617,1071.39361702128,308.25,232.872340425532,981.659574468085,1071.11170212766,233.164893617021,119.877659574468,585.734042553191,1409.47872340426,470.117021276596,214.622340425532,1032.73936170213,130.654255319149,188,21.9648039219831,10.9766240275761,0.866177224925336,0.94,0.671428571428571,-1.07597029974249,50222.7659574468,34570.6489361702,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_707266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707354,975.078125,98.6640625,89.40625,629.0390625,1327.671875,746.4375,322.7578125,256.40625,1101.0546875,1676.2265625,658.1640625,109.0546875,1068.7578125,1934.3046875,1282.4140625,648.3125,1881.0390625,3886.0234375,422.015625,242.5078125,1043.546875,3685.453125,271.0,258.0078125,611.359375,902.484375,393.34375,204.328125,1058.9296875,129.9296875,128,19.179089655948,8.51230843949564,0.896109633093324,0.920863309352518,0.646464646464647,-0.348672929353783,50760.3125,35724.34375,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_707354,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707409,2988.54166666667,346.205555555556,199.872222222222,691.419444444444,4662.60555555556,3624.10555555556,370.394444444445,275.963888888889,1099.81944444444,5434.57777777778,556.625,123.877777777778,1101.01666666667,708.408333333333,549.141666666667,284.605555555556,1394.04444444444,1105.15555555556,361.894444444445,247.908333333333,978.338888888889,1089.48611111111,249.191666666667,139.527777777778,584.897222222222,1590.64166666667,505.269444444445,221.458333333333,1058.59444444444,130.013888888889,360,35.3868131389558,13.0960553505689,0.928998723268984,0.947368421052632,0.493827160493827,-0.792611769700242,50795.7666666667,34878.3472222222,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_707409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707573,1428.18061674009,251.096916299559,100.911894273128,657.334801762115,2622.95154185022,1590.96035242291,438.748898678414,263.299559471366,1096.2731277533,2433.19823788546,546.022026431718,113.68281938326,1070.73568281938,2631.43612334802,655.26872246696,369.607929515419,4458.02643171806,1639.91189427313,285.136563876652,229.312775330396,1015.03083700441,1361.91189427313,221.321585903084,194.541850220264,601.660792951542,1048.3127753304,432.885462555066,316.149779735683,1044.04405286344,129.678414096916,227,20.397466748799,14.2783430497991,0.714137252804998,0.953781512605042,0.687878787878788,-0.123395792501075,50617.3039647577,35539.3436123348,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_707573,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707728,1091.65189873418,499.651898734177,97.1772151898734,628.778481012658,1509.57594936709,1483.26582278481,3235.06329113924,261.930379746835,1109.66455696203,2128.90506329114,2946.62658227848,109.398734177215,1069.06329113924,763.689873417722,1095.4746835443,289.677215189873,1586.95569620253,1196.01898734177,315.189873417722,241.835443037975,1002.98101265823,1053.50632911392,213.424050632911,166.835443037975,659.835443037975,1167.48101265823,522.955696202532,706.107594936709,1028.43670886076,131.373417721519,158,15.7822605770216,13.0542437943428,0.561986154061199,0.897727272727273,0.658333333333333,1.05368667863666,51323.6898734177,35057.9556962025,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_707728,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
707742,1613.51147540984,625.032786885246,160.777049180328,633.036065573771,1076.45245901639,1939.76721311475,467.144262295082,253.288524590164,1090.22295081967,2927.2393442623,472.298360655738,108.668852459016,1070.32786885246,1040.92786885246,563.563934426229,326.091803278689,1548.52459016393,1435.88524590164,271.629508196721,225.960655737705,1003.05573770492,1534.99344262295,250.445901639344,194.924590163934,611.731147540984,955.803278688525,450.839344262295,221.704918032787,1020.77049180328,128.616393442623,305,23.5894643819285,16.4807554350157,0.715464597693368,0.97444089456869,0.828804347826087,-1.56174516715123,51684.5606557377,35261.5213114754,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_707742,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
708811,1703.47863247863,216.303418803419,264.51282051282,738.410256410256,6957.97008547009,1556.15384615385,302.982905982906,257.683760683761,1092.34188034188,3327.3547008547,558.713675213675,134.188034188034,1072.49145299145,2090.0811965812,731.619658119658,330.128205128205,1890.55128205128,4345.30769230769,390.410256410256,274.166666666667,1061.40170940171,4642.88888888889,269.15811965812,249.564102564103,699.277777777778,1463.20512820513,432.692307692308,246.777777777778,1082.4188034188,130.521367521368,234,30.2716109604689,10.1376067359536,0.94225785316681,0.936,0.492631578947368,0.56483700226768,50614.1068376068,35630.9230769231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_708811,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
708926,1113.90588235294,366.229411764706,116.858823529412,624.111764705882,1203.97058823529,1214.31176470588,2199.78823529412,270.435294117647,1086.91764705882,1757.57647058824,1266.98235294118,109.329411764706,1065.15882352941,4768.87058823529,1084.07647058824,1104.75882352941,1827.68823529412,5438.67647058824,487.811764705882,250.7,1582.51764705882,4478.32941176471,309.135294117647,1293.61764705882,792.635294117647,993.011764705882,462.705882352941,384.311764705882,1024.12941176471,130.835294117647,170,15.1495388863465,14.3291455679516,0.324612838519364,0.96045197740113,0.80952380952381,0.559195033145046,50239.6647058824,35259.6588235294,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_708926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
708966,1954.75935828877,573.133689839572,94.2459893048128,670.251336898396,2461.37967914439,2713.71657754011,1297.40106951872,262.149732620321,1092.88770053476,3308.31016042781,595.24064171123,112.893048128342,1071.35294117647,651.914438502674,415.288770053476,276.51871657754,1565.5614973262,1007.18181818182,288.181818181818,230.144385026738,999.181818181818,958.818181818182,214.219251336898,138.139037433155,579.064171122995,1367.54010695187,534.609625668449,854.914438502674,1043.93582887701,131.144385026738,187,16.8627650976034,14.330546399531,0.527050896622357,0.954081632653061,0.785714285714286,0.100067826254138,52017.1176470588,34526.7379679144,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_708966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
709506,457.057142857143,970.046428571429,239.407142857143,608.021428571429,209.225,573.014285714286,407.782142857143,273.996428571429,1107.49285714286,1051.85714285714,523.814285714286,100.6,1062.575,2290.57142857143,1083.575,833.528571428571,2495.43928571429,3718.45714285714,368.775,239.596428571429,1027.73928571429,3480.04642857143,264.492857142857,550.075,726.371428571429,577.75,329.417857142857,195.935714285714,984.735714285714,130.289285714286,280,19.674928839822,18.2166673973673,0.377812199067598,0.952380952380952,0.775623268698061,1.28798097941086,50671.9964285714,35435.125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_709506,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
710352,1010.66666666667,407.105263157895,91.8333333333333,612.035087719298,527.026315789474,1071.4649122807,753.877192982456,265.333333333333,1107.11403508772,2349.65789473684,757.061403508772,119.280701754386,1072.62280701754,735.263157894737,498.236842105263,333.517543859649,1420.10526315789,1130.27192982456,314.754385964912,237.350877192982,992.868421052632,1046.09649122807,227.649122807018,186.622807017544,613.763157894737,773.447368421053,406.035087719298,207.298245614035,1027.4649122807,132.473684210526,114,14.5695745100295,10.0106229040279,0.726571411346173,0.957983193277311,0.74025974025974,0.43284391345317,50257.5087719298,34824.9824561404,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_710352,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
711089,939.630136986301,121.58904109589,81.3150684931507,643.849315068493,1763.79452054795,1057.38356164384,327.808219178082,261.095890410959,1094.60273972603,1728.91780821918,546.369863013699,121.972602739726,1057.32876712329,2484.09589041096,707.164383561644,415.479452054795,1779.60273972603,2589.90410958904,388.068493150685,233.424657534247,1039.98630136986,1513.87671232877,224.232876712329,173.095890410959,603.72602739726,1165.93150684932,474.082191780822,217.424657534247,1080.56164383562,133.109589041096,73,10.3332366042538,8.99915422313754,0.49147081557922,0.960526315789474,0.811111111111111,0.625038274030142,50116.0547945205,35208.0410958904,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_711089,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
711300,1489.72275641026,170.782051282051,65.8509615384615,627.043269230769,1333.41987179487,2098.43429487179,1080.71794871795,272.636217948718,1100.21955128205,2809.76923076923,715.153846153846,117.815705128205,1077.10416666667,473.597756410256,355.665064102564,251.907051282051,1574.35737179487,788.934294871795,221.423076923077,219.532051282051,999.927884615385,758.294871794872,176.049679487179,164.125,581.748397435897,578.873397435897,375.044871794872,201.709935897436,984.8125,128.019230769231,624,31.2044121573773,27.7407506991969,0.457905435637545,0.851296043656207,0.696428571428571,-1.15213185450528,51712.2628205128,34624.4054487179,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_711300,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
711750,2129.91707317073,363.092682926829,114.2,662.234146341463,2181.60975609756,2003.16097560976,1456.49268292683,264.10243902439,1118.47317073171,4144.46341463415,549.946341463415,112.473170731707,1086.99512195122,1095.65365853659,493.317073170732,292.707317073171,1601.3512195122,1109.06829268293,230.019512195122,215.107317073171,1401.64390243902,801.492682926829,184.512195121951,220.19512195122,593.292682926829,1691.8,466.009756097561,1936.58536585366,1070.26829268293,129.507317073171,205,22.233395981028,11.798432260482,0.847583139916867,0.953488372093023,0.683333333333333,0.556678393249094,51563.7365853659,35685.7609756098,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_711750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
712573,2129.34806629834,275.911602209945,124.46408839779,711.966850828729,2814.67955801105,3112.77348066298,1758.44198895028,269.729281767956,1143.75138121547,5095.54696132597,3966.93922651934,116.767955801105,1076.44198895028,900.24861878453,806.309392265193,302.259668508287,1645.99447513812,1351.77900552486,419.281767955801,255.806629834254,983.469613259669,1123.44198895028,282.055248618785,155.530386740331,587.773480662983,2874.77900552486,554.198895027624,900.453038674033,1090.4861878453,130.243093922652,181,18.7762762398062,12.5662676418202,0.743025563885622,0.937823834196891,0.773504273504274,-0.0672409643780941,50714.7458563536,35170.8563535912,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_712573,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
712858,2907.60305343511,268.354961832061,87.2442748091603,634.862595419847,1088.31679389313,3401.30916030534,1865.71374045802,266.267175572519,1099.98473282443,5337.20610687023,2224.3358778626,114.236641221374,1087.45419847328,737.267175572519,516.706106870229,308.43893129771,1463.06106870229,1006.04961832061,265.801526717557,229.053435114504,986.69465648855,930.339694656488,188.225190839695,139.996183206107,593.270992366412,1514.56488549618,489.053435114504,722.164122137405,1052.52671755725,130.335877862595,262,18.7566983417875,18.2392029319802,0.233277935434199,0.963235294117647,0.725761772853186,0.266501536295492,51344.465648855,35047.1832061069,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_712858,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
713424,1523.02906976744,484.813953488372,77.4244186046512,613.877906976744,580.31976744186,1598.98837209302,386.941860465116,248.81976744186,1105.40697674419,3483.93023255814,537.151162790698,110.279069767442,1070.45930232558,944.238372093023,591.779069767442,322.622093023256,1687.86627906977,1278.38953488372,315.540697674419,234.052325581395,1024.83720930233,1208.75581395349,230.174418604651,635.441860465116,708.279069767442,1895.28488372093,519.226744186047,235.151162790698,1046.56976744186,133.401162790698,172,15.0644762762048,14.7611562216011,0.199660133007356,0.960893854748603,0.764444444444444,-0.819710211721454,52052.4360465116,34457.9534883721,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_713424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
713516,3728.05660377358,916.792452830189,766.172955974843,634.047169811321,1583.37106918239,4056.70440251572,467.028301886792,272.094339622641,1102.84591194969,6829.64465408805,547.389937106918,117.059748427673,1078.72641509434,3885.11949685535,824.072327044025,499.01572327044,3882.79874213837,2725.35220125786,338.632075471698,241.062893081761,1032.46855345912,1808.79559748428,322.267295597484,586.729559748428,671.116352201258,2061.60691823899,510.704402515723,241.952830188679,1042.97798742138,129.440251572327,318,24.0241670030634,17.4673177634367,0.686560398107768,0.927113702623907,0.757142857142857,-1.00110935680451,50880.1855345912,35380.3018867925,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_713516,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
713656,464.188405797101,837.478260869565,214.021739130435,609.398550724638,198.572463768116,531.333333333333,350.952898550725,252.623188405797,1104.27898550725,1237.58695652174,1327.44202898551,114.329710144928,1063.63043478261,1075.73913043478,570.213768115942,293.677536231884,1627.38768115942,1088.06884057971,238.652173913043,226.014492753623,1171.29710144928,641.253623188406,140.289855072464,120.18115942029,585.807971014493,686.0,406.764492753623,207.670289855072,1016.95289855072,132.003623188406,276,21.0833943007668,16.6900981976764,0.611009942384494,0.968421052631579,0.811764705882353,0.332535877411478,51168.8550724638,33993.7572463768,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_713656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
713840,3802.95431472081,371.284263959391,107.431472081218,628.918781725888,1593.06091370558,3652.47208121827,3484.51776649746,270.507614213198,1085.69035532995,7463.28934010152,749.263959390863,125.807106598985,1077.97461928934,782.416243654822,508.111675126904,277.791878172589,1549.55329949239,1356.47715736041,321.700507614213,232.121827411168,996.802030456853,1628.10152284264,236.568527918782,192.746192893401,585.350253807107,2839.98984771574,551.710659898477,503.685279187817,1078.05076142132,132.380710659898,197,20.0514690907044,12.6681782208092,0.775145265525537,0.938095238095238,0.681660899653979,0.671323991483608,51964.5482233503,35172.0862944162,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_713840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
714297,1952.0,816.452702702703,153.141891891892,635.810810810811,1962.71621621622,1999.39864864865,1036.79054054054,269.432432432432,1096.00675675676,3396.91891891892,2217.69594594595,120.486486486486,1074.39189189189,617.587837837838,440.567567567568,268.851351351351,1412.37837837838,950.493243243243,291.952702702703,231.283783783784,996.702702702703,914.689189189189,208.310810810811,133.047297297297,579.121621621622,1418.49324324324,567.756756756757,714.547297297297,1077.94594594595,133.351351351351,148,17.4759703119859,10.8953901566462,0.781863382998926,0.954838709677419,0.657777777777778,-0.684131066135862,51157.9121621622,34957.2432432432,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_714297,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
714393,764.345323741007,177.071942446043,56.3812949640288,606.992805755396,677.158273381295,998.604316546763,359.381294964029,262.798561151079,1084.69784172662,2080.30935251799,545.78417266187,116.05035971223,1064.34532374101,773.410071942446,632.294964028777,315.064748201439,1619.19424460432,1044.61151079137,300.129496402878,230.820143884892,999.748201438849,955.661870503597,192.525179856115,153.964028776978,587.230215827338,1803.76978417266,548.712230215827,239.230215827338,1016.25899280576,131.309352517986,139,14.1297416479429,12.5779636819424,0.45561588498201,0.932885906040268,0.709183673469388,-0.523683781128435,50673.5467625899,34473.0647482014,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_714393,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
714942,529.08431372549,591.827450980392,153.190196078431,615.192156862745,97.7372549019608,659.866666666667,417.172549019608,264.911764705882,1124.07058823529,1401.51960784314,1522.45882352941,126.947058823529,1062.83921568627,949.643137254902,535.174509803922,293.617647058824,1570.14509803922,907.886274509804,202.819607843137,217.966666666667,1152.88823529412,653.345098039216,141.982352941176,127.617647058824,584.490196078431,568.050980392157,372.892156862745,200.325490196078,978.55294117647,129.905882352941,510,35.3325435846316,18.5386950222728,0.851292276978827,0.955056179775281,0.75,-0.153641493457924,51208.9039215686,33834.668627451,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_714942,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
715794,1640.30864197531,150.074074074074,74.6728395061728,648.222222222222,2093.97530864198,1595.33950617284,2211.3024691358,254.641975308642,1103.41975308642,2626.32098765432,501.654320987654,106.444444444444,1074.16049382716,4960.5,691.012345679012,502.086419753086,2884.26543209877,2423.53086419753,316.567901234568,231.858024691358,1019.12345679012,2647.13580246914,236.592592592592,212.382716049383,603.993827160494,907.043209876543,404.327160493827,1439.26543209877,1022.1049382716,130.87037037037,162,17.2101525956761,12.1848390704948,0.706209459840577,0.947368421052632,0.723214285714286,1.02077872186958,51031.8703703704,35657.975308642,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_715794,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
716191,3076.37988826816,272.659217877095,116.284916201117,619.709497206704,1150.69273743017,3089.65363128492,950.960893854749,270.469273743017,1095.08379888268,5534.68156424581,2138.22905027933,115.40782122905,1086.90502793296,1007.45251396648,494.893854748603,277.659217877095,1904.51955307263,1423.48603351955,308.877094972067,236.614525139665,1056.43016759777,1194.1843575419,219.787709497207,153.653631284916,652.631284916201,2790.59776536313,532.396648044693,493.31843575419,1069.82681564246,129.782122905028,179,19.2200165639342,11.9745121350854,0.782203526794845,0.967567567567568,0.658088235294118,0.767642208547125,51346.5810055866,35310.2067039106,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_716191,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
716872,3070.42942942943,503.381381381381,141.681681681682,639.162162162162,1711.70570570571,3693.64264264264,4759.78978978979,276.942942942943,1102.41141141141,4361.32732732733,2291.22822822823,119.456456456456,1076.02102102102,1548.76876876877,498.702702702703,350.528528528529,1531.53153153153,2035.98198198198,324.51951951952,237.339339339339,982.144144144144,1743.62762762763,230.93993993994,139.501501501502,582.636636636637,1268.60960960961,529.846846846847,312.837837837838,1047.28828828829,131.783783783784,333,24.0703171537076,17.9420120039317,0.666617573122493,0.965217391304348,0.762013729977117,-1.24297021128716,51847.5855855856,34294.0690690691,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_716872,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
717544,2640.46153846154,395.230769230769,196.733974358974,701.602564102564,5940.07692307692,2657.13141025641,409.323717948718,270.147435897436,1113.30448717949,3411.52564102564,889.173076923077,155.471153846154,1066.375,671.903846153846,400.102564102564,264.63782051282,1465.33974358974,800.304487179487,200.057692307692,215.477564102564,1043.62820512821,629.326923076923,140.916666666667,123.400641025641,583.967948717949,980.544871794872,498.833333333333,223.49358974359,1061.00641025641,131.596153846154,312,22.7328015539879,17.5297758269137,0.636686750325716,0.954128440366972,0.787878787878788,0.139597200787873,51304.0737179487,33994.875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_717544,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
717713,2219.55014326648,249.67335243553,67.8853868194842,636.641833810888,1368.66189111748,2209.93123209169,2609.95988538682,265.484240687679,1093.00286532951,3789.6446991404,893.048710601719,133.504297994269,1074.56446991404,746.616045845272,459.068767908309,314.194842406877,2434.26934097421,1498.27507163324,308.489971346705,228.638968481375,1017.5558739255,1584.99140401146,230.799426934097,208.117478510029,589.0888252149,1173.9340974212,441.289398280802,722.461318051576,1054.82521489971,129.799426934097,349,22.997676024937,19.507803722951,0.529594269912102,0.961432506887052,0.755411255411255,0.913447787752559,50966.547277937,35895.0573065903,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_717713,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
718666,2150.936,241.624,102.224,637.424,1968.408,1869.624,351.36,258.296,1088.576,4659.112,903.48,119.64,1069.96,1040.336,559.16,298.432,1769.76,2051.728,335.864,237.992,992.208,2194.024,277.232,370.144,624.12,1311.744,473.736,240.472,1047.016,130.816,125,23.422234998151,6.99876986986919,0.954313000360096,0.892857142857143,0.568181818181818,-1.23378275406937,52077.528,34550.168,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_718666,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
718849,561.59793814433,659.253313696613,157.506627393225,608.564064801178,89.5213549337261,538.914580265096,391.705449189985,257.80559646539,1115.10309278351,1324.49042709867,1050.07805596465,123.9911634757,1065.48453608247,949.79086892489,531.094256259205,285.413843888071,1565.66863033873,815.901325478645,201.463917525773,215.724594992636,1057.53608247423,640.325478645066,138.583210603829,126.864506627393,583.888070692194,564.748159057437,376.231222385862,200.812960235641,983.503681885125,128.877761413844,679,41.2665980424207,21.1104980234318,0.85924529134609,0.959039548022599,0.632805219012116,-1.03178545819014,51177.2606774669,33836.8070692194,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_718849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
718991,1458.57534246575,345.760273972603,175.58904109589,680.383561643836,3848.13698630137,1514.03424657534,363.856164383562,265.815068493151,1089.49315068493,2185.41095890411,514.369863013699,112.143835616438,1080.20547945205,1592.0,1009.20547945205,1865.57534246575,1653.59589041096,1189.54109589041,282.753424657534,230.232876712329,999.027397260274,1013.56849315068,194.534246575342,192.246575342466,638.260273972603,1012.7602739726,493.616438356164,218.965753424658,1011.35616438356,130.184931506849,146,16.2064463562538,11.515326242055,0.703656945601503,0.960526315789474,0.760416666666667,1.38139737106246,51453.7602739726,34954.5547945205,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_718991,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
719206,2908.04473684211,292.292105263158,104.171052631579,656.281578947368,1980.75789473684,3532.80526315789,3563.48421052632,262.910526315789,1109.32368421053,5318.19473684211,1351.28684210526,121.915789473684,1075.56315789474,676.807894736842,697.842105263158,375.481578947368,1553.21315789474,1213.97631578947,280.907894736842,228.755263157895,1017.09473684211,1096.54210526316,201.976315789474,396.426315789474,644.342105263158,1494.02894736842,481.007894736842,423.681578947368,1065.70526315789,129.223684210526,380,30.0579302472423,16.1409288058191,0.84358604904643,0.952380952380952,0.664335664335664,-0.934736214226762,50526.25,34276.4105263158,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_719206,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
719728,2169.26595744681,208.202127659574,73.531914893617,619.244680851064,530.797872340426,2143.79787234043,1739.40425531915,262.234042553192,1094.45744680851,3216.95744680851,1093.55319148936,115.957446808511,1075.67021276596,1094.20212765957,708.63829787234,313.202127659574,1878.51063829787,2880.8085106383,350.297872340426,238.712765957447,1075.65957446809,3575.81914893617,247.978723404255,1796.37234042553,817.287234042553,1260.53191489362,500.86170212766,314.851063829787,1045.79787234043,130.489361702128,94,12.0749287743883,9.93093337921712,0.568848399535948,0.979166666666667,0.854545454545454,0.438859495446822,51906.4787234043,34148.8085106383,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_719728,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
719799,906.26213592233,163.650485436893,50.2815533980583,638.669902912621,1263.46601941748,1121.65048543689,2770.87378640777,257.330097087379,1112.46601941748,2184.92233009709,1347.67961165049,108.194174757282,1057.61165048544,1565.33009708738,839.980582524272,810.52427184466,2113.58252427184,4646.21359223301,414.864077669903,252.815533980583,1095.1359223301,4669.57281553398,4858.72815533981,2016.07766990291,589.592233009709,1201.6213592233,425.980582524272,720.873786407767,1046.91262135922,131.058252427184,103,12.7868497289524,10.2567616093414,0.597144632724861,0.936363636363636,0.72027972027972,1.35079655758175,51187.3980582524,35588.6601941748,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67+,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_719799,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
720132,3395.95477386935,501.165829145729,107.206030150754,639.663316582915,2089.02010050251,3287.54773869347,4423.53266331658,277.698492462312,1116.391959799,5402.02010050251,1603.0,124.537688442211,1078.97989949749,867.326633165829,564.527638190955,524.407035175879,1457.49246231156,1416.97989949749,338.964824120603,255.974874371859,1001.93969849246,898.371859296482,221.221105527638,137.507537688442,584.768844221105,2401.5527638191,624.939698492462,379.587939698493,1095.70854271357,132.909547738693,199,17.6060658613127,15.8049533913455,0.440608586861354,0.921296296296296,0.650326797385621,1.19719172857478,50702.527638191,35126.5778894472,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_720132,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
720281,966.187969924812,889.721804511278,186.714285714286,607.834586466165,360.827067669173,919.360902255639,525.992481203008,276.962406015038,1100.18045112782,1840.4962406015,552.917293233083,111.368421052632,1070.41353383459,1126.45112781955,554.481203007519,354.428571428571,1563.12030075188,1681.15037593985,308.135338345865,234.075187969925,1021.64661654135,1647.06015037594,229.12030075188,1618.33082706767,1534.58646616541,790.218045112782,386.210526315789,210.864661654135,1031.7969924812,130.353383458647,133,13.1954871222251,12.85827666533,0.224626156084605,0.943262411347518,0.78698224852071,-0.188628141702825,51646.8045112782,35628.7518796993,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_720281,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
720487,1550.22171945701,187.339366515837,166.126696832579,710.918552036199,6923.27149321267,2121.10407239819,350.230769230769,260.31221719457,1092.50678733032,2723.21266968326,640.384615384615,148.529411764706,1068.09954751131,663.606334841629,406.37556561086,268.058823529412,1477.15384615385,785.782805429864,193.904977375566,215.321266968326,1024.61538461538,637.574660633484,142.782805429864,124.619909502262,586.018099547511,1153.60633484163,553.864253393665,227.986425339366,1039.67873303167,130.20814479638,221,20.5403529733935,13.756266475976,0.742614531343021,0.965065502183406,0.726973684210526,0.543247791516729,51303.556561086,34022.07239819,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_720487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
721370,2421.0289532294,238.777282850779,145.973273942094,667.47438752784,2734.69487750557,3014.77505567929,328.3429844098,266.6570155902,1102.98886414254,4522.99109131403,539.634743875278,119.541202672606,1085.19376391982,822.391982182628,707.153674832962,278.316258351893,1722.14031180401,1280.46547884187,387.476614699332,247.300668151448,995.494432071269,1210.06236080178,250.334075723831,163.069042316258,585.360801781737,2486.29621380846,550.628062360802,230.93986636971,1066.94654788419,129.080178173719,449,33.5946297076563,17.481929745251,0.853935599589072,0.941299790356394,0.695046439628483,-0.0469898767648781,50910.8017817372,34718.0378619154,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_721370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
721973,1381.7972972973,282.195945945946,120.932432432432,668.743243243243,3195.97297297297,1383.35810810811,1413.94594594595,265.263513513513,1099.4527027027,3140.33108108108,713.27027027027,113.22972972973,1071.89864864865,1689.88513513514,523.067567567568,278.804054054054,1501.17567567568,2353.72297297297,304.006756756757,235.614864864865,991.452702702703,2023.03378378378,215.337837837838,182.331081081081,587.932432432432,1310.76351351351,481.790540540541,263.02027027027,1047.58108108108,131.445945945946,148,18.9722004348279,10.1659758152621,0.844322491075074,0.91358024691358,0.708133971291866,-0.13809835773863,51629.5202702703,35378.7094594595,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_721973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
722682,1776.05602240896,255.733893557423,105.100840336134,620.985994397759,715.616246498599,1823.32773109244,427.605042016807,258.145658263305,1091.73949579832,2937.77871148459,658.669467787115,120.392156862745,1074.918767507,576.078431372549,421.274509803922,266.865546218487,1386.12324929972,835.574229691877,263.705882352941,221.960784313725,1001.57703081232,763.739495798319,185.316526610644,122.521008403361,586.711484593838,1233.76470588235,507.36974789916,219.644257703081,1034.3025210084,130.770308123249,357,30.0624667966907,15.3032044385568,0.860738805060125,0.946949602122016,0.624125874125874,0.682380257567471,50405.218487395,33872.8739495798,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_722682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
722764,1432.77586206897,152.077586206897,75.2155172413793,627.801724137931,1226.56896551724,1924.86206896552,361.094827586207,273.370689655172,1084.12931034483,3376.19827586207,550.51724137931,115.98275862069,1072.77586206897,2891.56896551724,1132.85344827586,350.681034482759,2169.74137931034,1544.60344827586,278.405172413793,221.146551724138,1024.16379310345,895.586206896552,205.396551724138,158.0,598.112068965517,2113.94827586207,510.172413793103,223.793103448276,1070.12931034483,132.301724137931,116,14.7606640098904,10.4243080681915,0.707990293805625,0.878787878787879,0.703030303030303,-1.56223814792196,50117.6724137931,35197.1637931034,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_722764,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
722929,421.236940298507,644.464552238806,148.333955223881,603.35447761194,103.164179104478,312.710820895522,242.955223880597,234.035447761194,1087.7052238806,848.723880597015,434.227611940299,100.238805970149,1065.10447761194,955.908582089552,517.656716417911,286.727611940299,1605.9552238806,1260.87126865672,240.268656716418,219.014925373134,1030.80410447761,933.475746268657,1035.56343283582,143.19776119403,937.766791044776,571.014925373134,376.942164179104,201.10447761194,983.061567164179,129.494402985075,536,26.7057268215869,25.644912331896,0.279046329027393,0.960573476702509,0.763532763532764,1.11587862916676,51457.1679104478,34101.796641791,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_722929,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
723260,2005.07246376812,104.135265700483,57.7487922705314,627.193236714976,862.492753623188,2423.49275362319,1227.14492753623,256.159420289855,1155.00966183575,3743.99033816425,487.333333333333,123.995169082126,1082.23671497585,3420.07246376812,516.855072463768,487.937198067633,1576.24154589372,4670.19806763285,371.864734299517,240.429951690821,993.599033816425,4181.8309178744,265.652173913043,296.874396135266,590.096618357488,1529.10144927536,439.207729468599,856.821256038647,1055.07246376812,130.502415458937,207,20.207571950472,14.8369307413621,0.678904811864231,0.818181818181818,0.579831932773109,0.0869602855410067,51065.8502415459,35890.3768115942,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_723260,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
723987,940.881188118812,306.970297029703,140.663366336634,644.811881188119,1933.47524752475,1035.64356435644,1381.07920792079,259.752475247525,1117.48514851485,2039.53465346535,3878.82178217822,106.594059405941,1067.22772277228,1077.66336633663,889.554455445545,910.415841584158,1881.14851485149,3065.23762376238,362.237623762376,242.237623762376,1020.27722772277,3085.25742574257,276.693069306931,329.069306930693,688.475247524752,1157.73267326733,430.326732673267,518.930693069307,1042.44554455446,131.425742574257,101,11.9850093562083,10.7842272144729,0.436282675203287,0.926605504587156,0.701388888888889,-0.986390243802842,51036.0891089109,35710.7128712871,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_723987,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
725730,1774.48571428571,201.92380952381,92.8952380952381,644.019047619048,2209.13333333333,1976.2380952381,388.114285714286,277.114285714286,1084.95238095238,3044.8380952381,542.466666666667,109.92380952381,1071.59047619048,660.961904761905,590.085714285714,466.066666666667,1514.0380952381,1054.57142857143,291.0,297.47619047619,999.828571428571,925.009523809524,220.104761904762,138.066666666667,590.914285714286,1351.51428571429,496.361904761905,257.466666666667,1024.01904761905,130.27619047619,105,15.0708387016398,8.98862861686496,0.802668630840306,0.921052631578947,0.7,1.41915747568827,50914.3142857143,35244.5333333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_725730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
726466,1833.18580375783,99.4133611691023,99.446764091858,665.757828810021,2933.06680584551,2003.81837160752,626.014613778706,266.895615866388,1097.27766179541,2997.50313152401,676.812108559499,121.60751565762,1077.99164926931,1144.6012526096,670.164926931106,428.35490605428,1618.15240083507,1375.13152400835,353.670146137787,243.089770354906,998.753653444676,1094.8267223382,237.989561586639,184.455114822547,585.739039665971,577.093945720251,372.941544885178,199.949895615866,985.327766179541,129.154488517745,479,33.9917670481754,18.0874685610507,0.846673209017739,0.950396825396825,0.643817204301075,0.531761936041563,51700.1962421712,34687.4885177453,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726466,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
726712,1543.23404255319,100.202127659574,64.0053191489362,617.739361702128,1080.3085106383,1743.07978723404,492.388297872341,266.521276595745,1095.13829787234,2603.79255319149,710.968085106383,104.909574468085,1091.51595744681,669.707446808511,506.744680851064,267.159574468085,1410.01595744681,1028.03723404255,282.127659574468,239.659574468085,991.771276595745,975.351063829787,215.957446808511,144.531914893617,591.81914893617,991.526595744681,454.952127659574,238.702127659574,1022.60638297872,128.234042553192,188,18.9493959491749,12.6879201432534,0.74275023815109,0.94949494949495,0.737254901960784,-0.514828050210216,50852.1063829787,35221.0265957447,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
726754,1965.71951219512,442.646341463415,318.451219512195,724.719512195122,7551.5243902439,2148.9756097561,436.292682926829,276.487804878049,1095.81707317073,2836.01219512195,537.90243902439,123.743902439024,1072.89024390244,1877.35365853659,819.536585365854,410.560975609756,2017.32926829268,1752.30487804878,282.219512195122,227.451219512195,1000.73170731707,1240.74390243902,338.256097560976,163.768292682927,592.451219512195,1225.78048780488,528.707317073171,236.80487804878,1034.64634146341,129.353658536585,82,14.7688411683625,7.12005139394552,0.876116454958652,0.901098901098901,0.683333333333333,1.46555787993448,51522.5365853659,34989.6219512195,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726754,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
727259,1189.05494505495,133.541758241758,71.4835164835165,627.428571428571,1597.80989010989,1205.2043956044,267.396703296703,241.60989010989,1080.58571428571,1752.4010989011,382.862637362637,101.442857142857,1073.12527472527,479.320879120879,306.861538461538,249.752747252747,1540.04725274725,735.112087912088,192.243956043956,212.910989010989,994.097802197802,657.213186813187,160.379120879121,140.276923076923,581.428571428571,591.251648351648,367.405494505495,201.889010989011,988.087912087912,127.727472527473,910,42.807792818593,27.2364634300417,0.771482845864028,0.966029723991507,0.747126436781609,-1.30804175671108,52020.9505494506,34845.7461538462,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_727259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
727472,2542.55989583333,129.677083333333,101.359375,739.229166666667,8532.53645833333,2976.32291666667,1248.6875,277.731770833333,1114.72135416667,5231.984375,1183.34114583333,131.466145833333,1083.18229166667,1005.45833333333,666.8515625,532.989583333333,1615.2265625,1268.703125,347.5234375,242.625,996.1953125,1118.27604166667,250.59375,144.588541666667,583.609375,580.526041666667,371.270833333333,202.005208333333,983.369791666667,128.8671875,384,25.9302492508624,18.9497747211568,0.682593773050813,0.977099236641221,0.761904761904762,-0.999079903750624,51723.1458333333,34680.6302083333,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_727472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
727706,1881.71333333333,403.626666666667,137.953333333333,651.093333333333,2660.8,2384.04,1614.04,264.42,1100.50666666667,3301.34666666667,2637.34,111.946666666667,1059.5,697.94,602.473333333333,273.24,1419.76666666667,1064.17333333333,335.773333333333,240.233333333333,979.133333333333,1032.96666666667,242.066666666667,135.173333333333,585.22,1643.71333333333,524.706666666667,1012.98666666667,1074.95333333333,130.193333333333,150,22.8788967644292,8.39521520856644,0.930244045035887,0.943396226415094,0.520833333333333,-0.67307653299995,50238.92,34391.6733333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_727706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
728111,1583.27242524917,125.837209302326,111.671096345515,674.697674418605,3664.36212624585,1874.28239202658,332.78073089701,270.023255813953,1093.61794019934,3526.70431893688,532.202657807309,129.372093023256,1081.56146179402,763.926910299003,436.697674418605,266.269102990033,1782.52491694352,1162.65780730897,267.02657807309,227.139534883721,1028.39867109635,970.97342192691,217.272425249169,146.083056478405,609.451827242525,1445.56810631229,455.730897009967,214.770764119601,1063.38205980066,131.199335548173,301,24.1974566393984,16.1247655584502,0.745609917025261,0.934782608695652,0.720095693779904,1.07217766409374,50080.2026578073,35398.9368770764,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_728111,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
729342,1269.125,160.639705882353,55.5,607.485294117647,394.198529411765,1624.55882352941,682.147058823529,256.691176470588,1082.11029411765,2928.44117647059,1280.38235294118,105.029411764706,1067.99264705882,660.426470588235,435.169117647059,265.558823529412,1449.13970588235,998.470588235294,282.588235294118,231.904411764706,990.279411764706,1067.75,202.654411764706,198.830882352941,592.507352941176,1564.55147058824,516.904411764706,415.139705882353,1033.04411764706,127.860294117647,136,15.4398405502432,11.722486387489,0.650815136207147,0.900662251655629,0.755555555555556,1.43660444447026,51326.9117647059,35030.3161764706,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_729342,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
730090,1963.57062146893,904.350282485876,232.683615819209,676.322033898305,4051.14124293785,2059.59322033898,4279.3220338983,257.559322033898,1094.83050847458,3589.39548022599,756.265536723164,113.932203389831,1075.32768361582,1543.37853107345,575.813559322034,326.700564971751,1942.52542372881,1217.93785310734,248.768361581921,218.38418079096,1016.58192090395,1105.21468926554,196.593220338983,170.056497175141,584.881355932203,1194.1581920904,489.604519774011,271.005649717514,1042.01129943503,132.983050847458,177,17.402694621118,13.0990694752678,0.658359638051498,0.941489361702128,0.69140625,0.730543878086384,52031.1355932203,34940.5536723164,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_730090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
731000,2541.22330097087,255.967637540453,137.802588996764,656.119741100324,2910.83495145631,2830.79611650485,311.799352750809,250.071197411003,1089.81553398058,4041.82524271845,609.288025889968,126.699029126214,1070.48867313916,743.045307443366,498.744336569579,271.721682847896,1523.17799352751,1151.83495145631,298.62783171521,235.229773462783,1013.65372168285,1075.83171521036,212.10355987055,215.181229773463,738.669902912621,771.909385113269,421.330097087379,208.805825242718,1028.87055016181,130.181229773463,309,32.4444113229394,12.4924127390339,0.922899671857958,0.936363636363636,0.537391304347826,0.723311517776528,51387.8414239482,33888.6925566343,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_731000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
731214,2580.61061946903,507.613569321534,342.610619469027,798.486725663717,10517.4867256637,2607.45132743363,448.592920353982,271.466076696165,1107.47197640118,4017.91150442478,640.345132743363,138.758112094395,1110.42477876106,2654.03244837758,703.159292035398,869.486725663717,1788.55162241888,3759.53687315634,329.082595870206,234.545722713864,1001.34218289086,4181.82595870206,250.557522123894,267.241887905605,652.828908554572,1230.70796460177,495.890855457227,228.88790560472,1072.41297935103,131.324483775811,339,30.6888424885184,14.196746636807,0.88656561174281,0.952247191011236,0.730603448275862,0.26049942025765,51900.9734513274,34257.1533923304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_731214,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
731320,2552.27272727273,835.692307692308,463.055944055944,629.524475524476,1305.66433566434,3502.64335664336,890.923076923077,269.923076923077,1295.58041958042,3849.40559440559,521.503496503497,129.958041958042,1074.71328671329,820.265734265734,390.909090909091,313.881118881119,1497.69230769231,984.993006993007,262.097902097902,223.587412587413,1004.83216783217,961.783216783217,221.181818181818,190.811188811189,587.258741258741,1043.93706293706,455.594405594406,268.405594405594,1051.48951048951,131.27972027972,143,16.3922733875269,11.3774358135258,0.719904541009804,0.947019867549669,0.680952380952381,0.752990493992059,50835.7482517482,35887.0559440559,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_731320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
733298,2449.20903954802,292.186440677966,111.785310734463,614.435028248588,582.372881355932,3062.53107344633,368.005649717514,270.35593220339,1089.19774011299,3902.8813559322,649.254237288136,114.564971751412,1093.8418079096,700.960451977401,502.135593220339,275.949152542373,1374.20338983051,1073.24293785311,343.536723163842,245.779661016949,1001.69491525424,985.282485875706,242.118644067797,137.25988700565,585.751412429379,1763.99435028249,549.564971751412,224.214689265537,1039.19774011299,131.497175141243,177,22.3593634977713,10.2700865040034,0.888271247334813,0.946524064171123,0.546296296296296,-0.775349453982413,50145.9717514124,34112.9096045198,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_733298,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
733698,1757.07014028056,157.066132264529,59.4729458917836,628.330661322645,1548.82765531062,2374.64328657315,359.214428857715,250.214428857715,1093.8496993988,3192.88577154309,524.749498997996,110.190380761523,1078.6372745491,732.426853707415,667.068136272545,272.869739478958,1563.40280561122,1141.29458917836,287.745490981964,233.761523046092,985.657314629258,1068.75751503006,213.11623246493,144.991983967936,590.855711422846,1405.41482965932,478.779559118236,218.148296593186,1021.60721442886,130.270541082164,499,43.3522164788143,14.8701903540016,0.939332201747995,0.95047619047619,0.472537878787879,-0.769361601717098,51816.7314629259,34454.1142284569,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_733698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
733869,832.89156626506,229.114457831325,160.590361445783,663.55421686747,4249.47590361446,1279.62048192771,383.704819277108,254.355421686747,1082.03614457831,1532.24698795181,610.228915662651,106.433734939759,1052.36144578313,1816.63855421687,515.89156626506,318.433734939759,1809.90361445783,6866.18072289157,601.620481927711,266.265060240964,1105.29518072289,6781.96987951807,334.373493975904,209.246987951807,589.265060240964,860.439759036145,465.680722891566,238.439759036144,1019.96987951807,132.210843373494,166,20.9246851173465,10.1582726790203,0.874254234339856,0.959537572254335,0.83,0.0720784674950582,50477.1626506024,34713.8373493976,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_733869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
734751,2400.88194444444,553.059027777778,182.586805555556,640.854166666667,1213.73958333333,2680.40972222222,372.3125,267.336805555556,1099.29166666667,3540.35069444444,571.798611111111,126.125,1083.71527777778,605.395833333333,433.583333333333,277.569444444444,1415.33333333333,1007.46527777778,327.399305555556,239.340277777778,981.041666666667,964.055555555556,226.878472222222,122.309027777778,583.802083333333,1264.25694444444,510.701388888889,224.934027777778,1062.65972222222,131.708333333333,288,24.9351524714872,14.837765149063,0.803685633333412,0.95049504950495,0.685714285714286,-0.798581591691012,50504.8506944444,34026.8333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_734751,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
735426,2382.76068376068,81.1196581196581,47.2393162393162,609.923076923077,1131.95726495726,2583.47008547008,567.854700854701,266.102564102564,1083.37606837607,4747.86324786325,1155.01709401709,112.623931623932,1082.54700854701,1270.98290598291,465.871794871795,285.42735042735,1479.10256410256,1004.54700854701,279.871794871795,227.273504273504,989.410256410256,929.452991452992,196.846153846154,139.290598290598,580.333333333333,2117.37606837607,506.470085470086,298.102564102564,1056.19658119658,128.094017094017,117,17.2433964060918,8.66432740035197,0.86459336337354,0.928571428571429,0.664772727272727,-1.10671329693412,51045.5726495726,35117.8290598291,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_735426,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
735501,2377.5034965035,127.041958041958,67.8671328671329,629.300699300699,1638.87412587413,2527.3006993007,338.909090909091,268.72027972028,1089.11188811189,4283.34265734266,821.41958041958,115.923076923077,1067.72727272727,1014.43356643357,576.356643356643,271.237762237762,1708.13986013986,1437.77622377622,330.132867132867,244.713286713287,1053.57342657343,1268.32167832168,227.657342657343,153.125874125874,2957.16783216783,1585.38461538462,505.909090909091,278.608391608392,1099.2027972028,131.594405594406,143,22.6080712941082,8.26640624349642,0.930756509360944,0.89375,0.523809523809524,-1.13841795320409,51154.0699300699,35238.4685314685,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_735501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
735824,1245.27738927739,70.4055944055944,54.1888111888112,617.261072261072,1697.04428904429,1388.81118881119,279.118881118881,241.160839160839,1081.37062937063,2200.91841491841,515.778554778555,104.592074592075,1068.5337995338,4612.65268065268,1032.89044289044,399.769230769231,3334.98135198135,6794.32400932401,453.156177156177,255.104895104895,1037.22843822844,7156.55011655012,316.347319347319,260.785547785548,634.447552447552,846.706293706294,419.95337995338,221.599067599068,1022.79020979021,128.202797202797,429,31.150018837611,18.1302173741064,0.813167958546046,0.947019867549669,0.65,-0.438072431386846,51892.6386946387,34801.1258741259,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_735824,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
736329,3829.59493670886,1603.46835443038,214.405063291139,683.569620253165,4508.82278481013,4043.6329113924,1659.93670886076,275.835443037975,1179.41772151899,6166.49367088608,1364.35443037975,127.481012658228,1078.21518987342,718.177215189873,681.924050632911,1031.15189873418,1788.46835443038,1709.78481012658,315.974683544304,238.544303797468,1021.13924050633,2251.30379746835,241.493670886076,279.025316455696,708.949367088608,2870.46835443038,594.835443037975,252.886075949367,1079.6582278481,129.341772151899,79,12.704825547954,8.5407682516845,0.740327836357063,0.849462365591398,0.598484848484849,-0.760727204598355,51523.9493670886,35035.2151898734,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_736329,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
737066,1427.71590909091,203.011363636364,62.6363636363636,644.556818181818,2856.95454545455,1250.94318181818,1096.125,261.136363636364,1086.59090909091,2497.72727272727,537.943181818182,115.590909090909,1056.17045454545,667.261363636364,496.681818181818,283.261363636364,1507.85227272727,1064.26136363636,296.579545454545,227.477272727273,997.193181818182,1051.05681818182,215.068181818182,167.193181818182,1260.28409090909,1066.43181818182,469.977272727273,278.534090909091,1049.40909090909,129.181818181818,88,11.9355166376694,9.45170698371283,0.610653904137915,0.916666666666667,0.733333333333333,-1.46077421533987,51564.7613636364,35467.3863636364,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_737066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
738518,1205.42016806723,602.109243697479,276.18487394958,719.071428571429,5708.10084033613,1547.67647058824,2081.76470588235,272.819327731092,1097.59663865546,2902.75630252101,1238.65966386555,131.441176470588,1070.56302521008,1887.8487394958,1229.5,1155.58403361345,1738.84453781513,2198.25630252101,480.008403361345,298.243697478992,1031.99579831933,1254.95798319328,271.197478991597,156.357142857143,614.647058823529,1070.17647058824,493.172268907563,398.563025210084,1039.55882352941,133.151260504202,238,19.0319914019766,15.9901489642636,0.54231980734345,0.963562753036437,0.826388888888889,0.355446538165407,51601.1806722689,33889.3487394958,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_738518,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
739210,976.765765765766,162.801801801802,124.054054054054,670.540540540541,2597.43243243243,979.756756756757,367.702702702703,270.837837837838,1097.72072072072,2285.0,763.513513513514,119.081081081081,1073.26126126126,1270.52252252252,561.009009009009,510.630630630631,2585.91891891892,2060.00900900901,306.666666666667,263.342342342342,1022.44144144144,2385.89189189189,233.684684684685,221.153153153153,625.648648648649,1156.06306306306,424.567567567568,211.459459459459,1059.75675675676,128.09009009009,111,15.6215963469756,9.1640963234206,0.809855109756241,0.973684210526316,0.711538461538462,-0.914619590701353,50699.5225225225,35727.0990990991,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_739210,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
739445,1681.83333333333,540.26,42.0466666666667,626.54,1391.36,1479.64666666667,1597.62,256.373333333333,1123.58,3322.73333333333,1141.59333333333,111.04,1072.87333333333,669.906666666667,448.353333333333,645.333333333333,1541.79333333333,1132.34666666667,289.713333333333,228.846666666667,1020.79333333333,1093.86,263.886666666667,889.173333333333,641.593333333333,1657.76,442.506666666667,366.626666666667,1047.21333333333,132.826666666667,150,18.5232942536732,10.3961752044069,0.827647191397879,0.955414012738854,0.678733031674208,-1.06609067607526,51023.8466666667,35770.06,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
739531,1462.99408284024,316.396449704142,175.319526627219,663.923076923077,2279.12426035503,1941.07100591716,1476.44378698225,258.402366863905,1098.30769230769,3258.04142011834,516.526627218935,109.224852071006,1063.96449704142,3483.14792899408,718.769230769231,372.14201183432,2234.18343195266,2152.59763313609,308.976331360947,230.065088757396,1004.69822485207,1433.95857988166,216.195266272189,162.343195266272,582.266272189349,1679.72189349112,497.224852071006,534.988165680473,1054.24852071006,131.171597633136,169,17.872737698376,13.4674972497056,0.657422935759095,0.857868020304569,0.621323529411765,0.583037517567192,52078.0355029586,34982.4615384615,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739531,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
739658,1790.8361774744,237.730375426621,116.641638225256,658.040955631399,2344.37542662116,1560.99317406143,1050.98293515358,265.587030716724,1090.48464163823,3480.38566552901,1506.70307167236,110.784982935154,1068.23549488055,6136.39249146758,961.836177474403,326.82252559727,1715.8771331058,5089.07849829352,368.436860068259,242.484641638225,1009.05802047782,4927.8156996587,262.59385665529,239.440273037543,597.576791808874,1617.22184300341,502.590443686007,377.897610921502,1042.80546075085,130.474402730375,293,25.0161224412145,15.0465781626806,0.798891444332299,0.942122186495177,0.665909090909091,-0.661150564689428,51391.6996587031,35436.6279863481,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
740105,1159.38961038961,288.142857142857,73.3896103896104,629.818181818182,832.623376623377,833.051948051948,561.688311688312,259.311688311688,1097.42857142857,2707.45454545455,506.246753246753,102.961038961039,1060.49350649351,3284.81818181818,1280.77922077922,2713.31168831169,2015.75324675325,1452.8961038961,314.038961038961,225.896103896104,1019.05194805195,1172.74025974026,218.233766233766,431.636363636364,686.233766233766,1430.4025974026,458.311688311688,269.038961038961,1033.85714285714,129.896103896104,77,10.8235899876735,9.06498209890031,0.546405394237847,0.9625,0.777777777777778,-0.327537333045514,50940.038961039,35548.0909090909,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_740105,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
740217,798.727586206897,202.579310344828,83.948275862069,607.520689655172,545.455172413793,986.148275862069,384.941379310345,254.648275862069,1089.55517241379,1339.46896551724,563.051724137931,103.058620689655,1063.4275862069,678.2,485.1,282.572413793103,1397.82068965517,997.055172413793,308.920689655172,234.375862068966,986.272413793103,964.631034482759,234.265517241379,127.944827586207,595.520689655172,893.072413793103,475.358620689655,221.927586206897,1018.14827586207,130.724137931034,290,27.527761572709,13.5541592219307,0.870379518040304,0.947712418300654,0.604166666666667,-0.632319443264008,50450.5275862069,34915.1275862069,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_740217,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
740411,1462.15277777778,380.701388888889,351.090277777778,600.215277777778,213.861111111111,1878.75,490.173611111111,251.326388888889,1096.875,3612.69444444444,556.756944444444,110.395833333333,1069.57638888889,1152.70138888889,556.527777777778,269.298611111111,1877.79861111111,993.763888888889,223.694444444444,217.645833333333,1057.06944444444,834.986111111111,166.284722222222,131.333333333333,1280.5,2215.88888888889,556.777777777778,248.243055555556,1022.91666666667,129.354166666667,144,16.2795086648304,11.5731025472854,0.70329311399724,0.935064935064935,0.75,1.47908110900546,51510.0694444444,34245.8402777778,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_740411,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
741146,2196.54035087719,317.578947368421,68.7017543859649,657.080701754386,1612.4,2955.35789473684,2082.97543859649,268.740350877193,1147.97192982456,3481.37192982456,754.547368421053,128.845614035088,1072.79649122807,802.263157894737,552.049122807018,970.40701754386,1700.61754385965,1209.90175438596,290.782456140351,236.231578947368,1000.49824561404,1378.44912280702,238.845614035088,253.722807017544,597.989473684211,1169.83157894737,452.315789473684,804.680701754386,1066.05263157895,131.8,285,23.6452894386227,15.4569419873447,0.756753202682181,0.95959595959596,0.7421875,0.145435821381145,51128.0421052632,35843.5157894737,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_741146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
742177,1262.18378378378,219.691891891892,134.367567567568,633.4,2641.73513513514,1482.66486486486,336.345945945946,247.816216216216,1085.62162162162,3086.2972972973,498.313513513513,108.718918918919,1072.17837837838,811.87027027027,464.12972972973,263.605405405405,1499.67027027027,1079.85405405405,302.691891891892,233.340540540541,983.589189189189,1003.01621621622,215.8,129.443243243243,586.443243243243,1902.8,508.205405405405,224.686486486486,1052.59459459459,130.254054054054,185,19.1169936805443,12.3623387327728,0.76277200357259,0.939086294416244,0.685185185185185,-1.0406259037174,51528.7243243243,34419.6162162162,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_742177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
742186,893.984962406015,175.90977443609,128.503759398496,650.383458646617,2608.31578947368,854.210526315789,354.353383458647,258.601503759398,1081.36842105263,2145.35338345865,512.210526315789,112.045112781955,1066.08270676692,962.533834586466,673.541353383459,292.240601503759,1831.29323308271,1344.03759398496,334.511278195489,239.112781954887,1007.45112781955,1253.85714285714,239.345864661654,208.917293233083,752.796992481203,941.518796992481,406.075187969925,280.706766917293,1037.51127819549,129.240601503759,133,17.7460875670684,9.63139997415395,0.839904826834536,0.923611111111111,0.738888888888889,1.48094058876262,51615.5488721805,35547.3007518797,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_742186,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
742527,1567.9010989011,261.622710622711,155.377289377289,668.043956043956,4125.17216117216,1721.9010989011,556.161172161172,262.062271062271,1090.91575091575,2306.62637362637,901.0,167.567765567766,1084.53113553114,760.575091575092,559.835164835165,291.087912087912,1394.7619047619,1244.22344322344,414.388278388278,252.875457875458,978.868131868132,1272.27838827839,278.776556776557,131.59706959707,584.776556776557,1275.48717948718,523.263736263736,234.450549450549,1054.15384615385,131.03663003663,273,20.6937293323664,17.0299898962522,0.568107832803465,0.954545454545455,0.764705882352941,1.37890565720985,50965.8388278388,34567.7838827839,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_742527,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
743561,2290.17171717172,581.070707070707,104.848484848485,649.969696969697,2213.27272727273,3168.59595959596,499.222222222222,272.484848484848,1121.37373737374,5003.62626262626,552.242424242424,108.222222222222,1082.56565656566,2478.54545454545,835.484848484848,587.949494949495,1717.78787878788,3587.60606060606,395.080808080808,242.979797979798,1044.33333333333,2831.15151515152,254.353535353535,416.454545454545,629.333333333333,2244.62626262626,537.414141414141,413.050505050505,1045.30303030303,130.59595959596,99,12.3706013916062,10.2093959540349,0.564701778926645,0.951923076923077,0.825,-0.0482465544706302,50960.6060606061,35368.5757575758,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_743561,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
744326,3007.52752293578,235.302752293578,101.279816513761,625.47247706422,1202.02293577982,3218.01834862385,345.47247706422,259.050458715596,1089.77064220183,4667.69266055046,620.036697247706,115.201834862385,1077.75688073394,849.02752293578,482.096330275229,431.114678899083,1609.71100917431,973.816513761468,260.146788990826,232.270642201835,998.174311926606,921.463302752294,207.816513761468,152.591743119266,606.252293577982,1057.02293577982,449.357798165138,228.362385321101,1034.43577981651,128.137614678899,218,31.8050077479029,8.9471192368808,0.959616462478783,0.923728813559322,0.412878787878788,0.754920936492806,51884.6972477064,34756.6834862385,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_744326,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
744460,1768.94505494505,105.857142857143,56.9505494505495,613.725274725275,664.137362637363,1875.46703296703,426.428571428571,250.664835164835,1087.2032967033,4211.48351648352,840.791208791209,112.593406593407,1079.5989010989,506.010989010989,357.89010989011,264.384615384615,1385.31318681319,842.972527472527,239.807692307692,226.571428571429,993.538461538462,796.554945054945,181.708791208791,123.796703296703,582.412087912088,2807.22527472527,508.758241758242,279.554945054945,1031.25274725275,131.587912087912,182,17.8910500567853,13.0307867691331,0.685214759940608,0.952879581151832,0.823529411764706,-1.56693300472276,50343.9945054945,34255.3956043956,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_744460,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
744802,2436.05555555556,328.949735449735,174.642857142857,711.518518518518,5513.85978835979,2148.59788359788,1274.10846560847,274.383597883598,1115.40740740741,4623.03968253968,823.402116402116,119.10582010582,1077.53968253968,1561.69312169312,1191.7671957672,845.873015873016,1869.4417989418,3373.84920634921,429.730158730159,247.828042328042,1024.6164021164,2862.19841269841,266.251322751323,413.783068783069,687.796296296296,1672.47883597884,486.084656084656,520.481481481482,1081.01851851852,131.010582010582,378,33.7182203769705,14.4767767636753,0.903140173103453,0.942643391521197,0.5625,-0.920786609741373,51491.1957671958,35543.4470899471,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_744802,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
745128,1073.31609195402,203.994252873563,185.402298850575,686.293103448276,5037.69540229885,1435.0,321.057471264368,255.298850574713,1097.91954022989,2111.83333333333,555.477011494253,123.741379310345,1074.48850574713,695.264367816092,405.574712643678,270.057471264368,1472.47126436782,892.235632183908,197.258620689655,212.965517241379,1199.14367816092,645.85632183908,149.741379310345,121.373563218391,585.913793103448,865.494252873563,455.948275862069,218.557471264368,1031.51724137931,129.258620689655,174,15.4259911363177,14.4464956428105,0.350658065377634,0.950819672131148,0.773333333333333,1.26968660607873,51459.2643678161,34202.6494252874,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_745128,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
745602,1410.61363636364,348.136363636364,150.579545454545,631.0,2346.85227272727,1047.59090909091,456.818181818182,251.818181818182,1093.04545454545,2810.89772727273,463.863636363636,100.977272727273,1070.92045454545,1831.36363636364,1222.93181818182,1426.17045454545,2299.25,3990.32954545455,503.568181818182,248.727272727273,1106.18181818182,3564.06818181818,288.306818181818,597.090909090909,695.931818181818,1191.23863636364,445.147727272727,238.522727272727,1034.39772727273,129.920454545455,88,12.7335891037576,8.80987928404676,0.722030296379222,0.946236559139785,0.727272727272727,-0.712954626810315,51182.8409090909,35679.7840909091,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_745602,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
745673,675.759259259259,141.694444444444,80.6574074074074,634.842592592593,1495.48148148148,602.37962962963,801.537037037037,249.509259259259,1087.36111111111,1270.22222222222,523.314814814815,106.703703703704,1066.26851851852,728.518518518518,462.416666666667,281.287037037037,1470.59259259259,1152.48148148148,283.425925925926,233.037037037037,981.305555555556,1191.24074074074,213.805555555556,158.907407407407,588.574074074074,864.212962962963,471.638888888889,294.425925925926,1019.38888888889,127.324074074074,108,15.2141829574036,9.07500950040704,0.802625319085381,0.939130434782609,0.72,-1.15830444976296,51831.1111111111,35204.3888888889,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_745673,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
747975,1126.97222222222,314.381944444444,231.5,705.340277777778,5721.94444444444,1276.23611111111,367.659722222222,257.708333333333,1092.03472222222,2644.46527777778,514.548611111111,111.875,1085.03472222222,596.847222222222,403.229166666667,264.076388888889,1405.125,947.319444444444,265.638888888889,231.881944444444,1006.77777777778,890.1875,194.625,143.722222222222,584.229166666667,1355.18055555556,492.861111111111,222.6875,1036.23611111111,130.902777777778,144,14.4376052184718,12.684198393627,0.477645254701666,0.972972972972973,0.791208791208791,1.5707963267949,51421.5,34858.6666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_747975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
748056,1527.58895705521,443.312883435583,285.40490797546,714.926380368098,6656.80368098159,1556.58895705521,390.349693251534,280.441717791411,1100.76073619632,2476.03067484663,750.78527607362,127.674846625767,1068.09202453988,894.723926380368,449.374233128834,283.472392638037,1525.30061349693,1157.57055214724,217.742331288344,214.478527607362,1642.27607361963,806.098159509202,179.104294478528,201.79754601227,588.128834355828,1006.70552147239,430.82208588957,262.803680981595,1086.33742331288,129.509202453988,163,23.0427736359429,9.38906409596849,0.913221979493108,0.926136363636364,0.565972222222222,0.705186118520615,51711.3558282209,35576.9202453988,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_748056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
748392,1424.13,224.33,74.93,602.72,607.72,1082.24,403.38,255.79,1067.63,3049.9,1290.81,113.1,1079.98,673.71,437.72,272.78,1486.87,1025.14,291.4,231.86,993.67,995.0,222.83,167.27,582.6,1578.91,479.46,348.56,1012.47,129.82,100,13.3065410918472,9.74145595745228,0.681218397025706,0.934579439252336,0.699300699300699,0.508884998369863,50530.9,35743.95,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_748392,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
748828,1616.28787878788,346.40404040404,87.0656565656566,659.737373737374,1729.78282828283,2313.19191919192,4221.89898989899,266.823232323232,1119.94444444444,3728.84343434343,1482.83838383838,127.580808080808,1080.31313131313,1649.92424242424,1063.79292929293,1818.49494949495,2056.70707070707,3214.73737373737,377.277777777778,490.964646464646,1063.93434343434,3329.28787878788,244.080808080808,260.636363636364,689.429292929293,1997.37878787879,590.525252525253,528.666666666667,1113.66161616162,133.19696969697,198,17.3064310307486,14.5781389524062,0.538924834631456,0.951923076923077,0.776470588235294,0.0650489854883961,51020.7929292929,34415.0202020202,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_748828,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
749102,1779.24832214765,294.147651006711,148.308724832215,633.939597315436,1036.53691275168,3039.69127516779,2161.10067114094,270.825503355705,1099.79865771812,4244.57046979866,860.624161073825,110.087248322148,1076.8322147651,1612.1677852349,609.308724832215,292.194630872483,1803.54362416107,3346.77852348993,366.791946308725,244.697986577181,1046.93959731544,3884.73825503356,255.335570469799,323.93288590604,746.89932885906,1933.59731543624,479.657718120805,411.48322147651,1035.41610738255,132.355704697987,149,14.2835919193092,13.4279752189597,0.340904501331261,0.949044585987261,0.70952380952381,0.637346503502758,51992.932885906,35217.9597315436,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_749102,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
749934,3999.84738955823,367.722891566265,93.6546184738956,634.646586345381,1221.34136546185,4418.51004016064,692.779116465863,274.522088353414,1115.12449799197,6120.34136546185,604.751004016064,140.056224899598,1086.50602409639,2314.93172690763,653.690763052209,317.795180722892,1768.54618473896,3466.44176706827,374.755020080321,239.682730923695,1018.77510040161,2868.23694779116,1838.8313253012,246.349397590361,581.417670682731,1853.65863453815,541.25702811245,253.807228915663,1045.07228915663,132.293172690763,249,21.0907693034019,15.7141985084158,0.666981033241071,0.946768060836502,0.697478991596639,-0.2505480342347,50869.5020080321,35883.3895582329,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_749934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
750773,1727.74418604651,284.883720930233,170.43023255814,658.197674418605,3827.05813953488,1675.77906976744,336.046511627907,262.895348837209,1075.04651162791,3804.02325581395,493.372093023256,113.779069767442,1074.59302325581,695.651162790698,420.302325581395,273.558139534884,1497.79069767442,883.953488372093,204.046511627907,218.127906976744,1159.3488372093,719.244186046512,166.325581395349,155.802325581395,598.302325581395,2390.68604651163,517.418604651163,225.186046511628,1060.02325581395,128.209302325581,86,12.2665625157352,9.37124585137371,0.645255616638977,0.877551020408163,0.651515151515151,-1.22439766205983,51624.976744186,35301.7325581395,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_750773,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
751931,1669.01923076923,221.9375,98.9326923076923,705.870192307692,3691.51442307692,1622.36538461538,1908.54807692308,261.403846153846,1211.125,2869.25,675.423076923077,131.091346153846,1124.14423076923,1911.47596153846,566.629807692308,312.254807692308,1806.29807692308,3070.93269230769,355.269230769231,240.052884615385,1037.83173076923,2527.28846153846,261.206730769231,399.302884615385,833.447115384615,1002.85096153846,409.086538461538,1359.36057692308,1035.70673076923,129.860576923077,208,21.0938378830377,12.6045657334405,0.801833668665925,0.949771689497717,0.742857142857143,1.18624004118342,51257.9855769231,35832.4230769231,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_751931,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
752464,2977.71317829457,329.806201550388,81.6356589147287,604.503875968992,365.93023255814,3707.28682170543,667.387596899225,271.527131782946,1084.07751937984,5420.32558139535,612.085271317829,114.542635658915,1072.63565891473,3517.59689922481,1279.54263565891,2382.98449612403,2022.6511627907,3998.64341085271,365.426356589147,237.658914728682,1052.41860465116,3115.06201550388,1588.96124031008,708.46511627907,611.364341085271,3767.7519379845,521.054263565891,277.596899224806,1039.47286821705,128.403100775194,129,17.8773659154165,10.0841387648637,0.825724949523769,0.826923076923077,0.565789473684211,0.0197279928146207,51109.7441860465,35753.5348837209,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_752464,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
752890,1808.87053571429,222.6875,77.4241071428571,640.049107142857,1919.00446428571,2053.58928571429,999.366071428571,259.705357142857,1098.0625,3289.91964285714,1361.97767857143,109.205357142857,1061.5,607.9375,401.611607142857,261.8125,1576.37053571429,1038.38392857143,242.857142857143,226.642857142857,1015.83928571429,943.540178571429,204.71875,312.875,1293.36607142857,1208.48214285714,473.714285714286,389.147321428571,1041.06696428571,128.741071428571,224,22.867494568679,13.4649801188273,0.808259671448192,0.868217054263566,0.649275362318841,-1.33596459941794,51731.3660714286,35119.6741071429,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_752890,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
753159,3641.82417582418,381.505494505494,115.120879120879,607.78021978022,223.186813186813,5111.41758241758,1150.58241758242,274.362637362637,1082.94505494505,6701.84615384615,835.230769230769,118.626373626374,1062.53846153846,1360.54945054945,518.087912087912,271.747252747253,1436.62637362637,1608.95604395604,307.505494505494,235.472527472527,1006.12087912088,1550.46153846154,222.791208791209,152.582417582418,739.791208791209,2453.08791208791,567.802197802198,279.901098901099,1037.45054945055,129.252747252747,91,13.9992603720695,8.40060471540331,0.799943822331084,0.919191919191919,0.777777777777778,-0.0820069831832907,50518.7692307692,34460.8461538462,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_753159,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
753249,1025.59726962457,241.529010238908,88.5017064846416,616.433447098976,1165.05802047782,1148.29010238908,3143.59044368601,239.320819112628,1090.11945392491,1309.8566552901,752.508532423208,103.662116040956,1066.90102389078,452.047781569966,326.696245733788,253.447098976109,1428.04778156997,744.409556313993,208.508532423208,216.750853242321,996.829351535836,645.976109215017,143.959044368601,116.641638225256,582.982935153584,744.204778156997,447.805460750853,301.907849829352,1011.30716723549,131.638225255973,293,21.8146361407098,17.1783744235037,0.616352812601475,0.951298701298701,0.7325,-0.696514947625319,50587.5494880546,33981.0136518771,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_753249,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
753562,2110.83056478405,573.056478405316,213.641196013289,691.119601328904,4536.99335548173,2365.46843853821,2782.71760797342,263.531561461794,1105.04983388704,3409.54817275748,1154.22259136213,122.880398671096,1073.18272425249,871.624584717608,461.983388704319,285.56146179402,1529.72093023256,1057.88704318937,218.132890365449,219.136212624585,1327.4950166113,660.249169435216,152.87707641196,127.235880398671,592.358803986711,1458.28903654485,533.488372093023,397.006644518272,1075.06644518272,130.93023255814,301,26.1301137602715,14.978892832299,0.819385738310207,0.926153846153846,0.723557692307692,1.48451491208805,51399.7475083056,34275.5315614618,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_753562,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
754348,3153.0,565.805825242718,106.640776699029,641.436893203884,2441.56310679612,1326.71844660194,457.990291262136,268.805825242718,1083.06796116505,4268.83495145631,545.038834951456,118.922330097087,1072.99029126214,832.640776699029,680.514563106796,324.155339805825,1804.78640776699,1421.36893203884,306.912621359223,232.427184466019,999.52427184466,1412.44660194175,225.73786407767,188.26213592233,620.300970873786,1262.36893203884,476.174757281553,224.320388349515,1039.92233009709,128.864077669903,103,17.5838947216106,7.65802024022332,0.900182289577322,0.927927927927928,0.572222222222222,-0.910792758371001,51577.1941747573,35461.9611650485,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_754348,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
754908,1975.02898550725,230.775362318841,98.1449275362319,653.11231884058,929.775362318841,2293.48188405797,2760.13405797101,262.547101449275,1102.82971014493,3730.45289855072,516.510869565217,106.13768115942,1079.33695652174,797.358695652174,570.518115942029,282.63768115942,1590.28260869565,1205.85869565217,260.286231884058,222.789855072464,1014.15942028986,996.235507246377,198.050724637681,171.300724637681,583.384057971014,1091.8152173913,418.782608695652,726.688405797101,1033.31884057971,129.978260869565,276,23.3616845147105,16.5582364972843,0.70543209901565,0.836363636363636,0.627272727272727,-0.43234868313518,51346.634057971,35531.6594202899,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_754908,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
755345,3324.21854304636,531.973509933775,154.708609271523,651.64238410596,1850.15231788079,4343.94039735099,1052.20198675497,269.344370860927,1098.07947019868,6597.17549668874,1277.92052980132,127.135761589404,1087.11258278146,736.566225165563,822.639072847682,278.764900662252,1437.82781456954,1101.40728476821,349.78476821192,242.026490066225,987.96357615894,1066.72185430464,235.17880794702,144.76821192053,571.152317880795,2389.91059602649,537.006622516556,305.76821192053,1089.20529801325,131.03642384106,302,22.3944083489511,17.9831425939354,0.595952992754117,0.893491124260355,0.604,-0.0279450327652089,50515.0662251656,34758.7450331126,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_755345,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
755864,2150.09225092251,1000.27675276753,137.538745387454,658.726937269373,2415.73431734317,2259.30258302583,2630.30258302583,272.136531365314,1264.43911439114,4221.44280442804,1370.81549815498,118.557195571956,1085.94833948339,5319.91881918819,1114.33579335793,651.214022140221,3512.84132841328,7409.54243542435,450.077490774908,339.284132841328,1209.90036900369,7168.45018450184,294.177121771218,273.992619926199,654.627306273063,1369.56088560886,449.553505535055,328.678966789668,1061.23247232472,129.247232472325,271,24.3971535414121,15.0783121727627,0.786150022599286,0.912457912457912,0.615909090909091,0.739445551373485,50902.3579335793,35776.667896679,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_755864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
756374,1241.22962962963,418.607407407407,234.333333333333,689.8,4532.27407407407,1230.26666666667,377.044444444444,271.948148148148,1097.24444444444,2927.52592592593,555.162962962963,123.407407407407,1072.82222222222,780.696296296296,510.703703703704,270.785185185185,1520.14814814815,1050.03703703704,279.525925925926,229.037037037037,995.340740740741,996.903703703704,208.392592592593,166.155555555556,583.17037037037,1864.00740740741,524.666666666667,223.288888888889,1066.7037037037,133.014814814815,135,19.7411501636505,8.70418090635154,0.897548573028997,0.9375,0.610859728506787,-0.583291543511721,50782.037037037,35185.9481481481,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_756374,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
756643,1910.1743119266,334.908256880734,155.082568807339,701.064220183486,4354.38532110092,1056.25688073394,1338.08256880734,266.596330275229,1089.35779816514,3574.90825688073,583.43119266055,113.559633027523,1080.23853211009,901.651376146789,712.917431192661,691.119266055046,1564.57798165138,1139.89908256881,288.330275229358,226.183486238532,994.798165137615,996.293577981651,219.706422018349,189.642201834862,583.651376146789,1474.65137614679,480.275229357798,1605.52293577982,1073.96330275229,131.275229357798,109,14.6266595992723,10.6716955627689,0.683867961033177,0.819548872180451,0.619318181818182,-0.519846634902988,51179.3944954128,35557.2293577982,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_756643,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
758180,716.105263157895,149.236842105263,72.9736842105263,637.263157894737,1293.26315789474,995.092105263158,370.697368421053,271.763157894737,1089.40789473684,1560.47368421053,576.118421052632,119.460526315789,1063.03947368421,589.026315789474,465.5,334.684210526316,1563.39473684211,857.934210526316,222.236842105263,216.052631578947,1008.78947368421,782.986842105263,190.697368421053,330.618421052632,641.302631578947,1203.96052631579,470.118421052632,223.03947368421,1080.88157894737,130.394736842105,76,11.3878975463566,8.44798325357192,0.67057835088476,1.0,0.863636363636364,0.0,50101.5,35195.0,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_758180,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
758346,444.353887399464,815.935656836461,227.87399463807,623.243967828418,1080.09115281501,527.13672922252,345.072386058981,260.721179624665,1114.07506702413,943.394101876676,471.278820375335,106.171581769437,1059.21983914209,2629.19302949062,921.782841823056,399.434316353887,3395.04021447721,3263.99463806971,360.552278820375,242.88471849866,1031.82573726542,3272.49865951743,271.479892761394,419.522788203753,660.115281501341,784.699731903485,414.193029490617,210.844504021448,1021.72654155496,129.544235924933,373,27.2730523178291,17.4950116978885,0.767143005832759,0.956410256410256,0.683150183150183,1.04469590491965,51706.1045576407,35019.1394101877,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_758346,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
758389,1520.17816091954,208.626436781609,137.068965517241,667.385057471264,3088.9367816092,1950.34482758621,392.804597701149,282.224137931034,1095.84482758621,2064.09770114943,671.011494252874,141.275862068966,1061.5,565.333333333333,409.367816091954,262.747126436782,1352.08620689655,864.82183908046,262.477011494253,225.224137931034,982.729885057471,818.867816091954,186.540229885057,118.890804597701,586.505747126437,1213.94827586207,577.775862068965,229.810344827586,1035.70114942529,129.862068965517,174,16.357703738452,13.5318594451012,0.561838582786314,0.966666666666667,0.836538461538462,1.51173862326352,50336.4310344828,34615.0517241379,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_758389,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
758874,1452.98324022346,500.765363128492,121.932960893855,650.865921787709,2740.24581005587,1778.54748603352,2713.69832402235,266.575418994413,1148.90502793296,2715.0,792.709497206704,109.597765363128,1069.51955307263,830.474860335196,724.039106145251,1234.68156424581,1813.86592178771,1276.37988826816,292.368715083799,229.603351955307,1014.50837988827,1182.4469273743,223.424581005587,598.067039106145,696.536312849162,1021.6312849162,434.139664804469,809.36312849162,1053.65363128492,131.949720670391,179,19.089467001381,12.4692878465705,0.757183250604421,0.917948717948718,0.672932330827068,-0.175031603115345,51227.5474860335,35583.2122905028,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_758874,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
759243,1260.04829545455,305.377840909091,104.272727272727,639.028409090909,1561.36647727273,1219.35795454545,349.650568181818,271.383522727273,1104.67329545455,2257.51988636364,761.184659090909,111.661931818182,1066.69318181818,1550.51704545455,523.872159090909,300.974431818182,1584.96306818182,1663.85511363636,392.329545454545,231.730113636364,1017.03125,1264.10227272727,213.826704545455,1463.59943181818,656.448863636364,862.849431818182,393.247159090909,214.573863636364,1048.11363636364,130.894886363636,352,22.5229071154704,20.2051726333202,0.441839036315817,0.956521739130435,0.728778467908903,0.0625408323951531,50798.4943181818,35439.7017045455,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_759243,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
759672,917.685714285714,220.468571428571,664.091428571429,613.702857142857,618.742857142857,845.862857142857,1440.51428571429,269.234285714286,1117.84571428571,1345.95428571429,678.388571428571,109.188571428571,1069.74857142857,3121.6,754.24,431.36,1902.23428571429,3684.62857142857,390.594285714286,245.708571428571,1018.08571428571,3234.42857142857,271.285714285714,476.085714285714,638.405714285714,920.64,460.571428571429,248.48,1004.47428571429,128.354285714286,175,16.4396665000536,13.5712623320524,0.564373856682941,0.951086956521739,0.78125,-0.522990878618886,50881.6171428571,35770.3371428571,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_759672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
759871,598.924078091106,653.646420824295,164.984815618221,618.227765726681,86.529284164859,629.140997830803,410.494577006508,276.167028199566,1117.34273318872,1370.45986984816,697.796095444685,115.767895878525,1057.37527114967,1415.36659436009,631.633405639913,297.43600867679,1708.59652928416,1879.7136659436,309.251626898048,248.169197396963,1060.14750542299,1622.18872017354,215.082429501085,142.357917570499,3009.45119305857,690.232104121475,410.973969631236,203.702819956616,1007.29934924078,130.325379609544,461,31.9863813917398,18.4293550359913,0.817335131465892,0.95643153526971,0.66235632183908,0.559841990690315,50327.3557483731,34910.4056399132,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_759871,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
760050,414.161764705882,612.058823529412,168.008403361345,602.432773109244,107.584033613445,488.048319327731,306.010504201681,244.058823529412,1087.30882352941,1177.48319327731,713.275210084034,111.733193277311,1059.41386554622,1734.92857142857,566.966386554622,1015.48109243697,1903.79411764706,1900.68277310924,330.867647058824,1065.1512605042,1107.49579831933,1253.73109243697,216.258403361345,350.445378151261,1314.53781512605,567.361344537815,372.840336134454,201.254201680672,984.733193277311,131.586134453782,476,31.2108187470238,20.0072625675116,0.767510700753573,0.942574257425742,0.652949245541838,-0.740106725113318,51285.4579831933,33834.6176470588,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760050,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
760212,1652.02604166667,457.197916666667,495.505208333333,691.9375,1560.08854166667,1578.4375,779.234375,253.942708333333,1136.35416666667,2369.078125,492.010416666667,103.848958333333,1084.61458333333,1500.25,574.583333333333,435.880208333333,1586.96354166667,3075.58854166667,362.604166666667,240.401041666667,1007.890625,2922.015625,266.151041666667,210.59375,582.96875,779.78125,392.598958333333,481.317708333333,1145.03125,130.0,192,20.3377990162906,12.3661854378819,0.793906763370307,0.95049504950495,0.664359861591695,-0.840690003979374,51206.8541666667,35648.5833333333,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
761244,591.797619047619,693.238095238095,177.444444444444,610.837301587302,82.5555555555556,631.404761904762,428.242063492063,276.686507936508,1124.3253968254,1391.63095238095,711.257936507937,114.757936507937,1061.76587301587,3336.36904761905,543.202380952381,324.753968253968,1497.5873015873,4274.95238095238,363.801587301587,244.265873015873,1058.84523809524,3951.12301587302,243.075396825397,227.861111111111,681.150793650794,627.087301587302,388.396825396825,201.039682539683,991.031746031746,129.607142857143,252,21.365390876242,15.5284033240003,0.686847309592082,0.929889298892989,0.705882352941177,0.997730413611042,50344.0793650794,34880.4880952381,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_761244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
761322,1924.34472934473,197.91452991453,129.467236467236,664.022792022792,3557.40455840456,2436.31339031339,459.877492877493,259.364672364672,1093.74643874644,3847.83760683761,1017.70085470085,119.435897435897,1105.33618233618,822.891737891738,608.811965811966,284.48717948718,1446.80626780627,1200.59829059829,349.646723646724,243.071225071225,979.190883190883,1106.19658119658,242.621082621083,174.264957264957,581.051282051282,1782.54985754986,537.923076923077,249.253561253561,1092.94586894587,131.410256410256,351,33.194231743314,13.5543570867806,0.912832275005433,0.946091644204852,0.75974025974026,0.0547877860506674,51636.3076923077,34363.1452991453,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_761322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
761549,918.124137931034,115.034482758621,79.1793103448276,642.551724137931,2353.66206896552,971.255172413793,370.51724137931,256.351724137931,1086.27586206897,1788.93103448276,488.441379310345,107.034482758621,1069.14482758621,1152.79310344828,594.744827586207,301.31724137931,1888.48965517241,1699.82068965517,305.91724137931,234.572413793103,992.503448275862,1739.96551724138,230.089655172414,145.165517241379,593.075862068966,1041.92413793103,491.151724137931,221.944827586207,1039.13103448276,130.137931034483,145,18.1534709257751,10.2471773849066,0.825450282059186,0.960264900662252,0.71078431372549,1.1249350111529,51732.4689655172,35005.1655172414,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_761549,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
761741,4389.26265060241,605.710843373494,2512.59036144578,649.224096385542,2432.55903614458,4394.41445783133,1027.58313253012,277.113253012048,1159.58313253012,6959.60722891566,771.626506024096,120.61686746988,1167.23373493976,7327.90120481928,898.742168674699,385.375903614458,1899.16385542169,8212.58554216868,454.178313253012,253.920481927711,1064.09638554217,7845.94698795181,311.636144578313,275.344578313253,604.722891566265,2374.95903614458,516.315662650602,424.90843373494,1080.83373493976,131.73734939759,415,23.5696979272352,22.5765541760987,0.287223690293283,0.969626168224299,0.820158102766798,1.00493611568857,51052.2385542169,35675.3638554217,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_761741,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
761825,597.577167019027,677.150105708245,193.044397463002,617.014799154334,93.816067653277,652.188160676533,430.274841437632,266.862579281184,1120.45031712474,1470.24524312896,1141.86469344609,130.816067653277,1066.32346723044,897.23044397463,543.215644820296,285.515856236786,1600.90274841438,988.775898520084,217.978858350951,219.536997885835,1192.60042283298,628.07399577167,136.319238900634,121.255813953488,583.135306553911,567.570824524313,373.541226215645,200.103594080338,980.0,129.454545454545,473,26.7152689353752,22.7081767551074,0.526770718837724,0.959432048681542,0.729938271604938,1.20856217195699,51192.8202959831,33859.577167019,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_761825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762011,1456.34054054054,530.545945945946,227.313513513514,624.394594594595,1025.0,1308.72972972973,371.118918918919,256.567567567568,1087.90810810811,2761.75675675676,455.362162162162,123.810810810811,1070.51351351351,1031.78378378378,530.221621621622,410.075675675676,1499.77837837838,1254.88108108108,356.383783783784,245.210810810811,1003.82702702703,1240.27027027027,268.097297297297,210.232432432432,634.167567567568,1710.3027027027,454.367567567568,235.578378378378,1030.81621621622,131.535135135135,185,15.550565820451,15.1799136521124,0.217030986730296,0.973684210526316,0.822222222222222,-1.13069155616368,50978.8756756757,35826.0972972973,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762011,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762141,3581.51820728291,491.582633053221,1847.42857142857,637.893557422969,1529.79831932773,2981.81792717087,1588.0756302521,268.574229691877,1194.6218487395,5315.98319327731,557.515406162465,114.056022408964,1178.89635854342,905.268907563025,609.022408963585,594.913165266106,1656.70028011204,1080.6918767507,277.949579831933,229.145658263305,996.624649859944,1023.28571428571,226.366946778711,193.980392156863,586.882352941176,1569.00840336134,489.420168067227,431.619047619048,1079.60784313725,132.302521008403,357,29.7194789333688,15.6359633702242,0.850411357196701,0.941952506596306,0.649090909090909,-0.566204102141063,51115.7535014006,35650.268907563,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762141,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762330,1294.45510204082,166.1,80.1428571428571,629.00612244898,1588.59795918367,1310.18163265306,402.44693877551,260.126530612245,1086.07551020408,2545.0,635.202040816327,107.834693877551,1076.11632653061,1645.67346938776,764.226530612245,321.35306122449,1570.77551020408,2816.56530612245,331.008163265306,238.373469387755,998.095918367347,2777.68367346939,262.081632653061,224.077551020408,654.402040816327,931.175510204082,413.012244897959,251.583673469388,1011.73265306122,129.297959183673,490,41.8802738304838,15.0371838992147,0.933317668398225,0.972222222222222,0.875,-0.0148304421582995,50580.5530612245,35408.8775510204,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762330,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762381,2106.484375,376.6953125,123.84375,696.0703125,3233.125,1577.7734375,1955.7734375,269.390625,1102.5390625,3249.5078125,546.6875,109.671875,1076.625,2247.4296875,671.0703125,427.25,1839.7578125,1117.453125,271.6171875,224.34375,992.0,1047.75,236.34375,216.9765625,582.109375,1133.59375,440.265625,1404.0234375,1055.1171875,130.390625,128,16.239883545719,10.6911347437485,0.752733091658613,0.895104895104895,0.666666666666667,0.420052948816538,51171.078125,35569.5859375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762381,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762406,632.065972222222,698.857638888889,179.583333333333,617.013888888889,93.2274305555556,536.756944444444,390.4375,256.286458333333,1113.75520833333,1372.09027777778,1786.42361111111,124.663194444444,1062.53819444444,932.565972222222,529.652777777778,286.105902777778,1565.02256944444,874.586805555556,202.260416666667,220.918402777778,1102.11805555556,635.126736111111,136.015625,124.9375,584.366319444444,567.329861111111,374.067708333333,199.767361111111,986.664930555556,130.348958333333,576,36.3176368082832,20.3346776675642,0.828552137492709,0.963210702341137,0.666666666666667,1.00983845183079,51174.9652777778,33874.1927083333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
762440,979.041379310345,489.455172413793,214.248275862069,653.420689655172,2925.55172413793,981.151724137931,359.206896551724,257.565517241379,1095.72413793103,1678.87586206897,947.972413793103,128.234482758621,1070.55172413793,1737.2,710.503448275862,306.896551724138,2394.1724137931,3984.28965517241,375.531034482759,250.386206896552,1063.19310344828,5588.53793103448,242.565517241379,179.662068965517,3094.34482758621,1027.50344827586,497.475862068966,218.234482758621,1034.05517241379,129.862068965517,145,16.8920578231091,10.9477029273451,0.761557246708635,0.966666666666667,0.823863636363636,-0.299846534709198,51537.0827586207,34114.3517241379,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762440,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
763595,1870.69196428571,272.618303571429,126.790178571429,649.017857142857,1795.28125,2136.29910714286,326.488839285714,251.15625,1099.77232142857,3706.20758928571,1163.734375,118.292410714286,1073.54241071429,777.705357142857,425.944196428571,259.004464285714,1579.90848214286,1372.58035714286,276.705357142857,231.180803571429,1043.91741071429,1246.296875,205.397321428571,152.979910714286,608.125,1075.20089285714,427.370535714286,206.638392857143,1014.76785714286,130.0,448,30.1792040867171,19.0782157466292,0.774834359314684,0.957264957264957,0.727272727272727,-0.598246078319646,50015.6785714286,34309.109375,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_763595,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
765439,3431.44017094017,679.397435897436,2541.51282051282,613.209401709402,559.465811965812,3593.73504273504,1192.82905982906,281.055555555556,1137.7264957265,5179.59401709402,617.807692307692,114.021367521368,1070.25213675214,715.247863247863,442.474358974359,278.470085470085,1449.41025641026,1048.2094017094,273.645299145299,231.41452991453,984.457264957265,974.700854700855,214.538461538462,156.649572649573,586.25641025641,1626.70512820513,540.58547008547,340.619658119658,1036.89743589744,130.773504273504,234,18.1489163979548,16.5488578707991,0.4105518778221,0.939759036144578,0.764705882352941,1.07290265568242,51217.2692307692,35441.8461538462,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_765439,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
765442,866.614285714286,679.411904761905,366.528571428571,995.680952380952,2228.00714285714,1076.40714285714,368.947619047619,266.42619047619,1107.26428571429,2166.78095238095,749.807142857143,123.595238095238,1068.69761904762,3787.01904761905,682.369047619048,438.82380952381,2460.95238095238,4541.61904761905,458.457142857143,255.22380952381,1065.12857142857,4495.30238095238,262.840476190476,770.197619047619,2158.00238095238,1019.06428571429,448.190476190476,218.921428571428,1057.8119047619,130.980952380952,420,31.0510497938384,17.6334488927293,0.823107385408637,0.950226244343891,0.729166666666667,-0.129692114392321,50608.0119047619,34347.8023809524,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_765442,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
765540,3056.94065281899,824.86350148368,1887.45697329377,642.747774480712,1893.87240356083,2736.10979228487,848.166172106825,263.178041543027,1106.46884272997,4760.86943620178,1173.07121661721,116.513353115727,1072.89910979228,1119.60534124629,531.216617210682,284.842729970326,1823.98516320475,1115.3293768546,230.186943620178,221.510385756677,1225.3175074184,915.287833827893,173.430267062315,156.824925816024,1721.14243323442,1484.02077151335,545.712166172107,652.225519287834,1047.99703264095,131.510385756677,337,29.1995529742367,15.3663652510397,0.850327769167832,0.896276595744681,0.641904761904762,-0.919142174872286,51896.4629080119,34878.2789317507,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_765540,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
765603,1284.54198473282,177.374045801527,209.862595419847,715.75572519084,6223.48091603053,1361.34351145038,332.832061068702,255.167938931298,1097.61832061069,3119.12213740458,897.442748091603,124.236641221374,1069.63358778626,2518.58778625954,558.198473282443,286.81679389313,1765.12213740458,1448.31297709924,346.137404580153,238.221374045802,998.022900763359,1280.53435114504,241.564885496183,134.458015267176,828.190839694656,1010.25954198473,468.961832061069,267.045801526718,1060.45801526718,132.687022900763,131,16.2424292072927,10.4715601009303,0.764432254231963,0.903448275862069,0.671794871794872,0.948384827306738,51306.0076335878,34208.1297709924,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_765603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
766137,1337.19760479042,493.808383233533,145.568862275449,657.065868263473,4015.93413173653,1692.26946107784,354.359281437126,266.191616766467,1108.18562874252,3338.1497005988,543.736526946108,113.538922155689,1075.77844311377,2983.28143712575,767.658682634731,315.880239520958,1744.9880239521,4003.97005988024,322.898203592814,239.059880239521,1004.06586826347,3795.07784431138,240.862275449102,197.940119760479,587.437125748503,1860.38922155689,514.173652694611,223.910179640718,1050.16766467066,131.377245508982,167,16.5758814957802,12.8360086741094,0.632722460592288,0.965317919075144,0.802884615384615,-1.20699784162139,51227.6407185629,34968.2035928144,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_766137,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
766795,381.205607476636,806.352024922118,210.395638629283,610.869158878505,127.582554517134,462.255451713396,372.897196261682,264.713395638629,1129.73520249221,1054.70716510903,624.495327102804,108.442367601246,1065.2523364486,721.028037383178,413.585669781931,270.501557632399,1449.55763239875,1268.82242990654,268.520249221184,229.507788161994,987.866043613707,1261.66666666667,205.816199376947,150.133956386293,591.906542056075,579.788161993769,366.996884735203,198.096573208723,984.352024922118,128.227414330218,321,21.2230944353375,19.2849968050106,0.417493778977405,0.966867469879518,0.764285714285714,-1.04635949730583,51575.7133956386,35220.0903426791,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_766795,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
767408,1908.27320261438,245.725490196078,915.904575163399,626.290196078431,1482.62614379085,1413.94248366013,343.81045751634,250.030065359477,1089.3045751634,2272.95424836601,522.467973856209,112.250980392157,1073.99869281046,1527.65751633987,700.922875816993,395.980392156863,1624.73333333333,1828.67843137255,387.751633986928,249.515032679739,1012.28366013072,1836.48235294118,263.746405228758,214.197385620915,590.449673202614,578.649673202614,374.494117647059,200.066666666667,982.58431372549,129.228758169935,765,35.5004594098001,27.5323279185098,0.631287992643694,0.972045743329098,0.780612244897959,0.412432107771214,51687.8954248366,34711.1450980392,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_767408,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
767991,1714.32460732984,428.471204188482,106.094240837696,626.753926701571,1472.73821989529,1916.84293193717,335.319371727749,262.591623036649,1120.13612565445,3234.76439790576,504.602094240838,105.947643979058,1076.1780104712,560.219895287958,379.303664921466,263.277486910995,1412.05235602094,878.068062827225,263.329842931937,226.596858638743,993.717277486911,821.267015706806,191.738219895288,135.057591623037,585.837696335079,1524.6387434555,497.418848167539,223.246073298429,1030.84293193717,131.403141361257,191,25.5412221963776,9.65338346978545,0.925824752886001,0.918269230769231,0.510695187165775,-0.976381209125376,51056.0,35023.1047120419,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_767991,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
768669,1051.55329949239,232.903553299492,89.761421319797,615.593908629442,811.279187817259,1435.89847715736,329.741116751269,254.690355329949,1090.31979695431,2383.20304568528,949.553299492386,112.756345177665,1069.80203045685,1404.27411167513,482.507614213198,267.274111675127,1621.06598984772,3130.3807106599,323.005076142132,234.340101522843,1059.59898477157,3752.75634517767,233.522842639594,351.192893401015,1506.12182741117,1514.28426395939,477.269035532995,214.868020304568,1041.59898477157,131.111675126904,197,18.2416675528644,13.9741997055484,0.642769862423263,0.960975609756098,0.772549019607843,0.966190240037909,50034.1725888325,34305.5989847716,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_768669,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
768696,1943.71126760563,206.450704225352,113.725352112676,634.288732394366,1903.07746478873,2925.02112676056,326.253521126761,263.584507042254,1083.5985915493,3601.48591549296,511.246478873239,112.901408450704,1075.39436619718,866.80985915493,748.880281690141,276.669014084507,1682.3661971831,1224.67605633803,365.901408450704,242.478873239437,993.014084507042,1145.67605633803,246.19014084507,123.316901408451,578.542253521127,1749.93661971831,534.5,222.647887323944,1024.93661971831,130.922535211268,142,18.5778062496683,10.6845542423464,0.81806579294778,0.8875,0.556862745098039,-0.577047805511268,50898.161971831,34715.8802816901,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_768696,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
768803,2736.60377358491,231.933962264151,88.7594339622642,617.490566037736,571.509433962264,2952.39150943396,955.160377358491,269.679245283019,1095.44811320755,5513.24056603774,750.853773584906,114.88679245283,1070.44339622642,826.240566037736,709.429245283019,473.018867924528,1681.93867924528,1038.95754716981,277.5,232.146226415094,1006.60849056604,948.844339622642,207.051886792453,155.202830188679,596.311320754717,1283.65094339623,494.325471698113,218.551886792453,1080.09433962264,134.122641509434,212,20.7964496148223,13.115746770872,0.776049176948197,0.946428571428571,0.815384615384615,1.48057166220256,51414.108490566,35175.0566037736,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_768803,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
769159,1775.60469314079,303.238267148014,99.6371841155235,626.983754512635,1419.14981949458,1594.25992779783,2715.93140794224,263.43321299639,1093.74007220217,2293.40613718412,1321.40252707581,114.512635379061,1068.38989169675,731.992779783394,444.234657039711,289.570397111913,1628.51624548736,1203.13898916968,284.027075812274,227.889891696751,998.471119133574,1090.37003610108,209.490974729242,181.036101083032,582.317689530686,997.694945848376,513.537906137184,312.629963898917,1039.69855595668,131.70036101083,554,28.8938696017295,24.782481611006,0.514138369530679,0.958477508650519,0.732804232804233,0.713669236533441,51870.3501805054,34285.4981949458,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_769159,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
769643,1609.968,380.632,124.888,620.648,731.064,1354.808,361.552,267.712,1099.864,2657.544,631.464,116.976,1066.272,1242.48,844.616,955.56,1576.736,1360.128,317.544,229.392,1006.568,1216.336,238.52,235.296,617.544,965.376,422.112,235.816,1082.816,129.128,125,21.7705925236208,7.55618244687525,0.937834757610553,0.880281690140845,0.469924812030075,0.534208583969213,51859.928,35467.352,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_769643,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
770924,503.785714285714,894.725274725275,251.642857142857,664.406593406593,124.230769230769,655.384615384615,392.269230769231,282.554945054945,1106.28571428571,1568.41208791209,816.89010989011,114.857142857143,1064.24725274725,1039.6043956044,638.807692307692,279.39010989011,1798.3021978022,1507.13186813187,360.653846153846,245.417582417582,1085.96153846154,1323.16483516484,249.818681318681,172.472527472527,4830.16483516484,758.89010989011,411.489010989011,205.532967032967,1031.37912087912,130.43956043956,182,17.8653466975033,13.0595144853875,0.68238069653007,0.962962962962963,0.713725490196078,0.639342583451076,51113.3241758242,35214.2802197802,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_770924,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
770937,2084.17647058824,997.911764705882,163.888235294118,678.3,3555.62352941176,2599.62352941176,1748.45294117647,278.823529411765,1102.53529411765,3479.2,5622.52941176471,116.7,1077.2,697.752941176471,488.770588235294,279.029411764706,1466.27647058824,1022.54705882353,287.423529411765,231.517647058824,995.464705882353,946.376470588235,215.664705882353,146.735294117647,584.764705882353,1179.87647058824,531.370588235294,960.058823529412,1120.9,133.729411764706,170,17.3908256106951,12.5355969741694,0.693125768404795,0.939226519337017,0.769230769230769,-1.44610016501656,50951.3294117647,35304.2235294118,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_770937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
772496,594.732142857143,994.011904761905,258.910714285714,607.357142857143,172.458333333333,437.267857142857,286.410714285714,242.845238095238,1095.85714285714,1089.45238095238,475.982142857143,105.619047619048,1068.54761904762,740.654761904762,415.642857142857,272.797619047619,1468.57738095238,742.136904761905,190.25,212.886904761905,1000.39285714286,652.684523809524,153.922619047619,125.684523809524,603.130952380952,757.744047619048,423.142857142857,213.095238095238,1030.47619047619,135.154761904762,168,15.3523368809889,13.9560239645945,0.416689590210621,0.93854748603352,0.75,1.03132368397317,51503.4404761905,34147.7380952381,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_772496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
773597,1866.58620689655,215.837164750958,100.572796934866,669.833333333333,2430.83524904215,1559.27586206897,1150.70498084291,262.540229885057,1090.18199233716,2212.14942528736,2864.70114942529,114.478927203065,1069.1091954023,775.258620689655,598.354406130268,293.007662835249,1555.90421455939,1207.16475095785,322.063218390805,237.988505747126,994.287356321839,1126.9061302682,244.735632183908,134.490421455939,583.513409961686,672.477011494253,406.166666666667,209.442528735632,989.555555555556,129.090038314176,522,35.862268031849,18.7224531820584,0.852905390556803,0.961325966850829,0.687747035573123,0.404522446042642,51644.2222222222,34822.0632183908,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_773597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
773961,1718.30952380952,171.962585034014,173.462585034014,691.561224489796,4321.69387755102,2218.44897959184,341.020408163265,268.952380952381,1091.43197278912,3092.75170068027,748.173469387755,125.829931972789,1071.73129251701,2441.16666666667,752.721088435374,936.421768707483,2863.51020408163,3205.38775510204,381.659863945578,242.387755102041,1129.75850340136,2916.91496598639,226.819727891156,663.551020408163,692.295918367347,1286.22448979592,497.506802721088,281.479591836735,1104.31292517007,131.190476190476,294,33.6952105717176,11.3879295186886,0.941157318161086,0.91304347826087,0.452307692307692,-0.837804531428138,51354.6666666667,35154.4285714286,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_773961,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
774004,698.198757763975,271.670807453416,271.527950310559,767.590062111801,8511.5652173913,810.093167701863,1559.62732919255,260.130434782609,1097.07453416149,1991.96273291925,2063.06211180124,117.354037267081,1079.66459627329,657.577639751553,721.962732919255,308.037267080745,1543.15527950311,1118.67701863354,289.844720496894,229.39751552795,1006.53416149068,1568.58385093168,230.006211180124,251.913043478261,719.217391304348,1141.86335403727,481.267080745342,240.006211180124,1065.2298136646,129.565217391304,161,17.2504041778269,11.9277317130212,0.722427662789529,0.930635838150289,0.728506787330317,0.341731637633517,50627.0745341615,35249.7142857143,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
774333,2442.18260869565,270.191304347826,107.698550724638,646.330434782609,2834.69275362319,2639.52463768116,2258.29565217391,267.507246376812,1102.58260869565,3921.94202898551,704.739130434783,130.431884057971,1081.85797101449,1877.13043478261,797.889855072464,1007.27246376812,1892.44057971014,2148.5884057971,294.133333333333,227.904347826087,1035.04637681159,1779.68115942029,227.863768115942,420.289855072464,692.802898550725,1293.51014492754,435.715942028986,480.330434782609,1055.26376811594,130.368115942029,345,25.3295039833776,17.856699420622,0.709230885280275,0.940054495912806,0.69,0.282465654542546,51027.5797101449,35857.7565217391,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
774486,1967.35627530364,243.178137651822,74.748987854251,606.894736842105,451.004048582996,2778.07287449393,492.955465587045,263.291497975709,1086.87449392713,3586.48987854251,704.408906882591,110.263157894737,1068.48582995951,3846.02834008097,886.421052631579,864.105263157895,1784.38461538462,3567.02834008097,354.093117408907,236.939271255061,1034.36437246964,3101.97570850202,248.101214574899,345.117408906883,720.874493927126,1536.95546558704,504.793522267206,225.838056680162,1033.2995951417,133.275303643725,247,20.9216003993675,15.7460512755119,0.658453125108158,0.908088235294118,0.684210526315789,-1.06918513962769,50340.2307692308,34783.4412955466,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_774486,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
774918,439.324483775811,693.843657817109,170.088495575221,605.911504424779,109.448377581121,389.69616519174,292.834808259587,240.643067846608,1097.70206489676,955.705014749262,520.100294985251,106.802359882006,1065.42772861357,871.132743362832,501.300884955752,278.702064896755,1529.86725663717,916.861356932153,206.504424778761,220.309734513274,1136.97935103245,692.501474926254,144.513274336283,123.823008849558,588.209439528024,568.020648967552,375.890855457227,201.16814159292,983.802359882006,130.315634218289,339,23.6574346422857,18.2947825530066,0.634015129295398,0.952247191011236,0.743421052631579,1.38027365614394,51292.0737463127,33903.3864306785,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774918,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
774969,1553.58108108108,300.13963963964,138.90990990991,640.698198198198,1892.8963963964,1797.96846846847,364.400900900901,258.954954954955,1090.37387387387,3452.5,600.563063063063,113.563063063063,1075.41891891892,628.851351351351,444.693693693694,270.391891891892,1422.50900900901,965.806306306306,313.648648648649,237.463963963964,981.391891891892,927.076576576577,211.86036036036,130.099099099099,584.427927927928,1730.88738738739,556.725225225225,233.495495495496,1074.05855855856,129.554054054054,222,24.7511897630317,11.5947863794756,0.883488048950121,0.94468085106383,0.770833333333333,0.0119705558388292,50877.3468468468,34335.3063063063,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774969,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
775300,926.64406779661,234.737288135593,66.1779661016949,601.491525423729,299.330508474576,848.533898305085,592.101694915254,242.076271186441,1077.71186440678,2226.72881355932,744.915254237288,111.593220338983,1063.1186440678,1263.82203389831,606.677966101695,284.881355932203,1662.10169491525,3364.85593220339,363.720338983051,243.559322033898,1072.17796610169,8797.51694915254,355.033898305085,287.822033898305,1092.04237288136,1536.74576271186,515.85593220339,243.372881355932,1034.60169491525,131.101694915254,118,13.4062516898155,11.2242335246012,0.546837508594225,0.951612903225806,0.756410256410256,1.13989334701287,50968.1186440678,33732.3983050847,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_775300,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
775628,746.979797979798,374.111111111111,37.6767676767677,607.959595959596,478.818181818182,600.59595959596,2475.07070707071,245.050505050505,1089.59595959596,1621.0303030303,624.212121212121,94.7878787878788,1060.33333333333,4887.81818181818,807.30303030303,614.838383838384,2105.0505050505,4992.90909090909,381.444444444444,236.949494949495,1062.45454545455,4214.60606060606,248.090909090909,196.525252525253,584.959595959596,686.474747474747,363.282828282828,787.636363636364,1002.0101010101,128.636363636364,99,12.2925715943568,10.2442629390797,0.552715204618577,0.951923076923077,0.825,-0.23103304128179,51326.5656565657,35556.3333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_775628,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
776213,1010.38461538462,273.769230769231,181.384615384615,690.451923076923,4143.80769230769,1295.16346153846,349.009615384615,268.836538461538,1094.01923076923,2309.86538461538,522.682692307692,118.105769230769,1072.57692307692,774.807692307692,643.855769230769,355.057692307692,1485.20192307692,1197.02884615385,357.75,269.384615384615,998.990384615385,1139.96153846154,251.884615384615,190.769230769231,655.451923076923,1074.64423076923,469.269230769231,232.25,1030.91346153846,126.528846153846,104,14.1213648885662,9.41921807097515,0.745040745058534,0.945454545454545,0.742857142857143,-1.22567814625883,50457.3557692308,35314.5961538462,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_776213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
776547,1046.85840707965,383.420353982301,191.305309734513,682.544247787611,5156.8185840708,856.70796460177,345.853982300885,272.849557522124,1107.94247787611,1864.91150442478,773.092920353982,110.62389380531,1062.58849557522,3799.1814159292,571.517699115044,316.650442477876,1589.61946902655,7760.45132743363,427.407079646018,250.79203539823,1014.33185840708,7922.03539823009,277.088495575221,1083.83628318584,679.092920353982,855.491150442478,397.482300884956,231.407079646018,1055.51769911504,131.088495575221,226,21.0420678735641,15.2748681860842,0.687778630544897,0.833948339483395,0.570707070707071,-0.615414733832188,50793.5619469027,35457.5398230088,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_776547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
776958,2348.1067961165,390.733009708738,163.02427184466,642.956310679612,1983.79611650485,2800.0145631068,371.582524271845,273.830097087379,1082.58252427184,3809.85436893204,583.645631067961,122.752427184466,1075.35436893204,1447.41262135922,1135.50970873786,1989.97572815534,2147.76699029126,1354.32038834951,307.150485436893,232.519417475728,1030.73300970874,1070.19417475728,204.820388349515,496.655339805825,788.733009708738,1526.67475728155,500.78640776699,251.694174757282,1037.65048543689,130.140776699029,206,23.8301754776791,11.2602530803166,0.88131952969245,0.940639269406393,0.57703081232493,-0.962853592564862,50443.4368932039,35156.8834951456,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_776958,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
777472,618.645962732919,205.981366459627,83.5217391304348,615.285714285714,913.23602484472,601.006211180124,1166.19254658385,259.95652173913,1076.42236024845,1691.15527950311,790.391304347826,106.142857142857,1069.60869565217,885.83850931677,514.285714285714,286.863354037267,1876.5900621118,1285.5900621118,283.782608695652,237.006211180124,1043.60248447205,1091.60248447205,215.285714285714,182.018633540373,607.006211180124,1287.23602484472,485.639751552795,345.447204968944,1017.84472049689,129.503105590062,161,18.8557337074275,10.8932439902746,0.816238412746237,0.941520467836257,0.770334928229665,1.55663952704638,51866.1739130435,35389.652173913,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_777472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
777703,4202.26898047722,1423.46854663774,957.039045553145,674.501084598699,3880.68980477223,5016.77657266811,536.375271149675,279.422993492408,1224.74403470716,7613.95010845987,575.731019522777,123.091106290672,1086.10845986985,2372.25379609544,676.637744034707,825.253796095445,1726.37093275488,2475.28199566161,347.431670281996,252.82863340564,1007.15401301518,2117.27765726681,248.793926247289,323.843817787419,588.991323210412,2677.83080260304,570.733188720174,308.947939262473,1080.19956616052,131.386117136659,461,27.4164581228577,22.0193331973698,0.595786464029657,0.964435146443515,0.71583850931677,-1.48074373900415,51368.4815618221,35104.6420824295,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_777703,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
777877,1774.33076923077,329.269230769231,79.3923076923077,633.907692307692,1738.01538461538,2124.37692307692,2650.07692307692,259.546153846154,1103.48461538462,3668.1,618.592307692308,122.723076923077,1074.65384615385,4559.63846153846,1117.24615384615,1032.18461538462,2073.79230769231,4444.63846153846,451.576923076923,257.1,1066.58461538462,3531.03846153846,301.438461538462,492.284615384615,658.569230769231,1412.73076923077,431.892307692308,484.4,1063.89230769231,129.515384615385,130,16.6127948163229,9.98843804328789,0.79906119154932,0.955882352941176,0.722222222222222,-0.506857647886239,50910.4384615385,35814.6076923077,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_777877,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
778228,1379.0310880829,149.787564766839,77.2331606217617,639.663212435233,2061.03626943005,1778.35233160622,437.145077720207,262.025906735751,1090.44041450777,2538.47668393782,528.927461139896,108.715025906736,1072.97409326425,3595.66321243523,1550.44041450777,1316.16062176166,2229.65803108808,6503.23316062176,520.927461139896,263.637305699482,1078.17098445596,7345.13989637306,331.79274611399,691.870466321243,752.290155440415,998.39378238342,428.891191709845,251.896373056995,1029.0414507772,130.139896373057,193,19.1776965130935,12.8963846748112,0.740126318532281,0.936893203883495,0.781376518218624,-1.53761407379787,50679.3160621762,35365.0259067358,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_778228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
778809,584.710691823899,1154.37106918239,320.427672955975,620.496855345912,117.327044025157,564.106918238994,345.163522012579,264.522012578616,1098.62264150943,1299.69182389937,563.446540880503,106.018867924528,1059.5786163522,594.918238993711,564.955974842767,781.251572327044,1433.72955974843,1020.33962264151,254.452830188679,223.289308176101,1041.92452830189,1024.38993710692,197.352201257862,285.830188679245,721.547169811321,585.088050314465,375.465408805031,195.698113207547,985.735849056604,132.496855345912,159,15.3101536358889,13.2475722742202,0.50128857450491,0.946428571428571,0.757142857142857,0.567131319135559,50208.0188679245,34843.2578616352,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_778809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
778950,1779.2578125,284.140625,91.9921875,630.28125,1266.1484375,3020.453125,3714.7734375,260.59375,1091.34375,4014.9375,1868.515625,114.875,1077.921875,844.7734375,498.2578125,308.9453125,1482.625,1338.1171875,303.6953125,238.015625,993.328125,1491.9375,224.4765625,345.2734375,646.7265625,2081.6796875,509.234375,347.3984375,1055.1875,130.96875,128,16.0891307038535,10.3177179105566,0.767302789338592,0.955223880597015,0.711111111111111,-0.614969366674339,51898.859375,34161.4140625,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_778950,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
779785,1542.42702702703,363.097297297297,123.297297297297,627.983783783784,1487.24324324324,1704.00540540541,397.264864864865,265.594594594595,1089.76756756757,2826.61081081081,638.118918918919,117.464864864865,1079.74054054054,647.713513513513,554.156756756757,272.151351351351,1588.04864864865,1140.37297297297,329.810810810811,238.313513513514,994.918918918919,1129.12432432432,223.367567567568,150.27027027027,590.081081081081,1308.03783783784,530.783783783784,229.897297297297,1046.23783783784,130.745945945946,185,20.0061028106606,13.0390165500971,0.758432194483247,0.848623853211009,0.608552631578947,-1.20196405833989,50865.3135135135,33985.3135135135,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_779785,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
780413,1353.64545454545,481.513636363636,76.3181818181818,632.368181818182,1659.78181818182,1445.57272727273,373.227272727273,262.954545454545,1094.96818181818,3325.76363636364,649.986363636364,120.759090909091,1072.22272727273,823.640909090909,913.959090909091,305.572727272727,1557.42272727273,1237.64545454545,373.131818181818,252.709090909091,982.909090909091,1189.70454545455,267.777272727273,139.718181818182,599.486363636364,2330.9,567.909090909091,259.240909090909,1063.41363636364,129.759090909091,220,21.9520441709555,13.3444632288144,0.794020027495434,0.887096774193548,0.611111111111111,0.594778048698096,51888.1636363636,34607.6727272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_780413,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
781184,2003.79487179487,692.302564102564,193.712820512821,660.092307692308,3027.45641025641,2667.8,467.969230769231,265.45641025641,1170.27179487179,3409.19487179487,493.707692307692,125.6,1073.66153846154,2275.63076923077,877.28717948718,391.374358974359,2113.8,6141.58974358974,458.194871794872,246.323076923077,1077.34871794872,6074.50256410256,409.379487179487,241.087179487179,585.174358974359,1326.48205128205,423.030769230769,278.307692307692,1065.36923076923,128.907692307692,195,21.2428716972217,11.8550857526484,0.829791458018714,0.919811320754717,0.65,-0.445474969725385,51232.8974358974,35820.4769230769,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_781184,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
781508,982.229166666667,546.798611111111,90.2152777777778,642.159722222222,1357.22916666667,820.923611111111,2076.35416666667,247.340277777778,1078.93055555556,2085.63888888889,495.506944444444,103.388888888889,1083.71527777778,714.854166666667,442.847222222222,284.236111111111,1483.36805555556,1179.53472222222,307.638888888889,233.118055555556,991.979166666667,1166.04861111111,234.4375,162.916666666667,581.756944444444,971.006944444444,397.402777777778,782.652777777778,1014.27083333333,129.229166666667,144,17.9742033149401,10.2301715652732,0.822227791176771,0.941176470588235,0.770053475935829,0.266254657941855,51243.0,35531.9444444444,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_781508,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
782097,2229.92052980132,105.652317880795,77.4139072847682,636.986754966887,1890.58609271523,2471.88079470199,666.639072847682,265.503311258278,1106.61920529801,3632.15894039735,541.400662251656,108.443708609272,1080.81125827815,3505.94039735099,924.112582781457,770.377483443709,6753.16887417219,3579.30463576159,363.443708609272,240.513245033113,1031.67549668874,2769.65231788079,248.516556291391,254.533112582781,636.427152317881,1081.04635761589,426.599337748344,301.175496688742,1024.62582781457,130.019867549669,302,25.6620711386221,15.4413886363114,0.798706895164612,0.904191616766467,0.653679653679654,0.852220324050313,51267.0397350993,35575.8841059603,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_782097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
783229,761.491803278689,356.289617486339,76.4808743169399,605.464480874317,830.349726775956,856.366120218579,2458.53551912568,251.213114754098,1095.54644808743,1897.5737704918,1750.61202185792,103.03825136612,1063.10382513661,983.75956284153,912.51912568306,1138.42076502732,1750.68306010929,1130.72131147541,292.950819672131,234.633879781421,990.51912568306,1017.13114754098,209.601092896175,307.584699453552,620.475409836066,1055.84153005464,492.786885245902,247.409836065574,1034.87431693989,133.169398907104,183,19.6581120606553,11.9328660571792,0.794686598057218,0.933673469387755,0.740890688259109,-1.42716319524649,51525.6284153005,34536.8907103825,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_783229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
784188,803.064039408867,171.423645320197,304.507389162562,780.546798029557,11043.3891625616,706.305418719212,375.394088669951,274.029556650246,1102.91625615764,1728.53694581281,829.832512315271,124.911330049261,1068.47783251232,925.566502463054,444.349753694581,293.980295566502,1559.06403940887,1279.30541871921,305.241379310345,900.192118226601,1003.28078817734,1100.08866995074,229.625615763547,282.349753694581,607.142857142857,1045.69458128079,462.448275862069,283.039408866995,1094.68472906404,131.743842364532,203,20.3109225741575,12.8076088207981,0.77612636736211,0.966666666666667,0.780769230769231,1.41558044687632,51860.8719211823,35319.6748768473,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_784188,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
785936,2067.91428571429,367.468571428571,185.405714285714,672.937142857143,3975.51428571429,2730.86285714286,466.822857142857,277.8,1116.01142857143,3256.15428571429,1381.74857142857,147.588571428571,1064.14285714286,1154.37714285714,727.817142857143,297.668571428571,1890.37714285714,1260.01142857143,279.062857142857,229.88,1138.41142857143,953.76,186.44,137.348571428571,2134.0,756.588571428571,428.154285714286,209.491428571429,1025.4,400.811428571429,175,19.7194862840966,11.7035093061474,0.804834206116491,0.940860215053764,0.694444444444444,1.06861355518688,51062.7257142857,33788.6742857143,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_785936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
786147,1146.23703703704,399.955555555556,77.2888888888889,606.97037037037,528.911111111111,1199.85925925926,321.807407407407,253.881481481481,1112.88148148148,2555.02962962963,413.533333333333,99.4074074074074,1067.85185185185,1118.4,977.355555555556,1507.05185185185,1637.97037037037,1723.83703703704,384.62962962963,243.955555555556,1017.62222222222,1459.40740740741,257.82962962963,400.562962962963,759.140740740741,1283.71851851852,438.933333333333,222.044444444444,1010.92592592593,128.644444444444,135,17.1088470562744,10.0529626220561,0.809159870932257,0.9375,0.703125,-0.426125800214439,50749.1925925926,35252.3703703704,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_786147,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
786803,496.165217391304,914.252173913044,240.907246376812,629.95652173913,108.776811594203,636.736231884058,395.452173913043,280.811594202899,1118.29565217391,1365.69855072464,1096.07826086957,111.310144927536,1064.28115942029,817.994202898551,639.663768115942,332.539130434783,1605.60869565217,1848.87246376812,313.420289855072,236.144927536232,1039.6115942029,1857.21449275362,223.576811594203,221.078260869565,687.547826086957,812.582608695652,424.942028985507,207.817391304348,1045.75942028986,130.733333333333,345,25.3803811741118,17.4927576647438,0.724548707921534,0.947802197802198,0.714285714285714,-0.79284185219922,51112.5130434783,35192.6579710145,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_786803,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
787398,1629.53153153153,170.36036036036,73.3963963963964,622.054054054054,945.054054054054,1924.07207207207,389.81981981982,257.252252252252,1080.20720720721,3523.71171171171,574.675675675676,104.540540540541,1065.93693693694,693.36036036036,527.846846846847,281.261261261261,1520.36936936937,1034.68468468468,300.666666666667,234.45045045045,986.243243243243,964.144144144144,226.990990990991,131.882882882883,586.306306306306,2184.76576576577,481.621621621622,238.594594594595,1065.02702702703,128.972972972973,111,16.7082258039738,8.50081221357236,0.860896535755827,0.917355371900826,0.60989010989011,-0.800294292169822,50366.8468468468,35422.8018018018,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_787398,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
787771,2167.87826086957,1211.32173913043,550.730434782609,646.660869565217,2193.4,2701.53913043478,2954.97391304348,270.034782608696,1137.18260869565,3307.88695652174,2374.04347826087,112.539130434783,1073.95652173913,4300.60869565217,902.8,832.782608695652,2107.51304347826,4847.3652173913,373.921739130435,238.321739130435,1056.25217391304,3680.87826086957,266.017391304348,874.8,650.086956521739,1271.48695652174,492.739130434783,238.852173913043,1341.86086956522,132.4,115,15.4727167836466,9.71480402198694,0.778320868905233,0.92,0.68452380952381,-0.654955104500636,51503.6782608696,35044.4173913043,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_787771,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
788287,1263.93835616438,261.36301369863,95.8561643835616,657.267123287671,2152.02739726027,1717.3698630137,984.308219178082,258.438356164384,1091.99315068493,3014.38356164384,658.842465753425,109.253424657534,1076.33561643836,1320.1301369863,494.280821917808,275.77397260274,1445.75342465753,3220.66438356164,337.794520547945,227.13698630137,1100.19178082192,3101.70547945205,234.232876712329,247.020547945205,770.568493150685,1696.28082191781,475.260273972603,343.746575342466,1052.08904109589,131.979452054795,146,17.9416932919954,10.4177309917367,0.814157789167995,0.935897435897436,0.715686274509804,-1.16017253557198,50250.2465753425,35109.2671232877,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
788922,1869.42735042735,899.478632478632,249.606837606838,686.376068376068,5248.49572649573,1962.45299145299,4032.64102564103,262.74358974359,1139.29914529915,3756.23931623932,627.769230769231,114.871794871795,1083.25641025641,4191.88888888889,1048.44444444444,1324.91452991453,3853.8547008547,3022.90598290598,321.666666666667,230.623931623932,1052.63247863248,2109.41025641026,212.145299145299,259.598290598291,677.384615384615,1503.12820512821,464.709401709402,1045.57264957265,1060.69230769231,133.786324786325,117,13.5127628713522,11.1616874053608,0.563654361721703,0.975,0.75,-0.464421296538626,51101.4017094017,35665.4017094017,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788922,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789130,1659.01149425287,210.252873563218,103.67816091954,634.264367816092,1775.01149425287,1705.67816091954,314.505747126437,256.229885057471,1099.75862068966,3563.66666666667,561.022988505747,115.67816091954,1085.89655172414,543.080459770115,466.011494252874,260.712643678161,1379.70114942529,942.977011494253,280.35632183908,227.758620689655,993.275862068966,910.402298850575,210.908045977011,122.310344827586,578.183908045977,2520.14942528736,544.137931034483,224.35632183908,1046.73563218391,128.689655172414,87,16.2036350729615,6.88024980080552,0.905375653361462,0.945652173913044,0.776785714285714,-1.46655854335081,50228.6781609195,34349.1034482759,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_789130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789452,355.0,795.216066481994,187.994459833795,603.074792243767,123.196675900277,368.091412742382,300.141274238227,249.152354570637,1110.60941828255,775.094182825485,391.664819944598,95.2493074792244,1060.46260387812,928.562326869806,527.612188365651,283.639889196676,1550.85595567867,1091.17174515235,226.260387811634,223.268698060942,1344.19390581717,734.92243767313,160.570637119114,124.728531855956,589.229916897507,567.825484764543,360.728531855956,195.368421052632,978.698060941828,130.767313019391,361,22.4153807092111,20.8689379475804,0.364994313583661,0.96524064171123,0.781385281385281,-1.5214060410894,50185.7950138504,34985.1828254848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_789452,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789484,2102.9601029601,200.195624195624,108.07722007722,658.249678249678,3772.21879021879,2459.95881595882,397.868725868726,263.014157014157,1095.39897039897,3152.30373230373,581.611325611326,112.924066924067,1087.62033462033,794.577863577864,560.009009009009,286.191763191763,1461.61261261261,1212.3166023166,356.248391248391,244.088803088803,983.46332046332,1125.12998712999,241.743886743887,134.505791505792,587.400257400257,1188.98841698842,491.140283140283,219.33462033462,1032.26640926641,129.71685971686,777,41.4802748743002,24.9547001810003,0.798794467436912,0.956896551724138,0.664102564102564,-1.04269576903098,51778.148005148,34472.6731016731,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_789484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789648,1876.14444444444,325.922222222222,226.111111111111,680.4,6031.82222222222,2508.45555555556,302.933333333333,259.622222222222,1102.14444444444,2994.9,470.522222222222,112.388888888889,1087.33333333333,1070.74444444444,687.244444444444,282.255555555556,1635.91111111111,1228.0,329.088888888889,239.155555555556,988.877777777778,1000.77777777778,218.433333333333,131.566666666667,584.111111111111,1219.86666666667,499.333333333333,221.022222222222,1039.4,131.311111111111,90,13.7841913871148,8.30677359487284,0.798020381198948,0.947368421052632,0.75,-0.547302966756366,50830.5222222222,34726.4777777778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_789648,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789837,2326.8125,357.625,869.125,607.984375,611.65625,2955.140625,932.015625,262.734375,1087.234375,3982.171875,817.75,108.15625,1059.453125,4517.28125,774.40625,827.09375,2244.265625,4275.578125,458.5,235.796875,1050.671875,2561.171875,238.453125,236.53125,736.1875,1279.53125,464.375,462.59375,1056.765625,127.296875,64,11.9088699399778,7.34309228136846,0.787271133179434,0.853333333333333,0.727272727272727,-1.43256823962506,51047.921875,35598.203125,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_789837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
789934,782.390804597701,79.9655172413793,45.7816091954023,610.413793103448,605.195402298851,893.793103448276,266.712643678161,240.816091954023,1080.63218390805,1612.55172413793,503.35632183908,110.183908045977,1068.11494252874,697.218390804598,504.563218390805,289.816091954023,1495.94252873563,1141.96551724138,375.390804597701,246.080459770115,987.666666666667,1115.22988505747,250.103448275862,140.919540229885,593.068965517241,870.931034482759,462.413793103448,215.942528735632,1031.67816091954,132.862068965517,87,11.2479680986475,9.8795657301216,0.478032292574977,0.925531914893617,0.725,1.31339078130615,51027.4942528736,33988.4022988506,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_789934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
790578,1531.86466165414,630.278195488722,85.5338345864662,665.781954887218,3178.81954887218,1337.03007518797,416.165413533835,262.556390977444,1113.99248120301,2559.90977443609,554.300751879699,109.022556390977,1066.45864661654,1062.57142857143,586.345864661654,385.142857142857,1571.40601503759,2143.3007518797,339.646616541353,233.323308270677,1000.78947368421,2717.4962406015,251.383458646617,238.09022556391,599.676691729323,942.496240601504,447.270676691729,230.285714285714,1026.45864661654,130.308270676692,133,15.7049929143439,10.7977273496069,0.726151538941528,0.95,0.738888888888889,0.393884274864073,51397.3533834586,35589.8270676692,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_790578,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
791524,849.556701030928,97.0721649484536,80.0,699.164948453608,1705.30927835052,864.752577319588,322.989690721649,262.505154639175,1084.50515463918,2263.56701030928,538.309278350515,111.989690721649,1063.46391752577,5227.41237113402,1072.54639175258,509.298969072165,1812.54639175258,2256.23711340206,311.752577319588,228.659793814433,1032.94845360825,1428.65979381443,215.113402061856,357.278350515464,665.649484536082,1664.74226804124,479.938144329897,221.453608247423,1054.16494845361,131.474226804124,97,12.9177039037643,9.56947455025001,0.671722286154258,0.941747572815534,0.678321678321678,-0.896805107476637,50024.9587628866,35239.1030927835,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_791524,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
791614,3293.25182481752,208.386861313869,184.36496350365,745.445255474453,4382.32116788321,3085.00729927007,659.489051094891,275.270072992701,1147.68248175182,6695.21167883212,816.945255474453,123.682481751825,1070.67153284672,6176.50364963504,1120.37226277372,389.959854014598,2686.61678832117,7219.73357664234,493.178832116788,284.113138686131,1076.12408759124,6313.90875912409,1886.20437956204,220.383211678832,594.715328467153,2929.24452554745,500.102189781022,457.85401459854,1077.01094890511,130.386861313869,274,21.1311223519545,18.240893168129,0.504820985311892,0.837920489296636,0.732620320855615,-1.45111391555115,50602.3576642336,35600.5510948905,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_791614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
791975,1748.47619047619,312.22619047619,144.047619047619,701.410714285714,5696.125,1884.80952380952,341.988095238095,264.958333333333,1108.25,3515.85119047619,515.136904761905,110.970238095238,1089.57142857143,1155.375,611.547619047619,281.505952380952,1828.79166666667,1144.67857142857,324.011904761905,236.630952380952,993.958333333333,1066.72023809524,240.690476190476,148.684523809524,587.482142857143,1353.18452380952,455.464285714286,221.505952380952,1049.08928571429,129.541666666667,168,19.0660502000593,11.292162797851,0.805742909966052,0.943820224719101,0.666666666666667,-1.11129955495447,50789.25,35263.7142857143,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_791975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
793010,2730.99152542373,559.067796610169,719.991525423729,624.322033898305,1116.49152542373,2628.45762711864,1953.66101694915,268.28813559322,1078.40677966102,5087.65254237288,738.152542372881,115.432203389831,1070.12711864407,1557.47457627119,588.440677966102,277.898305084746,4419.03389830509,4247.83050847458,377.508474576271,248.423728813559,1032.05084745763,3912.66101694915,518.661016949153,176.050847457627,592.983050847458,2257.75423728814,527.542372881356,327.338983050847,1051.25423728814,129.864406779661,118,14.3370641592765,10.599490297543,0.673368639180978,0.951612903225806,0.766233766233766,0.457256053578374,51471.8559322034,35110.0169491525,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
793382,1895.31395348837,911.883720930233,170.75,661.03488372093,3716.08139534884,2080.98255813953,1831.43023255814,264.662790697674,1104.72093023256,3161.37790697674,696.563953488372,110.604651162791,1070.24418604651,780.25,605.127906976744,279.162790697674,1734.09302325581,1208.72674418605,329.598837209302,235.883720930233,1032.33139534884,1060.0523255814,215.046511627907,176.122093023256,585.488372093023,1239.97093023256,518.755813953488,761.883720930233,1061.12209302326,130.872093023256,172,21.9229419261169,12.0159025104107,0.836414662775724,0.774774774774775,0.614285714285714,1.4708159111705,51250.2790697674,35032.1046511628,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793382,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
793569,831.866666666667,128.76,278.253333333333,845.946666666667,8497.76,745.186666666667,318.133333333333,269.866666666667,1086.56,1513.57333333333,580.706666666667,141.893333333333,1073.58666666667,2742.28,1353.26666666667,2454.24,1741.6,3504.86666666667,354.88,250.666666666667,1046.53333333333,2393.6,255.186666666667,503.626666666667,716.013333333333,1089.92,447.253333333333,216.386666666667,1079.61333333333,128.386666666667,75,12.0447259505531,7.99055825462255,0.748258544799381,0.914634146341463,0.694444444444444,-0.455536918279208,50128.0133333333,35226.4266666667,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_793569,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
793892,1254.63574351978,372.968622100955,213.107776261937,694.529331514325,5715.64938608458,1233.15825375171,377.432469304229,280.735334242838,1091.44747612551,1723.94133697135,686.603001364256,122.038199181446,1068.04092769441,631.208731241473,492.447476125512,271.628922237381,1472.73942701228,960.190995907231,269.245566166439,226.394270122783,987.907230559345,813.818553888131,195.12687585266,131.201909959072,578.881309686221,725.193724420191,420.334242837654,209.482946793997,1004.44338335607,130.619372442019,733,34.119913619414,27.4064971892381,0.595654820814836,0.965744400527009,0.74040404040404,-0.545520444699072,49877.0532060027,34956.3424283765,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793892,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
793997,501.291457286432,921.778894472362,228.733668341708,610.758793969849,197.442211055276,618.005025125628,369.844221105528,261.331658291457,1104.91959798995,1541.08040201005,820.331658291457,140.482412060301,1074.61306532663,1780.95979899497,651.753768844221,409.964824120603,2026.14070351759,1861.96984924623,335.748743718593,844.492462311558,1229.10552763819,1119.11557788945,213.638190954774,275.989949748744,734.427135678392,763.834170854271,428.592964824121,211.608040201005,1027.02512562814,128.859296482412,199,17.0036688512969,14.8964953298558,0.482174202521833,0.961352657004831,0.780392156862745,0.290633832918472,51103.1306532663,34018.864321608,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793997,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
794757,1744.89887640449,599.831460674157,95.5898876404494,610.887640449438,532.898876404494,1988.01123595506,682.601123595506,261.297752808989,1101.17415730337,2811.76404494382,495.556179775281,112.297752808989,1070.9606741573,6596.3595505618,1046.42696629213,551.97191011236,1967.89325842697,5443.26966292135,383.039325842697,239.370786516854,1042.77528089888,4515.02808988764,8658.78651685393,258.994382022472,616.404494382022,1208.60674157303,454.415730337079,418.505617977528,1020.88764044944,130.651685393258,178,19.5104738095985,12.1272308816418,0.783354327091572,0.936842105263158,0.669172932330827,-1.20882291096043,51044.9831460674,35775.1292134831,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_794757,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
795275,2601.36283185841,170.778761061947,88.4690265486726,630.137168141593,1806.06194690265,3039.62831858407,471.977876106195,264.159292035398,1115.70796460177,4648.74336283186,549.911504424779,118.433628318584,1073.50442477876,2583.39823008849,1292.90707964602,462.747787610619,2725.9203539823,6171.64159292035,478.371681415929,267.075221238938,1044.06194690265,6737.63716814159,289.544247787611,207.526548672566,618.535398230089,1990.88495575221,553.438053097345,248.491150442478,1040.4203539823,128.827433628319,226,19.9180985017692,17.9836821742994,0.429889567568639,0.758389261744966,0.54066985645933,-1.22826976885648,51740.9955752212,34932.3761061947,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_795275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
796591,959.339393939394,275.278787878788,100.866666666667,635.575757575758,2106.38787878788,1221.37575757576,1886.59393939394,252.29696969697,1105.28484848485,2708.84848484848,805.418181818182,114.490909090909,1070.89696969697,970.715151515152,704.854545454545,272.975757575758,2092.44242424242,1277.49090909091,308.157575757576,232.775757575758,1083.16363636364,1089.75757575758,200.606060606061,147.715151515152,4219.95151515152,1400.95757575758,531.672727272727,254.012121212121,1062.83636363636,130.49696969697,165,15.8045908628204,13.4164035680958,0.528565033859411,0.976331360946746,0.785714285714286,-0.982352566897017,51374.3636363636,34307.9212121212,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_796591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
796898,800.43661971831,1056.2676056338,1266.52112676056,717.077464788732,457.859154929578,499.042253521127,261.661971830986,235.028169014085,1084.97183098592,1029.87323943662,355.929577464789,95.4014084507042,1071.7676056338,887.098591549296,406.971830985916,322.330985915493,1692.10563380282,1163.11267605634,269.894366197183,356.669014084507,1052.64084507042,1061.71830985915,207.683098591549,182.345070422535,802.978873239437,596.140845070423,376.211267605634,206.87323943662,990.197183098592,129.704225352113,142,14.6972448736721,12.3144558756818,0.545861956951224,0.953020134228188,0.728205128205128,-0.976515571234492,52080.0,34681.0211267606,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_796898,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
797825,1084.37430167598,91.3463687150838,152.150837988827,695.329608938547,5389.78212290503,1307.00558659218,331.983240223464,253.430167597765,1080.97206703911,2561.11173184358,813.497206703911,123.921787709497,1065.61452513966,969.234636871508,534.100558659218,283.122905027933,1558.37430167598,1172.89944134078,237.022346368715,228.558659217877,1135.44134078212,687.290502793296,141.804469273743,125.050279329609,589.106145251397,1221.56983240223,497.932960893855,221.843575418994,1045.8156424581,129.782122905028,179,21.0092129340443,11.8512653336848,0.825707509564411,0.852380952380952,0.639285714285714,1.51202577578564,51152.6145251397,34031.1508379888,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_797825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
798073,506.781938325991,866.656387665198,209.911894273128,609.828193832599,107.308370044053,489.966960352423,332.519823788546,252.623348017621,1091.2268722467,1237.09911894273,1166.68502202643,117.480176211454,1068.57709251101,976.612334801762,549.662995594714,286.433920704846,1647.0550660793,1032.00220264317,237.964757709251,224.42731277533,1130.76431718062,632.830396475771,136.636563876652,123.854625550661,583.834801762115,582.651982378855,377.013215859031,201.689427312775,985.011013215859,129.38986784141,454,32.4153091355471,18.4053825400805,0.823167182613298,0.943866943866944,0.646723646723647,-0.774539802514927,51153.6828193833,33985.2775330396,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798073,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
798272,948.106382978723,180.308510638298,93.6063829787234,605.372340425532,609.702127659574,926.5,327.13829787234,263.117021276596,1074.51063829787,2244.52127659574,500.372340425532,108.191489361702,1077.68085106383,628.265957446809,444.585106382979,269.5,1468.42553191489,1254.47872340426,308.329787234043,230.425531914894,1023.77659574468,1392.3829787234,242.255319148936,431.234042553192,818.670212765957,1386.6914893617,444.787234042553,219.18085106383,1010.64893617021,130.531914893617,94,13.7882871920361,8.76440412049979,0.771984585319694,0.94949494949495,0.657342657342657,-0.948585606662871,50559.585106383,35511.5319148936,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798272,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
798565,1255.88023952096,142.622754491018,64.2994011976048,627.071856287425,1199.2874251497,1441.22754491018,369.658682634731,249.676646706587,1087.17964071856,3080.08383233533,745.958083832335,109.604790419162,1090.99401197605,1541.91017964072,632.784431137725,304.670658682635,1646.20958083832,4617.05389221557,439.023952095808,251.311377245509,1002.65269461078,5432.68862275449,282.191616766467,158.245508982036,588.718562874251,1776.1497005988,484.047904191617,231.586826347305,1035.64071856287,128.107784431138,167,23.9476017325035,9.09395250194378,0.925091709575689,0.922651933701657,0.491176470588235,-0.892978877722632,51162.2754491018,34529.5269461078,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798565,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
798698,1149.80530973451,380.716814159292,91.6017699115044,624.743362831858,1565.74336283186,1113.17699115044,789.805309734513,263.982300884956,1119.7610619469,2098.07079646018,483.75221238938,118.29203539823,1070.77876106195,793.548672566372,499.185840707965,567.345132743363,1530.99115044248,1030.55752212389,295.973451327434,225.353982300885,990.522123893805,991.610619469027,229.362831858407,294.017699115044,580.83185840708,1403.26548672566,515.504424778761,417.991150442478,1033.78761061947,131.203539823009,113,15.8117292331793,9.20297961631678,0.813163743708467,0.933884297520661,0.753333333333333,-0.126930799443922,51152.610619469,35827.0088495575,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
799265,384.904810644831,212.479017400205,107.25076765609,632.219037871034,1953.34390992835,498.553735926305,338.861821903787,256.580348004094,1079.21494370522,861.17911975435,464.049129989765,108.320368474923,1064.75230296827,821.844421699079,936.799385875128,342.519959058342,1626.08495394063,1027.82088024565,262.102354145343,226.972364380757,1009.44319344933,930.113613101331,215.208802456499,177.295803480041,619.254861821904,747.360286591607,395.443193449335,206.533265097236,1009.18116683726,133.556806550665,977,55.5893906059015,22.7596425521368,0.912344130819566,0.9541015625,0.550112612612613,-0.583456797082587,50251.548618219,35406.4595701126,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_799265,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
799712,996.435897435898,98.1367521367521,235.551282051282,758.230769230769,8507.93162393162,1107.63675213675,287.529914529914,245.948717948718,1086.83760683761,2357.28205128205,548.431623931624,125.555555555556,1069.49572649573,649.931623931624,770.17094017094,524.200854700855,1532.22222222222,985.982905982906,256.405982905983,226.410256410256,1002.2094017094,947.504273504274,191.081196581197,199.081196581197,634.764957264957,1222.54273504274,488.816239316239,243.290598290598,1070.88034188034,131.888888888889,234,23.1859987605016,12.8694085203864,0.831816412633028,0.947368421052632,0.782608695652174,-1.53082038036203,51347.735042735,33766.9316239316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_799712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
800068,1347.90163934426,249.071038251366,106.830601092896,641.568306010929,2541.15846994536,1748.19672131148,780.109289617486,259.945355191257,1093.3825136612,2680.77049180328,1199.90163934426,113.51912568306,1106.09836065574,698.874316939891,561.081967213115,283.31693989071,1425.73770491803,1136.69945355191,367.054644808743,248.355191256831,979.814207650273,1104.58469945355,260.284153005464,147.497267759563,586.448087431694,1168.60655737705,506.79781420765,258.956284153005,1041.94535519126,130.224043715847,183,17.4467662058209,13.5203834891837,0.632021700474473,0.943298969072165,0.717647058823529,-0.246994902393498,51647.9781420765,34384.3278688525,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_800068,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
800077,608.261976047904,728.763473053892,194.820359281437,641.278443113772,84.998502994012,726.461077844311,439.952095808383,283.760479041916,1116.50898203593,1552.91167664671,1071.84730538922,115.968562874252,1062.35928143713,1624.50449101796,532.422155688623,413.494011976048,1793.63922155689,2849.74700598802,331.90119760479,1075.3128742515,1122.71407185629,2325.53592814371,225.205089820359,254.267964071856,2603.75449101796,754.164670658683,463.538922155689,211.175149700599,1013.23353293413,130.547904191617,668,38.1819053197189,22.6267254470555,0.805494416957108,0.951566951566952,0.685128205128205,0.277244212849351,50304.2619760479,34917.5763473054,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_800077,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
800326,2039.43209876543,309.037037037037,168.888888888889,651.555555555556,2640.51851851852,2641.46913580247,4451.81481481481,262.160493827161,1089.06172839506,3188.88888888889,835.62962962963,109.234567901235,1072.34567901235,998.197530864198,595.012345679012,294.592592592593,1564.27160493827,1506.6049382716,342.79012345679,239.222222222222,990.641975308642,1332.65432098765,231.395061728395,159.41975308642,593.320987654321,954.901234567901,461.296296296296,437.358024691358,1031.49382716049,129.802469135802,81,12.4658423557091,9.4991380302931,0.647561338150435,0.835051546391753,0.613636363636364,0.512826549539749,51111.5185185185,35069.3086419753,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_800326,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
800359,879.235232067511,338.392405063291,112.684599156118,645.905063291139,947.53164556962,917.585443037975,1546.42721518987,269.892405063291,1089.64135021097,1312.20464135021,772.197257383966,3533.68037974684,1068.04852320675,2916.84599156118,1139.14767932489,930.35864978903,1688.94303797468,3654.12869198312,412.79641350211,248.955696202532,1007.68143459916,3805.30063291139,267.933544303797,230.539029535865,685.009493670886,1002.88818565401,538.488396624473,239.39135021097,1025.64767932489,130.430379746835,948,39.1846426636755,31.3068297682946,0.601388655430041,0.970317297850563,0.740625,0.27274958934045,50871.5601265823,34533.996835443,FAAGSCC_12,AG,1,tumor cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,tumor cells,Tumor,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_800359,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
801543,436.646907216495,723.471649484536,194.783505154639,624.528350515464,861.298969072165,518.270618556701,365.997422680412,263.35824742268,1103.80154639175,1166.95103092784,571.69587628866,113.551546391753,1057.25257731959,3603.7293814433,1229.13659793814,2501.39175257732,1914.12113402062,3643.52577319588,357.909793814433,238.615979381443,1053.40463917526,2643.81443298969,270.840206185567,604.79381443299,781.930412371134,792.05412371134,437.221649484536,216.216494845361,1043.57731958763,134.355670103093,388,30.0708005700283,16.6195609987496,0.833392872719222,0.946341463414634,0.668965517241379,-1.13677951830109,50190.6443298969,34832.8788659794,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_801543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
801582,1850.0,402.107692307692,145.469230769231,641.261538461538,1550.81923076923,2095.00769230769,380.2,279.115384615385,1080.82692307692,3320.44230769231,562.465384615385,117.819230769231,1088.54230769231,1100.20384615385,575.926923076923,301.192307692308,1737.18846153846,1524.81923076923,345.519230769231,234.715384615385,999.126923076923,1306.58076923077,236.561538461538,423.330769230769,583.869230769231,1519.01538461538,491.511538461538,235.761538461538,1043.51538461538,130.734615384615,260,26.6266015606707,12.7791599710612,0.877301544228643,0.935251798561151,0.590909090909091,-0.851942175107061,50439.0730769231,35461.4923076923,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_801582,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
802049,1981.92342342342,366.864864864865,168.594594594595,651.387387387387,2520.54954954955,2735.0,456.617117117117,270.815315315315,1092.79279279279,2563.95045045045,1008.65765765766,131.621621621622,1079.52702702703,615.211711711712,429.234234234234,263.914414414414,1423.73873873874,1091.23423423423,295.027027027027,232.617117117117,983.486486486486,906.68018018018,204.315315315315,130.828828828829,583.765765765766,1158.75675675676,560.779279279279,249.536036036036,1075.33333333333,132.378378378378,222,20.3842909671119,13.9297997648538,0.730082005423302,0.936708860759494,0.687306501547988,-0.677122008802488,50733.8603603604,33892.8828828829,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802049,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
802100,374.252808988764,847.820224719101,245.196629213483,624.308988764045,114.202247191011,424.280898876404,316.539325842697,251.23595505618,1116.24719101124,1005.74719101124,708.247191011236,100.044943820225,1066.03370786517,797.943820224719,646.342696629213,279.224719101124,1988.58988764045,1105.74157303371,258.842696629213,239.898876404494,1056.94382022472,963.865168539326,196.584269662921,164.88202247191,1422.48876404494,568.247191011236,356.38202247191,194.213483146067,982.775280898876,131.421348314607,178,15.8332454912896,14.3407031937942,0.423847330320252,0.951871657754011,0.794642857142857,1.40506669548284,50152.2078651685,34927.7696629213,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
802115,1538.76111111111,905.438888888889,159.877777777778,650.522222222222,2458.36111111111,1408.25555555556,593.355555555556,267.833333333333,1107.40555555556,2682.98888888889,509.588888888889,110.583333333333,1071.22777777778,2468.54444444444,1334.29444444444,3103.83888888889,2280.33333333333,3677.33888888889,385.6,244.25,1069.80555555556,3176.20555555556,368.144444444445,894.333333333333,905.283333333333,1293.49444444444,426.944444444444,219.655555555556,1048.35555555556,130.161111111111,180,20.7229955134659,11.0775013967855,0.845136114394661,0.942408376963351,0.625,-0.650735773675731,50863.6111111111,35403.4833333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802115,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
802338,2481.57045454545,250.840909090909,86.5840909090909,633.4,1631.46590909091,2395.35681818182,2912.98409090909,266.543181818182,1122.35,4202.83181818182,1047.10681818182,112.084090909091,1078.59772727273,1485.76590909091,711.647727272727,1171.80909090909,1693.08863636364,1247.63636363636,306.368181818182,234.031818181818,999.040909090909,1091.62272727273,224.381818181818,218.956818181818,623.318181818182,1137.76136363636,441.713636363636,504.072727272727,1046.64772727273,133.418181818182,440,28.423304402387,20.086566332117,0.707519755516393,0.950323974082074,0.7085346215781,-0.401179722921908,50970.8772727273,35534.6272727273,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802338,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
803349,363.38062283737,735.705882352941,188.567474048443,602.854671280277,115.584775086505,330.965397923875,253.477508650519,232.737024221453,1103.96885813149,739.747404844291,386.494809688581,106.031141868512,1065.03114186851,1144.45674740484,530.61937716263,359.643598615917,1651.18339100346,1136.76816608997,237.719723183391,251.429065743945,1259.97923875433,777.740484429066,155.200692041523,129.851211072664,600.21107266436,574.034602076125,374.415224913495,200.193771626298,988.384083044983,131.217993079585,289,23.5394781248001,15.6815611530378,0.745789794852617,0.973063973063973,0.83768115942029,-1.53898659680935,51314.7716262976,33909.2733564014,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_803349,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
803725,1529.07042253521,350.316901408451,156.514084507042,673.669014084507,3595.11267605634,1572.42957746479,407.154929577465,274.316901408451,1106.57746478873,3535.72535211268,753.119718309859,121.147887323944,1069.14084507042,1537.22535211268,616.197183098591,471.239436619718,1559.49295774648,3374.71126760563,342.471830985916,237.007042253521,1012.96478873239,3121.45070422535,247.577464788732,252.56338028169,618.457746478873,1364.66197183099,441.028169014084,245.528169014085,1061.06338028169,130.19014084507,142,15.9035861434748,11.6354554358057,0.681707701913782,0.928104575163399,0.696078431372549,-1.50046406536192,51727.0563380282,35525.6408450704,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_803725,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
803854,1133.38636363636,153.011363636364,95.2613636363636,667.602272727273,1028.28409090909,2017.44318181818,394.954545454545,268.363636363636,1131.05681818182,2387.45454545455,1792.54545454545,131.863636363636,1064.60227272727,771.420454545455,450.204545454545,267.534090909091,1682.48863636364,1142.07954545455,257.295454545455,230.022727272727,1051.36363636364,634.159090909091,146.522727272727,107.238636363636,578.431818181818,864.181818181818,427.829545454545,204.681818181818,1031.55681818182,130.125,88,15.4897252183097,7.20939924367141,0.885084135782266,0.956521739130435,0.698412698412698,-1.12557638816032,49950.4659090909,34380.0681818182,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,12,FAAGSCC_12_803854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
806200,3769.27118644068,399.347457627119,74.1694915254237,638.932203389831,1217.97457627119,3227.33898305085,1275.55084745763,262.389830508475,1086.99152542373,8042.72881355932,703.889830508475,118.440677966102,1078.14406779661,1230.22881355932,657.754237288136,306.991525423729,1766.13559322034,2593.64406779661,345.279661016949,235.322033898305,1020.11016949153,2497.0593220339,254.703389830508,441.35593220339,1574.10169491525,3563.65254237288,542.254237288136,397.627118644068,1048.63559322034,130.28813559322,118,14.3147788933836,11.620720349016,0.583937244851842,0.797297297297297,0.567307692307692,-0.0841384135697305,52003.8898305085,35214.3728813559,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_806200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
807026,1951.48863636364,406.022727272727,98.2272727272727,624.022727272727,1015.64772727273,2075.77272727273,1705.97727272727,254.363636363636,1107.70454545455,5103.57954545455,1099.44318181818,118.738636363636,1083.57954545455,1267.11363636364,562.238636363636,291.852272727273,1830.65909090909,1341.69318181818,248.272727272727,220.511363636364,1384.88636363636,736.034090909091,150.340909090909,123.181818181818,795.431818181818,1719.88636363636,520.647727272727,260.306818181818,1054.18181818182,132.25,88,12.8242579438277,9.02333860581162,0.710581531240524,0.916666666666667,0.727272727272727,0.895346588259024,51268.2386363636,34049.8636363636,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_807026,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
807048,1243.82442748092,389.503816793893,188.412213740458,671.435114503817,3373.32061068702,1600.93893129771,377.312977099237,267.770992366412,1092.41221374046,2166.41221374046,671.793893129771,126.824427480916,1073.70992366412,935.778625954198,913.229007633588,304.900763358779,1629.58015267176,1317.06106870229,436.427480916031,258.603053435115,982.259541984733,1125.06870229008,263.435114503817,144.900763358779,587.587786259542,1308.16030534351,543.0,227.664122137404,1092.32061068702,134.854961832061,131,15.5166928561623,10.9096776443053,0.711097937977201,0.935714285714286,0.682291666666667,-1.29841954093522,50766.3893129771,34073.9465648855,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_807048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
807286,2666.15853658537,192.414634146341,109.219512195122,637.073170731707,1556.79268292683,1422.46341463415,335.512195121951,264.268292682927,1085.40243902439,3564.9512195122,716.682926829268,115.865853658537,1062.91463414634,917.817073170732,543.439024390244,309.90243902439,1436.63414634146,1498.74390243902,355.963414634146,242.280487804878,1065.69512195122,1475.31707317073,248.121951219512,738.292682926829,744.634146341463,1149.79268292683,443.878048780488,228.817073170732,1076.82926829268,129.121951219512,82,11.3603070842896,9.98046557170428,0.477671798847055,0.872340425531915,0.573426573426573,0.405756986772414,50162.8902439024,35316.4146341463,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_807286,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
808137,1323.70930232558,118.813953488372,84.6860465116279,631.93023255814,839.244186046512,1207.96511627907,294.372093023256,254.313953488372,1092.10465116279,2982.58139534884,759.302325581395,113.732558139535,1072.0,792.441860465116,451.069767441861,272.860465116279,1687.26744186047,1246.98837209302,282.488372093023,229.174418604651,1014.22093023256,1124.6976744186,209.406976744186,140.802325581395,1652.03488372093,1333.31395348837,468.918604651163,216.802325581395,1032.32558139535,130.604651162791,86,15.8748184241835,6.97696778163142,0.898243049456788,0.914893617021277,0.716666666666667,-1.31837605576857,50133.1744186046,34684.9534883721,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_808137,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
809431,2197.73333333333,768.342857142857,110.704761904762,615.904761904762,728.438095238095,2573.47619047619,467.647619047619,269.266666666667,1121.40952380952,5011.71428571429,559.542857142857,114.114285714286,1067.42857142857,4941.93333333333,915.409523809524,349.742857142857,2542.2380952381,10008.7523809524,454.047619047619,261.428571428571,1036.78095238095,9130.80952380952,285.190476190476,163.238095238095,606.333333333333,2110.7619047619,544.2,331.27619047619,1026.12380952381,129.838095238095,105,17.0117203660452,7.972219943178,0.883394002074915,0.945945945945946,0.625,-0.933285099574728,51456.8666666667,35021.8666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_809431,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
809601,1584.91785714286,169.467857142857,186.357142857143,716.317857142857,7185.96785714286,2198.22142857143,353.825,262.039285714286,1099.38214285714,3026.65714285714,758.817857142857,142.989285714286,1069.03214285714,543.071428571429,341.257142857143,257.757142857143,1422.92857142857,720.45,184.046428571428,212.764285714286,997.742857142857,637.485714285714,142.510714285714,122.817857142857,588.692857142857,921.003571428571,477.946428571429,220.578571428571,1048.06428571429,140.2,280,25.5219206858247,14.2505973099428,0.829594079106435,0.958904109589041,0.8,0.0239651179425015,51318.2964285714,34001.7357142857,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_809601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
809899,505.542105263158,827.010526315789,234.342105263158,625.289473684211,120.773684210526,651.868421052632,445.526315789474,290.184210526316,1119.44210526316,1452.65789473684,829.08947368421,116.742105263158,1069.58947368421,651.826315789474,432.005263157895,347.236842105263,1556.62105263158,958.431578947368,269.184210526316,230.863157894737,985.71052631579,897.415789473684,208.505263157895,155.794736842105,594.7,590.731578947368,368.273684210526,199.3,988.278947368421,127.573684210526,190,18.4187209733186,13.1311527293175,0.701241058417078,0.969387755102041,0.7421875,0.720908964839503,51538.8894736842,35218.4894736842,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_809899,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
810148,1350.76315789474,286.447368421053,81.1184210526316,631.947368421053,2225.80263157895,1541.34210526316,3701.90789473684,251.736842105263,1086.89473684211,2277.84210526316,1944.63157894737,108.394736842105,1065.01315789474,717.578947368421,524.526315789474,269.5,1528.93421052632,1101.84210526316,324.171052631579,234.513157894737,985.526315789474,1022.13157894737,217.473684210526,193.184210526316,580.144736842105,1606.23684210526,497.171052631579,454.934210526316,1061.03947368421,132.355263157895,76,12.3461538139677,7.95288540586745,0.764891661997598,0.91566265060241,0.730769230769231,-1.43636126561763,51396.6842105263,34618.1973684211,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_810148,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
810203,820.084745762712,252.991525423729,205.016949152542,646.067796610169,2639.57627118644,745.203389830509,2938.83898305085,257.661016949152,1093.19491525424,1587.70338983051,2129.96610169492,107.161016949153,1065.5,1293.48305084746,576.415254237288,312.169491525424,1588.16949152542,2177.85593220339,304.194915254237,239.474576271186,1012.54237288136,1904.73728813559,235.110169491525,822.847457627119,741.152542372881,1087.54237288136,499.618644067797,389.728813559322,1045.97457627119,130.805084745763,118,14.2218077612755,10.6198794107207,0.665125004890036,0.936507936507936,0.766233766233766,-1.46726912369946,51777.7033898305,35111.5762711864,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_810203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
810220,984.188405797102,159.275362318841,68.2463768115942,610.166666666667,731.95652173913,1261.47101449275,1874.40579710145,251.492753623188,1079.29710144928,1815.53623188406,1516.90579710145,101.434782608696,1072.23188405797,823.652173913043,522.68115942029,270.188405797101,1608.92753623188,2466.23913043478,353.521739130435,239.144927536232,1049.19565217391,1991.1884057971,229.644927536232,214.746376811594,657.028985507246,947.565217391304,474.891304347826,569.231884057971,1035.3115942029,131.934782608696,138,16.8835588611932,10.518776688996,0.782206762502283,0.938775510204082,0.657142857142857,-0.873239762674787,50227.4347826087,34756.9927536232,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_810220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
811024,2351.93269230769,260.788461538462,435.0,805.586538461538,15501.0865384615,2744.16346153846,613.884615384615,296.048076923077,1112.05769230769,5282.70192307692,1015.5,168.605769230769,1079.26923076923,2101.38461538462,902.163461538462,560.067307692308,2061.43269230769,2493.13461538462,362.980769230769,241.682692307692,1023.57692307692,2202.52884615385,218.163461538462,177.740384615385,602.730769230769,2200.06730769231,515.384615384615,240.326923076923,1065.32692307692,131.701923076923,104,16.5136838536301,8.05341028260628,0.87302188804626,0.97196261682243,0.693333333333333,0.460998538551347,51752.2788461538,34746.3365384615,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_811024,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
811187,1207.05309734513,252.424778761062,89.2212389380531,661.150442477876,2341.47787610619,1295.27433628319,471.486725663717,261.628318584071,1162.76991150442,2255.05309734513,612.87610619469,109.982300884956,1075.61946902655,8245.28318584071,825.929203539823,392.654867256637,7867.69911504425,5380.88495575221,379.486725663717,243.716814159292,1033.15044247788,3476.14159292035,251.884955752212,231.469026548673,617.230088495575,1154.40707964602,452.353982300885,397.053097345133,1042.63716814159,131.247787610619,113,14.2228955748534,10.612701768154,0.665755161294753,0.904,0.627777777777778,0.242518196283114,50611.017699115,35551.6902654867,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_811187,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
811209,628.279569892473,581.277777777778,167.964157706093,617.517921146953,95.3620071684588,652.209677419355,430.594982078853,270.284946236559,1118.06810035842,1580.26344086022,1547.50716845878,124.206093189964,1064.00358422939,946.879928315412,534.804659498208,286.752688172043,1549.99641577061,1017.94086021505,217.145161290323,221.252688172043,1205.73655913978,631.030465949821,137.564516129032,125.218637992832,584.229390681004,565.283154121864,373.437275985663,200.543010752688,984.367383512545,130.139784946237,558,34.5214773790648,20.6447923534192,0.801475592377835,0.967071057192374,0.6975,-0.569486347282304,51178.8727598566,33911.9229390681,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_811209,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
811787,460.140096618358,981.75845410628,246.231884057971,606.990338164251,133.434782608696,467.985507246377,335.487922705314,261.884057971014,1109.19806763285,963.173913043478,626.256038647343,101.859903381643,1065.2270531401,911.913043478261,611.420289855072,333.632850241546,1548.84057971014,2315.93719806763,317.275362318841,237.690821256039,1004.0,1932.4154589372,238.294685990338,171.541062801932,625.444444444444,588.816425120773,374.038647342995,199.748792270531,980.478260869565,128.222222222222,207,18.6332805183989,14.1660963983624,0.649621516496911,0.945205479452055,0.716262975778547,-0.718014104860526,51590.1256038647,35186.7004830918,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_811787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
811963,978.298245614035,177.649122807018,127.289473684211,662.324561403509,4366.78070175439,1132.70175438596,607.350877192982,260.078947368421,1083.83333333333,1481.94736842105,688.666666666667,113.175438596491,1071.85964912281,1541.01754385965,703.043859649123,299.0,1847.19298245614,1715.22807017544,278.114035087719,228.473684210526,1067.18421052632,1310.21052631579,198.280701754386,171.912280701754,1977.92105263158,882.868421052632,464.482456140351,588.087719298246,1012.52631578947,129.070175438596,114,14.6607356314477,9.94378067497412,0.734822622170376,0.966101694915254,0.814285714285714,0.144909958440948,51890.8596491228,34909.4473684211,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_811963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
812775,1423.734375,199.5546875,77.1171875,643.875,2255.140625,1493.578125,1539.5,264.8359375,1113.9140625,3209.640625,591.5,115.1171875,1075.140625,4007.1484375,724.7734375,285.6953125,1666.0546875,2606.578125,305.40625,233.359375,992.6953125,1903.53125,224.65625,180.546875,592.046875,1723.296875,486.96875,710.03125,1073.421875,130.6171875,128,14.9678875414786,13.2718142498736,0.46237234363938,0.735632183908046,0.470588235294118,0.152754219637417,51583.125,35513.2734375,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_812775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
813335,2974.43820224719,1067.08988764045,123.438202247191,715.955056179775,4390.98876404494,4455.11235955056,1498.58426966292,279.337078651685,1268.75280898876,4745.19101123595,609.977528089888,118.584269662921,1080.56179775281,716.269662921348,635.191011235955,398.067415730337,1632.78651685393,975.741573033708,274.932584269663,228.404494382022,997.224719101124,906.056179775281,219.078651685393,184.730337078652,578.573033707865,1467.06741573034,567.887640449438,1207.7191011236,1333.68539325843,129.977528089888,89,11.4927178037512,10.6406690668548,0.377862168886507,0.881188118811881,0.674242424242424,1.34668485492878,51139.2696629214,35643.0112359551,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_813335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
813645,496.733333333333,834.050980392157,210.423529411765,625.094117647059,107.513725490196,589.176470588235,389.8,271.945098039216,1120.31764705882,1330.80784313725,642.992156862745,113.309803921569,1058.62352941176,929.56862745098,1125.93725490196,2457.23529411765,1638.07843137255,2927.35294117647,336.6,239.419607843137,1047.42352941176,3114.6862745098,285.301960784314,804.698039215686,799.227450980392,614.996078431373,379.313725490196,197.619607843137,991.627450980392,130.835294117647,255,21.7973119190809,15.0283123711718,0.724326480146329,0.944444444444444,0.75,1.06012998984371,50188.7215686275,34850.6901960784,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_813645,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
813865,381.895287958115,250.429319371728,83.4240837696335,609.120418848168,102.350785340314,594.973821989529,408.602094240838,272.073298429319,1113.81151832461,1272.73821989529,1481.59685863874,108.052356020942,1062.71204188482,815.047120418848,727.17277486911,310.973821989529,1804.08376963351,1192.02094240838,288.602094240838,229.638743455497,1086.18848167539,1075.12565445026,214.272251308901,149.376963350785,935.910994764398,567.680628272251,363.649214659686,195.178010471204,982.167539267016,131.801047120419,191,17.5152806142682,13.9558000231081,0.604271404429701,0.959798994974874,0.749019607843137,-0.635832636198123,50169.1832460733,34914.0837696335,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_813865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
814054,646.617283950617,232.037037037037,150.882716049383,661.203703703704,3356.03086419753,738.796296296296,303.117283950617,248.222222222222,1084.41975308642,1541.05555555556,517.493827160494,111.382716049383,1058.50617283951,637.493827160494,880.296296296296,319.333333333333,1448.1975308642,2085.94444444444,329.938271604938,239.833333333333,992.679012345679,1298.41358024691,229.981481481481,229.086419753086,649.314814814815,886.462962962963,483.623456790123,221.864197530864,1031.29012345679,130.425925925926,162,21.7299869154338,9.59981228895793,0.897124810349573,0.931034482758621,0.771428571428571,-0.0623023569901444,51654.5555555556,34101.6234567901,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_814054,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
814412,877.758928571429,462.026785714286,106.714285714286,633.696428571429,1032.8125,911.526785714286,1368.375,276.383928571429,1094.5,2042.61607142857,1382.61607142857,116.383928571429,1065.59821428571,662.785714285714,898.321428571429,683.794642857143,1770.83928571429,1064.44642857143,275.633928571429,228.9375,1008.80357142857,965.232142857143,210.758928571429,351.714285714286,868.883928571429,1143.65178571429,520.267857142857,259.776785714286,1046.39285714286,132.910714285714,112,14.5245588397677,9.92087043066095,0.73037995321036,0.982456140350877,0.8,0.0507269548723469,50340.1339285714,35113.6071428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_814412,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
815767,762.74025974026,319.519480519481,125.142857142857,646.012987012987,2924.25974025974,730.753246753247,461.0,264.493506493507,1088.66233766234,2072.28571428571,752.818181818182,116.194805194805,1063.02597402597,3028.32467532468,625.402597402597,313.701298701299,1814.72727272727,1380.98701298701,304.857142857143,235.558441558442,1013.64935064935,1225.19480519481,216.701298701299,301.116883116883,746.181818181818,1508.71428571429,588.12987012987,249.948051948052,1102.22077922078,131.376623376623,77,11.1113791783102,8.82128334788834,0.608053113685926,0.9625,0.777777777777778,1.35343632397184,52082.025974026,34640.8701298701,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_815767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
816612,1186.75903614458,184.265060240964,102.55421686747,637.66265060241,1848.38554216867,1111.5421686747,320.0,256.78313253012,1094.59036144578,2203.3734939759,632.602409638554,132.21686746988,1065.44578313253,2309.92771084337,703.710843373494,416.566265060241,1769.20481927711,4643.50602409639,426.542168674699,246.855421686747,1032.24096385542,4886.31325301205,274.698795180723,219.903614457831,615.192771084337,1116.01204819277,510.361445783133,242.626506024096,1022.39759036145,128.313253012048,83,15.6497660767648,6.81356285964012,0.900247772836081,0.932584269662921,0.691666666666667,0.320716182861423,52082.6385542169,35037.734939759,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_816612,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
819407,2743.37583892617,445.187919463087,1272.35570469799,631.523489932886,1434.78523489933,3775.42953020134,533.96644295302,279.020134228188,1114.28187919463,6054.28859060403,588.228187919463,116.362416107383,1083.10738255034,3288.6711409396,652.697986577181,344.812080536913,1863.41610738255,5677.89932885906,408.644295302013,246.167785234899,1036.90604026846,5340.67785234899,263.463087248322,237.691275167785,593.194630872483,1902.34228187919,482.704697986577,228.953020134228,1050.69127516779,131.288590604027,149,19.8404183230261,10.875328020477,0.836386560428345,0.796791443850267,0.591269841269841,0.298644771541411,50888.6979865772,35441.6912751678,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_819407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
820060,2817.81707317073,471.317073170732,212.19512195122,682.390243902439,2667.9756097561,3621.17073170732,361.085365853659,273.40243902439,1093.4512195122,4779.28048780488,603.30487804878,127.243902439024,1080.90243902439,788.182926829268,614.256097560976,282.426829268293,1438.09756097561,1179.98780487805,403.451219512195,252.451219512195,992.158536585366,1142.35365853659,266.121951219512,133.817073170732,586.158536585366,2023.15853658537,551.512195121951,229.439024390244,1053.64634146341,128.329268292683,82,15.4264717276384,7.02448736514593,0.890311075749255,0.854166666666667,0.532467532467532,1.06203554051973,50466.1829268293,33890.1829268293,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_820060,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
820250,1010.32575757576,366.909090909091,170.818181818182,648.416666666667,2691.45454545455,1212.90151515152,357.522727272727,265.545454545455,1089.27272727273,2783.0,611.348484848485,126.265151515152,1103.35606060606,845.212121212121,513.416666666667,280.530303030303,1351.53787878788,1246.43181818182,372.371212121212,247.204545454545,981.181818181818,1179.83333333333,248.977272727273,128.242424242424,574.583333333333,2029.14393939394,562.242424242424,227.886363636364,1061.40909090909,131.037878787879,132,17.151530283198,9.8384767209098,0.819120888967916,0.916666666666667,0.705882352941177,-1.49772758599959,50450.1439393939,34522.9242424242,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_820250,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
820316,1889.66153846154,349.946153846154,122.907692307692,648.523076923077,2084.36153846154,3176.33846153846,4532.41538461538,269.630769230769,1108.06923076923,3477.48461538462,1802.33076923077,122.830769230769,1075.15384615385,666.053846153846,589.784615384615,268.138461538462,1501.55384615385,1012.35384615385,285.576923076923,230.607692307692,980.715384615385,989.069230769231,218.115384615385,140.323076923077,580.423076923077,1433.48461538462,498.061538461538,333.584615384615,1053.71538461538,130.838461538462,130,18.0676889728975,9.5991265521011,0.847191964516255,0.855263157894737,0.580357142857143,-1.11965621337968,51847.4846153846,34261.7769230769,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_820316,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
820362,926.815384615385,178.046153846154,87.1846153846154,646.115384615385,2238.45384615385,1089.03076923077,355.4,251.915384615385,1094.21538461538,2510.68461538462,616.738461538462,113.630769230769,1065.96923076923,960.076923076923,445.769230769231,281.653846153846,1534.13076923077,1274.94615384615,336.784615384615,237.684615384615,998.8,1194.28461538462,233.323076923077,139.853846153846,597.892307692308,1606.77692307692,544.776923076923,227.038461538462,1045.33076923077,129.876923076923,130,14.7138416764563,11.2950279335461,0.640873598335817,0.942028985507246,0.773809523809524,0.983298237910563,51249.2307692308,34176.2230769231,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_820362,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
820656,1476.20192307692,461.423076923077,147.442307692308,632.153846153846,1470.76923076923,3064.76923076923,600.115384615385,275.903846153846,1096.09615384615,2165.63461538462,471.778846153846,109.259615384615,1074.39423076923,784.605769230769,461.125,278.067307692308,1518.56730769231,976.451923076923,223.788461538462,218.692307692308,1106.44230769231,869.557692307692,199.317307692308,209.115384615385,2367.95192307692,777.355769230769,426.105769230769,213.432692307692,1004.27884615385,126.394230769231,104,14.9212239711905,9.01243247447076,0.796983645805333,0.920353982300885,0.742857142857143,-0.221634406650607,51743.625,35555.2019230769,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_820656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
821703,2648.04093567251,728.502923976608,598.736842105263,671.210526315789,2833.18128654971,3724.09356725146,550.777777777778,277.590643274854,1163.73684210526,4809.29824561404,631.111111111111,120.53216374269,1076.53801169591,751.982456140351,488.923976608187,382.152046783626,1509.16374269006,1186.00584795322,333.280701754386,239.315789473684,999.994152046784,1121.9298245614,250.286549707602,162.058479532164,592.385964912281,1891.15204678363,520.818713450292,311.122807017544,1060.38011695906,129.771929824561,171,20.9701067045359,10.7648564374769,0.858183555940959,0.914438502673797,0.74025974025974,0.155407916420497,51271.8362573099,35501.081871345,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_821703,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
822288,598.845036319613,862.697336561743,223.769975786925,613.866828087167,106.81598062954,545.239709443099,363.135593220339,255.765133171913,1109.23486682809,1319.52542372881,1628.26150121065,113.164648910412,1068.16949152542,1475.96368038741,596.958837772397,421.966101694915,1779.15012106538,1761.12832929782,299.220338983051,707.387409200968,1095.50121065375,725.515738498789,154.583535108959,154.581113801453,596.27602905569,570.46004842615,374.992736077482,198.852300242131,987.910411622276,127.433414043584,413,26.7135092709715,19.8664470817644,0.668529738810886,0.945080091533181,0.722027972027972,-1.24255995262748,51128.2760290557,33861.8619854722,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_822288,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
822483,1314.77419354839,455.913978494624,228.935483870968,697.720430107527,5861.31182795699,1035.9247311828,340.397849462366,256.741935483871,1089.70967741935,2025.72043010753,737.903225806452,135.924731182796,1072.49462365591,1256.84946236559,623.225806451613,291.397849462366,1656.91397849462,905.698924731183,253.591397849462,223.591397849462,1019.55913978495,819.322580645161,180.89247311828,150.709677419355,582.440860215054,1146.69892473118,567.236559139785,234.118279569892,1076.01075268817,131.064516129032,93,13.2718565792582,8.94232176678494,0.738931303841532,0.93,0.715384615384615,-1.22581358794534,50812.8494623656,33820.7204301075,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_822483,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
822841,435.102244389027,543.346633416459,138.009975062344,607.498753117207,93.6084788029925,589.339152119701,422.977556109726,261.83042394015,1139.09725685786,1154.97755610973,1173.4114713217,120.56608478803,1056.7680798005,987.366583541147,596.775561097257,290.693266832918,1589.06234413965,903.825436408978,212.077306733167,224.231920199501,1084.06234413965,640.389027431421,143.962593516209,122.663341645885,588.284289276808,565.269326683292,375.099750623441,199.982543640898,986.618453865337,127.860349127182,401,25.7566162024563,19.9301985061695,0.63344285437244,0.95249406175772,0.729090909090909,-1.00772089139064,51172.6907730673,33766.3117206983,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_822841,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
822887,1100.80434782609,256.884057971014,59.8478260869565,595.644927536232,349.492753623188,1311.30434782609,290.485507246377,256.840579710145,1073.42753623188,2454.63043478261,429.217391304348,108.86231884058,1064.28260869565,1721.66666666667,569.36231884058,281.173913043478,1844.1884057971,1417.91304347826,298.391304347826,230.173913043478,1027.21739130435,1228.31884057971,221.782608695652,189.369565217391,636.18115942029,1689.34057971014,436.326086956522,228.108695652174,1006.27536231884,127.405797101449,138,14.9165651327338,12.4192570467999,0.553902471849062,0.896103896103896,0.758241758241758,-1.50314692990872,50779.2898550725,35783.9927536232,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_822887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
823411,837.730769230769,219.269230769231,136.346153846154,677.730769230769,3242.0,871.105769230769,340.586538461538,263.442307692308,1099.54807692308,1529.22115384615,596.701923076923,123.144230769231,1059.91346153846,566.701923076923,571.413461538462,445.326923076923,1461.42307692308,963.711538461538,245.615384615385,224.461538461538,1013.46153846154,868.240384615385,197.201923076923,135.576923076923,591.471153846154,892.673076923077,429.25,283.432692307692,1050.85576923077,129.461538461538,104,16.551675613578,8.16140934093027,0.869980236300809,0.920353982300885,0.722222222222222,-0.103062480239292,50089.4134615385,34922.2307692308,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_823411,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
823458,501.047244094488,792.929133858268,212.858267716535,620.732283464567,118.370078740157,669.535433070866,431.88188976378,286.448818897638,1128.88188976378,1461.55118110236,785.291338582677,120.062992125984,1070.22047244094,625.464566929134,404.944881889764,277.708661417323,1458.85826771654,1030.7874015748,306.433070866142,237.409448818898,988.188976377953,983.007874015748,227.590551181102,149.732283464567,585.472440944882,570.952755905512,363.724409448819,201.220472440945,988.763779527559,128.818897637795,127,13.9613290854496,11.6182379891318,0.554516428969498,0.940740740740741,0.751479289940828,0.758953527876614,51550.1338582677,35207.968503937,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_823458,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
824522,989.467391304348,241.054347826087,260.152173913043,749.913043478261,6219.21739130435,868.695652173913,308.326086956522,258.20652173913,1090.14130434783,1953.08695652174,524.619565217391,150.989130434783,1060.44565217391,843.402173913043,460.880434782609,281.75,1422.19565217391,1016.76086956522,218.695652173913,219.684782608696,1382.54347826087,683.771739130435,158.423913043478,129.804347826087,578.054347826087,1058.09782608696,474.0,221.032608695652,1057.67391304348,131.217391304348,92,13.0926074874484,9.28438938587013,0.705075556833883,0.893203883495146,0.707692307692308,-1.51848209646313,50192.4130434783,35021.9891304348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824522,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
824575,646.128014842301,595.838589981447,149.894248608534,620.612244897959,89.7328385899814,528.936920222635,402.419294990724,258.092764378479,1119.36363636364,1306.67903525046,2073.47309833024,122.549165120594,1066.1280148423,909.794063079777,510.959183673469,286.055658627087,1556.22820037106,961.441558441558,215.406307977737,230.274582560297,1162.65306122449,629.638218923933,136.480519480519,123.842300556586,582.65120593692,568.486085343228,373.74025974026,199.627087198516,984.354359925788,130.166975881262,539,29.0342429392086,24.1402228665112,0.555614964998529,0.967684021543986,0.740384615384615,-1.02081019933565,51163.8033395176,33893.6846011132,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
824856,355.218181818182,479.105454545455,132.614545454545,624.614545454545,112.370909090909,415.614545454546,296.767272727273,242.309090909091,1092.28363636364,906.92,551.941818181818,106.363636363636,1056.90545454545,887.501818181818,516.472727272727,443.149090909091,1622.57454545455,1108.95272727273,252.96,771.0,1124.20363636364,831.058181818182,159.68,184.887272727273,634.192727272727,568.076363636364,377.410909090909,201.92,987.512727272727,130.978181818182,275,20.8389584788172,16.852731821539,0.5882037544155,0.961538461538462,0.763888888888889,-0.372290362620368,51300.7527272727,33873.3236363636,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
824984,359.127118644068,690.466101694915,164.177966101695,594.39406779661,109.902542372881,319.262711864407,252.974576271186,232.419491525424,1094.12711864407,760.453389830509,387.046610169492,98.1949152542373,1065.11016949153,1079.69491525424,529.699152542373,367.241525423729,1667.83474576271,1510.37711864407,268.182203389831,330.830508474576,1302.24576271186,981.944915254237,179.991525423729,175.716101694915,614.381355932203,571.860169491525,376.419491525424,199.631355932203,984.779661016949,131.563559322034,236,19.9320931697149,15.1137627502472,0.651949139366117,0.951612903225806,0.776315789473684,-1.22992831951757,51318.1991525424,33925.2288135593,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
826090,1474.70769230769,174.107692307692,59.5846153846154,609.738461538462,516.430769230769,2269.07692307692,454.076923076923,254.030769230769,1090.52307692308,2909.96923076923,746.169230769231,114.969230769231,1064.15384615385,1178.49230769231,800.169230769231,294.661538461538,1814.69230769231,1616.81538461538,359.015384615385,250.723076923077,1214.78461538462,5067.78461538462,377.753846153846,1212.01538461538,2589.06153846154,1216.89230769231,541.261538461538,229.707692307692,1039.24615384615,131.692307692308,65,11.3039901143649,8.10301553427968,0.697250139360346,0.844155844155844,0.601851851851852,0.0918351375757631,50947.3538461538,33677.2153846154,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_826090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
826189,472.357142857143,660.109523809524,170.347619047619,605.647619047619,111.447619047619,642.185714285714,408.87619047619,264.247619047619,1104.44761904762,1366.13333333333,578.109523809524,113.738095238095,1064.72380952381,975.133333333333,542.242857142857,287.233333333333,1528.45714285714,942.938095238095,219.295238095238,219.880952380952,1144.19523809524,627.890476190476,136.57619047619,121.919047619048,582.266666666667,569.085714285714,374.561904761905,202.271428571429,974.295238095238,134.385714285714,210,18.997771061559,14.2293387916549,0.662569504407924,0.933333333333333,0.686274509803922,-0.771794582818666,51199.4142857143,33939.7285714286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_826189,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
826927,510.03125,1052.475,264.65,617.6875,546.35625,524.10625,679.2,260.98125,1115.03125,886.8,443.18125,117.725,1059.8875,1924.5125,560.26875,281.50625,2003.9625,1723.15625,347.925,244.70625,1022.54375,1477.125,247.0625,189.48125,596.4875,778.6875,386.275,231.6,1004.38125,128.1375,160,15.8220498343806,12.9277410647946,0.576536792152214,0.935672514619883,0.761904761904762,-1.31645260808561,50746.95625,35851.48125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_826927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
828083,706.157894736842,299.342105263158,156.043859649123,618.377192982456,483.008771929825,824.947368421053,688.19298245614,260.921052631579,1096.94736842105,1424.14912280702,862.456140350877,111.149122807018,1068.09649122807,685.09649122807,488.122807017544,278.236842105263,1449.85087719298,1204.71929824561,373.026315789474,246.070175438596,984.412280701754,1088.4649122807,268.30701754386,134.263157894737,588.140350877193,896.605263157895,496.254385964912,280.991228070175,1019.09649122807,129.736842105263,114,13.0792658849742,11.1256109131799,0.525765401029097,0.926829268292683,0.730769230769231,0.524857942645845,50747.6315789474,35156.3596491228,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828083,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
828120,1092.64948453608,66.4432989690722,53.7319587628866,611.072164948454,647.525773195876,1249.79381443299,681.226804123711,244.989690721649,1077.47422680412,3156.63917525773,1198.14432989691,103.556701030928,1075.83505154639,955.072164948454,490.762886597938,271.041237113402,1884.44329896907,1441.26804123711,317.39175257732,246.0,1052.42268041237,1212.03092783505,227.639175257732,150.257731958763,694.639175257732,1375.96907216495,452.041237113402,520.670103092784,1021.74226804124,127.422680412371,97,12.4184966580298,9.9351113541423,0.599966282391598,0.950980392156863,0.808333333333333,-1.27332864045551,51335.4536082474,35300.5979381443,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
828473,883.078947368421,123.868421052632,90.7017543859649,638.789473684211,2109.49122807018,787.543859649123,317.956140350877,253.605263157895,1085.14035087719,2101.30701754386,645.517543859649,112.149122807018,1067.18421052632,1324.70175438596,494.087719298246,282.324561403509,1523.98245614035,1088.93859649123,283.868421052632,233.921052631579,997.236842105263,1054.34210526316,228.578947368421,175.342105263158,602.614035087719,1064.54385964912,422.271929824561,325.938596491228,1055.34210526316,128.859649122807,114,18.45070768544,7.96173197210914,0.902106413559479,0.897637795275591,0.703703703703704,-1.52401334510994,51782.6052631579,35523.0175438596,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_828473,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
828761,1141.70621468927,389.203389830508,104.966101694915,628.101694915254,1416.66666666667,1452.66666666667,1993.46892655367,261.265536723164,1086.70621468927,2645.24293785311,1892.50847457627,105.581920903955,1086.42372881356,715.502824858757,508.090395480226,271.186440677966,1590.19209039548,2079.95480225989,304.932203389831,236.129943502825,1023.8813559322,2266.85310734463,218.632768361582,572.909604519774,590.672316384181,1412.94915254237,480.0,381.819209039548,1035.16384180791,130.971751412429,177,22.1226403960623,11.4736456689915,0.854993831268314,0.815668202764977,0.561904761904762,0.285832817277219,50802.2259887006,35189.8587570621,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828761,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
829465,1025.96078431373,174.56862745098,56.2843137254902,595.382352941176,360.009803921569,958.980392156863,339.460784313725,252.117647058824,1083.35294117647,2405.46078431373,440.980392156863,101.745098039216,1073.96078431373,938.235294117647,487.735294117647,287.450980392157,1628.00980392157,927.676470588235,213.803921568627,216.862745098039,1192.25490196078,667.735294117647,159.43137254902,143.313725490196,587.872549019608,1904.21568627451,590.235294117647,267.205882352941,1034.86274509804,128.803921568627,102,13.592363227648,9.6663120598735,0.703032648414015,0.980769230769231,0.772727272727273,0.990403747932566,51837.0490196078,34848.4117647059,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_829465,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
829577,1721.22727272727,386.897727272727,64.5340909090909,632.602272727273,1286.10227272727,1813.45454545455,3320.63636363636,254.977272727273,1099.39772727273,3670.39772727273,1496.93181818182,108.829545454545,1066.54545454545,712.704545454545,543.102272727273,277.488636363636,1634.43181818182,1055.56818181818,308.147727272727,239.522727272727,991.556818181818,998.636363636364,224.284090909091,138.568181818182,589.25,1660.82954545455,532.454545454545,451.931818181818,1072.0,133.409090909091,88,14.4642611940189,7.7909159443351,0.842541048827575,0.916666666666667,0.698412698412698,-0.289575648343151,51865.0795454545,34690.6477272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_829577,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
829616,1281.58467741935,256.532258064516,112.012096774194,631.850806451613,2086.07661290323,1972.13709677419,1659.24596774194,259.604838709677,1085.24193548387,2335.12096774194,3320.25,134.137096774194,1065.82258064516,617.266129032258,414.25,270.576612903226,1407.73387096774,1038.10483870968,306.153225806452,234.649193548387,986.927419354839,990.604838709677,215.225806451613,124.721774193548,578.338709677419,1100.79435483871,484.213709677419,284.850806451613,1041.37096774194,130.616935483871,248,31.3084752703237,10.5205181110805,0.941852067295577,0.908424908424908,0.666666666666667,-0.185800731589274,50822.4556451613,34527.185483871,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_829616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
830625,1059.20202020202,123.272727272727,93.6666666666667,635.878787878788,1297.9696969697,1279.41414141414,287.646464646465,254.79797979798,1089.0202020202,2326.77777777778,489.888888888889,111.585858585859,1073.59595959596,942.363636363636,539.737373737374,286.242424242424,1539.38383838384,1065.81818181818,250.727272727273,228.393939393939,1127.73737373737,892.282828282828,180.818181818182,252.727272727273,1517.9696969697,1201.32323232323,500.969696969697,222.838383838384,1025.71717171717,131.383838383838,99,18.6800050911598,7.02738295179989,0.926539242703065,0.916666666666667,0.831932773109244,1.5259291806491,50550.9191919192,34414.1313131313,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_830625,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
831376,1102.52631578947,296.759398496241,119.233082706767,619.616541353383,1113.08270676692,1873.61654135338,1642.57142857143,270.112781954887,1097.31578947368,2356.31578947368,525.052631578947,105.496240601504,1067.33834586466,1165.84210526316,596.285714285714,427.218045112782,1579.18045112782,1806.40601503759,308.18045112782,232.383458646617,1001.3007518797,2090.06015037594,234.518796992481,199.0,1677.48872180451,1425.29323308271,448.729323308271,265.165413533835,1040.15789473684,129.902255639098,133,16.3060516025058,10.8849310537293,0.744574522120801,0.910958904109589,0.682051282051282,-0.28961377738526,51144.037593985,35483.2706766917,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_831376,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
831682,588.264367816092,361.241379310345,258.954022988506,600.770114942529,250.229885057471,621.724137931035,277.586206896552,242.655172413793,1088.67816091954,1699.89655172414,447.64367816092,101.16091954023,1072.72413793103,708.333333333333,445.563218390805,275.367816091954,1451.64367816092,1048.40229885057,306.35632183908,235.540229885057,979.931034482759,992.367816091954,216.563218390805,135.0,592.183908045977,1319.20689655172,507.609195402299,229.0,1003.36781609195,130.586206896552,87,10.8644430684599,10.1751122051976,0.350529578864513,0.945652173913044,0.790909090909091,-1.47221288485104,51267.1494252874,34559.5172413793,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_831682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
831916,683.793427230047,168.103286384977,61.8028169014084,612.488262910798,652.81220657277,744.699530516432,1134.18779342723,255.427230046948,1098.56338028169,1228.21126760563,1342.779342723,106.901408450704,1062.86854460094,5597.99061032864,1135.92957746479,1418.05164319249,3588.67605633803,6969.99530516432,495.469483568075,273.12676056338,1038.47887323944,10344.3661971831,430.211267605634,2322.52112676056,920.920187793427,1880.31924882629,701.605633802817,517.511737089202,1078.62910798122,131.267605633803,213,17.5145094012905,15.5269441586226,0.462692321364464,0.963800904977376,0.835294117647059,0.380307499209078,51722.9812206573,34854.8356807512,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_831916,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
832080,494.927807486631,814.029411764706,202.697860962567,611.695187165775,95.3048128342246,573.858288770053,404.647058823529,258.633689839572,1140.97860962567,1348.54278074866,1276.85294117647,127.465240641711,1066.73529411765,1059.39839572193,606.441176470588,293.286096256685,1598.56417112299,1000.91978609626,217.216577540107,220.92513368984,1162.05614973262,633.414438502674,142.887700534759,127.735294117647,588.208556149733,557.697860962567,372.596256684492,200.524064171123,988.572192513369,130.275401069519,374,22.1839698524629,21.5278402636781,0.241409824728602,0.956521739130435,0.772727272727273,-0.786865861748816,51140.5240641711,33773.1336898396,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_832080,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
833500,1127.89743589744,177.096153846154,180.0,725.185897435897,7158.53846153846,1313.66025641026,313.019230769231,264.647435897436,1094.45512820513,2733.16025641026,502.346153846154,115.980769230769,1060.57692307692,895.647435897436,679.576923076923,371.532051282051,1702.28205128205,1247.64743589744,260.371794871795,222.589743589744,1012.76923076923,1589.67948717949,190.282051282051,164.929487179487,603.705128205128,1565.17948717949,515.730769230769,253.429487179487,1059.26282051282,130.942307692308,156,16.8076522203968,11.847369224502,0.709327084654451,0.934131736526946,0.705882352941177,1.33204245737112,51249.9679487179,35153.2884615385,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_833500,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
835074,586.55,178.59,120.47,641.63,1940.76,674.01,743.92,243.31,1091.26,1714.51,2531.76,99.58,1063.11,6427.9,888.25,1914.56,1606.78,3726.22,350.62,238.68,998.03,2087.9,226.8,218.42,650.47,1244.47,473.04,532.69,1060.28,131.13,100,12.7472677338704,10.0094338162069,0.619214473754376,0.952380952380952,0.757575757575758,0.902331614407363,51249.2,34711.68,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,12,FAAGSCC_12_835074,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
835303,774.59375,369.572916666667,111.833333333333,617.239583333333,553.739583333333,767.0,388.03125,255.75,1127.89583333333,1898.64583333333,450.895833333333,103.15625,1060.0625,6547.08333333333,1131.66666666667,612.697916666667,3684.76041666667,5399.625,427.25,251.6875,1021.04166666667,4633.76041666667,274.322916666667,366.9375,605.229166666667,1243.15625,440.3125,293.052083333333,1044.3125,128.822916666667,96,13.612348105093,9.08146883978546,0.744924008977499,0.941176470588235,0.738461538461539,1.06437208646735,51181.6875,35513.8229166667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_835303,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
835370,488.981981981982,698.114114114114,172.78978978979,606.672672672673,88.1921921921922,627.234234234234,456.198198198198,267.525525525526,1127.3993993994,1147.65765765766,1592.84684684685,121.363363363363,1065.04804804805,948.216216216216,536.723723723724,281.987987987988,1635.11711711712,929.768768768769,218.324324324324,222.891891891892,1034.67567567568,768.804804804805,153.423423423423,125.774774774775,587.261261261261,566.843843843844,372.12012012012,199.333333333333,974.399399399399,128.306306306306,333,22.4069634545248,20.3191218130578,0.421514310128126,0.862694300518135,0.69375,1.30890303787015,51192.5315315315,33767.4954954955,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_835370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
835815,509.76,703.671111111111,176.333333333333,613.424444444444,106.64,415.306666666667,303.346666666667,244.068888888889,1105.60222222222,900.373333333333,683.206666666667,104.335555555556,1062.48888888889,1127.10222222222,482.88,275.52,1590.30444444444,1662.40888888889,322.426666666667,236.733333333333,1008.07333333333,1407.08666666667,223.113333333333,173.562222222222,820.811111111111,574.546666666667,381.94,198.393333333333,980.851111111111,129.531111111111,450,31.168017388406,18.5916403815268,0.802615031195898,0.957446808510638,0.764006791171477,1.56486454424148,51464.6266666667,34032.1333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_835815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
836662,2449.84057971014,223.231884057971,81.3478260869565,600.057971014493,269.492753623188,2301.47826086957,867.0,261.188405797101,1081.0,5907.27536231884,714.68115942029,117.028985507246,1077.40579710145,756.434782608696,495.304347826087,263.855072463768,1438.68115942029,1072.33333333333,292.246376811594,232.63768115942,1010.82608695652,1056.72463768116,212.898550724638,141.159420289855,644.405797101449,2640.3768115942,567.304347826087,281.797101449275,1034.8115942029,132.217391304348,69,9.73811151082778,9.01069967718005,0.379229667600713,0.932432432432432,0.766666666666667,0.654541412196846,50516.9710144928,34472.2028985507,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_836662,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
836774,751.102803738318,53.2616822429907,40.2897196261682,597.476635514019,269.084112149533,747.364485981308,233.579439252336,227.130841121495,1080.14953271028,1667.47663551402,391.485981308411,99.9719626168224,1063.66355140187,709.635514018692,774.92523364486,438.11214953271,1690.16822429907,996.242990654206,280.07476635514,231.364485981308,1011.71028037383,885.728971962617,193.616822429907,144.158878504673,594.523364485981,705.457943925234,402.420560747664,206.616822429907,997.018691588785,128.03738317757,107,11.8883825805242,11.4699330152742,0.262978079087717,0.946902654867257,0.743055555555556,0.912881086730339,51415.4859813084,33869.0841121495,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_836774,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
836834,1791.94594594595,236.554054054054,122.067567567568,639.810810810811,1741.62162162162,2176.18918918919,378.567567567568,279.324324324324,1118.14864864865,3998.37837837838,681.702702702703,113.351351351351,1064.08108108108,2133.22972972973,650.162162162162,296.540540540541,1716.39189189189,2535.16216216216,340.824324324324,236.689189189189,1016.87837837838,1648.31081081081,243.662162162162,323.297297297297,1515.87837837838,1533.90540540541,523.702702702703,227.472972972973,1021.56756756757,129.972972972973,74,10.3469432431068,9.42154207539006,0.413370663570014,0.870588235294118,0.672727272727273,-0.0019166173494951,51027.7837837838,35242.3648648649,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_836834,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
837955,1720.73469387755,222.795918367347,40.4183673469388,600.040816326531,433.602040816327,1122.78571428571,530.744897959184,253.489795918367,1077.47959183673,3307.5306122449,495.938775510204,107.377551020408,1064.14285714286,893.867346938776,564.479591836735,288.714285714286,1545.35714285714,1303.62244897959,319.897959183673,235.408163265306,983.030612244898,1280.32653061224,239.438775510204,223.897959183673,772.183673469388,1882.16326530612,491.734693877551,249.551020408163,1006.75510204082,130.510204081633,98,16.5186507223945,7.94119269968584,0.876862639763315,0.890909090909091,0.583333333333333,0.869621267382874,52010.0714285714,35208.2244897959,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_837955,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
838505,3133.76470588235,271.529411764706,97.5735294117647,619.632352941176,377.382352941176,1722.52941176471,722.132352941176,258.514705882353,1089.92647058824,2634.48529411765,1658.16176470588,116.132352941176,1063.60294117647,755.882352941176,489.044117647059,269.941176470588,1617.80882352941,1140.80882352941,289.544117647059,234.588235294118,1075.70588235294,1049.42647058824,197.147058823529,169.823529411765,778.911764705882,804.455882352941,421.514705882353,213.514705882353,1035.92647058824,133.044117647059,68,10.5230659870751,9.25860840712621,0.475271051998654,0.839506172839506,0.515151515151515,-0.188711886409889,51334.3823529412,33807.6764705882,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_838505,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
839448,1288.96739130435,339.891304347826,198.195652173913,652.380434782609,3159.30434782609,1617.75,380.880434782609,273.152173913043,1082.83695652174,2248.83695652174,589.673913043478,126.304347826087,1080.04347826087,653.336956521739,651.684782608696,292.108695652174,1427.59782608696,1141.83695652174,315.597826086957,228.913043478261,984.108695652174,1021.69565217391,216.630434782609,132.760869565217,577.782608695652,979.913043478261,502.29347826087,220.25,1024.90217391304,128.728260869565,92,15.5043377851254,7.59098618635324,0.871944894239511,0.929292929292929,0.657142857142857,0.495097543951375,50629.8369565217,35029.4891304348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839448,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
840830,842.933333333333,381.053333333333,46.4266666666667,630.893333333333,1165.54666666667,782.546666666667,2077.21333333333,259.053333333333,1219.36,1392.42666666667,881.173333333333,95.16,1098.34666666667,3269.26666666667,1480.18666666667,1043.46666666667,5788.6,1766.53333333333,311.866666666667,236.573333333333,1062.37333333333,1406.52,214.533333333333,448.28,689.16,901.8,439.786666666667,1133.05333333333,1019.84,133.2,75,11.5681359028612,8.24845901834866,0.701130792550066,0.974025974025974,0.757575757575758,-0.562643878127716,50941.0666666667,35401.6266666667,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_840830,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
841129,486.013698630137,638.205479452055,166.037671232877,599.270547945206,118.482876712329,795.616438356164,441.465753424658,270.866438356164,1116.89383561644,1622.56849315068,630.883561643836,117.010273972603,1062.6301369863,933.537671232877,526.777397260274,284.599315068493,1550.36301369863,1017.80136986301,226.174657534247,222.058219178082,1156.08904109589,632.729452054794,136.212328767123,120.907534246575,582.441780821918,571.318493150685,375.178082191781,201.47602739726,983.801369863014,129.047945205479,292,20.3503415398187,18.3252301202816,0.434881697012035,0.954248366013072,0.768421052631579,-0.608558761893953,51213.5650684932,33951.5239726027,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_841129,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
841971,967.311377245509,88.6706586826347,76.0898203592814,645.119760479042,2175.44311377246,1243.17964071856,263.796407185629,237.473053892216,1086.71856287425,1989.74251497006,534.065868263473,116.808383233533,1059.88622754491,697.712574850299,464.221556886228,277.730538922156,1481.74850299401,1021.68263473054,269.994011976048,229.85628742515,1014.10778443114,938.958083832335,192.892215568862,165.922155688623,609.14371257485,816.437125748503,431.664670658683,211.131736526946,1015.90419161677,130.443113772455,167,19.7418458845745,11.3722771741116,0.817414928158556,0.888297872340426,0.676113360323887,0.13204089360157,51402.628742515,33893.2215568862,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_841971,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
844135,434.995305164319,803.441314553991,180.201877934272,612.333333333333,559.183098591549,452.718309859155,309.197183098592,259.511737089202,1091.8544600939,1048.19718309859,601.31455399061,107.586854460094,1061.6338028169,1090.28638497653,597.178403755869,293.69014084507,1563.21126760563,1287.68075117371,242.389671361502,222.464788732394,1555.19248826291,769.262910798122,159.286384976526,127.56338028169,583.948356807512,712.408450704225,400.422535211268,204.173708920188,1023.15023474178,129.87323943662,213,23.2161301611826,11.7952789329714,0.861319346469015,0.955156950672646,0.691558441558442,-1.17577166306675,50247.985915493,34983.0845070423,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_844135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_9,
